Citrus Sinensis ID: 022482
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.986 | 0.640 | 0.721 | 1e-124 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.986 | 0.690 | 0.628 | 1e-112 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.898 | 0.642 | 0.710 | 1e-109 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.922 | 0.553 | 0.542 | 2e-80 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.922 | 0.557 | 0.525 | 7e-77 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.770 | 0.556 | 0.620 | 2e-75 | |
| P46573 | 412 | Protein kinase APK1B, chl | no | no | 0.793 | 0.570 | 0.571 | 5e-75 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.777 | 0.539 | 0.586 | 2e-74 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.777 | 0.539 | 0.578 | 4e-74 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.783 | 0.596 | 0.561 | 1e-73 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 444 bits (1142), Expect = e-124, Method: Compositional matrix adjust.
Identities = 223/309 (72%), Positives = 241/309 (77%), Gaps = 17/309 (5%)
Query: 1 MGWFPCAGKS---------SKNAKKKHHNKP-----IDQIPSTSEKLKVNSTVDVKKEA- 45
MG F C S N +K ++P I +PS EKL + K+E
Sbjct: 1 MGCFSCFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKRELL 60
Query: 46 -SKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
+DG IAAHTF FRELAA T NF D LGEGGFGRVYKGRL+ST QVVA+KQLDR
Sbjct: 61 LPRDGLG-QIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 105 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK 164
NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDK
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ LDW RM+IAAGAAKGLE+LHDKANPPVIYRD K SNILL EG+HPKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284
GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYSFGVV LE+ITGRKAID+ GE
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 285 NLVAWVTVL 293
NLVAW L
Sbjct: 300 NLVAWARPL 308
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 205/326 (62%), Positives = 233/326 (71%), Gaps = 34/326 (10%)
Query: 1 MGWFPCAGKSSKNAKKKH-----------------HNKPIDQIPSTSEKLKVNSTVDVKK 43
MG F C+ KSSK ++ +K DQ +S+ KV+ DV
Sbjct: 1 MGCFGCSKKSSKRSETNKDTVINRKIVGGTTSVAKSDKRDDQTQPSSDSTKVSPYRDVNN 60
Query: 44 EASKDGGSDHIA----------------AHTFTFRELAAVTKNFRADCLLGEGGFGRVYK 87
E G D ++ A TFTF+ELA T NFR+DC LGEGGFG+V+K
Sbjct: 61 EGGV-GKEDQLSLDVKGLNLNDQVTGKKAQTFTFQELAEATGNFRSDCFLGEGGFGKVFK 119
Query: 88 GRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147
G +E +QVVAIKQLDRNG+QG REF+VEVL LSL HPNLV LIG+CA+GDQRLLVYEY
Sbjct: 120 GTIEKLDQVVAIKQLDRNGVQGIREFVVEVLTLSLADHPNLVKLIGFCAEGDQRLLVYEY 179
Query: 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207
MP GSLEDHLH LP KK LDW TRM+IAAGAA+GLEYLHD+ PPVIYRDLKCSNILLG
Sbjct: 180 MPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGAARGLEYLHDRMTPPVIYRDLKCSNILLG 239
Query: 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLE 267
E Y PKLSDFGLAK+GP GDKTHVSTRVMGTYGYCAP+YAMTGQLT KSD+YSFGVVLLE
Sbjct: 240 EDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLE 299
Query: 268 IITGRKAIDNTRAAGEHNLVAWVTVL 293
+ITGRKAIDNT+ + NLV W L
Sbjct: 300 LITGRKAIDNTKTRKDQNLVGWARPL 325
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 393 bits (1010), Expect = e-109, Method: Compositional matrix adjust.
Identities = 194/273 (71%), Positives = 219/273 (80%), Gaps = 7/273 (2%)
Query: 17 KHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCL 76
+ +NK + P T + N+ D KE + ++IAA TF+FRELA TKNFR +CL
Sbjct: 32 RDNNKTHPENPKTVNEQNKNN--DEDKEVT-----NNIAAQTFSFRELATATKNFRQECL 84
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEGGFGRVYKG+LE T +VA+KQLDRNGLQGN+EF+VEVLMLSLLHH +LVNLIGYCA
Sbjct: 85 IGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVLMLSLLHHKHLVNLIGYCA 144
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
DGDQRLLVYEYM GSLEDHL DL PD+ LDW TR+RIA GAA GLEYLHDKANPPVIY
Sbjct: 145 DGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKANPPVIY 204
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDLK +NILL ++ KLSDFGLAKLGPVGDK HVS+RVMGTYGYCAPEY TGQLT KS
Sbjct: 205 RDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQLTTKS 264
Query: 257 DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
DVYSFGVVLLE+ITGR+ ID TR E NLV W
Sbjct: 265 DVYSFGVVLLELITGRRVIDTTRPKDEQNLVTW 297
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (765), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 158/291 (54%), Positives = 197/291 (67%), Gaps = 18/291 (6%)
Query: 11 SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKN 70
SK+A +K +++P+ Q+ ST+ S+ + + S H+ FTF +L T+N
Sbjct: 84 SKSANEKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHL--RKFTFNDLKLSTRN 141
Query: 71 FRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
FR + LLGEGGFG V+KG +E T VA+K L+ +GLQG++E+L E+ L
Sbjct: 142 FRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLG 201
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGA 179
L HPNLV L+GYC + DQRLLVYE+MP GSLE+HL LP L W+ RM+IA GA
Sbjct: 202 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGA 256
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKGL +LH++A PVIYRD K SNILL Y+ KLSDFGLAK P KTHVSTRVMGTY
Sbjct: 257 AKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 316
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWV 290
GY APEY MTG LT KSDVYSFGVVLLE++TGR+++D R GEHNLV W
Sbjct: 317 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 367
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 7e-77, Method: Compositional matrix adjust.
Identities = 153/291 (52%), Positives = 195/291 (67%), Gaps = 18/291 (6%)
Query: 11 SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKN 70
S++A + +++P+ + ST+ S++ + + H+ F+F +L T+N
Sbjct: 78 SQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELNIYSHLKK--FSFIDLKLATRN 135
Query: 71 FRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
FR + LLGEGGFG V+KG +E T VA+K L+ +GLQG++E+L E+ L
Sbjct: 136 FRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINYLG 195
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGA 179
L HPNLV L+GYC + DQRLLVYE+MP GSLE+HL LP L W+ RM+IA GA
Sbjct: 196 NLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGA 250
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKGL +LH++A PVIYRD K SNILL Y+ KLSDFGLAK P KTHVSTRVMGTY
Sbjct: 251 AKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTY 310
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWV 290
GY APEY MTG LT KSDVYSFGVVLLE++TGR+++D R GEHNLV W
Sbjct: 311 GYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWA 361
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 147/237 (62%), Positives = 171/237 (72%), Gaps = 9/237 (3%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQV------VAIKQLDRNGLQGNRE 112
FT EL +TK+FR D +LGEGGFG VYKG ++ +V VA+K L++ GLQG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 113 FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
+L EV L L HPNLV LIGYC + D RLLVYE+M GSLE+HL L W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHL--FRKTTAPLSWSRR 174
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
M IA GAAKGL +LH+ A PVIYRD K SNILL Y KLSDFGLAK GP GD+THVS
Sbjct: 175 MMIALGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
TRVMGTYGY APEY MTG LT +SDVYSFGVVLLE++TGRK++D TR + E NLV W
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDW 290
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 5e-75, Method: Compositional matrix adjust.
Identities = 140/245 (57%), Positives = 174/245 (71%), Gaps = 10/245 (4%)
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQ 108
+FTF EL A T+NFR D +LGEGGFG V+KG ++ T V+A+K+L+++G Q
Sbjct: 56 SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115
Query: 109 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD 168
G++E+L EV L HPNLV LIGYC + + RLLVYE+MP GSLE+HL + L
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
WT R+++A GAAKGL +LH+ A VIYRD K SNILL Y+ KLSDFGLAK GP GDK
Sbjct: 176 WTLRLKVALGAAKGLAFLHN-AETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDK 234
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288
+HVSTR+MGTYGY APEY TG LT KSDVYS+GVVLLE+++GR+A+D R GE LV
Sbjct: 235 SHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVE 294
Query: 289 WVTVL 293
W L
Sbjct: 295 WARPL 299
|
Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (712), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 142/242 (58%), Positives = 174/242 (71%), Gaps = 12/242 (4%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ---------VVAIKQLDRNGLQG 109
FTF EL TKNFR D LLGEGGFG V+KG ++ T+ VVA+KQL G QG
Sbjct: 74 FTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSGIVVAVKQLKPEGFQG 133
Query: 110 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
++E+L EV L L HPNLV L+GYCA+G+ RLLVYE+MP GSLE+HL + L W
Sbjct: 134 HKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRR--GAQPLTW 191
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
RM++A GAAKGL +LH+ A VIYRD K +NILL ++ KLSDFGLAK GP GD T
Sbjct: 192 AIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNT 250
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
HVST+V+GT+GY APEY TG+LT KSDVYSFGVVLLE+I+GR+A+DN+ E++LV W
Sbjct: 251 HVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGGNEYSLVDW 310
Query: 290 VT 291
T
Sbjct: 311 AT 312
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 278 bits (711), Expect = 4e-74, Method: Compositional matrix adjust.
Identities = 140/242 (57%), Positives = 172/242 (71%), Gaps = 12/242 (4%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ---------VVAIKQLDRNGLQG 109
FTF EL T+NFR D LLGEGGFG V+KG ++ T VVA+K+L G QG
Sbjct: 71 FTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQG 130
Query: 110 NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
++E+L EV L L HPNLV L+GYC +G+ RLLVYE+MP GSLE+HL + L W
Sbjct: 131 HKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR--GAQPLTW 188
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
RM++A GAAKGL +LHD A VIYRD K +NILL ++ KLSDFGLAK GP GDKT
Sbjct: 189 AIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKT 247
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
HVST+VMGT+GY APEY TG+LT KSDVYSFGVVLLE+++GR+A+D ++ E +LV W
Sbjct: 248 HVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDW 307
Query: 290 VT 291
T
Sbjct: 308 AT 309
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 276 bits (706), Expect = 1e-73, Method: Compositional matrix adjust.
Identities = 136/242 (56%), Positives = 173/242 (71%), Gaps = 10/242 (4%)
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLES---------TNQVVAIKQLDRNGLQ 108
F+ EL + T+NFR D ++GEGGFG V+KG ++ T V+A+K+L++ G Q
Sbjct: 55 NFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQ 114
Query: 109 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD 168
G+RE+L E+ L L HPNLV LIGYC + + RLLVYE+M GSLE+HL + L
Sbjct: 115 GHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLS 174
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
W TR+R+A GAA+GL +LH+ A P VIYRD K SNILL Y+ KLSDFGLA+ GP+GD
Sbjct: 175 WNTRVRMALGAARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDN 233
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288
+HVSTRVMGT GY APEY TG L++KSDVYSFGVVLLE+++GR+AID + GEHNLV
Sbjct: 234 SHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVD 293
Query: 289 WV 290
W
Sbjct: 294 WA 295
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| 255568155 | 375 | receptor serine-threonine protein kinase | 0.986 | 0.778 | 0.914 | 1e-156 | |
| 37625033 | 376 | protein kinase-like protein [Vitis aesti | 0.989 | 0.779 | 0.901 | 1e-151 | |
| 225448749 | 376 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.779 | 0.897 | 1e-151 | |
| 224098142 | 372 | predicted protein [Populus trichocarpa] | 0.976 | 0.776 | 0.907 | 1e-146 | |
| 225439781 | 396 | PREDICTED: serine/threonine-protein kina | 0.983 | 0.734 | 0.847 | 1e-143 | |
| 147866816 | 425 | hypothetical protein VITISV_003379 [Viti | 0.949 | 0.661 | 0.896 | 1e-143 | |
| 449451703 | 383 | PREDICTED: serine/threonine-protein kina | 0.989 | 0.765 | 0.839 | 1e-140 | |
| 224112923 | 334 | predicted protein [Populus trichocarpa] | 0.875 | 0.775 | 0.926 | 1e-139 | |
| 356572387 | 380 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.768 | 0.814 | 1e-139 | |
| 356505176 | 379 | PREDICTED: serine/threonine-protein kina | 0.986 | 0.770 | 0.817 | 1e-138 |
| >gi|255568155|ref|XP_002525053.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223535634|gb|EEF37300.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 557 bits (1436), Expect = e-156, Method: Compositional matrix adjust.
Identities = 268/293 (91%), Positives = 277/293 (94%), Gaps = 1/293 (0%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MGWFPCAGKSS +AKKK +P DQIPS+S+K K + +DVK E SKDGGSDHIAAHTFT
Sbjct: 1 MGWFPCAGKSSNDAKKKLKKRPDDQIPSSSDKTKPSLALDVK-ETSKDGGSDHIAAHTFT 59
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRADCLLGEGGFGRVYKGRLEST+QVVAIKQLDRNGLQGNREFLVEVLML
Sbjct: 60 FRELAAATKNFRADCLLGEGGFGRVYKGRLESTSQVVAIKQLDRNGLQGNREFLVEVLML 119
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 120 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 179
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 180 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 239
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAW L
Sbjct: 240 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPL 292
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|37625033|gb|AAQ96340.1| protein kinase-like protein [Vitis aestivalis] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1391), Expect = e-151, Method: Compositional matrix adjust.
Identities = 264/293 (90%), Positives = 276/293 (94%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAW L
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPL 293
|
Source: Vitis aestivalis Species: Vitis aestivalis Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225448749|ref|XP_002281418.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297736456|emb|CBI25327.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1388), Expect = e-151, Method: Compositional matrix adjust.
Identities = 263/293 (89%), Positives = 276/293 (94%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDL+CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLQCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAW L
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPL 293
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224098142|ref|XP_002311125.1| predicted protein [Populus trichocarpa] gi|118486473|gb|ABK95076.1| unknown [Populus trichocarpa] gi|222850945|gb|EEE88492.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1351), Expect = e-146, Method: Compositional matrix adjust.
Identities = 266/293 (90%), Positives = 273/293 (93%), Gaps = 4/293 (1%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG F CAGKSSKN KK KP DQIPS+S+K K N DVK EASKDGGS+HIAAHTFT
Sbjct: 1 MGCFSCAGKSSKNDSKK---KPDDQIPSSSDKTKSNGAPDVK-EASKDGGSEHIAAHTFT 56
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELA TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML
Sbjct: 57 FRELANATKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 116
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL+DLPPDKKRLDW TRM+IAAGAA
Sbjct: 117 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLYDLPPDKKRLDWNTRMKIAAGAA 176
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLE+LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 177 KGLEHLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 236
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAW L
Sbjct: 237 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWARPL 289
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439781|ref|XP_002276042.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] gi|297741502|emb|CBI32634.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 250/295 (84%), Positives = 267/295 (90%), Gaps = 4/295 (1%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIP--STSEKLKVNSTVDVKKEASKDGGSDHIAAHT 58
MGWF C+GKS++ KKK KP+DQI +TSEKLK N + +VK EASK+GG DHIAA T
Sbjct: 1 MGWFLCSGKSNQATKKKR-KKPVDQIQVQTTSEKLKANPSFNVK-EASKNGGPDHIAAQT 58
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL 118
FTFRELAA TKNFR +CLLGEGGFGRVYKGR+ +TNQ VAIKQLDRNGLQGNREFLVEVL
Sbjct: 59 FTFRELAAATKNFRGECLLGEGGFGRVYKGRIANTNQAVAIKQLDRNGLQGNREFLVEVL 118
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD+ KKRLDW TRM+IAAG
Sbjct: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDVSLGKKRLDWNTRMKIAAG 178
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
AAKGLEYLHDKA+PPVIYRDLKCSNILLGE +HPKLSDFGLAKLGPVGD THVSTRVMGT
Sbjct: 179 AAKGLEYLHDKASPPVIYRDLKCSNILLGEDFHPKLSDFGLAKLGPVGDNTHVSTRVMGT 238
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN++AAGEHNLVAW L
Sbjct: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKAAGEHNLVAWARPL 293
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147866816|emb|CAN80987.1| hypothetical protein VITISV_003379 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1320), Expect = e-143, Method: Compositional matrix adjust.
Identities = 252/281 (89%), Positives = 264/281 (93%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFT 60
MG FPCAGKS+K KK DQIPSTSE+LKVNS+VD +K+ASKDGGSDHIAAHTFT
Sbjct: 1 MGCFPCAGKSNKKGKKNQEKNSKDQIPSTSERLKVNSSVDGRKDASKDGGSDHIAAHTFT 60
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML 120
FRELAA TKNFRA+CLLGEGGFGRVYKGRLESTN++VAIKQLDRNGLQGNREFLVEVLML
Sbjct: 61 FRELAAATKNFRAECLLGEGGFGRVYKGRLESTNKIVAIKQLDRNGLQGNREFLVEVLML 120
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
SLLHHPNLVNLIGYCADGDQRLLVYEYM LGSLEDHLHDLPPDKKRLDW TRM+IAAGAA
Sbjct: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMALGSLEDHLHDLPPDKKRLDWNTRMKIAAGAA 180
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
KGLEYLHDKA+PPVIYRDL CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG
Sbjct: 181 KGLEYLHDKASPPVIYRDLXCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281
YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN ++
Sbjct: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNYKSC 281
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449451703|ref|XP_004143601.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 505 bits (1300), Expect = e-140, Method: Compositional matrix adjust.
Identities = 251/299 (83%), Positives = 265/299 (88%), Gaps = 6/299 (2%)
Query: 1 MGWFPCAGKSSKNAKKKHHNKPI----DQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAA 56
MGWF C+G S+K K++ ++ D IPSTSEKL V +T + K + KDGG+D IA
Sbjct: 1 MGWFLCSGISNKKEKQQQQHQVHKKDDDPIPSTSEKLMVKATFNGKNDTLKDGGADQIAG 60
Query: 57 HT--FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL 114
T F+FRELAA TK FRADCLLGEGGFG+VYKGRLES NQVVAIKQLDRNGLQGNREFL
Sbjct: 61 QTITFSFRELAAATKYFRADCLLGEGGFGQVYKGRLESINQVVAIKQLDRNGLQGNREFL 120
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW TRM+
Sbjct: 121 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWNTRMK 180
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE YHPKLSDFGLAKLGPVGD THVSTR
Sbjct: 181 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEDYHPKLSDFGLAKLGPVGDNTHVSTR 240
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+RAAGEHNLVAW L
Sbjct: 241 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSRAAGEHNLVAWAQPL 299
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112923|ref|XP_002316332.1| predicted protein [Populus trichocarpa] gi|222865372|gb|EEF02503.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 501 bits (1289), Expect = e-139, Method: Compositional matrix adjust.
Identities = 241/260 (92%), Positives = 248/260 (95%), Gaps = 1/260 (0%)
Query: 34 KVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLEST 93
K N +DVK EASKDG S++IAAHTFTFRELA TKNFRADCLLGEGGFGRVYKGRLEST
Sbjct: 1 KSNMALDVK-EASKDGSSEYIAAHTFTFRELANATKNFRADCLLGEGGFGRVYKGRLEST 59
Query: 94 NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153
NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL
Sbjct: 60 NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 119
Query: 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213
EDHLHDLPPDKKRLDW TRM++AAGAAKGLEYLHD ANPPVIYRDLKCSNILLGEGYHPK
Sbjct: 120 EDHLHDLPPDKKRLDWNTRMKVAAGAAKGLEYLHDSANPPVIYRDLKCSNILLGEGYHPK 179
Query: 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
LSDFGLAKLGPVGD+THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK
Sbjct: 180 LSDFGLAKLGPVGDETHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 239
Query: 274 AIDNTRAAGEHNLVAWVTVL 293
AIDN+RAAGEHNLVAW L
Sbjct: 240 AIDNSRAAGEHNLVAWARPL 259
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572387|ref|XP_003554350.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 500 bits (1288), Expect = e-139, Method: Compositional matrix adjust.
Identities = 241/296 (81%), Positives = 261/296 (88%), Gaps = 4/296 (1%)
Query: 1 MGWFPCAGKS---SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAH 57
MGW PC+G S +K K + + + QI +T+ KLK NS+ K+ SK+G DHIAA
Sbjct: 1 MGWIPCSGYSGTKNKVEKMEAQDSLVGQIKATTGKLKRNSSTK-SKDTSKNGNPDHIAAQ 59
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV 117
TF+FRELA T+NFRA+CLLGEGGFGRVYKGRLES NQVVAIKQLDRNGLQGNREFLVEV
Sbjct: 60 TFSFRELATATRNFRAECLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG LEDHLHD+PP KK+LDW TRM+IAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKQLDWNTRMKIAA 179
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG+ THVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+++AGE NLVAW L
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPL 295
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505176|ref|XP_003521368.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 498 bits (1283), Expect = e-138, Method: Compositional matrix adjust.
Identities = 242/296 (81%), Positives = 258/296 (87%), Gaps = 4/296 (1%)
Query: 1 MGWFPCAGKS---SKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAH 57
MGW PC+G S +K K + + + QI +T KLK NS+ K+ SK+G DHIAA
Sbjct: 1 MGWIPCSGYSGTKNKVEKMEVQDSLVGQIKATPGKLKRNSSTK-SKDTSKNGNPDHIAAQ 59
Query: 58 TFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV 117
TF FRELA T+NFR DCLLGEGGFGRVYKGRLES NQVVAIKQLDRNGLQGNREFLVEV
Sbjct: 60 TFAFRELATATRNFRNDCLLGEGGFGRVYKGRLESINQVVAIKQLDRNGLQGNREFLVEV 119
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG LEDHLHD+PP KKRLDW TRM+IAA
Sbjct: 120 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGCLEDHLHDIPPGKKRLDWNTRMKIAA 179
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG+ THVSTRVMG
Sbjct: 180 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGENTHVSTRVMG 239
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN+++AGE NLVAW L
Sbjct: 240 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNSKSAGEQNLVAWARPL 295
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 296 | ||||||
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.888 | 0.512 | 0.860 | 4.6e-121 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.976 | 0.764 | 0.739 | 1.2e-113 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.912 | 0.592 | 0.787 | 3.6e-112 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.807 | 0.577 | 0.778 | 6.4e-99 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.834 | 0.680 | 0.759 | 7.4e-98 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.851 | 0.652 | 0.716 | 2.2e-96 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.898 | 0.627 | 0.683 | 1.6e-95 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.787 | 0.611 | 0.764 | 4.8e-94 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.831 | 0.632 | 0.701 | 3.5e-91 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.851 | 0.647 | 0.679 | 3.6e-89 |
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1191 (424.3 bits), Expect = 4.6e-121, P = 4.6e-121
Identities = 228/265 (86%), Positives = 240/265 (90%)
Query: 31 EKLKVNSTVDVKKE--ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKG 88
+K K + KKE A K+G + HIAA TFTFRELAA TKNFR +CLLGEGGFGRVYKG
Sbjct: 41 DKSKSRRGPEQKKELTAPKEGPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKG 100
Query: 89 RLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148
RLE+T Q+VA+KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM
Sbjct: 101 RLETTGQIVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 160
Query: 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208
PLGSLEDHLHDLPPDK+ LDW+TRM IAAGAAKGLEYLHDKANPPVIYRDLK SNILLG+
Sbjct: 161 PLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGD 220
Query: 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268
GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV LE+
Sbjct: 221 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLEL 280
Query: 269 ITGRKAIDNTRAAGEHNLVAWVTVL 293
ITGRKAIDN RA GEHNLVAW L
Sbjct: 281 ITGRKAIDNARAPGEHNLVAWARPL 305
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 1.2e-113, P = 1.2e-113
Identities = 221/299 (73%), Positives = 238/299 (79%)
Query: 1 MGWFPCXXXXXXXXXXXXXXX-PIDQIPS-----TSEKLKVNSTVDVKKEASKDGGSDHI 54
MGW PC +D+ S TSEK + S++ SK GSDHI
Sbjct: 1 MGWIPCSGKSSGRNKTRRNGDHKLDRKSSDCSVSTSEKSRAKSSLS----ESKSKGSDHI 56
Query: 55 AAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL 114
A TFTF ELA T+NFR +CL+GEGGFGRVYKG L ST+Q AIKQLD NGLQGNREFL
Sbjct: 57 VAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLASTSQTAAIKQLDHNGLQGNREFL 116
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD+ P K+ LDW TRM+
Sbjct: 117 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMK 176
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IAAGAAKGLEYLHDK PPVIYRDLKCSNILL + Y PKLSDFGLAKLGPVGDK+HVSTR
Sbjct: 177 IAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTR 236
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID++R+ GE NLVAW L
Sbjct: 237 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPL 295
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 215/273 (78%), Positives = 230/273 (84%)
Query: 23 IDQIPSTSEKLKVNSTVDVKKEA--SKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEG 80
I +PS EKL + K+E +DG IAAHTF FRELAA T NF D LGEG
Sbjct: 37 ISGLPSGGEKLSSKTNGGSKRELLLPRDG-LGQIAAHTFAFRELAAATMNFHPDTFLGEG 95
Query: 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140
GFGRVYKGRL+ST QVVA+KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ
Sbjct: 96 GFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 155
Query: 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK 200
RLLVYE+MPLGSLEDHLHDLPPDK+ LDW RM+IAAGAAKGLE+LHDKANPPVIYRD K
Sbjct: 156 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFK 215
Query: 201 CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260
SNILL EG+HPKLSDFGLAKLGP GDK+HVSTRVMGTYGYCAPEYAMTGQLT+KSDVYS
Sbjct: 216 SSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYS 275
Query: 261 FGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
FGVV LE+ITGRKAID+ GE NLVAW L
Sbjct: 276 FGVVFLELITGRKAIDSEMPHGEQNLVAWARPL 308
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 982 (350.7 bits), Expect = 6.4e-99, P = 6.4e-99
Identities = 186/239 (77%), Positives = 206/239 (86%)
Query: 51 SDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN 110
+++IAA TF+FRELA TKNFR +CL+GEGGFGRVYKG+LE T +VA+KQLDRNGLQGN
Sbjct: 59 TNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGN 118
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT 170
+EF+VEVLMLSLLHH +LVNLIGYCADGDQRLLVYEYM GSLEDHL DL PD+ LDW
Sbjct: 119 KEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWD 178
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230
TR+RIA GAA GLEYLHDKANPPVIYRDLK +NILL ++ KLSDFGLAKLGPVGDK H
Sbjct: 179 TRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQH 238
Query: 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
VS+RVMGTYGYCAPEY TGQLT KSDVYSFGVVLLE+ITGR+ ID TR E NLV W
Sbjct: 239 VSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTW 297
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 189/249 (75%), Positives = 209/249 (83%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
V K A+ G S+++ A FTFRELA TKNFR +CL+GEGGFGRVYKG+LE+ QVVA+K
Sbjct: 19 VAKNAN--GPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVK 76
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
QLDRNGLQG REFLVEVLMLSLLHH NLVNLIGYCADGDQRLLVYEYMPLGSLEDHL DL
Sbjct: 77 QLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLLDL 136
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
P +K LDW TR++IA GAAKG+EYLHD+A+PPVIYRDLK SNILL Y KLSDFGLA
Sbjct: 137 EPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLA 196
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
KLGPVGD HVS+RVMGTYGYCAPEY TG LT KSDVYSFGVVLLE+I+GR+ ID R
Sbjct: 197 KLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLELISGRRVIDTMRP 256
Query: 281 AGEHNLVAW 289
+ E NLV W
Sbjct: 257 SHEQNLVTW 265
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
Identities = 182/254 (71%), Positives = 212/254 (83%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
+ +E +K G +I+AH FTFREL TKNF D LGEGGFGRVYKG++E+ QVVA+K
Sbjct: 53 ISEEIAKLG-KGNISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVK 111
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
QLDRNG QGNREFLVEV+MLSLLHH NLVNL+GYCADGDQR+LVYEYM GSLEDHL +L
Sbjct: 112 QLDRNGYQGNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLEL 171
Query: 161 PPDKKR-LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219
+KK+ LDW TRM++AAGAA+GLEYLH+ A+PPVIYRD K SNILL E ++PKLSDFGL
Sbjct: 172 ARNKKKPLDWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGL 231
Query: 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279
AK+GP G +THVSTRVMGTYGYCAPEYA+TGQLT+KSDVYSFGVV LE+ITGR+ ID T+
Sbjct: 232 AKVGPTGGETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTK 291
Query: 280 AAGEHNLVAWVTVL 293
E NLV W + L
Sbjct: 292 PTEEQNLVTWASPL 305
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 950 (339.5 bits), Expect = 1.6e-95, P = 1.6e-95
Identities = 192/281 (68%), Positives = 215/281 (76%)
Query: 27 PSTSEKLKVNSTVDVKKEA----------SKDGG-SDHIA---AHTFTFRELAAVTKNFR 72
PS S+ LKV+ DV KE +KD D + A TFTF EL+ T NF+
Sbjct: 41 PS-SDCLKVSICGDVSKEIVTKKDQLALDAKDTNVEDEVIVKKAQTFTFEELSVSTGNFK 99
Query: 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+DC LGEGGFG+VYKG +E NQVVAIKQLDRNG QG REF+VEVL LSL HPNLV LI
Sbjct: 100 SDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVVEVLTLSLADHPNLVKLI 159
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G+CA+G QRLLVYEYMPLGSL++HLHDLP K L W TRM+IAAGAA+GLEYLHD P
Sbjct: 160 GFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMKP 219
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
PVIYRDLKCSNIL+ EGYH KLSDFGLAK+GP G +THVSTRVMGTYGYCAP+YA+TGQL
Sbjct: 220 PVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQL 279
Query: 253 TLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
T KSDVYSFGVVLLE+ITGRKA DNTR +LV W L
Sbjct: 280 TFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPL 320
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 936 (334.5 bits), Expect = 4.8e-94, P = 4.8e-94
Identities = 179/234 (76%), Positives = 203/234 (86%)
Query: 56 AHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV 115
A +FTF+ELAA T+NFR LLGEGGFGRVYKGRL+S QVVAIKQL+ +GLQGNREF+V
Sbjct: 63 ARSFTFKELAAATRNFREVNLLGEGGFGRVYKGRLDS-GQVVAIKQLNPDGLQGNREFIV 121
Query: 116 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
EVLMLSLLHHPNLV LIGYC GDQRLLVYEYMP+GSLEDHL DL +++ L W TRM+I
Sbjct: 122 EVLMLSLLHHPNLVTLIGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKI 181
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A GAA+G+EYLH ANPPVIYRDLK +NILL + + PKLSDFGLAKLGPVGD+THVSTRV
Sbjct: 182 AVGAARGIEYLHCTANPPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRV 241
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
MGTYGYCAPEYAM+G+LT+KSD+Y FGVVLLE+ITGRKAID + GE NLV W
Sbjct: 242 MGTYGYCAPEYAMSGKLTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTW 295
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 909 (325.0 bits), Expect = 3.5e-91, P = 3.5e-91
Identities = 176/251 (70%), Positives = 202/251 (80%)
Query: 39 VDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVA 98
V KE+ K+ I A +F FRELA T +FR + L+GEGGFGRVYKG++E T QVVA
Sbjct: 44 VGTNKESPKN-----IKAKSFKFRELATATNSFRQEFLIGEGGFGRVYKGKMEKTGQVVA 98
Query: 99 IKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
+KQLDRNGLQGNREFLVE+ LSLLHHPNL NLIGYC DGDQRLLV+E+MPLGSLEDHL
Sbjct: 99 VKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCLDGDQRLLVHEFMPLGSLEDHLL 158
Query: 159 DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218
D+ ++ LDW +R+RIA GAAKGLEYLH+KANPPVIYRD K SNILL + KLSDFG
Sbjct: 159 DVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIYRDFKSSNILLNVDFDAKLSDFG 218
Query: 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278
LAKLG VGD +VS+RV+GTYGYCAPEY TGQLT+KSDVYSFGVVLLE+ITG++ ID T
Sbjct: 219 LAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKSDVYSFGVVLLELITGKRVIDTT 278
Query: 279 RAAGEHNLVAW 289
R E NLV W
Sbjct: 279 RPCHEQNLVTW 289
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 890 (318.4 bits), Expect = 3.6e-89, P = 3.6e-89
Identities = 172/253 (67%), Positives = 194/253 (76%)
Query: 41 VKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIK 100
+ +E K G + F F+EL A T NF DC++GEGGFGRVYKG L S NQVVA+K
Sbjct: 56 ITEEIKKYGNVKN-CGRIFKFKELIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVK 114
Query: 101 QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
+LDRNGLQG REF EV++LSL HPNLVNLIGYC + +QR+LVYE+MP GSLEDHL DL
Sbjct: 115 RLDRNGLQGTREFFAEVMVLSLAQHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDL 174
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
P LDW TRMRI GAAKGLEYLHD A+PPVIYRD K SNILL ++ KLSDFGLA
Sbjct: 175 PEGSPSLDWFTRMRIVHGAAKGLEYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLA 234
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
+LGP K HVSTRVMGTYGYCAPEYAMTGQLT KSDVYSFGVVLLEII+GR+AID R
Sbjct: 235 RLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRP 294
Query: 281 AGEHNLVAWVTVL 293
E NL++W L
Sbjct: 295 TEEQNLISWAEPL 307
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 296 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-59 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-57 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-57 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-57 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-54 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-38 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-37 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-36 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-36 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-34 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-34 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-32 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-31 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-31 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-29 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-29 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-28 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-26 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-26 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-25 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-25 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-24 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-24 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-23 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-23 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-23 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-22 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 8e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-21 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-19 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-19 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-19 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-19 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-19 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-18 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-18 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-17 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-17 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 9e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-16 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-16 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-16 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 7e-16 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-16 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-15 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-15 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-14 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-13 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-13 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-13 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-10 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-06 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 2e-59
Identities = 77/195 (39%), Positives = 104/195 (53%), Gaps = 11/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGYC 135
LGEGGFG VY R + T + VAIK + + E L E+ +L L+HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
D + LV EY GSL+D L + +L +RI +GLEYLH +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 196 YRDLKCSNILLGEG-YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-YAMTGQLT 253
+RDLK NILL KL+DFGL+KL + + ++GT Y APE G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 254 LKSDVYSFGVVLLEI 268
KSD++S GV+L E+
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 2e-57
Identities = 79/199 (39%), Positives = 104/199 (52%), Gaps = 11/199 (5%)
Query: 77 LGEGGFGRVYKGRLESTN----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG L+ VA+K L + Q EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C + + ++V EYMP G L D+L K L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQIARGMEYLESK-- 122
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
I+RDL N L+GE K+SDFGL++ D V + APE G+
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180
Query: 252 LTLKSDVYSFGVVLLEIIT 270
T KSDV+SFGV+L EI T
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 6e-57
Identities = 75/199 (37%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 77 LGEGGFGRVYKGRLESTN----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG+L+ VA+K L + Q EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C + + +V EYM G L +L + +L + + A A+G+EYL K
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
I+RDL N L+GE K+SDFGL++ D + APE G+
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179
Query: 252 LTLKSDVYSFGVVLLEIIT 270
T KSDV+SFGV+L EI T
Sbjct: 180 FTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 7e-57
Identities = 78/200 (39%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG VYKG L E T VA+K L + EFL E ++ L HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C G+ +V EYMP G L D L +L +++A AKG+EYL K
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RDL N L+ E K+SDFGL++ D + APE G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 252 LTLKSDVYSFGVVLLEIITG 271
T KSDV+SFGV+L EI T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 3e-54
Identities = 79/203 (38%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 77 LGEGGFGRVYKGRLE---STNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VYKG+L+ VA+K L + + R +FL E ++ L HPN+V L+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
G C + + LV EYM G L D+L P+K L + A AKG+EYL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
K ++RDL N L+GE K+SDFGL++ D T + APE
Sbjct: 123 SK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
G T KSDV+SFGV+L EI T
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 7e-54
Identities = 77/206 (37%), Positives = 107/206 (51%), Gaps = 17/206 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLV 129
+ LGEG FG+VY R + T ++VAIK + + ++ +RE L E+ +L L HPN+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L D D+ LV EY G L D L L D+ R LEYL
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEAR-------FYLRQILSALEYL 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H K +++RDLK NILL E H KL+DFGLA+ + ++T V GT Y APE
Sbjct: 114 HSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEV 167
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ D++S GV+L E++TG+
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 2e-52
Identities = 77/199 (38%), Positives = 105/199 (52%), Gaps = 12/199 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG G FG VYK + + T ++VA+K L + ++ E+ +L L HPN+V LI
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D D LV EY G L D+L L +IA +GLEYLH +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-T 253
I+RDLK NILL E K++DFGLAK + + ++T V GT Y APE + G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 254 LKSDVYSFGVVLLEIITGR 272
K DV+S GV+L E++TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL-----MLSLLHHPNLV 129
LLG G FG VY + T +++A+K ++ L G+ E +E L +LS L HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE---LSGDSEEELEALEREIRILSSLQHPNIV 62
Query: 130 NLIGYC--ADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLE 184
G + + + EY+ GSL L LP R +T ++ +GL
Sbjct: 63 RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-YTRQI------LEGLA 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH +++RD+K +NIL+ KL+DFG AK + + V GT + AP
Sbjct: 116 YLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + +D++S G ++E+ TG+
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-38
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+GGFG VYK R + T + VAIK + + + + E+ +L HPN+V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
D+ +V E+ GSL+D L + L + + KGLEYLH +I+
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIH 121
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K +NILL KL DFGL+ T ++GT + APE K+
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 257 DVYSFGVVLLEIITGR 272
D++S G+ +E+ G+
Sbjct: 179 DIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-37
Identities = 72/217 (33%), Positives = 111/217 (51%), Gaps = 13/217 (5%)
Query: 77 LGEGGFGRVYKG----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK L + + N+E L E +++ + HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C Q L+ + MPLG L D++ + K + + AKG+ YL +K
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL V +K + + + A E +
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 252 LTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLV 287
T KSDV+S+GV + E++T G K + A +L+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-36
Identities = 70/194 (36%), Positives = 107/194 (55%), Gaps = 8/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V++G L VAIK L + L ++F EV L L H +L++L C+
Sbjct: 14 LGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
G+ ++ E M GSL L P+ + L + + +A A+G+ YL ++ I+
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN---SIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL NIL+GE K++DFGLA+L + + ++S+ Y + APE A G + KS
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 186 DVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 69/203 (33%), Positives = 103/203 (50%), Gaps = 16/203 (7%)
Query: 77 LGEGGFGRVYKGRLE----STNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V R + +T + VA+K L+ +G Q +F E+ +L L H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C R L+ EY+P GSL D+L + +++ + ++ KG++YL +
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST--RVMGTYGYCAPEYA 247
I+RDL NIL+ K+SDFGLAK+ P + + Y APE
Sbjct: 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
T + + SDV+SFGV L E+ T
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 1e-35
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 21/210 (10%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LGEG FG+VYKG L + VAIK L N + EF E ++S L HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAG 178
L+G C +++EY+ G L + L P K LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+EYL ++ ++RDL N L+GEG K+SDFGL++ D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268
+ PE + G+ T +SD++SFGVVL EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 75/198 (37%), Positives = 106/198 (53%), Gaps = 11/198 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G T +V A+K L + G FL E ++ L H LV L C+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKV-AVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + +V EYM GSL D L + K+L + +AA A+G+ YL + I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDL NIL+GE K++DFGLA+L + T + + APE A G+ T+K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+SFG++L EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 69/220 (31%), Positives = 99/220 (45%), Gaps = 24/220 (10%)
Query: 72 RADCL-----LGEGGFGRVYKGRLESTNQ-----VVAIKQLDRNGLQGNRE-FLVEVLML 120
+ D + LGEG FG+V+ G +VA+K L R+ F E +L
Sbjct: 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELL 62
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HD--------LPPDKKRLDWT 170
+ H N+V G C +GD ++V+EYM G L L H L +
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230
++IA A G+ YL A+ ++RDL N L+G K+ DFG+++ D
Sbjct: 123 QLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179
Query: 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
V M + PE M + T +SDV+SFGVVL EI T
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 6e-34
Identities = 73/202 (36%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
LG+G FG+V R + T ++ A+K L + + +E L E +LS ++HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 134 YCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLEYLHDKA 190
+ A + LV EY P G L HL + R R AA LEYLH
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERAR-FYAAEIVLALEYLHSLG 113
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK NILL H KL+DFGLAK + +T GT Y APE +
Sbjct: 114 ---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLAPEVLLGK 168
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
D +S GV+L E++TG+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-32
Identities = 68/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
N++ L+G G FG VYKG T VAIKQ+ ++ + + E+ +L L HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL--DWTTRMRIAAGAAKGLEY 185
+V IG D ++ EY GSL + P + L + ++ +GL Y
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV------LQGLAY 114
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAP 244
LH++ VI+RD+K +NIL + KL+DFG+A KL V V+GT + AP
Sbjct: 115 LHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAP 168
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + SD++S G ++E++TG
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 121 bits (303), Expect = 8e-32
Identities = 77/216 (35%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-----LMLSLLH 124
++R LGEG FG VY R ++VA+K L L+ + + ++ SL H
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
PN+V L + D LV EY+ GSLED L K L + + I A LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQILSALE 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKL----GPVGDKTHVSTRVMGTY 239
YLH K +I+RD+K NILL G KL DFGLAKL G + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 240 GYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGR 272
GY APE + + SD++S G+ L E++TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 117 bits (297), Expect = 9e-32
Identities = 60/213 (28%), Positives = 104/213 (48%), Gaps = 31/213 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G+G FG+VY R +S ++ +K++D + + + RE + EV +L L+HPN++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 134 YCADGDQRLLVYEYMPLGSLEDHL------HDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ + +V EY G L + P+++ LDW ++ L+YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL------CLALKYLH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
+ +++RD+K NI L KL DFG++K+ + ++ V+GT Y +PE
Sbjct: 121 SRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYYLSPELC 175
Query: 246 ----YAMTGQLTLKSDVYSFGVVLLEIITGRKA 274
Y KSD++S G VL E+ T +
Sbjct: 176 QNKPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-31
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 17/204 (8%)
Query: 76 LLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG+G FG V R + +T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C +R LV EY+P GSL D+L ++RLD + A+ KG+EYL K
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPEY 246
++RDL NIL+ K+ DFGL K+ P DK + R G + Y APE
Sbjct: 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 69/204 (33%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V++G +T V A+K L + G ++FL E ++ L HP L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V E M GSL ++L + L + +AA A G+ YL + I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 249
RDL N+L+GE K++DFGLA++ G K + + APE A+
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIK--------WTAPEAALY 178
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GR 272
+ ++KSDV+SFG++L EI+T GR
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-31
Identities = 70/201 (34%), Positives = 101/201 (50%), Gaps = 20/201 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G+G FG V G Q VA+K L + + FL E +++ L HPNLV L+G
Sbjct: 13 TIGKGEFGDVMLGDYR--GQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G+ +V EYM GSL D+L + + ++ A +G+EYL +K +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+RDL N+L+ E K+SDFGLAK G K V + APE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 253 TLKSDVYSFGVVLLEIIT-GR 272
+ KSDV+SFG++L EI + GR
Sbjct: 177 STKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 69/197 (35%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG VYKG L+ N VA+K + FL E +L HPN+V LIG
Sbjct: 2 KIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C +V E +P GSL L K RL ++++ AA G+EYL K
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---C 114
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RDL N L+GE K+SDFG+++ G T + APE G+ T
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 255 KSDVYSFGVVLLEIITG 271
+SDV+S+G++L E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 65/219 (29%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV--EVLMLSLL-HHPNLVNL 131
++GEG F V + + TN+ AIK LD+ L + + V E +L+ L HP ++ L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D + V EY P G L ++ LD AA LEYLH K
Sbjct: 68 YYTFQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG- 122
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVM-------------- 236
+I+RDLK NILL + H K++DFG AK L P
Sbjct: 123 --IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 237 ---GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT Y +PE SD+++ G ++ +++TG+
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 64/201 (31%), Positives = 106/201 (52%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNLV L+G C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ ++ + +A + +EYL K I+
Sbjct: 73 REPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL-------GPVGDKTHVSTRVMGTYGYCAPEYAMT 249
RDL N L+GE + K++DFGL++L G K + + APE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--------WTAPESLAY 179
Query: 250 GQLTLKSDVYSFGVVLLEIIT 270
+ ++KSDV++FGV+L EI T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 73/224 (32%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L++L H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-----------WTTRMRIAAGAA 180
G C +G L+V+EYM G L L PD K L + IA+ A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
G+ YL A+ ++RDL N L+G+G K+ DFG+++ D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK----AIDNTRA 280
+ PE + + T +SD++SFGVVL EI T K + NT A
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 69/202 (34%), Positives = 93/202 (46%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGR-LESTNQV--VAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNL 131
LG+G FG V +G S +V VA+K L + L +FL E ++ L H NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G ++V E PLGSL D L +T A A G+ YL K
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLESKR- 117
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST---RVMGTYGYCAPEYAM 248
I+RDL NILL K+ DFGL + P + +V +V + +CAPE
Sbjct: 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLR 173
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
T + SDV+ FGV L E+ T
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 35/210 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIG-Y 134
LG+G G VYK R + T ++ A+K++ +G + R+ L+ E+ L P +V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAGAAKGLEYLHDKANP 192
+G+ +V EYM GSL D L KK + IA KGL+YLH K +
Sbjct: 69 YKEGEIS-IVLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 193 PVIYRDLKCSNILL---GEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPE--- 245
+I+RD+K SN+L+ GE K++DFG++K L D+ + T V GT Y +PE
Sbjct: 121 -IIHRDIKPSNLLINSKGE---VKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQ 173
Query: 246 ---YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y+ +D++S G+ LLE G+
Sbjct: 174 GESYSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-28
Identities = 69/206 (33%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVN 130
F LGEG +G VYK + T QVVAIK + +E + E+ +L P +V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA---GAAKGLEYLH 187
G +V EY GS+ D + K L T IAA KGLEYLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTL---TEEEIAAILYQTLKGLEYLH 116
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY 246
I+RD+K NILL E KL+DFG++ +L K + V+GT + APE
Sbjct: 117 SNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEV 170
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
K+D++S G+ +E+ G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 74/212 (34%), Positives = 106/212 (50%), Gaps = 21/212 (9%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGE FG++YKG L Q+VAIK L D N Q EF E +++ LHHPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD-------------KKRLDWTTRMRIAAG 178
+G +++EY+ G L + L P K LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+EYL ++ +++DL NIL+GE H K+SD GL++ D V + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE M G+ + SD++SFGVVL EI +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 17/199 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G VYK +T + VAIK++ + N+E ++ E+L++ HPN+V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAGAAKGLEYLHDKANPP 193
GD+ +V EYM GSL D + + + + +GLEYLH +
Sbjct: 85 LVGDELWVVMEYMDGGSLTDII-----TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---N 136
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VI+RD+K NILL + KL+DFG A+L K + V+GT + APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVIKRKDY 193
Query: 253 TLKSDVYSFGVVLLEIITG 271
K D++S G++ +E+ G
Sbjct: 194 GPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-27
Identities = 71/211 (33%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 77 LGEGGFGRVYKGR---LESTNQ--VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ L T +VA+K L L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAGA 179
G C DGD ++V+EYM G L L PD K L + + IA+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A G+ YL A+ ++RDL N L+G K+ DFG+++ D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE M + T +SDV+SFGV+L EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 9e-27
Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
++ ++G G VY N+ VAIK++D Q + + L EV +S +HPN
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+V GD+ LV Y+ GSL D + P LD + KGLEYL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG--LDEAIIATVLKEVLKGLEYL 118
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTH-VSTRVMGTYGYCAP 244
H I+RD+K NILLGE K++DFG+ A L GD+T V +GT + AP
Sbjct: 119 HSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAP 175
Query: 245 EYAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
E M K+D++SFG+ +E+ TG
Sbjct: 176 E-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 71/199 (35%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G + + VAIK L + G FL E ++ L HP LV L
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L P+ +L + +AA A+G+ ++ K I+
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKN---YIH 125
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 254
RDL+ +NIL+ E K++DFGLA+L + + R + + APE G T+
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 255 KSDVYSFGVVLLEIIT-GR 272
KSDV+SFG++L EI+T GR
Sbjct: 183 KSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 35/212 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G+VYK R + T ++VA+K++ ++ +E + E+ +L L HPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR---MENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-------- 181
+ +V+EYM HDL L + ++ K
Sbjct: 64 KEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL+YLH +++RD+K SNIL+ KL+DFGLA+ + T + T Y
Sbjct: 112 GLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWY 167
Query: 242 CAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
PE + + + D++S G +L E+ G+
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 67/205 (32%), Positives = 102/205 (49%), Gaps = 24/205 (11%)
Query: 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIGYCA 136
G +GRV+ + +ST + AIK + + + + L E +LS P +V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 137 DGDQRL-LVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + L LV EY+P L SL +++ L D R+ A LEYLH +
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARI-------YIAEIVLALEYLH---SN 112
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS------TRVMGTYGYCAPEY 246
+I+RDLK NIL+ H KL+DFGL+K+G V + +++ R++GT Y APE
Sbjct: 113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+ + D +S G +L E + G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 77 LGEGGFGRV----YKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
LGEG FG+V Y + T ++VA+K L R Q N + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C++ + L+ EY+PLGSL D+L K +L+ + A +G+ YLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAM 248
I+RDL N+LL K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
+ + SDV+SFGV L E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 68/200 (34%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G+ V AIK + R G +F+ E ++ L HPNLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDV-AIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EYM G L ++L + K +L + + + + +EYL I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE K+SDFGLA+ V D + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 254 LKSDVYSFGVVLLEIITGRK 273
KSDV+SFGV++ E+ + K
Sbjct: 180 SKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-26
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRLE--STNQV---VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + + VAIK + + ++ EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRI---AAGAAKGLE 184
L+G + G L+V E M G L+ +L P+ + L T + AA A G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YL K ++RDL N ++ E K+ DFG+ + D + + + AP
Sbjct: 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E G T KSDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 70/204 (34%), Positives = 97/204 (47%), Gaps = 23/204 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG GGFGRV +++S N+ A+K + + + + E +L +HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 134 YCADGDQRLLVY---EYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLEYLHDK 189
Y D++ +Y EY G L L D + D +T R A EYLH++
Sbjct: 59 YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARF-YIACVVLAFEYLHNR 112
Query: 190 ANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+IYRDLK N+LL GY KL DFG AK G KT GT Y APE +
Sbjct: 113 G---IIYRDLKPENLLLDSNGY-VKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIIL 165
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
D +S G++L E++TGR
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-26
Identities = 62/199 (31%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++++T ++ A K+LD+ L +G + L E +L + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D LV M G L+ H++++ + + AA GLE+LH +
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++YRDLK N+LL + + ++SD GLA G K GT GY APE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 254 LKSDVYSFGVVLLEIITGR 272
D ++ G L E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGN---REFLVEVLMLSLLHHPNLVN 130
LLG G FG VY+G A+K+ L +G G ++ E+ +LS L HPN+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+G + D + E +P GSL L + + TR + GLEYLHD+
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHDR 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-----GTYGYCAP 244
++RD+K +NIL+ KL+DFG+AK V G+ + AP
Sbjct: 122 N---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170
Query: 245 EYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
E G L +D++S G +LE+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 25/205 (12%)
Query: 77 LGEGGFGRVYKG--RLESTNQV-VAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG ++S +V VA+K L + + +EFL E +++ L HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C G+ +LV E PLG L +L P + ++ A G+ YL K
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESKH 115
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
++RDL N+LL + K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
G+ + KSDV+S+GV L E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 72/198 (36%), Positives = 111/198 (56%), Gaps = 12/198 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G +V A+K L + G FL E ++ L H LV L +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKV-AVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + +V EYM GSL D L D + + L + +AA A G+ Y+ ++ N I+
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYI-ERMN--YIH 125
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 255
RDL+ +NIL+G+G K++DFGLA+L + D + + + + APE A+ G+ T+K
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+SFG++L E++T GR
Sbjct: 184 SDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G G V K T +++A+K + ++ L E+ +L + P +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ + EYM GSL+ L + R+ +IA KGL YLH+K +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM--------GTYGYCAPEYA 247
+RD+K SNIL+ KL DFG VS +++ GT Y APE
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSYMAPERI 171
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
++KSD++S G+ L+E+ TGR
Sbjct: 172 QGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 65/205 (31%), Positives = 109/205 (53%), Gaps = 9/205 (4%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLV-EVLMLSLLHHPN 127
+F+ LG+G +G VYK + S NQ A+K++D + Q RE V E+ +L+ ++HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+++ DG++ +V EY P G L + +K + RI +GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++ +++RDLK +NILL K+ D G++K+ K +++ +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ KSD++S G +L E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNL 131
+G G FG V +GRL+ + VAIK L + G +FL E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G +++ EYM GSL+ L +D + + + G A G++YL +
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEM 125
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 243
++RDL NIL+ K+SDFGL++ + D T T G + A
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIRWTA 176
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE + T SDV+SFG+V+ E+++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 65/218 (29%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVYKGR----LESTNQ-VVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
+G+G FGRV++ R L +VA+K L + +F E +++ HPN+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------------DKKRLDWTTR 172
L+G CA G L++EYM G L + L P + L T +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ IA A G+ YL ++ ++RDL N L+GE K++DFGL++ D S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ PE + T +SDV+++GVVL EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 65/198 (32%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV R + + + A+K L + + ++ L E +L + HP LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D LV EY+P G L HL R AA LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD--- 121
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++YRDLK N+LL + K++DFG AK V +T+ + GT Y APE ++
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKR--VKGRTYT---LCGTPEYLAPEIILSKGYG 176
Query: 254 LKSDVYSFGVVLLEIITG 271
D ++ G+++ E++ G
Sbjct: 177 KAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 25/208 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQV---VAIKQLDR-NGLQGNREFLVEVLMLSLLHHPNLVNL 131
++G+G FG VY G L ++ A+K L+R L+ +FL E +++ HPN+++L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 132 IGYCADGD-QRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+G C + L+V YM G L + + P K L + AKG+EYL
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL-- 114
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVMGTYGYC 242
A+ ++RDL N +L E + K++DFGLA+ V + T V +
Sbjct: 115 -ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK----WM 169
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T + T KSDV+SFGV+L E++T
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 44/215 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG +G VYK R + T ++VA+K++ + G+ L E+ +L L HPN+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHPNIVKLL 64
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+EY DL KK LD ++ K GL
Sbjct: 65 DVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNLIKSIMYQLLRGLA 112
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y H +++RDLK NIL+ KL+DFGLA+ + +T+ + V+ T Y AP
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAP 167
Query: 245 EYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
E + L S D++S G + E+ITG+
Sbjct: 168 E------ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 1e-24
Identities = 75/206 (36%), Positives = 116/206 (56%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R D LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTL-KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L ++ + +V E+M GSL D L + D K L + +AA A G+ Y+ +
Sbjct: 64 VPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYI-E 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ N I+RDL+ +NIL+G+ K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
+ G+ T+KSDV+SFG++L E++T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-24
Identities = 69/204 (33%), Positives = 107/204 (52%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKG----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LLG G FG V+KG +S VAIK + DR+G Q +E +L + L H +V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLH----DLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L+G C G LV + PLGSL DH+ L P ++ L+W ++ AKG+ YL
Sbjct: 74 LLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDP-QRLLNWCVQI------AKGMYYL 125
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ +++R+L NILL +++DFG+A L DK + + + A E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
+ G+ T +SDV+S+GV + E+++
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-24
Identities = 70/195 (35%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG V+ GRL + N VA+K R L + +FL E +L HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C Q+ +Y M L D L L + RL +++ AA G+EYL K
Sbjct: 62 CT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT--YGYCAPEYAMTGQL 252
I+RDL N L+ E K+SDFG+++ D + ST M + APE G+
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 253 TLKSDVYSFGVVLLE 267
+ +SDV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 2e-24
Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 76 LLGEGGFGRVYKGRLE------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNL 128
LG G FG VY+G S VA+K L + Q +EFL E ++S +HPN+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEY 185
V L+G C + + ++ E M G L +L D ++ L + I AKG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
L I+RDL N L+ E + K+ DFGLA+ D +
Sbjct: 122 LEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE + G+ T +SDV+SFGV++ EI+T
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 3e-24
Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 11/208 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V+ G +V AIK + R G +F+ E ++ L HP LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV+E+M G L D+L + + T + + +G+ YL VI+
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL N L+GE K+SDFG+ + + D+ ST + +PE + + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 257 DVYSFGVVLLEIIT-GRKAIDNTRAAGE 283
DV+SFGV++ E+ + G+ +N R+ E
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN-RSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-24
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 9/202 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG V+K ++ +V A+KQ+D + + E + E +L+ L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + +V EY G L L + L R GL +LH K +
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK--MQRGRPLPEDQVWRFFIQILLGLAHLHSKK---I 122
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RD+K N+ L + K+ D G+AKL + D T+ + ++GT Y +PE
Sbjct: 123 LHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 255 KSDVYSFGVVLLEIITGRKAID 276
KSDV++ GVVL E TG+ D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 3e-24
Identities = 75/206 (36%), Positives = 112/206 (54%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R + LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L ++ + +V EYM GSL D L RL M AA A G+ Y+ +
Sbjct: 64 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM--AAQIASGMAYV-E 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ N ++RDL+ +NIL+GE K++DFGLA+L + D + + + + APE A
Sbjct: 120 RMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
+ G+ T+KSDV+SFG++L E+ T GR
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 63/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIGY 134
+G+G FG V K R +S +++ K++D + + ++ LV EV +L L HPN+V
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 135 CADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D + L V EY G L + ++K ++ RI L H++++P
Sbjct: 68 IIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDP 127
Query: 193 P--VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEYA 247
V++RDLK +NI L + KL DFGLAK+ KT+V GT Y +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQL 182
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
KSD++S G ++ E+
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK R + T ++VAIK++ + L E+ +L L+HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
LV+E+M D + ++ L + +GL + H +
Sbjct: 67 FRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH-SHG--I 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPEYAMT-G 250
++RDLK N+L+ KL+DFGLA+ PV TH V TR Y APE +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDK 174
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
+ D++S G + E+++ R
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-24
Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 17/208 (8%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L+ L H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK---------KRLDWTTRMRIAAGAAKG 182
G C +GD ++V+EYM G L L PD L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ YL A+ ++RDL N L+GE K+ DFG+++ D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE M + T +SDV+S GVVL EI T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 6e-24
Identities = 68/204 (33%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 77 LGEGGFGRVYKG-----RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G ++ VA+K L + Q +FL+E L++S +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLH 187
LIG + R ++ E M G L+ L + P +R L + A AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ I+RD+ N LL G G K++DFG+A+ R M + P
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEI 268
E + G T K+DV+SFGV+L EI
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 1e-23
Identities = 63/200 (31%), Positives = 89/200 (44%), Gaps = 12/200 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ-LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG G V K RL++T + A+K ++ L E+ + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 136 ADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D + EY GSL+ + R+ +IA KGL YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--- 125
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+I+RD+K SNILL KL DFG++ +L T GT Y APE
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPERIQGKPY 180
Query: 253 TLKSDVYSFGVVLLEIITGR 272
++ SDV+S G+ LLE+ R
Sbjct: 181 SITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 2e-23
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V K R+ + AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR-------MRIAAGA 179
+G C L EY P G+L D L + P + T + AA
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G++YL K I+RDL NIL+GE Y K++DFGL++ G + +V + MG
Sbjct: 122 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 173
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T SDV+S+GV+L EI++
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 61/199 (30%), Positives = 88/199 (44%), Gaps = 13/199 (6%)
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
G+G FG+V + T ++ A+K +++ R L E +L L+HP LVNL
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + LV + + G L HL K + LEYLH K +
Sbjct: 69 FQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---I 121
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RD+K NILL E H ++DF +A T T GT GY APE ++
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCRQGYSV 178
Query: 255 KSDVYSFGVVLLEIITGRK 273
D +S GV E + G++
Sbjct: 179 AVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 71/212 (33%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM--------LSL 122
FR +LG G FG+V + T ++ AIK L + + E VE LM +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 123 LHHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
HP LVNL C + + V EY G L H+H + R + AA
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR-----AVFYAACVVL 112
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTY 239
GL+YLH+ ++YRDLK N+LL K++DFGL K +G GD+T ST GT
Sbjct: 113 GLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-GDRT--ST-FCGTP 165
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
+ APE T D + GV++ E++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLL-HHPNLVNL 131
+LG+G FG+V+ L+ TNQ AIK L ++ + + + +VE +LSL HP L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ V EY+ G L H+ + D AA GL++LH K
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSKG- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++YRDLK NILL H K++DFG+ K +GD + GT Y APE + +
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQK 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D +SFGV+L E++ G+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-23
Identities = 58/208 (27%), Positives = 105/208 (50%), Gaps = 19/208 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIG 133
++G G FG V+ R ++ ++V IKQ+ + + E +L LL HPN++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+ ++V EY P G+L +++ L + L + ++ +A L ++H K
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHHVHTK 120
Query: 190 ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+++RDLK NILL + K+ DFG++K+ + K+ T V+GT Y +PE
Sbjct: 121 L---ILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAID 276
KSD+++ G VL E+ + ++A +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-23
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V + + + AIK L + + R+F E+ +L L HHPN++NL
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR-------MRIAAGA 179
+G C + + EY P G+L D L + P + T ++ A+
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A G++YL +K I+RDL N+L+GE K++DFGL++ G++ +V + MG
Sbjct: 129 ATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMGRL 180
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T KSDV+SFGV+L EI++
Sbjct: 181 PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 3e-23
Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAIKQ++ Q +E ++ E+L++ HPN+VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P K + ++GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
+G+G FG VYK + TNQVVAIK +D + E + E+ LS P + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
G + ++ EY GS D L D+ + + R + GLEYLH++
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL-----LGLEYLHEEG---K 119
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYAMTGQ 251
I+RD+K +NILL E KL+DFG++ G T ++ +GT + APE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 252 LTLKSDVYSFGVVLLEIITG 271
K+D++S G+ +E+ G
Sbjct: 175 YDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 4e-23
Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 74 DCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHP 126
LGEG FG+V K + VA+K L + + + + + E+ M+ ++ H
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP----DKKRLDWTTR--------MR 174
N++NL+G C +V EY G+L D L P +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
A A+G+E+L K I+RDL N+L+ E + K++DFGLA+ D +T
Sbjct: 137 FAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV+L EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQ-LDRNGLQGNREF-LVEVLMLSLLHHPNLVNLI 132
++GEG +G V K R ++T ++VAIK+ + + ++ L EV +L L H N+VNL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY+ L LE LPPD + W + + Y H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--------LQAIAYCHS 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+I+RD+K NIL+ E KL DFG A+ + ++ V T Y APE
Sbjct: 119 HN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPE--- 171
Query: 249 TGQLTLKS-------DVYSFGVVLLEIITGR 272
L + DV++ G ++ E++ G
Sbjct: 172 ---LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 9e-23
Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGY 134
LLG+G FG V+KG L+ V A+K + Q + +FL E +L HPN+V LIG
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C QR +Y M L D L L K L ++ A AA G+ YL K
Sbjct: 61 CT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---C 114
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
I+RDL N L+GE K+SDFG+++ G + + + + APE G+ +
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 255 KSDVYSFGVVLLEIIT 270
+SDV+S+G++L E +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 71/218 (32%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVY------------KGRLESTNQ----VVAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ K E+ N +VA+K L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH-------DLPPDKKRLDWTTR 172
LS L PN+ L+G C ++ EYM G L L L + K L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ +A A G+ YL + ++RDL N L+G+ Y K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + A E + G+ T KSDV++FGV L EI+T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG+VY T +++A+K+ + N + +E E+ +L LL HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
++ + EY G+LE+ L + LD +GL YLH +
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRV---MGTYGYCAPEYAMTG 250
++RD+K +NI L KL DFG A L + T + V GT Y APE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKN--NTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 251 QLTLK---SDVYSFGVVLLEIITGRK 273
+ +D++S G V+LE+ TG++
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-22
Identities = 71/210 (33%), Positives = 114/210 (54%), Gaps = 19/210 (9%)
Query: 76 LLGEGGFGRVYKG----RLESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVN 130
+LG G FG VYKG E+ VAIK L+ G + N EF+ E L+++ + HP+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD---KKRLDWTTRMRIAAGAAKGLEYLH 187
L+G C + LV + MP G L D++H+ + + L+W ++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++ +++RDL N+L+ H K++DFGLA+L +K + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRKAID 276
+ T +SDV+S+GV + E++T G K D
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 3e-22
Identities = 64/212 (30%), Positives = 100/212 (47%), Gaps = 21/212 (9%)
Query: 77 LGEGGFGRVYKGRLEST-----NQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LGE FG+VYKG L T Q VAIK L D+ EF E +M S L HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAG 178
L+G +++ Y L + L P K L+ + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
A G+E+L ++ V+++DL N+L+ + + K+SD GL + D + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ +PE M G+ ++ SD++S+GVVL E+ +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 35/225 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQV----------------VAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ + + + VA+K L + + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDL-----------PPDKKR 166
LS L PN++ L+G C D D ++ EYM G L L H L PP
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 167 L--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+++ + +A A G++YL ++ ++RDL N L+GE K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII 269
GD + R + + A E + G+ T SDV++FGV L EI+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-22
Identities = 76/198 (38%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R TN+VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLH---SHE 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM-TG 250
I+RD+K NILL E KL+DFG A L + +GT + APE AM G
Sbjct: 136 RIHRDIKAGNILLTEPGTVKLADFGSASL------VSPANSFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEI 268
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-22
Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 70 NFRADCLLGEGGFGRVYKG---RLESTN--QVVAIKQLDRNGLQGN-REFLVEVLMLSLL 123
N LGEG FG+V K RL+ VA+K L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPD 163
+HP+++ L G C+ LL+ EY GSL L + PD
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
++ L + A ++G++YL A +++RDL N+L+ EG K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
D ++ + A E T +SDV+SFGV+L EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 72/208 (34%), Positives = 102/208 (49%), Gaps = 28/208 (13%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K R T Q+VAIK+ + + L E+ ML L HPNLVNLI
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY L LE + +P K++ W T + + + H
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCH- 117
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKT-HVSTRVMGTYGYCAPE 245
K N I+RD+K NIL+ + KL DFG A++ GP D T +V+TR Y APE
Sbjct: 118 KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPE 170
Query: 246 YAMTGQLTLKS--DVYSFGVVLLEIITG 271
+ G DV++ G V E++TG
Sbjct: 171 L-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 70/206 (33%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLL-HHPNLV 129
+LG+G FG+V L+ T+++ A+K L ++ + + + VE M L+L HP L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 130 NLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
L C RL V EY+ G L H+ R D AA GL++LH+
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE 114
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +IYRDLK N+LL EG H K++DFG+ K G +G T ++ GT Y APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-I 167
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGR 272
++ Q + D ++ GV+L E++ G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 4e-22
Identities = 68/217 (31%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQL-------DRNGLQGNREFLVEVLMLSLLHHP 126
LGEG + VYK R + T ++VAIK++ ++G+ N L E+ +L L HP
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI--NFTALREIKLLQELKHP 62
Query: 127 NLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLHD-----LPPDKKRLDWTTRMRIAAGA 179
N++ L+ + + LV+E+M LE + D P D K T
Sbjct: 63 NIIGLLDVFGH--KSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT-------- 111
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDK-TH-VSTRVM 236
+GLEYLH +++RDLK +N+L+ KL+DFGLA+ G K TH V TR
Sbjct: 112 LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW- 167
Query: 237 GTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G + E++
Sbjct: 168 ----YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-22
Identities = 74/210 (35%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY TN+VVA+K++ +G Q N ++ + EV L L HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL+DFG A K+ + +GT + APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
Q K DV+S G+ +E+ + + N A
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNMNA 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-22
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 77 LGEGGFGRVY------------KGRLESTNQ--VVAIKQLDRNGLQGNR-EFLVEVLMLS 121
LGEG FG V+ +G E Q +VA+K L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKK--------RLDWTTRM 173
L +PN++ L+G C D ++ EYM G L L + + +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 174 RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233
+A A G++YL A+ ++RDL N L+G Y K++DFG+++ GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + + A E + G+ T SDV++FGV L E+ T
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-22
Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLL-HHPNLVNL 131
+LG+G FG+V L+ + A+K L ++ + + + +VE +L+L +P L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ V E++ G L H+ D K R D AA GL++LH K
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK N++L H K++DFG+ K GD ++ GT Y APE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T D +SFGV+L E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 7e-22
Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSL-LHHPNLVNL 131
+LG+G FG+V L+ TN+ AIK L ++ + + + +VE +L+L HP L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 132 IGYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+C + V EY+ G L H+ R D AA GL++LH K
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+IYRDLK N+LL + H K++DFG+ K G+ ++ GT Y APE
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKG 170
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
+ D +SFGV+L E++ G+
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 8e-22
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI-GYC 135
LG+G FG+VYK + + T A K + + +F+VE+ +LS HPN+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ +L+ E+ G+L+ + +L + ++ + R + + L +LH
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSHK--- 123
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
VI+RDLK NILL KL+DFG++ + + +GT + APE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181
Query: 254 -----LKSDVYSFGVVLLEIITGR 272
K+D++S G+ L+E+
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 8e-22
Identities = 67/218 (30%), Positives = 109/218 (50%), Gaps = 27/218 (12%)
Query: 77 LGEGGFGRVYKGRLE--------------STNQ--VVAIKQLDRNGLQGNR-EFLVEVLM 119
LGEG FG V+ E S NQ +VA+K L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLP-----PDKKRLDWTTR 172
+S L PN++ L+ C D ++ EYM G L L H+ D + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ +A A G++YL ++ ++RDL N L+G+ Y K++DFG+++ GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R + + + E + G+ T SDV++FGV L EI+T
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 1e-21
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 28/214 (13%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVN 130
+LGEG FG V +G+L + + VA+K + + + EFL E + HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 131 LIGYCADGDQR------LLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGA 179
LIG C + +++ +M G L L LP ++L T ++
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---EKLPLQTLLKFMVDI 122
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVM 236
A G+EYL +N I+RDL N +L E ++DFGL+K GD + ++ +
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T KSDV++FGV + EI T
Sbjct: 180 K---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-21
Identities = 71/221 (32%), Positives = 106/221 (47%), Gaps = 45/221 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLV----EVLMLSLLHHPNLVNL 131
+GEG +G+VYK R + T ++VA+K++ L +E F + E+ +L L+H N+VNL
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVR---LDNEKEGFPITAIREIKILRQLNHRNIVNL 71
Query: 132 IGYCADGDQRL----------LVYEYMP---LGSLEDHLHDLPPD------KKRLDWTTR 172
D L LV+EYM +G LE L D K+ L+
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE---- 127
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
GL Y H K ++RD+KCSNILL KL+DFGLA+L + +
Sbjct: 128 ---------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
+V+ T Y PE + + + DV+S G +L E+ T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G ++ +V A+K L + G + FL E ++ L H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L + ++ + +A A+G+ Y+ K I+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKS--DEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIH 126
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY--GYCAPEYAMTGQLTL 254
RDL+ +N+L+ E K++DFGLA+ V + + R + + APE G T+
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 255 KSDVYSFGVVLLEIIT 270
KSDV+SFG++L EI+T
Sbjct: 184 KSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 2e-21
Identities = 67/198 (33%), Positives = 107/198 (54%), Gaps = 18/198 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEG FG V +G E T Q VA+K + + + FL E +++ LHH NLV L+G
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V E M G+L + L + + ++ + A+G+EYL K +++
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYLESKK---LVH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVG-DKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDL NIL+ E K+SDFGLA++G +G D + + + + APE + + K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 256 SDVYSFGVVLLEIIT-GR 272
SDV+S+GV+L E+ + GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 2e-21
Identities = 69/207 (33%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 77 LGEGGFGRVYKGR---LESTNQV--VAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V + L ++ V VA+K L RE L+ E+ ++S L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYL 186
NL+G C G L++ EY G L + L +KR L + + AKG+ +L
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLR-----RKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCA 243
K I+RDL N+LL G K+ DFGLA+ + D +V + R+ + A
Sbjct: 158 ASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMA 211
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE T +SDV+S+G++L EI +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-21
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 19/220 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHH 125
F+ +LG G FG VYKG E VAIK+L + + N+E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKG 182
P++ L+G C +L + + MP G L D++ D + L+W ++ AKG
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ YL ++ +++RDL N+L+ H K++DFGLAKL +K + + +
Sbjct: 122 MNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281
A E + T +SDV+S+GV + E++T G K D A+
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 3e-21
Identities = 62/203 (30%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 77 LGEGGFGRV----YKGRLESTNQVVAIKQLD-RNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V Y ++T + VA+K L +G + E+ +L L+H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C + L+ E++P GSL+++L P +K +++ +++ A KG++YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYA 247
++RDL N+L+ + K+ DFGL K DK + + + + + APE
Sbjct: 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ + + SDV+SFGV L E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+GEG G V+K + T + VA+K++ L+G + L E+ L HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDL-----PPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G +LV EYMP L + L D K RM + KG+ Y+H
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY---MRMLL-----KGVAYMHAN 118
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++RDLK +N+L+ K++DFGLA+L + S +V T Y APE
Sbjct: 119 G---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYG 174
Query: 250 GQ-LTLKSDVYSFGVVLLEIITGR 272
+ D+++ G + E++ G
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 3e-21
Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 27/202 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R +T ++VAIK L+ + E + E+ ML HPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D+ +V EY GSL+D P + ++ + R KGL YLH+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE-----TLKGLAYLHETG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYA- 247
I+RD+K +NILL E KL+DFG++ T + +GT + APE A
Sbjct: 122 --KIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRKSFIGTPYWMAPEVAA 174
Query: 248 --MTGQLTLKSDVYSFGVVLLE 267
G K D+++ G+ +E
Sbjct: 175 VERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 5e-21
Identities = 74/210 (35%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R TN+VVAIK++ +G Q N ++ + EV L + HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L I GA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL+DFG A + + +GT + APE + G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
Q K DV+S G+ +E+ + + N A
Sbjct: 200 QYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-21
Identities = 73/213 (34%), Positives = 108/213 (50%), Gaps = 26/213 (12%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPNLVNL 131
++GEG FG+V K R+ + AIK++ + + R+F E+ +L L HHPN++NL
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHD---LPPD---------KKRLDWTTRMRIAAGA 179
+G C L EY P G+L D L L D L + AA
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G++YL K I+RDL NIL+GE Y K++DFGL++ G + +V + MG
Sbjct: 134 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGRL 185
Query: 240 G--YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ A E T SDV+S+GV+L EI++
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-21
Identities = 72/210 (34%), Positives = 99/210 (47%), Gaps = 19/210 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY LGS D L KK L + GA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH---SHN 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL DFG A + + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280
Q K DV+S G+ +E+ + + N A
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-20
Identities = 67/201 (33%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLH-HPNLVNL 131
+LG+G FG+V RL+ + ++ A+K L ++ + + + + E +LSL HP L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 132 IGYCADGDQRLL-VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
C RL V E++ G L H+ +R D AA L +LHDK
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG 116
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK N+LL H KL+DFG+ K G KT ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D ++ GV+L E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 1e-20
Identities = 68/197 (34%), Positives = 110/197 (55%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G V+ +T Q VAIKQ++ Q +E ++ E+L++ L +PN+VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH AN VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA-----LEFLH--AN-QVI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K N+LLG KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 68/209 (32%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG- 133
++GEG +G+VYK R + T Q+VAIK +D E E +L +HPN+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 134 -----YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ DQ LV E GS+ D + L KRL I +GL YLH+
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
VI+RD+K NILL + KL DFG+ A+L + + GT + APE
Sbjct: 132 NK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEVI 185
Query: 246 ---YAMTGQLTLKSDVYSFGVVLLEIITG 271
+SDV+S G+ +E+ G
Sbjct: 186 ACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 65/197 (32%), Positives = 105/197 (53%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAI+Q++ Q +E ++ E+L++ +PN+VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A LE+LH VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LEFLHSNQ---VI 138
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P K + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E+I G
Sbjct: 196 KVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 2e-20
Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 9/204 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG+G FG R + +V K+++ L + R+ L E+++LSLL HPN++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + L+ EY G+L D + + + + + + Y+H KA +
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIH-KAG--I 122
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RD+K NI L + KL DFG++K+ +G + ++ V+GT Y +PE +
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 255 KSDVYSFGVVLLEIITGRKAIDNT 278
KSD+++ G VL E++T ++ D T
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 66/224 (29%), Positives = 98/224 (43%), Gaps = 62/224 (27%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF--------LVEVLML-SLLHHPN 127
LG+G FG VY R + T ++VAIK++ ++F L EV L L HPN
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------ 181
+V L + D+ V+EYM E +L+ L K R + +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLM--KDR----KGKPFSESVIRSIIYQI 108
Query: 182 --GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----THVSTRV 235
GL ++H K +RDLK N+L+ K++DFGLA+ + + +VSTR
Sbjct: 109 LQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR- 162
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYS-------FGVVLLEIITGR 272
Y APE + L+S YS G ++ E+ T R
Sbjct: 163 ----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-20
Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 13/211 (6%)
Query: 76 LLGEGGFGRVYKGRL----ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVN 130
+LG G FG VYKG E+ VAIK L N + N+E L E +++ + P +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L+G C +L V + MP G L D++ + +K R+ + AKG+ YL +
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDL N+L+ H K++DFGLA+L + + + + + A E +
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 251 QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280
+ T +SDV+S+GV + E++T G K D A
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 9e-20
Identities = 66/197 (33%), Positives = 107/197 (54%), Gaps = 14/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G G VY +T Q VAIKQ++ Q +E ++ E+L++ +PN+VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V EY+ GSL D + + D+ ++ R + A L++LH VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LDFLHSNQ---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RD+K NILLG KL+DFG A++ P +++ ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 255 KSDVYSFGVVLLEIITG 271
K D++S G++ +E++ G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 1e-19
Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 11/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G+ + +V AIK + G +F+ E ++ L HP LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V E+M G L L+ L + +L + + +G+EYL + I+
Sbjct: 70 QQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYAMTGQLTLK 255
RDL N L+ K+SDFG+ + V D + S+ + PE + + K
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 256 SDVYSFGVVLLEIIT 270
SDV+SFGV++ E+ T
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-19
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHPN 127
LG G FG V+ + E +V +K L LQ EF E+ M L H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQ--SEFRRELDMFRKLSHKN 69
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAAGAAKG 182
+V L+G C + + ++ EY LG L+ L D L ++ + A G
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+++L +N ++RDL N L+ K+S L+K + + + +
Sbjct: 130 MDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALIPLRWL 185
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
APE + KSDV+SFGV++ E+ T
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLD---RNGLQGNREFLV---EVLMLSLLHHPNLV 129
+LG+G +G VY G L + Q++A+KQ++ N L +E+ EV +L L H N+V
Sbjct: 7 VLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+G C D + + E++P GS+ L+ P L + G+ YLH+
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNN 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK----LGPVGDKTHVSTRVMGTYGYCAPE 245
V++RD+K +N++L KL DFG A+ +G G +++ + GT + APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277
KSD++S G + E+ TG+ + +
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 2e-19
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
++ G G YKG+ +K++ D N + + E+ + L HPN+V LIG
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNIVKLIGL 751
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C L++EY+ +L + L + L W R +IA G AK L +LH + +P V
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGIAKALRFLHCRCSPAV 804
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+ +L I++ P L L L K +S+ Y APE T +T
Sbjct: 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITE 857
Query: 255 KSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
KSD+Y FG++L+E++TG+ D ++V W
Sbjct: 858 KSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEW 891
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVL-----MLSLLHHPNL 128
LG G F Y+ R T ++A+KQ+ RN +E +VE L +++ L+HP++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 129 VNLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ ++G C D L V E+M GS+ L K+ + ++ +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL----RGLSYLH 120
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLA-KLGPVGDKT-HVSTRVMGTYGYCAP 244
+ +I+RD+K +N+L+ G +++DFG A +L G +++GT + AP
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E Q DV+S G V++E+ T +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 66/206 (32%), Positives = 104/206 (50%), Gaps = 26/206 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV------EVLMLSLLHHPNLV 129
L+GEG +G V K + + T Q+VAIK+ L+ + +V E+ ML L H NLV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF----LESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDH--LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
NLI + LV+E++ DH L DL LD + + +G+E+ H
Sbjct: 64 NLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY 246
+ +I+RD+K NIL+ + KL DFG A+ L G+ V T + T Y APE
Sbjct: 118 ---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPEL 171
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITG 271
+ ++ D+++ G ++ E++TG
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-19
Identities = 58/199 (29%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNLIGYC 135
G FG VY + ST AIK L ++ + + +M+ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 136 ADGDQRLLVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D LV EY+ SL L LP DW + A G+E LH +
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLP-----EDWAKQY--IAEVVLGVEDLHQRG-- 117
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+I+RD+K N+L+ + H KL+DFGL++ G + + +GT Y APE +
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGD 170
Query: 253 TLKSDVYSFGVVLLEIITG 271
SD +S G V+ E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-19
Identities = 65/196 (33%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG VYKG T +VVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G + ++ EY+ GS D L P L+ T I KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP-----LEETYIATILREILKGLDYLHSERK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 256 SDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VY+ R ++ ++VA+K++ +R+G+ + L E+ +L L HPN+V L
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLLLNLRHPNIVELK 72
Query: 133 GYCADGDQR---LLVYEY--MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
G LV EY L SL D++ + + ++ +GL+YLH
Sbjct: 73 EVVV-GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQL------LRGLQYLH 125
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
+ +I+RDLK SN+LL + K++DFGLA+ G T + T Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLWYRAPELL 180
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
T T D+++ G +L E++ +
Sbjct: 181 LGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-19
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ V AIK + + G EF+ E ++ L H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EYM G L ++L + KR + + + +G+ YL K I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIH 123
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ + K+SDFGL++ V D + S+ +G+ + PE + + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 254 LKSDVYSFGVVLLEIIT 270
KSDV++FGV++ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-19
Identities = 63/196 (32%), Positives = 98/196 (50%), Gaps = 11/196 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG V+KG T QVVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G + ++ EY+ GS D L P D+ ++ + + KGL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSEKK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 256 SDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
+ +G G FGRV+ R + A+K + + L+ + E +L + HP
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 127 NLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
++ L + + DQR L + EY+P G L +L + R +T + A+ LE
Sbjct: 62 FIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALE 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH K ++YRDLK NILL + H KL+DFG AK + D+T + GT Y AP
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT---LCGTPEYLAP 167
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITG 271
E + D ++ G+++ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 4e-19
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 25/198 (12%)
Query: 93 TNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-VYEYM 148
T VAIK L + + + F E + + L+HPN+V L+ L V+EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 149 PLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205
P +L + L LP R+ L H++ +++RDLK NI+
Sbjct: 62 PGRTLREVLAADGALPAG-------ETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 206 L---GEGYHPKLSDFGLAKLGP-VGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 257
+ G H K+ DFG+ L P V D +T V+GT YCAPE +T SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 258 VYSFGVVLLEIITGRKAI 275
+Y++G++ LE +TG++ +
Sbjct: 172 LYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-19
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNL 131
++G G FG V++G L+ + VAIK L + R +FL E ++ H N++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G +++ EYM G+L+ +L D + +R G A G++YL D
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAM 248
++RDL NIL+ K+SDFGL+++ P G T ++ + APE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
+ T SDV+SFG+V+ E+++
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 9e-19
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 17/208 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLE 184
+V+L D LV M G L+ H++++ D++R + AA GLE
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLE 116
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
LH + ++YRDLK NILL + H ++SD GLA P G+ + RV GT GY AP
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAP 170
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + T D + G ++ E+I G+
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-19
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G VYKGR + T Q+VA+K++ L+ E + E+ +L L HPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ L++E++ + L+ +L LP + +D +G+ + H +
Sbjct: 65 QDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQILQGILFCHSRR- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V++RDLK N+L+ KL+DFGLA+ G V T + T Y APE +
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSP 177
Query: 252 L-TLKSDVYSFGVVLLEIITGR 272
+ D++S G + E+ T +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 36/210 (17%)
Query: 79 EGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-F----LVEVLMLSLLHHPNLVNL-- 131
EG +G VY+ R + T ++VA+K+L ++ +E F L E+ +L L HPN+V +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GL 183
+ ++ D+ +V EY+ HDL K L T + K G+
Sbjct: 72 VVVGSNLDKIYMVMEYVE--------HDL----KSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
+LHD +++RDLK SN+LL K+ DFGLA+ G T+++ T Y A
Sbjct: 120 AHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRA 174
Query: 244 PEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
PE + + + D++S G + E++T +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQV---VAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
+GEG FG VY+G S VA+K RE FL E ++ HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + + +V E PLG L +L +K LD + + + + L YL K
Sbjct: 73 IGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGYCAPEYAMTG 250
++RD+ N+L+ KL DFGL++ + D+++ +++ + APE
Sbjct: 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESINFR 183
Query: 251 QLTLKSDVYSFGVVLLEII 269
+ T SDV+ FGV + EI+
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG+G FGRVY T + +A+KQ+ D + + +E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 125 HPNLVNLIGYCADGDQRLLVY-EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
H +V G C D+ L ++ EYMP GS++D L L T + +G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGV 117
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYC 242
EYLH +++RD+K +NIL + KL DFG +K L + V GT +
Sbjct: 118 EYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+PE K+DV+S G ++E++T
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 64/196 (32%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+G+G FG V+KG T +VVAIK +D + E + E+ +LS P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ ++ EY+ GS D L P LD T I KGL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLEPGP-----LDETQIATILREILKGLDYLHSEKK---I 123
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +N+LL E KL+DFG+A G + D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 256 SDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 182 ADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 73/221 (33%), Positives = 108/221 (48%), Gaps = 24/221 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH---PNLV 129
++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
+ D+ + + M G L HL H + +K+ MR A GLE++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE-------MRFYATEIILGLEHM 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H++ V+YRDLK +NILL E H ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
G S D +S G +L +++ G + +H +
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-18
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQG---NREFLV----EVLMLSLLHHP 126
L+G G FG VY G S+ +++A+KQ L R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+V +G D D + EY+P GS+ L++ ++ L +I KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI----LKGLNYL 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-----LGPVGDKTHVSTRVMGTYGY 241
H++ +I+RD+K +NIL+ K+SDFG++K + + G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE T K+D++S G +++E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-18
Identities = 61/200 (30%), Positives = 104/200 (52%), Gaps = 13/200 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++++T ++ A K+LD+ L+ G + L+E +L ++ P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 134 YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
Y + L LV M G L+ H++++ ++ L+ + +A G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
++YRD+K N+LL + + +LSD GLA G T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPY 171
Query: 253 TLKSDVYSFGVVLLEIITGR 272
+ D ++ G + E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G V +ST + VA+K++D Q RE L EV+++ HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V E++ G+L D + R++ + K L +LH + VI
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLAVLKALSFLHAQG---VI 137
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTE 195
Query: 256 SDVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 196 VDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 27/209 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G +G VY R ST +AIK++ + + E+ + S L H N+V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
++ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ- 128
Query: 192 PPVIYRDLKCSNILLGEGYHP--KLSDFG----LAKLGPVGDKTHVSTRVMGTYGYCAPE 245
+++RD+K N+L+ Y K+SDFG LA + P + GT Y APE
Sbjct: 129 --IVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPE 179
Query: 246 YAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
G +D++S G ++E+ TG+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-18
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 76 LLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVN 130
++G G FG V +GRL+ VAIK L ++G + R+FL E ++ HPN+++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G +++ E+M G+L+ L + + + + G A G++YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYGYCAPEYA 247
++RDL NIL+ K+SDFGL++ T +G + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ T SDV+S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 4e-18
Identities = 69/211 (32%), Positives = 98/211 (46%), Gaps = 31/211 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM---LSLLHH--PNLVN 130
+G G G+VYK R + T V+A+KQ+ R G N+E +LM + L H P +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI----AAGAAKGLEYL 186
GY + E M + D L KR+ I K L YL
Sbjct: 79 CYGYFITDSDVFICMELM--STCLDKL------LKRIQGPIPEDILGKMTVAIVKALHYL 130
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPE 245
+K VI+RD+K SNILL + KL DFG++ +L V K TR G Y APE
Sbjct: 131 KEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK--TRSAGCAAYMAPE 184
Query: 246 Y----AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ +++DV+S G+ L+E+ TG+
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L H+ + K+ + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE----PHAVFYAAEIAIGLFFLHSKG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTG 250
+IYRDLK N++L H K++DFG+ K G KT TR GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQ 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAID 276
D ++FGV+L E++ G+ D
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-18
Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +YRDLK NILL + H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ TL D + G ++ E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-18
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + VAIK ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR------LDWTTRMRIAAGAAKGLE 184
L+G + G L++ E M G L+ +L L P+ + +++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YL+ AN ++RDL N ++ E + K+ DFG+ + D + + + +P
Sbjct: 134 YLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E G T SDV+SFGVVL EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-18
Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHH 125
+ + ++G G FG V GRL+ + VAIK L + R +FL E ++ H
Sbjct: 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGL 183
PN+++L G ++V EYM GSL+ L HD + + + G A G+
Sbjct: 65 PNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-----GQFTVIQLVGMLRGIASGM 119
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG---TYG 240
+YL D ++RDL NIL+ K+SDFGL+++ + D + G
Sbjct: 120 KYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPIR 174
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE + T SDV+S+G+V+ E+++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-18
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 11/210 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIG 133
LG+GGFG V ++ +T ++ A K+L++ L +G +VE +L+ +H +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV M G L H++++ + A GLE+LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--- 117
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+IYRDLK N+LL + ++SD GLA + D + GT G+ APE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
D ++ GV L E+I R RA GE
Sbjct: 176 FSVDYFALGVTLYEMIAARGPF---RARGE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-18
Identities = 62/198 (31%), Positives = 104/198 (52%), Gaps = 9/198 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKGR +T ++VA+K++ + +G + E+ ++ L H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
++ +LV+EYM L+ ++ D + LD T KG+ + H+ V+
Sbjct: 68 HTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RDLK N+L+ + KL+DFGLA+ + T + V T Y AP+ + +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYST 180
Query: 256 S-DVYSFGVVLLEIITGR 272
S D++S G ++ E+ITGR
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-18
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 18/201 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG FG++Y + +S ++ IK++D + ++ EV++L+ + HPN+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ + +V EY G L ++ L + + L W ++ + GL+++HD+
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIHDRK 121
Query: 191 NPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++RD+K NI L + G KL DFG+A+ + D ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 250 GQLTLKSDVYSFGVVLLEIIT 270
K+D++S G VL E+ T
Sbjct: 177 RPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 7e-18
Identities = 72/206 (34%), Positives = 104/206 (50%), Gaps = 24/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH---PNLV 129
++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+ P +V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
+ D+ + + M G L HL H + + + MR AA GLE++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHM 113
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H++ V+YRDLK +NILL E H ++SD GLA K H S +GT+GY APE
Sbjct: 114 HNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEV 166
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITG 271
G S D +S G +L +++ G
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 8e-18
Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV + + T + AIK L + ++ + E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
D ++ + E++ G L HL P D + A EYLH K
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------YHAELVLAFEYLHSKD 138
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK N+LL H K++DFG AK V D+T + GT Y APE +
Sbjct: 139 ---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LCGTPEYLAPEVIQSK 190
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D ++ GV+L E I G
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-17
Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 21/209 (10%)
Query: 77 LGEGGFGRVY--------KGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPN 127
LG+G FG VY KG E+ VA+K ++ + L+ EFL E ++ +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETR---VAVKTVNESASLRERIEFLNEASVMKGFTCHH 70
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKK----RLDWTTR--MRIAAGAAK 181
+V L+G + G L+V E M G L+ +L L P+ + R T + +++AA A
Sbjct: 71 VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+ YL+ K ++RDL N ++ + K+ DFG+ + D + + +
Sbjct: 131 GMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
APE G T SD++SFGVVL EI +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-17
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSL-LHHPNLVNL 131
+LG+G FG+V L+ T++V AIK L ++ + + + + E +L+L HP L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D+ V EY+ G L + ++ D AA L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
VIYRDLK NILL H KL+DFG+ K G + T +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEILQELE 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D ++ GV++ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-17
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 23/205 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHH---PN 127
L+G G +G VY+G+ T +VVA+K ++ + + V EV +LS L PN
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD----TPDDDVSDIQREVALLSQLRQSQPPN 63
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ G G + ++ EY GS+ + P +K + R + A L+Y+H
Sbjct: 64 ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVA-----LKYIH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
VI+RD+K +NIL+ + KL DFG+A L + + + +GT + APE
Sbjct: 119 ---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVI 173
Query: 248 MTGQL-TLKSDVYSFGVVLLEIITG 271
G+ K+D++S G+ + E+ TG
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 76/228 (33%), Positives = 107/228 (46%), Gaps = 44/228 (19%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL-D--RNGLQGNREFLVEVLMLS-L 122
+ + + LG+G +G V+K T +VVA+K++ D RN R F E++ L L
Sbjct: 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQEL 63
Query: 123 LHHPNLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLHD------LPPDKKRLDWTTRMR 174
HPN+V L+ A+ D+ + LV+EYM E LH L KR
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY------- 111
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHV 231
I K L+Y+H N VI+RDLK SNILL KL+DFGLA+ + V
Sbjct: 112 IMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
T + T Y APE + L S Y+ GV +L E++ G+
Sbjct: 169 LTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-17
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-LSLLHH---PNLVNLI 132
LG G G V K + T V+A K + + ++L L ++H P +V+
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVH---IGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 133 G-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G + + + + E+M GSL+ P + +IA +GL YL++
Sbjct: 70 GAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RD+K SNIL+ KL DFG++ G + + ++ +GT Y +PE G+
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGK 178
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T+KSDV+S G+ ++E+ G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 64/199 (32%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +AN +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL--EANN-FV 124
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
+RDL N+L+ E K+SDFGL K D + + + APE + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 255 KSDVYSFGVVLLEIIT-GR 272
KSDV+SFG++L EI + GR
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------FLVEVLMLSLLHH 125
L+G+G +GRVY +T +++A+KQ++ R E+ L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLE 184
N+V +G+ + + EY+P GS+ L +++ + + T + +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-----EGLA 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
YLH K +++RDLK N+L+ K+SDFG++K + + G+ + AP
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 245 EYAMTGQ--LTLKSDVYSFGVVLLEIITGRK 273
E + + K D++S G V+LE+ GR+
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-17
Identities = 66/205 (32%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V+L D LV M G L+ H++ + + + + AA GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ ++YRDLK NILL + H ++SD GLA P G + RV GT GY APE
Sbjct: 120 QER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D ++ G +L E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-17
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L H+ + K+ + AA + GL +LH +
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE----PQAVFYAAEISVGLFFLHRRG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTG 250
+IYRDLK N++L H K++DFG+ K V V+TR GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAID 276
D +++GV+L E++ G+ D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKG--RLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIG 133
LG G FG V KG ++ VAIK L + R E + E ++ L +P +V +IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
C + + +LV E G L L K + + + + + G++YL K
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMTG 250
++RDL N+LL ++ K+SDFGL+K LG D ++ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 251 QLTLKSDVYSFGVVLLE 267
+ + +SDV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-17
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ + + LG G FG V+ +V A+K + + G FL E ++ L H L
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKL 63
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + ++ E+M GSL D L K+ L + +A A+G+ ++
Sbjct: 64 VKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ 120
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMGTYGYCAPEYA 247
+ I+RDL+ +NIL+ K++DFGLA++ + D + + + APE
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAI 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GR 272
G T+KSDV+SFG++L+EI+T GR
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-17
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 34/220 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQV--VAIKQLDRNGLQGN-REFLVEVLMLSLL-HHPN 127
LGEG FG+V E N+V VA+K L + + + + + E+ M+ ++ H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 236 MGTYG-----YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T G + APE T +SDV+SFGV+L EI T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-17
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQLD-----RNGLQGNREFLVEVLMLSLLHHPNLV 129
LGEG FG V +G+L + + VA+K + R+ ++ +FL E + + HPN++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPNVM 63
Query: 130 NLIGYCADGDQR------LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAK 181
LIG C + +++ +M G L L L + L ++ A
Sbjct: 64 RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+EYL K+ I+RDL N +L E + ++DFGL+K GD +
Sbjct: 124 GMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T KSDV+SFGV + EI T
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-17
Identities = 72/229 (31%), Positives = 95/229 (41%), Gaps = 39/229 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL----MLSLLHHPNLVNL 131
LLG+G GRV+ RL+ T ++ A+K LD+ + R + VL +L+ L HP L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
LV +Y P G L L P K L AA LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG- 123
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-------------------- 231
++YRDLK NILL E H LSDF L+K V
Sbjct: 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 232 ----STRVM---GTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
S R GT Y APE ++G D ++ G++L E++ G
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 17/198 (8%)
Query: 77 LGEGGFGRVYKG--RLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG +++ + + VA+K L D N E L E ++ L +P +V +I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L L K + + + G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTY--GYCAPEYAMT 249
++RDL N+LL ++ K+SDFGL+K LG D+ + + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 250 GQLTLKSDVYSFGVVLLE 267
+ + KSDV+SFGV++ E
Sbjct: 173 YKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 26/211 (12%)
Query: 77 LGEGGFGRVYKG---RLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG+V G R S +VV +K+L FL EV L+HPN++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVV-VKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHD------LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
G C + LLV E+ PLG L+++L K R+A A GL +L
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD-----VLQRMACEVASGLLWL 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H +A+ I+ DL N L K+ D+GLA D + APE
Sbjct: 117 H-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 247 A-------MTGQLTLKSDVYSFGVVLLEIIT 270
+ T KS+++S GV + E+ T
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-16
Identities = 66/205 (32%), Positives = 102/205 (49%), Gaps = 11/205 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPN 127
FR +LG+GGFG V ++ +T ++ A K+L++ ++ G L E +L ++
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V+L D LV M G L+ H++++ D + AA GLE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ ++YRDLK NILL + H ++SD GLA P G+ V RV GT GY APE
Sbjct: 120 RER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVI 173
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D + G ++ E+I G+
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGR---LESTNQ----VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V + ++ + VA+K L N + L+ E+ ++ L+ H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLH-------DLPPD-----KKRLDWTTRMRI 175
++NL+G C ++ EY G+L + L D D +++L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL + I+RDL N+L+ E K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFG+++ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQ--VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V + N+ VA+K L + + LV E+ M+ ++ H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV+L EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-16
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK R + T +VVA+K+ LD + E+ +L L+HPN+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLEYL 186
++ LV+E++ DL KK +D + I K GL +
Sbjct: 68 IHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H V++RDLK N+L+ KL+DFGLA+ V +T+ V T Y APE
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEI 171
Query: 247 AMTGQL-TLKSDVYSFGVVLLEIITGRKAI 275
+ + + D++S G + E++T R+A+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
++GEG FGR + +++Q A+K++ + ++ +R+ E ++L+ + HPN+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIVAF 63
Query: 132 I-GYCADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ ADG +V EY G L + L P+ L W +M + G++++
Sbjct: 64 KESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H+K V++RD+K NI L + KL DFG A+L + + +GT Y PE
Sbjct: 117 HEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL--LTSPGAYACTYVGTPYYVPPEI 171
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT 270
KSD++S G +L E+ T
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 66/201 (32%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E + E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A LEYLH +
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHSRD- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRD+K N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 52/208 (25%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLH 124
NF+ + +G+G F VYK +VVA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD----WTTRMRIAAGAA 180
HPN++ + + ++ +V E G L + K+ + W +++ +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS--- 117
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE++H K +++RD+K +N+ + KL D GL + KT + ++GT
Sbjct: 118 -ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPY 171
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEI 268
Y +PE KSD++S G +L E+
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 3e-16
Identities = 65/200 (32%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVE-VLMLSLLHHPNLVNLI 132
+G+G FG+V + ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQ-----RERSFPEPRARFYAAEIASALGYLHSLN- 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK NILL H L+DFGL K G KT ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQP 172
Query: 252 LTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 3e-16
Identities = 70/211 (33%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGY 134
L+G G +G+VYKGR T Q+ AIK +D G + E E+ ML HH N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 135 CAD------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
DQ LV E+ GS+ D + + + + +W I +GL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQ 129
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 245
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 130 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 181
Query: 246 YAMTGQ-----LTLKSDVYSFGVVLLEIITG 271
+ KSD++S G+ +E+ G
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-16
Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R +T ++ AIK + L+ +F V E++M+ H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
D+ + E+ GSL+D H P + ++ + +R + +GL YLH K
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--- 249
++RD+K +NILL + H KL+DFG++ + +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIGTPYWMAPEVAAVERK 183
Query: 250 GQLTLKSDVYSFGVVLLEI 268
G D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPN 127
LGEG FG+V ++ VA+K L + + + LV E+ M+ ++ H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L P +++ + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
A+G+EYL A+ I+RDL N+L+ E K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+SFGV++ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQ----LDRNGLQGN--REFLVEVL-MLSLLHHPNL 128
+GEG +G VYK R +T + VA+K+ L G+ + RE + +L L HPN+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNI 63
Query: 129 VNLIGYCA--DGDQRL---LVYEYMP--LGSLEDHLHD--LPPDK-KRLDWTTRMRIAAG 178
V L+ C D+ L LV+E++ L + LPP+ K L
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL------- 116
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
+G+++LH +++RDLK NIL+ K++DFGLA+ + T V+ T
Sbjct: 117 -LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSVVVT 169
Query: 239 YGYCAPEYAMTGQLTLKS--DVYSFGVVLLEI 268
Y APE + Q + + D++S G + E+
Sbjct: 170 LWYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ----LDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G +G VYK T +A+K+ LD + + ++E+ +L P +V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + EYM GSL D L+ + + RI KGL++L ++ N
Sbjct: 66 GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEY----A 247
+I+RD+K +N+L+ KL DFG++ L KT++ G Y APE
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGG 177
Query: 248 MTGQLT--LKSDVYSFGVVLLEIITGR 272
T ++SDV+S G+ +LE+ GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 7e-16
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNL 131
++G G + +V RL+ T ++ A+K + + + + + + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 132 IGYCADGDQRLL-VYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C + RL V EY+ G L H+ LP + R ++ + +A L YLH
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLA------LNYLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEY 246
++ +IYRDLK N+LL H KL+D+G+ K G GD T + GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEI 167
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
D ++ GV++ E++ GR D
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 8e-16
Identities = 65/201 (32%), Positives = 95/201 (47%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R +++ + A+K L + + E L E +L HP L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY+ G L HL ++R+ R R A L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 9e-16
Identities = 67/201 (33%), Positives = 95/201 (47%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V + ++T + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A L+YLH + N
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDND 172
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 9e-16
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF-LVEV---LMLSLLHHPNLVNL 131
++G G + +V L+ T ++ A+K + + + + + V+ + + +HP LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 132 IGYCADGDQRL-LVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C + RL V E++ G L H+ LP + R +A + L +LH
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF-------YSAEISLALNFLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPE 245
++ +IYRDLK N+LL H KL+D+G+ K + P GD T ST GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT--ST-FCGTPNYIAPE 166
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
D ++ GV++ E++ GR D
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQ-VVAIKQLDRNGL---QGNRE-------FLVEVLML-SLL 123
LG G FG VYK R ++ Q ++A+K+++ + + RE + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
HPN+V + D+ +V + + L +H + L K+R I L
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
YLH + +++RDL +NI+LGE ++DFGLAK K T V+GT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE K+DV++FG +L ++ T
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+GEG G V + T + VA+K++D Q EV+++ HH N+V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
GD+ +V E++ G+L D + R++ + + L YLH++ VI+
Sbjct: 90 VGDELWVVMEFLEGGALTDIV-----THTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 257 DVYSFGVVLLEIITG 271
D++S G++++E+I G
Sbjct: 200 DIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 66/232 (28%), Positives = 92/232 (39%), Gaps = 49/232 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----FLVEVLMLSLLHHPNLVNL 131
++G G FG V+ R + T QV A+K L R R E +L+ P +V L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVL-RKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 132 IGYCADGDQRLL--VYEYMPLGSLEDHL---HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
Y + D+ L V EYMP G L + L P + R + + +A + L ++
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARF-YIAELVLALDSVHKLGFI 123
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT----------------- 229
H RD+K NIL+ H KL+DFGL K
Sbjct: 124 H---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 230 -----HVSTRVM-----GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
H RV GT Y APE L+ D +S GV+L E++ G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-15
Identities = 57/198 (28%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIG-YC 135
LG+G FG+VYK + + T + A K ++ + +++VE+ +L+ +HP +V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
DG +++ E+ P G+++ + +L D+ + ++ I + L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICRQMLEALQYLHSMK---II 132
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-- 253
+RDLK N+LL KL+DFG++ + S +GT + APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMCETMKDT 190
Query: 254 ---LKSDVYSFGVVLLEI 268
K+D++S G+ L+E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF-LVEV---LMLSLLHHPNLVNL 131
++G G + +V RL+ +Q+ A+K + + + + + V+ + +P LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 132 IGYCADGDQRL-LVYEYMPLGSLEDHLH---DLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
C RL LV EY+ G L H+ LP + R AA L +LH
Sbjct: 62 HS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-------YAAEICIALNFLH 113
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMGTYGYCAPE 245
++ +IYRDLK N+LL H KL+D+G+ K LGP GD T + GT Y APE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTT---STFCGTPNYIAPE 166
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
+ D ++ GV++ E++ GR D
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 67/201 (33%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E L E +L HP L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D+ V EY G L HL ++R+ R R A L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALGYLHSCD- 115
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
V+YRDLK N++L + H K++DFGL K G + D + T GT Y APE
Sbjct: 116 --VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYLAPEVLEDND 171
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 61/224 (27%), Positives = 104/224 (46%), Gaps = 27/224 (12%)
Query: 64 LAAVTKNFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNG--LQGNREFLVEV 117
+A LL EG FGR++ G L + V +K + + +Q L E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL-LLQES 59
Query: 118 LMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSLEDHLHD--LPPDKKRLDWTTR-- 172
+L L H N++ ++ C DG+ ++Y YM G+L+ L L +T+
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGP-----VG 226
+ +A A G+ YLH + VI++D+ N ++ E K++D L++ L P +G
Sbjct: 120 VHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
D + + M A E + + + SDV+SFGV+L E++T
Sbjct: 177 DNENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 43/219 (19%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---------LVEVLMLSLLHHP 126
+G G +G V + T + VAIK++ + F L E+ +L L H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 127 NLVNLIGYCADGDQR-----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-IAAGAA 180
N++ L+ +V E M E LH + + L ++
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLT-DDHIQYFLYQIL 113
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-----PVGDKT-HVSTR 234
+GL+YLH AN VI+RDLK SNIL+ K+ DFGLA+ G T +V TR
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
Query: 235 VMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
Y APE ++ T D++S G + E++T +
Sbjct: 171 W-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G V ++S+ ++VA+K++D Q RE L EV+++ H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
GD+ +V E++ G+L D + R++ + K L LH + VI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIV-----THTRMNEEQIAAVCLAVLKALSVLHAQG---VI 138
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +ILL KLSDFG V + ++GT + APE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 256 SDVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 197 VDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-15
Identities = 70/210 (33%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQL--------DRNGLQGNREFLVEVLMLSLLH 124
+LG+G FG+V+ K Q+ A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 125 HPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTR--MRIAAGAAK 181
HP +V L Y + +L L+ +++ G L L K + +T A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELAL 109
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L++LH +IYRDLK NILL E H KL+DFGL+K +K S GT Y
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
APE T +D +SFGV++ E++TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG+G FGRVY T + +A+KQ+ D + ++E E+ +L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 125 HPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
H +V G D +R L E+MP GS++D L + + TR + +G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV---TR-KYTRQILEG 118
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVM 236
+ YLH +++RD+K +NIL + KL DFG +K L G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----VT 170
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT + +PE K+D++S G ++E++T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLSL 122
+F LG G G V K + ++A IK RN Q RE L +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRN--QIIRE-------LKV 52
Query: 123 LHHPNLVNLIGY----CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
LH N ++G+ +DG+ + + E+M GSL+ L R+ +I+
Sbjct: 53 LHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKA----GRIPENILGKISIA 107
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
+GL YL +K +++RD+K SNIL+ KL DFG++ G + D ++ +GT
Sbjct: 108 VLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGT 161
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275
Y +PE T++SD++S G+ L+E+ GR I
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+VYK + + T + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
+ ++ E+ G+++ + +L P + ++ + + A L YLH+ +
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA-----LNYLHENK---I 124
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCAPEYAMTGQ 251
I+RDLK NIL KL+DFG++ T R +GT + APE M
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS-----AKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 252 -----LTLKSDVYSFGVVLLEI 268
K+DV+S G+ L+E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-15
Identities = 68/211 (32%), Positives = 101/211 (47%), Gaps = 26/211 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGY 134
++G G +G+VYKGR T Q+ AIK +D + E +E+ ML HH N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 135 ------CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
DQ LV E+ GS+ D + + + + DW I +GL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHA 139
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYGYCAPE 245
VI+RD+K N+LL E KL DFG+ A+L D+T V R +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRT-VGRRNTFIGTPYWMAPE 191
Query: 246 YAMTGQ-----LTLKSDVYSFGVVLLEIITG 271
+ +SD++S G+ +E+ G
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-15
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 35/218 (16%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNL 131
L+ G +G VY R + T Q A+K++++ L Q + F VE +L+ +P +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAENPFVVSM 66
Query: 132 IGYCADGDQRLL--VYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+C+ +R L V EY+ G +L ++ LP D R+ + A LEYL
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYF-------AETVLALEYL 117
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-------STR----- 234
H N +++RDLK N+L+ H KL+DFGL+K+G + T++ TR
Sbjct: 118 H---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 235 -VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
V GT Y APE + D ++ G++L E + G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-15
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 20/217 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+GEG FG+ + + + IK+++ + + E EV +LS + HPN+V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ +V +Y G L ++ L P+ + LDW ++ +A L+++HD+
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK 121
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RD+K NI L + KL DFG+A++ + ++ +GT Y +PE
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEICENR 176
Query: 251 QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
KSD+++ G VL E+ T + A + A NLV
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE---AGNMKNLV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-15
Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK----QLDRNGLQGNREFLVEVLMLSLLH---HPNLV 129
+G G +G VYK R + VA+K Q + +GL + + EV +L L HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLST--VREVALLKRLEAFDHPNIV 65
Query: 130 NLIGYCADG--DQRL---LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
L+ CA D+ LV+E++ L +L +PP + T + +GL+
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAE--TIKDLMRQFLRGLD 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS-TRVMGTYGYCA 243
+LH +++RDLK NIL+ G KL+DFGLA++ ++ T V+ T Y A
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRA 175
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEI 268
PE + D++S G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-15
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 77 LGEGGFGRVYKGRLES---TNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG+V G + S QVV +K+L + +Q +FL E L H NL+ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVV-VKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + LLV E+ PLG L+ +L + D TT R+A A GL +LH K N
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH-KNN 120
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA--MT 249
I+ DL N LL K+ D+GL+ D ++ + APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 250 GQL-----TLKSDVYSFGVVLLEI 268
G L T +S+V+S GV + E+
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 8e-15
Identities = 65/225 (28%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----REFLVEVLMLSLLHHPNLVNL 131
L+G+GG G VY ++ VA+K++ R L N + FL E + + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 132 IGYCADGDQRLLVYEYMP------LGSLEDHLHDLPPDKKRLDWTTR----MRIAAGAAK 181
C+DGD VY MP L SL + K L T + I
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-------------KLGPVGDK 228
+EY+H K V++RDLK NILLG + D+G A +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 229 THVST---RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T +++GT Y APE + + +D+Y+ GV+L +++T
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 43/215 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
+GEG +G VYK R + T ++VA+K++ L+ E + E+ +L L+HPN+V L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR---LETEDEGVPSTAIREISLLKELNHPNIVRL 63
Query: 132 --IGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------- 181
+ + + +L LV+E++ L DL KK +D + + K
Sbjct: 64 LDVVHS---ENKLYLVFEFLDL--------DL---KKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LG-PVGDKTHVSTRVMGT 238
G+ Y H V++RDLK N+L+ KL+DFGLA+ G PV TH V+ T
Sbjct: 110 QGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-T 162
Query: 239 YGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
Y APE + Q + D++S G + E++ R
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 65/208 (31%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 76 LLGEGGFGRVYKGRLESTN---QVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
+LG+G FG V + +L+S + Q VA+K L D EFL E + HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 131 LIGYC--ADGDQRL----LVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKG 182
LIG + RL ++ +M G L L + + L T +R A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+EYL K I+RDL N +L E ++DFGL+K GD +
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T SDV++FGV + EI+T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-14
Identities = 64/215 (29%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 70 NFRADCLLGEGGFGRVY------KGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLML 120
N+R LLG+G FGRVY GR + QV Q D + ++E E+ +L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQV----QFDPESPETSKEVSALECEIQLL 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLV--YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
L H +V G D ++ L EYMP GS++D L L + +
Sbjct: 59 KNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQ 114
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR-VMG 237
+G+ YLH +++RD+K +NIL + KL DFG +K + R V G
Sbjct: 115 ILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
T + +PE K+DV+S G ++E++T +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNRE---FLVEVLMLSLLH 124
N+R LLG G FG VY T + +A+KQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 125 HPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
H +V G D +++ L EYMP GS++D L + + TR R +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV---TR-RYTRQILQG 118
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK------LGPVGDKTHVSTRVM 236
+ YLH +++RD+K +NIL + KL DFG +K + G K+ V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
GT + +PE K+DV+S ++E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---------GNREFLVEVLMLSLLHHPN 127
+G+G FG+VY+ R + T ++ A+K L + + G R LV L+ P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE---SPF 57
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL-HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+V L LV +YM G L HL + + R + + A LE+L
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLA-----LEHL 112
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H ++YRDLK NILL H L DFGL+K +KT + GT Y APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEV 167
Query: 247 AMTGQ-LTLKSDVYSFGVVLLEIITG 271
+ + T D +S GV++ E+ G
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 70/225 (31%), Positives = 105/225 (46%), Gaps = 31/225 (13%)
Query: 77 LGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL----QGNR---EFLVEVLMLSLLHHPN 127
LG+G F +YKG L +S +V Q L +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
LV L G C D+ ++V EY+ G L+ LH + L W ++ +A A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 188 DKANPPVIYRDLKCSNILL-----GEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
DK +++ ++ NIL+ EGY P KLSD G+ V + R+
Sbjct: 119 DKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI----P 169
Query: 241 YCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
+ APE GQ LT+ +D +SFG LLEI + + +T ++ E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 20/211 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRN-GLQGNREFLVE--VLMLSLLHHPNLVNLIG 133
LG G +G V K R T ++A+K++ Q + L++ + M S+ P V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFYG 67
Query: 134 YC-ADGDQRLLVYEYMPL--GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+GD V+ M + SL+ + + +IA K LEYLH K
Sbjct: 68 ALFREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY---A 247
+ VI+RD+K SN+L+ KL DFG++ G + D T G Y APE
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSV-AKTIDAGCKPYMAPERINPE 178
Query: 248 MTGQ-LTLKSDVYSFGVVLLEIITGRKAIDN 277
+ + +KSDV+S G+ ++E+ TGR D+
Sbjct: 179 LNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-14
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LG+G FG+V + T+++ AIK L ++ + + + +VE +L+L P + +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
C RL V EY+ G L + + R + AA A GL +LH K
Sbjct: 67 HSCFQTMDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSKG- 121
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+IYRDLK N++L H K++DFG+ K V KT GT Y APE
Sbjct: 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-----GTPDYIAPEIIA 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAID 276
D ++FGV+L E++ G+ +
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-14
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFL--VEVLMLSLLHHPNLVNLI 132
+G G FG V K + + ++A+K++ + + L ++V+M S P +V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSS-DCPYIVKFY 69
Query: 133 GYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAGAAKGLEYLHDK 189
G +GD + E M + SL D + + + + +IA K L YL K
Sbjct: 70 GALFREGDC-WICMELMDI-SL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--K 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+I+RD+K SNILL + KL DFG++ G + D TR G Y APE
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI-AKTRDAGCRPYMAPERIDP 181
Query: 250 GQLT---LKSDVYSFGVVLLEIITGR 272
++SDV+S G+ L E+ TG+
Sbjct: 182 SARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-14
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 77 LGEGGFGRVYKGR-LESTNQVVAIK----QLDRNGLQGNREFLVEVL-MLSLLHHPNLVN 130
+GEG +G+V+K R L++ + VA+K Q G+ + V VL L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 131 LIGYCA----DGDQRL-LVYEYMPLGSLEDHLHDLP----PDKKRLDWTTRMRIAAGAAK 181
L C D + +L LV+E++ L +L +P P + D ++ +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQL------LR 121
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T Y
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWY 175
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE + D++S G + E+ +
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-14
Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
+G+G FG+V + R T ++ A+K + + + E L E +L+ ++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANP 192
++ LV ++ G L HL + R D +R R A LE LH K N
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQR----EGRFD-LSRARFYTAELLCALENLH-KFN- 113
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VIYRDLK NILL H L DFGL KL D + GT Y APE +
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGY 170
Query: 253 TLKSDVYSFGVVLLEIITG 271
T D ++ GV+L E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 5e-14
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIG 133
+G+GG+G+V+ + + T ++VA+K++ ++ L R L E +L+ LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 134 YCADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
D + L EY+P G +L ++L L D R + M A A L Y+H
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARF-YMAEMFEAVDALHELGYIH--- 124
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
RDLK N L+ H KL+DFGL+K G T+ ++ V+G+ Y APE
Sbjct: 125 ------RDLKPENFLIDASGHIKLTDFGLSK----GIVTYANS-VVGSPDYMAPEVLRGK 173
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D +S G +L E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 25/207 (12%)
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-----REFLVEVLMLSLLHHPNLV 129
LGEG + VYKGR + T Q+VA+K++ +G RE +L L H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIRE----ASLLKDLKHANIV 66
Query: 130 NLIGYCADGDQRLLVYEYM--PLGS-LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
L LV+EY+ L ++D L RL +R GL Y
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYC 119
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDV 174
Query: 247 AM-TGQLTLKSDVYSFGVVLLEIITGR 272
+ + + + D++ G + E+ TGR
Sbjct: 175 LLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNRE----FLVEVLMLSLLHHPNL 128
+LG+GG+G+V++ R T ++ A+K L + + N++ E +L + HP +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V+LI G + L+ EY+ G L HL + ++ T ++ + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLER---EGIFMEDTACFYLSE-ISLALEHLHQ 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYA 247
+ +IYRDLK NILL H KL+DFGL K G TH GT Y APE
Sbjct: 119 QG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAPEIL 172
Query: 248 MTGQLTLKSDVYSFGVVLLEIITG 271
M D +S G ++ +++TG
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 8/202 (3%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
NFR + +G G F VY+ VA+K++ D + + + E+ +L L+HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N++ + ++ +V E G L + K+ + T + LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 247 AMTGQLTLKSDVYSFGVVLLEI 268
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK--QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
LG G G VYK T +++A+K LD ++ ++ + E+ +L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
++ + E+M GSL+ + +++ RIA KGL YL + +
Sbjct: 68 FFVENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW---SLKI 116
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
++RD+K SN+L+ KL DFG++ +L KT+V GT Y APE Q
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYG 171
Query: 254 LKSDVYSFGVVLLEIITGR 272
+ SDV+S G+ +E+ GR
Sbjct: 172 IHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 66/223 (29%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VYK R T +VVA+K++ +++G L E+ +L L HPN+V LI
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKILKKLKHPNVVPLI 73
Query: 133 GYCAD-----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK------ 181
+ +R VY P HDL L +++ K
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSVKLTESQIKCYMLQL 124
Query: 182 --GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---------GPVGDKTH 230
G+ YLH+ +++RD+K +NIL+ K++DFGLA+ G G T
Sbjct: 125 LEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTR 181
Query: 231 VSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
T ++ T Y PE + + T D++ G V E+ T R
Sbjct: 182 KYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 64/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V + +S A+K L + + +E + E ++L L HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
++ V +Y+ G L HL ++R R R AA A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQ-----RERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+IYRDLK NILL H L+DFGL K G ++T ++ GT Y APE
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + V+KGR + T +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPV 194
LV+EY L+ L D + ++I +GL Y H + V
Sbjct: 74 HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---V 125
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLT 253
++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+ + + + +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
+ D++ G + E+ +GR + E +L+
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 48/202 (23%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHP 126
NF+ + +G G F VY+ + VA+K++ + + ++ + E+ +L L+HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N++ + + ++ +V E G L + K+ + T + +E++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 247 AMTGQLTLKSDVYSFGVVLLEI 268
KSD++S G +L E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 26/222 (11%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
+L ++F ++G G FG V R +S+ QV A+K L + + + F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMR 174
+++ + +V L + A D + L V EYMP G L + + +D+P R +T +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARF-YTAEVV 152
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVST 233
+A A + ++H RD+K N+LL + H KL+DFG K+ G T
Sbjct: 153 LALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT 202
Query: 234 RVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
V GT Y +PE + G + D +S GV L E++ G
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGYC 135
+GEG G V R + + + VA+K +D Q RE L EV+++ H N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
G++ ++ E++ G+L D + RL+ + + L YLH + VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQG---VI 139
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RD+K +ILL KLSDFG + ++GT + APE +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 256 SDVYSFGVVLLEIITG 271
D++S G++++E++ G
Sbjct: 198 VDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 25/215 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLS 121
+F LG G G V K + + + ++A IK RN + + E+ +L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLH 58
Query: 122 LLHHPNLVNLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P +V G + +DG+ + + E+M GSL+ L + KR+ +++
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVL 113
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL YL +K +++RD+K SNIL+ KL DFG++ G + D ++ +GT
Sbjct: 114 RGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRS 167
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275
Y +PE +++SD++S G+ L+E+ GR I
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 53/198 (26%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE--F----LVEVLMLSLLHHPNLVN 130
+G+G FG V+K R + T Q+VA+K++ L N + F L E+ +L LL H N+VN
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV----LMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 131 LIGYC---ADGDQR-----LLVYEYMPLGSLEDHLHDL------------PPDKKRLDWT 170
LI C A R LV+E+ HDL + K++
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCE--------HDLAGLLSNKNVKFTLSEIKKV--- 124
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGD 227
+M + GL Y+H +++RD+K +NIL+ + KL+DFGLA+ L
Sbjct: 125 MKMLL-----NGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176
Query: 228 KTHVSTRVMGTYGYCAPE 245
+ RV+ T Y PE
Sbjct: 177 PNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 57/216 (26%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFL-VEVLMLSLLHHPNLVN---- 130
+G+G +G V R + + IK+L+ RN + R+ E +LS L HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 131 ----------LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
++G+C GD +Y L++ L P+ + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
L+YLH+K +++RDLK N+ L K+ D G+A++ + ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
Y +PE KSDV++ G + E+ T + A +
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKGR + T+ +VA+K++ +G + EV +L L H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
LV+EY+ L+ +L D ++ +GL Y H + V+
Sbjct: 74 HTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTL 254
+RDLK N+L+ E KL+DFGLA+ + KT+ + V T Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 255 KSDVYSFGVVLLEIITGR 272
+ D++ G + E+ TGR
Sbjct: 185 QIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-13
Identities = 63/201 (31%), Positives = 93/201 (46%), Gaps = 15/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V R ++ + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
D+ V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLH--- 113
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+ ++YRDLK NILL H L+DFGL K + T ++ GT Y APE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 251 QLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPN 127
++ +G G +G V + + VAIK++ + + L E+ +L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 128 LVN----LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA-KG 182
++ L AD +V + M E LH + + L +R +G
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLLRG 119
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKT----HVSTRV 235
L+Y+H AN VI+RDLK SN+L+ E ++ DFG+A+ P K +V+TR
Sbjct: 120 LKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR- 175
Query: 236 MGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAI 275
Y APE ++ + T D++S G + E++ GR+ +
Sbjct: 176 ----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-13
Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLHHPNLVNL--I 132
+GEG +G VYK R TN+ +A+K+ L++ + E+ +L + H N+V L +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKK--RLDWTTRMRIAAGAAKGLEYLHDK 189
+ ++RL LV+EY+ L L+ H+ P K RL T +I G A Y H
Sbjct: 70 VHS---EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCHSH 121
Query: 190 ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK-LG-PVGDKTHVSTRVMGTYGYCAPEY 246
V++RDLK N+L+ + KL+DFGLA+ G PV TH T Y APE
Sbjct: 122 R---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEI 174
Query: 247 AM-TGQLTLKSDVYSFGVVLLEIITGR 272
+ + + D++S G + E++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF----LVEVLMLSLLHHPNLVNL 131
++GEG +G V K R + T ++VAIK+ + + N E L E+ ML L N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 132 IGYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY+ L LE+ + +PP+K R + ++ K + + H
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-SYIYQL------IKAIHWCHK 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+++RD+K N+L+ KL DFG A+ G + T + T Y +PE +
Sbjct: 119 ND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLL 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
D++S G +L E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 5e-13
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD---RNGLQGNREFLVEV-LMLSLLHHPNLVNLI 132
+GEG F V K + T + AIK + ++ Q N L E+ + L HPN++ LI
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN--LREIQALRRLSPHPNILRLI 64
Query: 133 GYCADGDQ-RL-LVYEYMPLGSLEDHLHDLPPDKKR-LDWTTRMRIAAGAAKGLEYLHDK 189
D RL LV+E M + +L++L +KR L K L+++H
Sbjct: 65 EVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----THVSTRVMGTYGYCAPE 245
+ +RD+K NIL+ + KL+DFG + + K ++STR Y APE
Sbjct: 120 G---IFHRDIKPENILI-KDDILKLADFGSCR--GIYSKPPYTEYISTR-----WYRAPE 168
Query: 246 YAMT-GQLTLKSDVYSFGVVLLEIIT 270
+T G K D+++ G V EI++
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 6e-13
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G+V T + VAIK+L R + + R + E+ +L + H N++ L+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 134 -YCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+ VY L + L+++ +K D + + +GL+Y+H A
Sbjct: 82 VFTPASSLEDFQDVYLVTHL--MGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIH-SA 137
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT- 249
+I+RDLK SNI + E K+ DFGLA+ +V+TR Y APE +
Sbjct: 138 G--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 190
Query: 250 GQLTLKSDVYSFGVVLLEIITGR 272
D++S G ++ E++TG+
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-13
Identities = 70/207 (33%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG-- 133
+G+G +G+VYK + + A+K LD + E E +L SL +HPN+V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 134 YCAD---GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
Y AD G Q LV E GS+ + + L +RLD I GA GL++LH
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH--- 145
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
N +I+RD+K +NILL KL DFG+ A+L + + S +GT + APE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 202
Query: 250 GQ-----LTLKSDVYSFGVVLLEIITG 271
Q + DV+S G+ +E+ G
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-13
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 13/214 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + V+KGR + T +VA+K++ +G + EV +L L H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA-GAAKGLEYLHDKANPPV 194
LV+EY L+ L + L ++I +GL Y H + +
Sbjct: 73 HTERCLTLVFEY-----LDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---I 124
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLT 253
++RDLK N+L+ E KL+DFGLA+ V KT+ + V T Y P+ + + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 254 LKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
D++ G +L E+ TGR + E +L+
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 18/211 (8%)
Query: 84 RVYKGRLESTNQVVAIKQL--DRNGLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140
+YKG N+ V I+ G + E+ L + N++ + G+ D
Sbjct: 35 SIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD 92
Query: 141 RL----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
L L+ EY G L + L +K L + T++ +A KGL L+ N P Y
Sbjct: 93 DLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--Y 146
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
++L + L+ E Y K+ GL K+ +V+ V +Y ++ + T+K
Sbjct: 147 KNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFS---EYTIKD 203
Query: 257 DVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
D+YS GVVL EI TG+ +N ++L+
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 20/201 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G FG V R + T Q VAIK++ + + R + E+ +L L H N+++L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSD 76
Query: 134 -YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ + + V E + LH L + L+ +GL+Y+H
Sbjct: 77 IFISPLEDIYFVTELL-----GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYVHSAG-- 128
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ- 251
V++RDLK SNIL+ E K+ DFGLA++ +VSTR Y APE +T Q
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQK 182
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
++ D++S G + E++ G+
Sbjct: 183 YDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEV-LMLSLLHHPNLVNL 131
++G+G FG+V + + + A+K L + + +E + E ++L + HP LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
++ V +++ G L HL ++R R R AA A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQ-----RERSFPEPRARFYAAEIASALGYLH--- 113
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG-PVGDKTHVSTRVMGTYGYCAPEYAMT 249
+ ++YRDLK NILL H L+DFGL K G D T T GT Y APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRK 170
Query: 250 GQLTLKSDVYSFGVVLLEIITG 271
D + G VL E++ G
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFL----VEVLMLSL 122
NF +LG G +G+V+ R ++ A+K L + + + E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 123 LHH-PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA- 179
+ P LV L Y D +L L+ +Y+ G L HL+ ++ + +R+
Sbjct: 61 VRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFT-ESEVRVYIAEI 114
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVMG 237
L++LH +IYRD+K NILL H L+DFGL+K L ++ + G
Sbjct: 115 VLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCG 168
Query: 238 TYGYCAPEYAMTGQLTLKS--DVYSFGVVLLEIITG 271
T Y APE G D +S GV+ E++TG
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG+ + ++VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 136 ADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ LV+EY+ ++ H L P+ +L +R GL Y+H +
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQRY-- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQ 251
+++RDLK N+L+ + KL+DFGLA+ V T+ + V T Y P+ + + +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLLGSTE 180
Query: 252 LTLKSDVYSFGVVLLEIITGRKA 274
+ D++ G + +E+I G A
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 35/223 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD----RNGLQGNREF----------LVEVLMLSL 122
LGEG +G+V K T ++VAIK++ N + +R+ L E+ +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ H N++ L+ +GD LV + M L + K RL + I G
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-------LGPVGDKTHVSTRV 235
L LH ++RDL +NI + K++DFGLA+ + + R
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 236 MGTYG-----YCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGR 272
T Y APE M + D++S G + E++TG+
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 4e-12
Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 76 LLGEGGFGRVYKG--RLESTNQV-VAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVN 130
+LG G FG + +G +L S ++ VAI L R G R FL E L L H N+V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G G+ ++V EYM G+L+ L + +L M + G A G++YL +
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG 127
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG---YCAPEYA 247
+++ L +L+ K+S F + DK+ M + APE
Sbjct: 128 ---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ SDV+SFG+V+ E+++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-12
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLIG 133
+G G +G VYK R T ++ A+K + L+ +F + E+ M+ H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
++ + EY GSL+D H P + ++ + R + +GL YLH K
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---T 249
++RD+K +NILL + KL+DFG+A + +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 250 GQLTLKSDVYSFGVVLLEI 268
G D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 72/268 (26%), Positives = 109/268 (40%), Gaps = 80/268 (29%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNLV 129
LG G FG+V + +T + VA+K L L+ L ++ + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 130 NLIGYCAD-GDQRLLVYEYMPLGSLEDHLH------------------------DLPPD- 163
NL+G C G +++ E+ G+L ++L D+ D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 164 KKRLDWTTRMRIAAGA--------------------------------------AKGLEY 185
K+RLD T + +A + AKG+E+
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYC 242
L A+ I+RDL NILL E K+ DFGLA+ D +V R+ +
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWM 248
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
APE T++SDV+SFGV+L EI +
Sbjct: 249 APETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 5e-12
Identities = 62/230 (26%), Positives = 101/230 (43%), Gaps = 49/230 (21%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLL 123
V ++ +GEG +G V + T VAIK++ + R L E+ +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ-TFCQRT-LREIKILRRF 60
Query: 124 HHPNLVNL------IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM---- 173
H N++ + + + D +V E M E L+ +L T +
Sbjct: 61 KHENIIGILDIIRPPSFESFNDV-YIVQELM-----ETDLY-------KLIKTQHLSNDH 107
Query: 174 ------RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
+I +GL+Y+H AN V++RDLK SN+LL K+ DFGLA+ + D
Sbjct: 108 IQYFLYQIL----RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IAD 157
Query: 228 KTHVSTRVMGTY----GYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
H T + Y Y APE + + K+ D++S G +L E+++ R
Sbjct: 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 68/232 (29%)
Query: 78 GEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNL 128
G G +GRVYK + + + AIK+ + Q RE + +L L H N+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRELKHENV 64
Query: 129 VNLIGYC-ADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDW--------TTRMRIAAG 178
V+L+ D+ + L+++Y HDL W R+ I
Sbjct: 65 VSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHRQAKRVSIPPS 108
Query: 179 AAK--------GLEYLHDKANPPVIYRDLKCSNILL-GEGYHP---KLSDFGLAKL--GP 224
K G+ YLH V++RDLK +NIL+ GEG K+ D GLA+L P
Sbjct: 109 MVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
Query: 225 V-----GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIIT 270
+ D V+ T Y APE + + K+ D+++ G + E++T
Sbjct: 166 LKPLADLDP------VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 59/199 (29%), Positives = 92/199 (46%), Gaps = 16/199 (8%)
Query: 77 LGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV ++ + VAIK+ +++ + ++ E +L+ ++HP VNL
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G D LV E++ G L KR AA EYL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN-- 151
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
++YRDLK N+LL + K++DFG AK+ V +T+ + GT Y APE +
Sbjct: 152 -IVYRDLKPENLLLDKDGFIKMTDFGFAKV--VDTRTYT---LCGTPEYIAPEILLNVGH 205
Query: 253 TLKSDVYSFGVVLLEIITG 271
+D ++ G+ + EI+ G
Sbjct: 206 GKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 9e-12
Identities = 64/217 (29%), Positives = 98/217 (45%), Gaps = 24/217 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
K+F L+G G FG V R ++T + A+K + ++ L F E +LS+ +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLD-WTTRMRIAAGAAKG 182
P + L D D LV EY P G L L ++ D+ + + +A +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGY 241
+ Y+H RD+K N+L+ H KL+DFG A+L +K S +GT Y
Sbjct: 121 MGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDY 169
Query: 242 CAPEYAMT------GQLTLKSDVYSFGVVLLEIITGR 272
APE T G ++ D +S GV+ E+I GR
Sbjct: 170 IAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 20/223 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG Q+VA+K + +G + E +L L H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 136 ADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ V+EYM + H L P RL +R GL Y+H +
Sbjct: 73 HTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQH-- 123
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++RDLK N+L+ KL+DFGLA+ + +T+ S V T Y P+ + G
Sbjct: 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGAT 179
Query: 253 TLKS--DVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293
S D++ G + +E++ G+ A E W TVL
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW-TVL 221
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K + T+++VA+K++ D G+ + L E+ +L L H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+EY DL KK D + I K GL
Sbjct: 66 DVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ H V++RDLK N+L+ + KL+DFGLA+ + + + S V+ T Y P
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPP 168
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEI 268
+ +L S D++S G + E+
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 65/247 (26%), Positives = 104/247 (42%), Gaps = 52/247 (21%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
+S S + + EL V + +G G G VYK T ++ A+K +
Sbjct: 57 SSSSSASGSAPSAAKSLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVI-- 107
Query: 105 NGLQGNREFLV------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH-- 156
GN E V E+ +L ++HPN+V + ++ E+M GSLE
Sbjct: 108 ---YGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 157 -----LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211
L D+ A G+ YLH + +++RD+K SN+L+ +
Sbjct: 165 ADEQFLADV---------------ARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKN 206
Query: 212 PKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMT----GQLT-LKSDVYSFGVVL 265
K++DFG+++ L D + S +GT Y +PE T G D++S GV +
Sbjct: 207 VKIADFGVSRILAQTMDPCNSS---VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263
Query: 266 LEIITGR 272
LE GR
Sbjct: 264 LEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-11
Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 77 LGEGGFGRVYKG---RLESTNQV----VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG+G F +++KG + ++ V +K LD++ + F M+S L H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C GD+ ++V EY+ GSL+ +L +K ++ + ++ +A A L +L DK
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 190 ANPPVIYRDLKCSNILL------GEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
+ + ++ N+LL G P KLSD G++ V K + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEILLERI----PW 170
Query: 242 CAPEYAMTGQ-LTLKSDVYSFGVVLLEIITG 271
PE Q L+L +D +SFG L EI +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 70/263 (26%), Positives = 109/263 (41%), Gaps = 76/263 (28%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGN--REFLVEV-LMLSLLHHPNL 128
LG G FG+V + ++ + VA+K L + G + + + E+ +++ + HH N+
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHHLNV 73
Query: 129 VNLIGYCADGDQRLLV-YEYMPLGSLEDHLHDL-------------------PPDKK-RL 167
VNL+G C L+V EY G+L ++L KK RL
Sbjct: 74 VNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRL 133
Query: 168 DWTTRMRIAAGA-------------------------------------AKGLEYLHDKA 190
D + + +A + A+G+E+L A
Sbjct: 134 DSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---A 190
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYA 247
+ I+RDL NILL E K+ DFGLA+ D +V R+ + APE
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL--PLKWMAPESI 247
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
T +SDV+SFGV+L EI +
Sbjct: 248 FDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 24/221 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
R+L +++ ++G G FG V R +S+ +V A+K L + + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLP-PDKKRLDWTTRMRI 175
+++ + P +V L +CA D + L V EYMP G L + + + P+K +T + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTR 234
A A + +H RD+K N+LL + H KL+DFG K+ G T
Sbjct: 154 ALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTA 203
Query: 235 VMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
V GT Y +PE + G + D +S GV L E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 28/223 (12%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVL 118
R+L +++ ++G G FG V R +ST +V A+K L + + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIA 176
+++ + P +V L D +V EYMP G L + + +D+P R +T + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF-YTAEVVLA 154
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG----LAKLGPVGDKTHVS 232
A + ++H RD+K N+LL + H KL+DFG + K G V T V
Sbjct: 155 LDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 233 TRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITG 271
GT Y +PE + G + D +S GV L E++ G
Sbjct: 205 ----GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVA-------IKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG G G V+K + + ++A IK RN + + E+ +L + P +V
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRN------QIIRELQVLHECNSPYIV 66
Query: 130 NLIG-YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
G + +DG+ + + E+M GSL+ L R+ +++ KGL YL +
Sbjct: 67 GFYGAFYSDGEISICM-EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K +++RD+K SNIL+ KL DFG++ G + D ++ +GT Y +PE
Sbjct: 122 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQ 175
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAI 275
+++SD++S G+ L+E+ GR I
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 17/206 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIG-- 133
+G+G +G+V+K + A+K LD + E E +L +L HPN+V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 134 YCAD---GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
Y D GDQ LV E GS+ D + +R++ I A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY-AMT 249
I+RD+K +NILL KL DFG++ + +GT + APE A
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAPEVIACE 199
Query: 250 GQL----TLKSDVYSFGVVLLEIITG 271
QL + DV+S G+ +E+ G
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 61/214 (28%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
++G+G +G V T + VAIK+++ + L E+ +L LL HP++V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 134 YCADGDQR-----LLVYEYMPLGSLEDHLH-------DLPPDKKRLDWTTRMRIAAGAAK 181
+R +V+E M E LH DL P+ + +R
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLR------- 114
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS-TRVMGTYG 240
L+Y+H AN V +RDLK NIL K+ DFGLA++ T + T + T
Sbjct: 115 ALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 241 YCAPEY--AMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + + T D++S G + E++TG+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 13/202 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G FG+V + + V V +K+L N + EFL + +L HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
C + LLV+EY LG L+ +L ++ R+A A G+ ++H K N
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH-KHN-- 119
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA------ 247
++ DL N L K+ D+G+ D + APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG 179
Query: 248 -MTGQLTLKSDVYSFGVVLLEI 268
+T + T S+V++ GV L E+
Sbjct: 180 LITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 25/216 (11%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
K+++ ++G G FG VY+ T++ VAIK++ ++ NRE L+ + L+H N
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHIN 120
Query: 128 LVNLIGY----CADGDQRLL----VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
++ L Y C +++ + V E++P ++ ++ + L +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK--LGPVGDKTHVSTRVM 236
+ L Y+H K + +RDLK N+L+ H KL DFG AK L +++ +R
Sbjct: 180 CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 237 GTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITG 271
Y APE + T D++S G ++ E+I G
Sbjct: 236 ----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-10
Identities = 43/150 (28%), Positives = 67/150 (44%), Gaps = 18/150 (12%)
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGL 183
PN+V L Y D LV ++ G L H+ P++ W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHVSTRVMGTYGYC 242
+ LH + ++ RDL +NILL + H +L+ F +++ D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
APE + T D +S G +L E++TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-10
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 77 LGEGGFGRVY-----KGRLESTNQV---VAIKQLDRN-GLQGNREFLVEVLMLSLLHHPN 127
LG+G FG VY K E +V + + +L+ N +Q N E +LS L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL------DWTTRMRIAAGAAK 181
+V + D ++ EY L+ L +L K L +W ++ +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------ 117
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
G+ Y+H + +++RDLK NI L K+ DFG+++L + ++T GT Y
Sbjct: 118 GVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYY 171
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEI 268
+PE KSD++S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 71/262 (27%), Positives = 101/262 (38%), Gaps = 71/262 (27%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPN 127
+LG G FG+V + +S+ VA+K L + L+ L + L+H H N
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKI-LIHIGNHLN 72
Query: 128 LVNLIGYCADGDQRLLV-YEYMPLGSLEDHLH----------DLPPDKKRLDWTT----- 171
+VNL+G C + L+V E+ G+L + L + P ++
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 172 -RMRIAAGAAKGLEYLHDK-----ANPP-------------------------------- 193
RI AG A L NPP
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 194 --VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV---STRVMGTYGYCAPEYAM 248
I+RDL NILL E K+ DFGLA+ D +V S R+ + APE
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIF 249
Query: 249 TGQLTLKSDVYSFGVVLLEIIT 270
T +SDV+SFGV+L EI +
Sbjct: 250 DKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
+ + + + +G G +G V + T + VAIK+L R + + R + E+ +L +
Sbjct: 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHM 71
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
H N++ L+ D Q LV YM + H L DK + +
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-------LVY 124
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
GL+Y+H +I+RDLK N+ + E K+ DFGLA+ +V TR
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR--- 178
Query: 238 TYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E++TG+
Sbjct: 179 --WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 49/199 (24%), Positives = 83/199 (41%), Gaps = 16/199 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
L G GRV+ V +K G +G L+E ++L ++HP+++ +
Sbjct: 74 LTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLV 127
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
G +V + D L + L + I +GL YLH + +I+
Sbjct: 128 SGAITCMVLPHYS----SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIH 180
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RD+K NI + + + D G A+ PV + + GT APE + K+
Sbjct: 181 RDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKA 237
Query: 257 DVYSFGVVLLEIITGRKAI 275
D++S G+VL E++ I
Sbjct: 238 DIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 63/213 (29%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHH 125
NF +LG G +G+V+ R S + ++ A+K L + + Q + +L H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 126 ----PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
P LV L Y D +L L+ +Y+ G L HL ++R +
Sbjct: 61 IRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQIYSGEIV 115
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE+LH +IYRD+K NILL H L+DFGL+K D+ + GT
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIE 171
Query: 241 YCAPEYAMTGQLTLKS--DVYSFGVVLLEIITG 271
Y AP+ G D +S GV++ E++TG
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 5e-09
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 80 GGFGRVYKGRLESTNQVVAIK------QLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
G FG+VY GR ++ +++ A+K +++N + + E L+L P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ LV EY+ G ++ LH D ++ + A L+YLH
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG--- 124
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKL 222
+I+RDLK N+L+ H KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 6e-09
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIK----QLDRNGLQGNREFLVEV-LMLSLLHHPNLVNL 131
+GEG +G+VYK R ++T ++VA+K ++D G+ L E+ L+ L +V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 132 IGY----CADGDQRL-LVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ +G L LV+EY+ L D P L T KG+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRP--LPAKTIKSFMYQLLKGVA 124
Query: 185 YLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLG--PVGDKTHVSTRVMGTYGY 241
+ H V++RDLK N+L+ + K++D GL + PV TH + T Y
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLWY 177
Query: 242 CAPEYAMTG-QLTLKSDVYSFGVVLLEIITG 271
APE + + D++S G + E+
Sbjct: 178 RAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 27/216 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFLVEVLML--SLLH 124
NF +LG G +G+V+ R + T ++ A+K L + L + VE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLE 59
Query: 125 H----PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
H P LV L Y + +L L+ +Y+ G + HL+ + +R +G
Sbjct: 60 HVRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE-----DEVRFYSGE 113
Query: 180 A-KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK--LGPVGDKTHVSTRVM 236
LE+LH ++YRD+K NILL H L+DFGL+K L ++T+
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY---SFC 167
Query: 237 GTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIITG 271
GT Y APE K+ D +S G+++ E++TG
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 7e-09
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 41/224 (18%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EV 117
++F ++G G FG V +L++ ++V A+K L++ + R+ LV +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 118 LMLSLLHHP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
++ LH+ NL ++ Y GD L L ED L P D R +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YLAE 110
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
M IA + L Y+H RD+K NIL+ H +L+DFG + L + D T S
Sbjct: 111 MVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQS 160
Query: 233 TRVMGTYGYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
+ +GT Y +PE AM G+ + D +S GV + E++ G
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 21/208 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G V + TN+ VAIK++ N + R L E+ +L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 134 YCADGDQR-----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ +VYE M + LH + + L +GL+Y+H
Sbjct: 72 IMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH- 125
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
AN V++RDLK SN+LL K+ DFGLA+ +K T + T Y APE +
Sbjct: 126 SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 249 T-GQLTLKSDVYSFGVVLLEIITGRKAI 275
+ T DV+S G + E++ GRK +
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVE 116
T E+ ++ + +G G +G V T VAIK+L R + L R + E
Sbjct: 9 TIWEVPDRYRDLKQ---VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-E 64
Query: 117 VLMLSLLHHPNLVNLIG-YCADG--DQRLLVYEYMP-----LGSLEDHLHDLPPDKKRLD 168
+ +L + H N++ L+ + D D+ Y MP LG L H ++L
Sbjct: 65 LRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--------EKLS 116
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
+ KGL+Y+H +I+RDLK N+ + E K+ DFGLA+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMT 173
Query: 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
+V TR Y APE + T D++S G ++ E++TG+
Sbjct: 174 GYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 43/222 (19%)
Query: 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
C +G G +G VYK + + + A+KQ++ G+ + E+ +L L HPN++ L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQ 64
Query: 133 G-YCADGDQRL-LVYEYMPLGSLEDHLHDL----------PPDKKRLDWTTRM--RIAAG 178
+ + D+++ L+++Y HDL +KK + M +
Sbjct: 65 KVFLSHSDRKVWLLFDYAE--------HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQ 116
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNIL-LGEGYHP---KLSDFGLAK-----LGPVGDKT 229
G+ YLH AN V++RDLK +NIL +GEG K++D G A+ L P+ D
Sbjct: 117 ILDGIHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIIT 270
V T+ Y APE + + K+ D+++ G + E++T
Sbjct: 174 PVVV----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 35/218 (16%)
Query: 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
C +G G +G VYK + + ++ A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQ 64
Query: 133 G-YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------G 182
+ + D+++ L+++Y + D H + + +++ G K G
Sbjct: 65 KVFLSHADRKVWLLFDY----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 183 LEYLHDKANPPVIYRDLKCSNIL-LGEGYHP---KLSDFGLAK-----LGPVGDKTHVST 233
+ YLH AN V++RDLK +NIL +GEG K++D G A+ L P+ D V
Sbjct: 121 IHYLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 234 RVMGTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLEIIT 270
T+ Y APE + + K+ D+++ G + E++T
Sbjct: 178 ----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 58/193 (30%), Positives = 92/193 (47%), Gaps = 31/193 (16%)
Query: 93 TNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----V 144
T Q VAIK+L R N R + VLM L++H N++ L+ Q+ L V
Sbjct: 40 TGQNVAIKKLSRPFQNVTHAKRAYRELVLM-KLVNHKNIIGLLN--VFTPQKSLEEFQDV 96
Query: 145 YEYMPLGSLEDHLH-----DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL 199
Y M L ++ +L DL D +R+ + + G+++LH + +I+RDL
Sbjct: 97 YLVMEL--MDANLCQVIQMDL--DHERMSYLLYQMLC-----GIKHLH---SAGIIHRDL 144
Query: 200 KCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVY 259
K SNI++ K+ DFGLA+ G ++ V+ Y Y APE + D++
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIW 201
Query: 260 SFGVVLLEIITGR 272
S G ++ E+I G
Sbjct: 202 SVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 41/217 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EVLMLSLLH 124
++G G FG V ++++T QV A+K L++ + R+ LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 125 HP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ NL ++ Y GD L L ED L P D R + M +A +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YLAEMVLAIDS 117
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L Y+H RD+K N+LL + H +L+DFG + L + D T S +GT
Sbjct: 118 VHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167
Query: 240 GYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
Y +PE AM G+ + D +S GV + E++ G
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 41/217 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR---------NGLQGNREFLV--EVLMLSLLH 124
++G G FG V +++ T ++ A+K L++ + R LV + ++ LH
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 125 HP-----NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ L ++ Y GD L L ED L P D R + M +A +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTL------LSKFEDRL---PEDMARF-YIAEMVLAIHS 117
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L Y+H RD+K N+LL H +L+DFG + L D T S+ +GT
Sbjct: 118 IHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTP 167
Query: 240 GYCAPEY--AM---TGQLTLKSDVYSFGVVLLEIITG 271
Y +PE AM G+ + D +S GV + E++ G
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQ--VVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG+G +G V R T++ VAIK++ + R L+ H N+ L
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67
Query: 132 IGY-CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+Y Y L +E LH + + L GL+Y+H A
Sbjct: 68 YDMDIVFPGNFNELYLYEEL--MEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH-SA 124
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---LGPVGDKTHVSTRVMGTYGYCAPEYA 247
N V++RDLK N+L+ K+ DFGLA+ P + + T + T Y APE
Sbjct: 125 N--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVATRWYRAPEIM 181
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGRKAI 275
++ Q K+ DV+S G +L E++ GRK +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 34/92 (36%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGT 238
A G+E+L A+ ++RDL N+L+ EG K+ DFGLA+ + D ++S
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRDSNYISKGSTFLP 304
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T SDV+SFG++L EI T
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 67/270 (24%), Positives = 101/270 (37%), Gaps = 64/270 (23%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLD------RNG---LQGNREFLVEVLMLSLLHHPN 127
+G G FG V R TN + A+K L RN ++ R+ L E +
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L D D V +Y+P G + L L ++ L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL---------------------------- 219
I+RD+K NIL+ H KL+DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 220 --AKLGPVGDKTHVSTRV-----------MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLL 266
+++ K R +GT Y APE + T D +S GV+L
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 267 EIITGRKA-IDNTRAAGEHNLVAWVTVLSF 295
E++ G+ + +T A + ++ W T L
Sbjct: 236 EMLVGQPPFLADTPAETQLKVINWETTLHI 265
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 3/94 (3%)
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ ++H K +I+RD+K +NILL KL DFG +K+ V GT Y
Sbjct: 156 VHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276
APE + K+D++S GV+L E++T ++ D
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 53/212 (25%), Positives = 91/212 (42%), Gaps = 37/212 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+G G +G V Q VA+K+L R L R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 135 CADGDQRLLVYEYMPLGSLED-------------HLHDLPPDKKRLDWTTRMRIAAGAAK 181
+ P S+E+ L+++ +K D + I +
Sbjct: 83 ------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-LLR 129
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
GL+Y+H +I+RDLK SN+ + E ++ DFGLA+ +V+TR Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 242 CAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
APE + D++S G ++ E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 59/230 (25%), Positives = 102/230 (44%), Gaps = 37/230 (16%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G G V+ ++ VA+K++ Q + L E+ ++ L H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 137 DGDQRL--------------LVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
L +V EYM L ++ + L + RL +R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLR------ 125
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK-LGP-VGDKTHVSTRVMG 237
GL+Y+H AN V++RDLK +N+ + E K+ DFGLA+ + P K ++S ++
Sbjct: 126 -GLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 238 TYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
+ Y +P ++ T D+++ G + E++TG+ AG H L
Sbjct: 182 KW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-----PLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 62/250 (24%), Positives = 99/250 (39%), Gaps = 76/250 (30%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLHHP 126
++G G FG V + + T + A+K+L ++ + + R+ L E +P
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA------DNP 61
Query: 127 NLVNLIGYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT---TRMRIAAGAAK 181
+V L Y + D + L+ EY+P G + L K+ +T TR IA
Sbjct: 62 WVVKL--YYSFQDENYLYLIMEYLPGGDMMTLL------MKKDTFTEEETRFYIAE-TIL 112
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG-DKTHVST------- 233
++ +H K I+RD+K N+LL H KLSDFGL G K+H +
Sbjct: 113 AIDSIH-KLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSH 165
Query: 234 ---------------------------RVM-----GTYGYCAPEYAMTGQLTLKSDVYSF 261
R + GT Y APE + + D +S
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSL 225
Query: 262 GVVLLEIITG 271
GV++ E++ G
Sbjct: 226 GVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 5/92 (5%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGT 238
A+G+E+L A+ ++RDL N+LL +G K+ DFGLA+ + D +VS
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLP 302
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T SDV+S+G++L EI +
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 5/93 (5%)
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL+YLH A +++RD+K N+L+ K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 241 YCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGR 272
Y APE M + T D++S G + E++ R
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 13/96 (13%)
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
AKG+ +L K I+RDL NILL G K+ DFGLA+ D + S V+
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVKGN 275
Query: 240 G-----YCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ APE T +SDV+S+G++L EI +
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 68/281 (24%), Positives = 103/281 (36%), Gaps = 63/281 (22%)
Query: 27 PSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFG--- 83
PS +E S +D EA D A + + FR L G FG
Sbjct: 109 PSGAEDSD-ASHLDFD-EAPPDAAGPVPLAQAKLKHDDEFLAH-FRVIDDLPAGAFGKIF 165
Query: 84 ----RVYKGRLE------STNQVVA-----IKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
R E STNQ I + + G + + E+L L L+H N+
Sbjct: 166 ICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225
Query: 129 VNLIGYCADGDQRLLVYE---YMPLGSLEDHLH------DLPPDKKRLDWTTRMRIAAGA 179
+ + + +L E YM + L+ + L TR I
Sbjct: 226 LKI--------EEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQL 276
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA----------KLGPVGDKT 229
+EY+HDK +I+RD+K NI L L DFG A G VG
Sbjct: 277 LCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVA 333
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
S ++ GYC ++T D++S G++LL++++
Sbjct: 334 TNSPEILAGDGYC--------EIT---DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 37/113 (32%), Positives = 60/113 (53%), Gaps = 11/113 (9%)
Query: 162 PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221
D LD +R ++ A+G+++L K I+RD+ N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 222 LGPVGDKTHVSTRVMGT----YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ D +V V G + APE T++SDV+S+G++L EI +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 39/219 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G +G V T VA+K+L R + + R + E+ +L + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 134 YCADGDQRLLVYEYMPLGSLED-------------HLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P SLE+ L+++ +K D + I
Sbjct: 84 V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-IL 130
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
+GL+Y+H + +I+RDLK SN+ + E K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 241 YCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278
Y APE + D++S G ++ E++TGR T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 3e-07
Identities = 54/223 (24%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNLIG- 133
+G G FG V+ + + T + K + GL+ + ++EV ++ L H N+V I
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 134 YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ +Q+L ++ E+ G L ++ +++ + I L Y H+ +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 193 P----VIYRDLKCSNILLGEGYH-----------------PKLSDFGLAKLGPVGDKTHV 231
P V++RDLK NI L G K+ DFGL+K + H
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH- 199
Query: 232 STRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGR 272
+GT Y +PE + T KSD+++ G ++ E+ +G+
Sbjct: 200 --SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 6e-07
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 26/214 (12%)
Query: 74 DCLLGEGGFGR--VYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNL 128
L+G+ V+ + + TN +VA+K+++ + + + E++ L HPN+
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNI 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ + + +V M GS ED L P+ L I L+Y+H
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHS 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLA--------KLGPVGDKTHVSTRVMGTYG 240
K I+R +K S+ILL LS + + V D S + +
Sbjct: 120 KG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLP--- 173
Query: 241 YCAPEY---AMTGQLTLKSDVYSFGVVLLEIITG 271
+ +PE + G KSD+YS G+ E+ G
Sbjct: 174 WLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 7e-07
Identities = 34/151 (22%), Positives = 55/151 (36%), Gaps = 17/151 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLV-NLIG 133
LL G RVY L + ++ +K +RE EV +L LL V ++
Sbjct: 5 LLKGGLTNRVY--LLGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
L+ E++ G D + + + A+ L LH
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPLLV 109
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ + DL NIL+ +G + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 48/189 (25%), Positives = 74/189 (39%), Gaps = 27/189 (14%)
Query: 93 TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152
T + V IK R G E +L ++HP+++ L G Y
Sbjct: 116 TCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKG--------TFTYNKFTCLI 161
Query: 153 LEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209
L + DL K+ + + I + ++YLH+ +I+RD+K NI +
Sbjct: 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFIN-- 216
Query: 210 YHPK---LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLL 266
HP L DFG A PV + GT APE D++S G+VL
Sbjct: 217 -HPGDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLF 274
Query: 267 EIITGRKAI 275
E+ T ++
Sbjct: 275 EMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 47/158 (29%), Positives = 77/158 (48%), Gaps = 20/158 (12%)
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
++S + H +L + G C G + ++V E++ G L+ L +K R+ ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQ 125
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNIL-----LGEGYHP--KLSDFGLAKLGPVGDKTHV 231
A L YL DK +++ ++ NIL L EG P KLSD G++ + + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 232 STRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEI 268
R+ + APE G L+ +D +SFG LLEI
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 31/231 (13%)
Query: 51 SDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGL 107
S +A TFT V K ++ +G G G V VA+K+L R N
Sbjct: 9 SVQVADSTFT------VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQT 62
Query: 108 QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL-----VYEYMPL--GSLEDHLHDL 160
R + E+++L ++H N+++L+ Q+ L VY M L +L +H +
Sbjct: 63 HAKRAYR-ELVLLKCVNHKNIISLLNVFTP--QKSLEEFQDVYLVMELMDANLCQVIH-M 118
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
D +R+ + + G+++LH +I+RDLK SNI++ K+ DFGLA
Sbjct: 119 ELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
+ + T + T Y APE + D++S G ++ E++ G
Sbjct: 171 R---TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 28/77 (36%), Positives = 43/77 (55%)
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+++RDLK +NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 254 LKSDVYSFGVVLLEIIT 270
K+D++S GV+L E++T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 30/205 (14%)
Query: 85 VYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNLIGYCADGDQ 140
VY R T +V ++ D E L EV++ HPN++ G
Sbjct: 16 VYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW 73
Query: 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK 200
++ +M GS L P+ + I GA +GL YLH I+R++K
Sbjct: 74 LWVISPFMAYGSANSLLKTYFPEG--MSEALIGNILFGALRGLNYLHQNG---YIHRNIK 128
Query: 201 CSNILLGEGYHPKLSDFGLAKLGPV---GDKTHV-------STRVMGTYGYCAPEYA--- 247
S+IL+ LS GL+ L + G K V ST V+ + +PE
Sbjct: 129 ASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPELLRQD 183
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ G +KSD+YS G+ E+ TGR
Sbjct: 184 LYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLLHHPNLVNLIG 133
+G G G V ++ VAIK+L R N R + E++++ ++H N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 83
Query: 134 YCADGDQRLL-----VYEYMPLGSLE-DHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
Q+ L VY M L + + D +R+ + + G+++LH
Sbjct: 84 VFTP--QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+I+RDLK SNI++ K+ DFGLA+ G ++ V+ Y Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVI 190
Query: 248 MTGQLTLKSDVYSFGVVLLEII------TGRKAID 276
+ D++S G ++ E++ GR ID
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 58/245 (23%), Positives = 89/245 (36%), Gaps = 33/245 (13%)
Query: 40 DVKKEASKDGGSDHIAAHTFTFREL----------AAVTKNFRADCLLGEGGFGRVY--K 87
DV D + ++ T +E + V + L G G V+
Sbjct: 53 DVTHATDYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCT 112
Query: 88 GRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147
+ + V +K + G E+ +L + H ++NLI +V
Sbjct: 113 KHGDEQRKKVIVKAVTGGKTPGR-----EIDILKTISHRAIINLIHAYRWKSTVCMV--- 164
Query: 148 MPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204
MP + DL R L + I + L YLH + +I+RD+K NI
Sbjct: 165 MP-----KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENI 216
Query: 205 LLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 263
L E + L DFG A KL D GT +PE K+D++S G+
Sbjct: 217 FLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGL 275
Query: 264 VLLEI 268
VL E+
Sbjct: 276 VLFEM 280
|
Length = 392 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 54 IAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGN 110
I TFT V K ++ +G G G V + VAIK+L R N
Sbjct: 15 IGDSTFT------VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK 68
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED--------HLHD--- 159
R + E++++ ++H N++ L+ + P SLE+ L D
Sbjct: 69 RAYR-ELVLMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANL 115
Query: 160 -----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214
+ D +R+ + + G+++LH +I+RDLK SNI++ K+
Sbjct: 116 CQVIQMELDHERMSYLLYQMLC-----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
DFGLA+ G ++ V+ Y Y APE + D++S G ++ E+I G
Sbjct: 168 LDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 33/88 (37%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 77 LGEGGFGRVYK----GRLESTNQV-VAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V + G + N + VA+K L + RE L+ E+ +LS L H N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL 157
NL+G C G L++ EY G L + L
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 32/89 (35%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 77 LGEGGFGRVYK----GRLESTNQV-VAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNLV 129
LG G FGRV + G S + + VA+K L ++ L+ L M L H N+V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
NL+G C G ++ EY G L D+LH
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-05
Identities = 32/88 (36%), Positives = 44/88 (50%), Gaps = 7/88 (7%)
Query: 77 LGEGGFGRV-----YKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLL-HHPNLV 129
LG G FG+V Y VA+K L + RE L+ E+ +LS L +H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIV 102
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL 157
NL+G C G L++ EY G L + L
Sbjct: 103 NLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 63/275 (22%), Positives = 100/275 (36%), Gaps = 74/275 (26%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLHHPN 127
LG G FG V R T + A+K L + + + R+ L E +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLG---SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+V L D D V +Y+P G SL + P D R + + A + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARF-YIAELTCAVESVHKMG 121
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA------------------------ 220
++H RD+K NIL+ H KL+DFGL
Sbjct: 122 FIH---------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMD 172
Query: 221 ---------------KLGPV---GDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVY 259
+L P+ + H ++ ++GT Y APE + T D +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232
Query: 260 SFGVVLLEIITGRKA-IDNTRAAGEHNLVAWVTVL 293
S GV+L E++ G+ + T + ++ W T L
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 26/162 (16%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLML 120
+F ++G+G FG V + + T ++ A+K L ++ + + R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAG 178
P +V+L D L+ E++P G L L +D + TR +A
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSED-----VTRFYMAE- 109
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
+E +H I+RD+K NIL+ G H KLSDFGL+
Sbjct: 110 CVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 2e-04
Identities = 57/245 (23%), Positives = 92/245 (37%), Gaps = 55/245 (22%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLM 119
++F + ++G G FG V + + T V A+K L + + + R+ LVE
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
L + V + D L+ E++P G D + L + T+ IA
Sbjct: 61 LWV------VKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAE-T 110
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT---------- 229
++ +H I+RD+K N+LL H KLSDFGL +T
Sbjct: 111 VLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL 167
Query: 230 -----------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLL 266
++ +GT Y APE M D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 267 EIITG 271
E++ G
Sbjct: 228 EMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 7/90 (7%)
Query: 76 LLGEGGFGRVYKGR---LESTNQV--VAIKQLDRNGLQGNREFLVEVL--MLSLLHHPNL 128
+LG G FG+V +G L + V VA+K L ++ L+ L M L H N+
Sbjct: 44 ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158
VNL+G C ++ EY G L ++LH
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 55/246 (22%), Positives = 90/246 (36%), Gaps = 59/246 (23%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLML 120
+F + ++G G FG V + + T + A+K L + + + R+ LVE
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--- 58
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAG 178
+V + D L+ E++P G + L D ++ + +A
Sbjct: 59 ---DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---------------KLG 223
A L ++H RD+K N+LL H KLSDFGL
Sbjct: 116 AIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166
Query: 224 PVGD------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
P D + ++ +GT Y APE M D +S GV++
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226
Query: 266 LEIITG 271
E++ G
Sbjct: 227 YEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 55/210 (26%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 77 LGEGGFGRVYKGRL------------ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH 124
LG G ++Y G L V +K LD + + F M+ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT--RMRIAAGAAKG 182
H ++V L G C + ++V E++ G L+ +H +K TT + ++A A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-----RKSDVLTTPWKFKVAKQLASA 117
Query: 183 LEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTY 239
L YL DK +++ ++ NILL EG + F KL G V +R +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERI 172
Query: 240 GYCAPEYAM-TGQLTLKSDVYSFGVVLLEI 268
+ APE + L++ +D +SFG L EI
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 63/250 (25%), Positives = 94/250 (37%), Gaps = 67/250 (26%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL------DRNGL---QGNREFLVEVLMLSLLHHPN 127
LG G FG V T+ + A+K L +RN + + R+ L E +
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA------DNEW 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L D D V +Y+P G + L + + L R IA +E +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIAE-LTLAIESVH 118
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---------------------KLGP-- 224
I+RD+K NIL+ H KL+DFGL + P
Sbjct: 119 KMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSD 175
Query: 225 ---------VGD----------KTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFG 262
GD K H ++ ++GT Y APE + T D +S G
Sbjct: 176 LWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235
Query: 263 VVLLEIITGR 272
V+L E++ G+
Sbjct: 236 VILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (90), Expect = 0.003
Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 63 ELAAVTKNF--RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEV 117
EL KN L +G FG+V + + T ++ K + N + E +V
Sbjct: 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQ 63
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
LM +PN + L +L+ +Y+ G L D L + +L +I
Sbjct: 64 LMK---DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIR 116
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAKLGPVGDKTHVS 232
+ L LH K N +I+ D+K N+L Y L D+GL K +G +
Sbjct: 117 QLVEALNDLH-KHN--IIHNDIKLENVL----YDRAKDRIYLCDYGLCK--IIGTPSCYD 167
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVY--SF-----GVVLLEIITG 271
GT Y +PE +K Y SF GV+ E++TG
Sbjct: 168 ----GTLDYFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.82 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.66 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.64 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.54 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.42 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.36 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.35 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.24 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.22 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.16 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.93 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.79 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.69 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.62 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.58 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.53 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.52 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.49 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.24 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.21 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.11 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.09 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.06 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.04 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.96 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.76 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.76 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.68 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.5 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.4 | |
| PLN02236 | 344 | choline kinase | 97.4 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.38 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.35 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.33 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.32 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.18 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.06 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.0 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.16 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.07 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.06 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.01 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.99 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.8 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.64 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-53 Score=355.50 Aligned_cols=206 Identities=33% Similarity=0.503 Sum_probs=185.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
...+|.+.+.||.|+||+||+|+++.++..||||.+.+.. ....+.+..|+.+|+.++|||||.+++++..++++|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467999999999999999999999999999999998764 33345578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC------CceEEcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG------YHPKLSDFG 218 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~------~~~kl~Dfg 218 (296)
||||.||+|.+|++. .+.+++..++.++.|++.||++||+++ ||||||||+|||++.. -.+||+|||
T Consensus 88 MEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 999999999999987 568999999999999999999999999 9999999999999764 458999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
+++....+ ......+|++.|||||+++...|+.++|+||+|+++|+|++|++||+..+..+
T Consensus 161 fAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 161 FARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 99976633 34556899999999999999999999999999999999999999999655444
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=344.64 Aligned_cols=206 Identities=32% Similarity=0.461 Sum_probs=187.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|+++++||+|+||.||.++.+++++.||+|++++..... .+....|..+|..++||.|++++..|++...+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 357999999999999999999999999999999998765443 34578899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
+||+.||.|...+++ .+.+++..+..++..|+.||.|||+.+ ||||||||+|||++.+|+++|+|||+|+..-
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999976 688999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. ....+..++||+.|||||++.+..|+..+|+||||+++|+||+|.+||.+.+...
T Consensus 177 ~--~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 177 K--DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK 232 (357)
T ss_pred c--CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH
Confidence 2 2233455899999999999999999999999999999999999999999887544
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-52 Score=333.08 Aligned_cols=210 Identities=25% Similarity=0.386 Sum_probs=185.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceee-EEecCCc-eEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIG-YCADGDQ-RLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~-~~~~~~~-~~lv 144 (296)
..|.+++.||.|+||.||++.+..+|+.+|.|.++-.... ..+++..|+.+|++|+||||+++++ .|.+++. ++||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3599999999999999999999999999999998744333 3456889999999999999999999 4544444 8999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN-PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~-~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||+|.+|+|...++.+...+..+++..++.++.|++.||..+|+.-+ ..|+||||||.||+++.+|.+||+|||+++..
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999998887888999999999999999999999998321 24999999999999999999999999999975
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .........+|||.||+||.+....|++++||||+||++|||+.-++||.+++.
T Consensus 179 ~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~ 233 (375)
T KOG0591|consen 179 S--SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL 233 (375)
T ss_pred c--chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH
Confidence 4 344455668999999999999999999999999999999999999999998753
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-50 Score=351.48 Aligned_cols=205 Identities=30% Similarity=0.490 Sum_probs=187.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCC---CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+|...+.||+|||+.+|.+++..+|+.||+|++++. .....+.+.+|+.+.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999999999999999999874 2345677899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+|..++|.+++++ ...++|.+++.+++||+.||.|||+++ |+|||||..|+|++++.+|||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999975 678999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. .......||||.|.|||++.+..++..+||||+||+||.||.|++||..++..+
T Consensus 171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH
Confidence 3 234556899999999999999999999999999999999999999999876444
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-51 Score=342.18 Aligned_cols=207 Identities=29% Similarity=0.415 Sum_probs=182.6
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-------hhHHHHHHHHHHhhcCCCcccceeeEEecC
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-------GNREFLVEVLMLSLLHHPNLVNLIGYCADG 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~ 138 (296)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||++.+.... ....+.+|+.+|++|+|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 4667899999999999999999999999999999999764322 223467999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC---CceEEc
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLS 215 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~---~~~kl~ 215 (296)
+..|+||||+.||+|.+++-. ++.+.+...+.+++|++.|+.|||++| |+||||||+|||++.+ ..+||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 999999999999999999965 677888888999999999999999999 9999999999999665 789999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
|||+|++.. ........||||.|.|||++.+.. +..++|+|||||++|-+|+|.+||++...+.
T Consensus 322 DFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~ 388 (475)
T KOG0615|consen 322 DFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP 388 (475)
T ss_pred ccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc
Confidence 999999743 444566789999999999998764 3347899999999999999999998776555
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=319.16 Aligned_cols=202 Identities=32% Similarity=0.429 Sum_probs=185.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||.|+||.|.+++.+.+|..+|+|++.+..... .+....|..+|+...||+++++++.+.+.+++|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46899999999999999999999999999999998765433 345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||.|.+++++ .+++++..++.++.|++.||+|||+++ |++||+||+|||+|.+|.+||+|||.++...
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 99999999999976 578999999999999999999999999 9999999999999999999999999998632
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
..+...||||.|+|||++....|..++|.|||||++|||+.|.+||.+.++..
T Consensus 196 ----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~ 248 (355)
T KOG0616|consen 196 ----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ 248 (355)
T ss_pred ----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH
Confidence 23667899999999999999999999999999999999999999999888743
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=327.89 Aligned_cols=198 Identities=30% Similarity=0.446 Sum_probs=180.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCc-eEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~lv~e~ 147 (296)
+.+.++.||+|+.|+||+++++.+++.+|+|++..+. ....+.+.+|+.+++.++||+||.+|+.|..+.. ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4666889999999999999999999999999995443 3345678999999999999999999999999985 9999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|++|+|+.++.. .+++++..+..|+.++++||.|||+ ++ ||||||||+|||++..|.|||||||.+......
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999976 4779999999999999999999996 77 999999999999999999999999999864433
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
....++||..|||||.+.+..|+.++||||||+.++|+.+|+.||...
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 455688999999999999999999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=340.59 Aligned_cols=218 Identities=26% Similarity=0.369 Sum_probs=192.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh---HHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+++.||+|+||.||+|+.+.||+.+|+|++++...... ..++.|..+|...++|.||++|..|.+.+++||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 579999999999999999999999999999999988755433 45778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||++..++.+ ...+++..+..++.+++-|+..||+.| +|||||||+|+|||..|++||+|||+|.....
T Consensus 221 EylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999976 688999999999999999999999999 99999999999999999999999999842110
Q ss_pred ----------------------CCcc-----------------------eeeecccccccccCccccccCCCCccchhHH
Q 022482 226 ----------------------GDKT-----------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260 (296)
Q Consensus 226 ----------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 260 (296)
.+.. ......+|||.|+|||++.+..|+..+|+||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 0012257999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCccccc-chHhhhhhh
Q 022482 261 FGVVLLEIITGRKAIDNTRAAGEH-NLVAWVTVL 293 (296)
Q Consensus 261 lG~~l~~ll~g~~pf~~~~~~~~~-~l~~~~~~~ 293 (296)
|||++||||.|.+||...++.+.. .+++|...|
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l 407 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL 407 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc
Confidence 999999999999999999988854 888887654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=339.47 Aligned_cols=210 Identities=30% Similarity=0.434 Sum_probs=185.4
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh---HHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
..-..+|.+++.||+|+|++|++|+++.+++.||||++.+.-.... ..+.+|-..|..| +||.|++++..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3345679999999999999999999999999999999876543322 3356777888888 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
+|+|+||+++|+|.+++++ -+.|++..++.++.||+.||+|||++| ||||||||+|||++.+++++|+|||.+
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999987 478999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-----------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 221 KLGPVGDKT-----------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 221 ~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+...+.... .....++||..|.+||++..+..+..+|||||||++|+|+.|.+||.+.+.-
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 865443322 1124589999999999999999999999999999999999999999987643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=312.62 Aligned_cols=204 Identities=29% Similarity=0.354 Sum_probs=177.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.|+.+..+|+|+||+|++|+++.||+.||||++..... .-.+-.++|+.+|++++|+|+|.++++|.-....++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 458889999999999999999999999999999854432 223346899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
||+..-|.+ ++. ....++...+..+++|++.|+.|+|+++ ++||||||+|||++.+|.+||||||.|+....
T Consensus 82 ~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 998554444 444 2567899999999999999999999999 99999999999999999999999999997553
Q ss_pred CcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.....+..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+.|.+...-
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi 208 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI 208 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH
Confidence 3334455789999999999998 58999999999999999999999999876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=329.00 Aligned_cols=204 Identities=30% Similarity=0.460 Sum_probs=182.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC----Cc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN----GL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~ 140 (296)
..+.|.+.+.||+|+||.|++|.+..++..||+|++.+. .. .....+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999999999999999988764 12 22345668999999999 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGL 219 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~ 219 (296)
+++||||+.||+|.+++.. .+++.+..+..+++|+++|++|||+++ |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999975 678999999999999999999999999 9999999999999999 9999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCC-CC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-LKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.+
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 98753 2333455689999999999999977 86 67899999999999999999999855
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=321.01 Aligned_cols=236 Identities=63% Similarity=1.035 Sum_probs=205.8
Q ss_pred cccccCHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeE
Q 022482 55 AAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134 (296)
Q Consensus 55 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~ 134 (296)
....|++.++..++++|.-...||+|+||.||+|.... +..||||.+.........+|..|+.++..++|||+++++++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 67779999999999999999999999999999998876 48899998866543314569999999999999999999999
Q ss_pred EecCC-ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceE
Q 022482 135 CADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 135 ~~~~~-~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~k 213 (296)
|.+.+ ..+||+||++.|+|.++++..... .++|..+..|+.++++||+|||+...++|+||||||+|||+|+++..|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99988 499999999999999999863221 889999999999999999999999888899999999999999999999
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhhhhh
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVL 293 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~~~~ 293 (296)
|+|||+++........ ......||..|+|||++..+..+.++|||||||++.||++|+.|.+...+.+...+++|..++
T Consensus 218 lsDFGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999754331111 111117999999999999999999999999999999999999999988877777899998665
Q ss_pred h
Q 022482 294 S 294 (296)
Q Consensus 294 ~ 294 (296)
.
T Consensus 297 ~ 297 (361)
T KOG1187|consen 297 L 297 (361)
T ss_pred H
Confidence 3
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=329.09 Aligned_cols=201 Identities=35% Similarity=0.493 Sum_probs=185.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+.+.. +...+.+|+.+++.++||||+.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5799999999999999999999999999999999875433 34568999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.| +|..++.. ++.++++.+..++.++++||.|||+.+ |+|||+||.|||++.+|.+|+||||+++...
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~-- 151 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMS-- 151 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcc--
Confidence 9985 99999965 788999999999999999999999999 9999999999999999999999999999743
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.+......+.|||.|||||++.++.|+..+|+|||||++|||++|++||....
T Consensus 152 ~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 152 TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 45556667889999999999999999999999999999999999999998544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=294.34 Aligned_cols=204 Identities=30% Similarity=0.428 Sum_probs=181.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.+|..++.||+|.||.||+|++..+|+.||||++......+ .....+|+..|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888999999999999999999999999999997654332 3457899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|++ .+|...++. ....++..++..++.+++++++|||++. |+||||||.|+||+++|.+||+|||+++.....
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 997 899999976 5678999999999999999999999999 999999999999999999999999999975544
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... ....+.|.+|.|||++.|. .|+..+|+||.||++.||+-|.+.|.+.+.-
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi 208 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI 208 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH
Confidence 332 3334789999999999876 6999999999999999999999988876643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=329.47 Aligned_cols=208 Identities=31% Similarity=0.503 Sum_probs=185.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh---HHHHHHHHHHhhcC-CCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~l 143 (296)
.++|.++++||+|+||.|+++..+.+++.+|||++++...-.. +....|-.++...+ ||.++.++..|...+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 4579999999999999999999999999999999988765443 34567878887765 9999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+.||++..+.+ ...|++..+..++..++.||.|||+++ |||||||.+|||+|.+|.+||+|||+|+..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999444432 478999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN 285 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 285 (296)
.. ....+.+++|||.|+|||++.+..|+.++|+|||||+|||||.|+.||.+.+.++.++
T Consensus 519 m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd 578 (694)
T KOG0694|consen 519 MG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD 578 (694)
T ss_pred CC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 32 3335677999999999999999999999999999999999999999999998888663
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-46 Score=318.05 Aligned_cols=206 Identities=28% Similarity=0.402 Sum_probs=181.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv 144 (296)
+.|+.++.||+|.||.||+|++..+|+.||+|+++.... ....-..+|+.+|++|+||||+++.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 458889999999999999999999999999999976542 2334567999999999999999999998776 689999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
+|||+ -+|.-++.. ..-.|++.++..++.||+.||.|||.++ |+|||||.+|||||.+|.+||+|||+|++..
T Consensus 197 FeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 99997 678777754 4668999999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
...... .+..+-|.+|.|||++.|. .|+..+|+||+||||.||++|++.|.+.+.-+
T Consensus 270 ~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 270 PSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred CCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 554333 4556789999999999886 69999999999999999999999999877543
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=314.40 Aligned_cols=204 Identities=25% Similarity=0.418 Sum_probs=186.7
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHH---HHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
....+|++.+.||+|.||.|-+|.....|..||||.+++....+.++ +++|+.++..|+||||+++|++|++.+.+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIV 129 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEE
Confidence 34568999999999999999999999999999999998877666554 789999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||..+|.|++|+.. .+.+++.++..+++||++|+.|+|.++ ++|||||.+|||+|.++++||+|||++-.
T Consensus 130 ivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhh
Confidence 99999999999999976 678999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
..... ....+||+|-|.+||++.+..| .+.+|.|||||+||.|+.|..||++.+
T Consensus 203 y~~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D 257 (668)
T KOG0611|consen 203 YADKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD 257 (668)
T ss_pred hcccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch
Confidence 54332 3446899999999999999887 478999999999999999999999765
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=325.83 Aligned_cols=203 Identities=30% Similarity=0.433 Sum_probs=182.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-c--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-L--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+-|++++.||.|+.|.|.+|++..||+.+|||++.+.. . .....+.+|+.+|+.+.||||+++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34889999999999999999999999999999998652 1 22356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||.|.+++.. ++++++.++..++.|++.|+.|+|..+ |||||+||+|+|++..+++||+|||.|.+-..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999976 788999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcceeeecccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+. ...+-||+|.|.+||++.|..|+ .++||||+|||||.||+|++||++.+-+
T Consensus 165 gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir 218 (786)
T KOG0588|consen 165 GK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR 218 (786)
T ss_pred Cc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH
Confidence 22 33456899999999999999885 5799999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=311.49 Aligned_cols=202 Identities=40% Similarity=0.636 Sum_probs=176.8
Q ss_pred CCccccccccCceEEEEEEECCCCeE-EEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCC-ceEEEEe
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQV-VAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 146 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-~~~lv~e 146 (296)
..+.+.||.|+||+||+|.+. |.. ||+|++....... .+.+.+|+.+|..++||||+++++++.++. ...+|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 445566999999999999998 555 9999997644332 458999999999999999999999999887 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~~~ 225 (296)
|+++|+|.++++.. .+..+++..+..++.|+++|+.|||+.++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999763 46789999999999999999999999985 89999999999999998 999999999986433
Q ss_pred CCcceeeecccccccccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......||+.|||||++. +..|+.++||||||+++|||+||+.||.+...
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 21 2233367999999999999 56899999999999999999999999998886
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=303.84 Aligned_cols=209 Identities=34% Similarity=0.441 Sum_probs=184.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhH---HHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.|++++.||+|.-|+||+|....++..+|+|++.+......+ +...|..+|+.++||.++.+|..|+.+...+++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 3588899999999999999999999999999999887655443 4567889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|||+||+|...+++. .+..+++..++.++.+++-||+|||..| ||+|||||+|||+.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999874 5788999999999999999999999999 99999999999999999999999998632110
Q ss_pred ---------------------------------CCc---------------------ceeeecccccccccCccccccCC
Q 022482 226 ---------------------------------GDK---------------------THVSTRVMGTYGYCAPEYAMTGQ 251 (296)
Q Consensus 226 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~ 251 (296)
..+ ...+..++||..|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01223468999999999999999
Q ss_pred CCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 252 LTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 252 ~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.+.++|+|+|||++||||.|..||.+.+..+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~ 342 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE 342 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh
Confidence 9999999999999999999999999887665
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=305.52 Aligned_cols=210 Identities=29% Similarity=0.414 Sum_probs=184.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh-HHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
-.+.|++...||.|..++||+|++..+++.||||+++....... +.+++|+..++.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34679999999999999999999999999999999987655544 78899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC-
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP- 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~- 224 (296)
+||.+|++.+.++... ...+++..+..|++++++||.|||.+| .||||||+.||||+.+|.|+|+|||.+....
T Consensus 104 pfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999998743 455999999999999999999999999 9999999999999999999999999875322
Q ss_pred CCCcceee-ecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVS-TRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~-~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.+...... ..++||++|||||+++.. .|+.++||||||++..||.+|..||....+-
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 22222222 457899999999996553 7999999999999999999999999876643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=317.26 Aligned_cols=207 Identities=31% Similarity=0.449 Sum_probs=189.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
..|+..+.||+|+.|.||.|+...+++.||||.+........+-+..|+.+|+..+|+|||.+++.|...+.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 46888899999999999999999999999999998887777778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+||+|.+.+.. ..+++.++..|+++++.||+|||..+ |+|||||.+|||++.+|.+||+|||+|.......
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 99999999854 56999999999999999999999999 9999999999999999999999999998644333
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHN 285 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~ 285 (296)
......+|||+|||||++....|+++.||||||++++||+.|++||.+.++...-.
T Consensus 424 -~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 424 -SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred -CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence 24566889999999999999999999999999999999999999999877655443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=296.17 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=177.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv 144 (296)
+.|..++.|++|+||.||+|+++.+++.||+|+++...... --..++|+.+|.+.+|||||.+-+++... +.+|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35899999999999999999999999999999996543111 12357999999999999999999988643 679999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||||+ .+|...+... .++|...+++.++.|+++|++|||... |+||||||+|+|++..|.+||+|||+|+...
T Consensus 156 Me~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 99997 7899988763 578999999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......+.|.+|.|||++.+. .|+...|+||+|||+.||+++++.|.+...
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 43 3335567889999999999876 699999999999999999999999987654
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=303.94 Aligned_cols=212 Identities=29% Similarity=0.453 Sum_probs=181.3
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC-----ceEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRLLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----~~~lv 144 (296)
.|.-.+++|.|+||.||.|....+++.||||++-.+ .+-..+|+.+|+.+.||||+++..+|.... +..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 477789999999999999999999999999988433 234458999999999999999998886432 34589
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~~~~~ 223 (296)
|||++ .+|.++++.+...+.+++...++-+.+|+++||+|||+.+ ||||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 99997 8999999876667888999999999999999999999999 9999999999999865 89999999999976
Q ss_pred CCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhhhhhh
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVLS 294 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~~~~~ 294 (296)
..++.+ .....|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.++. +.|++.++.|+
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG 243 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLG 243 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhC
Confidence 655543 334678999999999886 7999999999999999999999999985543 46666666654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=314.66 Aligned_cols=207 Identities=26% Similarity=0.333 Sum_probs=179.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+..|+.++..++||||+++++.+.+...+++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468999999999999999999999999999999965322 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999865 467899999999999999999999999 99999999999999999999999999874322
Q ss_pred CCcc---------------------------------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 022482 226 GDKT---------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272 (296)
Q Consensus 226 ~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~ 272 (296)
.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0112357999999999999989999999999999999999999
Q ss_pred CCCCCCCccc
Q 022482 273 KAIDNTRAAG 282 (296)
Q Consensus 273 ~pf~~~~~~~ 282 (296)
.||...+..+
T Consensus 234 ~Pf~~~~~~~ 243 (363)
T cd05628 234 PPFCSETPQE 243 (363)
T ss_pred CCCCCCCHHH
Confidence 9998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=305.66 Aligned_cols=212 Identities=31% Similarity=0.429 Sum_probs=176.9
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--------------chhHHHHHHHHHHhhcCCCccc
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------------QGNREFLVEVLMLSLLHHPNLV 129 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~~I~ 129 (296)
.....++|++.+.||+|.||.|-+|++..+++.||||++.+... ...+.+.+|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 34556789999999999999999999999999999999975321 1225788999999999999999
Q ss_pred ceeeEEecC--CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 130 NLIGYCADG--DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 130 ~~~~~~~~~--~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
+++++..+. +.+|||+|||..|.+.+.- ..+..+++.+++.+++.++.||+|||.++ |+||||||+|+|++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEc
Confidence 999999764 6899999999988876543 22333999999999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCC---CcceeeecccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 208 EGYHPKLSDFGLAKLGPVG---DKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++|++||+|||.+.....+ .........+|||.|+|||...++. .+.+.||||+||+||+|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999999754222 1122223368999999999987742 34678999999999999999999987654
Q ss_pred cc
Q 022482 281 AG 282 (296)
Q Consensus 281 ~~ 282 (296)
-+
T Consensus 325 ~~ 326 (576)
T KOG0585|consen 325 LE 326 (576)
T ss_pred HH
Confidence 43
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=303.18 Aligned_cols=205 Identities=33% Similarity=0.498 Sum_probs=175.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC--ceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~--~~~lv~ 145 (296)
..+|...+.||+|+||.||++.+.++|...|||.+........+.+.+|+.+|+.++|||||++++...... .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345788999999999999999999999999999987654333566889999999999999999999754444 688999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGP 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~~ 224 (296)
||+++|+|.+++.+. +.++++..+..+.+|+++||.|||+++ |+||||||+|||++. ++.+||+|||++....
T Consensus 96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 999999999999873 227999999999999999999999999 999999999999999 7999999999987544
Q ss_pred C-CCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 225 V-GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 225 ~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
. ...........||+.|||||++..+ ...+.+|||||||++.||+||+.||.+.
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~ 225 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF 225 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh
Confidence 2 1222334457899999999999853 3445899999999999999999999973
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=310.52 Aligned_cols=205 Identities=27% Similarity=0.378 Sum_probs=180.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhH-HHHHHHHHHhhcC-CCcccceeeEEecCC-ceE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLH-HPNLVNLIGYCADGD-QRL 142 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~e~~~l~~l~-h~~I~~~~~~~~~~~-~~~ 142 (296)
.+-++|.+.+.||.|.||.||+|+...+++.||||.+++.-....+ --++|+..|++++ ||||+++.+++.+++ .+|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3567899999999999999999999999999999998665433322 2478999999999 999999999999988 999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+|||||+ .+|++.++.+ +..|++..++.|++||++||+++|.+| +.|||+||+|||+.....+||+|||+|+.
T Consensus 87 fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred eeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccc
Confidence 9999996 9999999874 678999999999999999999999999 99999999999999888999999999996
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ...+..+.|.+|+|||++.. +.|+.+.|+||+||+++|+.+-++.|.+.+.
T Consensus 160 v~Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 160 VRSK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred cccC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 4332 23445678999999999865 5789999999999999999999999987664
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=294.13 Aligned_cols=207 Identities=28% Similarity=0.403 Sum_probs=179.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCc-ccceeeEEecCC-----
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPN-LVNLIGYCADGD----- 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~----- 139 (296)
...|...+.||+|+||+||+|+...+|+.||+|+++..... .-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34577788899999999999999999999999999765332 2245679999999999999 999999998877
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 140 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
..++|+||++ .+|..++.........++...++.+++|++.||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7899999996 8999999875543356888899999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|+........ ....++|..|.|||++.+. .|+...||||+||+++||+++++.|.+...
T Consensus 166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 99864433322 4456789999999999887 799999999999999999999999987765
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=301.44 Aligned_cols=201 Identities=28% Similarity=0.380 Sum_probs=178.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368999999999999999999999999999999865322 23455788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999875422
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~ 204 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF 204 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 22356899999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=311.23 Aligned_cols=206 Identities=26% Similarity=0.356 Sum_probs=178.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46899999999999999999999999999999996532 122345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcc------------------------------------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 022482 226 GDKT------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII 269 (296)
Q Consensus 226 ~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll 269 (296)
.... ......+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999889999999999999999999
Q ss_pred hCCCCCCCCCcc
Q 022482 270 TGRKAIDNTRAA 281 (296)
Q Consensus 270 ~g~~pf~~~~~~ 281 (296)
+|..||...+..
T Consensus 234 ~G~~Pf~~~~~~ 245 (364)
T cd05599 234 VGYPPFCSDNPQ 245 (364)
T ss_pred cCCCCCCCCCHH
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=312.33 Aligned_cols=206 Identities=25% Similarity=0.337 Sum_probs=176.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||||++.+... .....+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 368999999999999999999999999999999865321 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999853211
Q ss_pred CCcc---------------------------------------------eeeecccccccccCccccccCCCCccchhHH
Q 022482 226 GDKT---------------------------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYS 260 (296)
Q Consensus 226 ~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 260 (296)
.... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999889999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcc
Q 022482 261 FGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 261 lG~~l~~ll~g~~pf~~~~~~ 281 (296)
|||++|+|++|.+||...+..
T Consensus 234 lGvil~elltG~~Pf~~~~~~ 254 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH 254 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH
Confidence 999999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=311.50 Aligned_cols=205 Identities=26% Similarity=0.303 Sum_probs=177.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|.+++.||+|+||.||+|.+..+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+.+++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58899999999999999999999999999999975432 223457889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+++++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999865 456899999999999999999999999 999999999999999999999999997532110
Q ss_pred Cc---------------------------------------------ceeeecccccccccCccccccCCCCccchhHHH
Q 022482 227 DK---------------------------------------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 261 (296)
Q Consensus 227 ~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 261 (296)
.. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123579999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcc
Q 022482 262 GVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 262 G~~l~~ll~g~~pf~~~~~~ 281 (296)
||++|+|++|..||...+..
T Consensus 235 G~il~elltG~~Pf~~~~~~ 254 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT 254 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH
Confidence 99999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=293.72 Aligned_cols=209 Identities=27% Similarity=0.374 Sum_probs=182.4
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecC--CCcchhHHHHHHHHHHhhcCCCcccceeeEEec-----C
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-----G 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-----~ 138 (296)
.+...|...+.||.|+||.|+.+.+..+|+.||||++.. ......++..+|+.+|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 455677778999999999999999999999999999973 444556778899999999999999999999865 3
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+.+|+|+|+| +.+|...++. +..+++..+..+++|+++||.|+|+.+ |+|||+||.|++++.+..+||+|||
T Consensus 99 ~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 5689999999 4899999865 556999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
+|+...........+..+.|.+|.|||++.+ ..|+...||||+||++.|||+|++.|.+++...
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~ 235 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH 235 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH
Confidence 9997544333344455678999999998865 479999999999999999999999999887544
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=312.44 Aligned_cols=205 Identities=26% Similarity=0.306 Sum_probs=176.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|.+++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999865422 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999865 356889999999999999999999999 999999999999999999999999997421100
Q ss_pred C---------------------------------------------cceeeecccccccccCccccccCCCCccchhHHH
Q 022482 227 D---------------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSF 261 (296)
Q Consensus 227 ~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 261 (296)
. ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000123469999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcc
Q 022482 262 GVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 262 G~~l~~ll~g~~pf~~~~~~ 281 (296)
||++|+|++|++||...++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~ 254 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL 254 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=280.80 Aligned_cols=204 Identities=31% Similarity=0.470 Sum_probs=184.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+++.||+|.||.||+|+.+.++-.||+|++.+.... ....+.+|+.+-+.|+||||+++|++|.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35699999999999999999999999999999999765322 235678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
+||...|+|...++. ....++++.....+++|++.|+.|+|..+ |+||||||+|+|++..+.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999975 23567899999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......+||..|++||...+..++..+|+|++|++.||++.|.+||.....
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 3345568999999999999999999999999999999999999999997773
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=305.36 Aligned_cols=200 Identities=32% Similarity=0.442 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56999999999999999999999999999999986532 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999865 456889999999999999999999999 99999999999999999999999999975432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 171 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 171 R-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred C-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 2 1235799999999999998899999999999999999999999987653
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=305.14 Aligned_cols=202 Identities=28% Similarity=0.407 Sum_probs=179.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36999999999999999999999999999999996542 223456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999965 456899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~ 205 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH
Confidence 2234579999999999999899999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=311.24 Aligned_cols=206 Identities=27% Similarity=0.315 Sum_probs=177.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++.+.+++.+++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 369999999999999999999999999999999865322 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999865 456889999999999999999999999 99999999999999999999999999742210
Q ss_pred CC-----------------------------------------cceeeecccccccccCccccccCCCCccchhHHHHHH
Q 022482 226 GD-----------------------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVV 264 (296)
Q Consensus 226 ~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~ 264 (296)
.. ........+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0000113479999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCcc
Q 022482 265 LLEIITGRKAIDNTRAA 281 (296)
Q Consensus 265 l~~ll~g~~pf~~~~~~ 281 (296)
+|+|++|+.||...+..
T Consensus 234 lyell~G~~Pf~~~~~~ 250 (376)
T cd05598 234 LYEMLVGQPPFLADTPA 250 (376)
T ss_pred eeehhhCCCCCCCCCHH
Confidence 99999999999876654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=302.51 Aligned_cols=197 Identities=31% Similarity=0.399 Sum_probs=172.5
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999875322 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCccee
Q 022482 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (296)
Q Consensus 152 sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (296)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999865 457899999999999999999999999 999999999999999999999999998742211 112
Q ss_pred eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 200 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH
Confidence 2345799999999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=303.33 Aligned_cols=203 Identities=32% Similarity=0.420 Sum_probs=183.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..|+....||+|+||.||+|.+..+++.||+|++...... +..++..|+.+|.+++++||.++|+.|.....++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4577889999999999999999999999999999865443 356789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|.||++.+.++. +..+.+..+..++++++.|+.|||..+ .+|||||+.|||+..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999965 455588889999999999999999999 9999999999999999999999999997644333
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ....++||+.|||||++.+..|+.++||||||+++|||++|.+|+.+.++
T Consensus 166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP 216 (467)
T KOG0201|consen 166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP 216 (467)
T ss_pred h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc
Confidence 2 33568999999999999988999999999999999999999999998876
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=309.40 Aligned_cols=204 Identities=26% Similarity=0.360 Sum_probs=178.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-C-----CcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-H-----PNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~I~~~~~~~~~~~~ 140 (296)
+..+|.++++||+|+||.|.+|.+..|++.||||+++.. ..-.+....|+.+|..++ | -|+|+++++|...++
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 334789999999999999999999999999999999544 444556678999999987 3 489999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC--CceEEcccC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG--YHPKLSDFG 218 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~--~~~kl~Dfg 218 (296)
.+||+|.+. .+|+++++.. ...+++...++.++.|++.||.+||+.+ |||+||||+|||+.+. ..|||+|||
T Consensus 263 lciVfELL~-~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 263 LCIVFELLS-TNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeeehhhh-hhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 999999995 9999999873 4567999999999999999999999999 9999999999999543 479999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.+........ ..+.+..|.|||++.|..|+.+.||||||||++||++|.+.|.+.+..+
T Consensus 337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 9987443332 4568889999999999999999999999999999999999998776544
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=293.81 Aligned_cols=203 Identities=31% Similarity=0.469 Sum_probs=176.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999999999999999998654322 22356789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998887542 2346899999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......||..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 1 12235689999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=290.17 Aligned_cols=210 Identities=30% Similarity=0.402 Sum_probs=189.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHH---HHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.++++||+|.||.|.+++.+.+++.||+|++++......++ -+.|-..|+..+||.+..+...|..++.+++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 56999999999999999999999999999999998876665554 356888999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||..||.|.-.+.+ ...+++.....+-..|+.||.|||+.+ ||+||||.+|+|+|.+|++||+|||+|+...
T Consensus 248 eyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I- 319 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI- 319 (516)
T ss_pred EEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence 99999999988865 677999999999999999999999999 9999999999999999999999999998522
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchH
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~ 287 (296)
........+||||.|+|||++....|++++|+|.+||++|||++|++||.+.+-...+.|+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI 380 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI 380 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH
Confidence 2334456789999999999999999999999999999999999999999998877766554
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=303.10 Aligned_cols=200 Identities=29% Similarity=0.416 Sum_probs=176.1
Q ss_pred cCCCccccccccCceEEEEEEECCCC-eEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46999999999999999999876554 689999986432 22344677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999965 457899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .....||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+.
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 21 2245799999999999988899999999999999999999999987654
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=307.59 Aligned_cols=207 Identities=25% Similarity=0.330 Sum_probs=179.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+..|+.++..++||+|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36889999999999999999999999999999986432 223345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999865 456899999999999999999999999 99999999999999999999999999864321
Q ss_pred CCc---------------------------------ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCC
Q 022482 226 GDK---------------------------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272 (296)
Q Consensus 226 ~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~ 272 (296)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCCccc
Q 022482 273 KAIDNTRAAG 282 (296)
Q Consensus 273 ~pf~~~~~~~ 282 (296)
.||...+...
T Consensus 234 ~Pf~~~~~~~ 243 (360)
T cd05627 234 PPFCSETPQE 243 (360)
T ss_pred CCCCCCCHHH
Confidence 9998766543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=301.20 Aligned_cols=207 Identities=31% Similarity=0.396 Sum_probs=186.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcC-CCcccceeeEEecCCce
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 141 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~ 141 (296)
.+...|.+.+.||.|.||.||++..+.+|+.+|+|.+.+..... ...+.+|+.+|+.+. ||||+.++++|++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 45678999999999999999999999999999999998765543 357899999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC----CCceEEccc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----GYHPKLSDF 217 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~----~~~~kl~Df 217 (296)
++|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.+ |+||||||+|+|+.. ++.++++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999763 3999999999999999999999999 999999999999943 357999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 283 (296)
|++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+.+..+.
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~ 246 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI 246 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH
Confidence 99987544 3345568999999999999989999999999999999999999999998875543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=298.57 Aligned_cols=198 Identities=31% Similarity=0.407 Sum_probs=172.0
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||++.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999865321 22345678999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCccee
Q 022482 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (296)
Q Consensus 152 sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (296)
+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988864 456899999999999999999999999 9999999999999999999999999987422211 11
Q ss_pred eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.....||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 201 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 22356999999999999889999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=305.80 Aligned_cols=205 Identities=25% Similarity=0.332 Sum_probs=176.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
..++|++.+.||+|+||.||++.+..+++.+|+|++.+.. ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999999999999999986422 1223457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 121 VMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999854 35889999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||...+.
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 3221 11223457999999999987643 77899999999999999999999986653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=298.70 Aligned_cols=198 Identities=30% Similarity=0.415 Sum_probs=172.8
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||++.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 23346778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCccee
Q 022482 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (296)
Q Consensus 152 sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (296)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99988864 456899999999999999999999999 999999999999999999999999998742221 112
Q ss_pred eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 232 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~ 201 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH
Confidence 23457999999999999889999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=297.63 Aligned_cols=195 Identities=31% Similarity=0.419 Sum_probs=171.4
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 22335577899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccc
Confidence 999865 456899999999999999999999999 999999999999999999999999998753221 12233
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~ 198 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV 198 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH
Confidence 45799999999999998999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=296.86 Aligned_cols=202 Identities=32% Similarity=0.463 Sum_probs=174.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCC-CcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~ 145 (296)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..++..+.| ++|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4889999999999999999999999999999986532 2233456788888888876 46888999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999865 456889999999999999999999999 99999999999999999999999999864222
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 154 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 154 GGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred CCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 111 22345799999999999998999999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=302.67 Aligned_cols=205 Identities=30% Similarity=0.378 Sum_probs=180.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 469999999999999999999999999999999865321 33456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999975 367899999999999999999999999 99999999999999999999999999875433
Q ss_pred CC---------------------------cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 226 GD---------------------------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 226 ~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001223356999999999999999999999999999999999999999876
Q ss_pred Cc
Q 022482 279 RA 280 (296)
Q Consensus 279 ~~ 280 (296)
+.
T Consensus 234 ~~ 235 (350)
T cd05573 234 TL 235 (350)
T ss_pred CH
Confidence 64
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.77 Aligned_cols=203 Identities=30% Similarity=0.441 Sum_probs=174.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+|.+.+.||+|+||.||+|.+..+++.||+|++.+... ........|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 48889999999999999999999999999999875422 1223455677777766 5899999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998865 456899999999999999999999999 99999999999999999999999999874222
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 11 1223457999999999999999999999999999999999999999876643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=302.03 Aligned_cols=207 Identities=26% Similarity=0.328 Sum_probs=177.5
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
....++|++.+.||+|+||.||+|.+..+++.+|+|++.+... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 3345789999999999999999999999999999999864221 2234467899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 999999999999999854 45888999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.
T Consensus 191 ~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 191 KMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred EcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 543221 1122345799999999998754 378899999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=290.44 Aligned_cols=204 Identities=27% Similarity=0.401 Sum_probs=174.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 569999999999999999999999999999999865432 2234677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 589988864 2345788999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~ 210 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK 210 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 1 1233468999999999865 46889999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=291.26 Aligned_cols=203 Identities=26% Similarity=0.392 Sum_probs=173.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46799999999999999999999999999999998754322 23456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 788887754 2456889999999999999999999999 999999999999999999999999998743221
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......+++.|+|||++.+. .++.++|+|||||++|+|++|..||.+..
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 1 122335689999999998654 57889999999999999999999998643
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=295.47 Aligned_cols=200 Identities=31% Similarity=0.465 Sum_probs=171.7
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHH---hhcCCCcccceeeEEecCCceEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLML---SLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
|++.+.||+|+||.||+|.+..+++.||||++.+.. ......+..|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678999999999999999999999999999996532 12234556666554 456799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988753 56899999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. ........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 21 1122346799999999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.07 Aligned_cols=208 Identities=23% Similarity=0.249 Sum_probs=181.1
Q ss_pred CCCccccccccCceEEEEEEECCC-CeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLEST-NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.|.+.+.||+|++|.||+|.+..+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 499999999999999999998877 7889999876554444556788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988653334567899999999999999999999999 99999999999999999999999999986433322
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~ 276 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ 276 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 2233456799999999999988999999999999999999999999986543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.18 Aligned_cols=207 Identities=29% Similarity=0.425 Sum_probs=187.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCc-eEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-RLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-~~lv~ 145 (296)
++|..++.+|+|+||.+++++++..++.+++|.+...... ..+....|+.+++++.||||+.+++.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5799999999999999999999999999999999765433 34467899999999999999999999999888 89999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
+||+||+|.+.+... .+.-++++.+..++.|++.|+.|||+.. |+|||||+.|||++.++.|+|+|||+++....
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999773 2577999999999999999999999988 99999999999999999999999999997654
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.. ......+||+.|+.||++.+.+|..++|||||||++|||++-+++|...+..+
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~ 213 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE 213 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence 43 24556789999999999999999999999999999999999999999887655
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=293.28 Aligned_cols=197 Identities=34% Similarity=0.515 Sum_probs=168.5
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhh-cCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++..... ........|..++.. .+||||+++++++...+..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 223344556666654 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998865 456899999999999999999999999 9999999999999999999999999997532222 2
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 23345799999999999988899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=297.89 Aligned_cols=205 Identities=36% Similarity=0.512 Sum_probs=177.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.+++++.||+|.||.||+|.+..+ ..||+|.+... ....+++.+|+.+|++|+|++||++++++..+..++|||||++
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCC-CcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 356778899999999999999853 36899998654 3445788899999999999999999999999889999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
.|+|.+|++. ..+..+...+...++.||++|++||.+++ +|||||..+|||++++..+||+|||+++........
T Consensus 285 ~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 285 KGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 9999999986 45678899999999999999999999999 999999999999999999999999999953333322
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
. ...-.--..|.|||.+..+.++.+||||||||+||||+| |+.||.+++-.+
T Consensus 360 ~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e 412 (468)
T KOG0197|consen 360 A-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE 412 (468)
T ss_pred e-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH
Confidence 2 111223467999999999999999999999999999999 999998877554
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=297.06 Aligned_cols=198 Identities=31% Similarity=0.407 Sum_probs=171.5
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||++.+..+++.||+|++..... .....+..|+.+++.++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999965322 22345678899999999999999999999999999999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 152 sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
+|.+++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99998864 4568999999999999999999997 78 9999999999999999999999999986422211 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~ 202 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH
Confidence 122356999999999999889999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=296.10 Aligned_cols=207 Identities=26% Similarity=0.378 Sum_probs=186.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh--HHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+..-|.+.+.||+|.|++|-+|++.-+|+.||||++.+...... ..+..|+..++..+|||||++|++...+..+|||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 45679999999999999999999999999999999988766543 4578999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE-cCCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili-~~~~~~kl~Dfg~~~~~ 223 (296)
+|.=++|+|.+|+.+ ....+.+..+.+++.||+.|+.|+|+.+ +|||||||+|+.+ ..-|-|||.|||++-..
T Consensus 96 LELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999976 3677999999999999999999999999 9999999999987 56789999999999766
Q ss_pred CCCCcceeeecccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.++.+ ....||+..|.|||++.+..|+ +++|||||||+||-|++|++||...+..+
T Consensus 170 ~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 170 QPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred CCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 66554 3457899999999999999987 46799999999999999999998766554
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.12 Aligned_cols=204 Identities=25% Similarity=0.298 Sum_probs=175.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||++.+..+++.||+|++.+.. ......+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46999999999999999999999999999999986422 122345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999864 2456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 211 11223469999999999863 357789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=293.36 Aligned_cols=198 Identities=32% Similarity=0.482 Sum_probs=170.5
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999986532 12334566777777766 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999998865 456899999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~ 202 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 223457999999999999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=299.89 Aligned_cols=204 Identities=26% Similarity=0.325 Sum_probs=175.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 3569999999999999999999999999999999864321 2234467899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||++|++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999854 35888999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcceeeecccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... ........||+.|+|||++.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 194 ANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred CCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 221 1122345799999999998653 478899999999999999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=292.66 Aligned_cols=194 Identities=27% Similarity=0.447 Sum_probs=169.6
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2234567888888888 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999988854 467999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 22345799999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=293.86 Aligned_cols=197 Identities=32% Similarity=0.464 Sum_probs=170.1
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999986532 12234466788888765 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999998865 456899999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 22345689999999999988999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.13 Aligned_cols=202 Identities=30% Similarity=0.443 Sum_probs=173.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3778899999999999999999999999999986532 122345667888888775 577888999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999865 456999999999999999999999999 99999999999999999999999999874322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 11 122345689999999999988899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.43 Aligned_cols=204 Identities=24% Similarity=0.280 Sum_probs=175.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||++++..+++.||+|++.+.. ......+.+|..++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999986432 122334678889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999965 2356899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .......||+.|+|||++.+ +.++.++|+|||||++|+|++|+.||...+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 221 12223569999999999875 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=291.61 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=178.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 3679999999999999999999999999999999875422 234568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.++ |+||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999865 4568999999999999999999998532 999999999999999999999999998753221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12235689999999999988999999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=291.51 Aligned_cols=198 Identities=32% Similarity=0.507 Sum_probs=169.7
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhh-cCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|.+.... .........|..++.. .+||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999999999999999986532 1223445667777765 4899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999998865 456899999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 233467999999999999989999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=297.90 Aligned_cols=205 Identities=29% Similarity=0.384 Sum_probs=177.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 368999999999999999999999999999999975422 23345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999752 357999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCcceeeecccccccccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...+.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 2221 223357899999999986 45678899999999999999999999976553
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=294.69 Aligned_cols=209 Identities=29% Similarity=0.432 Sum_probs=171.4
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC-Cc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~-~~ 140 (296)
++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+..|+.+++.+ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 57999999999999999999752 3456799999865332 2345688999999999 899999999988764 45
Q ss_pred eEEEEecCCCCCHHHHhccCCC----------------------------------------------------------
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPP---------------------------------------------------------- 162 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~---------------------------------------------------------- 162 (296)
+++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 7899999999999999864211
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeeccccccccc
Q 022482 163 DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242 (296)
Q Consensus 163 ~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~ 242 (296)
....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++...............+++.|+
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 0234788889999999999999999999 9999999999999999999999999997543222222222334667899
Q ss_pred CccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 243 APEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 243 aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~ 282 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCc
Confidence 9999988899999999999999999997 9999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=286.27 Aligned_cols=203 Identities=26% Similarity=0.339 Sum_probs=175.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||.||+|++..+++.+|+|++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 369999999999999999999999999999999865422 223567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.++.+..+... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998766655432 456899999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... ......|++.|+|||++.+..++.++|+|||||++|+|++|++||...+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 211 1223568999999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=293.02 Aligned_cols=197 Identities=30% Similarity=0.439 Sum_probs=168.4
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHH-HHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|.. +++.++||||+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 12233444444 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999998865 457899999999999999999999999 999999999999999999999999998742221 12
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 23345799999999999998999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=291.85 Aligned_cols=196 Identities=28% Similarity=0.445 Sum_probs=170.2
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|..++..+ +||+|+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2234567888888887 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999988864 457999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 2234679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=293.08 Aligned_cols=198 Identities=30% Similarity=0.432 Sum_probs=168.1
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHH-HHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999865321 1222334443 456788999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..... ...
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccccc--CCC
Confidence 999999865 456888999999999999999999999 99999999999999999999999999874221 112
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 202 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH
Confidence 233457999999999999989999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=291.59 Aligned_cols=197 Identities=30% Similarity=0.428 Sum_probs=168.2
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHH-HHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865322 1223344444 467889999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988854 456889999999999999999999999 999999999999999999999999998742221 12
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|..||...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 23345789999999999988899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=291.68 Aligned_cols=194 Identities=28% Similarity=0.451 Sum_probs=168.6
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.+|+|++.+.. ......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999997542 22334567788887766 799999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--~~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC--CC
Confidence 999988864 457999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 22345799999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=293.67 Aligned_cols=198 Identities=29% Similarity=0.412 Sum_probs=169.0
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHH-HHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.+|+|++..... .....+..|.. +++.++||||+++++++...+..++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865321 22234445544 56778999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988864 467899999999999999999999999 999999999999999999999999998742221 11
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence 223457999999999999989999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=291.18 Aligned_cols=198 Identities=31% Similarity=0.451 Sum_probs=169.9
Q ss_pred cccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 74 DCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.+.||+|+||.||++++. .+++.||+|++..... .....+..|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 367999999999999874 4688999999865321 223456789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 9999999999865 456888899999999999999999999 999999999999999999999999998642221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~ 205 (323)
T cd05584 154 G--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR 205 (323)
T ss_pred C--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH
Confidence 1 122335799999999999988899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=289.84 Aligned_cols=198 Identities=34% Similarity=0.531 Sum_probs=169.4
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhh-cCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.... .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999999999999999986542 1223445567777765 5899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-- 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--
Confidence 999999865 456889999999999999999999999 99999999999999999999999999874222211
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~ 202 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH
Confidence 223457999999999999889999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=284.50 Aligned_cols=198 Identities=29% Similarity=0.421 Sum_probs=171.5
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||+|+||+||++.+..+++.+|+|.+....... ...+..|+.+++.++||||+++.+++......++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999986543222 24567899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9887543334567999999999999999999999999 99999999999999999999999999875433221 122
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...||+.|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 3568999999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=319.82 Aligned_cols=224 Identities=28% Similarity=0.337 Sum_probs=190.4
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD 139 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~ 139 (296)
+...-.++|.++++||+|+||.|.+++.+.+++.||+|++.+... .+..-|..|..+|..-+.+=|++++..|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 344455789999999999999999999999999999999977432 23455888999999888999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
++|+||||++||+|...+.++ .++++..++.++..++-||..||+.| +|||||||+|||+|..|+++|+|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999762 37999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCccccc-chHhhhhhh
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH-NLVAWVTVL 293 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~-~l~~~~~~~ 293 (296)
|-.... +....+...+|||.|.+||++.. +.|++.+|+||+||++|||++|..||......+-. .+.+....|
T Consensus 222 Clkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 222 CLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL 300 (1317)
T ss_pred HHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc
Confidence 965432 23344556789999999999852 57899999999999999999999999977655422 444444333
Q ss_pred h
Q 022482 294 S 294 (296)
Q Consensus 294 ~ 294 (296)
.
T Consensus 301 ~ 301 (1317)
T KOG0612|consen 301 S 301 (1317)
T ss_pred C
Confidence 3
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=297.04 Aligned_cols=210 Identities=31% Similarity=0.491 Sum_probs=179.1
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.....+...+...||+|.||+||+|++.. .||||+++.... ...+.|..|+..+++.+|.||+-+.+++-.+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 333445567888999999999999999974 399999876543 345679999999999999999999999988766
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.||+.+|.|.+|+.+++. ...+|.....+.|++|+++|+.|||.++ |||||||..|||+.++++|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 999999999999999986 3578999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.....-..........|...|||||+++.. .|++++|||||||++|||++|..||....++.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 753333222223334588899999999754 68999999999999999999999999666655
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=291.43 Aligned_cols=203 Identities=26% Similarity=0.400 Sum_probs=171.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecC-----CceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~~~~ 142 (296)
+|++.+.||+|+||.||+|.+..++..||||.+... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999999999999999998643 223345678999999999999999999988543 2479
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 789988864 456899999999999999999999999 99999999999999999999999999974
Q ss_pred CCCCCc-ceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDK-THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~ 213 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh
Confidence 322111 112233578999999999876 5788999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=292.31 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=174.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||++.+..+++.+|+|++.+.. ......+..|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46899999999999999999999999999999986422 122334678889999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999965 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. ........||+.|+|||++. ...++.++|+|||||++|+|++|+.||...+
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 21 11223357999999999986 3457889999999999999999999998654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=304.50 Aligned_cols=211 Identities=26% Similarity=0.329 Sum_probs=180.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----- 139 (296)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 44689999999999999999999999999999999875533 23345778999999999999999988775432
Q ss_pred ---ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 140 ---QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 140 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
.+++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence 367999999999999998764444567999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999754333223333446799999999999998999999999999999999999999986553
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=287.70 Aligned_cols=197 Identities=31% Similarity=0.500 Sum_probs=170.3
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..+++.+ +||||+++++++...+.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997532 22334566788888877 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998865 457999999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.....+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 22335689999999999999999999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=276.34 Aligned_cols=207 Identities=24% Similarity=0.338 Sum_probs=182.0
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.++|.+-+.||+|.|+.|+++.+..+|+.+|+|+++... ..+.+++.+|+.+-+.|+||||+++.+.+.+....|+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 35678999999999999999999999999999999986543 3356788999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~ 220 (296)
|+|++.|++|..-+-. ...+++..+-..++|++.||.|+|.++ |||||+||+|+++. ..--+||+|||++
T Consensus 88 vFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLA 160 (355)
T ss_pred EEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceE
Confidence 9999999999876644 366888899999999999999999999 99999999999994 3446999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.... .........|||.|||||++....|+..+||||.||+||-||.|.+||.+.+.+.
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 8654 2233445789999999999999999999999999999999999999999865443
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=289.90 Aligned_cols=202 Identities=28% Similarity=0.372 Sum_probs=171.8
Q ss_pred CCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
+|++.+.||+|+||.||++++. .+++.||+|++.+... .....+..|+.+++.+ +||+|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4889999999999999999874 4688999999864321 2234567899999998 489999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999865 456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 211 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCC
Confidence 53222211 22345799999999999765 47889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=307.06 Aligned_cols=210 Identities=26% Similarity=0.345 Sum_probs=176.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeE-Eec------CCc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGY-CAD------GDQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~-~~~------~~~ 140 (296)
.++++.+.|.+|||+.||+|.+...+..||+|++-..+....+.+.+|+.++++|. |+|||.+++. ... .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 46889999999999999999999988999999987777777788999999999996 9999999993 221 124
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
++|+||||.||.|-+++..+. ..+|++.++++|++++++|+++||... +||||||||-+||||+.+|..||||||.+
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence 679999999999999997643 345999999999999999999999985 78999999999999999999999999998
Q ss_pred ccCCCCCccee-------eecccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 221 KLGPVGDKTHV-------STRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 221 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
........... .....-|+.|+|||.+ .+...++++|||||||+||.|+...+||+.....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l 264 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL 264 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce
Confidence 64222221100 0113468999999987 4567899999999999999999999999977433
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=298.34 Aligned_cols=205 Identities=32% Similarity=0.458 Sum_probs=176.7
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecC------CceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------~~~~ 142 (296)
.|...+.||+|+||.||+++++.+|..||||.++... ....+...+|+.++++++|||||+++++=++. +...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556788999999999999999999999999997633 34456788999999999999999999976543 3567
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc--CCC--ceEEcccC
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGY--HPKLSDFG 218 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~--~~~--~~kl~Dfg 218 (296)
+|||||.||+|...+.. +.+..++++.++..++..+..||.|||+++ |+||||||.||++- .+| ..||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999976 345678999999999999999999999999 99999999999993 333 46999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.|+...... ....+.||..|++||++.+ +.|+..+|.|||||++|++.||..||-.....
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999654433 4566889999999999984 78899999999999999999999999765544
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=293.46 Aligned_cols=195 Identities=23% Similarity=0.278 Sum_probs=171.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|.+.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+++.++||||+++++++......++|||++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 579999999999999999999999999999997532 34678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 166 ~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 166 K-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred C-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 5 788888754 456889999999999999999999999 9999999999999999999999999986422211
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 11223457999999999999889999999999999999999999887654
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=281.37 Aligned_cols=203 Identities=32% Similarity=0.474 Sum_probs=176.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|++.+.||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488899999999999999999999999999998654322 22346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999887542 2356899999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......|++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 1 11234689999999999888899999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=270.89 Aligned_cols=206 Identities=28% Similarity=0.394 Sum_probs=181.1
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------hhHHHHHHHHHHhhc-CCCcccceee
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLL-HHPNLVNLIG 133 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~I~~~~~ 133 (296)
.-+.+-..|..-+.||.|..++|.++.++.+++.+|+|++...... -.++-+.|+.+|+++ .||+|+++.+
T Consensus 11 aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D 90 (411)
T KOG0599|consen 11 AAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQD 90 (411)
T ss_pred hHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeee
Confidence 3445667899999999999999999999999999999998642211 123456789999987 6999999999
Q ss_pred EEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceE
Q 022482 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~k 213 (296)
+|+.+...++|+|.|+.|.|.+++.. .-.+++.....|++|++.++.|||..+ |+||||||+|||++++.+++
T Consensus 91 ~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 91 VYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 99999999999999999999999965 678999999999999999999999999 99999999999999999999
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
|+|||.+....++.+ ....||||.|+|||.+.. ..|+..+|+||+||++|.||.|.+||...
T Consensus 164 isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR 231 (411)
T KOG0599|consen 164 ISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR 231 (411)
T ss_pred EeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH
Confidence 999999997766654 345799999999999854 35788899999999999999999999754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=286.31 Aligned_cols=202 Identities=27% Similarity=0.373 Sum_probs=177.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 3679999999999999999999999999999998865422 233568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999865 45688899999999999999999975 6 99999999999999999999999999864322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 1 12234689999999999988899999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=296.42 Aligned_cols=203 Identities=26% Similarity=0.376 Sum_probs=168.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC--------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-------- 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-------- 138 (296)
...+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457999999999999999999999999999999885432 2345799999999999999999877432
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEccc
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDF 217 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Df 217 (296)
..+++||||++ ++|.+++.........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 24678999997 5787777543344677999999999999999999999999 99999999999998654 7999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9997543222 12235689999999998664 689999999999999999999999987653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=282.06 Aligned_cols=210 Identities=30% Similarity=0.471 Sum_probs=174.0
Q ss_pred hcCCCccccccccCceEEEEEEECC----------------CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES----------------TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVN 130 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~ 130 (296)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998642 3457999998754322 3456889999999999999999
Q ss_pred eeeEEecCCceEEEEecCCCCCHHHHhccCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 022482 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLP---------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195 (296)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~---------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~iv 195 (296)
+++++.+.+..++||||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999885421 11234677889999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCC
Q 022482 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRK 273 (296)
Q Consensus 196 Hrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~ 273 (296)
||||||+|||++.++.++|+|||++................++..|+|||++.++.++.++|||||||++|+|++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975443333223333456788999999988889999999999999999986 677
Q ss_pred CCCCCCc
Q 022482 274 AIDNTRA 280 (296)
Q Consensus 274 pf~~~~~ 280 (296)
||...+.
T Consensus 241 p~~~~~~ 247 (304)
T cd05096 241 PYGELTD 247 (304)
T ss_pred CCCcCCH
Confidence 8876543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=270.44 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=178.3
Q ss_pred HHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCC
Q 022482 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~ 139 (296)
|.+...++ .+.||+|+|+.|--+....++..||||++.+.......++.+|+.++..++ |+||++++++|+++.
T Consensus 75 F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 55555555 467999999999999999999999999999987778889999999999985 999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEcc
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSD 216 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~D 216 (296)
..|||||.+.||+|...+++ ...|++.++.++...++.||.+||.+| |.|||+||+|||-...+ .+||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred eEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 99999999999999999976 577999999999999999999999999 99999999999996554 479999
Q ss_pred cCCcccCCCC-----CcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVG-----DKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|.++.-.... ..+......+|+..|||||+.. ...|+.+.|.|||||++|.||+|.+||.+.=.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 9887521111 1122234468999999999863 23588999999999999999999999987644
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=288.98 Aligned_cols=198 Identities=31% Similarity=0.407 Sum_probs=171.2
Q ss_pred cccccccCceEEEEEEE---CCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 74 DCLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++.||+|+||.||++.+ ..+++.+|+|++..... .....+..|+.+++.++||||+++++++.+++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 36799999999999886 35789999999975332 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~- 152 (318)
T cd05582 81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE- 152 (318)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence 99999999864 456899999999999999999999999 9999999999999999999999999987533221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.
T Consensus 153 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 153 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred -CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 123346799999999999888889999999999999999999999986553
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=288.56 Aligned_cols=201 Identities=26% Similarity=0.335 Sum_probs=172.0
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---- 139 (296)
.+.++|++.+.||+|+||.||++.+..++..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 45688999999999999999999999999999999986532 233456778999999999999999999986543
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 140 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
..++||||+. ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecC
Confidence 4689999997 56766653 34788899999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 168 g~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 168 GLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999743221 12233568999999999999899999999999999999999999998665
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=278.26 Aligned_cols=203 Identities=28% Similarity=0.419 Sum_probs=168.3
Q ss_pred cCCCccccccccCceEEEEEEECC-CCeEEEEEEecCCCcc--hhHHHHHHHHHHhhc---CCCcccceeeEEe-----c
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCA-----D 137 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~I~~~~~~~~-----~ 137 (296)
.+|++.+.||+|+||.||+|.+.. ++..||+|.+...... ......+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999854 4688999988643322 223455677766655 6999999999885 2
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
....++||||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999996 6899988653 2345899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|++...... .......||+.|+|||.+.+..++.++|||||||++|+|++|++||.+.+.
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 999754322 223345689999999999888899999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.17 Aligned_cols=201 Identities=21% Similarity=0.310 Sum_probs=166.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC------CcccceeeEEecC-C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH------PNLVNLIGYCADG-D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~I~~~~~~~~~~-~ 139 (296)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ........|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 4578999999999999999999999999999999986432 223445567777766654 4588888888765 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCC--------
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGY-------- 210 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~-------- 210 (296)
.+++|||++ |++|.+++.. ...+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~ 277 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTN 277 (467)
T ss_pred eEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccc
Confidence 688999988 7889988865 4578999999999999999999997 58 99999999999998765
Q ss_pred --------ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 211 --------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 211 --------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||+..+..
T Consensus 278 ~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 278 RALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred cccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 499999998763211 123467999999999999999999999999999999999999999876543
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=279.11 Aligned_cols=201 Identities=29% Similarity=0.412 Sum_probs=183.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
-|.++..||+|+||.||+|.++.+|+.+|||.++.. .+.+++..|+.+++++..|++|++|+.|.....+|+|||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 477889999999999999999999999999998754 467889999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
.|++.+.++- .+.++++.++..+++..+++|+|||... -+|||||..|||++.+|..||+|||.+-.. .+..
T Consensus 112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQL--TDTM 183 (502)
T KOG0574|consen 112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQL--TDTM 183 (502)
T ss_pred CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchh--hhhH
Confidence 9999999875 3678999999999999999999999998 899999999999999999999999998643 2333
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.....+.|||.|||||++..-.|+..+||||||++..||..|++||.+..+
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP 234 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP 234 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc
Confidence 344567899999999999988999999999999999999999999997664
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=263.67 Aligned_cols=212 Identities=29% Similarity=0.385 Sum_probs=181.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC-----CceE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQRL 142 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~~~~ 142 (296)
.++|++.+.||+|||+.|+++....+++.||+|++.....++.+..++|+...++++|||+++++++...+ ...|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 46899999999999999999999999999999999877777888899999999999999999999876443 3489
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
++++|+..|+|.+.+......+..+++.++..|+.++++||.+||+.. +++.||||||.|||+++.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999999877666778999999999999999999999986 4799999999999999999999999999874
Q ss_pred CCCCCcce-------eeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTH-------VSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....-... ....-..|..|.|||.+.- ...+.++|||||||++|+|+.|.-||+..-.
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 32221110 0111246889999999854 4578899999999999999999999985443
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=275.02 Aligned_cols=195 Identities=30% Similarity=0.482 Sum_probs=168.4
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||+|+||.||++.+..+|+.||+|.+...... .......|+.+++.++||||+++++++.+....++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998643221 223456799999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9887542 2345888999999999999999999999 9999999999999999999999999987543221 122
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...|+..|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 3568999999999988889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=280.42 Aligned_cols=204 Identities=27% Similarity=0.415 Sum_probs=173.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|.+.+.||+|+||.||+|.+..++..+|+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5699999999999999999999999999999998654322 234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 97 588888754 2345888999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. ......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+..
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 211 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE 211 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1 1223467899999998865 45788999999999999999999999876643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=306.17 Aligned_cols=209 Identities=26% Similarity=0.396 Sum_probs=176.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ....++.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999965322 22356888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 146 EYMPLGSLEDHLHDLPP-------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
||++|++|.+++..... .....+...+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 1234566778899999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCc----------------ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDK----------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 9975411100 0111224699999999999998999999999999999999999999976543
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=288.90 Aligned_cols=209 Identities=31% Similarity=0.476 Sum_probs=172.7
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.+ +|+||+++++++...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 469999999999999999998643 335799999975432 2345678899999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCC------------------------------------------------------------
Q 022482 142 LLVYEYMPLGSLEDHLHDLP------------------------------------------------------------ 161 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~------------------------------------------------------------ 161 (296)
++||||+++++|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885311
Q ss_pred ------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecc
Q 022482 162 ------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235 (296)
Q Consensus 162 ------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 235 (296)
....++++..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++...............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01134788889999999999999999999 999999999999999999999999998754332222222223
Q ss_pred cccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 236 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.++..|+|||++.+..++.++|||||||++|+|++ |+.||.....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 35667999999988899999999999999999997 9999976554
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.28 Aligned_cols=196 Identities=30% Similarity=0.408 Sum_probs=164.9
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhc---CCCcccceeeEEecCCceEEEEecCCC
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLL---HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
||+|+||.||+|.+..+++.||+|++.+..... ......|..++..+ +||||+++++++.+.+..++||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986532221 22334455565554 699999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998865 567899999999999999999999999 9999999999999999999999999987422211 1
Q ss_pred eeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~ 203 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ 203 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH
Confidence 22345799999999998764 4789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=287.14 Aligned_cols=202 Identities=23% Similarity=0.257 Sum_probs=174.5
Q ss_pred HHhcCCCccccccccCceEEEEEEEC--CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+..+|.+.+.||+|+||.||+|... .++..||+|.+... ....+|+.+++.++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34567999999999999999999764 35678999987543 234579999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
+||++. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 164 v~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 788888843 467899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+...
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 443333333456799999999999988999999999999999999999999987654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=290.42 Aligned_cols=189 Identities=31% Similarity=0.485 Sum_probs=169.6
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~ 154 (296)
+-||+|+.|.||+|+.. ++.||||+++. .-..+++-|++|+||||+.+.++|.....++||||||..|-|.
T Consensus 130 eWlGSGaQGAVF~Grl~--netVAVKKV~e-------lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH--NETVAVKKVRE-------LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhccCcccceeeeecc--CceehhHHHhh-------hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 44999999999999987 78899998842 2235788999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeec
Q 022482 155 DHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234 (296)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 234 (296)
+.++. ...++......|..+|+.++.|||.+. |||||||.-||||+.+..|||+|||.++..... .....
T Consensus 201 ~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMS 270 (904)
T KOG4721|consen 201 EVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMS 270 (904)
T ss_pred HHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhh
Confidence 99975 788999999999999999999999999 999999999999999999999999999853322 22345
Q ss_pred ccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 235 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
++||..|||||++.+...+.++|||||||+|||||||..||.+-+...
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 789999999999999999999999999999999999999999877544
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=289.34 Aligned_cols=206 Identities=29% Similarity=0.387 Sum_probs=185.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
-...|.+.+.||+|.|+.|.++++..++..||||++.+.... ..+.+.+|+++++.++||||++++.+.+.+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 345799999999999999999999999999999999876443 335688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.++.+.+++.+ .+++.+..+..++.|+++|++|||+++ |||||||++|||++.+.++||+|||++.+..
T Consensus 134 ~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence 999999999999976 567777899999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........+|++.|.|||++.+..| .+++|+||+|+++|.|+.|.+||++.+..+
T Consensus 207 ---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~ 262 (596)
T KOG0586|consen 207 ---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE 262 (596)
T ss_pred ---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc
Confidence 3334556899999999999998876 578999999999999999999999766444
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=280.21 Aligned_cols=196 Identities=27% Similarity=0.383 Sum_probs=166.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.+|...+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 457788999999999999999999999999999865432 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+. ....+..+..++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 154 ~~~~~L~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGT--------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCccccc--------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999998653 23456778899999999999999999 9999999999999999999999999997543221
Q ss_pred cceeeecccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
.......||..|+|||.+... ..+.++|||||||++|+|++|+.||..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 112335799999999987432 334689999999999999999999974
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=287.28 Aligned_cols=208 Identities=32% Similarity=0.471 Sum_probs=172.8
Q ss_pred cCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
++|++.+.||+|+||.||+|.+ ..++..||+|++.... ......+.+|+.+++.+ +||||+++++++...+..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4699999999999999999974 3456789999986543 23345678899999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC-----------------------------------------------------------
Q 022482 142 LLVYEYMPLGSLEDHLHDLPP----------------------------------------------------------- 162 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~----------------------------------------------------------- 162 (296)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999999864210
Q ss_pred ------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 163 ------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 163 ------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++..........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1125788889999999999999999999 9999999999999999999999999997543322211
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
......++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1222334567999999999899999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=286.62 Aligned_cols=203 Identities=24% Similarity=0.355 Sum_probs=172.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCC-----ceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----~~~ 142 (296)
+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999999999999999986432 223456788999999999999999999998776 789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 688887754 467899999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....... ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||...+..
T Consensus 153 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 153 EEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred cccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 4322211 12234578999999998774 4788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.58 Aligned_cols=201 Identities=25% Similarity=0.323 Sum_probs=172.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~----- 138 (296)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999999999999999986542 22345677899999999999999999988643
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 139 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
...++||||++ ++|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 34689999997 56777663 34788899999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|+++..... .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+
T Consensus 164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999753222 12233568999999999998899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=285.47 Aligned_cols=201 Identities=26% Similarity=0.328 Sum_probs=172.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------ 138 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 5678999999999999999999999999999999986532 23345677899999999999999999987543
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
...++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999997 57777763 24788899999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99753221 112335689999999999998999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=274.61 Aligned_cols=202 Identities=31% Similarity=0.470 Sum_probs=175.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|++.+.||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|++|+++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3778899999999999999999999999999986543222 2346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999999988542 2346899999999999999999999999 999999999999999999999999998753222
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .....|+..|+|||.+.+..++.++|+||+||++|+|++|+.||....
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 11 123468999999999998899999999999999999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=274.26 Aligned_cols=203 Identities=32% Similarity=0.471 Sum_probs=175.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|+..+.||+|+||.||+|.+..+++.+|+|.+...... ....+.+|+.+++.++|++|+++++.+...+..+++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377789999999999999999999999999998654322 22346789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888542 2346999999999999999999999999 999999999999999999999999998653221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......|+..|+|||.+.+..++.++|+|||||++|+|++|..||.....
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 12235689999999999888999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=270.67 Aligned_cols=203 Identities=26% Similarity=0.357 Sum_probs=175.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+|++.+.||+|+||.||+|.+..+++.+|+|++..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34799999999999999999999999999999998755444455678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998864 456899999999999999999999999 9999999999999999999999999997542221
Q ss_pred cceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......|+..|+|||.+. ...++.++|+|||||++|+|++|+.||.+.+
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~ 213 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1122346889999999874 3457789999999999999999999997554
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=273.49 Aligned_cols=210 Identities=31% Similarity=0.510 Sum_probs=177.4
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 458889999999999999998743 3578999998765433 3467889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 143 LVYEYMPLGSLEDHLHDLP----------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
+||||+++++|.+++.... .....+++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986532 22355788999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~ 231 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999875332222222223446788999999999999999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=269.30 Aligned_cols=205 Identities=30% Similarity=0.410 Sum_probs=176.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-----hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|.+.+.||+|++|.||.|.+..+++.+|+|.+...... ....+.+|+.+++.++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4689999999999999999999999999999998654321 23457889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999865 356888999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCccee-eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
........ .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch
Confidence 32211111 1234578899999999998899999999999999999999999976543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=281.88 Aligned_cols=201 Identities=25% Similarity=0.368 Sum_probs=172.3
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecC----
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG---- 138 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~---- 138 (296)
..+.++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 4567899999999999999999999999999999999865422 2334567899999999999999999987543
Q ss_pred --CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 139 --DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 139 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3468999988 7899888743 46999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999753221 223568999999999877 468889999999999999999999997654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=272.06 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=176.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46889999999999999999999999999999987654444556778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999999865 457899999999999999999999999 999999999999999999999999998653221
Q ss_pred ceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........|+..|+|||++. +..++.++|+|||||++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 12223456899999999874 4468889999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=271.66 Aligned_cols=205 Identities=27% Similarity=0.436 Sum_probs=172.6
Q ss_pred cCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|++.+.||+|+||.||+|.+. ..+..||+|.+..... .....+.+|+..++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46899999999999999999765 4467899999875432 2234678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999865 2356899999999999999999999999 9999999999999999999999999876432
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
... ........++..|+|||.+.+..++.++|||||||++|++++ |..||.+.+.
T Consensus 159 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 159 SEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred ccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 211 111112335678999999988899999999999999999875 9999986654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=271.00 Aligned_cols=199 Identities=36% Similarity=0.565 Sum_probs=176.6
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhH--HHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|++.+.||+|+||+||++.+..+++.+|+|++......... ...+|+.+++.++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 67889999999999999999999999999999876544333 2356999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 98899999973 467899999999999999999999999 999999999999999999999999998743 122
Q ss_pred ceeeecccccccccCccccc-cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
........++..|+|||++. +..++.++|+||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 22334567899999999998 778899999999999999999999999977
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=274.76 Aligned_cols=203 Identities=30% Similarity=0.429 Sum_probs=179.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+|++.+.||+|++|.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+......++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35799999999999999999999999999999999776656667788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999853 45788999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 171 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred --cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234688999999999888889999999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=278.17 Aligned_cols=206 Identities=32% Similarity=0.507 Sum_probs=172.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeE----EEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|.+..+++. ||+|.+.... ....+.+..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4699999999999999999998665553 8999986543 23446788899999999999999999998764 5779
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999875 2346888999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
.............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 43333222222334678999999999899999999999999999998 99999875543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=305.78 Aligned_cols=213 Identities=23% Similarity=0.397 Sum_probs=175.9
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEec--CC
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GD 139 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~ 139 (296)
......+|.+.+.||+|+||.||+|.+..++..+|+|.+...... ....+..|+.+++.++||||++++++|.+ ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 344567899999999999999999999999999999998754322 34567889999999999999999998854 35
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeEeccCCCCcEEEcCC------
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN----PPVIYRDLKCSNILLGEG------ 209 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~----~~ivHrdikp~Nili~~~------ 209 (296)
.+|+||||+++++|.+++.........+++..++.|+.||+.||.|||+.+. .+|+||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6899999999999999987543344679999999999999999999998431 239999999999999642
Q ss_pred -----------CceEEcccCCcccCCCCCcceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 210 -----------YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 210 -----------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
+.++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999997543221 1234579999999999864 357889999999999999999999997
Q ss_pred CCC
Q 022482 277 NTR 279 (296)
Q Consensus 277 ~~~ 279 (296)
..+
T Consensus 245 ~~~ 247 (1021)
T PTZ00266 245 KAN 247 (1021)
T ss_pred cCC
Confidence 543
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=273.44 Aligned_cols=202 Identities=29% Similarity=0.427 Sum_probs=167.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhc---CCCcccceeeEEec-----CC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL---HHPNLVNLIGYCAD-----GD 139 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~-----~~ 139 (296)
+|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588999999999999999999999999999998653221 123455666666654 79999999998864 24
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..+++||++. ++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 5888888653 2345899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|++||.....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 97543221 12235689999999999888999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=272.45 Aligned_cols=209 Identities=33% Similarity=0.515 Sum_probs=176.3
Q ss_pred cCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+..........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4688999999999999999985 23456789999876554555678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 144 VYEYMPLGSLEDHLHDLPP---------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~---------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 9999999999999864321 1235899999999999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999875433222222223345778999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.55 Aligned_cols=204 Identities=29% Similarity=0.420 Sum_probs=180.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
...+|++.+.||+|++|.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++|||
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 34679999999999999999999998999999999976655556678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999854 45788999999999999999999999 999999999999999999999999998753322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred cc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 21 12234688999999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=271.88 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=176.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.+.|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 35699999999999999999999999999999999776555567788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|..++.. ....+++..+..++.|++.+|.|||+.+ ++||||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~- 163 (292)
T cd06644 91 CPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT- 163 (292)
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-
Confidence 999999888754 2356899999999999999999999999 999999999999999999999999998642211
Q ss_pred cceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...+
T Consensus 164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 164 -LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 111233568889999999853 346788999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=272.35 Aligned_cols=199 Identities=32% Similarity=0.458 Sum_probs=177.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|++|.||++.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 368999999999999999999999999999999865432 23456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999865 467899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 234568999999999988888899999999999999999999998665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=273.54 Aligned_cols=200 Identities=27% Similarity=0.350 Sum_probs=175.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++.+.+++.+++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 368999999999999999999999999999999865422 2234578899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999965 3568999999999999999999997 57 999999999999999999999999998643221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223568899999999988889999999999999999999999997554
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=272.76 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=166.6
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEec----CCceEEEEec
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEY 147 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~ 147 (296)
..||+|++|.||+|.. +|+.||||.+....... .+.+.+|+.+++.++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999998 48899999997653332 3567799999999999999999999876 3578899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+++|+|.+++.. ...+++.....++.|++.||.|||+. + ++||||||+||++++++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999965 45688899999999999999999985 7 889999999999999999999999998753221
Q ss_pred CcceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. ....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~ 229 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE 229 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH
Confidence 1 23468899999999976 678999999999999999999999999776443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=269.11 Aligned_cols=206 Identities=22% Similarity=0.372 Sum_probs=177.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..++..||||.+.... ......+..|+.+++.++||||+++++.+.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999875432 223345788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654334556899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 21 11223468889999999988888999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=270.88 Aligned_cols=210 Identities=37% Similarity=0.577 Sum_probs=176.9
Q ss_pred cCCCccccccccCceEEEEEEECCCC-----eEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++.+.||+|+||.||+|.+...+ ..+|+|.+..... .....+.+|+..++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 36889999999999999999876554 6799999865432 23356788999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC
Q 022482 143 LVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~ 210 (296)
++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999865311 1156888999999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
.++|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.+....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999875433332222333456888999999988899999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=269.39 Aligned_cols=196 Identities=27% Similarity=0.396 Sum_probs=172.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 36888999999999999999999999999999986542 23345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999996652 3678889999999999999999999 999999999999999999999999998753222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 1223578999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=273.54 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=173.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 579999999999999999999999999999999865432 2234567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 689888865 2456889999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+.
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 12234578899999988654 578899999999999999999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=277.42 Aligned_cols=207 Identities=30% Similarity=0.452 Sum_probs=182.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHH---HHHHHHHHhhcC-CCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|.++.+||+|+||.|.++..+.+.+.||||+++++...+.++ -+.|-++|.... -|.+++++.+|..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46888999999999999999999999999999998775544433 345666776654 67899999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.||+|-..+++ -+++.+..+..++..|+-||-+||+++ |++||||.+|||++.+|++||+|||+++...
T Consensus 429 MEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999999876 467888889999999999999999999 9999999999999999999999999998644
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 284 (296)
.+.. .+..++|||.|+|||++....|+.++|+||+||+|||||.|++||++.+.++.+
T Consensus 502 ~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF 559 (683)
T KOG0696|consen 502 FDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF 559 (683)
T ss_pred cCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 3333 345689999999999999999999999999999999999999999999887754
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=265.37 Aligned_cols=203 Identities=29% Similarity=0.387 Sum_probs=177.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|.+.+.||+|++|.||+|.+..+++.|++|.+.... .....++..|+.+++.++||||+++++.+.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4788899999999999999999999999999986532 23456688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999998752 2467899999999999999999999999 9999999999999999999999999987543322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 12233468899999999998889999999999999999999999997665
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=288.58 Aligned_cols=197 Identities=37% Similarity=0.496 Sum_probs=176.1
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
|.-++.||.|+||.||-|++..+.+.||||++.-.+.. .-+++..|+..|+.++|||++.+.++|.-+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 56678899999999999999999999999998755433 345789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|- |+..|.+.- .+.++-+.++..|+.+.+.||+|||+.+ .||||||..|||+++.|.|||+|||.+.+..+.
T Consensus 108 Cl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 96 777777754 3578999999999999999999999999 999999999999999999999999999864433
Q ss_pred cceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..++|||+|||||++. .+.|+-++||||||++..||...++|+.+++.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 3578999999999985 46899999999999999999999999988774
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.83 Aligned_cols=200 Identities=32% Similarity=0.475 Sum_probs=168.4
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+.||+|+||.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 369999999999999998899999998864432 2345688999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999864 2346889999999999999999999999 9999999999999999999999999987532211111111
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....+..|+|||.+.++.++.++|+|||||++|+|++ |..||.....
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 1123456999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=282.80 Aligned_cols=209 Identities=28% Similarity=0.422 Sum_probs=173.4
Q ss_pred hcCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~ 140 (296)
.++|.+.+.||+|+||.||+|.+.. .+..||||++..... ...+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4579999999999999999998743 245799999965432 23456889999999996 9999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCC----------------------------------------------------------
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPP---------------------------------------------------------- 162 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~---------------------------------------------------------- 162 (296)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998754210
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 163 ----------------------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 163 ----------------------------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
....+++..+..++.|++.||.|||+.+ |+||||||+||++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0134788888999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999999999875433222222223456788999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.70 Aligned_cols=203 Identities=29% Similarity=0.384 Sum_probs=179.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|.+.+.||+|++|.||+|.+..+++.+++|.+..........+.+|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57999999999999999999999889999999997665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999865 2357899999999999999999999999 9999999999999999999999999987533211
Q ss_pred ceeeecccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112235688899999999776 78889999999999999999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.05 Aligned_cols=205 Identities=26% Similarity=0.387 Sum_probs=177.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||.|++|.||+|.+..++..+|+|.+..........+..|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35699999999999999999999888999999998766555556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST- 156 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc-
Confidence 999999999865 2356899999999999999999999999 999999999999999999999999998643221
Q ss_pred cceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
........+++.|+|||.+.. ..++.++|+||||+++|+|++|+.||...+.
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 157 -LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred -ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 112233568999999999753 3467789999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=266.12 Aligned_cols=206 Identities=24% Similarity=0.386 Sum_probs=179.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|++|.||+|.+..+++.||+|.++... ......+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999899999999886422 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654444567899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 21 11223468889999999988889999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=266.35 Aligned_cols=203 Identities=26% Similarity=0.350 Sum_probs=176.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+|++.+.||+|+||.||++.+..++..+|+|.++... ....+.+..|+.+++.++||||+++++.+.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4888999999999999999999999999999986432 234456778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 153 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-- 153 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccc--
Confidence 999999988542 2455889999999999999999999999 999999999999999999999999998753221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 154 GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 112233568899999999988889999999999999999999999998655
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=271.42 Aligned_cols=202 Identities=29% Similarity=0.447 Sum_probs=179.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46999999999999999999999999999999997665555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998853 45899999999999999999999999 99999999999999999999999999875332221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 12234688899999999888899999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=276.47 Aligned_cols=192 Identities=24% Similarity=0.357 Sum_probs=166.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+|.+.+.||+|+||.||+|.+..++..||+|+.... ....|+.+++.++||||+++++++......++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45799999999999999999999999999999986433 234689999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++..+.++|+|||++......
T Consensus 139 ~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 139 YS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred cC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 96 688888754 2456899999999999999999999999 999999999999999999999999999742221
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 275 (296)
.......||+.|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999989999999999999999999855554
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=268.24 Aligned_cols=206 Identities=24% Similarity=0.383 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+|.+.+.||+|++|.||+|.+..++..+++|.+..... ....++.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 468899999999999999999998999999998865322 23356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988654444567899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 22 11223468899999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=270.51 Aligned_cols=209 Identities=33% Similarity=0.529 Sum_probs=177.4
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+..........+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35888999999999999999853 3456789999876655556678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~ 211 (296)
||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 2345889999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999975433322222333456788999999988889999999999999999999 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=268.32 Aligned_cols=211 Identities=28% Similarity=0.451 Sum_probs=173.7
Q ss_pred HhcCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
..++|++.+.||+|++|.||+|.+.. ++..+|+|.+..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 34679999999999999999998642 356799998864322 234567889999999999999999999999899
Q ss_pred eEEEEecCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPD------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 234577888999999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~ 227 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN 227 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999875433222222222345778999999988889999999999999999999 7899976543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=268.24 Aligned_cols=201 Identities=26% Similarity=0.419 Sum_probs=174.6
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
|++.+.||+|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 67889999999999999999999999999999766555566788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQ 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc--cc
Confidence 999988754 2456899999999999999999999999 999999999999999999999999998643221 11
Q ss_pred eeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......++..|+|||++. +..++.++|+|||||++|+|++|++||...+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 212 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN 212 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC
Confidence 223356899999999984 3457789999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=284.52 Aligned_cols=197 Identities=23% Similarity=0.261 Sum_probs=170.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+|.+.+.||+|+||.||+|.+..++..||||.... ....+|+.+++.++|+||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 4479999999999999999999999999999996432 2356899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++......
T Consensus 242 ~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 788888754 2346899999999999999999999999 9999999999999999999999999997543322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
.........||..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 22223345799999999999998999999999999999999998876654
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.38 Aligned_cols=207 Identities=31% Similarity=0.451 Sum_probs=171.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCe----EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|.+..++. .+++|.+..... ....++..|+..++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 468899999999999999999877665 477777754322 223456778888899999999999998754 56788
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
++||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999965 2356899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.............++..|+|||.+.++.++.++|+|||||++|||++ |..||.+.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~ 219 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 33332222233456778999999988899999999999999999998 999998765443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.96 Aligned_cols=203 Identities=33% Similarity=0.474 Sum_probs=179.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.|+.-++||+||||.||-++.+.||+.||.|.+.+.... ...-.+.|-.+|+..+.+.||.+-..|+..+.+++||
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 3578889999999999999999999999999988654332 2234678899999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
..|.||+|.-++.+.. +..|++..+..++.+|+.+|++||+.+ ||+||+||+|||+|+.|+++|+|+|+|.....
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999887643 367999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+.. ....+||..|||||++.++.|+...|+|||||++|+|+.|+-||....
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~K 390 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRK 390 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhh
Confidence 332 223489999999999999999999999999999999999999997544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.94 Aligned_cols=209 Identities=29% Similarity=0.441 Sum_probs=171.1
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC-Cc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~-~~ 140 (296)
++|++.+.||+|+||.||+|.+.. +++.||+|++..... .....+..|+.+++.+ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 479999999999999999997543 457899999865432 2234577899999999 799999999987654 56
Q ss_pred eEEEEecCCCCCHHHHhccCCCC---------------------------------------------------------
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPD--------------------------------------------------------- 163 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~--------------------------------------------------------- 163 (296)
.+++|||+++++|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988542110
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccC
Q 022482 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243 (296)
Q Consensus 164 ~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 243 (296)
...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++................++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136889999999999999999999999 99999999999999999999999999975433222222223445678999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 244 PE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=263.88 Aligned_cols=206 Identities=24% Similarity=0.300 Sum_probs=174.3
Q ss_pred HHHhcCCCcc-ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecC----
Q 022482 65 AAVTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG---- 138 (296)
Q Consensus 65 ~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~---- 138 (296)
..++++|.+. ++||-|-.|.|..+.++.+++.+|+|++. +....++|+.+-=.. .|||||.++++|++.
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3466677765 56999999999999999999999999974 335666777654443 699999999998653
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEc
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLS 215 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~ 215 (296)
..+.+|||.++||.|.+.++.. ....|++.++..|+.||..|+.|||+.+ |.||||||+|+|+. .+..+||+
T Consensus 132 kcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred eeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEec
Confidence 5678999999999999999873 3567999999999999999999999999 99999999999995 44579999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 283 (296)
|||+++.-. ........+.||+|.|||++....|+...|+||+||++|.||+|.+||.......+
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai 271 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC
Confidence 999998532 23344557899999999999998999999999999999999999999998776443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=287.89 Aligned_cols=198 Identities=29% Similarity=0.421 Sum_probs=176.2
Q ss_pred cccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHH
Q 022482 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED 155 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~ 155 (296)
+||+|.||+||-|++..+...+|||.++.......+-+.+|+.+-+.|+|.|||++++.+.++++.-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999999999999999999987666667778899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE-cCCCceEEcccCCcccCCCCCcceee
Q 022482 156 HLHDLPPDKKRL--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVS 232 (296)
Q Consensus 156 ~~~~~~~~~~~~--~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili-~~~~~~kl~Dfg~~~~~~~~~~~~~~ 232 (296)
.+... .+++ .+..+..+.+||+++|.|||+.. |||||||-+|+|+ +-.|.+||.|||.++... .-+..+
T Consensus 662 LLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA--ginP~T 733 (1226)
T KOG4279|consen 662 LLRSK---WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA--GINPCT 733 (1226)
T ss_pred HHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhc--cCCccc
Confidence 99762 4555 77888999999999999999999 9999999999999 468999999999998643 334445
Q ss_pred ecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 233 TRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 233 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..+.||..|||||++..+ .|+.++|||||||++.||.||++||......
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp 784 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP 784 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh
Confidence 667899999999999876 5899999999999999999999999765543
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=268.16 Aligned_cols=209 Identities=35% Similarity=0.522 Sum_probs=173.6
Q ss_pred cCCCccccccccCceEEEEEEEC----CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 45888999999999999999853 3567899999864332 233567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC
Q 022482 144 VYEYMPLGSLEDHLHDLPP-------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~-------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~ 210 (296)
||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853110 1235788899999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN 232 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999975433322222233445678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=268.05 Aligned_cols=211 Identities=30% Similarity=0.433 Sum_probs=176.1
Q ss_pred hcCCCccccccccCceEEEEEEECCC-----CeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||.||+|.+... +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 35789999999999999999988643 47899999865432 3345678899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPD------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999998653221 234788899999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 228 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence 9999875433322222233456788999999988889999999999999999998 99999765533
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=271.03 Aligned_cols=200 Identities=26% Similarity=0.402 Sum_probs=162.5
Q ss_pred cccccccCceEEEEEEEC--CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--CCceEEEEecCC
Q 022482 74 DCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMP 149 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~ 149 (296)
.+.||+|+||.||+|.+. .++..+|+|.+..... ...+.+|+.+++.++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999965 4678899999865432 3456789999999999999999999854 456789999986
Q ss_pred CCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE----cCCCceEEcccCCc
Q 022482 150 LGSLEDHLHDLP-----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLA 220 (296)
Q Consensus 150 ~~sL~~~~~~~~-----~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili----~~~~~~kl~Dfg~~ 220 (296)
++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +..+.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 68888764321 11235899999999999999999999999 9999999999999 45678999999999
Q ss_pred ccCCCCCcc-eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......... .......||+.|+|||++.+. .++.++|+||+||++|+|++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 754322211 112345789999999998774 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=264.08 Aligned_cols=203 Identities=29% Similarity=0.489 Sum_probs=174.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---------hHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4788999999999999999998889999999886543221 1457789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999965 356888999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc----ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDK----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 216 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT 216 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence 75432111 111122457889999999988889999999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=264.18 Aligned_cols=204 Identities=28% Similarity=0.365 Sum_probs=172.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-----cchhHHHHHHHHHHhhcCCCcccceeeEEecC--Cce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~ 141 (296)
.+|++.+.||+|+||.||.|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46899999999999999999999999999999875321 12234677899999999999999999988764 467
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999865 345788889999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 5322111 111223458889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=282.83 Aligned_cols=206 Identities=35% Similarity=0.517 Sum_probs=175.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCe---E-EEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---V-VAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
++-.+.+.||+|+||.||+|.....+. . ||+|...... .....++..|++++++++||||+++||+......+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 455667999999999999998865422 3 8999887522 34556799999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++|||+|+||+|.+++++. ...++..+...++.+++.||+|||+.+ ++||||-.+|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999999872 346999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
... ..........--..|+|||.+....|+.++|||||||++||+++ |..||.+....+
T Consensus 311 ~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~ 370 (474)
T KOG0194|consen 311 AGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE 370 (474)
T ss_pred CCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH
Confidence 543 11111111124468999999999999999999999999999999 899999887553
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=264.27 Aligned_cols=205 Identities=31% Similarity=0.506 Sum_probs=175.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|.+.+.||+|++|.||+|.+..+++.+|+|.+... ......+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3588889999999999999999999999999998654 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999998652 2356889999999999999999999999 99999999999999999999999999875433221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~ 211 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 211 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 1 1112234567999999988889999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=265.60 Aligned_cols=205 Identities=34% Similarity=0.525 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|++.+.||.|++|.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 458999999999999999999988 8889999998766555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999763 3456899999999999999999999999 99999999999999999999999999975432211
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 160 --~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~ 211 (261)
T cd05148 160 --LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211 (261)
T ss_pred --cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 1112345678999999988889999999999999999998 89999766543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.30 Aligned_cols=205 Identities=29% Similarity=0.476 Sum_probs=174.1
Q ss_pred cCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..+ ...+|+|.+...... ....+..|+.+++.++||||+++++++...+..+++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5689999999999999999988643 457999988654322 345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999865 2347899999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
............++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 2222222222334678999999988899999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=289.24 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=182.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+.|.|+..||.|+||.||+|..+.++-..|.|+|.........+++.|+.+|..+.||+|+++++.|...+.+|++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34788899999999999999999988888999998877778889999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.||-.+..+.. .+..+++.++..+++|++.||.|||+.+ |||||||..|||++-+|.++|+|||.+.. ....
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t 183 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKST 183 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhH
Confidence 99999988866 4678999999999999999999999999 99999999999999999999999999853 2223
Q ss_pred ceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......+.|||+|||||+.+. ..|+.++||||||++|.||..+.+|-...+
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 344556899999999999864 478999999999999999999999976544
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=270.53 Aligned_cols=207 Identities=34% Similarity=0.439 Sum_probs=178.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|++|.||+|.+..+++.+|+|.+...... ....+..|+.+++.++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688999999999999999999999999999999765433 3346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998652 3467899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcc---------------------------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 226 GDKT---------------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 226 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111246888999999999888999999999999999999999999766
Q ss_pred Cc
Q 022482 279 RA 280 (296)
Q Consensus 279 ~~ 280 (296)
+.
T Consensus 236 ~~ 237 (316)
T cd05574 236 NR 237 (316)
T ss_pred ch
Confidence 53
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=266.03 Aligned_cols=203 Identities=28% Similarity=0.417 Sum_probs=172.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 48889999999999999999999999999999864322 2235677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68988886532 2356899999999999999999999999 9999999999999999999999999987532221
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......+++.|+|||++.+. .++.++|+|||||++|+|++|++||....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 112234578899999988654 46889999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=266.69 Aligned_cols=209 Identities=32% Similarity=0.527 Sum_probs=175.7
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|.+.+.||+|+||.||++... .++..+|+|.+..........+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46888999999999999999743 3467899998876655556778999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 144 VYEYMPLGSLEDHLHDLPP-----------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
+|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865321 1135788999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++ |.+||.....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH
Confidence 9999999875433222122223345678999999988899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=265.78 Aligned_cols=205 Identities=32% Similarity=0.501 Sum_probs=171.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCe----EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|.+..+++ .||+|.+..... .....+..|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 568899999999999999999876666 479999865432 234567889999999999999999998865 45789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
++||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..
T Consensus 86 ~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 86 VTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 9999999999999865 2356899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.............++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 33222211222234678999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.68 Aligned_cols=201 Identities=32% Similarity=0.421 Sum_probs=177.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|.+.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36889999999999999999999999999999986543 33345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999864 37899999999999999999999999 9999999999999999999999999997643321
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 12233568889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=261.74 Aligned_cols=204 Identities=28% Similarity=0.442 Sum_probs=172.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||++.... +..+|+|.+.... .....+..|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 458889999999999999998765 5679999886543 33467888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998642 245889999999999999999999999 99999999999999999999999999875322221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
. ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~ 208 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY 208 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 1 1112235568999999988889999999999999999999 99999876543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=268.17 Aligned_cols=216 Identities=27% Similarity=0.363 Sum_probs=178.3
Q ss_pred cCHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEe-
Q 022482 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCA- 136 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~- 136 (296)
+.++......++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334445556788999999999999999999999999999999876432 2235677899999998 6999999999874
Q ss_pred ----cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 137 ----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 137 ----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
..+..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 345689999999999999987643334567899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|+|||++....... .......|++.|+|||++.. ..++.++|+|||||++|+|++|+.||...+.
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 999999987533221 12223468999999998853 3478899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=261.41 Aligned_cols=204 Identities=25% Similarity=0.352 Sum_probs=174.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec-CCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~~lv~e 146 (296)
+|++.+.||.|++|.||++.+..+++.+|+|.+..... ...+.+..|+.+++.++|+|++++++.+.. ....+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 48899999999999999999999899999999865432 234567889999999999999999998864 446789999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ....+++.++..++.|++.|+++||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999998652 2456899999999999999999999999 999999999999999999999999998754222
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~ 207 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM 207 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 1 122345688999999999998899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=261.06 Aligned_cols=204 Identities=27% Similarity=0.429 Sum_probs=178.7
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||.|+||.|+.+++..+++.+++|.+.... .....++.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5889999999999999999999999999999886543 33445678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999998752 2456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 1 22345689999999999888889999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=263.00 Aligned_cols=207 Identities=30% Similarity=0.440 Sum_probs=170.2
Q ss_pred CCccccccccCceEEEEEEECCC---CeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCc-----
Q 022482 71 FRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----- 140 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~----- 140 (296)
|.+.+.||+|+||.||+|....+ +..||+|.+..... .....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67889999999999999987653 47899999875432 234568889999999999999999998866544
Q ss_pred -eEEEEecCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 141 -RLLVYEYMPLGSLEDHLHDLP--PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 141 -~~lv~e~~~~~sL~~~~~~~~--~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
.+++|||+++++|..++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999885421 22356899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN 221 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99975433322211222335678999999988889999999999999999999 9999976554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.36 Aligned_cols=210 Identities=31% Similarity=0.451 Sum_probs=173.8
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|.+.+.||+|++|.||+|.+.. ++..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 568999999999999999999976 6788999988654322 2346888999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEcc
Q 022482 143 LVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSD 216 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~D 216 (296)
+||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 99999999999999865321 1235889999999999999999999999 99999999999998654 589999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999975422221111122234567999999998899999999999999999997 99999875543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=268.23 Aligned_cols=205 Identities=28% Similarity=0.416 Sum_probs=175.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||++.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368899999999999999999999999999999875432 22346778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999965 356899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCcc-------------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKT-------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1100 011124578889999999888899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=260.60 Aligned_cols=203 Identities=39% Similarity=0.562 Sum_probs=175.3
Q ss_pred ccccccCceEEEEEEECCC---CeEEEEEEecCCCcch-hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+... +..+++|.+....... ...+.+|+..++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999866 8899999997654333 56788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 151 GSLEDHLHDLPPD-----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 151 ~sL~~~~~~~~~~-----~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999763211 477999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
...........++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 322222334567889999999988889999999999999999999 6999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=263.89 Aligned_cols=205 Identities=32% Similarity=0.437 Sum_probs=173.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecC------C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG------D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~------~ 139 (296)
..+.|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.+ +||||+++++.+... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567899999999999999999999999999999986543 3345678899999888 699999999998753 4
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 578999999999999998652 2356889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+....... .......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 87532221 12234568999999999863 357889999999999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=264.06 Aligned_cols=201 Identities=30% Similarity=0.423 Sum_probs=178.3
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+|++.+.||.|+||.||+|.+..+++.+|+|.+..... ...+.+.+|+..++.++||||+++++.+.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58899999999999999999999999999999975432 234678889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999865 357899999999999999999999999 999999999999999999999999998754332
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 2 12335688899999999888899999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=268.65 Aligned_cols=202 Identities=27% Similarity=0.396 Sum_probs=175.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+.|.....||+|+||.||++.+..++..||||.+..........+.+|+..++.++||||+++++.+...+..++||||+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 101 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL 101 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence 34555677999999999999999889999999987655455566889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 102 ~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~- 172 (292)
T cd06658 102 EGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV- 172 (292)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-
Confidence 99999998743 45889999999999999999999999 9999999999999999999999999986432211
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 173 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 223 (292)
T cd06658 173 -PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP 223 (292)
T ss_pred -ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234688999999999888899999999999999999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=264.78 Aligned_cols=203 Identities=30% Similarity=0.383 Sum_probs=174.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468999999999999999999999999999998864322 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|++++.|..++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9998888877643 346899999999999999999999999 999999999999999999999999999754332
Q ss_pred CcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 21 1223457889999999876 4578899999999999999999999986554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=262.75 Aligned_cols=203 Identities=31% Similarity=0.479 Sum_probs=173.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|++|.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 468999999999999999998764 5679999886543 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999998652 3456888899999999999999999999 99999999999999999999999999975432221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
. ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||....
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 209 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC
Confidence 1 1122345678999999988889999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=266.11 Aligned_cols=203 Identities=29% Similarity=0.420 Sum_probs=172.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 35799999999999999999999989999999998654322 22346689999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 997 5899988652 346889999999999999999999999 999999999999999999999999998643221
Q ss_pred CcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+
T Consensus 157 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 157 SK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred Cc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11 1122346888999998865 457889999999999999999999997655
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=281.13 Aligned_cols=216 Identities=26% Similarity=0.338 Sum_probs=184.5
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh---HHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
|..++.||-|+||.|++++..++...||+|.+++...... ..+..|..+|...+.+-||++|..|.+.+++|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 6677889999999999999999999999999877654333 2356788999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC----
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG---- 223 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~---- 223 (296)
++||++-.++-+ .+-|++..++.++..+..|+++.|..| +|||||||+|||||.+|++||+|||+|.-.
T Consensus 711 IPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999998865 467899999999999999999999999 999999999999999999999999998421
Q ss_pred -----CCCCc-------------------------------ceeeecccccccccCccccccCCCCccchhHHHHHHHHH
Q 022482 224 -----PVGDK-------------------------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLE 267 (296)
Q Consensus 224 -----~~~~~-------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 267 (296)
..++- ....-..+||+.|+|||++....|+..+|+||.||+|||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 11000 000112579999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccc-chHhhhhhh
Q 022482 268 IITGRKAIDNTRAAGEH-NLVAWVTVL 293 (296)
Q Consensus 268 ll~g~~pf~~~~~~~~~-~l~~~~~~~ 293 (296)
|+.|++||.+..+-+.. .+.+|-..|
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l 890 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFL 890 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcc
Confidence 99999999888777644 778886554
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.38 Aligned_cols=205 Identities=29% Similarity=0.448 Sum_probs=176.8
Q ss_pred HHhcCCCc--cccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 66 AVTKNFRA--DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 66 ~~~~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.+..-|++ .++||+|.||+||-|.++.+|+.||||++.+-.. .....++.|+.+|+++.||.|+.+-..|+..+.+
T Consensus 559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv 638 (888)
T KOG4236|consen 559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV 638 (888)
T ss_pred hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence 33333443 5889999999999999999999999999976433 3346688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC---CceEEcccC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLSDFG 218 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~---~~~kl~Dfg 218 (296)
++|||.+. |+..+.+.. ..++++++...+.++.||+.||.|||-.+ |+|+||||+|||+.+. -.+||||||
T Consensus 639 FVVMEKl~-GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 639 FVVMEKLH-GDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred EEEehhhc-chHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeecccc
Confidence 99999996 666666543 35788999999999999999999999999 9999999999999544 369999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.+++... ......++|||.|+|||++.++.|...-|+||+||++|--|.|..||...+
T Consensus 713 fARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 713 FARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred ceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 9997433 234556889999999999999999999999999999999999999997544
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=266.90 Aligned_cols=207 Identities=33% Similarity=0.501 Sum_probs=170.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCe--EEEEEEecCC-CcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRN-GLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..++. .+++|.+... .....+.+.+|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999877664 4688877532 222345678899999988 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 145 YEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999865221 1235888999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+|+|||++...... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||...+..
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~ 225 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA 225 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999998632111 01111223457999999988889999999999999999997 99999876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=260.23 Aligned_cols=204 Identities=32% Similarity=0.493 Sum_probs=173.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|++|.||+|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 568999999999999999998764 5779999986543 33567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.... ...+++..+..++.|++.||.+||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999986532 356899999999999999999999999 99999999999999999999999999975432211
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. .......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+.
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 1 1111223457999999988889999999999999999999 9999976553
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=267.00 Aligned_cols=207 Identities=30% Similarity=0.443 Sum_probs=173.9
Q ss_pred cCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
++|.+.+.||+|+||.||++.+ ..++..+|+|.+..... .....+.+|+.+++.+ +||||+++++.+...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4699999999999999999975 33456899998865432 2345688899999999 799999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999998652 2234899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~ 249 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV 249 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc
Confidence 5433222112222346778999999988889999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=261.31 Aligned_cols=204 Identities=29% Similarity=0.386 Sum_probs=173.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-----chhHHHHHHHHHHhhcCCCcccceeeEEecC--Cce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~ 141 (296)
.+|+..+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468999999999999999999999999999998864321 1234578899999999999999999988753 567
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999865 345888999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 5322111 111123458889999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=268.93 Aligned_cols=206 Identities=34% Similarity=0.520 Sum_probs=169.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeE--EEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..++.. +++|.+.... ......+.+|+.++..+ +||||+++++++...+.+++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 4688999999999999999998877754 5777665432 22345678899999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 145 YEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999864221 1235889999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+.
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 229 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh
Confidence 99999998632111 11111224567999999988888999999999999999998 9999976554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.40 Aligned_cols=209 Identities=31% Similarity=0.445 Sum_probs=172.4
Q ss_pred cCCCccccccccCceEEEEEEECC-------CCeEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 139 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~ 139 (296)
++|.+.+.||+|+||.||+|.+.. +...+|+|.+.... ......+..|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 469999999999999999998643 23569999987542 23345677899999998 7999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
..++||||+.+++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999975321 1245888999999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999999999999875432221111112234568999999988889999999999999999998 8999976554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=266.01 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=171.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..+|.+.+.||+|+||.||+|.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 367999999999999999999999999999999986543222 2356789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 777777643 2345788889999999999999999999 999999999999999999999999998743221
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......+++.|+|||.+.+. .++.++|+|||||++|+|++|..||...+.
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 1 112234578899999998764 578899999999999999999999986654
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=270.13 Aligned_cols=202 Identities=20% Similarity=0.260 Sum_probs=167.9
Q ss_pred cccccccc--CceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 73 ADCLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 73 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++++||+| +|++||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 789999999999999999999975432 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999998642 2345899999999999999999999999 99999999999999999999999986542211110
Q ss_pred -----ceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 -----THVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 -----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 214 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP 214 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 001112346778999999976 358899999999999999999999998643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.13 Aligned_cols=204 Identities=26% Similarity=0.379 Sum_probs=173.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36889999999999999999999899999999886532 22345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+++++|.+++.... ....+++..+..++.|++.||.|||+ .+ ++||||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999886521 13478999999999999999999996 57 999999999999999999999999998643221
Q ss_pred CcceeeecccccccccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 212 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch
Confidence 12234578899999998554 347889999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=267.49 Aligned_cols=211 Identities=31% Similarity=0.453 Sum_probs=175.5
Q ss_pred hcCCCccccccccCceEEEEEEECCC-----CeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
.++|++.+.||+|+||.||++.+... ...+|+|.+..... .....+.+|+.+++.+ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 35689999999999999999987643 37899999865422 2334678899999999 79999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
.+++|||+++++|.+++.... .....+++..++.++.|++.||+|||+.+ |+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 999999999999999986421 23456889999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999985433322222222334567999999988889999999999999999998 99999866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=265.56 Aligned_cols=209 Identities=32% Similarity=0.477 Sum_probs=172.5
Q ss_pred CCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... .....+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47889999999999999998743 235788888865432 234568889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 144 VYEYMPLGSLEDHLHDLP--------------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~--------------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
+|||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999876421 11245788999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
|++++++.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+..+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 9999999999999999875332222111222345678999999988889999999999999999998 99999765543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=259.81 Aligned_cols=202 Identities=32% Similarity=0.414 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|++|.||+|.+..++..+++|.+..... ...+.+|+.+++.++||||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 579999999999999999999998899999999865432 567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999864 2467899999999999999999999999 99999999999999999999999999875433221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 22334588899999999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=266.40 Aligned_cols=209 Identities=30% Similarity=0.492 Sum_probs=172.8
Q ss_pred cCCCccccccccCceEEEEEEECC----------------CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES----------------TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNL 131 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~ 131 (296)
++|++.+.||+|+||.||++.+.. +...+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 569999999999999999986432 345789999875432 234578899999999999999999
Q ss_pred eeEEecCCceEEEEecCCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcE
Q 022482 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPD-------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (296)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~-------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Ni 204 (296)
++++...+..++||||+++++|.+++...... ...+++..+..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99999999999999999999999998653211 234778889999999999999999999 99999999999
Q ss_pred EEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCCc
Q 022482 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTRA 280 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~~ 280 (296)
+++.++.++|+|||++................++..|++||...++.++.++|+|||||++|+|++ |..||...+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 999999999999999875433222222222344678999999888889999999999999999998 7899976543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=280.39 Aligned_cols=206 Identities=28% Similarity=0.360 Sum_probs=184.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++.++..||-||||.|=++..+.....+|+|++++.... +.+.+..|-.+|..++.|.|+++|-.|.++.++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4567788899999999999988765556899988765443 3445778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|-|-||.|...+.. .+.|++..+..++..+++|++|||+++ ||+|||||+|++++.+|-+||.|||.++....
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999976 678999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 284 (296)
+. .++.++|||.|.|||++.+...+.++|.||||+++||||+|.+||++.++-...
T Consensus 573 g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY 628 (732)
T KOG0614|consen 573 GR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY 628 (732)
T ss_pred CC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH
Confidence 44 467799999999999999999999999999999999999999999988865433
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.59 Aligned_cols=203 Identities=24% Similarity=0.403 Sum_probs=174.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc------chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+|+..+.||+|++|.||++.+..+++.+|+|++..... .....+..|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48889999999999999999999999999999864331 123567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCccc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKL 222 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~ 222 (296)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999865 456889999999999999999999999 99999999999998765 599999999875
Q ss_pred CCCCCc--ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 223 GPVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 223 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 432211 111223468889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=262.86 Aligned_cols=202 Identities=30% Similarity=0.410 Sum_probs=176.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..|+..+.||+|+||.||.|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 45888899999999999999999889999999987543 23345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999998853 45888999999999999999999999 9999999999999999999999999986533222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...++
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 122234678899999999888899999999999999999999999986553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=265.76 Aligned_cols=201 Identities=24% Similarity=0.355 Sum_probs=170.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||+|++|.||+|.+..+|+.+|+|.+...... ....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 488899999999999999999999999999998643221 224567899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 688887754 2456899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. ......++..|+|||.+.+. .++.++|+|||||++|+|++|..||....
T Consensus 154 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~ 204 (284)
T cd07839 154 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204 (284)
T ss_pred C--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC
Confidence 1 11234578899999998764 46889999999999999999999875433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=261.11 Aligned_cols=203 Identities=35% Similarity=0.520 Sum_probs=171.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|++|.||+|.+..+ ..||+|.+..... ....+.+|+.+++.++||||+++++.+. .+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 5699999999999999999988765 4599999875433 3456889999999999999999999875 45689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999652 2345788999999999999999999999 99999999999999999999999999975433222
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. ......++..|+|||...+..++.++|+|||||++|+|++ |..||.+...
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred c-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 1 1122346678999999988889999999999999999999 8989976654
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.44 Aligned_cols=208 Identities=31% Similarity=0.448 Sum_probs=173.1
Q ss_pred CCCccccccccCceEEEEEEECCC-----CeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 478889999999999999987543 578999998754322 23557889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc
Q 022482 144 VYEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~ 211 (296)
++||+.+++|.+++.... .....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999984211 11245788889999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
++|+|||+++...............+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 232 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999875433332222333456788999999988889999999999999999998 8889976544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=264.77 Aligned_cols=210 Identities=28% Similarity=0.448 Sum_probs=171.9
Q ss_pred hcCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||.||+|.+.. .+..||+|.+..... .....+.+|+..++.++||||+++++++.+.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4679999999999999999997642 355799998864432 2334577899999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPD------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
++||||+++++|.+++...... ....+...+..++.|++.||.|||+.+ ++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEEC
Confidence 9999999999999999653211 233566788899999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~ 227 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999875433222222222345678999999988889999999999999999998 8999976543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=260.19 Aligned_cols=201 Identities=31% Similarity=0.467 Sum_probs=170.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
+|++.+.||+|++|.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 58899999999999999998864 66799999865433 34567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||.++........
T Consensus 83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 99999998652 346899999999999999999999999 999999999999999999999999998753221111
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 206 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC
Confidence 1111223457999999998899999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.32 Aligned_cols=203 Identities=33% Similarity=0.501 Sum_probs=168.8
Q ss_pred cCC-CccccccccCceEEEEEEE----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecC--Cc
Q 022482 69 KNF-RADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQ 140 (296)
Q Consensus 69 ~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~ 140 (296)
++| .+.+.||+|+||.||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8999999999999988653 34678899999875432 2345678899999999999999999987653 45
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.+++|||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence 7899999999999999854 45899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcce-eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 214 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP 214 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCc
Confidence 7543322211 1112235667999999988889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=264.80 Aligned_cols=202 Identities=30% Similarity=0.438 Sum_probs=177.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|.+.+.||+|+||.||++.+..++..+++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57999999999999999999998889999999987555455567888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999854 45788999999999999999999999 99999999999999999999999998864332221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12234688899999999888889999999999999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.65 Aligned_cols=212 Identities=28% Similarity=0.433 Sum_probs=174.7
Q ss_pred hcCCCccccccccCceEEEEEEEC-------CCCeEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~ 138 (296)
..+|.+.+.||+|+||.||+|.+. ..+..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356889999999999999999752 234579999886432 23346788999999999 799999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
...++||||+.+++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999865321 1345788889999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||...+..+
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999975433222222223345678999999988889999999999999999998 889987655433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.00 Aligned_cols=208 Identities=30% Similarity=0.469 Sum_probs=171.9
Q ss_pred cCCCccccccccCceEEEEEEECCC--------------CeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceee
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLEST--------------NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIG 133 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~ 133 (296)
++|++.+.||+|+||.||+|.+..+ ...||+|.+..... .....+.+|+.+++.++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 23589999875432 23356889999999999999999999
Q ss_pred EEecCCceEEEEecCCCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEE
Q 022482 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPP--------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (296)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~--------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nil 205 (296)
++...+..++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854210 1124688899999999999999999999 999999999999
Q ss_pred EcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 022482 206 LGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTR 279 (296)
Q Consensus 206 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~ 279 (296)
+++++.++|+|||++................++..|+|||.+.++.++.++|+|||||++|+|++ |..||...+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 99999999999999875433322222223345678999999988889999999999999999988 778887654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=260.30 Aligned_cols=203 Identities=30% Similarity=0.453 Sum_probs=172.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|++.+.||+|++|.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 458899999999999999998764 45699998875433 3466889999999999999999999999989999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999998652 236899999999999999999999999 99999999999999999999999999875433221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 207 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN 207 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 1 1122335678999999988889999999999999999998 9999976553
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=289.84 Aligned_cols=210 Identities=34% Similarity=0.550 Sum_probs=181.9
Q ss_pred CCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+..+.+.||+|+||.||+|.... ....||||.++..... ..++|++|+.++..++|||||++++++.+.+.+++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 45667889999999999998643 3567999999776555 67789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceE
Q 022482 144 VYEYMPLGSLEDHLHDLPPD----------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~----------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~k 213 (296)
|+|||..|+|.+|+....+. ..+++..+...|+.||+.|+.||-++. +|||||-.+|+||+++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 99999999999999753221 233888999999999999999999999 99999999999999999999
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
|+|||+++..-..++........--.+|||||.|..+.++.+|||||+||+|||+++ |..||.+..-.+
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 999999986555555444444455679999999999999999999999999999999 999998765443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=262.42 Aligned_cols=206 Identities=34% Similarity=0.517 Sum_probs=173.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCe----EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|.+..++. .+|+|....... .....+.+|+.+++.++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568999999999999999999876654 589998865543 234567889999999999999999999887 78899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+...
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999865 2345899999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
.............++..|+|||.+....++.++|+||||+++|++++ |+.||...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 43322222222224568999999988889999999999999999998 99999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=260.67 Aligned_cols=207 Identities=30% Similarity=0.432 Sum_probs=168.2
Q ss_pred CCccccccccCceEEEEEEECCCCe--EEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC------Cc
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQ 140 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------~~ 140 (296)
|.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877665 58999886542 23345678899999999999999999976432 24
Q ss_pred eEEEEecCCCCCHHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 141 RLLVYEYMPLGSLEDHLHD--LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~--~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
.+++|||+.+++|.+++.. .......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999988742 1122355889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
++................+++.|+|||.+.+..++.++|+|||||++|+|++ |+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 220 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN 220 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9976433322111222346678999999998889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=259.37 Aligned_cols=204 Identities=28% Similarity=0.373 Sum_probs=173.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCC-----CcchhHHHHHHHHHHhhcCCCcccceeeEEecC--Cce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN-----GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~ 141 (296)
.+|++.+.||+|++|.||+|.+..+++.+|+|.+... .......+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4689999999999999999999999999999987532 122334678899999999999999999998764 457
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999864 345888999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 5322111 111123468899999999988888999999999999999999999997653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=264.00 Aligned_cols=201 Identities=31% Similarity=0.429 Sum_probs=175.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..|...+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 347778899999999999999998899999999875432 3345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 84 LGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred cCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 999999998853 46889999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 11223467889999999998889999999999999999999999997554
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=267.04 Aligned_cols=199 Identities=26% Similarity=0.379 Sum_probs=173.7
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
|.....||+|+||.||+|.+..++..||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||+++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~ 102 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG 102 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence 44456799999999999999988999999998765445556788899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 103 ~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~ 172 (297)
T cd06659 103 GALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 172 (297)
T ss_pred CCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--c
Confidence 999998743 45889999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233568899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=263.76 Aligned_cols=209 Identities=32% Similarity=0.482 Sum_probs=176.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCC----------------eEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTN----------------QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVN 130 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~ 130 (296)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357999999999999999999876533 5689999875432 23456888999999999999999
Q ss_pred eeeEEecCCceEEEEecCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP-------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 131 ~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~-------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
+++++...+..+++||++++++|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999865321 1236899999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh--CCCCCCCCC
Q 022482 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT--GRKAIDNTR 279 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~--g~~pf~~~~ 279 (296)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||...+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence 9999999999999999875433333333334556788999999988889999999999999999998 788887544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=262.48 Aligned_cols=205 Identities=39% Similarity=0.588 Sum_probs=171.5
Q ss_pred ccccccccCceEEEEEEEC----CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 73 ADCLLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+.+.||.|+||.||+|... ..+..|+||.+..... .....+.+|+..++.++||||+++++++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4678999999999999987 4567899999955332 3367889999999999999999999999988889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..|+.|++.||+|||+.+ ++|+||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999999872 3567999999999999999999999999 9999999999999999999999999998653333
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.............|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~ 213 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE 213 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 3333334557788999999988889999999999999999999 789998765433
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=260.97 Aligned_cols=203 Identities=28% Similarity=0.430 Sum_probs=172.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc----------hhHHHHHHHHHHhhcCCCcccceeeEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------GNREFLVEVLMLSLLHHPNLVNLIGYCADGD 139 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~ 139 (296)
+|.+.+.||+|++|.||+|.+..+++.+|+|.+...... ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578899999999999999999988999999987532111 1234678999999999999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999865 357889999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+................++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 97533222122223346888999999987654 7889999999999999999999997544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=261.51 Aligned_cols=206 Identities=28% Similarity=0.480 Sum_probs=172.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCe---EEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
..|++.+.||+|+||.||+|.+..+++ .||+|.+.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 358889999999999999999876654 69999986542 22345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998652 356899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceeeeccc---ccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKTHVSTRVM---GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
............ .+..|+|||.+.+..++.++|+|||||++|||++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 222111111111 1357999999988899999999999999999986 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=262.54 Aligned_cols=202 Identities=27% Similarity=0.409 Sum_probs=174.3
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||+|++|.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 58899999999999999999998999999999875442 2345688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+ +++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998652 356899999999999999999999999 9999999999999999999999999987543322
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......++..|+|||.+.+. .++.++|||||||++|+|++|.+||....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 1 112234689999999998654 46889999999999999999988886544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=266.73 Aligned_cols=209 Identities=29% Similarity=0.460 Sum_probs=172.0
Q ss_pred cCCCccccccccCceEEEEEEEC-------CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 139 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~ 139 (296)
.+|.+.+.||+|+||.||+|.+. .....+|+|.+..... .....+..|+.+++.+ +||||+++++++...+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 57889999999999999999863 2345789998865422 2345678899999999 6999999999999989
Q ss_pred ceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999865321 1245888999999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999975432221111112234467999999988889999999999999999999 9999976654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=264.45 Aligned_cols=212 Identities=29% Similarity=0.371 Sum_probs=176.3
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecC---
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--- 138 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~--- 138 (296)
.+....++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+..|+.+++.+ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 33445678999999999999999999999999999999986542 2245667888899888 799999999998754
Q ss_pred --CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 139 --DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 139 --~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
...++||||+++++|.+++.........+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence 3579999999999999988643334567899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++........ ......|+..|+|||.+... .++.++|+|||||++|+|++|+.||...+.
T Consensus 172 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 172 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred cccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 999875332211 12234688899999988643 367899999999999999999999986653
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=262.55 Aligned_cols=203 Identities=29% Similarity=0.369 Sum_probs=168.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHH-HHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+. .++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 368899999999999999999999999999999875432 22334555555 4666789999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|++ ++|.+++.........+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 788888765433456799999999999999999999987 8 99999999999999999999999999875322
Q ss_pred CCcceeeecccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW 210 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcc
Confidence 1 11223468889999998865 34688999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=260.47 Aligned_cols=206 Identities=29% Similarity=0.472 Sum_probs=172.5
Q ss_pred cCCCccccccccCceEEEEEEECCCC---eEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.+...... ....+..|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46889999999999999999886443 37999998654322 345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++... ...+++..+..++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999998652 346899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCccee-eecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~ 215 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN 215 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence 3221111 111223567999999998889999999999999999887 9999976553
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=237.72 Aligned_cols=213 Identities=25% Similarity=0.358 Sum_probs=180.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.|.-.+.||+|.||+||+|++..+++.||+|.++.+... --....+|+.+++.+.|.||++++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 466678899999999999999999999999998754322 234678999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|+ .+|..|... .++.++.+.+..++.|++++|.++|+++ +.|||+||.|++|+.+|.+||+|||+++......
T Consensus 83 cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 96 788888765 3677999999999999999999999999 9999999999999999999999999998644333
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHh-CCCCCCCCCcccccchHhhhhhh
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVAWVTVL 293 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~l~~~~~~~ 293 (296)
. ....-+.|.+|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+.++ .|...++.|
T Consensus 156 r--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~l 219 (292)
T KOG0662|consen 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLL 219 (292)
T ss_pred E--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHh
Confidence 2 22334679999999999886 58889999999999999987 888888777654 444444444
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=259.79 Aligned_cols=203 Identities=30% Similarity=0.399 Sum_probs=164.4
Q ss_pred ccccccCceEEEEEEEC--CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||++++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 46899999999999764 3456799998865432 23346788999999999999999999999999999999999999
Q ss_pred CHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 152 SLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 152 sL~~~~~~~~~-~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
+|.+++..... .....++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999864321 1234566778889999999999999999 9999999999999999999999999987533222222
Q ss_pred eeecccccccccCccccccC-------CCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTG-------QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
......++..|+|||++.+. .++.++|+||||+++|+|++ |+.||...+.
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh
Confidence 22234578889999998642 35779999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=263.48 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=176.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|++|.||++.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46889999999999999999999999999999886543 23346788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999998865 3568999999999999999999997 57 999999999999999999999999998643211
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 11235689999999999888899999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=265.62 Aligned_cols=209 Identities=24% Similarity=0.325 Sum_probs=173.4
Q ss_pred CCCccccccccCceEEEEEEECC--CCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecC--CceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~ 142 (296)
+|.+.+.||+|++|.||+|.+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48889999999999999999988 78999999997632 23345677899999999999999999999988 7899
Q ss_pred EEEecCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC----CCceEEccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPD-KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----GYHPKLSDF 217 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~----~~~~kl~Df 217 (296)
+||||+. ++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.++|+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999997 5777766432222 247899999999999999999999999 999999999999998 999999999
Q ss_pred CCcccCCCCCc-ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 218 GLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 218 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
|++........ ........++..|+|||.+.+. .++.++|+|||||++|+|++|++||...+...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~ 223 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKI 223 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccc
Confidence 99875432222 1122234678899999988664 57889999999999999999999998766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=259.16 Aligned_cols=202 Identities=28% Similarity=0.434 Sum_probs=172.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc------chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+|++.+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999875 588899998864321 112457789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999865 356889999999999999999999999 999999999999999999999999998743
Q ss_pred CCC----CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVG----DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... ..........|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 211 11112223568899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=260.92 Aligned_cols=210 Identities=26% Similarity=0.385 Sum_probs=174.9
Q ss_pred hcCCCccccccccCceEEEEEEECC----CCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEec-CCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES----TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~ 141 (296)
.++|.+.+.||+|+||.||+|.+.. ++..|++|.+.... ......+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578999999999999999999876 35789999886432 2334567889999999999999999998765 5678
Q ss_pred EEEEecCCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPD----KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~----~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
+++++|+++++|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998653222 156899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|+++...............++..|+|||.+.+..++.++|||||||++|++++ |++||...++
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 225 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP 225 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH
Confidence 99975433332222223446778999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=258.02 Aligned_cols=201 Identities=29% Similarity=0.420 Sum_probs=179.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+|.+.+.||+|++|.||+|.+..+++.+++|++..... .....+..|+..++.++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 68889999999999999999999999999999876544 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
++++|.+++.. ...+++..+..++.|++.|+.|||+ .+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999965 3678999999999999999999999 99 9999999999999999999999999987543222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 2 1223468889999999988889999999999999999999999997765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=257.42 Aligned_cols=200 Identities=30% Similarity=0.443 Sum_probs=174.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-----chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+|+..+.||+|++|.||+|.+..++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47888999999999999999998899999998864331 2345688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999865 345889999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcceeeecccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 222 223456889999999987766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=263.72 Aligned_cols=201 Identities=29% Similarity=0.398 Sum_probs=171.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-----hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+|.+.+.||+|++|.||+|.+..+++.||+|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488899999999999999999988999999999755432 234567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+ +++|.+++... ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 89999998652 236999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 3221 1222356788999998855 457889999999999999999988887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=273.03 Aligned_cols=208 Identities=31% Similarity=0.465 Sum_probs=171.9
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcC-CCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~ 141 (296)
++|.+.+.||+|+||.||+|++. .+++.||+|++...... ....+..|+.++..+. ||||+++++++...+..
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45888999999999999999864 34578999999754322 2346788999999997 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC-----------------------------------------------------------
Q 022482 142 LLVYEYMPLGSLEDHLHDLPP----------------------------------------------------------- 162 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~----------------------------------------------------------- 162 (296)
++||||+++|+|.++++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864211
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 163 -----------------------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 163 -----------------------------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
....+++..+..++.|++.||.|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 1124677788899999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
+++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|||++ |..||....
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999975322221112223456788999999988889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=265.25 Aligned_cols=199 Identities=26% Similarity=0.406 Sum_probs=161.2
Q ss_pred ccccccCceEEEEEEECC--CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--CCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~ 150 (296)
..||+|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999654 567899999865432 3457789999999999999999998854 457789999986
Q ss_pred CCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE----cCCCceEEcccCCcc
Q 022482 151 GSLEDHLHDLP-----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAK 221 (296)
Q Consensus 151 ~sL~~~~~~~~-----~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili----~~~~~~kl~Dfg~~~ 221 (296)
++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 67877764211 12235889999999999999999999999 9999999999999 566789999999997
Q ss_pred cCCCCCcc-eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 54332211 112235689999999998764 57889999999999999999999997554
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=258.14 Aligned_cols=208 Identities=31% Similarity=0.430 Sum_probs=179.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||.|++|.||+|....++..+++|++..... .....+.+|+..++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468999999999999999999988899999999865432 2456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.... ....+++..+..++.|++.||++||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999986521 1356899999999999999999999999 9999999999999999999999999987543332
Q ss_pred cc--eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......|+..|+|||.+... .++.++|+|||||++|+|++|+.||...+.
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 22 122335688999999998776 788999999999999999999999986553
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=260.01 Aligned_cols=207 Identities=32% Similarity=0.431 Sum_probs=175.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD------ 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~------ 139 (296)
..++|++.+.||+|++|.||+|.+..++..+++|++..... ....+.+|+.+++.+ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 35789999999999999999999998899999999875543 346688999999998 6999999999997644
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
.+++||||+++++|.+++......+..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||.
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998654333567899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+...... ........|+..|+|||.+.. ..++.++|+|||||++|+|++|+.||...+
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 8753222 122233568899999998754 246788999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=260.73 Aligned_cols=203 Identities=34% Similarity=0.502 Sum_probs=169.8
Q ss_pred cCCCccccccccCceEEEEEEE----CCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--CCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~ 142 (296)
.+|++.+.||+|+||.||++.. ..++..||+|.+..........+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4688999999999999999974 45688999999876655556678899999999999999999998754 34688
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999998652 345889999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCccee-eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 223 GPVGDKTHV-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 223 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
......... .....++..|+|||.+.+..++.++|+|||||++|+|++|..|+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 433222111 1112234569999999888899999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=258.97 Aligned_cols=202 Identities=28% Similarity=0.381 Sum_probs=161.4
Q ss_pred ccccccCceEEEEEEECC--CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 75 CLLGEGGFGRVYKGRLES--TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
+.||+|+||.||+|.... ....+++|.+..... .....+.+|+..++.++||||+++++.+......++||||++++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999996532 345788888754432 22345778999999999999999999999999999999999999
Q ss_pred CHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 152 SLEDHLHDLPPD-KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 152 sL~~~~~~~~~~-~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
+|.+++...... ....++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999998653221 233567788899999999999999999 9999999999999999999999999986432222111
Q ss_pred eeecccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS 214 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 1222345678999998743 356789999999999999999 888987654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=257.92 Aligned_cols=204 Identities=35% Similarity=0.540 Sum_probs=171.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|++|.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++|++|+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3579999999999999999998764 56699999865433 3467889999999999999999999875 4568899999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999998652 2356899999999999999999999999 9999999999999999999999999997543322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 11 1112234567999999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=282.85 Aligned_cols=208 Identities=22% Similarity=0.263 Sum_probs=162.0
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCe-EEEEEEec-----------------CCCcchhHHHHHHHHHHhhcCC
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ-VVAIKQLD-----------------RNGLQGNREFLVEVLMLSLLHH 125 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~~-----------------~~~~~~~~~~~~e~~~l~~l~h 125 (296)
...+..+|++.+.||+|+||.||+|..+.... ..++|.+. .........+.+|+.+++.++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 34567889999999999999999987643221 12222110 1111223457789999999999
Q ss_pred CcccceeeEEecCCceEEEEecCCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcE
Q 022482 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLP-PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (296)
Q Consensus 126 ~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~-~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Ni 204 (296)
|||+++++++...+..|+|++++. ++|.+++.... ..........+..++.|++.||.|||+.+ |+||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 999999999999999999999985 67777764311 11233446678889999999999999999 99999999999
Q ss_pred EEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
|++.++.++|+|||++....... ........||..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~ 369 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369 (501)
T ss_pred EECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999997543221 122234579999999999999899999999999999999999876443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=257.62 Aligned_cols=204 Identities=24% Similarity=0.347 Sum_probs=176.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||+|+||.+|++.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5889999999999999999999999999999986432 23345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999988642 2345789999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH
Confidence 112234578899999999888889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=257.56 Aligned_cols=204 Identities=34% Similarity=0.517 Sum_probs=172.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.... ++.+|+|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4579999999999999999998654 67899999876543 3467889999999999999999999874 4678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.+++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998652 3456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |++||.+.+.
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 209 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh
Confidence 11 1122345678999999988889999999999999999999 9999986654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=258.73 Aligned_cols=205 Identities=28% Similarity=0.462 Sum_probs=171.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCe---EEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|+..+.||+|++|.||+|.+..++. .+++|.+.... ....+.+..|+.+++.++||||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468889999999999999999875554 79999986542 23345688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999865 2356899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceee-ecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 225 VGDKTHVS-TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
........ .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||...+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 22211111 11123457999999988889999999999999999998 999997554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=268.10 Aligned_cols=209 Identities=31% Similarity=0.456 Sum_probs=169.5
Q ss_pred hcCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC-C
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG-D 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~-~ 139 (296)
.++|++.+.||+|+||.||+|.+ ..+++.||||.++.... .....+.+|+.++..+ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35799999999999999999985 34578899999975432 2345678899999999 689999999987654 4
Q ss_pred ceEEEEecCCCCCHHHHhccCCC---------------------------------------------------------
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPP--------------------------------------------------------- 162 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~--------------------------------------------------------- 162 (296)
..+++|||+++++|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999854210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeeccc
Q 022482 163 ------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236 (296)
Q Consensus 163 ------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 236 (296)
....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124678888999999999999999999 9999999999999999999999999987532222111122233
Q ss_pred ccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 237 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 5677999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=261.65 Aligned_cols=209 Identities=30% Similarity=0.420 Sum_probs=173.8
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEec----
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD---- 137 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~---- 137 (296)
+.....+.|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+..|+.+++.+ +||||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 33345578999999999999999999999999999999986543 2345677888888888 69999999998853
Q ss_pred --CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 138 --GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 138 --~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
.+..+++|||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence 45789999999999999998652 2345888889999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|||++....... .......|++.|+|||.+. +..++.++|+|||||++|+|++|..||....
T Consensus 164 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 164 DFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred eCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 999987432211 1123356899999999875 3457889999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=256.78 Aligned_cols=201 Identities=24% Similarity=0.350 Sum_probs=169.2
Q ss_pred HHHHHHHhcCCCccccc--cccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh-cCCCcccceeeEEec
Q 022482 61 FRELAAVTKNFRADCLL--GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 137 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~ 137 (296)
..+...+.+.|.+.+.+ |+|+||.||++.+..++..+|+|.+........ |+..... .+||||+++++.+..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 33445566778888887 999999999999999999999999865432211 2222222 279999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSD 216 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~D 216 (296)
.+..++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999865 347899999999999999999999999 99999999999999888 999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
||++...... ....++..|+|||++.+..++.++|+||||+++|+|++|+.||....
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9998753221 12458899999999998889999999999999999999999998544
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=260.02 Aligned_cols=194 Identities=31% Similarity=0.454 Sum_probs=161.5
Q ss_pred cccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHh---hcCCCcccceeeEEecCCceEEEEecCC
Q 022482 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLS---LLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~---~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.||+|+||.||++.+..+++.+|+|.+...... ......+|..+++ ..+||+|+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999988654322 1122334443333 3479999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998864 456999999999999999999999999 9999999999999999999999999986432211
Q ss_pred eeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 230 HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.....|+..|+|||.+.+ ..++.++|+||+||++|+|++|..||.....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 123468999999999864 5678999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=256.88 Aligned_cols=205 Identities=36% Similarity=0.553 Sum_probs=174.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|.+.+.||+|++|.||+|.+.. +..+|+|.+..... ...++.+|+.+++.++||||+++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 4579999999999999999999764 57799999875443 356788999999999999999999999988899999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999652 2356899999999999999999999999 9999999999999999999999999987543211
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred hh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 11 1112234568999999998889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=256.63 Aligned_cols=212 Identities=26% Similarity=0.327 Sum_probs=176.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCe----EEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEec-C
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-G 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~ 138 (296)
.....|+..+.||+|.||.||+|...+++. .+|||.++... ..-.....+|+.+++.++|||++.+..+|.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 345579999999999999999996655433 68999986542 1223556799999999999999999999877 7
Q ss_pred CceEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC----CceE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG----YHPK 213 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~----~~~k 213 (296)
..+++++||.+ -+|...++.... ....++...+..|+.|++.++.|||++. |+||||||.|||+..+ |.||
T Consensus 101 ~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 78999999997 788888864322 2356888999999999999999999999 9999999999999766 9999
Q ss_pred EcccCCcccCCCCCcce-eeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 214 LSDFGLAKLGPVGDKTH-VSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|+|||+++.....-+.. ....++.|.+|.|||++.|. .|+.+.|+||+||++.|||+-++.|...+.+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k 246 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEK 246 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhh
Confidence 99999999766655544 33446789999999999886 6899999999999999999999999866543
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.15 Aligned_cols=204 Identities=30% Similarity=0.370 Sum_probs=175.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv~ 145 (296)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++++.+. +.+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 368889999999999999999999999999999875432 3345688999999999999999999988653 4689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987643334566899999999999999999999999 99999999999999999999999999865322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .....++..|+|||.+.+..++.++|+|||||++|+|++|..||....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 21 123457889999999988899999999999999999999999998663
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=257.13 Aligned_cols=205 Identities=27% Similarity=0.394 Sum_probs=176.2
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec--CCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~ 145 (296)
+|.+.+.||.|++|.||++.+..++..+|+|.+..... .....+..|+.+++.++||||+++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 48889999999999999999999999999999865433 233467789999999999999999997754 35678999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-----DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH-----~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||+|+||++++++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998764444677999999999999999999999 777 999999999999999999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 86433221 1223468999999999988889999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.99 Aligned_cols=195 Identities=31% Similarity=0.478 Sum_probs=170.3
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecC----CCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCc--eEEEE
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR----NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--RLLVY 145 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--~~lv~ 145 (296)
++..+||+|+|-+||+|.|..+|..||--.++. ......+++..|+.+|+.|+||||+++|+++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 556789999999999999999999988654432 223445789999999999999999999999987665 77899
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCceEEcccCCcccCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~~~~ 224 (296)
|.+..|+|..|+++ ..++....++.|++||+++|.|||++. +||+|||||-+||||+ ..|.|||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999987 567888899999999999999999986 7999999999999995 67899999999998744
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
... ...++|||.|||||++. ..|+..+||||||.++.||+|+..||.
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh
Confidence 322 33478999999999986 789999999999999999999999996
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=263.77 Aligned_cols=205 Identities=33% Similarity=0.515 Sum_probs=170.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCe----EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|+..+.||+|+||.||+|.+..++. .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 468889999999999999999877665 468888765432 2234678899999999999999999988654 5678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
++||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++...
T Consensus 86 v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999865 2346888999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.............++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~ 217 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 33222222222345678999999988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=266.93 Aligned_cols=211 Identities=30% Similarity=0.437 Sum_probs=172.6
Q ss_pred cCCCccccccccCceEEEEEEECC-------CCeEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGD 139 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~ 139 (296)
.+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468999999999999999998643 22368999886432 22345788899999999 7999999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
..+++|||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999865321 2345788889999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999875432221111122234567999999999899999999999999999998 899997665433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.56 Aligned_cols=198 Identities=29% Similarity=0.449 Sum_probs=163.7
Q ss_pred cccccCceEEEEEEEC--CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCC
Q 022482 76 LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~s 152 (296)
.||+|+||.||+|.+. ..+..||+|++..... .....+.+|+.+++.++||||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999765 4456799999865432 22356889999999999999999999875 457899999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceee
Q 022482 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232 (296)
Q Consensus 153 L~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 232 (296)
|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++............
T Consensus 81 L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 9999864 2457899999999999999999999999 999999999999999999999999999753332221111
Q ss_pred -ecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 233 -TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 233 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 11223568999999988889999999999999999996 9999986654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=268.13 Aligned_cols=201 Identities=28% Similarity=0.355 Sum_probs=172.6
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecC-----
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG----- 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~----- 138 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4678899999999999999999999999999999998643 223345677899999999999999999988643
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 139 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
...++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 35799999996 688888743 2888999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|++....... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9997543221 1223457889999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=254.09 Aligned_cols=198 Identities=36% Similarity=0.520 Sum_probs=168.7
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+.||+|++|.||++.+.. ++.|++|.+...... ....+..|+.+++.++||||+++++++.+....++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 899999998765443 445788999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.............
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999865 2346788999999999999999999999 9999999999999999999999999987533221111111
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
...++..|+|||.+.++.++.++|+|||||++|+|++ |..||....
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 1233567999999988889999999999999999999 899997654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=258.75 Aligned_cols=201 Identities=30% Similarity=0.403 Sum_probs=176.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+...+..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 358889999999999999999999999999999876533 3345678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+.+++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999998752 2678999999999999999999999 88 999999999999999999999999998643221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 1 112568889999999988899999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=262.19 Aligned_cols=202 Identities=29% Similarity=0.411 Sum_probs=172.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|++|.||+|.+..+++.+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999999988999999988653322 23457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887643 345899999999999999999999999 999999999999999999999999998753332
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 2 112234578899999998753 46788999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.06 Aligned_cols=194 Identities=32% Similarity=0.464 Sum_probs=171.3
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||.|++|.||+|.+..+++.+|+|++..... .....+..|+.+++.++||||+++++.+.+....+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999999999999999975432 2345688899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999965 345889999999999999999999999 9999999999999999999999999997543322 223
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...+++.|++||.+.+..++.++|+||||+++|+|++|..||...+.
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 197 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence 35688999999999888899999999999999999999999987763
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=258.84 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=174.7
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.|...+.||+|++|.||++.+..++..+++|.+..........+.+|+.+++.++||||+++++++...+..++++||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 35556899999999999999988899999999865544445667889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
+++|.+++.. .++++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-- 169 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-- 169 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCC--
Confidence 9999999864 45888999999999999999999999 9999999999999999999999999876432211
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 11223468899999999988889999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.58 Aligned_cols=209 Identities=31% Similarity=0.502 Sum_probs=173.4
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++.+.||+|+||.||+|.+.. ++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 568999999999999999998743 578899999865432 23456888999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcE
Q 022482 143 LVYEYMPLGSLEDHLHDLP------------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~------------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Ni 204 (296)
++|||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhhe
Confidence 9999999999999986421 11234788889999999999999999999 99999999999
Q ss_pred EEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 205 LLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+++.++.++|+|||.+................++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+...
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999874322221111222334667999999988899999999999999999998 8889976543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=257.61 Aligned_cols=193 Identities=31% Similarity=0.437 Sum_probs=162.0
Q ss_pred cccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHH---HHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEV---LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~---~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.||+|+||.||+|.+..+++.||+|.+....... ......|. .+++...||+|+++++.+...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987543221 11233333 34444579999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998854 457999999999999999999999999 9999999999999999999999999987432211
Q ss_pred eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 230 HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.....|+..|+|||.+.++ .++.++|+||+||++|+|++|+.||.+..
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 1234689999999998754 68899999999999999999999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=254.58 Aligned_cols=197 Identities=30% Similarity=0.474 Sum_probs=164.1
Q ss_pred cccccCceEEEEEEE--CCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCC
Q 022482 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 151 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~ 151 (296)
.||+|+||.||+|.+ ..++..+|+|++..... ...+.+..|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 45678999999864432 23456788999999999999999999875 45678999999999
Q ss_pred CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCccee
Q 022482 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231 (296)
Q Consensus 152 sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 231 (296)
+|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||.||++++++.++|+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999864 356899999999999999999999999 99999999999999999999999999975433222111
Q ss_pred -eecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 232 -STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 232 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 112234578999999988888999999999999999998 9999986644
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=254.47 Aligned_cols=202 Identities=28% Similarity=0.422 Sum_probs=175.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||+|++|.||+|.+..+++.+|+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 58899999999999999999999999999999875432 2345688899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~~~~~~~~ 226 (296)
+++++|.+++... ....+++..+..++.|++.+|+|||+++ ++|+||+|+||+++++ +.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999652 2345899999999999999999999999 9999999999999755 46799999999754322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 2 1223568889999999988888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=257.97 Aligned_cols=201 Identities=29% Similarity=0.441 Sum_probs=174.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.|++.+.||+|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4788899999999999999999999999999986543 233456788999999886 999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999854 36889999999999999999999999 99999999999999999999999999875433
Q ss_pred CCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||...+.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 32 122334688999999988654 468899999999999999999999976544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.97 Aligned_cols=202 Identities=28% Similarity=0.391 Sum_probs=171.3
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.......||+|+||.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++|+||++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 34445689999999999999998899999999877665566778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccCCCC
Q 022482 150 LGSLEDHLHDLPPDKKRL--DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~--~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~~~~ 226 (296)
+++|.+++... ...+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. .+.++|+|||.+......
T Consensus 89 ~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~ 162 (268)
T cd06624 89 GGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI 162 (268)
T ss_pred CCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence 99999998652 2334 78888999999999999999999 999999999999976 679999999998753221
Q ss_pred CcceeeecccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 163 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 163 N--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred C--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 1 1122345788999999986643 7889999999999999999999997543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=254.25 Aligned_cols=204 Identities=38% Similarity=0.547 Sum_probs=173.7
Q ss_pred CCccccccccCceEEEEEEECCCC----eEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+++.+.||.|+||.||++.+...+ ..+|+|.+...... ....+..|+..++.++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 457789999999999999998766 88999999665433 4567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.... ...+++..+..++.|++.||++||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999986521 122899999999999999999999999 99999999999999999999999999976443
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....... ...++..|+|||.+.+..++.++|+||||+++|+|++ |.+||...+.
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~ 210 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN 210 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 3221111 2236789999999988889999999999999999998 8899876443
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=256.79 Aligned_cols=201 Identities=27% Similarity=0.438 Sum_probs=178.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
..+|+++++||.|+|+.|.+++.+++.+.||+|++++.- .++.+-...|-....+. +||.++.+..+|..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357999999999999999999999999999999997643 33344456666666654 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|.||++||+|--.+++ ..+++++.+..+...++-||.|||++| |++||||.+|+|++..|++||+|+|.++..
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999888865 678999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
- .....+..++|||.|.|||++.+..|...+|+|+|||+++||+.|+-||+-
T Consensus 402 l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 L--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred C--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 2 233445678999999999999999999999999999999999999999974
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=255.24 Aligned_cols=201 Identities=33% Similarity=0.490 Sum_probs=170.2
Q ss_pred ccccccCceEEEEEEECC-CC--eEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLES-TN--QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|++|.||+|.+.. ++ ..+|+|.+..... ...+.+..|+..++.++||||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998865 33 3689999987665 456678899999999999999999999988 889999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999876321 56899999999999999999999999 9999999999999999999999999997543322111
Q ss_pred -eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 231 -VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 231 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
......++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 207 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 1112456788999999988889999999999999999998 99999765443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=254.37 Aligned_cols=203 Identities=30% Similarity=0.441 Sum_probs=176.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|.+.+.||+|++|.||+|.+..++..+++|.+...... ....+..|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588999999999999999999988999999998765443 556788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999865 345788999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccee--eecccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHV--STRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~ 210 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD 210 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence 2111 11245788999999998766 7889999999999999999999997553
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.18 Aligned_cols=196 Identities=31% Similarity=0.442 Sum_probs=168.7
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||+|+||.||+|.+..+++.+|+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999999999999999999865432 2233457899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 152 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIK 152 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccc
Confidence 9998652 2246899999999999999999999999 9999999999999999999999999987533211 122
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 34578899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=259.15 Aligned_cols=201 Identities=29% Similarity=0.463 Sum_probs=168.9
Q ss_pred CCCccccccccCceEEEEEEE----CCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecC--CceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~ 142 (296)
.|++.+.||+|+||.||++.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 478899999999999999974 4568889999986543 23345688999999999999999999998775 5688
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999998642 345899999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
....... .......++..|+|||.+.+..++.++|||||||++|+|++++.|+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 4332211 11223456778999999988889999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.36 Aligned_cols=199 Identities=35% Similarity=0.527 Sum_probs=164.2
Q ss_pred ccccccCceEEEEEEECCCCe--EEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQ--VVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+..++. .+++|.+.... ......+..|+.+++.+ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 46888876432 23345678899999999 799999999999999999999999999
Q ss_pred CCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 151 GSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 151 ~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
++|.+++..... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999865321 1235789999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
++...... ........+..|+|||++.+..++.++|+|||||++|+|++ |..||...+
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 98532111 11111223567999999988889999999999999999997 999997654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=257.23 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=167.9
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHH-HhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+-+..||.|+||+|++..++.+|+..|||.++.... .+..+++.|... ++.-++||||++|+....++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 3445679999999999999999999999999987665 344567777764 44557999999999999999999999999
Q ss_pred CCCCHHHHhcc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 149 PLGSLEDHLHD-LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 149 ~~~sL~~~~~~-~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+ .+|+.+++. +...+..++++.+..|....+.||.||.+..+ |+|||+||+|||++..|.+||||||++-....
T Consensus 146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-- 220 (361)
T KOG1006|consen 146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-- 220 (361)
T ss_pred h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH--
Confidence 6 788766543 22346789999999999999999999997655 99999999999999999999999999864322
Q ss_pred cceeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
......-.|...|||||.+... .|+.++|+||||++|||+.||..|+..=
T Consensus 221 -SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 221 -SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred -HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 2223345688899999999653 5899999999999999999999999743
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=251.00 Aligned_cols=202 Identities=31% Similarity=0.453 Sum_probs=170.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+++..||.|+.|.|++++.+.+|...|||..++++- +...+++..+.++...+ +|+||+.+++|..+...++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 45667889999999999999999999999999987643 34456777777766654 89999999999999999999998
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|. ..+..++.. ..+++++..+..+...+++||.||.++++ |+|||+||+|||+|+.|++||||||++-......
T Consensus 173 Ms-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 173 MS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeeccc
Confidence 84 555555554 35679999999999999999999998764 9999999999999999999999999987543322
Q ss_pred cceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......|.+.|||||.+.- ..|+.++||||||++++||.||+.||.+-+.
T Consensus 247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 3344679999999999864 3689999999999999999999999998543
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=253.99 Aligned_cols=198 Identities=34% Similarity=0.546 Sum_probs=165.7
Q ss_pred ccccccCceEEEEEEECCCC---eEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+...+ ..+|+|.+...... ....+..|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876544 78999998765442 4456888999999999999999999875 4568999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||+|||..+ ++||||||+||+++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999975 346899999999999999999999999 9999999999999999999999999987543322211
Q ss_pred e-eecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 231 V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 231 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 1 111123467999999988899999999999999999998 9999987654
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=254.13 Aligned_cols=199 Identities=35% Similarity=0.558 Sum_probs=173.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||.|++|.||+|... ++.+|+|.+..... ..+.+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46899999999999999999876 78899999976543 4567889999999999999999999999889999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 999999998652 2236899999999999999999999999 99999999999999999999999999975422111
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 2234567999999988889999999999999999997 9999976643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.51 Aligned_cols=203 Identities=28% Similarity=0.352 Sum_probs=174.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36899999999999999999999999999999886432 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|++++.+..+... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9997666665543 355899999999999999999999999 999999999999999999999999998754333
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .......++..|+|||++.+. .++.++|+||||+++|+|++|++||...+
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 22 122335678899999999887 78899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=289.98 Aligned_cols=211 Identities=36% Similarity=0.525 Sum_probs=178.6
Q ss_pred cCCCccccccccCceEEEEEEECCCC-----eEEEEEEecCC-CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
..-++...||+|+||.||.|...... ..||+|.+.+. +.++..+|.+|..+++.++||||+++++++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 34667889999999999999876433 24899988764 3455678999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 143 LVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
+++|||.||+|..|+++... ....++...+..++.++++++.||++++ +|||||..+|+|++....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999986321 2466888999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
|+..-..+.......-.--..|||||.+..+.++.++|||||||++||+++ |..||.+.+-.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH
Confidence 984333333322222223468999999999999999999999999999999 999998877554
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=267.62 Aligned_cols=201 Identities=23% Similarity=0.283 Sum_probs=170.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 144 (296)
...|++++.||+||.+.||++...+ ...||+|.+... .....+-+..|+.+|.+|. |.+|++++++-..++.+|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3569999999999999999998775 455677765432 2334466899999999995 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||+=+ .+|..+++.. ...++...++.+.+|++.|+.++|..+ |||.||||.|+|+-. |.+||+|||+|....
T Consensus 439 mE~Gd-~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99854 7899999762 233443488999999999999999999 999999999999865 499999999999888
Q ss_pred CCCcceeeecccccccccCccccccCC-----------CCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQ-----------LTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
...........+||+.||+||.+.... .++++|||||||+||+|+.|++||..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 888888888899999999999985432 45789999999999999999999973
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=258.18 Aligned_cols=202 Identities=28% Similarity=0.408 Sum_probs=171.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||.|++|.||+|.+..+++.||||.+..... .....+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48889999999999999999999999999998864332 2234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 6898888652 3456899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cceeeecccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 155 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred c--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 1 112235688899999886644 5788999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=257.47 Aligned_cols=205 Identities=29% Similarity=0.441 Sum_probs=173.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+|++.+.||.|++|.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 488899999999999999999999999999998754322 2355678999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
. ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 8 58888876432 2356899999999999999999999999 99999999999999999999999999874322211
Q ss_pred ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......++..|++||.+.+. .++.++|+|||||++|+|++|+.||.+.+..
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 11224578899999988664 5688999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=254.08 Aligned_cols=198 Identities=31% Similarity=0.473 Sum_probs=168.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEe-cCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~-~~~~~~lv~e~ 147 (296)
.+|.+.+.||+|++|.||++... +..+|+|.+.... ..+.+.+|+.+++.++|+|++++++++. ..+..+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46899999999999999999775 7789999986442 3456889999999999999999999764 45678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999998652 2345888999999999999999999999 9999999999999999999999999987432211
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....++..|+|||++.+..++.++|+|||||++|+|++ |+.||...+.
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 12234567999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=258.25 Aligned_cols=202 Identities=34% Similarity=0.490 Sum_probs=167.9
Q ss_pred ccccccCceEEEEEEECCCC------eEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 75 CLLGEGGFGRVYKGRLESTN------QVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+.||+|+||.||+|.+.... +.+|+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999886433 689999876543 23455788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-----ceEEcccCC
Q 022482 148 MPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-----HPKLSDFGL 219 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~---~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-----~~kl~Dfg~ 219 (296)
+++++|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999864221 2244788999999999999999999999 99999999999998877 899999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
+................++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 875433322222223345788999999998899999999999999999998 999997554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=255.71 Aligned_cols=204 Identities=29% Similarity=0.433 Sum_probs=169.6
Q ss_pred cCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|.+.+.||+|+||.||+|.+... ...+++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4588999999999999999987643 3468999886554 3344578889999999999999999998875 557899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++..+.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999652 345899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 3211 11112234567999999988889999999999999999996 9999976653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=260.85 Aligned_cols=204 Identities=29% Similarity=0.431 Sum_probs=171.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecC--CceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+|+.+++.++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357999999999999999999999999999999986433221 23456799999999999999999998765 56899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+. ++|.+++... ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999997 5888887652 356899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..... ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+.
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 33221 1122345788999999865 4578899999999999999999999986654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=253.72 Aligned_cols=203 Identities=36% Similarity=0.529 Sum_probs=170.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|.+...||+|++|.||+|.+..+. .+|+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 56889999999999999999887654 58999886543 23456788999999999999999998875 45688999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999652 2345788999999999999999999999 99999999999999999999999999975433221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. ......++..|+|||...+..++.++|+||||+++|+|++ |..||.+...
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 1 1112345678999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=240.52 Aligned_cols=202 Identities=26% Similarity=0.331 Sum_probs=170.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
...-+..||+|++|.|-+.++..+|...|+|.+...-. +...+.++|+.+.... .+|.++.+|+........|+.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 34456789999999999999999999999999865422 3344567787766554 699999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|+ .+|+.+..+....+..+++..+.+|+..+++||.|||++-. ++|||+||+||||+.+|++|+||||++-.....-
T Consensus 127 M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 96 89998887766678899999999999999999999998754 9999999999999999999999999997543221
Q ss_pred cceeeecccccccccCcccccc----CCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT----GQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
..+...|...|||||.+.. ..|+.++||||||+++.||.+++.||+.
T Consensus 204 ---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 ---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred ---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 1222458889999999854 3689999999999999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=250.02 Aligned_cols=200 Identities=32% Similarity=0.477 Sum_probs=178.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.|.+.+.||+|++|.||++.+..+++.+++|++..........+.+|+.+++.++|++|+++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47888999999999999999998899999999977655456778899999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998652 257899999999999999999999999 99999999999999999999999999875433321
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23456889999999998888899999999999999999999999866
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=264.42 Aligned_cols=204 Identities=26% Similarity=0.382 Sum_probs=170.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCC-----c
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----Q 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----~ 140 (296)
+.++|.+.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 4578999999999999999999999999999999986432 223456778999999999999999999876543 4
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++++||+. ++|.+.+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 789999996 688887743 56899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc-ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ ........|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~ 214 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD 214 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 75322211 111223468899999998754 468889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=255.73 Aligned_cols=200 Identities=31% Similarity=0.410 Sum_probs=174.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
-|++.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+..++.++||||+++++.+...+..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 47788999999999999999998899999999865432 23356788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ..+++..+..++.|++.|+.+||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999853 46889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......++..|+|||.+.+...+.++|+|||||++|+|++|..||...+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 156 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred -hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 11223468889999999988888999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=257.99 Aligned_cols=205 Identities=24% Similarity=0.319 Sum_probs=169.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcC-CCcccceeeEEecCCc-----
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ----- 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~----- 140 (296)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3689999999999999999999999999999988654322 2356778999999995 6999999999887665
Q ss_pred eEEEEecCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPD-KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFG 218 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~-~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg 218 (296)
.++||||+++ +|.+++...... ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999984 888887643222 456899999999999999999999999 999999999999998 8899999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++........ ......+++.|+|||++.+ ..++.++|+||||+++|+|++|..||...+
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9874322211 1122356888999998865 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=253.37 Aligned_cols=201 Identities=25% Similarity=0.386 Sum_probs=160.5
Q ss_pred cccccCceEEEEEEECCC--CeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCC
Q 022482 76 LLGEGGFGRVYKGRLEST--NQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~s 152 (296)
.||+|+||.||++..... ...+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999975432 3456777765443 2344678899999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceee
Q 022482 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232 (296)
Q Consensus 153 L~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 232 (296)
|.+++..........++..+..++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99998753323345677788899999999999999999 999999999999999999999999998532221111122
Q ss_pred ecccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 233 TRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 233 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
....++..|+|||++.. ..++.++|||||||++|+|++ |..||...+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Confidence 34567889999998753 235678999999999999997 677886544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=251.16 Aligned_cols=205 Identities=27% Similarity=0.436 Sum_probs=180.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|.+.+.||.|++|.||++.+..+++.+++|.+..... .....+..|+..++.++|||++++++.+...+..++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 58889999999999999999999999999999976543 4456688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.........+++..+..++.|++.||.+||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764333577999999999999999999999999 9999999999999999999999999987543322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......|++.|+|||...+..++.++|+||+|+++|+|++|..||...+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 22333568999999999988889999999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=250.14 Aligned_cols=198 Identities=34% Similarity=0.504 Sum_probs=166.1
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+.||+|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36899999999999865 5788999998655332 234678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++......... ...
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 999864 2345789999999999999999999999 999999999999999999999999998643222111 111
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
...++..|+|||++.+..++.++|+||||+++|++++ |..||.....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~ 200 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN 200 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 1234567999999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=253.51 Aligned_cols=194 Identities=27% Similarity=0.369 Sum_probs=164.9
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchh---HHHHHHHHH-HhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~-l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|++|.||+|.+..+++.||+|.+.+...... ..+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999999999999999875433221 223344433 4445899999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999865 356899999999999999999999999 99999999999999999999999999874322
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 199 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 22346888999999998888899999999999999999999999765543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=253.74 Aligned_cols=194 Identities=26% Similarity=0.389 Sum_probs=161.2
Q ss_pred ccccccCceEEEEEEECC------------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 75 CLLGEGGFGRVYKGRLES------------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
+.||+|+||.||+|.... ....+++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 23358889876554444556788899999999999999999999989999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc-------eEEc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-------PKLS 215 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~-------~kl~ 215 (296)
+||||+++++|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998864 2356899999999999999999999999 999999999999987664 8999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccc-cCCCCccchhHHHHHHHHHHH-hCCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-TGQLTLKSDVYSFGVVLLEII-TGRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~ 280 (296)
|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 215 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch
Confidence 99998643211 1235788899999886 456888999999999999998 58999876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=257.03 Aligned_cols=194 Identities=29% Similarity=0.437 Sum_probs=162.5
Q ss_pred ccccccCceEEEEEEECCCCe-------EEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 75 CLLGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+.||+|+||.||+|.+...+. .+++|.+........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998865443 4888887655444556788899999999999999999999998999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc--------eEEcccCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--------PKLSDFGL 219 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~--------~kl~Dfg~ 219 (296)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999998752 346889999999999999999999999 999999999999987665 68999998
Q ss_pred cccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhC-CCCCCCCCc
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITG-RKAIDNTRA 280 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~ 280 (296)
+..... .....++..|+|||++.+. .++.++|+|||||++|+|++| ..||...+.
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 864322 1234578899999999764 578899999999999999998 567665544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=255.31 Aligned_cols=207 Identities=26% Similarity=0.410 Sum_probs=173.1
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++.+.||+|+||.||+|+... +.+.+++|.+...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 468899999999999999999753 3467999988654433 3467889999999999999999999999989999
Q ss_pred EEEecCCCCCHHHHhccCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDK-----KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~-----~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
+||||+++++|.+++....... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999987532111 26899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
|++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||....
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~ 223 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc
Confidence 99864322211 11222356778999999988888999999999999999999 889996543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=257.33 Aligned_cols=199 Identities=27% Similarity=0.386 Sum_probs=173.0
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
|.....||+|+||.||++....+++.+|+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 33457899999999999999999999999998655444556688899999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 102 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~ 171 (292)
T cd06657 102 GALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 171 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--c
Confidence 999998743 45789999999999999999999999 9999999999999999999999999986432221 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+
T Consensus 172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1233468899999999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=253.03 Aligned_cols=204 Identities=29% Similarity=0.474 Sum_probs=171.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||++.+.. +..+++|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4679999999999999999998654 5569999886542 234678889999999999999999999887 778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999652 2456788899999999999999999999 9999999999999999999999999987543222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.. ......++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 209 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH
Confidence 11 1112335677999999988889999999999999999999 9999986543
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.31 Aligned_cols=198 Identities=32% Similarity=0.478 Sum_probs=171.5
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999875543 3345678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc-----
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK----- 228 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~----- 228 (296)
.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999875 347899999999999999999999999 99999999999999999999999999875332211
Q ss_pred -ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 229 -THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 229 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
........++..|+|||...+..++.++|+||||+++|+|++|..||...+..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11223356788999999998888899999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.94 Aligned_cols=205 Identities=30% Similarity=0.420 Sum_probs=179.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..+.|.+.+.||+|++|.||+|.+..++..+++|++..... ....+..|+.+++.++|+||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 44568889999999999999999998899999999976543 45678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999762 237899999999999999999999999 999999999999999999999999998643222
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......++..|++||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 112234578899999999888899999999999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=256.62 Aligned_cols=203 Identities=25% Similarity=0.364 Sum_probs=169.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 468999999999999999999998999999999865432 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~~~ 225 (296)
|++ ++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++. ++.++|+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 6888877542 2334678888999999999999999999 999999999999985 56799999999974322
Q ss_pred CCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .......+++.|+|||.+.+. .++.++|+|||||++|+|++|.+||...+
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 111234578899999988664 57889999999999999999999997654
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=257.99 Aligned_cols=205 Identities=19% Similarity=0.211 Sum_probs=158.1
Q ss_pred hcCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCcchhH-----------HHHHHHHHHhhcCCCcccceee
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQGNR-----------EFLVEVLMLSLLHHPNLVNLIG 133 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~-----------~~~~e~~~l~~l~h~~I~~~~~ 133 (296)
.++|.+.+.||+|+||.||+|.+..+ +..+|+|+.......... ....+...+..+.|++|+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 46799999999999999999998877 667777765432211111 1122334455678999999998
Q ss_pred EEecCC----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC
Q 022482 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (296)
Q Consensus 134 ~~~~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~ 209 (296)
.+.... ..+++++++. .++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 765543 3467888774 577766644 234577888999999999999999999 9999999999999999
Q ss_pred CceEEcccCCcccCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 210 YHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999754322111 111224699999999999999999999999999999999999999987743
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=257.89 Aligned_cols=203 Identities=27% Similarity=0.379 Sum_probs=171.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv 144 (296)
++|++.+.||+|++|.||+|.+..+++.+++|.+....... ...+.+|+.+++.++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46999999999999999999999999999999986543222 23456899999999999999999998877 889999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+. ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 5998888652 236899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||...+.
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~ 212 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE 212 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 321 112234578899999988664 468899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=256.40 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=160.3
Q ss_pred cccccCceEEEEEEECC------------------------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccce
Q 022482 76 LLGEGGFGRVYKGRLES------------------------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~ 131 (296)
.||+|+||.||+|.... ....|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999987432 123588898865544445567888999999999999999
Q ss_pred eeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-
Q 022482 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY- 210 (296)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~- 210 (296)
++++...+..++||||+++++|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999998864 2456889999999999999999999999 99999999999997543
Q ss_pred ------ceEEcccCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHH-hCCCCCCCCCcc
Q 022482 211 ------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEII-TGRKAIDNTRAA 281 (296)
Q Consensus 211 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll-~g~~pf~~~~~~ 281 (296)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+|||||++|+|+ +|..||......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999987532111 12357788999998865 46889999999999999995 699999876543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=250.11 Aligned_cols=203 Identities=29% Similarity=0.408 Sum_probs=178.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv~ 145 (296)
+|++.+.||+|++|.||+|.+..++..+++|++..... ...+.+.+|+..++.++||||+++++.+... +..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47888999999999999999998999999999876543 3456788999999999999999999999988 8899999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|++++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999875 337899999999999999999999999 99999999999999999999999999876443
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...........++..|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 332111234568899999999988889999999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=263.29 Aligned_cols=206 Identities=24% Similarity=0.331 Sum_probs=172.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEec----CCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~ 140 (296)
+..+|.+.+.||+|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 3468999999999999999999999999999999986542 2234567789999999999999999998763 346
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccc
Confidence 799999996 689888854 456899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCc--ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDK--THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
........ ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~ 217 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNY 217 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCCh
Confidence 64322211 111223468899999999865 4578899999999999999999999976653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=253.39 Aligned_cols=204 Identities=29% Similarity=0.455 Sum_probs=172.5
Q ss_pred CCCccccccccCceEEEEEEECC-CCeEEEEEEecCCC----------cchhHHHHHHHHHHhh-cCCCcccceeeEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNG----------LQGNREFLVEVLMLSL-LHHPNLVNLIGYCAD 137 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~ 137 (296)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....++..|+.++.. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 67889999875321 1122346677777764 789999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
.+..+++|||+++++|.+++.........+++..++.++.|++.+|.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999875433345679999999999999999999996 67 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
||.+....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99997643322 2234568889999999998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=252.94 Aligned_cols=204 Identities=29% Similarity=0.466 Sum_probs=178.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 48889999999999999999999999999999875432 2344677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998664444567899999999999999999999999 999999999999999999999999999764333
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22234588899999999888899999999999999999999999986654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=251.43 Aligned_cols=192 Identities=31% Similarity=0.478 Sum_probs=163.0
Q ss_pred ccccccCceEEEEEEECCCC----------eEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 75 CLLGEGGFGRVYKGRLESTN----------QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999998766 35788877544332 5678899999999999999999999888 778999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-------ceEEccc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-------HPKLSDF 217 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-------~~kl~Df 217 (296)
|||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999998752 236889999999999999999999999 99999999999999887 7999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|++..... .....++..|+|||.+.+. .++.++|+|||||++|+|++ |..||...+.
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 99875322 1224567789999998776 78899999999999999999 6888876643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=255.32 Aligned_cols=205 Identities=33% Similarity=0.503 Sum_probs=172.8
Q ss_pred cCCCccccccccCceEEEEEEEC----CCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEec--CCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~ 141 (296)
..|++.+.||+|+||.||+|... .+++.+|+|.+...... ....+..|+.+++.+.||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45888899999999999999864 34789999999765443 45678899999999999999999999877 5578
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999652 335899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcce-eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 644222111 1112234567999999988889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=257.51 Aligned_cols=199 Identities=37% Similarity=0.495 Sum_probs=170.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
...|.+.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 3568999999999999999999998899999999864332 2234678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||++....
T Consensus 94 ~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 94 MEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 99997 677776643 2346899999999999999999999999 9999999999999999999999999987532
Q ss_pred CCCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. ....+++.|+|||++. ...++.++|+||||+++|+|++|..||.+.+
T Consensus 167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 21 2346788999999874 3567889999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=251.45 Aligned_cols=203 Identities=25% Similarity=0.431 Sum_probs=174.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|.+.+.||+|+||.||+|.+..++..+|+|.+..... .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 48889999999999999999999999999999865422 2345677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPVG 226 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~~~~ 226 (296)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998652 2345789999999999999999999999 99999999999998875 4699999998754322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 156 --~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 156 --MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred --cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 112223468899999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=250.43 Aligned_cols=202 Identities=30% Similarity=0.507 Sum_probs=171.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|++.+.||+|+||.||++.+.. +..+|+|.+..... ....+..|+.+++.++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 368889999999999999998864 66899998865433 3456888999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
.+++|.+++.. ....+++..+..++.|++.|+.+||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999864 2346889999999999999999999999 99999999999999999999999999874322111
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
.......++..|+|||.+.++.++.++|+||||+++|+|++ |..||....
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 206 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 11112335578999999988889999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=248.48 Aligned_cols=201 Identities=32% Similarity=0.468 Sum_probs=177.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|.+.+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++|||++++++++.+....+++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 48889999999999999999998899999999976654 3456788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999865 367899999999999999999999999 9999999999999999999999999997543322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .....++..|+|||...+..++.++|+||||+++|+|++|..||...+
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 21 233568899999999988788899999999999999999999997544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=261.48 Aligned_cols=203 Identities=27% Similarity=0.383 Sum_probs=171.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC-----C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~ 139 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++|+||+++++++... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 4568999999999999999999999999999999986532 22334567899999999999999999988654 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcc
Confidence 4799999996 789888864 457999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+....... .......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 213 (337)
T cd07858 155 ARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213 (337)
T ss_pred ccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCC
Confidence 97543221 12233467889999998865 468889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=250.94 Aligned_cols=197 Identities=33% Similarity=0.535 Sum_probs=167.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.+|++.+.||+|+||.||++.. +++.+|+|.+.... ....+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4589999999999999999864 47889999986432 345788999999999999999999998654 579999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999998652 2346889999999999999999999999 999999999999999999999999998753221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
......+..|+|||.+.+..++.++|+|||||++|+|++ |+.||...+.
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 203 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH
Confidence 112234567999999988889999999999999999998 9999976654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=256.75 Aligned_cols=207 Identities=27% Similarity=0.412 Sum_probs=170.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----- 139 (296)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345799999999999999999999999999999988543222 2234567999999999999999999886644
Q ss_pred ---ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 140 ---QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 140 ---~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
..++||||+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECc
Confidence 3599999996 688887754 2346899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcc--eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999754322211 111234578889999988664 468899999999999999999999976653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=254.75 Aligned_cols=204 Identities=31% Similarity=0.464 Sum_probs=177.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+.+.||+|++|.||+|.+..+++.+|+|++..... .....+.+|..+++.+. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 468999999999999999999999999999999865322 23356788999999998 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||++.+++|.+++.. ...+++..+..++.|++.||.+||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999975 347999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCcc------------------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKT------------------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
..... .......++..|+|||+..+..++.++|+||||++++++++|+.||...+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 32211 12223467899999999988888999999999999999999999998665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=254.06 Aligned_cols=201 Identities=28% Similarity=0.409 Sum_probs=170.0
Q ss_pred CCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
.|++.+.||+|+||.||+|.+. .+|..||+|.+..... ...+.+..|+.+++.+ +|++|+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4788999999999999999875 4688999999865322 2235577899999999 589999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999865 456889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcceeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
...... ........|+..|+|||.+.+. .++.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 211 (290)
T cd05613 154 EFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD 211 (290)
T ss_pred eccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcC
Confidence 532221 1122235688999999998753 4678899999999999999999999743
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=252.87 Aligned_cols=202 Identities=28% Similarity=0.413 Sum_probs=171.0
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|++.+.||.|++|.||+|.+..+|..||+|++...... ....+..|+.+++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 67889999999999999999999999999998654322 2346778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
. ++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 78999886522 246899999999999999999999999 99999999999999999999999999874322211
Q ss_pred ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......++..|+|||++.+. .++.++|+||||+++|+|++|++||...+.
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 205 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE 205 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11223568899999987654 568899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=260.82 Aligned_cols=206 Identities=26% Similarity=0.366 Sum_probs=173.4
Q ss_pred HHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC
Q 022482 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 138 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~ 138 (296)
..++..+.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3445667899999999999999999999999999999999986532 22345577899999999999999999988643
Q ss_pred ------CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 139 ------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 139 ------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888876 7899888753 45899999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|+|||++..... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999875322 1223467889999998866 4678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=260.70 Aligned_cols=205 Identities=31% Similarity=0.441 Sum_probs=171.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhc-CCCcccceeeEEecC--Cc
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG--DQ 140 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~--~~ 140 (296)
.+.++|.+.+.||+|+||.||+|.+..+++.+|+|.+... .......+.+|+.+++.+ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3567899999999999999999999988999999988542 223344567899999999 999999999988654 36
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 799999997 699998854 26788899999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc---eeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKT---HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 754332211 12223568999999998765 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=250.00 Aligned_cols=199 Identities=33% Similarity=0.500 Sum_probs=160.0
Q ss_pred ccccccCceEEEEEEECC---CCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEe-cCCceEEEEecCC
Q 022482 75 CLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLLVYEYMP 149 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~-~~~~~~lv~e~~~ 149 (296)
+.||+|+||.||+|.+.. ....+|+|.+.... ......+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999885432 233457788999999999999999999765 4556889999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
+++|.+++... ....++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999998652 334677788889999999999999999 999999999999999999999999998743221110
Q ss_pred --eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 230 --HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 230 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 11112345678999999988889999999999999999999 566676543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=295.13 Aligned_cols=207 Identities=29% Similarity=0.383 Sum_probs=175.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.-+|.-...||.|.||.||.|.+..+|+..|+|-+.... ......+.+|..++..++|||++++|++=.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 45557888999999999999999999999999999775432 2233457899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
.||||++|+|.+.+.. +.-.++.-...+..|++.|++|||+.| ||||||||.||+++.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999865 344566666778899999999999999 999999999999999999999999999754
Q ss_pred CCCCcc--eeeecccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVGDKT--HVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...... ..-...+||+.|||||++.+. ....++|||||||++.||+||+.||.+.+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 433211 111236799999999999764 35678999999999999999999998654
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=252.31 Aligned_cols=199 Identities=28% Similarity=0.339 Sum_probs=165.9
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecC--CceEEEEe
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVYE 146 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~--~~~~lv~e 146 (296)
|++.+.||+|+||.||+|.+..++..+|+|.+..... ........|+..++.+. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 6788999999999999999999999999999865421 22233457888888875 99999999999987 88999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++. +.++|+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 588887754 2356899999999999999999999999 999999999999999 99999999999754322
Q ss_pred CcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .....++..|+|||.+.. ..++.++|+|||||++|+|++|..||...+.
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~ 204 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH
Confidence 11 122457889999997644 4578899999999999999999999976654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=252.21 Aligned_cols=202 Identities=28% Similarity=0.417 Sum_probs=172.1
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEEEe
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLVYE 146 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv~e 146 (296)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++|||++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999999999999999997653 23345678899999999999999999999988 88999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 997 5888888652 257899999999999999999999999 999999999999999999999999999754333
Q ss_pred CcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 21 11223456888999998765 3578899999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=249.87 Aligned_cols=207 Identities=30% Similarity=0.420 Sum_probs=167.4
Q ss_pred CCccccccccCceEEEEEEEC---CCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCC------
Q 022482 71 FRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------ 139 (296)
|.+.+.||+|+||.||+|.+. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 357899999986542 223456788999999999999999999886532
Q ss_pred ceEEEEecCCCCCHHHHhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 140 QRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
..++++||+.+++|.+++... ......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 236889999999998886431 112235788999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|++................+++.|++||.+.+..++.++|||||||++|+|++ |++||...+.
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 99875433222112222345678999999988889999999999999999999 8999976554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.77 Aligned_cols=206 Identities=27% Similarity=0.375 Sum_probs=171.2
Q ss_pred HhcCCC-ccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--------------hHHHHHHHHHHhhcCCCcccce
Q 022482 67 VTKNFR-ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------------NREFLVEVLMLSLLHHPNLVNL 131 (296)
Q Consensus 67 ~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~I~~~ 131 (296)
+.++|. +.+.||+|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 446676 4577999999999999999999999999986543221 1246789999999999999999
Q ss_pred eeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc
Q 022482 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~ 211 (296)
++++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCC
Confidence 999999999999999997 689998854 456899999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccCCCCC------------cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 212 PKLSDFGLAKLGPVGD------------KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
++|+|||.+....... .........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987533110 01111223468889999998764 4688999999999999999999999866
Q ss_pred Cc
Q 022482 279 RA 280 (296)
Q Consensus 279 ~~ 280 (296)
+.
T Consensus 238 ~~ 239 (335)
T PTZ00024 238 NE 239 (335)
T ss_pred CH
Confidence 54
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=259.39 Aligned_cols=202 Identities=27% Similarity=0.358 Sum_probs=171.9
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCC--
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD-- 139 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-- 139 (296)
...+.++|++.+.||+|++|.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 345678899999999999999999999999999999998643222 2345778999999999999999999987653
Q ss_pred ----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 140 ----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 140 ----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
.+++|||++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999998 7899888753 46899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|||++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998753221 123457889999999876 357889999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=260.99 Aligned_cols=204 Identities=24% Similarity=0.339 Sum_probs=170.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC---------
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--------- 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--------- 138 (296)
..+|.+.+.||.|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999999999999999998766555566788999999999999999999876543
Q ss_pred -----CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCce
Q 022482 139 -----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHP 212 (296)
Q Consensus 139 -----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~ 212 (296)
...++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++ +++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 689888743 46889999999999999999999999 99999999999997 55678
Q ss_pred EEcccCCcccCCCCCc-ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|+|||.+........ ........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 224 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999875322111 111122357889999998754 4678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=261.50 Aligned_cols=210 Identities=30% Similarity=0.421 Sum_probs=176.6
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-h------hHHHHHHHHHHhhcCCCcccceeeEEec-
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-G------NREFLVEVLMLSLLHHPNLVNLIGYCAD- 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~------~~~~~~e~~~l~~l~h~~I~~~~~~~~~- 137 (296)
.+.++|.++..||.|||+.||+|.+......||+|+-..+... + .....+|..+-+.|+||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4556899999999999999999999988899999987644221 1 1235789999999999999999999964
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEE
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKL 214 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl 214 (296)
.+.++-|+|||+|-+|+-|++. ...+++.++..|+.|++.||.||.+.. +||||-||||.|||+- ..|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 5677889999999999999875 677999999999999999999999874 7899999999999994 5678999
Q ss_pred cccCCcccCCCCCcc-----eeeecccccccccCccccccC----CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 215 SDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTG----QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|||++++....... ..+....||.+|++||++.-+ ..+.++||||+||++|.++.|+.||.+...
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 999999875544332 334456799999999998643 357789999999999999999999986554
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=254.92 Aligned_cols=203 Identities=26% Similarity=0.344 Sum_probs=167.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
+|...+.||+|+||.||++.+..+++.+|+|.+..... .....+..|+.++..+. ||||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 46677899999999999999999999999999875432 33456788999898886 99999999999998999999999
Q ss_pred CCCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 148 MPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 148 ~~~~sL~~~~~~~-~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
+. +++.++.... ......+++..+..++.|++.||+|||+. + ++||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 86 5665543211 11246789999999999999999999975 7 99999999999999999999999999864322
Q ss_pred CCcceeeecccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. ......|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 11 11234588899999998776 68899999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=260.47 Aligned_cols=208 Identities=30% Similarity=0.463 Sum_probs=182.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
....+.+.||+|-||.|.+|.-.. +..||+|.++...... ..+|..|+++|.+|+||||+.++++|..++.+++|+||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 457889999999999999998764 6899999998755443 47899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
++.|+|.+|+....... ........|+.||++|++||.+.+ +|||||.++|+|++.++++||+|||.++-.-.++
T Consensus 617 mEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999997642222 344556779999999999999999 9999999999999999999999999999766777
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHH--hCCCCCCCCCccc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII--TGRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll--~g~~pf~~~~~~~ 282 (296)
......+.+-..+|||||.+..+.++.++|+|+||+++||++ +...||...+.+.
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 766666667788999999999999999999999999999985 5999999877665
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=253.14 Aligned_cols=206 Identities=31% Similarity=0.418 Sum_probs=170.9
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---- 139 (296)
...++|++.+.||+|++|.||+|.+..+++.||+|.++.... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345689999999999999999999999999999999865422 22345678999999999999999999987654
Q ss_pred ------ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceE
Q 022482 140 ------QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 140 ------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~k 213 (296)
..++|+||+++ ++..++.. ....+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.++
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 77777654 2356899999999999999999999999 99999999999999999999
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|++||...+
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999875433221 111223467789999988653 56889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=254.46 Aligned_cols=198 Identities=36% Similarity=0.508 Sum_probs=169.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..|...+.||+|+||.||++.+..++..+|+|.+..... .....+..|+.+++.++|||++++++++.+.+..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 347788999999999999999998999999999864422 22346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+. ++|.+.+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 9997 577777643 2456899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.....|+..|+|||.+. ++.++.++|+|||||++|+|++|..||...+
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 12346888999999974 4568889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=255.53 Aligned_cols=206 Identities=29% Similarity=0.414 Sum_probs=169.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCC------
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------ 139 (296)
.++|++.+.||+|++|.||+|.+..+++.+|+|.+......+ .....+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999999999999999886433222 235678999999999999999999875433
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 140 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
..++||||+. ++|...+.. ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4689999986 577777654 2457999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcc---------eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKT---------HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|++......... .......+++.|+|||.+.+. .++.++|+|||||++|+|++|++||.+.+.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 998753322211 111224578889999987654 578899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=258.44 Aligned_cols=203 Identities=27% Similarity=0.363 Sum_probs=174.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCC-----ceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----~~~ 142 (296)
+|++.+.||.|++|.||+|.+..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999999889999999987543 334457889999999999999999999988765 789
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
++|||+. ++|.+++.. ...+++..+..++.|++.||++||+.+ ++||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 688888865 347999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCc-ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... ........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 433321 0112234678899999999887 789999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=264.35 Aligned_cols=198 Identities=26% Similarity=0.353 Sum_probs=173.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh--------HHHHHHHHHHhhcC---CCcccceeeEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--------REFLVEVLMLSLLH---HPNLVNLIGYCAD 137 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~---h~~I~~~~~~~~~ 137 (296)
..|..++.+|+|+||.|++|.++.+...|+||.+.+...-.. -.+-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 459999999999999999999999999999999876542211 12457999999997 9999999999999
Q ss_pred CCceEEEEecC-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 138 GDQRLLVYEYM-PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 138 ~~~~~lv~e~~-~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
++++||+||.- +|.+|.+++.. +..+++.++..|++|++-|+++||+.+ |||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999974 46689999965 778999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCc-cchhHHHHHHHHHHHhCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL-KSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
||.+.... ......++||..|.|||++.|..|-- .-||||||++||.++....||.+
T Consensus 714 fgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99997633 33344678999999999999988754 46999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=250.68 Aligned_cols=201 Identities=27% Similarity=0.387 Sum_probs=173.1
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|.+.+.||+|++|.||+|.+..+++.+++|.+...... ....+..|+.+++.++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67788999999999999999989999999998654332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 7 588888765 2357899999999999999999999999 9999999999999999999999999987543332
Q ss_pred ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 112234578899999998776 788999999999999999999999976553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=252.01 Aligned_cols=197 Identities=36% Similarity=0.498 Sum_probs=168.8
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.|...+.||+|++|.||+|.+..++..+++|.+..... .....+..|+.+++.++|||++++++++.+.+..++|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36777889999999999999999999999999864322 223457789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 996 677777654 2456889999999999999999999999 99999999999999999999999999864221
Q ss_pred CcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.....|+..|+|||++. +..++.++|+|||||++|+|++|..||...+
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 12356889999999984 3567889999999999999999999997654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=256.32 Aligned_cols=199 Identities=26% Similarity=0.373 Sum_probs=168.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---- 139 (296)
.+..+|.+.+.||+|++|.||+|.+..+++.||+|.+.+... .....+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 345789999999999999999999998999999999865322 22345778999999999999999999987543
Q ss_pred --ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 140 --QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 140 --~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
.+++|+||+. .+|..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 92 FQDFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred CceEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence 4689999986 5777665 245889999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
|++...... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+
T Consensus 162 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 162 GLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 998753221 123457889999999876 458889999999999999999999998765
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=254.89 Aligned_cols=201 Identities=23% Similarity=0.334 Sum_probs=164.4
Q ss_pred ccccccc--CceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 74 DCLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 74 ~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
...||.| +||+||++.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3456766 9999999999999999999998754322 23567889999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC-c
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD-K 228 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 228 (296)
+++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++||+.+....... .
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999987632 345899999999999999999999999 9999999999999999999999997653211110 0
Q ss_pred c----eeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 T----HVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......++..|+|||++.+. .++.++|+|||||++|+|++|+.||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 0 000112346679999999764 47889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=254.69 Aligned_cols=201 Identities=28% Similarity=0.374 Sum_probs=171.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEec-CCceE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRL 142 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~~ 142 (296)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.... ......+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46788999999999999999999999999999999886432 2234567789999999999999999999876 45788
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+++||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||.+..
T Consensus 87 lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 5789888753 45788888999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~ 211 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH 211 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3221 122457888999998765 5688999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=243.46 Aligned_cols=194 Identities=36% Similarity=0.470 Sum_probs=170.4
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
||.|++|.||++.+..+++.+++|.+...... ....+..|+.+++.++||||+++++.+...+..++|||++.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999998765432 345678899999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeee
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 233 (296)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999865 346899999999999999999999999 9999999999999999999999999987533221 1233
Q ss_pred cccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||...+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 4568889999999988888899999999999999999999997665
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=252.04 Aligned_cols=194 Identities=23% Similarity=0.277 Sum_probs=160.8
Q ss_pred CceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhc
Q 022482 81 GFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLH 158 (296)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~ 158 (296)
++|.||.+++..+++.||+|++... .......+..|+.+++.++||||+++++++.+.+..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 4455666666778999999998754 23344678899999999999999999999999999999999999999999987
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc-----ceeee
Q 022482 159 DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK-----THVST 233 (296)
Q Consensus 159 ~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 233 (296)
.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 52 2346889999999999999999999999 99999999999999999999999998864322111 11112
Q ss_pred cccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 234 RVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 234 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...++..|+|||++.+. .++.++|+||+||++|+|++|..||.+.+
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 24567889999998763 57889999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=250.78 Aligned_cols=204 Identities=25% Similarity=0.325 Sum_probs=175.8
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC--C----cccceeeEEecC
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--P----NLVNLIGYCADG 138 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~----~I~~~~~~~~~~ 138 (296)
..+.++|.+...+|+|.||.|..+.+..++..||||+++. -....+..+-|+..|+.+.+ | -++++.+||...
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3457899999999999999999999999999999999843 23344566789999998842 3 378899999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC----------
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---------- 208 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---------- 208 (296)
++.++|+|.+ |.++.+++.. +.-.+++..++..+.+|+++++++||+.+ ++|-||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k 237 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPK 237 (415)
T ss_pred CceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccC
Confidence 9999999988 6799999977 35677999999999999999999999999 999999999999931
Q ss_pred ----------CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 209 ----------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 209 ----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
...++++|||.+....... ...+.|..|.|||++.+-.++..+||||+||||+||++|...|...
T Consensus 238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred CccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3358999999998643332 4567899999999999999999999999999999999999999877
Q ss_pred Cc
Q 022482 279 RA 280 (296)
Q Consensus 279 ~~ 280 (296)
+.
T Consensus 313 en 314 (415)
T KOG0671|consen 313 EN 314 (415)
T ss_pred Cc
Confidence 63
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=268.55 Aligned_cols=209 Identities=31% Similarity=0.449 Sum_probs=182.3
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEec-----C
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD-----G 138 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~-----~ 138 (296)
....+.|.|..+||.|.+|.||+++...+++..|+|+..... ....++..|..+|+.+ +|||++.+|++|.- .
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 344567999999999999999999999999999999987654 3346777889999887 59999999999863 5
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+.+|||||||.||+..|+++... +.++.|..+..|++.++.|+.+||... ++|||||-.|||++.++.|||+|||
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 78999999999999999998854 788999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.+.... .........+|||.|||||++... .|+.++|+||||++..||..|.+|+.++.+-
T Consensus 169 vSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm 234 (953)
T KOG0587|consen 169 VSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM 234 (953)
T ss_pred eeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh
Confidence 987533 233344557899999999999653 4778999999999999999999999988753
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=253.39 Aligned_cols=202 Identities=26% Similarity=0.307 Sum_probs=166.7
Q ss_pred CCCccccccccCceEEEEEEECCC--CeEEEEEEecCCC--cchhHHHHHHHHHHhhc-CCCcccceeeEEecC----Cc
Q 022482 70 NFRADCLLGEGGFGRVYKGRLEST--NQVVAIKQLDRNG--LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADG----DQ 140 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~----~~ 140 (296)
+|++.+.||+|+||.||++.+..+ +..||+|.+.... ......+.+|+.+++.+ +||||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 488899999999999999999887 8899999986422 12245677899999988 599999999875432 45
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.+++++++. ++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999885 789988854 467899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc--eeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKT--HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......... .......|+..|+|||.+.+ ..++.++|+|||||++|+|++|.+||...+
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 753322211 11223468999999998765 468899999999999999999999998755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=247.43 Aligned_cols=200 Identities=30% Similarity=0.441 Sum_probs=167.5
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhc---CCCcccceeeEEecCCc-----
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLL---HHPNLVNLIGYCADGDQ----- 140 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~h~~I~~~~~~~~~~~~----- 140 (296)
|++.+.||+|++|.||+|.+..+++.+|+|.+....... ...+..|+.+++.+ +||||+++++.+...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999999889999999996432221 23455677666655 69999999999988776
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999997 58988886522 236899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
........ .....++..|+|||.+.+..++.++|+|||||++|+|++|.+||....
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 75432221 122357889999999998889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=246.10 Aligned_cols=204 Identities=26% Similarity=0.341 Sum_probs=170.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-----cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+|.+.+.||+|+||.||++.+...+..+++|+..... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5889999999999999999998777666666654321 12233566788999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988654344567999999999999999999999999 999999999999975 579999999987532
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 221 12223567889999999988888999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=273.65 Aligned_cols=147 Identities=30% Similarity=0.438 Sum_probs=132.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+.+++.++||||+++++++...+..++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 35799999999999999999999999999999999754322 235677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
|||+.|++|.+++.. ...+++..++.++.|++.||.|||..+ |+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999865 346888999999999999999999999 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=247.69 Aligned_cols=201 Identities=28% Similarity=0.391 Sum_probs=169.1
Q ss_pred CCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 70 NFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
+|++.+.||+|++|.||++.+. .+++.+|+|.+..... .....+..|+.+++.+ +||+|+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4788999999999999999864 4578899999864322 2234577899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+.+++|.+++.. ...+++..+..++.|++++|.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999864 356889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCcceeeecccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
....... .......|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||...
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 211 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVD 211 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccC
Confidence 5333221 1122346889999999987654 778999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=250.16 Aligned_cols=199 Identities=36% Similarity=0.489 Sum_probs=169.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..|...+.||+|++|.||+|.+..+++.+|+|.+..... ....++.+|+.+++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 347778999999999999999999999999999864322 22345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+. ++|.+.+.. ....+++..+..++.|++.|+.|||+.+ ++||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 678777643 2355889999999999999999999999 99999999999999999999999999875332
Q ss_pred CCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ....++..|+|||.+. ...++.++|||||||++|+|++|..||.+.+.
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 1 2345888999999974 34678899999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=255.39 Aligned_cols=201 Identities=26% Similarity=0.376 Sum_probs=171.5
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCc---
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 140 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--- 140 (296)
.+.++|.+.+.||+|++|.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 35678999999999999999999999999999999986532 2233556789999999999999999998876554
Q ss_pred ---eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 141 ---RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 141 ---~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999998 6799998854 46899999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|++...... .....++..|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+.
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999753221 2234578899999998653 678899999999999999999999976543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=246.34 Aligned_cols=200 Identities=31% Similarity=0.419 Sum_probs=172.2
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... ......+..|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567889999999999999999999999999987653 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
. ++|.+++... ...+++..+..++.|++.||++||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 6899999752 246899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++||...+
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 12223467789999998776 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=246.05 Aligned_cols=201 Identities=29% Similarity=0.400 Sum_probs=169.6
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|.+.+.||+|++|.||+|....+++.++||.+..... .......+|+..++.++ ||||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 6788999999999999999998899999999865422 12234456888999998 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 78999888652 1357899999999999999999999999 9999999999999999999999999987533221
Q ss_pred ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......++..|+|||++.+ ..++.++|+||||+++++|++|++||...+.
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 1123457889999998754 4578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=261.53 Aligned_cols=199 Identities=30% Similarity=0.384 Sum_probs=170.0
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh-cCCCcccceeeEEecCCceEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL-LHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+...|.+...+|.|+|+.|..+.+..+++..++|++.+.. .+..+|+.++.. -+||||+++.+++.+..+.|+|
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 35678999999999999999999999999999999997652 223345544444 4799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE-cCCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili-~~~~~~kl~Dfg~~~~~ 223 (296)
||.+.|+.|.+.+.. .+....++..|+++|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++..
T Consensus 395 ~e~l~g~ell~ri~~-----~~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 395 MELLDGGELLRRIRS-----KPEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred ehhccccHHHHHHHh-----cchhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999998888754 22333677889999999999999999 9999999999999 69999999999999864
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... ....+-|..|.|||++....|++++||||||++||+||+|+.||......
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 433 33456789999999999999999999999999999999999999865554
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=246.87 Aligned_cols=200 Identities=30% Similarity=0.459 Sum_probs=166.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|++|.||+|.+..+++.||||.+...... ....+..|+.++..+ .||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 5689999999999999999999998999999999754322 334456677666555 49999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+. ++|.+++... ...+++..+..++.|++.||+|||+ .+ ++||||+|+||++++++.++|+|||++.....
T Consensus 95 ~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred ccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 985 6777776542 3478999999999999999999997 57 99999999999999999999999999875322
Q ss_pred CCcceeeecccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 12235788999999987553 788999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=240.31 Aligned_cols=182 Identities=27% Similarity=0.315 Sum_probs=156.2
Q ss_pred cCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhcc
Q 022482 80 GGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159 (296)
Q Consensus 80 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~ 159 (296)
|.+|.||++++..+++.+|+|.+.... ....|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999996543 223444555556799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccc
Q 022482 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (296)
Q Consensus 160 ~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (296)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999999 999999999999999999999999987643221 12234677
Q ss_pred cccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 899999998888899999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=249.44 Aligned_cols=199 Identities=35% Similarity=0.542 Sum_probs=170.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh--cCCCcccceeeEEecCC----ceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCADGD----QRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~~~----~~~ 142 (296)
....+..+||+|.||.||+|... ++.||||+++. .+.+.+..|-.+++. +.|+||+++++.-.-.+ .++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 34567889999999999999887 68999999963 445667777777775 57999999998866544 889
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK------ANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~------~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
||++|.+.|+|.+|+.. ..+++....+++..++++|+|||+. .+++|+|||||..|||+.++++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999964 6799999999999999999999973 356899999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCC-CC-----ccchhHHHHHHHHHHHhCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-LT-----LKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
||+|....++.........+||.+|||||++.+.. .. .+.||||+|.++|||++....++.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~ 426 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADP 426 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccC
Confidence 99999877777766666789999999999997753 22 258999999999999998776654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=273.07 Aligned_cols=199 Identities=32% Similarity=0.411 Sum_probs=161.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------ 138 (296)
....+|+.++.||+||||.||+++++-+|..||||+|+... ......+.+|+..|..|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45667889999999999999999999999999999998664 22235688999999999999999998642100
Q ss_pred --------------------------------------------------------------------------------
Q 022482 139 -------------------------------------------------------------------------------- 138 (296)
Q Consensus 139 -------------------------------------------------------------------------------- 138 (296)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 022482 139 ---------------------------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185 (296)
Q Consensus 139 ---------------------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~ 185 (296)
..+||-||||+..+|.+++... ...-....++.++++|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHH
Confidence 1147899999977777777651 1111467889999999999999
Q ss_pred HHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC----------------CCCcceeeecccccccccCcccccc
Q 022482 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP----------------VGDKTHVSTRVMGTYGYCAPEYAMT 249 (296)
Q Consensus 186 lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~ 249 (296)
+|++| ||||||||.|||+++++.|||+|||++.... .+......+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999997511 0111223345789999999999977
Q ss_pred CC---CCccchhHHHHHHHHHHHh
Q 022482 250 GQ---LTLKSDVYSFGVVLLEIIT 270 (296)
Q Consensus 250 ~~---~~~~~DiwslG~~l~~ll~ 270 (296)
.. |+.++|+||||++++||+.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc
Confidence 54 9999999999999999983
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=279.68 Aligned_cols=207 Identities=29% Similarity=0.526 Sum_probs=168.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+...|...+.||+|+||.||+|.+..++..||+|.+...... ...|+..++.++||||+++++++.+.+..++||
T Consensus 687 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 687 DILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred HHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3445688889999999999999999888999999998643221 124578899999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.++++. +++..+..++.|+++|++|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 763 Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred eCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999843 7889999999999999999995433339999999999999988887765 555432111
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhhh
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVT 291 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~~ 291 (296)
.....+|+.|+|||++.+..++.++|||||||++|||++|+.||+... .....+++|++
T Consensus 835 ------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 893 (968)
T PLN00113 835 ------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWAR 893 (968)
T ss_pred ------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHH
Confidence 112367899999999999899999999999999999999999996432 22334555554
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=243.23 Aligned_cols=205 Identities=24% Similarity=0.376 Sum_probs=172.5
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecC--CCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC-----ceE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-----QRL 142 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-----~~~ 142 (296)
+.+..+.||.|+||.||.+.+..+|+.||+|++.. ........+.+|+.+|..++|.|++..++...-.. .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 35567889999999999999999999999998853 22334567889999999999999999988765432 457
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+++|.+. .+|...+-. ...++...++.+++||+++|.|||+.+ |.||||||.|+|++.+..+||||||+++.
T Consensus 134 V~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 8888886 778777743 677899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcccc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~ 283 (296)
....+... ...-+.|.+|.|||+++|. .|+...||||+||++.|||..+..|....+-+.
T Consensus 206 ee~d~~~h-MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQ 266 (449)
T KOG0664|consen 206 WDQRDRLN-MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQ 266 (449)
T ss_pred cchhhhhh-hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHH
Confidence 54443322 2234578999999999986 589999999999999999999999988776553
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=252.64 Aligned_cols=201 Identities=31% Similarity=0.489 Sum_probs=173.3
Q ss_pred CCccccccccCceEEEEEEECCC----CeEEEEEEecC-CCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLEST----NQVVAIKQLDR-NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..+.+.||.|-||.||.|.+..- .-.||||..+. ....+.+.|+.|..+++.++||||+++++++.+ ...|+||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 45567899999999999987532 33588998876 345567789999999999999999999999976 5789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|.++.|.|.+|++. ++..++...+..+++|++.||+|||+.. .|||||..+|||+.....+||+|||+++....
T Consensus 470 EL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 99999999999987 5678999999999999999999999999 99999999999999999999999999997655
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
......+ ...-...|||||.+.-..++.++|+|-|||++||+|. |..||.+-.
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk 597 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK 597 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc
Confidence 5443333 2334567999999998999999999999999999988 999997543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.62 Aligned_cols=211 Identities=34% Similarity=0.500 Sum_probs=185.3
Q ss_pred CCccccccccCceEEEEEEECCCCe----EEEEEEecCC-CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+..++||+|+||+||+|.+...|+ +||||++... ......++++|+..+..++|||++++++++..+. .-||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4557889999999999999866555 5788887643 4455678999999999999999999999997765 77899
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
+|+++|+|.+|++. .+..+.......|++||++|+.|||++. ++||||-.+|+|+..-..+|+.|||+++....
T Consensus 777 q~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 99999999999987 4677888999999999999999999999 99999999999999999999999999998777
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccccchHh
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVA 288 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~l~~ 288 (296)
...........--+.|||-|.+....|+.++||||+||++||++| |..|+++...+++.++.+
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 666554444445678999999999999999999999999999999 999999999999887755
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=230.85 Aligned_cols=210 Identities=22% Similarity=0.404 Sum_probs=169.4
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeE-EecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGY-CADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~-~~~~~~~~l 143 (296)
.+.+.|.+.+.||+|-||.+.++.++.++..+++|.+++. .....+|.+|...--.| .|.||+.-|++ |+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 3557899999999999999999999999999999999765 44567888888654444 58999988875 667788889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE--cCCCceEEcccCCcc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL--GEGYHPKLSDFGLAK 221 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili--~~~~~~kl~Dfg~~~ 221 (296)
+|||++.|+|.+-+.. ..+.+.....++.|+++||.|||+.+ +||||||.+|||| .+..++||||||..+
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999988743 66889999999999999999999999 9999999999999 344589999999987
Q ss_pred cCCCCCcceeeecccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhh
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWV 290 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~ 290 (296)
...... ...-.+..|.+||+.... ...+.+|+|+||+++|.+|||.+||. ...-.+....+|.
T Consensus 172 k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 172 KVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWE 239 (378)
T ss_pred ccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHH
Confidence 422211 122345679999976432 34678999999999999999999999 4444444455554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=238.43 Aligned_cols=138 Identities=22% Similarity=0.307 Sum_probs=117.8
Q ss_pred HHHHh-cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-----C---CcccceeeE
Q 022482 64 LAAVT-KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----H---PNLVNLIGY 134 (296)
Q Consensus 64 ~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~~I~~~~~~ 134 (296)
+..|. .+|.+.+.||-|.|++||+|.+..+...||+|+++.. ....+..+.|+.+|++++ | .+||++++.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34455 7999999999999999999999999999999998544 345567789999999873 2 479999999
Q ss_pred Eec----CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 135 CAD----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 135 ~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
|.. ..+++||+|++ |.+|..++... .-..++...+++|++|++.||.|||...+ |||.||||+|||+.
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeeee
Confidence 975 45889999998 78999998763 45678999999999999999999997654 99999999999993
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=252.96 Aligned_cols=211 Identities=31% Similarity=0.469 Sum_probs=178.3
Q ss_pred CCCccccccccCceEEEEEEECC-CCe--EEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES-TNQ--VVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++.+.||+|.||.|++|.+.. +|+ .||||.+...... ...+|++|+..+..|+|+|++++|+++.+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 45667899999999999998864 333 5899999776555 56789999999999999999999999988 6778999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|++++|+|.+.+++ ..+..|....+..++.||+.|+.||.+++ +|||||..+|+++-....|||+|||+.+-...
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999987 34567888888999999999999999999 99999999999998888999999999986544
Q ss_pred CCcceeee-cccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccccch
Q 022482 226 GDKTHVST-RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNL 286 (296)
Q Consensus 226 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~l 286 (296)
.+...... ...--..|+|||.+....++.++|+|++||++|||++ |+.||-+.....+-..
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 44322211 1223457999999999999999999999999999999 9999998776654433
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=233.48 Aligned_cols=206 Identities=27% Similarity=0.418 Sum_probs=170.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEec--------C
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------G 138 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--------~ 138 (296)
..|.-...||+|.||.||+|+.+++++.||+|++--. ...--....+|+.+|..+.|+|++.+++.+.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 4566778899999999999999999999999865321 11122356799999999999999999987753 2
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
..+|+||.+|+ .+|.-.+.. ...+++..++..++.+++.+|.|+|... |+|||+||.|+||+.+|.++|+|||
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 34789999997 677777754 4578999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcc--eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 219 LAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 219 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+++.....++. ......+.|.+|.+||.+.+. .|++..|||+-||++.+|.+|.+.|.+.+.-
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq 235 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ 235 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH
Confidence 99754443322 123345679999999998875 7999999999999999999999999876543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=224.31 Aligned_cols=199 Identities=36% Similarity=0.480 Sum_probs=173.7
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
|.+.+.||+|++|.||++.+..+++.+++|.+...... ....+..|+..++.++|+|++++++.+...+..++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 56788999999999999999988999999999876554 56778899999999999999999999999899999999999
Q ss_pred CCCHHHHhccCCCCCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 150 LGSLEDHLHDLPPDKKR-LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~-~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+++|.+++... .. +++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~- 152 (225)
T smart00221 81 GGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDL- 152 (225)
T ss_pred CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-
Confidence 99999998652 23 788999999999999999999999 9999999999999999999999999987643332
Q ss_pred ceeeecccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
........++..|++||.+ ....++.++|+|+||+++++|++|+.||+.
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 0122335678889999998 566778899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=259.31 Aligned_cols=204 Identities=30% Similarity=0.512 Sum_probs=177.6
Q ss_pred CCCccccccccCceEEEEEEECCCCe---EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
...|.++||.|.||.|++|+.+..++ .||||.++.... ....+|+.|+.++-+++||||+++-+++.......||+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 45788999999999999999887664 699999965433 34567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|||+.|+|+.|++. +++.|+..++..+++.|+.++.||-+++ +|||||..+|||++.+-..|++|||++++...
T Consensus 710 EyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 99999999999987 4577999999999999999999999999 99999999999999999999999999997644
Q ss_pred CCcceeeecccc--cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 226 GDKTHVSTRVMG--TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+. .......-| -.+|.|||.+....++.++|+||+|++|||.++ |..||.++.-
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN 840 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 840 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch
Confidence 43 122222222 368999999999999999999999999999987 9999987763
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=249.44 Aligned_cols=214 Identities=30% Similarity=0.473 Sum_probs=184.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+......||.|.||.||.|.++...-.||||.++.+ .-...+|+.|+.+++.++|||+|+++++|..+..+|||+||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf 344 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF 344 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence 34455667899999999999999999999999999655 34568899999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
|..|+|.+|+.+. +...++.-.+.+++.||.+|++||...+ +|||||..+|.|+.++..||++|||++++.....
T Consensus 345 M~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 345 MCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred ccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999999874 4566777788899999999999999999 9999999999999999999999999999754433
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcccccchHh
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEHNLVA 288 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~~l~~ 288 (296)
++. ...-.....|.|||-+.-..++.++|||+|||+|||+.| |.-||.+.+......|.+
T Consensus 420 YTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE 480 (1157)
T KOG4278|consen 420 YTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE 480 (1157)
T ss_pred eec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh
Confidence 322 111223467999999998899999999999999999998 999999888776554443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=237.73 Aligned_cols=209 Identities=27% Similarity=0.397 Sum_probs=169.2
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh--cCCCcccceeeEEecC---
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG--- 138 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~~--- 138 (296)
...+..+..+.+.||+|.||.||+|.++ |+.||||++... +++.+.+|.++++. |+|+||+.+++.-..+
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 3567788999999999999999999998 889999999643 34566677777664 6999999999876543
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEeccCCCCcEEEcCCCce
Q 022482 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-----KANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 139 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-----~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
..+|||.+|.+.|||.||+.. ..++.+.+..++..++.+|++||. +|++-|.|||||..|||+..++..
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 357899999999999999965 678899999999999999999994 678889999999999999999999
Q ss_pred EEcccCCcccCCCCC--cceeeecccccccccCccccccCCC------CccchhHHHHHHHHHHHh----------CCCC
Q 022482 213 KLSDFGLAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMTGQL------TLKSDVYSFGVVLLEIIT----------GRKA 274 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~~l~~ll~----------g~~p 274 (296)
-|+|+|+|....... -.......+||.+|||||++..... -..+||||||.++||++. -++|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999996433321 1222334689999999999965421 135899999999999974 3577
Q ss_pred CCCCCccc
Q 022482 275 IDNTRAAG 282 (296)
Q Consensus 275 f~~~~~~~ 282 (296)
|.+.-+.+
T Consensus 436 yyd~Vp~D 443 (513)
T KOG2052|consen 436 YYDVVPSD 443 (513)
T ss_pred cccCCCCC
Confidence 77554433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=221.80 Aligned_cols=211 Identities=21% Similarity=0.326 Sum_probs=176.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCC--ceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD--QRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~--~~~l 143 (296)
..++|++.+.+|.|.|+.||.|.+..+++.++||++++ .....+.+|+.+|+.|. +|||++++++..++. ...+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45679999999999999999999999999999999864 34578899999999996 999999999998764 5679
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCCccc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAKL 222 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~~~~ 222 (296)
|+||+...+...... .++...+...++++++||.|+|++| |.|||+||.|++|+.. -.++|+|+|++.+
T Consensus 113 iFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred HhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhh
Confidence 999999888777663 4777889999999999999999999 9999999999999754 5699999999987
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhhhhhh
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWVTVLS 294 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~~~~~ 294 (296)
..++..- ...+.+..|-.||++.. ..|+.+-|+|||||++..|+..+.||..... ..+.|+....+|+
T Consensus 183 YHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLG 251 (338)
T KOG0668|consen 183 YHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLG 251 (338)
T ss_pred cCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhC
Confidence 6655432 23467889999999866 4688899999999999999999999975433 3345666665554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=247.73 Aligned_cols=202 Identities=23% Similarity=0.285 Sum_probs=143.7
Q ss_pred hcCCCccccccccCceEEEEEEECCC----CeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeE------Eec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST----NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY------CAD 137 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~------~~~ 137 (296)
.++|.+.+.||+|+||.||+|.+..+ +..||+|.+...... .....+ .++...+.++..+... ...
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence 45799999999999999999999988 899999987643211 111111 1111122222222221 234
Q ss_pred CCceEEEEecCCCCCHHHHhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPP----------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~----------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp 201 (296)
....++|+||+.+++|.+++..... .........+..++.|++.||.|||+.+ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 5678999999999999998864210 0011223456689999999999999999 99999999
Q ss_pred CcEEEcC-CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCC----------------------CCccchh
Q 022482 202 SNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ----------------------LTLKSDV 258 (296)
Q Consensus 202 ~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----------------------~~~~~Di 258 (296)
+|||+++ ++.+||+|||++....... ........+++.|+|||.+.... ++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 6799999999997543222 12233467899999999764322 3345699
Q ss_pred HHHHHHHHHHHhCCCCCCC
Q 022482 259 YSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 259 wslG~~l~~ll~g~~pf~~ 277 (296)
|||||++|||+++..|++.
T Consensus 363 wSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred HHHHHHHHHHHhCcCCCch
Confidence 9999999999998877653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-33 Score=241.01 Aligned_cols=208 Identities=24% Similarity=0.270 Sum_probs=178.2
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC------CcccceeeEEe
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH------PNLVNLIGYCA 136 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~~I~~~~~~~~ 136 (296)
.+..+..+|.+....|+|-|++|..|.+..-|..||||+|..+..-. ..=+.|+.+|+.|+. -|+++++-.|.
T Consensus 426 igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 426 IGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34566778999999999999999999999999999999997764432 334589999999963 48999999999
Q ss_pred cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEc
Q 022482 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLS 215 (296)
Q Consensus 137 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~ 215 (296)
..++++||+|.+. .+|.+.++.+.. +..+....+..+++|++-||..|..++ |+|.||||+|||+++. ..+|||
T Consensus 505 hknHLClVFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLC 579 (752)
T KOG0670|consen 505 HKNHLCLVFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLC 579 (752)
T ss_pred hcceeEEEehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeec
Confidence 9999999999985 899999988753 456888899999999999999999999 9999999999999865 568999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|||.|......+. .....+..|.|||++.|-.|+...|+||+||+||||.||+..|.+.+-
T Consensus 580 DfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 580 DFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 9999976433322 223467789999999999999999999999999999999999987654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=219.17 Aligned_cols=187 Identities=39% Similarity=0.553 Sum_probs=165.9
Q ss_pred CceEEEEEEECCCCeEEEEEEecCCCcch-hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhcc
Q 022482 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159 (296)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~ 159 (296)
+||.||+|.+..+++.+++|++....... ...+.+|+..++.++|+||+++++.+......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999997655444 67889999999999999999999999998999999999998899999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccc
Q 022482 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (296)
Q Consensus 160 ~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (296)
...+++..+..++.+++.++.+||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 233889999999999999999999999 9999999999999999999999999997643322 223456888
Q ss_pred cccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
.|++||.+.+..++.++|+||||+++++|++|..||..
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=238.25 Aligned_cols=206 Identities=22% Similarity=0.302 Sum_probs=151.3
Q ss_pred hcCCCccccccccCceEEEEEEEC----------------CCCeEEEEEEecCCCcchhHH--------------HHHHH
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE----------------STNQVVAIKQLDRNGLQGNRE--------------FLVEV 117 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e~ 117 (296)
.++|.+.+.||+|+||.||+|.+. ..+..||||.+........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 458999999999999999999752 234679999986543222222 23466
Q ss_pred HHHhhcCCCcc-----cceeeEEec--------CCceEEEEecCCCCCHHHHhccCCC--------------------CC
Q 022482 118 LMLSLLHHPNL-----VNLIGYCAD--------GDQRLLVYEYMPLGSLEDHLHDLPP--------------------DK 164 (296)
Q Consensus 118 ~~l~~l~h~~I-----~~~~~~~~~--------~~~~~lv~e~~~~~sL~~~~~~~~~--------------------~~ 164 (296)
.++..++|.++ +++++++.. .+..++|+||+.+++|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 66666765543 566666543 3568999999999999998864211 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCc
Q 022482 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244 (296)
Q Consensus 165 ~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 244 (296)
..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.++|+|||++......... ......+|+.|+||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP 379 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP 379 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence 23466778899999999999999999 999999999999999999999999998653322111 11122358899999
Q ss_pred cccccCC--------------------CC--ccchhHHHHHHHHHHHhCCC-CCCC
Q 022482 245 EYAMTGQ--------------------LT--LKSDVYSFGVVLLEIITGRK-AIDN 277 (296)
Q Consensus 245 E~~~~~~--------------------~~--~~~DiwslG~~l~~ll~g~~-pf~~ 277 (296)
|.+.... +. ...|+||+||++|+|++|.. ||.+
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9885432 11 24699999999999999986 7753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=221.53 Aligned_cols=199 Identities=27% Similarity=0.323 Sum_probs=170.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------ 138 (296)
+..+|.-++.+|.|.- .|..+.+...+..||+|..... .....++..+|..++..++|+||++++.+|.-.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567888999999998 8889999999999999987543 223345677899999999999999999998543
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
...|+|||++. .+|...+. ..++-..+..|++|++.|+++||+.+ |+||||||+||++..+..+||.|||
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccch
Confidence 45799999996 89998885 34666889999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+++..... ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+.+
T Consensus 164 ~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 164 LARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred hhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 99853322 23445678999999999999899999999999999999999999998443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=243.50 Aligned_cols=205 Identities=26% Similarity=0.364 Sum_probs=182.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..++|.++..+|+|.||.||+++++.+++..|+|+++.....+..-+..|+-+++.++||||+.+++.+.-.+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34679999999999999999999999999999999987766677778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
||.||+|.+.++- ...+++.++...++..+++++|||+.+ -+|||||-.||++++.|.+|+.|||.+-.. .
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqi--t 163 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQI--T 163 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhh--h
Confidence 9999999998875 678999999999999999999999999 899999999999999999999999998542 2
Q ss_pred CcceeeecccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
........+.||++|||||+- ..+.|...+|+|++|+...|+-.-++|..+..+
T Consensus 164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp 220 (829)
T KOG0576|consen 164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP 220 (829)
T ss_pred hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch
Confidence 233345568899999999986 356789999999999999999888888766544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=238.76 Aligned_cols=202 Identities=28% Similarity=0.358 Sum_probs=161.0
Q ss_pred CCccccccccCce-EEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFG-RVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
|.-.+++|.|+-| .||+|... ++.||||.+-.. ...-..+|+..|+..+ ||||+++|+.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 4445778899886 58999987 789999987432 2235678999999884 999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---C--CceEEcccCCcccC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---G--YHPKLSDFGLAKLG 223 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~--~~~kl~Dfg~~~~~ 223 (296)
. .+|.+++..-............+.++.|+++||++||+.+ ||||||||.||||+. + .+++|.|||+|+..
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 6 8999999762111111111455788999999999999999 999999999999965 3 46899999999865
Q ss_pred CCCCcce-eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..+.... ......||..|+|||++.....+.++||+||||++|+.++ |.+||.+.-.+
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 5544322 2345679999999999998888889999999999999999 59999755443
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=235.53 Aligned_cols=206 Identities=33% Similarity=0.477 Sum_probs=169.3
Q ss_pred CCCccccccccCceEEEEEEECC-------CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcccceeeEEecCCc
Q 022482 70 NFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~ 140 (296)
+..+.+.||+|.||.|++|.... ....||||....... .+.+.+..|+.+++.+. |+||+.+++++.....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 44667799999999999987431 145799999865433 34567899999999985 9999999999999899
Q ss_pred eEEEEecCCCCCHHHHhccCC----------CCC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLP----------PDK--KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~----------~~~--~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
.++|+||+..|+|.++++... ... ..++...+..+++||+.|++||++.. ++||||-.+|||+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITK 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecC
Confidence 999999999999999997643 011 23888999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccCCCCCcceeeecccc--cccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMG--TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
+..+||+|||+++........... ...+ -..|||||.+....|+.++||||+|++|||+++ |..||.+..
T Consensus 454 ~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred CCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999854333322211 1112 234999999999999999999999999999999 999998733
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=218.22 Aligned_cols=212 Identities=26% Similarity=0.385 Sum_probs=174.0
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECC---CCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCC
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~ 139 (296)
...+.+.|.+++.||+|.|++||++.+.. ....||+|.+.... .-..+..|+.+|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 45566789999999999999999999877 78899999987653 3456889999999985 899999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFG 218 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg 218 (296)
...+||||++.....+++.. ++...+..+++.++.||.++|..| ||||||||+|++++. .+.-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 99999999999999998854 667889999999999999999999 999999999999964 5678999999
Q ss_pred Cccc-----------------CCC-------------------------CCcceeeecccccccccCccccccC-CCCcc
Q 022482 219 LAKL-----------------GPV-------------------------GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLK 255 (296)
Q Consensus 219 ~~~~-----------------~~~-------------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~ 255 (296)
++.. ..+ ...........||+.|.|||++.+. ..+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 9851 000 0000111235699999999999775 56788
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCcccccchHh
Q 022482 256 SDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVA 288 (296)
Q Consensus 256 ~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~ 288 (296)
+||||.||++..+++++.||.... ++...|.+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~-dd~~al~e 290 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAK-DDADALAE 290 (418)
T ss_pred cceeeccceeehhhccccccccCc-cccchHHH
Confidence 999999999999999999998443 33333433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=205.65 Aligned_cols=207 Identities=26% Similarity=0.359 Sum_probs=177.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.-.|++.+.||+|+||.+++|.+.-+++.||||.-+.. ...-.+..|...++.|. .++|+..|.+..+.-+-.|||
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 445799999999999999999999999999999986543 23446678888888885 799999999998888889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-----CCceEEcccCCc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-----GYHPKLSDFGLA 220 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-----~~~~kl~Dfg~~ 220 (296)
|.+ |.+|.|+..- .+.+|+...+..++.|++.-++|+|++. +|+|||||+|+||.. .+.+.++|||++
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 988 7899887754 4788999999999999999999999999 999999999999964 345899999999
Q ss_pred ccCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
+........ .......||.+||+-....+.+.+++.|+-|||-+++..|-|.+||.+...+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 865444321 12234679999999999999999999999999999999999999998776554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=195.70 Aligned_cols=184 Identities=41% Similarity=0.606 Sum_probs=159.8
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLED 155 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~ 155 (296)
||+|++|.||++....+++.+++|++...... ....+.+|+..++.+.|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999765432 34678899999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccCCCCCcceeeec
Q 022482 156 HLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDKTHVSTR 234 (296)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 234 (296)
++... ...+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 98652 146889999999999999999999999 999999999999999 89999999999975433221 1233
Q ss_pred ccccccccCccccccC-CCCccchhHHHHHHHHHH
Q 022482 235 VMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEI 268 (296)
Q Consensus 235 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l 268 (296)
..+...|++||.+... .++.+.|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 5578899999999777 788899999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=212.52 Aligned_cols=205 Identities=26% Similarity=0.302 Sum_probs=169.1
Q ss_pred CCCccccccccCceEEEEEEECCCC-eEEEEEEecCCCcchhHHHHHHHHHHhhcC----CCcccceeeEE-ecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREFLVEVLMLSLLH----HPNLVNLIGYC-ADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~----h~~I~~~~~~~-~~~~~~~l 143 (296)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|..++..+. .+++..+++.+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999998764 678888876543332235667888887776 36899999999 47788999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-----CceEEcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-----YHPKLSDFG 218 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-----~~~kl~Dfg 218 (296)
||+.+ |.+|.++..... ...++...+..|+.|++.+|.+||+.| ++||||||.|+++... ..+.|+|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 899999886643 578999999999999999999999999 9999999999999755 469999999
Q ss_pred Ccc--cCCCCCc----ce-e-eecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAK--LGPVGDK----TH-V-STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+++ ....... .. . .....||..|+++....+...+++.|+||++.++.+++.|..||.+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 998 3111111 01 1 1235699999999999999999999999999999999999999976654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=196.11 Aligned_cols=207 Identities=26% Similarity=0.329 Sum_probs=172.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC-CcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~ 145 (296)
....|++++.||+|+||.+|+|....+|+.||||+-.... ....+..|..+.+.|++ ..|+.+..+..+.++-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 4568999999999999999999999999999999864332 22356688899999874 78888888888888999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~~~ 222 (296)
+.+ |.+|.+...- ....++...+.-++-|++.-++|+|.++ ++||||||+|+|+. ....+.|+|||+++.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 988 7999988765 3567999999999999999999999999 99999999999995 456799999999974
Q ss_pred CCCCCc-----ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
...... ........||.+|.+-....+.+.+++.|+-|+|.++..+.-|..||.+..+..
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 322221 112234679999999888888888999999999999999999999999876543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=208.61 Aligned_cols=170 Identities=17% Similarity=0.121 Sum_probs=131.5
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECC-CCeEEEEEEecCCC-----cchhHHHHHHHHHHhhcCCCcccceeeEEec
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~ 137 (296)
...+..+|.+.+.||+|+||+||+|.+.. ++..+|||++.... ......+.+|+.+++.++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 34567889999999999999999998876 67888999875331 1224568899999999999999853322
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC-CCCcEEEcCCCceEEcc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL-KCSNILLGEGYHPKLSD 216 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdi-kp~Nili~~~~~~kl~D 216 (296)
.+..++||||++|++|... .. .. ...++.|++.||.|||+.+ |+|||| ||+|||++.++.++|+|
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 2467999999999999632 11 11 1457889999999999999 999999 99999999999999999
Q ss_pred cCCcccCCCCCccee------eecccccccccCccccccC
Q 022482 217 FGLAKLGPVGDKTHV------STRVMGTYGYCAPEYAMTG 250 (296)
Q Consensus 217 fg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 250 (296)
||+++.......... -....+++.|+|||.+...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999986443321111 1245688889999988543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=201.52 Aligned_cols=221 Identities=25% Similarity=0.372 Sum_probs=180.5
Q ss_pred HHHHHHHhcCCCccccccccCceEEEEEEECCCC-----eEEEEEEecC-CCcchhHHHHHHHHHHhhcCCCcccceeeE
Q 022482 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDR-NGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~-~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~ 134 (296)
..++..-..+++....+-+|.||.||.|.++... +.|.+|.+.. .+..+...++.|..++....|||++++.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455556678899999999999999999765422 3355565532 223334567888889999999999999998
Q ss_pred Eec-CCceEEEEecCCCCCHHHHhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC
Q 022482 135 CAD-GDQRLLVYEYMPLGSLEDHLHDLP----PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (296)
Q Consensus 135 ~~~-~~~~~lv~e~~~~~sL~~~~~~~~----~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~ 209 (296)
..+ .+..+.++.+...|+|..|+.... ..-..++..++..++.|++.|++|||+++ +||.||..+|.+|++.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 755 467788899999999999997322 12345677788889999999999999999 9999999999999999
Q ss_pred CceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccccc
Q 022482 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAGEH 284 (296)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~~~ 284 (296)
-++||+|=.+++...+.+.......--....||+||.+.+..|+..+|+|||||++|||+| |+.|+...++.+..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~ 508 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME 508 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence 9999999999998777777665555555678999999999999999999999999999999 99999988887643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=221.90 Aligned_cols=149 Identities=19% Similarity=0.244 Sum_probs=113.2
Q ss_pred cCC-CcccceeeEE-------ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 022482 123 LHH-PNLVNLIGYC-------ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194 (296)
Q Consensus 123 l~h-~~I~~~~~~~-------~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~i 194 (296)
++| +||..+++++ .....++++||++ +++|.+++.. ....+++..++.+++||+.||.|||+++ |
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 345 5777788776 2334567788887 5799999964 2456999999999999999999999999 9
Q ss_pred EeccCCCCcEEEcCCCc-------------------eEEcccCCcccCCCCCc--------------ceeeecccccccc
Q 022482 195 IYRDLKCSNILLGEGYH-------------------PKLSDFGLAKLGPVGDK--------------THVSTRVMGTYGY 241 (296)
Q Consensus 195 vHrdikp~Nili~~~~~-------------------~kl~Dfg~~~~~~~~~~--------------~~~~~~~~gt~~y 241 (296)
+||||||+|||++..+. +|++|||+++....... .......+||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999965444 55555555542110000 0001113588999
Q ss_pred cCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 242 ~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+|||++.+..++.++|||||||++|||++|.+|+...
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-24 Score=187.33 Aligned_cols=203 Identities=38% Similarity=0.560 Sum_probs=170.7
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCC-cccceeeEEecCCceEEEEe
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHP-NLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~I~~~~~~~~~~~~~~lv~e 146 (296)
|.+.+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 678889999999999999987 67899988765433 356788999999999988 79999999977777899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~~~ 225 (296)
++.++++.+++...... ..++......++.|++.++.++|+.+ ++|||+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777542111 37899999999999999999999999 99999999999999988 799999999874333
Q ss_pred CCcce----eeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTH----VSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..... ......|+..|++||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 32221 2355789999999999987 5788899999999999999999999776654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=182.70 Aligned_cols=172 Identities=12% Similarity=0.124 Sum_probs=132.6
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHH---------HHHHHHHHhhcCCCcccceeeEE
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---------FLVEVLMLSLLHHPNLVNLIGYC 135 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~h~~I~~~~~~~ 135 (296)
.-+.++|++.+.+|.|+||.||++.+ ++..+|+|++.......... +.+|+..+..+.||+|..+.+++
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 35678999999999999999999755 36679999997543332222 57888899999999999999886
Q ss_pred ecC--------CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 136 ADG--------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 136 ~~~--------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
... ...+++|||++|.+|.++.. +++ ....+++.++..+|+.+ ++|||++|+||+++
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~ 169 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVS 169 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEe
Confidence 643 35789999999999988731 222 24568999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHH
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 268 (296)
++| ++|+|||........... ........|..++|+||||+++..+
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred CCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 988 999999988643211100 1133344567789999999998654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=174.31 Aligned_cols=138 Identities=15% Similarity=0.067 Sum_probs=108.2
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcc--h-------h-----------------HHHHHHHHHHhhcCCCc
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--G-------N-----------------REFLVEVLMLSLLHHPN 127 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~ 127 (296)
...||+|++|.||+|.+. +|+.||||+++..... . . .....|+..+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999987 7999999998654221 1 0 11234889999998887
Q ss_pred ccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEeccCCCCcEEE
Q 022482 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL-HDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 128 I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~l-H~~~~~~ivHrdikp~Nili 206 (296)
+........ ...++||||++|+++...... ...+++..+..++.|++.+|.++ |+.+ |+||||||+||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 754433322 234899999998776554322 35688899999999999999999 6889 9999999999999
Q ss_pred cCCCceEEcccCCccc
Q 022482 207 GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~ 222 (296)
+ ++.++|+|||++..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-25 Score=207.14 Aligned_cols=205 Identities=25% Similarity=0.357 Sum_probs=167.4
Q ss_pred cCC-CccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhH----HHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 69 KNF-RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNR----EFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~----~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
+.| ....++|.|++|.|+.+......+.++.|.+... ...... .+..|+.+-..+.|||++..+..+.+....
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~ 396 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI 396 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence 345 5678899999998888887766666666654311 111111 145566777778999998888877777766
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+.+||||++ +|..++.. ...+...++-.++.|++.|++|+|+.| |.|||+||+|+++..+|.+||+|||.+.
T Consensus 397 ~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~ 468 (601)
T KOG0590|consen 397 LQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS 468 (601)
T ss_pred hhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence 667999998 99999865 357888999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc--eeeecccccccccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 222 LGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 222 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....+... ......+|+..|+|||++.+..|++. .||||.|+++++|.+|+.||......
T Consensus 469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccccc
Confidence 76665554 56667899999999999999999876 69999999999999999999765544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=167.96 Aligned_cols=140 Identities=16% Similarity=0.077 Sum_probs=110.4
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--------------------------hHHHHHHHHHHhhcCCC
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------------------------NREFLVEVLMLSLLHHP 126 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~h~ 126 (296)
+.+.||+|++|.||+|.+. +|+.||||+++...... ......|...+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 79999999987542110 11235788899999999
Q ss_pred cccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEE
Q 022482 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNIL 205 (296)
Q Consensus 127 ~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nil 205 (296)
++.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ .+ |+||||||+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 87555444333 34899999998755433211 3457788899999999999999999 89 999999999999
Q ss_pred EcCCCceEEcccCCcccC
Q 022482 206 LGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 206 i~~~~~~kl~Dfg~~~~~ 223 (296)
++ ++.++|+|||++...
T Consensus 151 l~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 151 YH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred EE-CCCEEEEEcccceec
Confidence 99 789999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=164.44 Aligned_cols=108 Identities=27% Similarity=0.254 Sum_probs=94.2
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
|+|.+++.. .+..+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||++......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 688888864 2456999999999999999999999886 999999999999999 9998753321
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 1258999999999999999999999999999999999999997654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=160.74 Aligned_cols=188 Identities=20% Similarity=0.149 Sum_probs=138.6
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCCcch----hHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEe
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG----NREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.+...|++|+||+|+++.. .+..++.+.+.....-. ...+.+|+.+|+.+. +++|++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998766 36677766665433211 124778999999995 5889999886 45799999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC-CCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL-KCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdi-kp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+.|.+|...... . ...++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998654311 1 1347789999999999999 999999 79999999999999999999985433
Q ss_pred CCcc---ee--------eecccccccccCccccccC-CCC-ccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKT---HV--------STRVMGTYGYCAPEYAMTG-QLT-LKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...- .. ......++.|++|+...-- ..+ ...+.++.|+-+|.++|++.|+....
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 00 1112367788888754321 233 46788899999999999998876443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-22 Score=161.33 Aligned_cols=137 Identities=21% Similarity=0.278 Sum_probs=108.5
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-----CCCcccceeeEEecCC---ceE-
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HHPNLVNLIGYCADGD---QRL- 142 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~I~~~~~~~~~~~---~~~- 142 (296)
.-.+.||+|++|.||. +..++.. +||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6666655 69998765555567789999999999 5799999999998874 333
Q ss_pred EEEec--CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeEeccCCCCcEEEcC----CCceEEc
Q 022482 143 LVYEY--MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL-EYLHDKANPPVIYRDLKCSNILLGE----GYHPKLS 215 (296)
Q Consensus 143 lv~e~--~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al-~~lH~~~~~~ivHrdikp~Nili~~----~~~~kl~ 215 (296)
+|||| +.+++|.+++.+ ..+++. ..++.|++.++ +|||+.+ |+||||||+|||++. +..++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557899999964 235555 35677888777 9999999 999999999999964 3379999
Q ss_pred c-cCCcc
Q 022482 216 D-FGLAK 221 (296)
Q Consensus 216 D-fg~~~ 221 (296)
| ||...
T Consensus 152 Dg~G~~~ 158 (210)
T PRK10345 152 DNIGEST 158 (210)
T ss_pred ECCCCcc
Confidence 9 55443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-23 Score=192.51 Aligned_cols=196 Identities=21% Similarity=0.229 Sum_probs=158.2
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~lv 144 (296)
...|.|.+.||+|+||.||.|...+ |+.||+|+-.+....+.-- -.+++.+|+ -+.|..+...+...+..++|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI---~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYI---CLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeee---hHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3568999999999999999999988 9999999986654432211 112222333 35566677777777888999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-------CCCceEEccc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-------EGYHPKLSDF 217 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-------~~~~~kl~Df 217 (296)
+||.+.|+|.+++. ..+.+++..++.++.|++..+..||..+ |||+||||+|+|+. +..-++|+||
T Consensus 773 ~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999996 3678999999999999999999999999 99999999999994 2335899999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 274 (296)
|.+...............++|-.+-=+|...|..++.++|.|.|+-+++.||.|+.-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 999754433333344456788888899999999999999999999999999999754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=168.58 Aligned_cols=206 Identities=19% Similarity=0.303 Sum_probs=133.1
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcC----------CCcccceeeEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLH----------HPNLVNLIGYCA 136 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~----------h~~I~~~~~~~~ 136 (296)
.+.....||.|+++.||.+.+..+++.+|+|++.... ....+.+.+|......+. |-.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455788999999999999999999999999885432 223345566655554432 223333333322
Q ss_pred ---------cC---C-----ceEEEEecCCCCCHHHHhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEe
Q 022482 137 ---------DG---D-----QRLLVYEYMPLGSLEDHLHD---LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196 (296)
Q Consensus 137 ---------~~---~-----~~~lv~e~~~~~sL~~~~~~---~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivH 196 (296)
.. . +.+++|+-+. ++|.+++.. ...............+..|+++.+++||+.| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 3367888875 788877542 1111122333444566799999999999999 999
Q ss_pred ccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccC--------CCCccchhHHHHHHHHHH
Q 022482 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--------QLTLKSDVYSFGVVLLEI 268 (296)
Q Consensus 197 rdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~~l~~l 268 (296)
+||+|+|++++.+|.++|+||+.... .+.... . ...+..|.+||..... .++.+.|.|+||+++|.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r--~g~~~~--~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVR--AGTRYR--C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEE--TTEEEE--G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHee--cCceee--c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999988764 222111 1 2345778999976432 467889999999999999
Q ss_pred HhCCCCCCCCCccccc
Q 022482 269 ITGRKAIDNTRAAGEH 284 (296)
Q Consensus 269 l~g~~pf~~~~~~~~~ 284 (296)
.||..||.-..+....
T Consensus 244 WC~~lPf~~~~~~~~~ 259 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADP 259 (288)
T ss_dssp HHSS-STCCCGGGSTS
T ss_pred HHccCCCCCCCccccc
Confidence 9999999977655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-23 Score=186.98 Aligned_cols=187 Identities=30% Similarity=0.427 Sum_probs=156.7
Q ss_pred cccccCceEEEEEEE---CCCCeEEEEEEecCCCcchh--HHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEecCC
Q 022482 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
++|+|+||.|++++. ...++.+|+|+..+...... .....|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998653 34577889988765432221 13345677777776 9999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
|+.|...+.. ...+.+.........++-|++.+|+.+ ++|||+|++||+++.+|++++.|||+++........
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999887754 556788888889999999999999999 999999999999999999999999999864333222
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
+||..|||||++. ....++|.||+|+++++|++|..||..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8999999999997 556789999999999999999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-21 Score=157.98 Aligned_cols=142 Identities=15% Similarity=0.108 Sum_probs=111.2
Q ss_pred CCCccccccccCceEEEEEE-ECCCCeEEEEEEecCCCcc------------------------hhHHHHHHHHHHhhcC
Q 022482 70 NFRADCLLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQ------------------------GNREFLVEVLMLSLLH 124 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 124 (296)
.|.+.+.||+|++|.||+|. +..+|+.||+|+++..... ....+..|+..++.+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48999999999999999998 6678999999998653211 0122467999999987
Q ss_pred CCc--ccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 022482 125 HPN--LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202 (296)
Q Consensus 125 h~~--I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~ 202 (296)
+.. ++++++. ...++||||+.|.+|...... ........+..++.|++.++.+||+.+. ++||||||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~ 178 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEY 178 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChh
Confidence 532 3344432 235899999998888765422 2345566778899999999999998875 999999999
Q ss_pred cEEEcCCCceEEcccCCccc
Q 022482 203 NILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 203 Nili~~~~~~kl~Dfg~~~~ 222 (296)
||+++ ++.++|+|||.+..
T Consensus 179 NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hEEEE-CCCEEEEEChhhhc
Confidence 99999 88999999999874
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.2e-22 Score=184.01 Aligned_cols=196 Identities=25% Similarity=0.250 Sum_probs=151.7
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHH---HHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNRE---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~---~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.|...+.||++.|=.|.+|++.. |. |+||++-+.. ....+. ..+|++ ...+++||.+++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 57778999999999999999875 55 8899885543 222333 344555 56678999999999988888889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc--C
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--G 223 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~--~ 223 (296)
+|+. .+|+|.+.. ..-+...+.+.|+.|++.||..+|..+ |+|+|||.+||||+.=+=+.|+||-.-+. .
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9985 899998854 344667788999999999999999999 99999999999999988899999976542 1
Q ss_pred ---CCCCcceeeecccccccccCccccccCC-----------CCccchhHHHHHHHHHHHh-CCCCCC
Q 022482 224 ---PVGDKTHVSTRVMGTYGYCAPEYAMTGQ-----------LTLKSDVYSFGVVLLEIIT-GRKAID 276 (296)
Q Consensus 224 ---~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~~ll~-g~~pf~ 276 (296)
.+.+..........-..|.|||.+.... .+++.||||+||++.||++ |++||.
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1122222222222345799999885421 4678999999999999988 899996
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-21 Score=182.03 Aligned_cols=175 Identities=29% Similarity=0.426 Sum_probs=130.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
....+|..++.|..|+||.||+++++.+.+.+|+| ++++... .+- ++.....|.++
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV---------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee----------------
Confidence 44568999999999999999999999999999994 4433221 111 22223334333
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+-...++. -+.++.. ++.|++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++.+-.
T Consensus 136 -----gDc~tllk~----~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 -----GDCATLLKN----IGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred -----chhhhhccc----CCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 333333332 1233322 267899999999 99999999999999999999999999864211
Q ss_pred CCc-------------ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccccc
Q 022482 226 GDK-------------THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH 284 (296)
Q Consensus 226 ~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~ 284 (296)
... ......++||+.|.|||++....|...+|+|++|+++|+.+-|..||.++++++.+
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 110 11122358999999999999999999999999999999999999999999877743
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-20 Score=149.71 Aligned_cols=134 Identities=22% Similarity=0.293 Sum_probs=112.4
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcch--------hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--------NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.||+|++|.||+|.+ .+..+++|+........ ...+.+|+.++..+.|++|+....++...+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 46778999865432211 1346789999999999998887777777788899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
|++|++|.+++... .. ....++.+++.+|.++|+.+ ++|||++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999988541 11 77889999999999999999 99999999999999 78999999999875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-21 Score=157.02 Aligned_cols=199 Identities=23% Similarity=0.410 Sum_probs=156.7
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
..+...|.+...|..|+|++..+. +++|++... .....++|.+|.-.|+.+.||||+.+++.+..+.+..+|..|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 455667889999999999998644 555665433 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEec-cCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYR-DLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHr-dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.|+|+..++. ...-..+..++.+++.+++++++|||+... ++-| -|....++|+++-+.+|. .+-.++
T Consensus 270 p~gslynvlhe--~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltaris-mad~kf----- 339 (448)
T KOG0195|consen 270 PFGSLYNVLHE--QTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARIS-MADTKF----- 339 (448)
T ss_pred cchHHHHHHhc--CccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhhee-ccccee-----
Confidence 99999999987 344556777899999999999999999863 5555 588999999998876654 122221
Q ss_pred cceeeecccccccccCccccccCCCC---ccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLT---LKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........-.|.|++||.++...-+ +++|+|||++++|||.|...||.+..+-+
T Consensus 340 -sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme 396 (448)
T KOG0195|consen 340 -SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME 396 (448)
T ss_pred -eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh
Confidence 1111223457899999999877543 46899999999999999999999876654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.7e-19 Score=145.98 Aligned_cols=130 Identities=23% Similarity=0.323 Sum_probs=105.6
Q ss_pred cccccCceEEEEEEECCCCeEEEEEEecCCCcc--------hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.||+|++|.||+|.. ++..+++|........ ....+.+|+.+++.+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 3678899986543211 124467899999999988766655555666778999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
++|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988743 110 78999999999999999 99999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=144.50 Aligned_cols=137 Identities=16% Similarity=0.040 Sum_probs=107.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc----------------------hhHHHHHHHHHHhhcCC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------------------GNREFLVEVLMLSLLHH 125 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h 125 (296)
...|.+.+.||+|+||.||++... +|+.+|||+++..... .......|+.++..+.+
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 334888999999999999999875 6899999987643210 01125678888888877
Q ss_pred Cc--ccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 126 PN--LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 126 ~~--I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
++ ++..++ ....++||||++|++|...... .....++.+++.++.++|+.+ ++||||+|+|
T Consensus 93 ~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred cCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 74 444443 2456899999999988765421 235678899999999999999 9999999999
Q ss_pred EEEcCCCceEEcccCCccc
Q 022482 204 ILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~ 222 (296)
|++++++.++|+|||.+..
T Consensus 156 ill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred EEEcCCCcEEEEECCcccc
Confidence 9999999999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-19 Score=164.40 Aligned_cols=140 Identities=23% Similarity=0.298 Sum_probs=112.1
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--Cc------chhHHHHHHHHHHhhcCCCcccceeeEEec
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GL------QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~ 137 (296)
.....|...+.||+|+||.||++.+.... +++|+.... .. .....+.+|+.+++.++|++++....+...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 33445677899999999999999876433 344432111 11 112457789999999999999888777777
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
....++||||++|++|.+++. ....++.|++.+|.+||+.+ ++||||||+||++ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999873 34678999999999999999 9999999999999 6779999999
Q ss_pred CCcccC
Q 022482 218 GLAKLG 223 (296)
Q Consensus 218 g~~~~~ 223 (296)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999863
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.7e-20 Score=159.41 Aligned_cols=124 Identities=28% Similarity=0.398 Sum_probs=105.3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
+.|+.|++|...+|.+|+... ......+...+..++.|+..|+.| ++ .+|+|+||.||++..+..++|.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr-~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRR-RTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCC-CcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999643 235667778889999999999999 77 99999999999999999999999999
Q ss_pred cccCCCCC----cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh
Q 022482 220 AKLGPVGD----KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270 (296)
Q Consensus 220 ~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~ 270 (296)
........ .........||..||+||.+.+..|+.++||||||++|+||+.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 86432222 1222344679999999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.3e-18 Score=135.40 Aligned_cols=135 Identities=19% Similarity=0.148 Sum_probs=96.1
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh--HH----------------------HHHHHHHHhhcCCCc-
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--RE----------------------FLVEVLMLSLLHHPN- 127 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~----------------------~~~e~~~l~~l~h~~- 127 (296)
+.+.||+|+||.||+|.+. +++.||||++........ .. ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 788999999865322111 11 124455555554332
Q ss_pred -ccceeeEEecCCceEEEEecCCCCCHHHH-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcE
Q 022482 128 -LVNLIGYCADGDQRLLVYEYMPLGSLEDH-LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNI 204 (296)
Q Consensus 128 -I~~~~~~~~~~~~~~lv~e~~~~~sL~~~-~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Ni 204 (296)
++++++. ...++||||++++.+... +... ... ..+..++.+++.++.++|. .+ ++||||+|+||
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Ni 146 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNI 146 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhE
Confidence 3444433 346899999998543211 1110 011 5678899999999999999 88 99999999999
Q ss_pred EEcCCCceEEcccCCccc
Q 022482 205 LLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~ 222 (296)
+++ ++.++|+|||.+..
T Consensus 147 li~-~~~~~liDfg~a~~ 163 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EEE-CCcEEEEECccccc
Confidence 999 88999999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-17 Score=126.81 Aligned_cols=135 Identities=21% Similarity=0.171 Sum_probs=112.1
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC--CcccceeeEEecCCceEEEEecCCC
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.+.||+|.++.||++.... ..+++|....... ...+..|+..++.+.+ ..+++++.+....+..+++|||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 45789999999999999864 6789999865433 4568889999999976 5889999888887889999999987
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..+..+ +......++.+++.++.++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 766443 4456677899999999999986433499999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-17 Score=136.61 Aligned_cols=135 Identities=21% Similarity=0.190 Sum_probs=103.6
Q ss_pred ccccc-ccCceEEEEEEECCCCeEEEEEEecCCCc-------------chhHHHHHHHHHHhhcCCCcc--cceeeEEec
Q 022482 74 DCLLG-EGGFGRVYKGRLESTNQVVAIKQLDRNGL-------------QGNREFLVEVLMLSLLHHPNL--VNLIGYCAD 137 (296)
Q Consensus 74 ~~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~I--~~~~~~~~~ 137 (296)
...|| .||.|+||.+... +..++||.+...+. .....+.+|+.++..+.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 34676 7888888888775 67789998854221 123457789999999998875 666666433
Q ss_pred CC-c---eEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 138 GD-Q---RLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 138 ~~-~---~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
.. . .++|||+++| .+|.+++.. ..+++. .+.|++.+|.+||+.| |+||||||.|||++.++.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 22 2 2599999997 689888753 234443 3678999999999999 9999999999999998899
Q ss_pred EEcccCCccc
Q 022482 213 KLSDFGLAKL 222 (296)
Q Consensus 213 kl~Dfg~~~~ 222 (296)
+|+|||.+..
T Consensus 182 ~LIDfg~~~~ 191 (239)
T PRK01723 182 WLIDFDRGEL 191 (239)
T ss_pred EEEECCCccc
Confidence 9999999975
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-19 Score=164.87 Aligned_cols=209 Identities=26% Similarity=0.306 Sum_probs=167.3
Q ss_pred cCCCccccccccCceEEEEEEECC-CCeEEEEEEecCCC--cchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 144 (296)
..|.+.+.||+|+|+.|-+..... ....+|.|.+.... ......+..|..+-+.+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 357788889999999998887643 34456667665443 222234455777777776 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCccc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-DKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKL 222 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH-~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~ 222 (296)
+++..|+++.+.+.. .....++...+...+.|+..++.|+| ..+ +.||||||+|.+++..+ .+++.|||++..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999888732 12225677788899999999999999 888 99999999999999999 999999999986
Q ss_pred CCC-CCcceeeecccc-cccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPV-GDKTHVSTRVMG-TYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
... ..........+| ++.|.|||...+. ...+..|+||+|+++..+++|..||+......
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 555 444444455678 9999999999885 44677899999999999999999998665444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.5e-17 Score=140.89 Aligned_cols=145 Identities=25% Similarity=0.282 Sum_probs=112.4
Q ss_pred CCCcccceeeEEec---------------------------CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 022482 124 HHPNLVNLIGYCAD---------------------------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIA 176 (296)
Q Consensus 124 ~h~~I~~~~~~~~~---------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~ 176 (296)
.||||+.+..+|.+ +...|+||..++ .+|.+++.. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999887643 234689999886 899999854 445667778899
Q ss_pred HHHHHHHHHHHcCCCCCeEeccCCCCcEEE--cCCC--ceEEcccCCcccCCCC----CcceeeecccccccccCccccc
Q 022482 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILL--GEGY--HPKLSDFGLAKLGPVG----DKTHVSTRVMGTYGYCAPEYAM 248 (296)
Q Consensus 177 ~ql~~al~~lH~~~~~~ivHrdikp~Nili--~~~~--~~kl~Dfg~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~ 248 (296)
.|+++|+.|||.++ |.|||+|.+|||+ ++++ .+.++|||+|--.... .........-|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999999 4444 4678999998532221 1222233356888899999885
Q ss_pred cCC------CCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 249 TGQ------LTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 249 ~~~------~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
... .-.++|.|+.|-+.||++....||..
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 421 12479999999999999999999987
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.6e-16 Score=139.83 Aligned_cols=158 Identities=32% Similarity=0.497 Sum_probs=130.0
Q ss_pred HhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-Eecc
Q 022482 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV-IYRD 198 (296)
Q Consensus 120 l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~i-vHrd 198 (296)
|+.+.|.|+.++++.+.+....+.|.+||..|+|.|.+.. ....+++.....+++.++.+|+|||+.. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 4568899999999999999999999999999999999875 4677888899999999999999999887 5 9999
Q ss_pred CCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCC-------CCccchhHHHHHHHHHHHhC
Q 022482 199 LKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ-------LTLKSDVYSFGVVLLEIITG 271 (296)
Q Consensus 199 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~~l~~ll~g 271 (296)
++..|.+++....+||.|||+.................-..-|.|||.+.+.. .+.+.|+||+|++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 99999999999999999999987653211111111122455699999997642 35679999999999999999
Q ss_pred CCCCCCCCcccc
Q 022482 272 RKAIDNTRAAGE 283 (296)
Q Consensus 272 ~~pf~~~~~~~~ 283 (296)
+.||+.......
T Consensus 155 ~~~~~~~~~~~~ 166 (484)
T KOG1023|consen 155 SGPFDLRNLVED 166 (484)
T ss_pred cCccccccccCC
Confidence 999987554443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.2e-15 Score=134.67 Aligned_cols=170 Identities=18% Similarity=0.201 Sum_probs=130.3
Q ss_pred EEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCC
Q 022482 87 KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166 (296)
Q Consensus 87 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~ 166 (296)
.|..+.++..|.|+..............+-+..|+.++||+|+++++.++..+..|+|+|.+ ..|..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 46667778889999887654444455777889999999999999999999999999999997 567777755
Q ss_pred CCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccc
Q 022482 167 LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246 (296)
Q Consensus 167 ~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 246 (296)
+....+...+.||+.||.+||+.+. ++|++|....|+++..|.+||++|.++........ .......-..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 3366778889999999999985544 99999999999999999999999998753222111 1111112223566665
Q ss_pred cccCCCCccchhHHHHHHHHHHHhC
Q 022482 247 AMTGQLTLKSDVYSFGVVLLEIITG 271 (296)
Q Consensus 247 ~~~~~~~~~~DiwslG~~l~~ll~g 271 (296)
+.... -..|.|-|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 53332 356999999999999999
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.1e-15 Score=136.15 Aligned_cols=146 Identities=18% Similarity=0.133 Sum_probs=95.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch----------------------------------hH--
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG----------------------------------NR-- 111 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------~~-- 111 (296)
...|+. +.||+|++|.||+|+.+.+|+.||||+.++.-... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 78999999999999999889999999997542100 01
Q ss_pred ----HHHHHHHHHhhcC----CCcccceeeEEec-CCceEEEEecCCCCCHHHHh--ccCCCCCCCCCHHHHHHHHHHHH
Q 022482 112 ----EFLVEVLMLSLLH----HPNLVNLIGYCAD-GDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAA 180 (296)
Q Consensus 112 ----~~~~e~~~l~~l~----h~~I~~~~~~~~~-~~~~~lv~e~~~~~sL~~~~--~~~~~~~~~~~~~~~~~i~~ql~ 180 (296)
++.+|+..+..+. +...+.+-.++.+ ....++||||++|+.+.+.. .........+.+..+..++.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1233333333332 3333333333332 45678999999999998742 21111111244444444555544
Q ss_pred HHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcccCCcccCC
Q 022482 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSDFGLAKLGP 224 (296)
Q Consensus 181 ~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~Dfg~~~~~~ 224 (296)
..| ++|+|++|.||+++.++ .++++|||++....
T Consensus 278 -------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 -------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred -------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 578 99999999999999888 99999999987543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.5e-14 Score=129.97 Aligned_cols=140 Identities=21% Similarity=0.169 Sum_probs=95.3
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchh----------------------------------------HHH
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----------------------------------------REF 113 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~ 113 (296)
.+.||+|++|.||+|+.. +|+.||||+.++.-.... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 467999999999999876 589999999865421100 013
Q ss_pred HHHHHHHhhcC-----CCcccceeeEE-ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHH
Q 022482 114 LVEVLMLSLLH-----HPNLVNLIGYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-GLEYL 186 (296)
Q Consensus 114 ~~e~~~l~~l~-----h~~I~~~~~~~-~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~-al~~l 186 (296)
.+|...+..+. ++++ .+-.++ ......++||||++|.+|.++.... ..... ...++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHH
Confidence 33444444432 2332 222222 2245678999999999998876421 11122 2345555555 47889
Q ss_pred HcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 187 H~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|..| ++|+|++|.||++++++.++++|||++....
T Consensus 274 ~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 274 LRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999 9999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=4.5e-14 Score=111.14 Aligned_cols=131 Identities=18% Similarity=0.070 Sum_probs=96.3
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCCCCC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~~~s 152 (296)
.+.|+.|..+.||++... +..+++|....... ....+..|+..++.+.+.++ ++++.+. ....++|||+++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence 356889999999999875 77899998754422 12345688888888865554 4455443 234589999999887
Q ss_pred HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 153 LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 153 L~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~--~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+.+.. .....++.+++.+|+.||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 75430 011335678999999999987 22249999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.9e-14 Score=127.14 Aligned_cols=204 Identities=26% Similarity=0.260 Sum_probs=162.2
Q ss_pred HhcCCCccccccc--cCceEEEEEEE--CCCCeEEEEEE--ecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCC
Q 022482 67 VTKNFRADCLLGE--GGFGRVYKGRL--ESTNQVVAIKQ--LDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~--~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~ 139 (296)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|. +..........-.+|+...+..+ |++.++.+..+...+
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 4456788899999 99999999988 77888999997 33333333344456666666664 899999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEE
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKL 214 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~----al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl 214 (296)
..++-+|++ +.+|..+.+. ...-++...++..+.+... |+..+|+.+ ++|-|+||.||++..+ ...++
T Consensus 192 ~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 192 ILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeec
Confidence 999999998 4888888765 2344788889999999999 999999999 9999999999999888 88999
Q ss_pred cccCCcccCCCCCc---ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 215 SDFGLAKLGPVGDK---THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+|||+......... .....+..|...|++||... +.++..+|++|+|-++.+..+|..+....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCC
Confidence 99999875443331 11123336888999999874 47888999999999999999988877654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=6.2e-13 Score=105.86 Aligned_cols=136 Identities=15% Similarity=0.091 Sum_probs=98.5
Q ss_pred cccccccCceEEEEEEECC------CCeEEEEEEecCCC----------------------cchhHH----HHHHHHHHh
Q 022482 74 DCLLGEGGFGRVYKGRLES------TNQVVAIKQLDRNG----------------------LQGNRE----FLVEVLMLS 121 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~----------------------~~~~~~----~~~e~~~l~ 121 (296)
...||.|--+.||.|.... .+..+|||+.+... ...... ..+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998654 35789999874210 000112 247889998
Q ss_pred hcCC--CcccceeeEEecCCceEEEEecCCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeEec
Q 022482 122 LLHH--PNLVNLIGYCADGDQRLLVYEYMPLGSLED-HLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL-HDKANPPVIYR 197 (296)
Q Consensus 122 ~l~h--~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~-~~~~~~~~~~~~~~~~~~~i~~ql~~al~~l-H~~~~~~ivHr 197 (296)
.+.. -.+++++++ ...++||||+.+..+.. .+.. ..++...+..+..+++.+|..| |..+ ++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8864 356666654 56789999997543321 1221 2344556777889999999998 8889 9999
Q ss_pred cCCCCcEEEcCCCceEEcccCCccc
Q 022482 198 DLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 198 dikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
||++.||++++ +.+.|+|||.+..
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCcee
Confidence 99999999974 6899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.8e-12 Score=97.77 Aligned_cols=131 Identities=24% Similarity=0.298 Sum_probs=100.2
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc-----ch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..+++|+-+.++.+... |..+++|.-.+... .. ..+..+|+.++..+.--.|.-.+-+..+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999664 44466664322211 11 1235678999999887777776667778888899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
|++|..|.+++... ...++..+-..+.-||..+ |+|+||.++||+++.++ +.++|||++.+
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888651 1346666777788899999 99999999999998775 99999999985
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=4.3e-12 Score=97.71 Aligned_cols=144 Identities=22% Similarity=0.229 Sum_probs=108.3
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEecCCC-----cc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+..+-+|+-+.|+++.+. |+.++||.-.... .. ...+..+|+.+|.++.--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678999999999999886 7877887532211 11 124567899999988766776666667777788899
Q ss_pred EecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEcccCCc
Q 022482 145 YEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLA 220 (296)
Q Consensus 145 ~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~Dfg~~ 220 (296)
|||++| .++.+++... ............++.++-+.+.-||..+ |+|+||..+||++..++ .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999986 3788887652 2223333344778899999999999999 99999999999996544 3589999999
Q ss_pred ccC
Q 022482 221 KLG 223 (296)
Q Consensus 221 ~~~ 223 (296)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.5e-11 Score=100.95 Aligned_cols=142 Identities=20% Similarity=0.240 Sum_probs=107.2
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCC--cccceeeEEecCC---ceEEEEecC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHP--NLVNLIGYCADGD---QRLLVYEYM 148 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~---~~~lv~e~~ 148 (296)
+.|+.|..+.+|++.... |+.+++|....... .....+..|..+++.+.+. .+++++.+..... ..++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998754 57899998765432 1345678899999998764 4567777765542 568999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-------------------------------------- 190 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~-------------------------------------- 190 (296)
+|.++.+.+.. ..+++.....++.+++++|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888765421 34666777778888888888888531
Q ss_pred ---------------CCCeEeccCCCCcEEEcC--CCceEEcccCCccc
Q 022482 191 ---------------NPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKL 222 (296)
Q Consensus 191 ---------------~~~ivHrdikp~Nili~~--~~~~kl~Dfg~~~~ 222 (296)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235899999999999988 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-12 Score=108.97 Aligned_cols=157 Identities=26% Similarity=0.356 Sum_probs=118.9
Q ss_pred HHHHhhcCCCcccceeeEEecC-----CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Q 022482 117 VLMLSLLHHPNLVNLIGYCADG-----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191 (296)
Q Consensus 117 ~~~l~~l~h~~I~~~~~~~~~~-----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~ 191 (296)
...|-++-|.||++++.++.+. ....++.||+..|+|..++++...+...+......+|+.|++.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3455567799999999887653 3568899999999999999987777888999999999999999999999986
Q ss_pred CCeEeccCCCCcEEEcCCCceEEcccCCccc--CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHH
Q 022482 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEII 269 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll 269 (296)
++|+|+++..+-|++..+|-+|+.----... ..............+-+.|.+||.=..-..+..+|||++|....+|.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7899999999999999888777652111100 00000111112234678899999755556677899999999999998
Q ss_pred hCCCC
Q 022482 270 TGRKA 274 (296)
Q Consensus 270 ~g~~p 274 (296)
.|..-
T Consensus 277 ilEiq 281 (458)
T KOG1266|consen 277 ILEIQ 281 (458)
T ss_pred Hheec
Confidence 77654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.2e-13 Score=128.09 Aligned_cols=210 Identities=21% Similarity=0.212 Sum_probs=154.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+.+.+.+-+-+|+++.++.+.-..++...++|+........ .+..+.+-.++-.-++|-++.....+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 346777888999999999999888888777776553322111 12222333333333456666555555556778999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc-C
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL-G 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~-~ 223 (296)
++|+.+++|...++.. ...+.+-....+..+..++++||... +.|||++|.|+++..++..++.|||.... .
T Consensus 883 ~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999998763 23455555667777889999999998 99999999999999999999999984221 0
Q ss_pred CC---------------------CC-------cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 022482 224 PV---------------------GD-------KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (296)
Q Consensus 224 ~~---------------------~~-------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 275 (296)
-. .. .........||+.|.+||...+......+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 00 001123357999999999999999999999999999999999999999
Q ss_pred CCCCccccc
Q 022482 276 DNTRAAGEH 284 (296)
Q Consensus 276 ~~~~~~~~~ 284 (296)
.+..+...+
T Consensus 1036 na~tpq~~f 1044 (1205)
T KOG0606|consen 1036 NAETPQQIF 1044 (1205)
T ss_pred CCcchhhhh
Confidence 988876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.4e-12 Score=116.46 Aligned_cols=197 Identities=24% Similarity=0.230 Sum_probs=148.2
Q ss_pred HhcCCCccccccccCceEEEEEEEC-CCCeEEEEEEecCCCcchhHH--HHHHHHHHhhcC-CCcccceeeEEecCCceE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLE-STNQVVAIKQLDRNGLQGNRE--FLVEVLMLSLLH-HPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~ 142 (296)
...+|..+..||.|.|+.|+.+... .++..|++|.....-.....+ -..|+.+...+. |.+++.++..+...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3456888899999999999987755 677889999775443332222 245666666664 889999988888888888
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCCcc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAK 221 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~~~ 221 (296)
+-.|||.++++..... ....+.+...+.+..|++.++.++|+.. ++|+|++|+||++..+ +.-++.|||++.
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 9999999998877662 2456778888999999999999999999 9999999999999875 778899999986
Q ss_pred cCCCCCcceeeeccccccccc--CccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYC--APEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 275 (296)
..... .....+..+++ ++.......+..+.|++|||..+.+.++|...-
T Consensus 416 ~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 416 RLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred cccee-----cccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 31111 11122334444 444444556778999999999999998876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.2e-11 Score=93.08 Aligned_cols=124 Identities=21% Similarity=0.173 Sum_probs=81.2
Q ss_pred EEEEEEECCCCeEEEEEEecCCCc----------------------c----hhHHHHHHHHHHhhcCCC--cccceeeEE
Q 022482 84 RVYKGRLESTNQVVAIKQLDRNGL----------------------Q----GNREFLVEVLMLSLLHHP--NLVNLIGYC 135 (296)
Q Consensus 84 ~V~~~~~~~~~~~vaiK~~~~~~~----------------------~----~~~~~~~e~~~l~~l~h~--~I~~~~~~~ 135 (296)
.||.|.... |..+|+|+.+.... . ......+|...|..+..- ++++++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388898754 77899998753110 0 012357899999999865 466676552
Q ss_pred ecCCceEEEEecCC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 136 ADGDQRLLVYEYMP--LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY-LHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 136 ~~~~~~~lv~e~~~--~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~-lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
...+||||+. |..+..+... .++......++.+++..+.. +|..| |+|+|+++.||+++++ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 4579999998 6555544322 11134456677888885555 57888 9999999999999988 99
Q ss_pred EEcccCCccc
Q 022482 213 KLSDFGLAKL 222 (296)
Q Consensus 213 kl~Dfg~~~~ 222 (296)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.6e-10 Score=99.72 Aligned_cols=171 Identities=19% Similarity=0.215 Sum_probs=131.8
Q ss_pred ceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec----CCceEEEEecCCC-CCHHHH
Q 022482 82 FGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLVYEYMPL-GSLEDH 156 (296)
Q Consensus 82 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~~lv~e~~~~-~sL~~~ 156 (296)
-.+.|++....+|..|++|+++............-+.+++++.|+||+++.++|.. +..+++|++|+++ .+|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789999999999999999955444433344456788999999999999998873 4567899999875 477776
Q ss_pred hccC-----------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 157 LHDL-----------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 157 ~~~~-----------~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
.... ...+...+++.+|.++.|+..||.++|+.| +..+-|.|.+|+++.+.+++|...|...+...
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 5432 123455788999999999999999999999 99999999999999888999988887765433
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~p 274 (296)
.. . |-+.. ..+-|.=.||.++..|.||..-
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 32 0 11211 2356889999999999999654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.9e-10 Score=93.64 Aligned_cols=139 Identities=17% Similarity=0.092 Sum_probs=97.7
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcch-----------hHHHHHHHHHHhhcCCCccc--ceeeEEec-----C
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----------NREFLVEVLMLSLLHHPNLV--NLIGYCAD-----G 138 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~I~--~~~~~~~~-----~ 138 (296)
+-......|+++.. .|+.|.||......... ...+.+|...+..|...+|. .++.+.+. .
T Consensus 30 v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 30 FRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 33333344666654 37789999764332110 11367888888887654443 33444432 2
Q ss_pred CceEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-------CC
Q 022482 139 DQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-------GY 210 (296)
Q Consensus 139 ~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-------~~ 210 (296)
...++|||++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++. +.
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 3468999999876 7998875321 234566777889999999999999999 999999999999975 46
Q ss_pred ceEEcccCCccc
Q 022482 211 HPKLSDFGLAKL 222 (296)
Q Consensus 211 ~~kl~Dfg~~~~ 222 (296)
.+.|+||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999999863
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.3e-10 Score=97.06 Aligned_cols=197 Identities=14% Similarity=0.177 Sum_probs=129.2
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeE----E--ecC-CceEEE
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY----C--ADG-DQRLLV 144 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~----~--~~~-~~~~lv 144 (296)
.....||+|+-+.+|-.-.- +. .+.|++.........+...|+ .+--.||-+..=+.| . .+. ...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Pppa~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPPAAQAQKVAEL--AATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCchHHHHHHHHh--ccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34677999999999865332 12 345888766554433333322 112245533221111 1 112 225678
Q ss_pred EecCCCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 145 YEYMPLGS-LEDHLHD--LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~s-L~~~~~~--~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
|+.+.|.. +..++.- ....-....|..+.+..+.++.|.+.||+.| .+-+|+.++|+|+++++.+.|+|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88887652 3333321 1111234678889999999999999999999 9999999999999999999999744332
Q ss_pred cCCCCCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhC-CCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITG-RKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~ 279 (296)
+. .......-.+|.+.|.+||... +..-+...|.|.||+++++||.| ++||++.-
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~ 226 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIP 226 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccc
Confidence 21 1222233357999999999765 23456779999999999999986 99998654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.2e-10 Score=92.18 Aligned_cols=135 Identities=19% Similarity=0.103 Sum_probs=102.1
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc----------------------hhHHHHHHHHHHhhcCCC--
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------------------GNREFLVEVLMLSLLHHP-- 126 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~-- 126 (296)
+.+...||-|--+.||.|.+.+ |..+|||.-+....+ ......+|...|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~-g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPK-GRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECCC-CCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 5677899999999999999875 788999975321100 112357899999988755
Q ss_pred cccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 127 ~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
.+++.+++ +...+|||+++|-.|...- +.......++..++.-+.-+-..| |||+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 67777776 5678999999986665432 123344556666666666666888 9999999999999
Q ss_pred cCCCceEEcccCCccc
Q 022482 207 GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~ 222 (296)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999988763
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.7e-09 Score=85.22 Aligned_cols=106 Identities=24% Similarity=0.248 Sum_probs=82.6
Q ss_pred hHHHHHHHHHHhhcCCCc--ccceeeEEecC----CceEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHH
Q 022482 110 NREFLVEVLMLSLLHHPN--LVNLIGYCADG----DQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182 (296)
Q Consensus 110 ~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~----~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~a 182 (296)
.....+|...+..|..-+ +++.+.+.... ...++|+|++++. +|.+++... ...+......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 345678888777775443 34555555442 2357999999874 799988652 225666778899999999
Q ss_pred HHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEcccCCccc
Q 022482 183 LEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLAKL 222 (296)
Q Consensus 183 l~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~Dfg~~~~ 222 (296)
+.-||..| |+|+|++|.|||++.++ .+.++||+.+..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999998887 899999998875
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.4e-08 Score=79.12 Aligned_cols=138 Identities=14% Similarity=0.103 Sum_probs=100.5
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecC---CC---cchhHHHHHHHHHHhhcCCCc--ccceeeEEe---c--CCceEE
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDR---NG---LQGNREFLVEVLMLSLLHHPN--LVNLIGYCA---D--GDQRLL 143 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~---~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~---~--~~~~~l 143 (296)
-|.||.+.|+..... |+.+-+|.-.. .. +.....+.+|+..|+.+..-+ ++++. ++. . ....+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 456888899987665 44688886531 01 234567899999999886433 44444 222 1 123578
Q ss_pred EEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc--eEEcccCCc
Q 022482 144 VYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~--~kl~Dfg~~ 220 (296)
|+|-+.| .+|.+++... ...+.+......++.+++.++.-||..+ +.|+|+.+.||+++.++. +.++||..+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9997753 5888887542 2335677777899999999999999999 999999999999986667 999999887
Q ss_pred cc
Q 022482 221 KL 222 (296)
Q Consensus 221 ~~ 222 (296)
+.
T Consensus 178 r~ 179 (216)
T PRK09902 178 RR 179 (216)
T ss_pred ch
Confidence 63
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.4e-09 Score=96.37 Aligned_cols=140 Identities=18% Similarity=0.146 Sum_probs=90.4
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchh----------------------------------------HHHH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN----------------------------------------REFL 114 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~ 114 (296)
+.|+.++-|.||.|...+ |+.||||+.+++-.... -++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999887 99999999865311100 0133
Q ss_pred HHHHHHhhcC-----CCcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHHc
Q 022482 115 VEVLMLSLLH-----HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG-LEYLHD 188 (296)
Q Consensus 115 ~e~~~l~~l~-----h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~a-l~~lH~ 188 (296)
+|...+..++ .+++.-..-+++....-.++|||++|..+.+...- ....++... ++..++++ +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~---ia~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL---KSAGIDRKE---LAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH---HhcCCCHHH---HHHHHHHHHHHHHHh
Confidence 4444444432 23322222222335677899999999988887421 113333222 22222222 233334
Q ss_pred CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 189 ~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
.| ++|.|..|.||+++.+|++.+.|||+.....
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 67 9999999999999999999999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.6e-07 Score=77.36 Aligned_cols=140 Identities=15% Similarity=0.168 Sum_probs=86.0
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccceeeEEecCCceEEEEecCCCCC
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~~~~~lv~e~~~~~s 152 (296)
..||+|..+.||+.. +..+++|..+... ....+.+|...++.+..-. +++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 468999999999842 4457788876532 3355788999998886443 4677888777777889999999863
Q ss_pred -HHHH---------------------hccCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHc-CCCCCeEecc
Q 022482 153 -LEDH---------------------LHDLPPDKKRLDWTTRMRIAA----------GAAK-GLEYLHD-KANPPVIYRD 198 (296)
Q Consensus 153 -L~~~---------------------~~~~~~~~~~~~~~~~~~i~~----------ql~~-al~~lH~-~~~~~ivHrd 198 (296)
+... ++........++.. ...+.. .+.. ...+|.. .....++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 11111111111110 000100 0011 1112221 1223579999
Q ss_pred CCCCcEEEcCCCceEEcccCCccc
Q 022482 199 LKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 199 ikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+.|.||++++++ +.++||+.+..
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999888 99999998874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.79 E-value=1e-07 Score=76.66 Aligned_cols=138 Identities=12% Similarity=0.101 Sum_probs=90.1
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHH---------HHHHHHHHhhc---CCCcccceee
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---------FLVEVLMLSLL---HHPNLVNLIG 133 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l---~h~~I~~~~~ 133 (296)
-+..+|.+.+++-......|.+.... |+.+++|..+.......+. ..+.+..+..+ .......++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45567888888888887777666543 7889999875433222221 12222222222 2233333332
Q ss_pred EE-----ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 134 YC-----ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 134 ~~-----~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
+. ......+++|||++|..|.+... +++ .+...+..++.-||+.| ++|+|..|.|+++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 22 22345578999999988876531 222 24456777899999999 999999999999986
Q ss_pred CCceEEcccCCcc
Q 022482 209 GYHPKLSDFGLAK 221 (296)
Q Consensus 209 ~~~~kl~Dfg~~~ 221 (296)
+ .++++||+.-+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 5 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.69 E-value=3.2e-09 Score=96.05 Aligned_cols=187 Identities=18% Similarity=0.109 Sum_probs=139.6
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc-ccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~lv~e~~ 148 (296)
.|....-+++|+++.+++.+...+...+ .+.+... ....-++.+|.+++||| .+..++-+..++..++.|+++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 3555666899999999999887766554 5655322 45567889999999999 777777788888999999999
Q ss_pred CCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 149 PLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 149 ~~~-sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
.++ +...-+. .....+...+...+++.-.++++++|+.- =+|+| ||+..+ +..+..||+.........
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 876 2222111 12334555566677788889999999886 58888 777655 588999999886544332
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
......+++.++|||+...+.+....|.|++|+-..++--|-+|-.
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3345679999999999999999999999999987777777776654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6.2e-07 Score=73.07 Aligned_cols=155 Identities=17% Similarity=0.093 Sum_probs=102.5
Q ss_pred ccccCHHHHHHHhcCCCcccccc---ccCceEEEEEEECCCCeEEEEEEecCCCcchh-------------------H--
Q 022482 56 AHTFTFRELAAVTKNFRADCLLG---EGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-------------------R-- 111 (296)
Q Consensus 56 ~~~~~~~~~~~~~~~y~~~~~lg---~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------------~-- 111 (296)
....+...+..+..+..+....| +|--+.||+|... ++..+|+|++......-. .
T Consensus 32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~l 110 (268)
T COG1718 32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKL 110 (268)
T ss_pred hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHH
Confidence 34455667777778777766655 5666789998764 478899999853221110 1
Q ss_pred ---HHHHHHHHHhhcC--CCcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 022482 112 ---EFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186 (296)
Q Consensus 112 ---~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~l 186 (296)
....|+..|+.+. +-.+++.+.+. ...|||||+... ..-.-. -..-++...++..+..++++.+.-|
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~--g~pAP~--LkDv~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDD--GLPAPR--LKDVPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCC--CCCCCC--cccCCcCchhHHHHHHHHHHHHHHH
Confidence 1345666666664 33455566554 447999998532 110000 0122233346777888888888888
Q ss_pred Hc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 187 HD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 187 H~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
-. .+ +||+||+.-|||+. ++.+.++|||-+...
T Consensus 183 ~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 183 YKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHhcC---cccccchhhheEEE-CCeEEEEECcccccc
Confidence 87 67 99999999999999 779999999998743
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.2e-09 Score=94.99 Aligned_cols=99 Identities=25% Similarity=0.397 Sum_probs=75.7
Q ss_pred HHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc-ce------eeecccccccccCccccccC
Q 022482 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK-TH------VSTRVMGTYGYCAPEYAMTG 250 (296)
Q Consensus 178 ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~------~~~~~~gt~~y~aPE~~~~~ 250 (296)
+++.|+.|+|...+ +||++|.|++|.++..+.+||+.|+.+........ .. ...-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34489999998765 99999999999999999999999998864322111 00 00112346789999999888
Q ss_pred CCCccchhHHHHHHHHHHHh-CCCCCCCC
Q 022482 251 QLTLKSDVYSFGVVLLEIIT-GRKAIDNT 278 (296)
Q Consensus 251 ~~~~~~DiwslG~~l~~ll~-g~~pf~~~ 278 (296)
..+.++|++|+||++|.+.. |+..+...
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhcc
Confidence 88899999999999999984 66555544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.9e-07 Score=73.85 Aligned_cols=141 Identities=21% Similarity=0.196 Sum_probs=84.2
Q ss_pred ccccCc-eEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEecCCCCCHH
Q 022482 77 LGEGGF-GRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (296)
Q Consensus 77 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~ 154 (296)
|..|.. ..||++... +..+.+|+..... ...+.+|+.+++.+. +--+++++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 444544 789998654 3567888875442 345667888888774 334567777777666789999999988776
Q ss_pred HHh-------------------ccCCCCCCCCCHH--HHHHH-----------------------HHHHHHHHHHHH-cC
Q 022482 155 DHL-------------------HDLPPDKKRLDWT--TRMRI-----------------------AAGAAKGLEYLH-DK 189 (296)
Q Consensus 155 ~~~-------------------~~~~~~~~~~~~~--~~~~i-----------------------~~ql~~al~~lH-~~ 189 (296)
... +........+... ..... ..++...|.... ..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111111111100 00000 111111111111 11
Q ss_pred CCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 190 ~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
....++|+|+.|.||++++++.+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 223499999999999999987788999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.2e-07 Score=74.39 Aligned_cols=145 Identities=21% Similarity=0.218 Sum_probs=83.0
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC--cccceeeEEec---CCceEEEEecC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP--NLVNLIGYCAD---GDQRLLVYEYM 148 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~---~~~~~lv~e~~ 148 (296)
++.|+.|..+.||++.... + .+++|..... .....+..|..+++.+... -+++++..... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 3568899999999998876 4 7889997544 4456777888888887533 35566654322 23468999999
Q ss_pred CCCCHHH----------------Hh---ccCCCCCCCCCHHH---H------HHH------------HHHHHH-HHHHHH
Q 022482 149 PLGSLED----------------HL---HDLPPDKKRLDWTT---R------MRI------------AAGAAK-GLEYLH 187 (296)
Q Consensus 149 ~~~sL~~----------------~~---~~~~~~~~~~~~~~---~------~~i------------~~ql~~-al~~lH 187 (296)
+|..+.. .+ +........+.... . ... ...+.. .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9887777 11 11111111111110 0 000 011111 223333
Q ss_pred c----CCCCCeEeccCCCCcEEEc-CCCceEEcccCCccc
Q 022482 188 D----KANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKL 222 (296)
Q Consensus 188 ~----~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~~ 222 (296)
. .....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 1234499999999999999 666678999998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=67.13 Aligned_cols=129 Identities=19% Similarity=0.164 Sum_probs=93.4
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCccc-ceeeEEecCCceEEEEecCCC
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~-~~~~~~~~~~~~~lv~e~~~~ 150 (296)
...+.|++|.+|.||++.+. |..+|+|+-+.++ ....+..|+++|..+.-.++. ++|.+.. .++.|||+.|
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G 96 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDG 96 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcC
Confidence 45678999999999999987 5678999876543 356788899999988766654 3444432 3455999998
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC-CCcEEEcCCCceEEcccCCccc
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK-CSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdik-p~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..|.+.... .+..++ ..++.+..-|...| |-|+.|+ |...++..++.+.|+||..|.+
T Consensus 97 ~~L~~~~~~-------~~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 97 RPLGKLEIG-------GDRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cchhhhhhc-------ccHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 888776532 122333 33455555677778 9999987 6666666666999999999984
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.52 E-value=2.6e-06 Score=68.32 Aligned_cols=133 Identities=22% Similarity=0.231 Sum_probs=92.7
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCC----------------cchhHHHHHHHHHHhhcC------CCcccce
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----------------LQGNREFLVEVLMLSLLH------HPNLVNL 131 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~~I~~~ 131 (296)
...||+|+.-.||.--+ +...+||+..... ........+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~---dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD---DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCC---CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45799999999986433 4446789887654 122345666776665555 7899999
Q ss_pred eeEEecCCceEEEEecCCC------CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEE
Q 022482 132 IGYCADGDQRLLVYEYMPL------GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (296)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~------~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nil 205 (296)
+++.+++-..-+|+|.+.. .+|.+++.. ..+++ .+. ..+-.-..+|-+.+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998632 378888843 44555 333 33444556778888 999999999999
Q ss_pred EcCC---C-ceEEcc-cCCcc
Q 022482 206 LGEG---Y-HPKLSD-FGLAK 221 (296)
Q Consensus 206 i~~~---~-~~kl~D-fg~~~ 221 (296)
+... . .+.|+| ||...
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 9432 2 577776 45443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.5e-06 Score=82.23 Aligned_cols=79 Identities=15% Similarity=0.234 Sum_probs=56.6
Q ss_pred cccccccCceEEEEEEECCCC--eEEEEEEecCCCc-chhHHHHHHHHHHhhcC-CCcc--cceeeEEecC---CceEEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGL-QGNREFLVEVLMLSLLH-HPNL--VNLIGYCADG---DQRLLV 144 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~I--~~~~~~~~~~---~~~~lv 144 (296)
.+.++.|.+..+|+......+ ..+++|+.+.... .....+.+|+.+++.+. |+++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 566888999999998765432 4677887654322 23456889999999985 6665 6777776654 467899
Q ss_pred EecCCCCC
Q 022482 145 YEYMPLGS 152 (296)
Q Consensus 145 ~e~~~~~s 152 (296)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998764
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.35 E-value=3.8e-06 Score=66.99 Aligned_cols=104 Identities=27% Similarity=0.291 Sum_probs=81.1
Q ss_pred HHHHHHHhhcCC-CcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 022482 114 LVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192 (296)
Q Consensus 114 ~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~ 192 (296)
..|..+++.+.+ +++++++|++ ..+++.||...+++....... ..-...+|..+..|+.+++..+.++++....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 357888888875 6999999998 346788998766554221000 0123468899999999999999999986555
Q ss_pred CeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 193 ~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
.+.-.|++|+|+-+++++++|++|......
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 599999999999999999999999988754
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.35 E-value=7.1e-06 Score=68.05 Aligned_cols=73 Identities=12% Similarity=0.102 Sum_probs=45.6
Q ss_pred ccccccCce-EEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC---cccceeeEEecC---CceEEEEec
Q 022482 75 CLLGEGGFG-RVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCADG---DQRLLVYEY 147 (296)
Q Consensus 75 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~I~~~~~~~~~~---~~~~lv~e~ 147 (296)
..|+.|+.. .||+. +..+++|..+.. .....+.+|...++.+... -++++++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457766665 58876 234677875442 2345788899999887532 344455443332 235889999
Q ss_pred CCCCCHH
Q 022482 148 MPLGSLE 154 (296)
Q Consensus 148 ~~~~sL~ 154 (296)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.1e-06 Score=75.72 Aligned_cols=137 Identities=19% Similarity=0.174 Sum_probs=85.7
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchh--------------------------------------HHHHH
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--------------------------------------REFLV 115 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------------~~~~~ 115 (296)
.+.||..+.|.||+|+.+. |+.||||+-++. .... -++..
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 3679999999999999887 999999987542 1110 01233
Q ss_pred HHHHHh----hcCCCc------ccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HH
Q 022482 116 EVLMLS----LLHHPN------LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG-LE 184 (296)
Q Consensus 116 e~~~l~----~l~h~~------I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~a-l~ 184 (296)
|++... .+.|-+ |+++|- .......|+|||++|..+.+.-.- ....++...+. ..+.++ +.
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~---~~l~~~~~~ 315 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDIL---NKLVEAYLE 315 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHH---HHHHHHHHH
Confidence 333222 223444 233322 223467899999999866654211 12445554333 333333 22
Q ss_pred HHHcCCCCCeEeccCCCCcEEEcC----CCceEEcccCCcccC
Q 022482 185 YLHDKANPPVIYRDLKCSNILLGE----GYHPKLSDFGLAKLG 223 (296)
Q Consensus 185 ~lH~~~~~~ivHrdikp~Nili~~----~~~~kl~Dfg~~~~~ 223 (296)
.|=..| ++|+|-.|.||++.. ++.+.+.|||+....
T Consensus 316 qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 316 QIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 333456 999999999999983 668999999998753
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.24 E-value=2.6e-05 Score=64.58 Aligned_cols=74 Identities=18% Similarity=0.172 Sum_probs=46.8
Q ss_pred ccccccCceEEEEEEECC-CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCCCCC
Q 022482 75 CLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~~~s 152 (296)
+.|..|-...+|++.... .++.|++|+..... ....+..+|+.+++.+...++ ++++.... -.++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778788999987553 24678889765432 222234578888888754443 44444332 247999999876
Q ss_pred H
Q 022482 153 L 153 (296)
Q Consensus 153 L 153 (296)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.21 E-value=3.7e-05 Score=64.61 Aligned_cols=140 Identities=15% Similarity=0.041 Sum_probs=78.6
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCCCCCHHH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSLED 155 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~~~sL~~ 155 (296)
+..|-.+.+|+... ++..+++|........-..+...|..+++.+....+ ++++.... -++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45677788998863 366788887644322211235678888888864433 34444321 368999999866532
Q ss_pred H-----------------hccCCCCCCCCCHH-HHHHHHHH---------HHHHHHHHHcC-----CCCCeEeccCCCCc
Q 022482 156 H-----------------LHDLPPDKKRLDWT-TRMRIAAG---------AAKGLEYLHDK-----ANPPVIYRDLKCSN 203 (296)
Q Consensus 156 ~-----------------~~~~~~~~~~~~~~-~~~~i~~q---------l~~al~~lH~~-----~~~~ivHrdikp~N 203 (296)
- ++.......+++.. .+.....+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 12221112222221 11111111 11112222111 12348999999999
Q ss_pred EEEcCCCceEEcccCCcccC
Q 022482 204 ILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~~ 223 (296)
|++++++ +.|+||..+...
T Consensus 158 il~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred EEEeCCC-CEEEeccccCcC
Confidence 9999876 789999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=6.6e-05 Score=65.24 Aligned_cols=159 Identities=15% Similarity=0.103 Sum_probs=83.5
Q ss_pred cCHHHHHHHhcCCCc-----cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccce
Q 022482 59 FTFRELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNL 131 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~ 131 (296)
.+..++..+...|.+ .+.|+.|....+|...... | .+++|+++.. ....+..|..+++.|...+ ++++
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQ-G-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCC-C-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcc
Confidence 344555556566765 2446667777899887543 3 5888987621 2233444555555543212 3333
Q ss_pred ee------EEecCCceEEEEecCCCCCHH-----------HHh---ccCCC----C---CCCCCH-HHHH----------
Q 022482 132 IG------YCADGDQRLLVYEYMPLGSLE-----------DHL---HDLPP----D---KKRLDW-TTRM---------- 173 (296)
Q Consensus 132 ~~------~~~~~~~~~lv~e~~~~~sL~-----------~~~---~~~~~----~---~~~~~~-~~~~---------- 173 (296)
+. +....+..++++++++|..+. ..+ +.... . ...+.+ ....
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 32 122345678999999986431 111 11100 0 001111 1100
Q ss_pred --HHHHH-HHHHHHHHHcC----CCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 174 --RIAAG-AAKGLEYLHDK----ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 174 --~i~~q-l~~al~~lH~~----~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..+.+ +...+..+... -+.++||+|+.|.||+++.+...-|+||+.+..
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 01111 11112222211 223499999999999998765568999999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=7.8e-05 Score=59.51 Aligned_cols=125 Identities=24% Similarity=0.307 Sum_probs=85.2
Q ss_pred cCCCccccccccCc-eEEEEEEECCCCeEEEEEEecC---CCc------------------chhHHHHHHHHHHhhc---
Q 022482 69 KNFRADCLLGEGGF-GRVYKGRLESTNQVVAIKQLDR---NGL------------------QGNREFLVEVLMLSLL--- 123 (296)
Q Consensus 69 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~e~~~l~~l--- 123 (296)
..++.++.||.|.- |.||++... |+.||+|++.. ... .....+..|.+....|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 56888999999999 999999886 78999999321 110 1112356676666555
Q ss_pred CCCcc--cceeeEEecC------------------CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 022482 124 HHPNL--VNLIGYCADG------------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183 (296)
Q Consensus 124 ~h~~I--~~~~~~~~~~------------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al 183 (296)
++.++ +++++|..-. ....||-||.+... .+... -+.++.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~----~~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIR----DIPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchh----HHHHHHHHH
Confidence 45566 8888887322 11235666654321 22223 355666777
Q ss_pred HHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 184 ~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
..+|..+ |+-+|+++.|.. .=+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999 999999999997 4478999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00013 Score=64.79 Aligned_cols=76 Identities=16% Similarity=0.124 Sum_probs=52.6
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCC------C-cchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN------G-LQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~l 143 (296)
.+.||.|.+..||++.+...++.++||...+. . .........|...|+.+. ..++++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35789999999999998754467999985421 1 123345667777777753 2456777766 4456789
Q ss_pred EEecCCCC
Q 022482 144 VYEYMPLG 151 (296)
Q Consensus 144 v~e~~~~~ 151 (296)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.05 E-value=8.2e-05 Score=63.86 Aligned_cols=155 Identities=19% Similarity=0.162 Sum_probs=87.2
Q ss_pred HHHHHhcCCCc-----cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccceeeE-
Q 022482 63 ELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGY- 134 (296)
Q Consensus 63 ~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~- 134 (296)
++..+..+|.+ .+.|..|....+|+.... +..+++|+... .....+..|+.++..+.+.+ +++++..
T Consensus 3 ~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~ 77 (296)
T cd05153 3 ELASFLADYDLGELLSFEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADR 77 (296)
T ss_pred HHHHHHHHcCCCchhheecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCC
Confidence 34444555554 345677777889988654 34688898754 22345667777777764332 4444331
Q ss_pred -----EecCCceEEEEecCCCCCHHH----H----------hccC----CCC---CCCCCHHHH----------HHHHHH
Q 022482 135 -----CADGDQRLLVYEYMPLGSLED----H----------LHDL----PPD---KKRLDWTTR----------MRIAAG 178 (296)
Q Consensus 135 -----~~~~~~~~lv~e~~~~~sL~~----~----------~~~~----~~~---~~~~~~~~~----------~~i~~q 178 (296)
....+..++|+++++|..+.. . ++.. ... .....+... ......
T Consensus 78 ~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 157 (296)
T cd05153 78 DGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRAL 157 (296)
T ss_pred CCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHH
Confidence 233456789999999866421 0 0110 000 000011000 001111
Q ss_pred HHHHHHHHHc----CCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 179 AAKGLEYLHD----KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 179 l~~al~~lH~----~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+..++.++.. .....+||+|+.|.||++++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 158 LADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 2333444443 1123499999999999999887778999998864
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.04 E-value=0.00015 Score=62.36 Aligned_cols=76 Identities=12% Similarity=0.022 Sum_probs=54.3
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC---CcccceeeEEec---CCceEEEEec
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH---PNLVNLIGYCAD---GDQRLLVYEY 147 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~~I~~~~~~~~~---~~~~~lv~e~ 147 (296)
.+.||.|..+.||.....+ + .+.+|..+. ......+..|...|+.+.. -.++++++++.. .+..++|||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4569999999999986543 3 466677532 1123567889999988853 357788887754 3568999999
Q ss_pred CCCCCH
Q 022482 148 MPLGSL 153 (296)
Q Consensus 148 ~~~~sL 153 (296)
++|.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.0004 Score=60.03 Aligned_cols=159 Identities=17% Similarity=0.205 Sum_probs=87.2
Q ss_pred CHHHHHHHhcCCCcc-----ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--cccee
Q 022482 60 TFRELAAVTKNFRAD-----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLI 132 (296)
Q Consensus 60 ~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~ 132 (296)
+-+++..+..+|.+. +.++.|....+|++... ++ .+++|+..... ....+..|..++..|...+ +++++
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 345555565666553 45667777889988643 34 57789875431 1234556666666664222 33443
Q ss_pred eE------EecCCceEEEEecCCCCCHH-----------HH---hcc----CCCCC-C--CCC-HHHHH-----------
Q 022482 133 GY------CADGDQRLLVYEYMPLGSLE-----------DH---LHD----LPPDK-K--RLD-WTTRM----------- 173 (296)
Q Consensus 133 ~~------~~~~~~~~lv~e~~~~~sL~-----------~~---~~~----~~~~~-~--~~~-~~~~~----------- 173 (296)
.. ....+..+++++|++|..+. .. ++. ..... . ..+ +....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 31 12245678999999875431 00 111 10000 0 000 00000
Q ss_pred -HHHHHHHHHHHHHHc----CCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 174 -RIAAGAAKGLEYLHD----KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 174 -~i~~ql~~al~~lH~----~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
.....+..+++++.. ....++||+|+.+.||+++.++.+.|+||+.+..
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 001122334444432 1223499999999999999887778999999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.7e-05 Score=67.23 Aligned_cols=133 Identities=14% Similarity=0.063 Sum_probs=94.5
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc----------------------hhHHHHHHHHHHhhcCCC--
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----------------------GNREFLVEVLMLSLLHHP-- 126 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~-- 126 (296)
+.+.+.||=|.-+.||.+-+.. |...++|.-+..... ..-...+|+..++.|...
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 6778899999999999998875 777888864321100 011245788888887532
Q ss_pred cccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 127 ~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
-+++.+++ +..++|||++.|..|...-+- . ..-.+...++..+.-|..+| +||+|..-=||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~---d~~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------E---DPPTLYDDLMGLIVRLANHG---LIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec-------C---ChHHHHHHHHHHHHHHHHcC---ceecccchheeEE
Confidence 24455544 567899999998777654321 1 12334555566666788889 9999999999999
Q ss_pred cCCCceEEcccCCcc
Q 022482 207 GEGYHPKLSDFGLAK 221 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~ 221 (296)
++++.++++||.-+.
T Consensus 236 ~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMV 250 (465)
T ss_pred ecCCCEEEeechHhh
Confidence 999999999997664
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00061 Score=59.44 Aligned_cols=73 Identities=15% Similarity=0.128 Sum_probs=47.5
Q ss_pred cccccCceEEEEEEECCCCeEEEEEEecC-------CCcchhHHHHHHHHHHhhcC--CC-cccceeeEEecCCceEEEE
Q 022482 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDR-------NGLQGNREFLVEVLMLSLLH--HP-NLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 76 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~-~I~~~~~~~~~~~~~~lv~ 145 (296)
.||.|....||++.+...++.++||.-.. .-.-...+...|...|+... .| .++++|.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999865446799996531 11233445567777777654 35 44455443 445667899
Q ss_pred ecCCC
Q 022482 146 EYMPL 150 (296)
Q Consensus 146 e~~~~ 150 (296)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99853
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00062 Score=58.65 Aligned_cols=144 Identities=22% Similarity=0.234 Sum_probs=82.6
Q ss_pred ccccccCceEEEEEEECC------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEec
Q 022482 75 CLLGEGGFGRVYKGRLES------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~ 147 (296)
+.+..|-...+|++.... .++.+++|+..... ....+..+|..+++.+...++ ++++..+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 345566667889887543 25778899875432 223455678888887754333 345555432 358899
Q ss_pred CCCCCHHHH-----------------hccCCCCC--C---CCC--HHHHH--------------------------HHHH
Q 022482 148 MPLGSLEDH-----------------LHDLPPDK--K---RLD--WTTRM--------------------------RIAA 177 (296)
Q Consensus 148 ~~~~sL~~~-----------------~~~~~~~~--~---~~~--~~~~~--------------------------~i~~ 177 (296)
++|..+... ++...... . ..+ +..+. .+..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 887765421 11111110 0 111 00111 1112
Q ss_pred HHHHHHHHHHc------CCCCCeEeccCCCCcEEEcCC----CceEEcccCCcccC
Q 022482 178 GAAKGLEYLHD------KANPPVIYRDLKCSNILLGEG----YHPKLSDFGLAKLG 223 (296)
Q Consensus 178 ql~~al~~lH~------~~~~~ivHrdikp~Nili~~~----~~~kl~Dfg~~~~~ 223 (296)
++...+..+-. ..+..++|+|+.|.||+++++ +.+.++||..|...
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~ 214 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN 214 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence 22233334432 133459999999999999874 78999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00096 Score=57.37 Aligned_cols=143 Identities=17% Similarity=0.207 Sum_probs=85.4
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecC--CCcchhHHHHHHHHHHhhcCCCc--ccceeeEEecCC--ceEEEE
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGD--QRLLVY 145 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~~--~~~lv~ 145 (296)
.+.+.+..|-.-.+|..... ++.++++ .+. .......+..+|+..++.+.--- +...++.+.+.. ..|.||
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 33444434444445555444 7778888 432 22334456678888888775422 334455555444 569999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHH-HHHHHHHHHHHcC-----------------------------------
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIA-AGAAKGLEYLHDK----------------------------------- 189 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~-~ql~~al~~lH~~----------------------------------- 189 (296)
++++|..+.+.... .... .+++ ..+...|..||+-
T Consensus 105 ~~veGe~~~~~~~~-----~~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~ 175 (321)
T COG3173 105 EWVEGEVVWSALPP-----ESLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG 175 (321)
T ss_pred EEecceeccCcCCc-----ccch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence 99997544332211 0000 1111 2444444445441
Q ss_pred --------------------CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 190 --------------------ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 190 --------------------~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
+...++|+|+.+.|++++.++.+-++||+.+.+..+.
T Consensus 176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 1247999999999999999988999999999875544
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0017 Score=55.12 Aligned_cols=32 Identities=31% Similarity=0.422 Sum_probs=26.6
Q ss_pred CCeEeccCCCCcEEEcCCCc-eEEcccCCcccC
Q 022482 192 PPVIYRDLKCSNILLGEGYH-PKLSDFGLAKLG 223 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~~~-~kl~Dfg~~~~~ 223 (296)
..++|+|+.|.||++++++. .-|+||+.+...
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 34899999999999987555 469999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0036 Score=54.17 Aligned_cols=31 Identities=19% Similarity=0.197 Sum_probs=28.2
Q ss_pred CCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
.++||+|+.+.|++++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3499999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0037 Score=54.94 Aligned_cols=144 Identities=15% Similarity=0.155 Sum_probs=80.7
Q ss_pred ccccccCceEEEEEEECC----CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCC
Q 022482 75 CLLGEGGFGRVYKGRLES----TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~ 149 (296)
..|..|-...+|++.... .++.+++|+..... ...-+...|..+++.+...++ +++++.+.. . .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557777899986432 24678889875543 222233678888888765444 345555532 2 5789988
Q ss_pred CCCHHHH-----------------hccCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHH----HHc-
Q 022482 150 LGSLEDH-----------------LHDLPPDKK--RLDWTTRMRIAAGA-----------------AKGLEY----LHD- 188 (296)
Q Consensus 150 ~~sL~~~-----------------~~~~~~~~~--~~~~~~~~~i~~ql-----------------~~al~~----lH~- 188 (296)
+.+|... ++....... ...+..+..++.++ ...+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 111111111 11122232332211 111111 121
Q ss_pred CCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccC
Q 022482 189 KANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLG 223 (296)
Q Consensus 189 ~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~ 223 (296)
.....++|+|+++.||++++ ++.+.++||..+...
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 11234999999999999976 468999999998753
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0017 Score=56.41 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=89.5
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCC------------------------cchh--HHHHHHHHHHhhcCC
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG------------------------LQGN--REFLVEVLMLSLLHH 125 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------~~~~--~~~~~e~~~l~~l~h 125 (296)
.+...|..|--+.||.|.... |..+|||++...- +... -....|+.-|+.++.
T Consensus 147 ~inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 344567788888999987654 7779999874210 0000 113467777777766
Q ss_pred CcccceeeEEecCCceEEEEecCCCCC-HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcE
Q 022482 126 PNLVNLIGYCADGDQRLLVYEYMPLGS-LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNI 204 (296)
Q Consensus 126 ~~I~~~~~~~~~~~~~~lv~e~~~~~s-L~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Ni 204 (296)
..|+-.--... ....|||+++-... ..-.+ ..-.++...+..+-.|++.-+.-|....+ +||.||+--|+
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 55432111111 24578999983211 00111 13446666677777788888887776544 99999999999
Q ss_pred EEcCCCceEEcccCCccc
Q 022482 205 LLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~ 222 (296)
|+.++ .+.++|.+-+..
T Consensus 297 LyhdG-~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LYHDG-KLYIIDVSQSVE 313 (520)
T ss_pred eEECC-EEEEEEcccccc
Confidence 98655 899999887753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0022 Score=54.62 Aligned_cols=73 Identities=18% Similarity=0.236 Sum_probs=46.8
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEEEEecCCC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
.+.++.|....+|... .+++.+.||+-.. .....+..|..-|+.|. .-.+++++.+....+..+|||||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 4568888889999887 4577899998752 22345677888777773 44678899998888888999999876
Q ss_pred C
Q 022482 151 G 151 (296)
Q Consensus 151 ~ 151 (296)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 5
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.35 E-value=3.7e-05 Score=76.82 Aligned_cols=158 Identities=14% Similarity=0.010 Sum_probs=112.0
Q ss_pred HHHHHhhcCCCcccceeeEEec--CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--CC
Q 022482 116 EVLMLSLLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK--AN 191 (296)
Q Consensus 116 e~~~l~~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~--~~ 191 (296)
|...++...|+++...+.-... +...+..++++.+|.+.+.+-+-..........-+.....+.+.+..-+|+. ++
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg 1358 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLG 1358 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCC
Confidence 4444555678888776665543 3456789999999999998865333333333333333334436666666643 34
Q ss_pred CCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhC
Q 022482 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g 271 (296)
...+|+++|+.|.+|..+-++++.++|+.++..+ .........+++.|++|++...-.++.++|+|..|+.+|.+..|
T Consensus 1359 ~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1359 NTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 4579999999999999999999999999984222 12222335678889999988777788889999999999999888
Q ss_pred CCCC
Q 022482 272 RKAI 275 (296)
Q Consensus 272 ~~pf 275 (296)
..+|
T Consensus 1437 n~~f 1440 (2724)
T KOG1826|consen 1437 NAYF 1440 (2724)
T ss_pred cHHH
Confidence 8877
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0066 Score=54.05 Aligned_cols=73 Identities=16% Similarity=0.107 Sum_probs=49.2
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCC----Cc---chhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN----GL---QGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~---~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~l 143 (296)
.+.||.|....||+..+. +..++||.-... +. ....+...|...|+.+. ...+++++.+.. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 567899999999999874 456889976521 11 13344455666666554 246777887766 45678
Q ss_pred EEecCCC
Q 022482 144 VYEYMPL 150 (296)
Q Consensus 144 v~e~~~~ 150 (296)
+||++++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 8999976
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0011 Score=65.11 Aligned_cols=154 Identities=21% Similarity=0.176 Sum_probs=109.6
Q ss_pred HHHHHHHHhhcCCCcccceeeEEecCCce----EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 022482 113 FLVEVLMLSLLHHPNLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188 (296)
Q Consensus 113 ~~~e~~~l~~l~h~~I~~~~~~~~~~~~~----~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~ 188 (296)
...|...+....|+|++.++.+-...... .+..+++...++...++. ...++...++.+..++..+|.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 34566777788999999999887654322 245577888888887765 5778889999999999999999999
Q ss_pred CCCCCeEeccCCCC---cEEEcCCCceEEc--ccCCcccCCCCCcceeeecccccccccCccccccCCCCcc--chhHHH
Q 022482 189 KANPPVIYRDLKCS---NILLGEGYHPKLS--DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK--SDVYSF 261 (296)
Q Consensus 189 ~~~~~ivHrdikp~---Nili~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Diwsl 261 (296)
.. ..|.-+... +...+..+.+.+. ||+.+........ .....-...+.+||......++.+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHH
Confidence 87 666655555 4444555566666 8888775433222 122234555778888776665544 699999
Q ss_pred HHHHHHHHhCCCCCC
Q 022482 262 GVVLLEIITGRKAID 276 (296)
Q Consensus 262 G~~l~~ll~g~~pf~ 276 (296)
|.....+..|..+-.
T Consensus 379 gll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISE 393 (1351)
T ss_pred HHHHhhhhhcCcccc
Confidence 999999988776543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0051 Score=53.74 Aligned_cols=143 Identities=16% Similarity=0.194 Sum_probs=78.1
Q ss_pred ccccccCceEEEEEEECCC---CeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.|..|=...+|++..... +..|++|+..... ...-+..+|..+++.+...++ +++++++. + . +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~-G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFG-N-G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeC-C-c--EeehhhcC
Confidence 3455566677888865432 2378888875432 222334578888888865555 34555542 2 2 48888877
Q ss_pred CCHHH--------------H---hccCCCCCC-CC-CHHHHHHHHHHH-------------------------HHHHHHH
Q 022482 151 GSLED--------------H---LHDLPPDKK-RL-DWTTRMRIAAGA-------------------------AKGLEYL 186 (296)
Q Consensus 151 ~sL~~--------------~---~~~~~~~~~-~~-~~~~~~~i~~ql-------------------------~~al~~l 186 (296)
..|.. . ++....... .. .+..+..+..++ +..+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65521 0 111111111 11 122222222211 1111112
Q ss_pred H-c-CCCCCeEeccCCCCcEEEcC-CCceEEcccCCccc
Q 022482 187 H-D-KANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKL 222 (296)
Q Consensus 187 H-~-~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~ 222 (296)
. . ..+...+|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 1 11224899999999999975 57899999999865
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0037 Score=55.33 Aligned_cols=74 Identities=20% Similarity=0.190 Sum_probs=49.1
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecC------CCcchhHHHHHHHHHHhhcC--CC-cccceeeEEecCCceEEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDR------NGLQGNREFLVEVLMLSLLH--HP-NLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--h~-~I~~~~~~~~~~~~~~lv 144 (296)
.+.||.|....||++.+...++.++||.-.. .-.-...+...|...|+... .| +++++|.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999854456788986421 11233456677888887664 35 45555544 44456678
Q ss_pred EecCC
Q 022482 145 YEYMP 149 (296)
Q Consensus 145 ~e~~~ 149 (296)
||+++
T Consensus 112 MEdL~ 116 (409)
T PRK12396 112 MEDLS 116 (409)
T ss_pred HHhCc
Confidence 88874
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0042 Score=53.91 Aligned_cols=73 Identities=19% Similarity=0.131 Sum_probs=55.7
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
..+.|++|++- |+++.. +. .....++..++.+.+..+.-+...-+ .-|||+...||+|+ .|+|.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~-ik-------~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-IK-------ADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeee-ee-------cccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEe
Confidence 34567777764 444432 21 23457788899998888888776653 89999999999999 899999999
Q ss_pred CCccc
Q 022482 218 GLAKL 222 (296)
Q Consensus 218 g~~~~ 222 (296)
-+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.016 Score=49.99 Aligned_cols=29 Identities=24% Similarity=0.323 Sum_probs=25.6
Q ss_pred CeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 193 ~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 4999999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.028 Score=48.92 Aligned_cols=141 Identities=23% Similarity=0.331 Sum_probs=79.8
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc------ccceee----EEecCCceEEEEe
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN------LVNLIG----YCADGDQRLLVYE 146 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------I~~~~~----~~~~~~~~~lv~e 146 (296)
|.+ .-..+|+..... | .+++|+.+.. ....++..|...+.-+.-.. +...-+ .+....+.+-+++
T Consensus 34 l~s-~eN~~f~~~~~~-g-~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 34 LNS-EENSNFRVQTED-G-RYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred ccc-ccCceEEEEecC-C-CeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 444 456788887764 3 3488988765 44566667777777663211 222212 2222236778999
Q ss_pred cCCCCCHHH-H------------------hccC----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHHcCC
Q 022482 147 YMPLGSLED-H------------------LHDL----PPDKKRLDWTT-------------RMRIAAGAAKGLEYLHDKA 190 (296)
Q Consensus 147 ~~~~~sL~~-~------------------~~~~----~~~~~~~~~~~-------------~~~i~~ql~~al~~lH~~~ 190 (296)
|++|..+.. . .+.. +.......+.. -.....++...+..+.+.-
T Consensus 109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~ 188 (331)
T COG2334 109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL 188 (331)
T ss_pred ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence 999877762 0 0111 11111122220 0112233444444444321
Q ss_pred ----CC---CeEeccCCCCcEEEcCCCc-eEEcccCCccc
Q 022482 191 ----NP---PVIYRDLKCSNILLGEGYH-PKLSDFGLAKL 222 (296)
Q Consensus 191 ----~~---~ivHrdikp~Nili~~~~~-~kl~Dfg~~~~ 222 (296)
+. .+||+|+.|.||+++.+.. ..++||+.+..
T Consensus 189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 12 2999999999999998875 88999999863
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.067 Score=47.67 Aligned_cols=76 Identities=17% Similarity=0.166 Sum_probs=44.3
Q ss_pred cccccccCceEEEEEEECCCC-e-----EEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEe
Q 022482 74 DCLLGEGGFGRVYKGRLESTN-Q-----VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~-~-----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e 146 (296)
.+.|..|-...+|++...... . .|.++.. .......-+..+|+.+++.+...++ +++++.+. -++|.|
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~e 129 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQE 129 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEE
Confidence 345555777889988654321 1 2444432 1221212234578889988875555 45555553 268999
Q ss_pred cCCCCCHH
Q 022482 147 YMPLGSLE 154 (296)
Q Consensus 147 ~~~~~sL~ 154 (296)
|++|.+|.
T Consensus 130 fIeGr~l~ 137 (383)
T PTZ00384 130 WVEGNTMG 137 (383)
T ss_pred EeccccCC
Confidence 99887654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.19 Score=43.78 Aligned_cols=70 Identities=17% Similarity=0.100 Sum_probs=41.1
Q ss_pred CceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--cccee---e--EEecCCceEEEEecCCCCC
Q 022482 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLI---G--YCADGDQRLLVYEYMPLGS 152 (296)
Q Consensus 81 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~---~--~~~~~~~~~lv~e~~~~~s 152 (296)
.-..||+..... +..+++|+.+... .....+..|...+..|.... ++... + ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 445789887543 5678899875432 23456667777776663221 22211 1 2233456778999988754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.039 Score=44.84 Aligned_cols=101 Identities=13% Similarity=0.070 Sum_probs=62.3
Q ss_pred EEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHH
Q 022482 97 VAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175 (296)
Q Consensus 97 vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i 175 (296)
..+|+++.-... ...-+..+..++..+. .|+++..= +.-.+-+|+|+|.... . ...- +
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~--------------i--~~~N-~ 146 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK--------------I--NFSN-F 146 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc--------------c--chhH-H
Confidence 445666544333 3344566777777553 45665521 2334568899985211 1 1111 2
Q ss_pred HHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 176 ~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
+..=+++|...|+.. ...+|+|-.|+|||-|..|.+||.|=+.
T Consensus 147 i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 147 ITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 222257788889432 1299999999999999999999999655
|
The function of this family is unknown. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.13 Score=42.06 Aligned_cols=73 Identities=26% Similarity=0.348 Sum_probs=47.2
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+..|..-..|...+. ...+.+|.-.. .....+..|+.-|+.|. .-.+.+++.+..+.++.|+||||++.+.+
T Consensus 24 v~gG~inea~~v~dg--~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 24 VSGGDINEAWRLRDG--TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred cCCccccceeEeecC--CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 333333344444332 34677786432 22345667777666664 45688899999999999999999987655
Q ss_pred H
Q 022482 154 E 154 (296)
Q Consensus 154 ~ 154 (296)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 4
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.17 Score=51.04 Aligned_cols=30 Identities=37% Similarity=0.323 Sum_probs=25.6
Q ss_pred CeEeccCCCCcEEEcCCC--ceE-EcccCCccc
Q 022482 193 PVIYRDLKCSNILLGEGY--HPK-LSDFGLAKL 222 (296)
Q Consensus 193 ~ivHrdikp~Nili~~~~--~~k-l~Dfg~~~~ 222 (296)
.+||+|+.+.||+++.++ .+. |+|||.+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999998775 555 999999864
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.1 Score=47.43 Aligned_cols=75 Identities=9% Similarity=0.069 Sum_probs=44.6
Q ss_pred cccccccCceEEEEEEECCC--------CeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCccc-ceeeEEecCCceEEE
Q 022482 74 DCLLGEGGFGRVYKGRLEST--------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV-NLIGYCADGDQRLLV 144 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~-~~~~~~~~~~~~~lv 144 (296)
.+.|..|=.-.+|++..... ++.|.+++.-... ...-+...|..+++.+...+|- ++++.+. -+.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t-e~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV-DELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc-cceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 34455666678888865421 4578888874432 2222445677777777654443 4555442 3457
Q ss_pred EecCCCCCH
Q 022482 145 YEYMPLGSL 153 (296)
Q Consensus 145 ~e~~~~~sL 153 (296)
.+|++|.+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899887644
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.017 Score=48.86 Aligned_cols=49 Identities=22% Similarity=0.146 Sum_probs=37.3
Q ss_pred HHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 173 ~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
...+..+-.++.-.+..- ..+||+|+.|+|++.++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 345555555666555540 1399999999999999999999999998864
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.061 Score=47.71 Aligned_cols=59 Identities=19% Similarity=0.070 Sum_probs=43.1
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~ 207 (296)
..++=+|..|.++..++.. ...++.....++.-...|+-.+-- .+ .+|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence 3466678888899888854 445666667777666677655543 45 99999999999993
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 296 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-52 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-51 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-45 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-43 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-24 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-23 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-23 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-23 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-23 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-23 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-23 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-23 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-22 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-22 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-22 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-22 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-22 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-22 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-22 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-22 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 7e-22 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-22 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-21 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-20 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-19 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-19 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-19 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-19 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 9e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 9e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-18 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-18 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-17 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-17 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-17 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-17 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-17 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-17 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-17 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-17 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-17 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 4e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 7e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 9e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 9e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-15 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-15 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 7e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-15 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 8e-15 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 8e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-14 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 8e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 9e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-13 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-13 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 6e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-11 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-11 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-11 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 8e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 8e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 9e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-09 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 452 bits (1166), Expect = e-162
Identities = 102/248 (41%), Positives = 141/248 (56%), Gaps = 4/248 (1%)
Query: 43 KEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQL 102
+A ++ +L T NF L+G G FG+VYKG L VA+K+
Sbjct: 13 NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRR 71
Query: 103 DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP 162
QG EF E+ LS HP+LV+LIG+C + ++ +L+Y+YM G+L+ HL+
Sbjct: 72 TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDL 131
Query: 163 DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222
+ W R+ I GAA+GL YLH +I+RD+K NILL E + PK++DFG++K
Sbjct: 132 PTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282
G D+TH+ST V GT GY PEY + G+LT KSDVYSFGVVL E++ R AI +
Sbjct: 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 283 EHNLVAWV 290
NL W
Sbjct: 249 MVNLAEWA 256
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 447 bits (1151), Expect = e-160
Identities = 104/244 (42%), Positives = 142/244 (58%), Gaps = 19/244 (7%)
Query: 57 HTFTFRELAAVTKNFRADC------LLGEGGFGRVYKGRLESTNQVVAIKQL----DRNG 106
H+F+F EL VT NF +GEGGFG VYKG + N VA+K+L D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITT 70
Query: 107 LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ ++F E+ +++ H NLV L+G+ +DGD LVY YMP GSL D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPP 129
Query: 167 LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226
L W R +IA GAA G+ +LH+ I+RD+K +NILL E + K+SDFGLA+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNL 286
+T +++R++GT Y APE + G++T KSD+YSFGVVLLEIITG A+D R L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 243
Query: 287 VAWV 290
+
Sbjct: 244 LDIK 247
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 436 bits (1124), Expect = e-155
Identities = 112/241 (46%), Positives = 150/241 (62%), Gaps = 5/241 (2%)
Query: 56 AHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-REFL 114
F+ REL + NF +LG GGFG+VYKGRL +VA+K+L QG +F
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQ 75
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
EV M+S+ H NL+ L G+C +RLLVY YM GS+ L + P + LDW R R
Sbjct: 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
IA G+A+GL YLHD +P +I+RD+K +NILL E + + DFGLAKL D THV+T
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTA 194
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEH--NLVAWVTV 292
V GT G+ APEY TG+ + K+DV+ +GV+LLE+ITG++A D R A + L+ WV
Sbjct: 195 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 293 L 293
L
Sbjct: 255 L 255
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 7e-82
Identities = 64/248 (25%), Positives = 94/248 (37%), Gaps = 24/248 (9%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL 118
L + + + G FG V+K +L N+ VA+K Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 119 MLSLLHHPNLVNLIGYCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR 174
L + H N++ IG G L+ + GSL D L + W
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 175 IAAGAAKGLEYLH-------DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
IA A+GL YLH D P + +RD+K N+LL ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 228 KTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282
+ +GT Y APE L+ D+Y+ G+VL E+ + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 283 EHNLVAWV 290
+
Sbjct: 246 MLPFEEEI 253
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-70
Identities = 71/212 (33%), Positives = 112/212 (52%), Gaps = 27/212 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNLV 129
+G+GGFG V+KGRL VVAIK L +G +EF EV ++S L+HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
L G + +V E++P G L L D + W+ ++R+ A G+EY+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ 141
Query: 190 ANPPVIYRDLKCSNILLGEG-----YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
NPP+++RDL+ NI L K++DFGL++ H + ++G + + AP
Sbjct: 142 -NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 245 EYAMTGQL---TLKSDVYSFGVVLLEIITGRK 273
E + + T K+D YSF ++L I+TG
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 7e-70
Identities = 80/260 (30%), Positives = 121/260 (46%), Gaps = 27/260 (10%)
Query: 15 KKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRAD 74
K HH+ P + +T ++ + + DG I +E
Sbjct: 2 KHHHHHHP-------MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK---------- 44
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLI 132
+G G FG V++ VA+K L EFL EV ++ L HPN+V +
Sbjct: 45 --IGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G +V EY+ GSL LH +++LD R+ +A AKG+ YLH++ NP
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
P+++R+LK N+L+ + Y K+ DFGL++L + S GT + APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPS 216
Query: 253 TLKSDVYSFGVVLLEIITGR 272
KSDVYSFGV+L E+ T +
Sbjct: 217 NEKSDVYSFGVILWELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 2e-66
Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G GGFG+VY+ VA+K D + Q E + ++L HPN++ L
Sbjct: 15 IGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C LV E+ G L L KR+ + A A+G+ YLHD+A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 193 PVIYRDLKCSNILLGEGYHP--------KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
P+I+RDLK SNIL+ + K++DFGLA+ +T + G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP 183
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E + SDV+S+GV+L E++TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-66
Identities = 69/198 (34%), Positives = 98/198 (49%), Gaps = 13/198 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V K + + VAIKQ++ + + F+VE+ LS ++HPN+V L G C
Sbjct: 16 VGRGAFGVVCKAKW--RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV EY GSL + LH P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 197 RDLKCSNILLGEGY-HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
RDLK N+LL G K+ DFG A D T G+ + APE + K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 256 SDVYSFGVVLLEIITGRK 273
DV+S+G++L E+IT RK
Sbjct: 184 CDVFSWGIILWEVITRRK 201
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 3e-66
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 18/210 (8%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+ K T +V+ +K+L R + R FL EV ++ L HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ + EY+ G+L + + W+ R+ A A G+ YLH +I+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKL------------GPVGDKTHVSTRVMGTYGYCAP 244
RDL N L+ E + ++DFGLA+L V+G + AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGRKA 274
E K DV+SFG+VL EII A
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 7e-66
Identities = 47/204 (23%), Positives = 87/204 (42%), Gaps = 21/204 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
L E G ++KGR + + +K L R+F E L + HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 135 CADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
C + +MP GSL + LH+ +D + ++ A A+G+ +LH P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ- 251
+ L ++++ E ++S + + S M + APE A+ +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 252 ---LTLKSDVYSFGVVLLEIITGR 272
+D++SF V+L E++T
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-65
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 36/254 (14%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VE 116
E + N + L+G G +G VYKG L+ + VA+K + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSF---ANRQNFINEKN 57
Query: 117 VLMLSLLHHPNLVNLIGYCADGD-----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT 171
+ + L+ H N+ I + LLV EY P GSL +L DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVS 112
Query: 172 RMRIAAGAAKGLEYLH------DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK---- 221
R+A +GL YLH D P + +RDL N+L+ +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 222 --LGPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVLLEIITGR 272
L G++ + + +GT Y APE + D+Y+ G++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 273 KAIDNTRAAGEHNL 286
+ + E+ +
Sbjct: 233 TDLFPGESVPEYQM 246
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-63
Identities = 66/201 (32%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G G FG VYKG+ + VA+K L+ + F EV +L H N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
Q +V ++ SL HLH + + + + IA A+G++YLH K +
Sbjct: 89 STA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SI 141
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---YAMTGQ 251
I+RDLK +NI L E K+ DFGLA +H ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
+ +SDVY+FG+VL E++TG+
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-61
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 24/210 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLIGY 134
+G+G FG+VY GR + VAI+ +D + + F EV+ H N+V +G
Sbjct: 41 IGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
C ++ +L + D K LD +IA KG+ YLH +
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++DLK N+ G ++DFGL + G + G + APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 252 L---------TLKSDVYSFGVVLLEIITGR 272
+ SDV++ G + E+
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-58
Identities = 54/215 (25%), Positives = 89/215 (41%), Gaps = 29/215 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G +G V+ G+ + VA+K + E+ L+ H N++ I
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
G Q L+ +Y GSL D+L LD + +++A + GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA +GT Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 243 APE------YAMTGQLTLKSDVYSFGVVLLEIITG 271
PE Q + +D+YSFG++L E+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 4e-58
Identities = 54/215 (25%), Positives = 91/215 (42%), Gaps = 29/215 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G +G V++G + + VA+K + + + E+ +L H N++ I
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
Q L+ Y +GSL D+L LD + +RI A GL +LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV--STRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA + + +GT Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 243 APE------YAMTGQLTLKSDVYSFGVVLLEIITG 271
APE + D+++FG+VL E+
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 5e-56
Identities = 55/216 (25%), Positives = 93/216 (43%), Gaps = 31/216 (14%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFL--VEVLMLSLLHHPNLVNLIG 133
+G+G FG V++G+ + VA+K + R + E+ +L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIA 103
Query: 134 YCADGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-- 187
+ Q LV +Y GSL D+L+ + + +++A A GL +LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 188 ---DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYC 242
+ P + +RDLK NIL+ + ++D GLA T +GT Y
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 243 APEYAMTGQL-------TLKSDVYSFGVVLLEIITG 271
APE + + ++D+Y+ G+V EI
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 63/195 (32%), Positives = 93/195 (47%), Gaps = 7/195 (3%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G G FG V+ GRL + N +VA+K + +FL E +L HPN+V LIG C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+V E + G L + RL T +++ AA G+EYL K I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLK 255
+RDL N L+ E K+SDFG+++ G + APE G+ + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 256 SDVYSFGVVLLEIIT 270
SDV+SFG++L E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-50
Identities = 71/205 (34%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VA+KQL +G R+F E+ +L LH +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G ++ LV EY+P G L D L + RLD + + ++ KG+EYL +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
++RDL NIL+ H K++DFGLAKL P+ +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ +SDV+SFGVVL E+ T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-50
Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C +R L+ EY+P GSL D+L K+R+D ++ + KG+EYL K
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
I+RDL NIL+ K+ DFGL K+ P + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAPE 187
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-49
Identities = 71/205 (34%), Positives = 105/205 (51%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG+G FG V R ++T +VVA+K+L + + R+F E+ +L L H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 133 GYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G C +R L+ EY+P GSL D+L K+R+D ++ + KG+EYL K
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPE 245
I+RDL NIL+ K+ DFGL K+ P + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK----EPGESPIFWYAPE 218
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
+ ++ SDV+SFGVVL E+ T
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFT 243
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-49
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C L+ + MP G L D++ + K + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 67/206 (32%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V + T ++VA+K L G Q + E+ +L L+H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C D LV EY+PLGSL D+L + + + A +G+ YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 244
I+RDL N+LL K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYAP 206
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E + SDV+SFGV L E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-48
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V R ++T + VA+K L +G + E+ +L L+H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 132 IGYCADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C + L+ E++P GSL+++L +K +++ +++ A KG++YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAP 244
++RDL N+L+ + K+ DFGL K + + + AP
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYAP 198
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E M + + SDV+SFGV L E++T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-47
Identities = 66/203 (32%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG V+KG ES V IK + D++G Q + +L + L H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C G LV +Y+PLGSL DH+ + L + AKG+ YL +
Sbjct: 81 LGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG- 135
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++R+L N+LL +++DFG+A L P DK + + + A E G+
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G +
Sbjct: 194 YTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 7e-47
Identities = 64/203 (31%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 77 LGEGGFGRVYKGRL----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LG G FG VYKG E VAIK+L + + N+E L E +++ + +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+G C L+ + MP G L D++ + K + + AKG+ YL D+
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+++RDL N+L+ H K++DFGLAKL +K + + + A E +
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
T +SDV+S+GV + E++T G K
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-46
Identities = 63/194 (32%), Positives = 102/194 (52%), Gaps = 7/194 (3%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
R+L N L+GE + K++DFGL++L GD + APE + ++KS
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 257 DVYSFGVVLLEIIT 270
DV++FGV+L EI T
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-46
Identities = 66/207 (31%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQL---DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG+G FG V +G VA+K L + + +F+ EV + L H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G +V E PLGSL D L + T R A A+G+ YL K
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 247
I+RDL N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 142 ---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK 273
T + SD + FGV L E+ T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 8e-46
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 16/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G G FG V+ G + ++V AIK + R G +F+ E ++ L HP LV L G C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKV-AIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ LV E+M G L D+L + T + + +G+ YL + VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE K+SDFG+ + V D + T GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 254 LKSDVYSFGVVLLEIIT-GRK 273
KSDV+SFGV++ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 13/197 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G +G VY+G + + VA+K L + EFL E ++ + HPNLV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ E+M G+L D+L + +++ + + +A + +EYL K I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 134
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+GE + K++DFGL++L + T+ + G + APE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GAKFPIKWTAPESLAYNKFS 190
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV++FGV+L EI T
Sbjct: 191 IKSDVWAFGVLLWEIAT 207
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 7e-45
Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLV 129
D LG G FG V +G + VAIK L + G + E + E ++ L +P +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
LIG C + +LV E G L L ++ + + + + G++YL +K
Sbjct: 74 RLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK 129
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCA 243
++RDL N+LL ++ K+SDFGL+K D + + + A
Sbjct: 130 N---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYA 181
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
PE + + +SDV+S+GV + E ++ G+K
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-44
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LG+G FG VY+G + VAIK ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL------HDLPPDKKRLDWTTRMRIAAGAAKGLE 184
L+G + G L++ E M G L+ +L P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV------MGT 238
YL+ ++RDL N ++ E + K+ DFG+ + D + M
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+PE G T SDV+SFGVVL EI T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-44
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQV--VAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG + V VA+K L + N E L E ++ L +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L +L + + + + + G++YL +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN-- 137
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 246
++RDL N+LL ++ K+SDFGL+K + + + + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPEC 191
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ + KSDV+SFGV++ E + G+K
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-44
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ +VA+K L L ++F E +L+ L H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAGA 179
G C DGD ++V+EYM G L L K L + + IA+
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV---- 235
A G+ YL + ++RDL N L+G K+ DFG+++ D V
Sbjct: 143 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 236 --MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M PE M + T +SDV+SFGV+L EI T
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-44
Identities = 67/236 (28%), Positives = 103/236 (43%), Gaps = 17/236 (7%)
Query: 44 EASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD 103
+ ++ D I ++ + + D +G G F VYKG T VA +L
Sbjct: 1 QEERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQ 60
Query: 104 RNGLQGN--REFLVEVLMLSLLHHPNLVNLIGYCAD---GDQRLLVY-EYMPLGSLEDHL 157
L + + F E ML L HPN+V G + +++ E M G+L+ +L
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 158 HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSD 216
K + KGL++LH + PP+I+RDLKC NI + G K+ D
Sbjct: 121 KRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGD 175
Query: 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GLA L + + V+GT + APE + DVY+FG+ +LE+ T
Sbjct: 176 LGLATLK----RASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-44
Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ + V A+K + + G EF E + L HP LV G C+
Sbjct: 16 LGSGQFGVVKLGKWKGQYDV-AVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+V EY+ G L ++L K L+ + + + +G+ +L I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIH 127
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ K+SDFG+ + V D + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 254 LKSDVYSFGVVLLEIIT-GRK 273
KSDV++FG+++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-44
Identities = 65/216 (30%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG+V+ E +VA+K L ++F E +L++L H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL-----------HDLPPDKKRLDWTTRMRIAAGAA 180
G C +G L+V+EYM G L L L + +A+ A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----- 235
G+ YL ++RDL N L+G+G K+ DFG+++ D V R
Sbjct: 169 AGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 236 -MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M PE + + T +SDV+SFGVVL EI T
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-44
Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V G+ V AIK + + G EF+ E ++ L H LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDV-AIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
++ EYM G L ++L + + R + + + +EYL K ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLH 143
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL N L+ + K+SDFGL++ V D + T +G+ + PE M + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 254 LKSDVYSFGVVLLEIIT 270
KSD+++FGV++ EI +
Sbjct: 200 SKSDIWAFGVLMWEIYS 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-44
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
LGEG FG VY+G + VA+K ++ N+ +F+ E +++ L HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + + ++ E P G L +L +K L T + + K + YL
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN-- 133
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPEY 246
++RD+ NIL+ KL DFGL++ + D+ + + +PE
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTRLPIKWMSPES 185
Query: 247 AMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+ F V + EI++ G++
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-44
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 16/205 (7%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
+G G G V GRL + VAIK L + R +FL E ++ HPN++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G G ++V EYM GSL+ L + + + G G+ YL D
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMT 249
++RDL N+L+ K+SDFGL+++ + D + G + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GRK 273
+ SDV+SFGVV+ E++ G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-43
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 23/221 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K++ LGEGGF V A+K++ + Q E E M L +HPN+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 129 VNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ L+ YC L+ + G+L + + L L + + G +GLE
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-------G 237
+H +RDLK +NILLG+ P L D G + + +
Sbjct: 149 AIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 238 TYGYCAPE------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
T Y APE + + + ++DV+S G VL ++ G
Sbjct: 206 TISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGE 243
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-43
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 77 LGEGGFGRVYKGRLESTNQV-------VAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLV 129
LG+G F +++KG V +K LD+ + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G C GD+ +LV E++ GSL+ +L +K ++ ++ +A A + +L +
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 190 ANPPVIYRDLKCSNILL--------GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
+I+ ++ NILL G KLSD G++ V+
Sbjct: 133 T---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 242 ------CAPEYAMTGQL-TLKSDVYSFGVVLLEIIT-GRK 273
PE + L +D +SFG L EI + G K
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-43
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LGE FG+VYKG L Q VAIK L D+ EF E ++ + L HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAG 178
L+G +++ Y G L + L D K L+ + + A
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV- 235
A G+EYL V+++DL N+L+ + + K+SD GL + D K ++ +
Sbjct: 137 IAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 236 ---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M APE M G+ ++ SD++S+GVVL E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-43
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQV----VAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVN 130
+G G FG VYKG L++++ VAIK L + G + +FL E ++ H N++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G + +++ EYM G+L+ L + + + G A G++YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 247
++RDL NIL+ K+SDFGL+++ + D + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+SFG+V+ E++T G +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-43
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVNLI 132
+G G FG V GRL VAIK L + R +FL E ++ HPN++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G ++V EYM GSL+ L + + + G A G++YL D
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMT 249
++RDL NIL+ K+SDFGL ++ + D + G + +PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 250 GQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+S+G+VL E+++ G +
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + + + FL E +++ L H NLV L+G
Sbjct: 201 IGKGEFGDVMLGDYR--GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 311
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 251
+RDL N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 252 LTLKSDVYSFGVVLLEIIT 270
+ KSDV+SFG++L EI +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-43
Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG V+ G T +V AIK L + G FL E ++ L H LV L
Sbjct: 192 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 248
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 303
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL+ +NIL+GE K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 363 DVWSFGILLTELTT 376
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-43
Identities = 61/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG VY G L + A+K L+R + +FL E +++ HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + L+V YM G L + + + + + AKG++YL K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V + A E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----ALE 202
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G+G FG VY G AIK L R +Q FL E L++ L+HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G + ++ YM G L + ++ + A+G+EYL ++
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK- 144
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V T A E
Sbjct: 145 --FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----ALE 198
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-42
Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 24/203 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V G VA+K + +N + FL E +++ L H NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR--GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 137 DGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+ L +V EYM GSL D+L + L ++ + + +EYL +
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FV 139
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV----MGTYGYCAPEYAMTGQ 251
+RDL N+L+ E K+SDFGL K T + ++ APE +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 190
Query: 252 LTLKSDVYSFGVVLLEIIT-GRK 273
+ KSDV+SFG++L EI + GR
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRV 213
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-42
Identities = 70/215 (32%), Positives = 103/215 (47%), Gaps = 30/215 (13%)
Query: 76 LLGEGGFGRVYKGRL--ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLVNL 131
++GEG FG+V K R+ + AIK++ + +R+F E+ ++ L HHPN++NL
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIAAGA 179
+G C L EY P G+L D L L + AA
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV---- 235
A+G++YL K I+RDL NIL+GE Y K++DFGL++ V K R+
Sbjct: 152 ARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPVRW 207
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
M A E T SDV+S+GV+L EI++
Sbjct: 208 M------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
LGEG FG V +G L + T+ VA+K + D + + EFL E + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 132 IGYCADGDQR-----LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+G C + + +++ +M G L +L L K + T ++ A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV----MGT 238
YL ++ ++RDL N +L + ++DFGL+K GD + ++ +
Sbjct: 162 YLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T KSDV++FGV + EI T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 2e-42
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 74 DCLLGEGGFGRVYKGRLESTNQV--VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
D LG G FG V +G + VAIK L E + E ++ L +P +V
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
LIG C + +LV E G L L ++ + + + + G++YL +K
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYA 247
++R+L N+LL ++ K+SDFGL+K D + + + APE
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPECI 511
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ + +SDV+S+GV + E ++ G+K
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 67/197 (34%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ G +V A+K L + G FL E ++ L H LV L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKV-AVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ EYM GSL D L P +L + +AA A+G+ ++ ++ I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL+ +NIL+ + K++DFGLA+L + D + T G + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV+SFG++L EI+T
Sbjct: 189 IKSDVWSFGILLTEIVT 205
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 69/194 (35%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG V+ G T +V AIK L + G FL E ++ L H LV L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV- 331
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ +V EYM GSL D L K L + +AA A G+ Y+ ++
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVH 386
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKS 256
RDL+ +NIL+GE K++DFGLA+L ++ + APE A+ G+ T+KS
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 257 DVYSFGVVLLEIIT 270
DV+SFG++L E+ T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 28/213 (13%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGNR--EFLVEVLMLSLLHHPNLVNL 131
LG+G FG V + +L + + VA+K L + + + EFL E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 132 IGYCADGDQR------LLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGL 183
+G + +++ +M G L L + + L T +R A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTRV----MG 237
EYL + I+RDL N +L E ++DFGL++ GD + ++++ +
Sbjct: 151 EYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
A E T+ SDV++FGV + EI+T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 64/206 (31%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G++ + + VA+K L + Q +FL+E L++S +H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLH 187
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ I+RD+ N LL G G K+ DFG+A+ M + P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E M G T K+D +SFGV+L EI +
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-42
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 21/205 (10%)
Query: 77 LGEGGFGRVYKGRL---ESTNQVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLI 132
+G G FG VY G L + A+K L+R + +FL E +++ HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 133 GYCADGD-QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
G C + L+V YM G L + + + + + AKG+++L K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG------TYGYCAPE 245
++RDL N +L E + K++DFGLA+ + V + A E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----ALE 266
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT 270
T + T KSDV+SFGV+L E++T
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-42
Identities = 62/209 (29%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNL 131
+GEG FG V++G S VAIK +N +FL E L + HP++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + ++ E LG L L K LD + + A + L YL K
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG------YCAPE 245
++RD+ N+L+ KL DFGL++ + D T+ + APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGKLPIKWMAPE 187
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIIT-GRK 273
+ T SDV+ FGV + EI+ G K
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVN 130
LG G FG VY+G++ + + VA+K L + Q +FL+E L++S +H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLH 187
IG R ++ E M G L+ L + P L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY--- 241
+ I+RD+ N LL G G K+ DFG+A+ D G
Sbjct: 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAMLPV 250
Query: 242 --CAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
PE M G T K+D +SFGV+L EI +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V VA+K L D + + + E+ +M + H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L ++++ + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A+G+EYL + I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV++ EI T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-41
Identities = 60/197 (30%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG G FG V+ +V A+K + + G FL E ++ L H LV L
Sbjct: 196 LGAGQFGEVWMATYNKHTKV-AVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ E+M GSL D L + + + +A A+G+ ++ + I+
Sbjct: 254 -KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIH 307
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT---YGYCAPEYAMTGQLT 253
RDL+ +NIL+ K++DFGLA++ + D + T G + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGAKFPIKWTAPEAINFGSFT 363
Query: 254 LKSDVYSFGVVLLEIIT 270
+KSDV+SFG++L+EI+T
Sbjct: 364 IKSDVWSFGILLMEIVT 380
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 9e-41
Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V VA+K L D + + + E+ +M + H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L ++++ + +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A+G+EYL + I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV++ EI T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-40
Identities = 60/203 (29%), Positives = 88/203 (43%), Gaps = 22/203 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQV---VAIKQL-DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG FG V++G S VAIK + +FL E L + HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G + ++ E LG L L K LD + + A + L YL K
Sbjct: 458 GVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR-- 511
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG-----YCAPEYA 247
++RD+ N+L+ KL DFGL++ + D T+ G + APE
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKLPIKWMAPESI 564
Query: 248 MTGQLTLKSDVYSFGVVLLEIIT 270
+ T SDV+ FGV + EI+
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILM 587
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-40
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
+GEG FGRV++ R +VA+K L + +F E +++ +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPDKKRLDWT 170
L+G CA G L++EYM G L + L P L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
++ IA A G+ YL ++ ++RDL N L+GE K++DFGL++ D K
Sbjct: 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ + M PE + T +SDV+++GVVL EI +
Sbjct: 232 ADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 57/261 (21%), Positives = 95/261 (36%), Gaps = 14/261 (5%)
Query: 16 KKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADC 75
HH+ +D ++ + + + R + ++F+
Sbjct: 4 HHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLS 63
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEV-LMLSLLHHPNLVNLI 132
LG G +G V+K R + ++ A+K+ G + L EV + HP V L
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+G L E SL+ H L L +LH +
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG-- 177
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++ D+K +NI LG KL DFGL +G + G Y APE + G
Sbjct: 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE-GDPRYMAPE-LLQGSY 232
Query: 253 TLKSDVYSFGVVLLEIITGRK 273
+DV+S G+ +LE+ +
Sbjct: 233 GTAADVFSLGLTILEVACNME 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-40
Identities = 62/200 (31%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLI 132
LG+G FG VY R + + ++A+K L + L+ + EV + S L HPN++ L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
GY D + L+ EY PLG++ L + D A L Y H K
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VI+RD+K N+LLG K++DFG + P + GT Y PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDLC---GTLDYLPPEMIEGRMH 184
Query: 253 TLKSDVYSFGVVLLEIITGR 272
K D++S GV+ E + G+
Sbjct: 185 DEKVDLWSLGVLCYEFLVGK 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-40
Identities = 67/226 (29%), Positives = 99/226 (43%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
LGEG FG+V K + VA+K L N + L E +L ++HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHL--------------------HDLPPDKKRLDWT 170
L G C+ LL+ EY GSL L PD++ L
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
+ A ++G++YL + +++RDL NIL+ EG K+SDFGL++ D
Sbjct: 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M A E T +SDV+SFGV+L EI+T
Sbjct: 208 KRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-40
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + E VA+K L + E+ +M L H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR----------MRIAAGA 179
NL+G C G L++ EY G L + L + + ++
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
A+G+ +L K I+RD+ N+LL G+ K+ DFGLA+ +M
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------------IMNDS 218
Query: 240 GYC------------APEYAMTGQLTLKSDVYSFGVVLLEIIT 270
Y APE T++SDV+S+G++L EI +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEV-LMLSLLHHPNLV 129
LG G FG+V + VA+K L + R + E+ ++ L +H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL--------------HDLPPDKKRLDWTTRMRI 175
NL+G C G L++ EY G L + L + D+ LD +
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-- 233
+ AKG+ +L K I+RDL NILL G K+ DFGLA+ V
Sbjct: 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 234 ----RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ M APE T +SDV+S+G+ L E+ +
Sbjct: 208 RLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 63/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + +T + VA+K L + +R + E+ +++ + HH N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 130 NLIGYCADGDQ-RLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRIA 176
NL+G C +++ E+ G+L +L K L + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVSTR 234
AKG+E+L + I+RDL NILL E K+ DFGLA+ R
Sbjct: 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 235 V----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ M APE T++SDV+SFGV+L EI +
Sbjct: 212 LPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 59/205 (28%), Positives = 97/205 (47%), Gaps = 8/205 (3%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+G G +GR K R +S +++ K+LD + + ++ LV EV +L L HPN+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 134 YCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
D L V EY G L + +++ LD +R+ L+ H +++
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 192 PP--VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
V++RDLK +N+ L + KL DFGLA++ + T + +GT Y +PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSPEQMNR 190
Query: 250 GQLTLKSDVYSFGVVLLEIITGRKA 274
KSD++S G +L E+
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-38
Identities = 48/202 (23%), Positives = 87/202 (43%), Gaps = 8/202 (3%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
+G G F VY+ VA+K++ L + + E+ +L L+HPN++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ ++ +V E G L + K+ + T + LE++H +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
V++RD+K +N+ + KL D GL + KT + ++GT Y +PE
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGY 213
Query: 253 TLKSDVYSFGVVLLEIITGRKA 274
KSD++S G +L E+ +
Sbjct: 214 NFKSDIWSLGCLLYEMAALQSP 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 36/221 (16%)
Query: 77 LGEGGFGRVYKGRL-------ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPN 127
LGEG FG+V + VA+K L + + + E+ +M + H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHL------------HDLPPDKKRLDWTTRMRI 175
++NL+G C ++ EY G+L ++L + +++L +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--KTHVST 233
A A+G+EYL K I+RDL N+L+ E K++DFGLA+ D K +
Sbjct: 197 AYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 234 RV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
R+ M APE T +SDV+SFGV+L EI T
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 14/200 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHHPNLVNLI 132
LG+G FG VY R + ++A+K L ++ L+ + E+ + S L HPN++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
Y D + L+ E+ P G L L R D A L Y H++
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK-- 134
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
VI+RD+K N+L+G K++DFG + P + GT Y PE
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 253 TLKSDVYSFGVVLLEIITGR 272
K D++ GV+ E + G
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
LG GG VY N VAIK + + E L EV S L H N+V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
I + D LV EY+ +L +++ L T + G+++ HD
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST-RVMGTYGYCAPEYAMTG 250
+++RD+K NIL+ K+ DFG+AK + + + T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
+D+YS G+VL E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGE 209
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-38
Identities = 46/220 (20%), Positives = 88/220 (40%), Gaps = 33/220 (15%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----------------EVLM 119
L +G F ++ N+ A+K+ +++ L+ R+F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL----PPDKKRLDWTTRMRI 175
++ + + + G + D+ ++YEYM S+ + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
Y+H++ N + +RD+K SNIL+ + KLSDFG ++ K S
Sbjct: 157 IKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV-DKKIKGS--- 210
Query: 236 MGTYGYCAPEYAMTGQLT---LKSDVYSFGVVLLEIITGR 272
GTY + PE + + + K D++S G+ L +
Sbjct: 211 RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-38
Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+F+ L+G GGFG+V+K + + IK++ N N + EV L+ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 129 VNLIGYCADGDQRL----------------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTR 172
V+ G D + E+ G+LE + ++LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLA 124
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ + KG++Y+H K +I RDLK SNI L + K+ DFGL
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDGKR 178
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
TR GT Y +PE + + D+Y+ G++L E++
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-38
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 41/226 (18%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + VA+K L ++ + E+ +M L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHL-------------------HDLPPDKKRLDWT 170
NL+G C L++EY G L ++L + D L +
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 171 TRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD--K 228
+ A AKG+E+L K+ ++RDL N+L+ G K+ DFGLA+
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 229 THVSTRV----MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
+ R+ M APE G T+KSDV+S+G++L EI +
Sbjct: 230 VRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-38
Identities = 54/273 (19%), Positives = 98/273 (35%), Gaps = 27/273 (9%)
Query: 17 KHHNKPIDQIP--STSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRAD 74
HH+ +P S ++ ++ G D A + ++ + +
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNL--VN 130
+G GG +V++ Q+ AIK ++ + E+ L+ L + +
Sbjct: 62 KQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L Y +V E L L KK +D R + + +H
Sbjct: 121 LYDYEITDQYIYMVMECGN-IDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE----- 245
+++ DLK +N L+ +G KL DFG+A + V +G Y PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 246 ------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+++ KSDV+S G +L + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-37
Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 35/223 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G FG+V K R ++ AIK++ + L EV++L+ L+H +V
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 136 ADGDQRL-------------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ + + EY G+L D +H + R+ +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEA 128
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL-------------GPVGDKT 229
L Y+H + +I+RDLK NI + E + K+ DFGLAK G
Sbjct: 129 LSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 230 HVSTRVMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVLLEIITG 271
++++ + GT Y A E TG K D+YS G++ E+I
Sbjct: 186 NLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 25/219 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +G GG +V++ Q+ AIK ++ + E+ L+ L
Sbjct: 28 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86
Query: 127 NL--VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + L Y +V E L L KK +D R + +
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 141
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+H +++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 245 E-----------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
E +++ KSDV+S G +L + G+
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 9/201 (4%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLV-EVLMLSLLHHPNLVNLIG 133
+GEG FG+ + + IK+++ + + RE EV +L+ + HPN+V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
+ +V +Y G L ++ + L+++HD+
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK--- 145
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+++RD+K NI L + +L DFG+A++ + ++ +GT Y +PE
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICENKPYN 203
Query: 254 LKSDVYSFGVVLLEIITGRKA 274
KSD+++ G VL E+ T + A
Sbjct: 204 NKSDIWALGCVLYELCTLKHA 224
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-37
Identities = 48/219 (21%), Positives = 83/219 (37%), Gaps = 25/219 (11%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +G GG +V++ Q+ AIK ++ + E+ L+ L
Sbjct: 9 RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 127 NL--VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + L Y +V E L L KK +D R + +
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWKNMLEAVH 122
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+H +++ DLK +N L+ +G KL DFG+A + V +GT Y P
Sbjct: 123 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 245 E-----------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
E +++ KSDV+S G +L + G+
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 16/201 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+G G FG V++ + + T A+K++ + E++ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAV 119
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
+G + E + GS L L L + A +GLEYLH + ++
Sbjct: 120 REGPWVNIFMELLEGGS----LGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---IL 172
Query: 196 YRDLKCSNILLG-EGYHPKLSDFGLAK-LGPVGDKTHVSTR--VMGTYGYCAPEYAMTGQ 251
+ D+K N+LL +G L DFG A L P G + T + GT + APE M
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
K D++S ++L ++ G
Sbjct: 233 CDAKVDIWSSCCMMLHMLNGC 253
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
+ + LG+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
++V G+ D D +V E SL + +K L R G +
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQ 155
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y A
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 209
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE + + DV+S G ++ ++ G+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-36
Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 27/218 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIGY 134
LG GGFG V++ + + + AIK++ + RE + EV L+ L HP +V
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 135 CADGD---------QRLLVY---EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
+ + ++ +Y + +L+D ++ + + + + I A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEA 130
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL----------GPVGDKTHVS 232
+E+LH K +++RDLK SNI K+ DFGL
Sbjct: 131 VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT 270
T +GT Y +PE + K D++S G++L E++
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-36
Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 16/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
+ + LG+GGF + ++ T +V A K + ++ L + +E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
++V G+ D D +V E SL + +K L R G +
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQ 129
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH VI+RDLK N+ L E K+ DFGLA K+ G++ V GT Y A
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 183
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE + + DV+S G ++ ++ G+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
L+G GG G VY+ ++VA+K + L + F E L P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
+ Q + + L L P L + I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+RD+K NIL+ L DFG+A T + +GT Y APE
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESH 211
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
T ++D+Y+ VL E +TG
Sbjct: 212 ATYRADIYALTCVLYECLTGS 232
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-36
Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
K + +G+G G VY +T Q VAI+Q++ + E+L++ +PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+VN + GD+ +V EY+ GSL D + + +D + + LE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH 133
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
VI+RD+K NILLG KL+DFG A++ P K T V GT + APE
Sbjct: 134 SNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEV 187
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR---EFLVEVLMLSLLHH 125
++F+ LLG+G F VY+ T VAIK +D+ + EV + L H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLD-WTTRMRIAAGAAKGLE 184
P+++ L Y D + LV E G + +L + K R G+
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEAR-HFMHQIITGML 126
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKTHVSTRVMGTYGYCA 243
YLH +++RDL SN+LL + K++DFGLA +L +K + GT Y +
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYIS 180
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE A L+SDV+S G + ++ GR
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ +GEG G V R + + + VA+K +D Q EV+++ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V + G++ ++ E++ G+L D + + L+ + + L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEAVLQALAYLH 158
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ VI+RD+K +ILL KLSDFG A++ K + V GT + APE
Sbjct: 159 AQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEV 212
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+ D++S G++++E++ G
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
+LG GG V+ R ++ VA+K L R L + F + E + L+HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 132 --IGYCADGDQRLLVY---EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
G A+ L Y EY+ +L D +H + + + + A A + L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS 132
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR---VMGTYGYCA 243
H +I+RD+K +NI++ K+ DFG+A+ + D + T+ V+GT Y +
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAAVIGTAQYLS 187
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE A + +SDVYS G VL E++TG
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHP 126
+ F +G+G FG V+KG T +VVAIK +D + E + E+ +LS P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ G + ++ EY+ GS D L LD T I KGL+YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 135
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE 245
H + I+RD+K +N+LL E KL+DFG+ +L K + +GT + APE
Sbjct: 136 HSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPE 189
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITG 271
K+D++S G+ +E+ G
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARG 215
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-35
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ + LG+G FG+VYK + + T + A K ++ + +++VE+ +L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L+G + ++ E+ P G+++ + +L + L + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH 134
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
K +I+RDLK N+L+ +L+DFG+ AK K +GT + APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEV 188
Query: 247 AMTGQLT-----LKSDVYSFGVVLLEIITG 271
M + K+D++S G+ L+E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-35
Identities = 55/218 (25%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGY 134
+L EGGF VY+ + + + A+K+L N + NR + EV M L HPN+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 135 CADGDQR-------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ G + L+ + G L + L + + L T ++I + ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA---KLGPVGDKTHVSTRVM-------G 237
+ PP+I+RDLK N+LL KL DFG A P + ++
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 238 TYGYCAPE---YAMTGQLTLKSDVYSFGVVLLEIITGR 272
T Y PE + K D+++ G +L + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 64/205 (31%), Positives = 93/205 (45%), Gaps = 12/205 (5%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN 127
+ F LGEG +G VYK + T Q+VAIKQ+ +E + E+ ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V G +V EY GS+ D + K L I KGLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH 142
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPEY 246
I+RD+K NILL H KL+DFG+ +L K + V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITG 271
+D++S G+ +E+ G
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEG 221
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 51/221 (23%), Positives = 89/221 (40%), Gaps = 22/221 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ +LG+G V++GR + T + AIK + + + E +L L+H
Sbjct: 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 126 PNLVNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
N+V L + R L+ E+ P GSL L + P + L + + + G+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGM 125
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+L + +++R++K NI+ G KL+DFG A+ + D + GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTE 179
Query: 240 GYCAPE--------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y P+ + D++S GV TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-35
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
++ ++G G V + VAIK+++ Q + + L+ E+ +S HHPN
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWT-TRMRIAA---GAAKGL 183
+V+ D+ LV + + GS+ D + + + IA +GL
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTR--VMGTYG 240
EYLH I+RD+K NILLGE +++DFG+ A L GD T R +GT
Sbjct: 135 EYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 241 YCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ APE + K+D++SFG+ +E+ TG
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-34
Identities = 28/243 (11%), Positives = 54/243 (22%), Gaps = 41/243 (16%)
Query: 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLM 119
L+ + + L G V+ R + A+K E
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 120 LSLLHHPNLVNLIGYC--------------------------ADGDQRLLVYEYMP--LG 151
+ L + LL+ L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLE 175
Query: 152 SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211
L L + + + A + L K +++ N+ +
Sbjct: 176 LLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGR 232
Query: 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEII 269
L D VG + S+ Y E+ T T + + G+ + +
Sbjct: 233 LMLGDVSALW--KVGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 270 TGR 272
Sbjct: 288 CLF 290
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-34
Identities = 65/216 (30%), Positives = 94/216 (43%), Gaps = 17/216 (7%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ LG GGFG V + + T + VAIKQ + NRE E+ ++ L+H
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 126 PNLVNLI------GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
PN+V+ A D LL EY G L +L+ + L + +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDI 130
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236
+ L YLH+ +I+RDLK NI+L + K+ D G AK + + V
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--LDQGELCTEFV- 184
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GT Y APE + T+ D +SFG + E ITG
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 29/240 (12%), Positives = 65/240 (27%), Gaps = 52/240 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------------------- 112
+LG+ + + T + + +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 113 -----FLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSLEDHLHDLPPD 163
F+ ++ ++ + D R +Y M L + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
K L R+++ + L LH +++ L+ +I+L + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGR 272
+ + G+ PE +T D ++ G+V+ I
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 22/219 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPN 127
+ +LG+G V++GR + T + AIK + + + E +L L+H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 128 LVNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+V L + R L+ E+ P GSL L + P + L + + + G+ +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L + +++R++K NI+ G KL+DFG A+ + D + GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEEY 181
Query: 242 CAPE--------YAMTGQLTLKSDVYSFGVVLLEIITGR 272
P+ + D++S GV TG
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 62/209 (29%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHH 125
F +LG GGFG V+ ++++T ++ A K+L++ L+ + + +VE +L+ +H
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 126 PNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGL 183
+V+L Y + L LV M G + H++++ D R A GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGL 302
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
E+LH + +IYRDLK N+LL + + ++SD GLA G GT G+ A
Sbjct: 303 EHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMA 357
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE + + D ++ GV L E+I R
Sbjct: 358 PELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-34
Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 14/209 (6%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEV-LMLSLLHHPNL 128
LG G +G V K R + Q++A+K++ Q + L+++ + + + P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V G + E M SL+ + + + +IA K LE+LH
Sbjct: 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE-- 245
K + VI+RD+K SN+L+ K+ DFG+ L G Y APE
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAGCKPYMAPERI 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
++KSD++S G+ ++E+ R
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 9e-34
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 21/206 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG+G +G VY GR S +AIK++ + ++ E+ + L H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHD----LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
++ + E +P GSL L L +++ + + T+ + +GL+YLHD
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-----EGLKYLHDNQ- 142
Query: 192 PPVIYRDLKCSNILL--GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---Y 246
+++RD+K N+L+ G K+SDFG +K + + GT Y APE
Sbjct: 143 --IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTETFTGTLQYMAPEIIDK 197
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
G +D++S G ++E+ TG+
Sbjct: 198 GPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 1e-33
Identities = 42/225 (18%), Positives = 75/225 (33%), Gaps = 26/225 (11%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNGLQGNREFLVEVLMLSL 122
+K LLGEG F +VY+ N Q +K EF + ++
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMER 120
Query: 123 L---HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAG 178
L + + +LV E G+L + ++ +K + + A
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-----------KLSDFGLAKLGPVGD 227
+E +HD +I+ D+K N +LG G+ L D G + +
Sbjct: 181 MLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237
Query: 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
K + T T G+ E + D + + ++ G
Sbjct: 238 KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 17/206 (8%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLV 129
F LG G G V+K + + V+A K + R ++ E+ +L + P +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
G + + E+M GSL+ L R+ +++ KGL YL +K
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD---KTHVSTRVMGTYGYCAPEY 246
+++RD+K SNIL+ KL DFG++ G + D + V GT Y +PE
Sbjct: 151 HK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSMANSFV-----GTRSYMSPER 201
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
+++SD++S G+ L+E+ GR
Sbjct: 202 LQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 47/206 (22%), Positives = 77/206 (37%), Gaps = 28/206 (13%)
Query: 76 LLGEGGFGRVYKG---RLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
+ GG G +Y + + V +K L +G + + E L+ + HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVN--GRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 132 IGYCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ D+ +V EY+ SL+ +L + L YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL 198
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H ++Y DLK NI+L E KL D G + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGY-LYGTPGFQAPEI 248
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
T+ +D+Y+ G L +
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 3e-33
Identities = 30/239 (12%), Positives = 64/239 (26%), Gaps = 51/239 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE----------------------- 112
+LG+ + + T + + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 113 -----FLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLVYEYM--PLGSLEDHLHDLPPD 163
F+ ++ ++ + D R +Y M L + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
K L R+++ + L LH +++ L+ +I+L + L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 224 PVGDKTHVSTRVMGTYGYCAPEY----------AMTGQLTLKSDVYSFGVVLLEIITGR 272
G S G+ PE +T D ++ G+ + I
Sbjct: 260 RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 16/220 (7%)
Query: 59 FTFRELAAVTKN-FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---L 114
+ + E VTKN FR +LG+GGFG V ++ +T ++ A K+L++ ++ + L
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232
Query: 115 VEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM 173
E +L ++ +V+L Y + L LV M G L+ H++ + R
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RA 288
Query: 174 RI-AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
AA GLE LH + ++YRDLK NILL + H ++SD GLA P G
Sbjct: 289 VFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK-- 343
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
RV GT GY APE + T D ++ G +L E+I G+
Sbjct: 344 GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-32
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 22/219 (10%)
Query: 68 TKNFRADCLLGEG--GFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLV-EVLMLSLL 123
+ ++G+G V R + T + V +++++ FL E+ + L
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA---GAA 180
+HPN+V ++ +V +M GS +D + D IA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-LAKLGPVGDKTHV----STRV 235
K L+Y+H ++R +K S+IL+ LS + G + V
Sbjct: 139 KALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 236 MGTYGYCAPEYAMTGQL--TLKSDVYSFGVVLLEIITGR 272
+ + +PE KSD+YS G+ E+ G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-32
Identities = 68/220 (30%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS-LLHHP 126
F L+G G +G+VYKGR T Q+ AIK +D G E E+ ML HH
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR 81
Query: 127 NLVNLIG-----YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA--- 177
N+ G D +L LV E+ GS+ D + + + + +W IA
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICR 136
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVM 236
+GL +LH VI+RD+K N+LL E KL DFG+ A+L + + +
Sbjct: 137 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FI 190
Query: 237 GTYGYCAPEYAMTGQLT-----LKSDVYSFGVVLLEIITG 271
GT + APE + KSD++S G+ +E+ G
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPNLVNL 131
+G G +G V K + + Q++A+K++ + + ++LM + P +V
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
G + E M S + + + +I K L +L +
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGL-AKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+I+RD+K SNILL + KL DFG+ +L + TR G Y APE
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDAGCRPYMAPERIDP 199
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
A ++SDV+S G+ L E+ TGR
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGR 226
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 76/263 (28%), Positives = 106/263 (40%), Gaps = 26/263 (9%)
Query: 17 KHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCL 76
HH+ IP+T + + D A F + K F
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDD---PEKLFSDLRE 61
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY GS D L K L + GA +GL YLH
Sbjct: 122 CYLREHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN--- 174
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR--VMGTYGYCAPEYAMTGQ 251
+I+RD+K NILL E KL DFG A + ++ +GT + APE +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWMAPEVILAMD 226
Query: 252 LT---LKSDVYSFGVVLLEIITG 271
K DV+S G+ +E+
Sbjct: 227 EGQYDGKVDVWSLGITCIELAER 249
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-32
Identities = 47/222 (21%), Positives = 82/222 (36%), Gaps = 20/222 (9%)
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEV-LMLSLLH 124
T F +G G FG V+K + AIK+ + G + L EV L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H ++V A+ D L+ EY GSL D + + + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG-----------LAKLGPVGDKTHVST 233
Y+H + +++ D+K SNI + P + + K+G +G T +S+
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 234 R--VMGTYGYCAPE-YAMTGQLTLKSDVYSFGVVLLEIITGR 272
G + A E K+D+++ + ++
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 58/238 (24%), Positives = 96/238 (40%), Gaps = 25/238 (10%)
Query: 44 EASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD 103
+ K G I + + +G G G+V+K R T V+A+KQ+
Sbjct: 5 SSGKQTGYLTIGGQRYQAEI-----NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR 59
Query: 104 RNGLQGNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL 160
R+G + + ++ +V++ P +V G + E M + +
Sbjct: 60 RSGNKEENKRILMDLDVVL-KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR-- 116
Query: 161 PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL- 219
+ + ++ K L YL +K VI+RD+K SNILL E KL DFG+
Sbjct: 117 --MQGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 220 AKLGPVGDKTHVSTRVMGTYGYCAPE-----YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+L R G Y APE +++DV+S G+ L+E+ TG+
Sbjct: 173 GRL----VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-30
Identities = 61/236 (25%), Positives = 100/236 (42%), Gaps = 16/236 (6%)
Query: 42 KKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQ 101
+E G F + +++ ++ LG G +G V R + T+ AIK
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 102 LDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159
+ + + + + EV +L LL HPN++ L + D LV E G L D +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-- 127
Query: 160 LPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSD 216
+ + + I G+ YLH +++RDLK N+LL + K+ D
Sbjct: 128 --IHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVD 182
Query: 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
FGL+ + K +GT Y APE + + K DV+S GV+L ++ G
Sbjct: 183 FGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 22/213 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLH- 124
+F ++G GGFG VY R T ++ A+K LD+ ++ + L E +MLSL+
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 125 --HPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAA 180
P +V + Y +L + + M G L HL + + MR AA
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-----QHGVFSEADMRFYAAEII 302
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
GLE++H++ V+YRDLK +NILL E H ++SD GLA K H V GT+G
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHG 355
Query: 241 YCAPEYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
Y APE G S D +S G +L +++ G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-30
Identities = 59/201 (29%), Positives = 90/201 (44%), Gaps = 12/201 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+LGEG F V R +T++ AIK L++ + + E ++S L HP V L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D ++ Y G L ++ D T R A LEYLH K
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFD-ETCTRFYTAEIVSALEYLHGKG- 150
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+I+RDLK NILL E H +++DFG AK+ K + +GT Y +PE
Sbjct: 151 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 208
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
SD+++ G ++ +++ G
Sbjct: 209 ACKSSDLWALGCIIYQLVAGL 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-30
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 21/206 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGY 134
+LG G G + R N+ VA+K++ +RE V++L HPN++
Sbjct: 31 VLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADRE--VQLLR-ESDEHPNVIRYFCT 86
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
D + + E +L++++ L+ T ++ GL +LH +
Sbjct: 87 EKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---QTTSGLAHLHSLN---I 139
Query: 195 IYRDLKCSNILLGE-----GYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEY-- 246
++RDLK NIL+ +SDFGL K L + V GT G+ APE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 247 -AMTGQLTLKSDVYSFGVVLLEIITG 271
T D++S G V +I+
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 17/226 (7%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
H F A + ++ +LG+G FG V + + T Q A+K + + ++ +
Sbjct: 10 HATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 113 ---FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDW 169
L EV +L L HPN++ L + D LV E G L D + +KR
Sbjct: 70 KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI----ISRKRFSE 125
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVG 226
RI G+ Y+H +++RDLK N+LL + + ++ DFGL+
Sbjct: 126 VDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HF 179
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + +GT Y APE + G K DV+S GV+L +++G
Sbjct: 180 EASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 59/220 (26%), Positives = 88/220 (40%), Gaps = 17/220 (7%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
H ++ + F LG G FG V+ S+ IK ++++ Q E
Sbjct: 6 HHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 113 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---D 168
E+ +L L HPN++ + D +V E G L + + K L
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPV 225
M+ A L Y H + V+++DLK NIL K+ DFGLA+L
Sbjct: 126 VAELMKQMMNA---LAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--F 177
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
H + GT Y APE +T K D++S GVV+
Sbjct: 178 KSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-28
Identities = 74/258 (28%), Positives = 109/258 (42%), Gaps = 19/258 (7%)
Query: 23 IDQIPSTSEKLK--VNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEG 80
I + ++ LK + +D + + D + + F LLG+G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKG 159
Query: 81 GFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLIGYCAD 137
FG+V + ++T + A+K L + + E L E +L HP L L Y
Sbjct: 160 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQ 218
Query: 138 GDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPVI 195
RL V EY G L HL ++R+ R R A L+YLH + N V+
Sbjct: 219 THDRLCFVMEYANGGELFFHLS-----RERVFSEDRARFYGAEIVSALDYLHSEKN--VV 271
Query: 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTL 254
YRDLK N++L + H K++DFGL K G T + GT Y APE
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPEVLEDNDYGR 328
Query: 255 KSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 329 AVDWWGLGVVMYEMMCGR 346
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 64/232 (27%), Positives = 98/232 (42%), Gaps = 26/232 (11%)
Query: 53 HIAAHTFTFRELAAVTKNFRAD----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ 108
H H + RE F C+LG+G FG V K + T Q A+K +++ +
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 109 GNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ EV +L L HPN++ L D +V E G L D + +KR
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKR 117
Query: 167 L---DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220
D ++ + Y+H +++RDLK NILL + K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ +GT Y APE + G K DV+S GV+L +++G
Sbjct: 172 T---CFQQNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 35/240 (14%)
Query: 53 HIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE 112
I + ++ + +++ LG G +G V + ++ + AIK + ++ R
Sbjct: 20 AINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRY 79
Query: 113 FLV-------------EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD 159
E+ +L L HPN++ L D LV E+ G L + +
Sbjct: 80 SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-- 137
Query: 160 LPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHP 212
R + AA K G+ YLH +++RD+K NILL +
Sbjct: 138 ----INRHKFDECD--AANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188
Query: 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
K+ DFGL+ K + +GT Y APE + + K DV+S GV++ ++ G
Sbjct: 189 KIVDFGLSS---FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV + + + A+K LD+ + ++ L E +L ++ P LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
D +V EY+ G + HL R R AA EYLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFS-EPHARFYAAQIVLTFEYLHSLD- 161
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK N+L+ + + +++DFG AK V +T + GT APE ++
Sbjct: 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGRTWT---LCGTPEALAPEIILSKG 214
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D ++ GV++ E+ G
Sbjct: 215 YNKAVDWWALGVLIYEMAAGY 235
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 58/279 (20%), Positives = 103/279 (36%), Gaps = 31/279 (11%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
P + + A + Q + + K + K + S +
Sbjct: 30 PNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAA 89
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVL------ 118
+ + ++G G V + +T A+K ++ + + E L EV
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 119 ---MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTR 172
+ + HP+++ LI LV++ M G L D+L +K L + +
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSI 205
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
MR A + +LH +++RDLK NILL + +LSDFG + + +
Sbjct: 206 MRSLLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--LEPGEKLR 257
Query: 233 TRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVL 265
GT GY APE + D+++ GV+L
Sbjct: 258 ELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 52/232 (22%), Positives = 91/232 (39%), Gaps = 36/232 (15%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHH 125
+ ++ +LG G G V + + VA+K++ + E +++L S H
Sbjct: 13 LKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALME--IKLLTESD-DH 68
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHL---HDLPPDKKRLDWTTRMRIAAGAAKG 182
PN++ + E +L+D + + + K + + A G
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127
Query: 183 LEYLHDKANPPVIYRDLKCSNILL-------------GEGYHPKLSDFGLAKL---GPVG 226
+ +LH +I+RDLK NIL+ E +SDFGL K G
Sbjct: 128 VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184
Query: 227 DKTHVSTRVMGTYGYCAPE-------YAMTGQLTLKSDVYSFGVVLLEIITG 271
+T+++ GT G+ APE +LT D++S G V I++
Sbjct: 185 FRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
+ + K F +LG G F V+ + T ++ A+K + ++ + E+ +L
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLK 61
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
+ H N+V L LV + + G L D + +R +T + A+ +
Sbjct: 62 KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI------LERGVYTEKD--ASLVIQ 113
Query: 182 ----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
++YLH+ +++RDLK N+L E ++DFGL+K+ ++ + +
Sbjct: 114 QVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMST 166
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT GY APE + D +S GV+
Sbjct: 167 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-27
Identities = 63/270 (23%), Positives = 110/270 (40%), Gaps = 26/270 (9%)
Query: 9 KSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIA-AHTFTFRELAAV 67
+S KN+ + ++ + + VK + + D A F R + A
Sbjct: 22 QSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAK 81
Query: 68 TKNFRAD------CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
+ +LG G FG+V+K +T +A K + G++ E E+ +++
Sbjct: 82 QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
L H NL+ L + +LV EY+ G L D + D + + T K
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-----ESYNLTELD--TILFMK 194
Query: 182 ----GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
G+ ++H +++ DLK NIL + K+ DFGLA+ +K V
Sbjct: 195 QICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---N 248
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE ++ +D++S GV+
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-27
Identities = 56/205 (27%), Positives = 87/205 (42%), Gaps = 14/205 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV----EVLMLSLLHHPNLVNL 131
LLGEG +G+V + T A+K L + L+ E+ +L L H N++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 132 --IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
+ Y + + +V EY G E + D P+K+ GLEYLH +
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLHSQ 128
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
++++D+K N+LL G K+S G+A+ G+ + PE A
Sbjct: 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG 185
Query: 250 GQL--TLKSDVYSFGVVLLEIITGR 272
K D++S GV L I TG
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 51/205 (24%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
+ + + + +G G +G V + T A K++ + ++ F E+ ++ L HP
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP 66
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRIAAGAAKGL 183
N++ L D LV E G L + + K+ D M+ A +
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVLSA---V 119
Query: 184 EYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
Y H V +RDLK N L KL DFGLA + T+V GT
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV-GTPY 173
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVL 265
Y +P+ + G + D +S GV++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 55/267 (20%), Positives = 92/267 (34%), Gaps = 19/267 (7%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
PC + + K+ + +
Sbjct: 93 PCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKH 152
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH 124
V ++ LG G FG V++ +T A K + E+ +S+L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HP LVNL D ++ +++YE+M G L + + D + + A +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-----EHNKMSEDE--AVEYMRQVC 265
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
GL ++H+ ++ DLK NI+ KL DFGL V GT
Sbjct: 266 KGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGT 319
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ APE A + +D++S GV+
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 65/214 (30%), Positives = 94/214 (43%), Gaps = 42/214 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K R T Q+VAIK+ D + + L E+ ML L HPNLVNL+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKHPNLVNLL 68
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
+ LV+EY L L+ + +P K + W T + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT--------LQAVNFCHK 120
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPE 245
I+RD+K NIL+ + KL DFG A+L GP V+TR Y +PE
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE 172
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
L + Y V V E+++G
Sbjct: 173 ------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 15/200 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIGY 134
+G+G F +V R T + VAIK +D+ L + EV ++ +L+HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
L+ EY G + D+L R+ ++Y H K +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQKR---I 135
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-- 252
++RDLK N+LL + K++DFG + VG K G Y APE G+
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LFQGKKYD 191
Query: 253 TLKSDVYSFGVVLLEIITGR 272
+ DV+S GV+L +++G
Sbjct: 192 GPEVDVWSLGVILYTLVSGS 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-26
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
+G+G FG+V + T ++ A+K +++ E E+ ++ L HP LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
Y ++ + +V + + G L HL + +++ L+YL ++
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFICELVMALDYLQNQR 135
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--YAM 248
+I+RD+K NILL E H ++DF +A + P + T + GT Y APE +
Sbjct: 136 ---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEMFSSR 189
Query: 249 TGQLTLKS-DVYSFGVVLLEIITGR 272
G + D +S GV E++ GR
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-26
Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 37/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGY 134
+LGEG RV T+Q A+K +++ EV ++ H N++ LI +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MRIAAGAAKGLEYLHDK 189
+ D+ LV+E M GS+ H+H KR + ++ A A L++LH+K
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIH------KRRHFNELEASVVVQDVASA---LDFLHNK 130
Query: 190 ANPPVIYRDLKCSNILLGEGYHP------KLSDFGLAK-LGPVGDKTHVSTRVM----GT 238
+ +RDLK NIL HP K+ DF L + GD + +ST + G+
Sbjct: 131 G---IAHRDLKPENILC---EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 239 YGYCAPEYAMTGQLTLKS-----DVYSFGVVL 265
Y APE D++S GV+L
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 26/225 (11%)
Query: 53 HIAAHTFTFRELAAVTKNFRAD----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ 108
H H + RE F C+LG+G FG V K + T Q A+K +++ +
Sbjct: 2 HHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK 61
Query: 109 GNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKR 166
+ EV +L L HPN++ L D +V E G L D + +KR
Sbjct: 62 NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKR 117
Query: 167 L---DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220
D ++ + Y+H +++RDLK NILL + K+ DFGL+
Sbjct: 118 FSEHDAARIIKQVFSG---ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T + R+ GT Y APE + G K DV+S GV+L
Sbjct: 172 TC--FQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-26
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 22/211 (10%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS 121
R T + +G G + + ++TN A+K +D++ E +E+ +L
Sbjct: 15 RNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLR 71
Query: 122 LLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRIAAG 178
HPN++ L DG +V E M G L D + +K + + +
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITK 127
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHP-KLSDFGLAKLGPVGDKTHVSTR 234
+EYLH + V++RDLK SNIL ++ DFG AK + + T
Sbjct: 128 T---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTP 180
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T + APE D++S GV+L
Sbjct: 181 C-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-26
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
LGEG +G V T + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHDK 189
+G+ + L EY G L D + + R +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG-----VVYLHGI 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + DV+S G+VL ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-26
Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LLG+G FG+V R ++T + A+K L + + E + E +L HP L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
Y RL V EY G L HL ++R+ R R A LEYLH +
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMT 249
V+YRD+K N++L + H K++DFGL K G T + GT Y APE +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE-VLE 178
Query: 250 GQLTLKS-DVYSFGVVLLEIITGR 272
++ D + GVV+ E++ GR
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (258), Expect = 9e-26
Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 17/201 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVEVLMLSLLHHPNLVNLI 132
LG G FGRV+ R + A+K L + + ++ E LMLS++ HP ++ +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKAN 191
G D Q ++ +Y+ G L L +R + AA LEYLH K
Sbjct: 73 GTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFP-NPVAKFYAAEVCLALEYLHSKD- 126
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
+IYRDLK NILL + H K++DFG AK V D T+ T + GT Y APE T
Sbjct: 127 --IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTY--T-LCGTPDYIAPEVVSTKP 179
Query: 252 LTLKSDVYSFGVVLLEIITGR 272
D +SFG+++ E++ G
Sbjct: 180 YNKSIDWWSFGILIYEMLAGY 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 64/243 (26%), Positives = 102/243 (41%), Gaps = 23/243 (9%)
Query: 40 DVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAI 99
+K KDG T ++ ++G G FG VY+ +L + ++VAI
Sbjct: 25 SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAI 84
Query: 100 KQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY-CADGDQRL-----LVYEYMPLGSL 153
K++ LQ R E+ ++ L H N+V L + + G+++ LV +Y+P ++
Sbjct: 85 KKV----LQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TV 139
Query: 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP- 212
K+ L + L Y+H + +RD+K N+LL
Sbjct: 140 YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVL 196
Query: 213 KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEII 269
KL DFG AK L + +R Y Y APE T DV+S G VL E++
Sbjct: 197 KLCDFGSAKQLVRGEPNVSYICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELL 251
Query: 270 TGR 272
G+
Sbjct: 252 LGQ 254
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 50/256 (19%), Positives = 101/256 (39%), Gaps = 25/256 (9%)
Query: 16 KKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADC 75
HH+ ++ + K+N ++ K + +V +
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQ------GSVYDYYDILE 57
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ ++T +V K ++ E+ +++ LHHP L+NL
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKAN 191
D + +L+ E++ G L D + + + + GL+++H+ +
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAA-----EDYKMSEAE--VINYMRQACEGLKHMHEHS- 169
Query: 192 PPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
+++ D+K NI+ + K+ DFGLA + V T + APE
Sbjct: 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTT-ATAEFAAPEIVDR 224
Query: 250 GQLTLKSDVYSFGVVL 265
+ +D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 42/214 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V K R + T ++VAIK+ D + + + E+ +L L H NLVNL+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLLKQLRHENLVNLL 90
Query: 133 GYCADGDQRLLVYEYMP---LGSLEDHLHDLPPDK-KRLDWTTRMRIAAGAAKGLEYLHD 188
C + LV+E++ L LE + L ++ + G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQI--------INGIGFCHS 142
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYGYCAPE 245
+I+RD+K NIL+ + KL DFG A+ P V+TR Y APE
Sbjct: 143 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE 194
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
L + Y V ++ E+ G
Sbjct: 195 ------LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 25/214 (11%)
Query: 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--------EV 117
A+ + LG G G V T + VAI+ + + E+
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+L L+HP ++ + + D + +V E M G L D + KRL T
Sbjct: 192 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFY 246
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
++YLH+ +I+RDLK N+LL E K++DFG +K+ +G+ + + T
Sbjct: 247 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 301
Query: 235 VMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVL 265
GT Y APE T D +S GV+L
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 60/271 (22%), Positives = 103/271 (38%), Gaps = 37/271 (13%)
Query: 13 NAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFR 72
+ HH+ +P S N K K+ + ++
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEP---------------LESQYQ 46
Query: 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV------EVLMLSLLHH- 125
LLG GGFG VY G S N VAIK ++++ + E EV++L +
Sbjct: 47 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 106
Query: 126 -PNLVNLIGYCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
++ L+ + D +L+ E P+ L D + ++ L + +
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAV 162
Query: 184 EYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+ H+ V++RD+K NIL+ KL DFG L T + GT Y
Sbjct: 163 RHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFD-GTRVYS 215
Query: 243 APEYAMTGQLT-LKSDVYSFGVVLLEIITGR 272
PE+ + + V+S G++L +++ G
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHHPNLVNLIGY 134
LGEG +G V T + VA+K +D E + E+ + +L+H N+V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHDK 189
+G+ + L EY G L D + + R +A + YLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAG-----VVYLHGI 124
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE---- 245
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 246 --YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + DV+S G+VL ++ G
Sbjct: 182 REFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 23/230 (10%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR 104
AS GG F + N+ LG+G F V + ++T A K ++
Sbjct: 5 ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT 64
Query: 105 NGLQGNREFLV--EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP 162
L + E + L HPN+V L + LV++ + G L + +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----- 119
Query: 163 DKKRLDWTTRMRIAAGAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLS 215
R ++ A+ + + Y H +++R+LK N+LL +G KL+
Sbjct: 120 -VAREFYSEAD--ASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLA 173
Query: 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
DFGLA V D GT GY +PE + D+++ GV+L
Sbjct: 174 DFGLAIE--VNDSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLH 124
+ N+ LG+G F V + ++T A K ++ L + E + L
Sbjct: 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 63
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HPN+V L + LV++ + G L + + R ++ A+ +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI------VAREFYSEAD--ASHCIQQIL 115
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
+ Y H +++R+LK N+LL +G KL+DFGLA V D G
Sbjct: 116 ESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGFA-G 169
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T GY +PE + D+++ GV+L
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 48/220 (21%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G V+K + T+++VA+K++ D G+ L E+ +L L H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKHKNIVRLH 67
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ LV+E+ DL KK D + + K GL
Sbjct: 68 DVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPEIVKSFLFQLLKGLG 115
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
+ H + V++RDLK N+L+ KL++FGLA+ PV + V+ T Y
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYR 168
Query: 243 APEYAMTGQLTLKSDVYSFGV-------VLLEIITGRKAI 275
P+ + + +YS + + E+ + +
Sbjct: 169 PPD------VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 70/206 (33%), Positives = 105/206 (50%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
+LG+G FG+V+ + TNQ AIK L ++ + + + +VE VL L+ HP L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-EHPFLTH 82
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
+ + L V EY+ G L H+ + D +R AA GL++LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFD-LSRATFYAAEIILGLQFLHS 136
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEY 246
K ++YRDLK NILL +G H K++DFG+ K +GD T GT Y APE
Sbjct: 137 KG---IVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPEI 189
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + D +SFGV+L E++ G+
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-25
Identities = 60/255 (23%), Positives = 107/255 (41%), Gaps = 23/255 (9%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ + ++ ++ G + + + A++ F + L
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESEL 61
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137
G G VY+ + + T + A+K L + + E+ +L L HPN++ L
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFET 119
Query: 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKANPP 193
+ LV E + G L D + ++ ++ R AA A K + YLH+
Sbjct: 120 PTEISLVLELVTGGELFDRI------VEKGYYSERD--AADAVKQILEAVAYLHENG--- 168
Query: 194 VIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDLK N+L K++DFGL+K+ V + + T GT GYCAPE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTVC-GTPGYCAPEILRGC 225
Query: 251 QLTLKSDVYSFGVVL 265
+ D++S G++
Sbjct: 226 AYGPEVDMWSVGIIT 240
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 59/264 (22%), Positives = 94/264 (35%), Gaps = 52/264 (19%)
Query: 57 HTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---- 112
F L + K + +G+G +G V T + AIK +++N ++
Sbjct: 14 LYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73
Query: 113 -FLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTT 171
EV ++ LHHPN+ L D LV E G L D L+ D
Sbjct: 74 RIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMD 133
Query: 172 RMRIAAG-----------------------------AAK-------GLEYLHDKANPPVI 195
++ + L YLH++ +
Sbjct: 134 VVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---IC 190
Query: 196 YRDLKCSNILLG--EGYHPKLSDFGLAKL---GPVGDKTHVSTRVMGTYGYCAPE--YAM 248
+RD+K N L + + KL DFGL+K G+ ++T+ GT + APE
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTT 249
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
K D +S GV+L ++ G
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
F+ + + G+G FG V G+ +ST VAIK++ ++ NRE L + L++LHHP
Sbjct: 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHP 79
Query: 127 NLVNLI------GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
N+V L G D L +V EY+P +L + +
Sbjct: 80 NIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 180 AKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHP-KLSDFGLAK-LGPVGDKTH-VSTRV 235
+ + LH N V +RD+K N+L+ E KL DFG AK L P + +R
Sbjct: 139 IRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR- 195
Query: 236 MGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
Y Y APE Q T D++S G + E++ G
Sbjct: 196 ---Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 21/208 (10%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G FG V +L++ ++V A+K L++ + E F E +L + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL- 139
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDK 189
+ A D + LV +Y G L L + RL R A ++ +H
Sbjct: 140 -HYAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLP-EEMARFYLAEMVIAIDSVHQL 194
Query: 190 ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
++RD+K NIL+ H +L+DFG S V GT Y +PE
Sbjct: 195 H---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 250
Query: 250 GQLTLKS-----DVYSFGVVLLEIITGR 272
+ D +S GV + E++ G
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 7e-25
Identities = 59/214 (27%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVL 118
+ V ++ LG G F V K R + T + A K + + L +R E EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 119 MLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL---DWTTRMRI 175
+L + HPN++ L + +L+ E + G L D L +K+ L + T ++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQ 116
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKLGPVGDKTHV 231
G+ YLH K + + DLK NI+L + P KL DFG+A +
Sbjct: 117 ILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF 168
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE L L++D++S GV+
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 60/208 (28%), Positives = 91/208 (43%), Gaps = 24/208 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G FG V R +ST +V A+K L + + + F E +++ + P +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL- 134
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHL--HDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
+ A D +V EYMP G L + + +D+P R A L+ +H
Sbjct: 135 -FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF-------YTAEVVLALDAIHS 186
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE--- 245
I+RD+K N+LL + H KL+DFG T V GT Y +PE
Sbjct: 187 MG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 242
Query: 246 -YAMTGQLTLKSDVYSFGVVLLEIITGR 272
G + D +S GV L E++ G
Sbjct: 243 SQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-25
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 22/215 (10%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--------EVLML 120
+ + LG G FG V+ + N+ V +K + + + + E+ +L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYE-YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
S + H N++ ++ + LV E + L + RLD I
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI----DRHPRLDEPLASYIFRQL 139
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+ YL K +I+RD+K NI++ E + KL DFG A G + GT
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTI 193
Query: 240 GYCAPEYAMTGQLTL--KSDVYSFGVVLLEIITGR 272
YCAPE + G + +++S GV L ++
Sbjct: 194 EYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 50/213 (23%), Positives = 79/213 (37%), Gaps = 29/213 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLI 132
++G G F V +++ T QV A+K +++ + E F E +L + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126
Query: 133 GYCA--DGDQRLLVYEYMPLGSLEDHL----HDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ A D + LV EY G L L +P + R A ++ +
Sbjct: 127 -HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARF-------YLAEIVMAIDSV 178
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H ++RD+K NILL H +L+DFG V GT Y +PE
Sbjct: 179 HRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEI 234
Query: 247 AMTGQLTLKSDVY-------SFGVVLLEIITGR 272
+ Y + GV E+ G+
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 67/207 (32%), Positives = 98/207 (47%), Gaps = 25/207 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
++G+G FG+V R ++ A+K L + + +E + E VL+ ++ HP LV
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVG 103
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L + +L V +Y+ G L HL ++R R R AA A L YLH
Sbjct: 104 LH-FSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAAEIASALGYLHS 157
Query: 189 KANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEY 246
++YRDLK NILL +G H L+DFGL K + T T GT Y APE
Sbjct: 158 LN---IVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPE- 209
Query: 247 AMTGQLTLKS-DVYSFGVVLLEIITGR 272
+ Q ++ D + G VL E++ G
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 62/213 (29%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R E EV +L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSIL 69
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ HPN++ L + +L+ E + G L D L K+ L A
Sbjct: 70 RQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFI 121
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH K + + DLK NI+L H KL DFGLA G +
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN- 177
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ GT + APE L L++D++S GV+
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-24
Identities = 54/231 (23%), Positives = 99/231 (42%), Gaps = 55/231 (23%)
Query: 74 DCLLGEGGFGRVYKGR--LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNL 131
C +G G +G VYK + ++ A+KQ++ G+ + E+ +L L HPN+++L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISL 83
Query: 132 IG-YCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA--------- 180
+ + D+++ L+++Y HDL + + +
Sbjct: 84 QKVFLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 181 ------KGLEYLHDKANPPVIYRDLKCSNILLGEGYHP----KLSDFGLAKL--GPVGDK 228
G+ YLH V++RDLK +NIL+ K++D G A+L P+
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
+ V+ T+ Y APE L L + D+++ G + E++T
Sbjct: 190 ADLDPVVV-TFWYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 60/229 (26%), Positives = 97/229 (42%), Gaps = 43/229 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-------------------- 115
+G+G +G V E+ N A+K L + L F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 116 ------EVLMLSLLHHPNLVNL--IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL 167
E+ +L L HPN+V L + + D +V+E + G + + P K L
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLKPL 134
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
KG+EYLH + +I+RD+K SN+L+GE H K++DFG++ D
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 228 KTHVSTRVMGTYGYCAPEYAMTGQLTL----KSDVYSFGVVLLEIITGR 272
+S V GT + APE +++ + DV++ GV L + G+
Sbjct: 192 A-LLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-24
Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 33/218 (15%)
Query: 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--------EV 117
A+ + LG G G V T + VAIK + + E+
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+L L+HP ++ + + D + +V E M G L D + KRL +
Sbjct: 67 EILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV----VGNKRL----KEATCK 117
Query: 178 GAAK----GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTH 230
++YLH+ +I+RDLK N+LL E K++DFG +K+ +G+ +
Sbjct: 118 LYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSL 172
Query: 231 VSTRVMGTYGYCAPE---YAMTGQLTLKSDVYSFGVVL 265
+ T GT Y APE T D +S GV+L
Sbjct: 173 MRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 26/208 (12%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM----LSLLHHPNL 128
+LG+G FG+V+ K Q+ A+K L + L+ V M L ++HP +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILVEVNHPFI 88
Query: 129 VNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYL 186
V L Y + +L L+ +++ G L L K+ + ++ A A L++L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLAELALALDHL 142
Query: 187 HDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAP 244
H +IYRDLK NILL EG H KL+DFGL+K +K GT Y AP
Sbjct: 143 HSLG---IIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKK---AYSFCGTVEYMAP 195
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E T +D +SFGV++ E++TG
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 49/217 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VYK + +S ++VA+K++ + G+ + E+ +L LHHPN+V+LI
Sbjct: 29 VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHHPNIVSLI 85
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
LV+E+M DL KK LD + + K G+
Sbjct: 86 DVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDSQIKIYLYQLLRGVA 133
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
+ H +++RDLK N+L+ KL+DFGLA+ PV TH V+ T Y
Sbjct: 134 HCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TLWYR 186
Query: 243 APEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
AP+ + + S D++S G + E+ITG+
Sbjct: 187 APD------VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 45/199 (22%), Positives = 81/199 (40%), Gaps = 22/199 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EV-LMLSLLHHPNLVNLIG 133
LG G F V + +ST Q A K L + + + E+ ++ P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDK 189
+ + +L+ EY G + + + + K G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSE-NDVIRLIKQILEGVYYLHQN 150
Query: 190 ANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+++ DLK NILL K+ DFG+++ +G + + GT Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELREIM-GTPEYLAPEI 204
Query: 247 AMTGQLTLKSDVYSFGVVL 265
+T +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 3e-24
Identities = 75/245 (30%), Positives = 110/245 (44%), Gaps = 37/245 (15%)
Query: 38 TVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVV 97
T + + +G D + F F L +LG+G FG+V + T+++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNF--LM----------VLGKGSFGKVMLSERKGTDELY 48
Query: 98 AIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVNLIGYCADGDQRL-LVYEYMPLG 151
A+K L ++ + + + +VE VL L P L L C RL V EY+ G
Sbjct: 49 AVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQLH-SCFQTMDRLYFVMEYVNGG 106
Query: 152 SLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEG 209
L H+ R AA A GL +L K +IYRDLK N++L EG
Sbjct: 107 DLMYHIQQ----VGRFK-EPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEG 158
Query: 210 YHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAMTGQLTLKS-DVYSFGVVLLE 267
H K++DFG+ K T T+ GT Y APE + Q KS D ++FGV+L E
Sbjct: 159 -HIKIADFGMCKENIWDGVT---TKTFCGTPDYIAPE-IIAYQPYGKSVDWWAFGVLLYE 213
Query: 268 IITGR 272
++ G+
Sbjct: 214 MLAGQ 218
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV------EVLMLSLLH----H 125
LLG+GGFG V+ G + VAIK + RN + G EV +L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 126 PNLVNLIGYCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
P ++ L+ + + +LV E +P L D++ +K L ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQ 153
Query: 185 YLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGD-KTHVSTRVMGTYGYC 242
+ H + V++RD+K NIL+ KL DFG L GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-----GTRVYS 205
Query: 243 APEYAMTGQLT-LKSDVYSFGVVLLEIITGR 272
PE+ Q L + V+S G++L +++ G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 74/265 (27%), Positives = 123/265 (46%), Gaps = 29/265 (10%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ D T+E L + E K+ + + + L ++F ++
Sbjct: 5 HHHHHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGL----QDFDLLRVI 60
Query: 78 GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVNLI 132
G G + +V RL+ T+++ A++ + + + + + E V + +HP LV L
Sbjct: 61 GRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVGLH 119
Query: 133 GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHDKA 190
C + RL V EY+ G L H+ +++L R +A + L YLH++
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP-EEHARFYSAEISLALNYLHERG 173
Query: 191 NPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYAM 248
+IYRDLK N+LL EG H KL+D+G+ K G T T GT Y APE +
Sbjct: 174 ---IIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-IL 225
Query: 249 TGQLTLKS-DVYSFGVVLLEIITGR 272
G+ S D ++ GV++ E++ GR
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-24
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 43/214 (20%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LGEG + VYKG+ + T+ +VA+K++ +G + EV +L L H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLEYLH 187
LV+EY+ DL K+ LD I K GL Y H
Sbjct: 70 HTEKSLTLVFEYLD--------KDL---KQYLD-DCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPE 245
+ V++RDLK N+L+ E KL+DFGLA+ P + V+ T Y P+
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRPPD 170
Query: 246 YAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
+ L S YS + + E+ TGR
Sbjct: 171 ------ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 24/197 (12%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGYC 135
LGEG F K + +NQ A+K + + ++ E+ + HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLHDKAN 191
D LV E + G L + + KK+ ++ A+ + + ++HD
Sbjct: 76 HDQLHTFLVMELLNGGELFERI------KKKKHFSETE--ASYIMRKLVSAVSHMHDVG- 126
Query: 192 PPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
V++RDLK N+L + K+ DFG A+L P ++ + T T Y APE
Sbjct: 127 --VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPELLN 182
Query: 249 TGQLTLKSDVYSFGVVL 265
D++S GV+L
Sbjct: 183 QNGYDESCDLWSLGVIL 199
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 5e-24
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
+LG+G FG+V R++ T + A+K L ++ + + + + E +L L+ +HP L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 88
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L C RL V E++ G L H+ +R D R R AA L +LHD
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFD-EARARFYAAEIISALMFLHD 142
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 247
K +IYRDLK N+LL H KL+DFG+ K G T T GT Y APE
Sbjct: 143 KG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAPE-I 195
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGR 272
+ L + D ++ GV+L E++ G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-24
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 42/219 (19%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGN-----REFLVEVL-MLSLLHHP 126
+G G +G VYK R + VA+K + G G RE V +L L HP
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--VALLRRLEAFEHP 74
Query: 127 NLVNLI----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
N+V L+ D + ++ LV+E++ DL + LD + A K
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPPGLPAETIK 123
Query: 182 --------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVST 233
GL++LH +++RDLK NIL+ G KL+DFGLA+ + ++
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQMALTP 178
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
V+ T Y APE + D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 6e-24
Identities = 68/219 (31%), Positives = 98/219 (44%), Gaps = 49/219 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-----FLVEVLMLSLLHHPNLVNL 131
LGEG F VYK R ++TNQ+VAIK++ ++ L E+ +L L HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GL 183
+ LV+++M DL + + + + K GL
Sbjct: 78 LDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSHIKAYMLMTLQGL 125
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTH-VSTRVMGTYG 240
EYLH +++RDLK +N+LL E KL+DFGLAK P TH V TR
Sbjct: 126 EYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----W 177
Query: 241 YCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
Y APE L + +Y GV +L E++
Sbjct: 178 YRAPE------LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 6e-24
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 26/209 (12%)
Query: 76 LLGEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPN 127
+LG+GG+G+V+ K +T ++ A+K L + + N + L + HP
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK-DTAHTKAERNILEEVKHPF 82
Query: 128 LVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEY 185
+V+LI Y +L L+ EY+ G L L ++ + A + L +
Sbjct: 83 IVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-----REGIFMEDTACFYLAEISMALGH 136
Query: 186 LHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCA 243
LH K +IYRDLK NI+L +G H KL+DFGL K T GT Y A
Sbjct: 137 LHQKG---IIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGTV---THTFCGTIEYMA 189
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE M D +S G ++ +++TG
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-24
Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 24/247 (9%)
Query: 36 NSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQ 95
N+ ++ K D + I + + ++G G FG V++ +L +++
Sbjct: 7 NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE 66
Query: 96 VVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY-----CADGDQRL-LVYEYMP 149
VAIK++ LQ R E+ ++ ++ HPN+V+L + + L LV EY+P
Sbjct: 67 -VAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209
++ K+ + + L Y+H + +RD+K N+LL
Sbjct: 122 E-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPP 177
Query: 210 YHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVL 265
KL DFG AK L + +R Y Y APE T D++S G V+
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVM 232
Query: 266 LEIITGR 272
E++ G+
Sbjct: 233 AELMQGQ 239
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 23/212 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM------LSLL 123
+F +LG+G FG+V + T+++ A+K L ++ + + + VE M
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALPG 399
Query: 124 HHPNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAK 181
P L L C RL V EY+ G L H+ R AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFK-EPHAVFYAAEIAI 453
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYG 240
GL +L K +IYRDLK N++L H K++DFG+ K T T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPD 507
Query: 241 YCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE D ++FGV+L E++ G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 7e-24
Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 49/217 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
+GEG +G VYK + + + A+K++ + G+ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKHSNIVKLY 66
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--------GLE 184
+ +LV+E++ DL KK LD + + AK G+
Sbjct: 67 DVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESVTAKSFLLQLLNGIA 114
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYC 242
Y HD+ V++RDLK N+L+ K++DFGLA+ PV TH ++ T Y
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167
Query: 243 APEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
AP+ + + S YS + + E++ G
Sbjct: 168 APD------VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-24
Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHHPNLVN 130
LG G FG+V G + T VA+K L+R ++ +V E+ L L HP+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD--VVGKIKREIQNLKLFRHPHIIK 75
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L + +V EY+ G L D++ R++ R+ ++Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHM 131
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
V++RDLK N+LL + K++DFGL+ + G+ S G+ Y APE ++G
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-VISG 184
Query: 251 QL--TLKSDVYSFGVVLLEIITGR 272
+L + D++S GV+L ++ G
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGT 208
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-24
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 28/201 (13%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG G G+V + T Q A+K L + +E V+ P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-QE--VD-HHWQASGGPHIVCILDVY 91
Query: 136 ADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA----AKGLEYLH 187
+ L++ E M G L + ++ +T R AA +++LH
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTERE--AAEIMRDIGTAIQFLH 145
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+ +RD+K N+L + KL+DFG AK + T T Y AP
Sbjct: 146 SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 245 EYAMTGQLTLKSDVYSFGVVL 265
E + D++S GV++
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 61/213 (28%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R E EV +L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ H N++ L + +L+ E + G L D L K+ L A
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSFI 121
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH K + + DLK NI+L H KL DFGLA + D
Sbjct: 122 KQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFK 176
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
GT + APE L L++D++S GV+
Sbjct: 177 NIF-GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 40/217 (18%)
Query: 77 LGEGGFGRVYKGR-LESTNQVVAIKQL----DRNGL--QGNREFLVEVL-MLSLLHHPNL 128
+GEG +G+V+K R L++ + VA+K++ G+ RE V VL L HPN+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAVLRHLETFEHPNV 76
Query: 129 VNLI----GYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-- 181
V L D + +L LV+E++ DL LD + K
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEPGVPTETIKDM 125
Query: 182 ------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRV 235
GL++LH V++RDLK NIL+ KL+DFGLA+ + +++ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMALTSVV 180
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ T Y APE + D++S G + E+ +
Sbjct: 181 V-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 58/220 (26%), Positives = 91/220 (41%), Gaps = 50/220 (22%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL----DRNGLQGNREFLVEVLMLSLLHHPNLVNLI 132
LGEG +G VYK TN+ VAIK++ + G+ + EV +L L H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQHRNIIELK 99
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA------KGLEYL 186
+ L++EY +DL KK +D + + + G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKL--GPVGDKTHVSTRVMGTY 239
H + ++RDLK N+LL K+ DFGLA+ P+ TH ++ T
Sbjct: 149 HSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII-TL 201
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
Y PE + L S YS V + E++
Sbjct: 202 WYRPPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 46/218 (21%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G + VYKG ++T VA+K++ + +G + E+ ++ L H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA------------KGL 183
++ LV+E+M +DL KK +D T G +GL
Sbjct: 73 HTENKLTLVFEFMD--------NDL---KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGY 241
+ H+ +++RDLK N+L+ + KL DFGLA+ PV + V+ T Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWY 174
Query: 242 CAPEYAMTGQLTLKSDVYSFGV-------VLLEIITGR 272
AP+ + + S YS + +L E+ITG+
Sbjct: 175 RAPD------VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 54/224 (24%), Positives = 88/224 (39%), Gaps = 34/224 (15%)
Query: 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--------NGLQGNREF 113
+N+ +LG G V + + T + A+K +D +Q RE
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 114 L---VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRL--- 167
V++L + HPN++ L LV++ M G L D+L + K L
Sbjct: 70 TLKEVDILR-KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEK 124
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227
+ MR + LH +++RDLK NILL + + KL+DFG + +
Sbjct: 125 ETRKIMRALLEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDP 176
Query: 228 KTHVSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVL 265
+ GT Y APE + D++S GV++
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 47/201 (23%), Positives = 80/201 (39%), Gaps = 21/201 (10%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-----EVLMLSLLHHPNLVNL 131
+G+G F V + T Q A+K +D + E + +L HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK----GLEYLH 187
+ + +V+E+M L + + + +A+ + L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEI----VKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 188 DKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
D +I+RD+K +LL KL FG+A +G+ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 245 EYAMTGQLTLKSDVYSFGVVL 265
E DV+ GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 1e-23
Identities = 63/266 (23%), Positives = 96/266 (36%), Gaps = 77/266 (28%)
Query: 77 LGEGGFGRVYKGRL-----ESTNQVVAIKQL-DRNGLQGNREFLVEV-LMLSLLHHPNLV 129
LG G FG+V + +T + VA+K L + +R + E+ +++ + HH N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 130 NLIG--------------YCADGDQRLLVY------------------------------ 145
NL+G +C G+ L Y
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGN--LSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 146 ---------------------EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
E L +E+ K L + + AKG+E
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
+L + I+RDL NILL E K+ DFGLA+ + AP
Sbjct: 208 FLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 264
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIIT 270
E T++SDV+SFGV+L EI +
Sbjct: 265 ETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 23/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---LVE--VLMLSLLHHPNLVN 130
++G G + +V RL+ T+++ A+K + + + + + E V + +HP LV
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-NHPFLVG 74
Query: 131 LIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLHD 188
L C + RL V EY+ G L H+ +++L R +A + L YLH+
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLP-EEHARFYSAEISLALNYLHE 128
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM-GTYGYCAPEYA 247
+ +IYRDLK N+LL H KL+D+G+ K G T T GT Y APE
Sbjct: 129 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIAPE-I 181
Query: 248 MTGQLTLKS-DVYSFGVVLLEIITGR 272
+ G+ S D ++ GV++ E++ GR
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 58/213 (27%), Positives = 89/213 (41%), Gaps = 28/213 (13%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLML 120
V + LG G F V K R +ST A K + + + +R + EV +L
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 68
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ HPN++ L + +L+ E + G L D L +K+ L A
Sbjct: 69 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLT----EEEATEFL 120
Query: 181 K----GLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVS 232
K G+ YLH + + DLK NI+L K+ DFGLA G++
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN- 176
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+ GT + APE L L++D++S GV+
Sbjct: 177 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 35/206 (16%), Positives = 85/206 (41%), Gaps = 22/206 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV-EVLMLSLLHH 125
+ + + LG G FG V++ S+ + K + G ++ + E+ +L++ H
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARH 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK---- 181
N+++L ++ ++++E++ + + ++ + R
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINT-----SAFELNERE--IVSYVHQVCE 113
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
L++LH + + D++ NI+ K+ +FG A+ GD + +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVL 265
Y APE ++ +D++S G ++
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 49/208 (23%), Positives = 85/208 (40%), Gaps = 22/208 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLH 124
T+ ++ LG+G F V + Q A ++ L + E + LL
Sbjct: 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK 68
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK--- 181
HPN+V L ++ L+++ + G L + + R ++ A+ +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDI------VAREYYSEAD--ASHCIQQIL 120
Query: 182 -GLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG 237
+ + H V++R+LK N+LL +G KL+DFGLA V + G
Sbjct: 121 EAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAG 175
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
T GY +PE D+++ GV+L
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 6e-23
Identities = 28/205 (13%), Positives = 58/205 (28%), Gaps = 41/205 (20%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPN 127
+R G + ++ + ++ VA+ +D G+ + +E L L LS + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+ ++ L+V E++ GSL++ +R A + H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAH 146
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
V S + + L+
Sbjct: 147 RA---GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA-- 179
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ D+ G L ++ R
Sbjct: 180 -----NPQDDIRGIGASLYALLVNR 199
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 38/212 (17%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV--EVLMLSLLHHPNLVNLIG 133
+G G FG R + T ++VA+K ++R V E++ L HPN+V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKE 83
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMR-----IAAGAAKGLEYLHD 188
++ EY G L + + + R ++ + Y H
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSG-----VSYCHS 134
Query: 189 KANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE- 245
+ +RDLK N LL P K+ DFG +K + + + V GT Y APE
Sbjct: 135 MQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEV 188
Query: 246 -----YAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y G+ +DV+S GV L ++ G
Sbjct: 189 LLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 52/274 (18%), Positives = 92/274 (33%), Gaps = 43/274 (15%)
Query: 5 PCAGKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFREL 64
P + + + P+ ++ + I ++
Sbjct: 10 PPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQV 69
Query: 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLL 123
LG G G+V + + T + A+K L EV L
Sbjct: 70 ------------LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRAS 112
Query: 124 HHPNLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MR 174
P++V ++ + L+V E + G L + D+ +T R M+
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMK 168
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHV 231
A ++YLH + +RD+K N+L KL+DFG AK + +
Sbjct: 169 SIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--L 220
Query: 232 STRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVL 265
+T T Y APE + D++S GV++
Sbjct: 221 TTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 65/268 (24%), Positives = 103/268 (38%), Gaps = 24/268 (8%)
Query: 18 HHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAVTKNFRADCLL 77
HH+ ++ +S S + T +NF +L
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVL 62
Query: 78 GEGGFGRVY---KGRLESTNQVVAIKQLDRNGLQGNREFLVEVLM-----LSLLHHPNLV 129
G G +G+V+ K T ++ A+K L + + + + P LV
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 130 NLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI-AAGAAKGLEYLH 187
L Y + +L L+ +Y+ G L HL ++R ++I LE+LH
Sbjct: 123 TLH-YAFQTETKLHLILDYINGGELFTHLSQ----RERFT-EHEVQIYVGEIVLALEHLH 176
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+IYRD+K NILL G H L+DFGL+K + GT Y AP+
Sbjct: 177 KLG---IIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDI 231
Query: 247 AMTGQLTLKSDV--YSFGVVLLEIITGR 272
G V +S GV++ E++TG
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-22
Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 54/226 (23%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-F----LVEVLMLSLLHHPNLVNL 131
+G+G FG V+K R T Q VA+K++ ++ +E F L E+ +L LL H N+VNL
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 132 IGYCADGDQRL--------LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK-- 181
I C LV+++ HDL L ++ K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-NVLVKFTLSEIKRV 129
Query: 182 ------GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVST 233
GL Y+H +++RD+K +N+L+ KL+DFGLA+ + + T
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 234 RVMGTYGYCAPEYAMTGQLTLKS-------DVYSFGVVLLEIITGR 272
+ T Y PE L L D++ G ++ E+ T
Sbjct: 187 NRVVTLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 5e-22
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLI 132
LGEG FG+V T Q VA+K + R L+ + + E+ L LL HP+++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
++V EY G L D++ +KKR+ R +EY H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL 252
+++RDLK N+LL + + K++DFGL+ + G+ S G+ Y APE + G+L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 253 --TLKSDVYSFGVVLLEIITGR 272
+ DV+S G+VL ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-22
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLV---EVLMLSLLHHPNLVNLI 132
LG G FG+V G+ E T VA+K L+R ++ E+ L L HP+++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
+ +V EY+ G L D++ RLD R+ G++Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE------Y 246
V++RDLK N+LL + K++DFGL+ + G+ S G+ Y APE Y
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLY 192
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
A G + D++S GV+L ++ G
Sbjct: 193 A--G---PEVDIWSSGVILYALLCGT 213
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-21
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V K ++ +G G G V ++ VAIK+L R N R E++++ +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCV 118
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+H N+++L+ + LV E M + +L + + LD +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERMSYLLY 171
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT--HVSTRV 235
G+++LH A +I+RDLK SNI++ K+ DFGLA+ +V TR
Sbjct: 172 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 228
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E++ +
Sbjct: 229 -----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 6e-21
Identities = 34/166 (20%), Positives = 64/166 (38%), Gaps = 14/166 (8%)
Query: 116 EVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
++ + N V + + + + +L+D + + + + I
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD-WMNRRCSLEDREHGVCLHI 169
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK----------LGPV 225
A+ +E+LH K +++RDLK SNI K+ DFGL +
Sbjct: 170 FIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
T +GT Y +PE + K D++S G++L E++
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-09
Identities = 21/102 (20%), Positives = 39/102 (38%), Gaps = 2/102 (1%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNLIG- 133
+G GGFG V++ + + + AIK++ + RE + EV L+ L HP +V
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRI 175
+ ++ E L + ++R
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-20
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V K ++ +G G G V + VAIK+L R N R + E++++ +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCV 81
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
+H N++ L+ + +V E M + +L + + LD +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVI--QMELDHERMSYLLY 134
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA-KLGPVGDKT-HVSTRV 235
G+++LH A +I+RDLK SNI++ K+ DFGLA G T +V TR
Sbjct: 135 QMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 191
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E+I G
Sbjct: 192 -----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 52/254 (20%), Positives = 95/254 (37%), Gaps = 67/254 (26%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
+K + LG G FG V + + + A+K++ ++ NRE + ++ +L H
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHV 60
Query: 127 NLVNLIGY-------------------------------------CADGDQRL-LVYEYM 148
N++ L+ Y ++ L ++ EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 149 P------LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202
P L S +P + + + + ++H + +RD+K
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISI-------YIYQLFRAVGFIH-SLG--ICHRDIKPQ 170
Query: 203 NILLGEGYHP-KLSDFGLAK-LGPVGDKTH-VSTRVMGTYGYCAPEYAMTGQL-TLKSDV 258
N+L+ + KL DFG AK L P + +R + Y APE + T D+
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDL 225
Query: 259 YSFGVVLLEIITGR 272
+S G V E+I G+
Sbjct: 226 WSIGCVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-19
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 38/222 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
+ K + + +G G +G V + + + VAIK+L R + + R E+L+L +
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHM 80
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLH-----DLPPDKKRLDWTTR 172
H N++ L+ LV +M + L +K +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY----- 130
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH-V 231
+ KGL+Y+H A V++RDLK N+ + E K+ DFGLA+ + T V
Sbjct: 131 --LVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTGYV 184
Query: 232 STRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
TR Y APE ++ D++S G ++ E++TG+
Sbjct: 185 VTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 43/227 (18%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLH 124
V + +GEG +G V VAIK++ + R L E+ +L
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFR 83
Query: 125 HPNLVNLIG----YCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKR------L 167
H N++ + + + + +V + M E L+ L D L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVG 226
+GL+Y+H AN V++RDLK SN+LL K+ DFGLA+ P
Sbjct: 139 -------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 227 DKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
D T T + T Y APE + + T D++S G +L E+++ R
Sbjct: 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 61/222 (27%), Positives = 92/222 (41%), Gaps = 37/222 (16%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V +R +G G +G V T VAIK+L R + L R E+ +L +
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHM 81
Query: 124 HHPNLVNLIG-YCADGDQRL-----LVYEYMPLGSLEDHLH------DLPPDKKRLDWTT 171
H N++ L+ + D LV +M L L D+ +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQF---- 132
Query: 172 RMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV 231
+ KGL Y+H A +I+RDLK N+ + E K+ DFGLA+ +V
Sbjct: 133 ---LVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 186
Query: 232 STRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
TR Y APE + T D++S G ++ E+ITG+
Sbjct: 187 VTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 45/161 (27%), Positives = 62/161 (38%), Gaps = 15/161 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V NFR +G G FG + G+ TN+ VAIK L
Sbjct: 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGD 65
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ + + G +V E LG SLED + T + IA +EY
Sbjct: 66 GIPQVYYFGPCGKYNAMVLEL--LGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEY 120
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAK 221
+H K +IYRD+K N L+G + + DF LAK
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-18
Identities = 57/217 (26%), Positives = 91/217 (41%), Gaps = 22/217 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH- 125
V +R +G G FG +Y G + + VAIK + + +E + ++
Sbjct: 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGG 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ + A+GD ++V E LG SLED + ++ T + +A +E
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMEL--LGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIE 119
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK---LSDFGLAKL-GPVGDKTHVSTR----VM 236
Y+H K I+RD+K N L+G G + DFGLAK H+ R +
Sbjct: 120 YIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 237 GTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
GT Y A G + + + D+ S G VL+ G
Sbjct: 177 GTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 50/234 (21%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNGLQGNREFLVEVLMLSLLH 124
++ +F+ LLGEG +G V + T ++VAIK+++ L R L E+ +L
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFK 67
Query: 125 HPNLVNLIG-YCADGDQRL----LVYEYMPLGSLEDHLH------DLPPDKKR------L 167
H N++ + D + ++ E M + LH L D + L
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTL 122
Query: 168 DWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA----KLG 223
+ ++ LH +N VI+RDLK SN+L+ K+ DFGLA +
Sbjct: 123 -------------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 224 PVGDKTHVSTRVMGTY----GYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ M + Y APE +T + DV+S G +L E+ R
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 5e-18
Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 22/217 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-H 125
V FR +G G FG +Y G TN+ VAIK + + + L E + +L
Sbjct: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGG 62
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ N+ + +GD +LV + LG SLED + ++L T + +A +E
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDL--LGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 117
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK---LSDFGLAKL-GPVGDKTHVSTR----VM 236
++H K+ ++RD+K N L+G G + DFGLAK H+ R +
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLT 174
Query: 237 GTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
GT Y A G + + + D+ S G VL+ + G
Sbjct: 175 GTARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-18
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 39/223 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V + ++ +G G +G V T VA+K+L R + + R E+ +L +
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHM 85
Query: 124 HHPNLVNLI-----GYCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKRLDWTT 171
H N++ L+ + + LV M L+ L D +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQF---- 136
Query: 172 RMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT-H 230
+ +GL+Y+H A+ +I+RDLK SN+ + E K+ DFGLA+ + T +
Sbjct: 137 ---LIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTGY 189
Query: 231 VSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
V+TR Y APE + D++S G ++ E++TGR
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 56/230 (24%), Positives = 94/230 (40%), Gaps = 40/230 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLD-RNGLQGNREFLVEVLMLSLLHH 125
+ + LG GG G V+ ++ VAIK++ + L E+ ++ L H
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDH 67
Query: 126 PNLVNLIG-YCADGDQRL-------------LVYEYMPLGSLEDHLH------DLPPDKK 165
N+V + G Q +V EYM E L L +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHA 122
Query: 166 RLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAK-LG 223
RL +GL+Y+H AN V++RDLK +N+ + E K+ DFGLA+ +
Sbjct: 123 RL-------FMYQLLRGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
P + + T Y +P ++ T D+++ G + E++TG+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-17
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 37/212 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGYC 135
LG G + V++ + N+ V +K L ++ E+ +L +L PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 136 ADGDQR--LLVYEYMPLGSLEDHLHDLPPDKKR------LDWTTRMRIAAGAAKGLEYLH 187
D R LV+E++ + L R L K L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLG-PVGDKTH-VSTRVMGTYGYCAP 244
+++RD+K N+++ E +L D+GLA+ P + V++R + P
Sbjct: 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEIITGRKAI 275
E + Q+ S D++S G +L +I ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 60/245 (24%), Positives = 94/245 (38%), Gaps = 60/245 (24%)
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR--NGLQGNREF----- 113
EL A+ + + G +G V G ++S VAIK++ + +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72
Query: 114 ----LVEVLMLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMPLGSLEDHLH------ 158
L E+ +L+ HHPN++ L + + +L LV E M L
Sbjct: 73 CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQ 127
Query: 159 --DLPPDKKR------LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210
+ P + L GL LH+ A V++RDL NILL +
Sbjct: 128 RIVISPQHIQYFMYHIL-------------LGLHVLHE-AG--VVHRDLHPGNILLADNN 171
Query: 211 HPKLSDFGLA-KLGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLE 267
+ DF LA + +KT +V+ R Y APE M T D++S G V+ E
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAE 226
Query: 268 IITGR 272
+ +
Sbjct: 227 MFNRK 231
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-17
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH- 125
V +++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGC 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
+ N+ + +G +LV + LG SLED L ++ T A ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDL--LGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQ 120
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPK-----LSDFGLAKL-GPVGDKTHVSTR---- 234
+H+K+ ++YRD+K N L+G + DFG+ K K H+ R
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 177
Query: 235 VMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272
+ GT Y G + + + D+ + G V + + G
Sbjct: 178 LSGTARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 39/158 (24%), Positives = 62/158 (39%), Gaps = 28/158 (17%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNLVNLIGYC 135
LG G G+V + + T + A+K L EV L P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 80
Query: 136 ADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR-----MRIAAGAAKGLEYL 186
+ L+V E + G L + D+ +T R M+ A ++YL
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEA---IQYL 133
Query: 187 HDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAK 221
H + +RD+K N+L KL+DFG AK
Sbjct: 134 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 9e-16
Identities = 51/235 (21%), Positives = 87/235 (37%), Gaps = 54/235 (22%)
Query: 8 GKSSKNAKKKHHNKPIDQIPSTSEKLKVNSTVDVKKEASKDGGSDHIAAHTFTFRELAAV 67
G S + A + HN S S++ + +SK S + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRK---QHHSSKPTASMPRPHSDWQ------I 51
Query: 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREF---------LVEVL 118
+ L+G G +G V + + +VVAIK++ R F L E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-------LRVFEDLIDCKRILREIA 104
Query: 119 MLSLLHHPNLVNL----IGYCADGDQRL-LVYEYMP--LGSLEDHLHDLPPDKKR----- 166
+L+ L+H ++V + I + L +V E L L +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 167 -LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220
L G++Y+H A +++RDLK +N L+ + K+ DFGLA
Sbjct: 165 LL-------------VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-15
Identities = 47/208 (22%), Positives = 81/208 (38%), Gaps = 43/208 (20%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V N+ L+G G +G VY ++T + VAIK+++R + + R L E+ +L+ L
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRL 82
Query: 124 HHPNLVNL----IGYCADGDQRL-LVYEYMPLGSLEDHLH-------DLPPDKKR----- 166
++ L I L +V E + L L + +
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYN 137
Query: 167 -LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225
L G ++H+ + +I+RDLK +N LL + K+ DFGLA+
Sbjct: 138 LL-------------LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181
Query: 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
T++ + + QLT
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLT 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 60/244 (24%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDR---NGLQGNREFLVEVLMLSLL 123
V + + LG+G +G V+K T +VVA+K++ N R E+++L+ L
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTEL 65
Query: 124 H-HPNLVNLIG-YCADGDQRL-LVYEYMPLGSLEDHLH------DLPPDKKR------LD 168
H N+VNL+ AD D+ + LV++YM E LH L P K+ +
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLI- 119
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
K ++YLH +++RD+K SNILL H K++DFGL++ +
Sbjct: 120 ------------KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 229 THVSTRVMGTYG-------------------YCAPEYAMTGQL-TLKSDVYSFGVVLLEI 268
+ + Y APE + T D++S G +L EI
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
Query: 269 ITGR 272
+ G+
Sbjct: 225 LCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-14
Identities = 30/175 (17%), Positives = 59/175 (33%), Gaps = 29/175 (16%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLEST--------NQVVAIKQLDRNG----------LQGN 110
+ ++ G +Y+ ST Q ++K ++G
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 111 REFLVEVLMLSLLHHPNLVNLIGY-CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLD 168
+ + L + +G+ R LV LG SL+ L P K L
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLS 157
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
+ +++A LE+LH+ ++ ++ NI + + L+ +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 8e-13
Identities = 31/175 (17%), Positives = 61/175 (34%), Gaps = 32/175 (18%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIK----------QLDR-----NGLQGNREF 113
+ +G GGFG +Y + + A L + ++
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAK-KDC 95
Query: 114 LVEVLMLSLLHHPNLVNLIGY----CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLD 168
+ + + L + + G R +V E LG L+
Sbjct: 96 IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQKISG----QNGTFK 149
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
+T +++ LEY+H+ ++ D+K +N+LLG + L+D+GL+
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 65.7 bits (159), Expect = 2e-12
Identities = 42/260 (16%), Positives = 69/260 (26%), Gaps = 65/260 (25%)
Query: 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL------QGNRE 112
F T+ + +GEG FG V++ + T + I ++ L + E
Sbjct: 11 VPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 113 FLVEVLMLSLLH---------HPNLVNLIG-YCADG------------------------ 138
L E+++ L + L +C G
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 139 -----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
DQ +V E+ G + + K T I L
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV------STRVMGTYGYC----- 242
+RDL N+LL + KL K + + + G
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV 242
Query: 243 -APEYAMTGQLTLKSDVYSF 261
E TG + D+Y
Sbjct: 243 SMDEDLFTGDGDYQFDIYRL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-12
Identities = 33/178 (18%), Positives = 63/178 (35%), Gaps = 31/178 (17%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQV-----VAIKQLDRNGLQ-----------GN 110
++ +G+GGFG +Y + S+ V +K +
Sbjct: 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 111 REFLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLLVYEYMPLG-SLEDHLHDLPPDKK 165
E + + + L + + G R ++ + G L+ K
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANA---K 147
Query: 166 RLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK--LSDFGLAK 221
R T ++++ LEY+H+ ++ D+K SN+LL + L D+GLA
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 45/219 (20%), Positives = 88/219 (40%), Gaps = 34/219 (15%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH----------- 124
LG G F V+ + N VA+K + R E+ +L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 125 HPNLVNLIGY----CADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+++ L+ + +G ++V+E LG +L + + + + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKY--EHRGIPLIYVKQISKQL 140
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP------KLSDFGLAKLGPVGDKTHVST 233
GL+Y+H + +I+ D+K N+L+ P K++D G A + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
R Y +PE + +D++S ++ E+ITG
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 48/219 (21%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL------HHPNLV 129
++G+G FG+V K +Q VA+K + RN + +R+ E+ +L L + N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 130 NLIGY-------CADGDQRLLVYEYMPLGSLEDHL-----HDLPPDKKRLDWTTRMRIAA 177
+++ C + +E + + +L + + R + A
Sbjct: 163 HMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKFQGFSLPLVR-------KFAH 207
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDK--THVST 233
+ L+ LH +I+ DLK NILL + K+ DFG + + T++ +
Sbjct: 208 SILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYTYIQS 262
Query: 234 RVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
R Y APE + + + D++S G +L E++TG
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 3e-10
Identities = 48/264 (18%), Positives = 82/264 (31%), Gaps = 74/264 (28%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HH 125
+ LG G F V+ + VA+K + ++ L E+ +L + +
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPND 97
Query: 126 PNLVNLIGYC-------ADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAA 177
PN ++ +G +V+E LG L + + L +I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNY--QGLPLPCVKKIIQ 153
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLG------------------------------ 207
+GL+YLH K +I+ D+K NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 208 -------------------EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
E K++D G A + TR Y + E +
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLI 266
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
+D++S + E+ TG
Sbjct: 267 GSGYNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL--------HHPN 127
L+G+G FG+V K + VAIK + +N + +EV +L L+ ++
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYY-- 117
Query: 128 LVNLIGY-------CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRM--RIAAG 178
+V+L + C LV+E L +L+DL + + + + A
Sbjct: 118 IVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQ 165
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP--KLSDFGLAKLGPVGDK--THVSTR 234
L +L +I+ DLK NILL K+ DFG + +G + ++ +R
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRIYQYIQSR 222
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y +PE + L D++S G +L+E+ TG
Sbjct: 223 F-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 59/248 (23%), Positives = 89/248 (35%), Gaps = 86/248 (34%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-----HHPNLVN 130
+G+G FGRV + + A+K + RN + R +E +L + ++ N+V
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIVK 100
Query: 131 LIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTTRMRIAA 177
G C L++E PLG SL + + + +
Sbjct: 101 YHGKFMYYDHMC-------LIFE--PLGPSLYEIITRNNYNGFHIEDIK-------LYCI 144
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP------------------------- 212
K L YL + + + DLK NILL + Y
Sbjct: 145 EILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGI 201
Query: 213 KLSDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGV 263
KL DFG A H ++TR Y APE + + SD++SFG
Sbjct: 202 KLIDFGCATF---KSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGC 247
Query: 264 VLLEIITG 271
VL E+ TG
Sbjct: 248 VLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 50/240 (20%), Positives = 79/240 (32%), Gaps = 74/240 (30%)
Query: 76 LLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL--------HHP 126
LGEG FG+V + VA+K + RN + +E+ +L +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII-RNVGKYREAARLEINVLKKIKEKDKENKFL- 83
Query: 127 NLVNLIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTTRM 173
V + + C + +E LG + + L + P R
Sbjct: 84 -CVLMSDWFNFHGHMC-------IAFE--LLGKNTFEFLKENNFQPYPLPHVR------- 126
Query: 174 RIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-------------------KL 214
+A L +LH+ + + DLK NIL ++
Sbjct: 127 HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 215 SDFGLAKLGPVGDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 271
+DFG A + H V+TR Y PE + DV+S G +L E G
Sbjct: 184 ADFGSATF---DHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 8e-05
Identities = 56/244 (22%), Positives = 90/244 (36%), Gaps = 82/244 (33%)
Query: 76 LLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP------NL 128
LGEG FG+V + ++ + VA+K + +N + E+ +L L+
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 129 VNLIGY-------CADGDQRLLVYEYMPLG-SLEDHLHD-----LPPDKKRLDWTTRMRI 175
V ++ + C +V+E LG S D + + D R ++
Sbjct: 80 VQMLEWFEHHGHIC-------IVFE--LLGLSTYDFIKENGFLPFRLDHIR-------KM 123
Query: 176 AAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP-------------------KLSD 216
A K + +LH + + DLK NIL + + K+ D
Sbjct: 124 AYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 217 FGLAKLGPVGDKTH---VSTRVMGTYGYCAPE------YAMTGQLTLKSDVYSFGVVLLE 267
FG A D+ H VSTR Y APE ++ DV+S G +L+E
Sbjct: 181 FGSATY---DDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILIE 226
Query: 268 IITG 271
G
Sbjct: 227 YYLG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.58 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.33 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.27 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.0 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.76 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.73 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.68 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.58 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.55 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.35 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.13 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.08 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 98.02 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.93 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.75 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.73 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.69 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.68 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.62 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.91 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.85 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.63 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.29 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 92.32 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 88.94 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.43 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-58 Score=391.48 Aligned_cols=206 Identities=29% Similarity=0.389 Sum_probs=187.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||+||+|++..+++.||||++.+.. ....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999999999999999997532 223467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999975 467999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 240 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG 240 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 44444556678999999999999999999999999999999999999999876543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-57 Score=389.42 Aligned_cols=203 Identities=26% Similarity=0.375 Sum_probs=185.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
..|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||++++++|.+++.+|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999997665556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+||+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-- 223 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 223 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC--
Confidence 99999999864 46999999999999999999999999 999999999999999999999999999864332
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~ 276 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 276 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 22344578999999999999999999999999999999999999999876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-57 Score=389.64 Aligned_cols=206 Identities=23% Similarity=0.350 Sum_probs=178.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999999765433 34568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
||+||+|.+++... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~- 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS- 177 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH-
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC-
Confidence 99999999999652 2456899999999999999999999999 99999999999999999999999999986432
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 178 -~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 231 (350)
T 4b9d_A 178 -TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK 231 (350)
T ss_dssp -HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 222234568999999999999999999999999999999999999999876543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-56 Score=391.59 Aligned_cols=204 Identities=25% Similarity=0.372 Sum_probs=186.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
..|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+|+.++||||++++++|.+.+.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 46999999999999999999999999999999998776666777899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+||+|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-- 300 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-- 300 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS--
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC--
Confidence 99999999864 46999999999999999999999999 999999999999999999999999999864332
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 301 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~ 354 (423)
T 4fie_A 301 VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK 354 (423)
T ss_dssp CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH
Confidence 223445789999999999999999999999999999999999999998765443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-55 Score=366.63 Aligned_cols=202 Identities=29% Similarity=0.433 Sum_probs=167.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||||++++... .....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999976432 23456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+ +|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6899999875 467999999999999999999999999 99999999999999999999999999985432
Q ss_pred CCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+..
T Consensus 165 ~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~ 218 (275)
T 3hyh_A 165 G---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP 218 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH
Confidence 2 22335689999999999988876 57899999999999999999999876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=377.28 Aligned_cols=202 Identities=24% Similarity=0.295 Sum_probs=176.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+.|.+.+.||+|+||.||+|++..+|+.||||+++..... .+|+.+++.++||||+++++++.+++.+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4588899999999999999999999999999999764332 36999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccCCCCC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 227 (296)
+||+|.++++. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+| .+||+|||+|+......
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999975 467999999999999999999999999 99999999999999887 69999999998644322
Q ss_pred cc---eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 228 KT---HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.. ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 263 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence 11 12234679999999999999999999999999999999999999998765543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-56 Score=377.60 Aligned_cols=205 Identities=30% Similarity=0.388 Sum_probs=175.1
Q ss_pred cCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|++++.||+|+||+||+|++. .+++.||||++++... .....+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999884 4688999999975432 223467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|||||+||+|.+++.+ ...+++..+..++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999976 467999999999999999999999999 999999999999999999999999999853
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
... .......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+
T Consensus 177 ~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~ 233 (304)
T 3ubd_A 177 IDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH
Confidence 322 222345789999999999999999999999999999999999999998766543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-55 Score=371.64 Aligned_cols=211 Identities=31% Similarity=0.485 Sum_probs=182.9
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......+++.+|+.+++.++||||+++++++.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46888999999999999999875 3578999999987766667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 144 VYEYMPLGSLEDHLHDLP---------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~---------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
|||||++|+|.++++... .....+++..+..|+.|++.||+|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999996531 23457999999999999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999986444333333444579999999999999999999999999999999999 999998876443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-54 Score=363.24 Aligned_cols=199 Identities=33% Similarity=0.483 Sum_probs=172.9
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec----CCceEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 144 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~~lv 144 (296)
|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||++++++|.+ .+.+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 3677889999999999999999999999999965432 234568899999999999999999999865 3468999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~~~ 223 (296)
||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++ .++.+||+|||+|+..
T Consensus 108 mEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 108 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 999999999999976 467999999999999999999999875 2499999999999997 4789999999999863
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.+.+
T Consensus 183 ~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 183 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred CCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 322 2345689999999999865 69999999999999999999999997644
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=368.67 Aligned_cols=211 Identities=31% Similarity=0.521 Sum_probs=176.0
Q ss_pred cCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......+++.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 35778899999999999999865 3688999999987766667789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 144 VYEYMPLGSLEDHLHDLPP-----------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~-----------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
|||||++|+|.++++.... ...++++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999975322 2356999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
||+|||+++...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999986544444444455789999999999999999999999999999999999 999998766443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-53 Score=360.14 Aligned_cols=202 Identities=32% Similarity=0.517 Sum_probs=169.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+++.+.+.||+|+||+||+|.+.. .||||+++... ....+.+.+|+.+++.++||||+++++++.+ +.++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 468889999999999999998753 48999986543 2334678999999999999999999998754 67899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
||+||+|.+++.. ....+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999965 2467999999999999999999999999 999999999999999999999999999865443
Q ss_pred CcceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.........+||+.|||||++.+ +.|+.++|||||||++|||+||+.||.+.+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 33334455789999999999964 3589999999999999999999999987553
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-53 Score=360.70 Aligned_cols=209 Identities=31% Similarity=0.462 Sum_probs=179.6
Q ss_pred CCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++++.+.||+|+||.||+|... .+++.||||+++... ....+++.+|+.+++.++||||+++++++.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4677899999999999999863 457899999996543 2335679999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~ 211 (296)
|||||++|+|.+++..... ....+++..+..|+.|++.||+|||+.+ |+||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999965321 1346899999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+||+|||+++...............||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+..
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999986444333334445689999999999999999999999999999999998 89999876643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=353.89 Aligned_cols=203 Identities=25% Similarity=0.377 Sum_probs=164.2
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCC-------
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGD------- 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------- 139 (296)
.++|++++.||+|+||.||+|+++.+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 34699999999999999999999999999999999755433 3456889999999999999999999987644
Q ss_pred -----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 140 -----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 140 -----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
..|+|||||+||+|.+++.... .....++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 3689999999999999997532 1223456678899999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcc----------eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 215 SDFGLAKLGPVGDKT----------HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
+|||+|+........ ......+||+.|||||++.+..|+.++|||||||++|||++ ||..
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~ 229 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST 229 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence 999999864332211 11233579999999999999999999999999999999996 7864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=360.65 Aligned_cols=206 Identities=26% Similarity=0.348 Sum_probs=177.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec------C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD------G 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~------~ 138 (296)
+.++|++++.||+|+||+||+|++..+|+.||||+++.... .....+.+|+.+|+.++||||+++++++.. .
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 34689999999999999999999999999999999976433 234567899999999999999999998764 3
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+.+|+|||||. |+|.+++.. ...+++..+..+++|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecc
Confidence 57899999996 789999865 568999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCC--cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+++...... ........+||+.|+|||++.+. .|+.++||||+||++|||++|++||.+.+.
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~ 268 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH
Confidence 998543221 22233457899999999998875 568999999999999999999999987654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=353.55 Aligned_cols=204 Identities=24% Similarity=0.333 Sum_probs=174.1
Q ss_pred HHHhcCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
..+.++|++.+.||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+++.+ +||||++++++|.+.++
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 356788999999999999999999874 467899999986543 345678899999988 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGL 219 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~ 219 (296)
+|+||||++|++|.+++. .+++.++..++.|++.||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 999999999999999983 3899999999999999999999999 9999999999999876 8999999999
Q ss_pred cccCCCCCc--------------------------ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCC
Q 022482 220 AKLGPVGDK--------------------------THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGR 272 (296)
Q Consensus 220 ~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~ 272 (296)
|+....... .......+||+.|+|||++.+. .|+.++||||+||++|+|++|+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~ 244 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence 975332211 1112335799999999999775 5899999999999999999999
Q ss_pred CCCCCCCc
Q 022482 273 KAIDNTRA 280 (296)
Q Consensus 273 ~pf~~~~~ 280 (296)
+||...+.
T Consensus 245 ~Pf~~~~~ 252 (361)
T 4f9c_A 245 YPFYKASD 252 (361)
T ss_dssp SSSSCCSS
T ss_pred CCCCCCCC
Confidence 99975543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=375.09 Aligned_cols=202 Identities=30% Similarity=0.425 Sum_probs=175.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHH---HHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~---e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++++.||+|+||.||+|++..+|+.||||++.+.... ......+ ++.+++.++||||++++++|.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 4699999999999999999999999999999999653211 1222333 456667778999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+|||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+.
T Consensus 269 lVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999976 467999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.... .....+||+.|||||++.+ ..|+.++|+|||||++|||++|++||.+.+..
T Consensus 342 ~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 342 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp CSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred cCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4332 2345689999999999965 57999999999999999999999999865543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=353.46 Aligned_cols=212 Identities=29% Similarity=0.411 Sum_probs=181.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCC-----CeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCC-CcccceeeEEecC-
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHH-PNLVNLIGYCADG- 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~- 138 (296)
..++|++.+.||+|+||.||+|.+..+ ++.||||.+...... ..+.+.+|+.+++.++| |||+++++++.++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 346899999999999999999987643 468999999765433 34568899999999965 9999999998664
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
+.+++|||||++|+|.++++.... ....+++..+..++.|++.||+|||+++ ||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 568999999999999999965211 1355899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999986554444444555789999999999999999999999999999999998 99999876543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=370.30 Aligned_cols=206 Identities=25% Similarity=0.359 Sum_probs=186.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||.||+|.++.+|+.||+|++........+.+.+|+.+|+.++||||++++++|.+.+.+|+|||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34689999999999999999999999999999999987666666778999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC--CceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG--YHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~--~~~kl~Dfg~~~~~~ 224 (296)
||+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++...
T Consensus 235 ~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~ 308 (573)
T 3uto_A 235 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 308 (573)
T ss_dssp CCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECC
T ss_pred ecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEcc
Confidence 9999999999864 2467999999999999999999999999 9999999999999754 899999999998654
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 309 ~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 309 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp TTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 332 234468999999999999999999999999999999999999999876644
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=343.48 Aligned_cols=202 Identities=27% Similarity=0.373 Sum_probs=162.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC----ceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----~~~l 143 (296)
.++|.+.+.||+|+||.||+|.+. |+.||||++.... ........|+..+..++||||+++++++.+++ .++|
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 356888999999999999999984 8999999996542 11222345666677889999999999998654 5799
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-----NPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~-----~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
|||||++|+|.++++. .++++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999975 46899999999999999999999871 1129999999999999999999999999
Q ss_pred CcccCCCCCcc--eeeecccccccccCccccccC------CCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 219 LAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 219 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
+++........ ......+||+.|+|||++.+. .++.++|||||||++|||+||.+||..
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~ 220 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence 99754333221 122346799999999999764 367789999999999999999887753
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=317.08 Aligned_cols=204 Identities=29% Similarity=0.425 Sum_probs=183.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34679999999999999999999999999999999976655556778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999965 35899999999999999999999999 999999999999999999999999998764332
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 170 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp TC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 22 23346799999999999999999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=324.04 Aligned_cols=204 Identities=30% Similarity=0.393 Sum_probs=181.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999996532 223456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999865 457899999999999999999999999 99999999999999999999999999975322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.. ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 211 (337)
T 1o6l_A 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH
Confidence 21 2234568999999999999999999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=327.81 Aligned_cols=205 Identities=32% Similarity=0.464 Sum_probs=177.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+..|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999996532 12334577899999887 69999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999975 467999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 175 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 175 ICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 222 22344568999999999999888999999999999999999999999877654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=322.10 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=182.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
..++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 45689999999999999999999999999999999965432 3345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999865 466999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 220 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK 220 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 332 23446799999999999888765 7899999999999999999999877643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=319.19 Aligned_cols=221 Identities=46% Similarity=0.779 Sum_probs=193.9
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
...++|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred HHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 35678999999999999999999975 58899999988776666778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999764444457999999999999999999999999 99999999999999999999999999976443
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcccccchHhhh
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWV 290 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~~~~l~~~~ 290 (296)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||....+.+...+..|.
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~ 256 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT
T ss_pred ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh
Confidence 33333334456899999999998889999999999999999999999999988777666666553
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=327.27 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=178.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+..|..+++.+ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 3579999999999999999999999999999999975432 2234577888888876 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999875 467999999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 204 ~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 204 LRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred ccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 222 22344578999999999999999999999999999999999999999754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=321.83 Aligned_cols=205 Identities=29% Similarity=0.368 Sum_probs=182.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.++|.+.+.||+|+||.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 557899999999999999999999999999999999764332 24678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~D 216 (296)
.++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .++|+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 9999999999999999965 467999999999999999999999999 99999999999998776 799999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~ 224 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99998644322 223467999999999999889999999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=321.28 Aligned_cols=206 Identities=33% Similarity=0.524 Sum_probs=180.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~ 142 (296)
..++|.+.+.||+|+||.||+|++..+++.||+|++.+.. ......+..|..+++.+ +||||+++++++.+.+..|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 4568999999999999999999999999999999996532 12345567888888876 8999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||+++.
T Consensus 95 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999965 456999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 224 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 224 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH
Confidence 32222 2234568999999999999999999999999999999999999999876643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=331.85 Aligned_cols=210 Identities=24% Similarity=0.281 Sum_probs=182.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
...++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|..++..++||||+++++++.+.+..+
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 150 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY 150 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence 345789999999999999999999999999999999864221 11233788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 151 lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 151 LVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp EEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999975 2467999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
..... .......+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.+..+
T Consensus 225 ~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 288 (437)
T 4aw2_A 225 LMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288 (437)
T ss_dssp CCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred cccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence 43322 22233468999999999997 4568999999999999999999999998766443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=316.96 Aligned_cols=200 Identities=34% Similarity=0.501 Sum_probs=180.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|..+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57999999999999999999999999999999986532 123456778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999975 457999999999999999999999999 99999999999999999999999999986332
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 12346799999999999999999999999999999999999999987654
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=328.77 Aligned_cols=207 Identities=26% Similarity=0.342 Sum_probs=180.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
..++|.+.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45689999999999999999999999999999999864211 123347789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 147 V~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 9999999999999864 45899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeeecccccccccCccccccCC----CCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQ----LTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+..+
T Consensus 219 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 280 (410)
T 3v8s_A 219 NKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280 (410)
T ss_dssp CTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh
Confidence 3322 22234568999999999997765 7889999999999999999999998766443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=320.90 Aligned_cols=205 Identities=29% Similarity=0.421 Sum_probs=180.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999999999999999996532 12345677899999887 79999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 99 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999975 356999999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 172 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 227 (353)
T 2i0e_A 172 IWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227 (353)
T ss_dssp CCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH
Confidence 222 12234568999999999999999999999999999999999999999876543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=316.55 Aligned_cols=207 Identities=28% Similarity=0.415 Sum_probs=180.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 56789999999999999999999999999999999865432 22356789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 99999999999865 456999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 333333445679999999999988765 7789999999999999999999986554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=318.06 Aligned_cols=201 Identities=28% Similarity=0.454 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|++..+++.||+|++.+.... ....+.+|..+++.+ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 4699999999999999999999999999999999754322 234577899999887 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999865 456999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.. .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...
T Consensus 162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 22 12234568999999999999999999999999999999999999999753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=321.87 Aligned_cols=204 Identities=27% Similarity=0.418 Sum_probs=180.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56999999999999999999999999999999986432 223456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999975 567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~ 224 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS 224 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc
Confidence 22 2345679999999999964 458899999999999999999999998655433
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=311.55 Aligned_cols=206 Identities=29% Similarity=0.391 Sum_probs=177.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 45789999999999999999999999999999999854332 233567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999975 457999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 162 SETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred cccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 3222 1223345799999999999999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=313.23 Aligned_cols=205 Identities=18% Similarity=0.276 Sum_probs=182.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4578999999999999999999999999999999996543 345568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC--CCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~--~~~~kl~Dfg~~~~~~ 224 (296)
|++|++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.++|+|||++....
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999965 2356999999999999999999999999 999999999999987 7899999999998654
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 156 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 209 (321)
T 1tki_A 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH
Confidence 332 223457999999999998888899999999999999999999999876543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=319.10 Aligned_cols=205 Identities=23% Similarity=0.331 Sum_probs=181.5
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4567899999999999999999999999999999999765432 34568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC---CceEEcccCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~---~~~kl~Dfg~~ 220 (296)
||||+.|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999999865 467899999999999999999999999 9999999999999764 45999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 179 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 235 (362)
T 2bdw_A 179 IEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235 (362)
T ss_dssp BCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 7643222 22346799999999999998999999999999999999999999987653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=309.07 Aligned_cols=209 Identities=31% Similarity=0.449 Sum_probs=183.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35799999999999999999999999999999999776666677889999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999976 2467999999999999999999999999 9999999999999999999999999997543322
Q ss_pred cce------------eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 228 KTH------------VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~ 229 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence 111 1114579999999999999999999999999999999999999998655443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=320.10 Aligned_cols=208 Identities=23% Similarity=0.283 Sum_probs=180.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-----cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-----LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567999999999999999999999999999999985321 12356788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc---eEEcccC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFG 218 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~---~kl~Dfg 218 (296)
++||||++|++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. ++|+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887543223456899999999999999999999999 999999999999976654 9999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 179 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 179 VAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp TCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred ceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 997643322 22334579999999999999899999999999999999999999998753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=318.49 Aligned_cols=201 Identities=28% Similarity=0.356 Sum_probs=180.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986532 123456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999975 356999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. ....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 244 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH
Confidence 2 23467999999999999999999999999999999999999999876543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=325.29 Aligned_cols=206 Identities=23% Similarity=0.305 Sum_probs=181.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 4667899999999999999999999999999999999765433 34568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~ 220 (296)
||||+.|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999875 467999999999999999999999999 99999999999997 4678999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.
T Consensus 161 ~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 161 IEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp BCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 7543322 223346799999999999998999999999999999999999999977654
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=326.01 Aligned_cols=210 Identities=25% Similarity=0.267 Sum_probs=182.0
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
...++|++.+.||+|+||.||+|++..+++.||+|++.+... .....+.+|..++..++||||+++++++.+.+..|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 345789999999999999999999999999999999965321 12234778999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 138 lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp EEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhee
Confidence 999999999999999652 347999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCcceeeecccccccccCccccc-------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAM-------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
..... .......+||+.|+|||++. +..++.++|+|||||++|||++|+.||...+..+
T Consensus 212 ~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 277 (412)
T 2vd5_A 212 LRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277 (412)
T ss_dssp CCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred ccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH
Confidence 43322 22233468999999999997 3568999999999999999999999998776544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=308.86 Aligned_cols=200 Identities=26% Similarity=0.379 Sum_probs=180.3
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
|...+.||+|+||.||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 77788999999999999999989999999999876666667788999999999999999999999999999999999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 196 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 196 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence 999999854 46999999999999999999999999 9999999999999999999999999987543322 1
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 23346799999999999998999999999999999999999999986543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=311.60 Aligned_cols=204 Identities=27% Similarity=0.377 Sum_probs=181.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 446799999999999999999999999999999998754322 35678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~D 216 (296)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 9999999999999999965 467999999999999999999999999 99999999999998877 899999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 162 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 162 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp CTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 99998643322 12345799999999999988999999999999999999999999986654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=316.88 Aligned_cols=205 Identities=22% Similarity=0.340 Sum_probs=182.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||.||+|.+..+++.+|+|++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 45689999999999999999999999999999999977655556678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC--CCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~--~~~~kl~Dfg~~~~~~ 224 (296)
|+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. .+.++|+|||++....
T Consensus 129 ~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 129 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999865 2457999999999999999999999999 999999999999974 5779999999998644
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 203 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 332 22335799999999999998999999999999999999999999987653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=321.21 Aligned_cols=206 Identities=29% Similarity=0.399 Sum_probs=173.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHH-HhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLM-LSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|++..+++.||+|++.+.... ....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999764322 22345566665 567899999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999875 456899999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~ 246 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 221 122345689999999999999999999999999999999999999998766443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=310.93 Aligned_cols=217 Identities=48% Similarity=0.820 Sum_probs=189.7
Q ss_pred cccccCHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceee
Q 022482 55 AAHTFTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIG 133 (296)
Q Consensus 55 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~ 133 (296)
....++..+.....++|.+.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456788899999999999999999999999999854 5889999998754322 2336889999999999999999999
Q ss_pred EEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCCeEeccCCCCcEEEcCCC
Q 022482 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK---ANPPVIYRDLKCSNILLGEGY 210 (296)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~---~~~~ivHrdikp~Nili~~~~ 210 (296)
++.+.+..++||||+.+++|.+++.........+++..+..++.|++.||+|||+. + |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCC
Confidence 99999999999999999999999987655566799999999999999999999999 8 99999999999999999
Q ss_pred ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
.++|+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 172 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 999999999986433322 22334569999999999988889999999999999999999999996
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=311.07 Aligned_cols=204 Identities=30% Similarity=0.435 Sum_probs=171.3
Q ss_pred hcCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
.++|++.+.||+|+||.||+|++. .+++.||+|++.+... .....+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 357999999999999999999985 6799999999976432 233457789999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999865 456899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 169 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 169 KESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 743221 1223346799999999999998999999999999999999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=328.65 Aligned_cols=206 Identities=29% Similarity=0.450 Sum_probs=182.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|.+.+.||+|+||.||+|++..+++.||+|++.+... .....+..|+.+++.++||||+++++++.+.+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 578999999999999999999999999999999965322 22356788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999998765444567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||....
T Consensus 342 ~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 342 GQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp TCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 221 2334589999999999999999999999999999999999999998754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=312.70 Aligned_cols=203 Identities=30% Similarity=0.419 Sum_probs=178.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999986432 12235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6899998865 467999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .....+||+.|+|||++.+..+ ++++|||||||++|+|++|+.||.+....
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~ 214 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP 214 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH
Confidence 332 2234579999999999988776 68999999999999999999999876543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.92 Aligned_cols=206 Identities=19% Similarity=0.216 Sum_probs=175.1
Q ss_pred hcCCCccccccccCceEEEEE-----EECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC---CCcccceeeEEecCC
Q 022482 68 TKNFRADCLLGEGGFGRVYKG-----RLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGD 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~ 139 (296)
.++|.+.+.||+|+||.||+| .+..+++.||+|++.... ..++..|..+++.++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 467999999999999999999 467788999999997543 446667777777776 899999999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC----------
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPP-DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---------- 208 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~-~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---------- 208 (296)
..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999964211 2467999999999999999999999999 999999999999988
Q ss_pred -CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 209 -GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 209 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++.+||+|||++...............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 289 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE 289 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence 89999999999965333233334455789999999999999999999999999999999999999996443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=310.14 Aligned_cols=207 Identities=25% Similarity=0.318 Sum_probs=180.5
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+ +||||+++++++...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 45689999999999999999999999999999999865432 34578899999999 8999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc-----eEEcccCCc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLSDFGLA 220 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~-----~kl~Dfg~~ 220 (296)
||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. ++|+|||++
T Consensus 85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 999 89999999752 467999999999999999999999999 999999999999998887 999999999
Q ss_pred ccCCCCCcce-----eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKTH-----VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~ 224 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT 224 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc
Confidence 8543322211 1234679999999999999999999999999999999999999999865443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.81 Aligned_cols=211 Identities=28% Similarity=0.437 Sum_probs=180.5
Q ss_pred hcCCCccccccccCceEEEEEEEC-------CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~ 138 (296)
.++|.+.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357999999999999999999874 3466899999976532 2345688999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999976321 1346899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999985443333223334567889999999999999999999999999999999 99999876544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=311.04 Aligned_cols=208 Identities=26% Similarity=0.396 Sum_probs=173.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCce--
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-- 141 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~-- 141 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 4578999999999999999999999999999999997653322 34678899999999999999999998765543
Q ss_pred --EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 142 --LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 142 --~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 999999999999999965 456999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 220 AKLGPVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 220 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 975433221 12223456899999999999999999999999999999999999999876643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=302.82 Aligned_cols=202 Identities=29% Similarity=0.405 Sum_probs=171.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------------------------hhHHHHHHHHHHh
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------------------------GNREFLVEVLMLS 121 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~ 121 (296)
.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999999999999999998654321 1245789999999
Q ss_pred hcCCCcccceeeEEec--CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccC
Q 022482 122 LLHHPNLVNLIGYCAD--GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDL 199 (296)
Q Consensus 122 ~l~h~~I~~~~~~~~~--~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdi 199 (296)
.++||||+++++++.+ .+..++||||+++++|.++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 9999999999999986 567899999999999988653 357999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCC
Q 022482 200 KCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 200 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
||+||+++.++.++|+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 9999999999999999999997643322 2233467999999999997765 3778999999999999999999998
Q ss_pred CCC
Q 022482 277 NTR 279 (296)
Q Consensus 277 ~~~ 279 (296)
+.+
T Consensus 242 ~~~ 244 (298)
T 2zv2_A 242 DER 244 (298)
T ss_dssp CSS
T ss_pred Ccc
Confidence 654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=304.82 Aligned_cols=207 Identities=27% Similarity=0.401 Sum_probs=175.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.++|++.+.||+|+||.||+|.+.. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 456789999999999999999999964 889999999654322 23567899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 97 v~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 169 (311)
T 3niz_A 97 VFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAF 169 (311)
T ss_dssp EEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred EEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceec
Confidence 999998 588888765 3456999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+
T Consensus 170 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~ 227 (311)
T 3niz_A 170 GIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227 (311)
T ss_dssp TSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT
T ss_pred CCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 3222 22334578999999999876 468999999999999999999999998765443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=336.82 Aligned_cols=206 Identities=29% Similarity=0.418 Sum_probs=181.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~ 142 (296)
..++|++.+.||+|+||.||+|.+..+++.||||++.+.. ......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4568999999999999999999999999999999986431 22345677888888877 6999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999975 457999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..
T Consensus 492 ~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 492 NIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp CCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 32222 2244578999999999999999999999999999999999999999876643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=325.33 Aligned_cols=205 Identities=31% Similarity=0.394 Sum_probs=172.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC---CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 35799999999999999999999999999999998643 222335567899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.++|+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999865 4579999999999999999999998 88 999999999999999999999999999753
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~ 355 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH
Confidence 222 22234468999999999999999999999999999999999999999876644
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=301.11 Aligned_cols=201 Identities=24% Similarity=0.353 Sum_probs=173.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999999754332 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9975 66665543 2467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CcceeeecccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 22233457899999999997765 799999999999999999988886433
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.89 Aligned_cols=200 Identities=28% Similarity=0.401 Sum_probs=156.6
Q ss_pred cCCCcc---ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEE
Q 022482 69 KNFRAD---CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+. +.||+|+||.||+|.+..+++.||||++... ......+|+.+++.+. ||||+++++++.+....++|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 445554 7899999999999999999999999999643 3456778999999997 99999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~Dfg~~~ 221 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+|||++.
T Consensus 85 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~ 157 (325)
T 3kn6_A 85 MELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157 (325)
T ss_dssp ECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred EEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccce
Confidence 999999999999976 467999999999999999999999999 99999999999997765 89999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 158 LKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp ECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred ecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 543322 223345789999999999999999999999999999999999999986543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=312.22 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=168.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999999999999999997643 3346688999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc--eEEcccCCcccCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFGLAKLGPV 225 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~--~kl~Dfg~~~~~~~ 225 (296)
+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999865 456999999999999999999999999 999999999999987665 99999999874222
Q ss_pred CCcceeeecccccccccCccccccCCCCcc-chhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLK-SDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 1 22234579999999999988877665 8999999999999999999986544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=303.67 Aligned_cols=208 Identities=26% Similarity=0.389 Sum_probs=165.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4579999999999999999999999999999999865432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~--~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|++ ++|.+++... ......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 6999888542 122356899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 215 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE 215 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 221 122345789999999999764 6899999999999999999999999876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.84 Aligned_cols=205 Identities=31% Similarity=0.463 Sum_probs=181.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356999999999999999999999999999999986532 12335578899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||++|++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 263 mEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999998752 2345999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 338 ~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 338 EGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp TTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred cCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 332 22345899999999999998899999999999999999999999987643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=312.73 Aligned_cols=208 Identities=28% Similarity=0.404 Sum_probs=168.6
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcC-CCcccceeeEEecCC--
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGD-- 139 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~-- 139 (296)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 356789999999999999999999999999999999986532 234456788999999997 999999999997544
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
.+|+||||+. ++|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 6899999997 689998864 46899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC-------------------cceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGD-------------------KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 97532210 1112234579999999999976 578999999999999999999999998766
Q ss_pred cc
Q 022482 280 AA 281 (296)
Q Consensus 280 ~~ 281 (296)
..
T Consensus 236 ~~ 237 (388)
T 3oz6_A 236 TM 237 (388)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=309.72 Aligned_cols=203 Identities=26% Similarity=0.397 Sum_probs=166.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 5578999999999999999999999999999999997542 34567789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEcccCCcccC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFGLAKLG 223 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Dfg~~~~~ 223 (296)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999865 456899999999999999999999999 999999999999975 889999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 256 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc
Confidence 322 1223467999999999999989999999999999999999999999765543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=312.42 Aligned_cols=209 Identities=20% Similarity=0.260 Sum_probs=179.8
Q ss_pred hcCCCcccccccc--CceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEG--GFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+| +||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 999999999999999999999975432 233567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998762 2356999999999999999999999999 999999999999999999999999987532
Q ss_pred CCCC-----cceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGD-----KTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 243 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 1111 1111223478999999999987 57899999999999999999999999875543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=306.28 Aligned_cols=208 Identities=30% Similarity=0.468 Sum_probs=176.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCe---EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..++. .||||++..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 3579999999999999999999975544 599999976432 334568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999965 2457999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 261 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR 261 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 33222 112223446788999999998899999999999999999999 99999776544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=310.30 Aligned_cols=211 Identities=25% Similarity=0.310 Sum_probs=183.4
Q ss_pred cCHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-----CCcccceee
Q 022482 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----HPNLVNLIG 133 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~I~~~~~ 133 (296)
+++.+...+.++|++.+.||+|+||.||+|.+..+++.||||++... .........|+.+++.+. ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 44445556778999999999999999999999999999999999643 233456778999999886 999999999
Q ss_pred EEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-----
Q 022482 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE----- 208 (296)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~----- 208 (296)
++...+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence 999999999999999 89999999762 2346999999999999999999999999 999999999999975
Q ss_pred --------------------CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHH
Q 022482 209 --------------------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEI 268 (296)
Q Consensus 209 --------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l 268 (296)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999853322 2345799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcc
Q 022482 269 ITGRKAIDNTRAA 281 (296)
Q Consensus 269 l~g~~pf~~~~~~ 281 (296)
++|+.||...+..
T Consensus 253 l~g~~pf~~~~~~ 265 (360)
T 3llt_A 253 YTGSLLFRTHEHM 265 (360)
T ss_dssp HHSSCSCCCSSHH
T ss_pred HHCCCCCCCCcHH
Confidence 9999999876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=319.96 Aligned_cols=201 Identities=25% Similarity=0.327 Sum_probs=170.5
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------ 138 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 457899999999999999999999999999999999754 223345678999999999999999999999655
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
...|+||||+. ++|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~-~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCS-EEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCC-CCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEE
Confidence 35699999997 45777663 34899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+++..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 210 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 210 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp CC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99854322 223346799999999999999999999999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=302.18 Aligned_cols=209 Identities=34% Similarity=0.524 Sum_probs=171.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..+|++.+.||+|+||.||+|.+. +..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 457999999999999999999874 888999999765433 2356889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 114 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp ECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred ecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999997521 1123899999999999999999999875 3599999999999999999999999999975322
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+
T Consensus 192 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~ 246 (309)
T 3p86_A 192 T--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ 246 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred c--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 2 122334679999999999999999999999999999999999999998766443
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=319.93 Aligned_cols=203 Identities=29% Similarity=0.457 Sum_probs=180.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999999965321 2345688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999965 467999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH
Confidence 322 2334579999999999988765 6899999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.79 Aligned_cols=201 Identities=27% Similarity=0.351 Sum_probs=174.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ..+|+.++..+ +||||+++++++.+.+..++|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 3567899999999999999999999999999999999765322 34677777777 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC----CceEEcccCCc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG----YHPKLSDFGLA 220 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~----~~~kl~Dfg~~ 220 (296)
|||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+.+. +.++|+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999865 457999999999999999999999999 9999999999998443 35999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 168 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 168 KQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp EECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred ccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 8543322 22334679999999999988889999999999999999999999998643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=297.69 Aligned_cols=204 Identities=24% Similarity=0.329 Sum_probs=182.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+.++|++.+.||+|+||.||+|.+..++..+|+|++........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 35678999999999999999999999999999999997765566778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~~ 222 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 86 ELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp ECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred eccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 99999999998865 456899999999999999999999999 9999999999999 7888999999999975
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...+.
T Consensus 159 ~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 159 FKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp CCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 43332 2234579999999999865 489999999999999999999999987654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=310.62 Aligned_cols=203 Identities=26% Similarity=0.374 Sum_probs=174.3
Q ss_pred cCCCc--cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRA--DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..|.+ .+.||+|+||.||+|.+..++..||+|++........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E 166 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVME 166 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 34544 5689999999999999999999999999987666667788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE--cCCCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL--GEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili--~~~~~~kl~Dfg~~~~~~ 224 (296)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+|||++....
T Consensus 167 ~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 167 YVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp CCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred CCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 9999999998864 2356899999999999999999999999 9999999999999 567899999999998644
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 241 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 241 PREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp TTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred Cccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 3322 2335699999999999888899999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=303.58 Aligned_cols=204 Identities=29% Similarity=0.358 Sum_probs=181.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456799999999999999999999999999999998654322 34678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~D 216 (296)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .++|+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999965 467899999999999999999999999 99999999999999887 799999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 163 fg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp CTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 99997643322 12345699999999999988999999999999999999999999987653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=309.80 Aligned_cols=218 Identities=29% Similarity=0.423 Sum_probs=182.9
Q ss_pred CHHHHHHHhcCCCccccccccCceEEEEEE-----ECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhc-CCCccccee
Q 022482 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLI 132 (296)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~I~~~~ 132 (296)
.........++|.+.+.||+|+||.||+|. +..+++.||||++...... ..+.+.+|+.+++.+ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 333444456789999999999999999998 5567799999999764332 345688999999999 789999999
Q ss_pred eEEecCCc-eEEEEecCCCCCHHHHhccCCCC------------------------------------------------
Q 022482 133 GYCADGDQ-RLLVYEYMPLGSLEDHLHDLPPD------------------------------------------------ 163 (296)
Q Consensus 133 ~~~~~~~~-~~lv~e~~~~~sL~~~~~~~~~~------------------------------------------------ 163 (296)
+++.+.+. .++||||+++++|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987654 89999999999999999763211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc
Q 022482 164 --------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229 (296)
Q Consensus 164 --------------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 229 (296)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 122899999999999999999999999 999999999999999999999999999865444433
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.......||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 44445678999999999999999999999999999999998 9999987654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=303.42 Aligned_cols=206 Identities=23% Similarity=0.346 Sum_probs=177.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCC--ceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~--~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999999999999999997543 233466789999999999999999999998765 77999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE----cCCCceEEcccCCc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLA 220 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili----~~~~~~kl~Dfg~~ 220 (296)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997532 2234999999999999999999999999 9999999999999 77888999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccc--------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAM--------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||.....
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 228 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 8643332 223457999999999986 46788999999999999999999999975443
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=299.39 Aligned_cols=202 Identities=25% Similarity=0.371 Sum_probs=171.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||.||+|.+ .+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5799999999999999999998 56889999999654322 23567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 997 599998865 2467899999999999999999999999 999999999999999999999999999753221
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 1 122335689999999999764 589999999999999999999999986543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=302.64 Aligned_cols=207 Identities=27% Similarity=0.366 Sum_probs=174.9
Q ss_pred HhcCCCcc-ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
+.+.|.+. +.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 45678885 7899999999999999999999999999776555667888999999884 799999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc---eEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~---~kl~Dfg~~~ 221 (296)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++|+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 90 FEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred EEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 999999999999975 356899999999999999999999999 999999999999987766 9999999987
Q ss_pred cCCCCCc-----ceeeecccccccccCcccccc-----CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDK-----THVSTRVMGTYGYCAPEYAMT-----GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 5332111 111223469999999999875 4578899999999999999999999987653
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=300.29 Aligned_cols=206 Identities=28% Similarity=0.358 Sum_probs=174.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 468999999999999999999999999999999986554322 355778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999998764 466999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+
T Consensus 155 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 210 (311)
T 4agu_A 155 PS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 22 22234578999999999876 568999999999999999999999998766443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=310.87 Aligned_cols=202 Identities=23% Similarity=0.300 Sum_probs=167.0
Q ss_pred HhcCCCcc-ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHH-hhcCCCcccceeeEEec----CCc
Q 022482 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQ 140 (296)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~I~~~~~~~~~----~~~ 140 (296)
+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +..+||||+++++++.. ...
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 44567776 789999999999999999999999999853 24566788776 45589999999999875 567
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEccc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Df 217 (296)
+++||||++|++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 89999999999999999762 2346999999999999999999999999 999999999999987 789999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 209 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 269 (400)
T 1nxk_A 209 GFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred ccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence 999854322 1233467899999999999999999999999999999999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=295.22 Aligned_cols=208 Identities=27% Similarity=0.419 Sum_probs=181.9
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 35678999999999999999999999999999999986432 23456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||.+....
T Consensus 84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999999864 457999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
............||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred CCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 3322223344679999999999987765 6789999999999999999999986554
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=299.99 Aligned_cols=207 Identities=29% Similarity=0.406 Sum_probs=173.4
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-----chhHHHHHHHHHHhhc---CCCcccceeeEEec
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-----QGNREFLVEVLMLSLL---HHPNLVNLIGYCAD 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~ 137 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 456799999999999999999999999999999999864221 1234566777777666 49999999999987
Q ss_pred CC-----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 138 GD-----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 138 ~~-----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
.. ..++|||++. ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCE
Confidence 65 4789999997 6999998763 2344999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...+..
T Consensus 160 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 160 KLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp EECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred EEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999997543222 233467999999999999999999999999999999999999999876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=313.43 Aligned_cols=202 Identities=27% Similarity=0.348 Sum_probs=170.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC-----C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~ 139 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 5678999999999999999999999999999999997542 23345788999999999999999999999776 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6899999986 699999965 467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcc--------------------eeeecccccccccCcccc-ccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 220 AKLGPVGDKT--------------------HVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 220 ~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
++........ ......+||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 9864332211 122456799999999986 45679999999999999999998555544
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=305.48 Aligned_cols=203 Identities=30% Similarity=0.442 Sum_probs=173.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCc----eEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ----RLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~----~~l 143 (296)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ........|+.+++.++||||+++++++..... +++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 357999999999999999999886 7899999996542 233445668889999999999999999987543 699
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC----------CCCCeEeccCCCCcEEEcCCCceE
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK----------ANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~----------~~~~ivHrdikp~Nili~~~~~~k 213 (296)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+|
T Consensus 100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEE
T ss_pred EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEE
Confidence 9999999999999965 4599999999999999999999999 8 99999999999999999999
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCccccccC-----CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||......
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999764443333333446799999999999763 4566889999999999999999999865543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=317.35 Aligned_cols=205 Identities=24% Similarity=0.346 Sum_probs=161.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC-----C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~ 139 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999999999999999996542 23345688999999999999999999998443 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..|+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccccc
Confidence 689999998 4899999865 467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcc-------------------------eeeecccccccccCcccc-ccCCCCccchhHHHHHHHHHHHh---
Q 022482 220 AKLGPVGDKT-------------------------HVSTRVMGTYGYCAPEYA-MTGQLTLKSDVYSFGVVLLEIIT--- 270 (296)
Q Consensus 220 ~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~ll~--- 270 (296)
++........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 9864322111 122345789999999986 45679999999999999999999
Q ss_pred --------CCCCCCCCC
Q 022482 271 --------GRKAIDNTR 279 (296)
Q Consensus 271 --------g~~pf~~~~ 279 (296)
|+++|.+.+
T Consensus 283 ~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSS 299 (458)
T ss_dssp TTCSSGGGCCCSCC---
T ss_pred ccccccccccccCCCCc
Confidence 777776654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=302.31 Aligned_cols=206 Identities=24% Similarity=0.343 Sum_probs=173.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------ 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------ 139 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45679999999999999999999999999999999975432 34567899999999999999999999986543
Q ss_pred ---------------------------------------------------ceEEEEecCCCCCHHHHhccCCCCCCCCC
Q 022482 140 ---------------------------------------------------QRLLVYEYMPLGSLEDHLHDLPPDKKRLD 168 (296)
Q Consensus 140 ---------------------------------------------------~~~lv~e~~~~~sL~~~~~~~~~~~~~~~ 168 (296)
..++||||+++++|.+++.... .....+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~ 162 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE 162 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence 2789999999999999997632 234456
Q ss_pred HHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc----------eeeeccccc
Q 022482 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT----------HVSTRVMGT 238 (296)
Q Consensus 169 ~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt 238 (296)
+..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++......... .......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6778999999999999999999 999999999999999999999999999864433211 122335799
Q ss_pred ccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 239 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
+.|+|||++.+..++.++|||||||++|+|++|..|+.
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 99999999999999999999999999999999988864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=314.08 Aligned_cols=208 Identities=31% Similarity=0.475 Sum_probs=178.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 3578999999999999999999998899999999875432 223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999865 2346899999999999999999999999 999999999999999999999999999753332
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~ 322 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ 322 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 22111122345778999999998889999999999999999998 99999876543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=301.34 Aligned_cols=212 Identities=32% Similarity=0.464 Sum_probs=181.6
Q ss_pred hcCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|.+.+.||+|+||.||+|.+ ..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45799999999999999999988 3456899999997543 23346788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPP--------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~--------------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp 201 (296)
++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999976322 1234899999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 202 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+||+++.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999986544433333344567889999999998889999999999999999999 9999987665
Q ss_pred cc
Q 022482 281 AG 282 (296)
Q Consensus 281 ~~ 282 (296)
..
T Consensus 259 ~~ 260 (314)
T 2ivs_A 259 ER 260 (314)
T ss_dssp GG
T ss_pred HH
Confidence 43
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=305.20 Aligned_cols=204 Identities=25% Similarity=0.367 Sum_probs=179.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------hhHHHHHHHHHHhhcCCCcccceeeEEec
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~ 137 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 4567899999999999999999999999999999999765321 22356789999999999999999999999
Q ss_pred CCceEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 138 GDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 138 ~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
.+..++||||+.++ +|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~D 173 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLID 173 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEee
Confidence 99999999998666 99999875 456999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
||++........ .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....
T Consensus 174 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 234 (335)
T 3dls_A 174 FGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234 (335)
T ss_dssp CTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG
T ss_pred cccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH
Confidence 999986443322 234579999999999988776 788999999999999999999997643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=307.72 Aligned_cols=215 Identities=28% Similarity=0.322 Sum_probs=177.1
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC-----CcchhHHHHHHHHHHhhcCCCcccceeeEEecC
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN-----GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG 138 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~ 138 (296)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 456788999999999999999999999999999999998643 234456788999999999999999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHH
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPD------------------------------------KKRLDWTTRMRIAAGAAKG 182 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~------------------------------------~~~~~~~~~~~i~~ql~~a 182 (296)
+..++||||+++++|.+++...... ...+++..+..++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999998521100 1224677888999999999
Q ss_pred HHHHHcCCCCCeEeccCCCCcEEEcCCC--ceEEcccCCcccCCCCC--cceeeecccccccccCcccccc--CCCCccc
Q 022482 183 LEYLHDKANPPVIYRDLKCSNILLGEGY--HPKLSDFGLAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMT--GQLTLKS 256 (296)
Q Consensus 183 l~~lH~~~~~~ivHrdikp~Nili~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 256 (296)
|.|||+.+ |+||||||+||+++.++ .++|+|||++....... .........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999999 99999999999998766 89999999997432211 1112334579999999999975 5788999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 257 DVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 257 DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|||||||++|+|++|+.||...+..
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~ 282 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDA 282 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChH
Confidence 9999999999999999999866543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=312.70 Aligned_cols=211 Identities=30% Similarity=0.419 Sum_probs=176.1
Q ss_pred hcCCCccccccccCceEEEEEE-----ECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||.||+|. +..++..||||++.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3579999999999999999999 44567899999996542 23345688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceEEc
Q 022482 142 LLVYEYMPLGSLEDHLHDLP---PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPKLS 215 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~---~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~kl~ 215 (296)
++||||+++++|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999986532 22356899999999999999999999999 99999999999998554 59999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999964222112222233568899999999999999999999999999999998 99999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=294.72 Aligned_cols=205 Identities=23% Similarity=0.334 Sum_probs=180.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 56789999999999999999999999999999999865432 2345678999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc---eEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~---~kl~Dfg~~~ 221 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. ++|+|||.+.
T Consensus 84 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 999999999998865 456899999999999999999999999 999999999999976655 9999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 213 (284)
T 3kk8_A 157 EVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213 (284)
T ss_dssp ECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh
Confidence 543322 223457999999999999989999999999999999999999999776543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=295.83 Aligned_cols=205 Identities=24% Similarity=0.336 Sum_probs=179.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 4568999999999999999999999999999999986543 234577899999998 7999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc-----eEEcccCCc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLSDFGLA 220 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~-----~kl~Dfg~~ 220 (296)
||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++|+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 89999999752 456999999999999999999999999 999999999999987766 999999999
Q ss_pred ccCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 223 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 223 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence 754333221 123346799999999999998999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=305.77 Aligned_cols=212 Identities=30% Similarity=0.502 Sum_probs=180.1
Q ss_pred HhcCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 4568999999999999999999987 3458999999976533 234568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPD--------------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLK 200 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~--------------------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdik 200 (296)
.++||||+++++|.+++...... ...+++..++.++.|++.||.|||+.+ |+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 99999999999999999763211 257999999999999999999999999 9999999
Q ss_pred CCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 201 CSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 201 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
|+||+++.++.++|+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999975332222222334568899999999998899999999999999999999 999998765
Q ss_pred cc
Q 022482 280 AA 281 (296)
Q Consensus 280 ~~ 281 (296)
..
T Consensus 282 ~~ 283 (343)
T 1luf_A 282 HE 283 (343)
T ss_dssp HH
T ss_pred hH
Confidence 43
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=294.60 Aligned_cols=205 Identities=29% Similarity=0.464 Sum_probs=159.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4579999999999999999999999999999999864321 2235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999875 2467899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 2221 22345789999999999988899999999999999999999999986553
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=299.30 Aligned_cols=204 Identities=24% Similarity=0.383 Sum_probs=178.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+.++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45678999999999999999999999999999999997665445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~~ 222 (296)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 86 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~ 158 (304)
T 2jam_A 86 QLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM 158 (304)
T ss_dssp CCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred EcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence 99999999999865 456899999999999999999999999 9999999999999 7888999999999975
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 159 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 212 (304)
T 2jam_A 159 EQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE 212 (304)
T ss_dssp CCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH
Confidence 3221 12335689999999999998999999999999999999999999986653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=300.89 Aligned_cols=212 Identities=28% Similarity=0.424 Sum_probs=162.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCe---EEEEEEecCC--CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCce-
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRN--GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR- 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~- 141 (296)
.++|++.+.||+|+||.||+|.+..++. .||+|++... .....+.+.+|+.+++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 4579999999999999999999887665 7999998754 233456788999999999999999999999877655
Q ss_pred -----EEEEecCCCCCHHHHhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 142 -----LLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 142 -----~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
++||||+.+++|.+++... ......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 8999999999999998542 122336899999999999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..+
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 99999976444333333334557889999999999999999999999999999999 999998765433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=298.71 Aligned_cols=205 Identities=34% Similarity=0.514 Sum_probs=174.5
Q ss_pred hcCCCccccccccCceEEEEEE----ECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC--Cce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~ 141 (296)
.++|++.+.||+|+||.||+|+ +..+++.||+|++........+.+.+|+.+++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4679999999999999999998 5668999999999876655667789999999999999999999998653 568
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999762 345999999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 64332211 2222345778899999999999999999999999999999999998753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=304.17 Aligned_cols=204 Identities=28% Similarity=0.419 Sum_probs=169.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999999999999999996543221 12345799999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 97 689888875 2456899999999999999999999999 999999999999999999999999999753322
Q ss_pred cceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 222234578999999999876 56899999999999999999999999876643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=303.70 Aligned_cols=207 Identities=32% Similarity=0.505 Sum_probs=170.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeE----EEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 5699999999999999999999877765 4777775432 234567889999999999999999999998754 788
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|+|++.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999976 2466999999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||.......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 227 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH
Confidence 44433333344567889999999999999999999999999999999 999998766544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.50 Aligned_cols=210 Identities=30% Similarity=0.458 Sum_probs=177.9
Q ss_pred hcCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
.++|.+.+.||+|+||.||+|.+ ..++..||+|++.... ......+.+|+.+++.+ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 46799999999999999999997 3457789999997542 23456788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPD-------------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~-------------------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp 201 (296)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCh
Confidence 99999999999999999763211 134799999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 202 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+||+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999975443333333444567889999999999899999999999999999998 9999987654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=292.89 Aligned_cols=219 Identities=47% Similarity=0.741 Sum_probs=187.6
Q ss_pred ccccCHHHHHHHhcCCCcc------ccccccCceEEEEEEECCCCeEEEEEEecCCC----cchhHHHHHHHHHHhhcCC
Q 022482 56 AHTFTFRELAAVTKNFRAD------CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----LQGNREFLVEVLMLSLLHH 125 (296)
Q Consensus 56 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h 125 (296)
...+++.++..+..+|... +.||+|+||.||+|.+ ++..||+|++.... ....+.+.+|+.+++.++|
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 4567888888888887766 8999999999999987 47889999986532 2334678899999999999
Q ss_pred CcccceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEE
Q 022482 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNIL 205 (296)
Q Consensus 126 ~~I~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nil 205 (296)
|||+++++++.+.+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil 165 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANIL 165 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEE
Confidence 999999999999999999999999999999986421 2356899999999999999999999999 999999999999
Q ss_pred EcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 206 LGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 206 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
++.++.++|+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 99999999999999986544333333445679999999998865 5788999999999999999999999876543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=305.57 Aligned_cols=211 Identities=30% Similarity=0.436 Sum_probs=181.4
Q ss_pred hcCCCccccccccCceEEEEEEECC-------CCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~ 138 (296)
.++|.+.+.||+|+||.||+|.+.. .+..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4679999999999999999999753 346899999976533 2345688999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 999999999999999999976321 1246999999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~ 300 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999986544333333444567899999999999999999999999999999999 99999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=292.68 Aligned_cols=204 Identities=30% Similarity=0.469 Sum_probs=178.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 579999999999999999999875 7779999997654 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 160 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 160 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc-
Confidence 99999999965 2456899999999999999999999999 9999999999999999999999999997543221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
........+|+.|+|||++.+..++.++|+||||+++|+|++ |+.||...+..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~ 214 (269)
T 4hcu_A 161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 214 (269)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 112223456788999999998899999999999999999999 99999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=304.28 Aligned_cols=207 Identities=31% Similarity=0.493 Sum_probs=175.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeE----EEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ......+.+|+.+++.++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 5799999999999999999999887765 7778775432 223345678999999999999999999886 467889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 92 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999875 2456888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.............++..|+|||++.+..++.++|||||||++|+|++ |+.||......+
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 225 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH
Confidence 55444444445668889999999998999999999999999999999 999998766444
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=297.59 Aligned_cols=208 Identities=28% Similarity=0.352 Sum_probs=176.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|.+.+.||+|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++.+....++||
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4567999999999999999999999999999999986543 234567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~~ 222 (296)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~ 176 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence 999999999988543223467999999999999999999999999 9999999999999 4567899999999975
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.... .......||+.|+|||++. ..++.++|||||||++|+|++|+.||...+..
T Consensus 177 ~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 177 FKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp -------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH
Confidence 4322 2233457999999999885 57889999999999999999999999876543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.09 Aligned_cols=200 Identities=28% Similarity=0.368 Sum_probs=169.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----- 139 (296)
+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 45789999999999999999999999999999999965432 23456789999999999999999999997653
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 140 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
.+|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 7999999864 46899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 174 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 174 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99863321 234578999999999877 6789999999999999999999999987654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=310.10 Aligned_cols=205 Identities=26% Similarity=0.378 Sum_probs=168.5
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--------chhHHHHHHHHHHhhcCCCcccceeeEEe
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLHHPNLVNLIGYCA 136 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~ 136 (296)
..+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3567899999999999999999999999999999999865321 11224788999999999999999999985
Q ss_pred cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---ceE
Q 022482 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY---HPK 213 (296)
Q Consensus 137 ~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~---~~k 213 (296)
. +..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 4 557999999999999998865 567999999999999999999999999 99999999999996544 599
Q ss_pred EcccCCcccCCCCCcceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 214 LSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|+|||++...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.....
T Consensus 283 l~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 283 ITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp ECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred EeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 9999999864322 22334679999999999864 5678899999999999999999999986543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.42 Aligned_cols=205 Identities=30% Similarity=0.440 Sum_probs=178.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 35678999999999999999999999999999999985422 2335678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~ 220 (296)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 99 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 99 VGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp EECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999998865 457999999999999999999999999 99999999999994 4567999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..
T Consensus 172 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 228 (486)
T 3mwu_A 172 TCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY 228 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred eECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 7543322 2334579999999999876 5899999999999999999999999876543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=293.84 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=180.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467999999999999999999999999999999986542 22345678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998865 457899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.....
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 220 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 222 122345789999999999988899999999999999999999999987653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=300.21 Aligned_cols=204 Identities=25% Similarity=0.385 Sum_probs=181.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||++.+..+++.+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467999999999999999999999999999999986542 23345688899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999865 457899999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 246 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 246 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH
Confidence 222 122345799999999999988899999999999999999999999987553
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=302.71 Aligned_cols=206 Identities=25% Similarity=0.355 Sum_probs=169.4
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
....++|++.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 345568999999999999999999999999999999997543322 345678999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-----CCCceEEccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-----EGYHPKLSDF 217 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-----~~~~~kl~Df 217 (296)
+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ..+.++|+||
T Consensus 110 lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcC
Confidence 9999997 599999876 456999999999999999999999999 99999999999994 4556999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 182 g~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 182 GLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp THHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 999753222 1222345689999999999875 489999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=318.03 Aligned_cols=204 Identities=28% Similarity=0.435 Sum_probs=180.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999999999999999996543 2345678899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLA 220 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~ 220 (296)
||||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.++|+|||++
T Consensus 104 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 9999999999999865 467999999999999999999999999 9999999999999 56789999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..
T Consensus 177 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 233 (484)
T 3nyv_A 177 THFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY 233 (484)
T ss_dssp HHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH
Confidence 7543332 2234579999999999866 6899999999999999999999999876543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=316.60 Aligned_cols=204 Identities=29% Similarity=0.423 Sum_probs=174.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
+.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999999999999999997543 23356788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Dfg~~~ 221 (296)
|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 999999999998865 456999999999999999999999999 999999999999976 4459999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
...... .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+.+..
T Consensus 188 ~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (494)
T 3lij_A 188 VFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243 (494)
T ss_dssp ECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 643322 233467999999999986 46899999999999999999999999876644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=291.99 Aligned_cols=204 Identities=28% Similarity=0.404 Sum_probs=178.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 346799999999999999999999999999999998654322 35678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~D 216 (296)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 83 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999999965 456899999999999999999999999 99999999999998877 899999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++....... ......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 156 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 156 FGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp CTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 99997543222 12345689999999999988999999999999999999999999987654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=315.69 Aligned_cols=204 Identities=26% Similarity=0.397 Sum_probs=177.2
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-------------chhHHHHHHHHHHhhcCCCcccceee
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-------------QGNREFLVEVLMLSLLHHPNLVNLIG 133 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~I~~~~~ 133 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+.+++.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 56789999999999999999999999999999999875432 22456889999999999999999999
Q ss_pred EEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC---
Q 022482 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY--- 210 (296)
Q Consensus 134 ~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~--- 210 (296)
++.+....++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999998865 456999999999999999999999999 99999999999998776
Q ss_pred ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.++|+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||.+.+..
T Consensus 187 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp SEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 69999999998644322 223457999999999986 46899999999999999999999999876644
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=293.90 Aligned_cols=203 Identities=32% Similarity=0.501 Sum_probs=176.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 3579999999999999999999999999999999854321 1235678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999865 356899999999999999999999999 9999999999999999999999999986432
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 213 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH
Confidence 22 223457899999999999989999999999999999999999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=296.82 Aligned_cols=210 Identities=30% Similarity=0.456 Sum_probs=181.5
Q ss_pred hcCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
.++|.+.+.||+|+||.||+|.+ ..++..||+|++..... ...+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 35799999999999999999985 45678999999976543 3346788999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPP--------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~--------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
.++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999975321 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+.++.++|+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.....
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 9999999999999986554443333444567889999999999899999999999999999999 9999987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=290.07 Aligned_cols=205 Identities=26% Similarity=0.407 Sum_probs=178.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.+.. +..||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4579999999999999999998874 67799999976543 356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999865 2345899999999999999999999999 9999999999999999999999999998644332
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 159 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 212 (268)
T 3sxs_A 159 Y-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS 212 (268)
T ss_dssp E-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred h-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH
Confidence 2 22233456788999999998889999999999999999999 99999865543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=299.52 Aligned_cols=215 Identities=24% Similarity=0.312 Sum_probs=182.9
Q ss_pred cCHHHHHHHhcCCCcc-ccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcC-CCcccceeeE
Q 022482 59 FTFRELAAVTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLH-HPNLVNLIGY 134 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~I~~~~~~ 134 (296)
..+.....+.++|.+. +.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3455566788889988 89999999999999999999999999986532 233567889999999985 6999999999
Q ss_pred EecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCc
Q 022482 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYH 211 (296)
Q Consensus 135 ~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~ 211 (296)
+.+.+..++||||+.+++|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 9999999999999999999999854 23467999999999999999999999999 999999999999987 789
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
++|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 173 ~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 239 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239 (327)
T ss_dssp EEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch
Confidence 9999999998643222 223457999999999999999999999999999999999999999876543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=298.55 Aligned_cols=204 Identities=27% Similarity=0.410 Sum_probs=174.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999999999999999986543332 345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999888888654 456999999999999999999999999 99999999999999999999999999975332
Q ss_pred CCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+.
T Consensus 177 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 177 P--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred C--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2 1223345789999999999775 688999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=304.73 Aligned_cols=206 Identities=30% Similarity=0.484 Sum_probs=166.5
Q ss_pred cCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|.+.+.||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999886 4577899999975432 3345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 125 ~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 125 TEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999975 2456999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCcce-eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 322111 1112235778999999999999999999999999999998 9999976553
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=301.25 Aligned_cols=201 Identities=24% Similarity=0.325 Sum_probs=167.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCC--CcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHH--PNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++| |||+++++++.+.+..++
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 456999999999999999999885 5889999998754332 33568899999999976 999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
|||+ .+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 87 v~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp EECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 9994 57899999976 467999999999999999999999999 99999999999997 578999999999865
Q ss_pred CCCCcceeeecccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 44333333445679999999999865 57888999999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=301.07 Aligned_cols=206 Identities=32% Similarity=0.427 Sum_probs=171.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-----hHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
...++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999999999999999986532221 2467899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+.+ +|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999984 89888865 2456888999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...+.
T Consensus 160 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 160 KSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp STTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 754322 2223345789999999998764 588999999999999999999999987653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=291.88 Aligned_cols=202 Identities=28% Similarity=0.445 Sum_probs=179.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357999999999999999999999999999999986432 12235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999875 356899999999999999999999999 9999999999999999999999999987533
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 221 2345789999999999998999999999999999999999999986553
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=299.27 Aligned_cols=208 Identities=32% Similarity=0.505 Sum_probs=170.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEE----EEEEecCC-CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVV----AIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+... .......+.+|+.+++.++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 357999999999999999999998877654 67766543 2344567889999999999999999999998754 78
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+|++++.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999976 2456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 544333333334557889999999999999999999999999999999 999998766544
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=302.95 Aligned_cols=201 Identities=26% Similarity=0.328 Sum_probs=167.5
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----- 139 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 45689999999999999999999999999999999975432 23456789999999999999999999997665
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 140 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
..++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEee
Confidence 6799999997 57888874 34889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.
T Consensus 173 ~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 173 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99753321 122345799999999999998999999999999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=306.02 Aligned_cols=205 Identities=22% Similarity=0.315 Sum_probs=171.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--------
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-------- 137 (296)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 356789999999999999999999999999999999864422 22379999999999999999999844
Q ss_pred ------------------------------CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 022482 138 ------------------------------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187 (296)
Q Consensus 138 ------------------------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH 187 (296)
....++||||++ ++|.+.+.........+++..+..++.|++.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334789999998 5877776543334678999999999999999999999
Q ss_pred cCCCCCeEeccCCCCcEEEc-CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHH
Q 022482 188 DKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVL 265 (296)
Q Consensus 188 ~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l 265 (296)
+.+ |+||||||+||+++ .++.++|+|||++....... ......||+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999997 68899999999998543332 22345789999999998775 489999999999999
Q ss_pred HHHHhCCCCCCCCCcc
Q 022482 266 LEIITGRKAIDNTRAA 281 (296)
Q Consensus 266 ~~ll~g~~pf~~~~~~ 281 (296)
|+|++|++||.+.+..
T Consensus 233 ~ell~g~~pf~~~~~~ 248 (383)
T 3eb0_A 233 GELILGKPLFSGETSI 248 (383)
T ss_dssp HHHHHSSCSSCCSSHH
T ss_pred HHHHhCCCCCCCCChH
Confidence 9999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=295.01 Aligned_cols=201 Identities=25% Similarity=0.271 Sum_probs=167.9
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
+.++|++.+.||+|+||+||+|.+..+++.||||++...... .......|+..+..+ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 456799999999999999999999999999999998654322 223344555555444 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+ +++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 67999888652 456999999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 208 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 208 GTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred ccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3222 2334569999999999876 7899999999999999999997776543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=300.73 Aligned_cols=209 Identities=24% Similarity=0.367 Sum_probs=181.4
Q ss_pred HHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------hhHHHHHHHHHHhhc-CCCcccce
Q 022482 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLL-HHPNLVNL 131 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~h~~I~~~ 131 (296)
......+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.+ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 334556778899999999999999999999989999999998654311 134567899999998 79999999
Q ss_pred eeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc
Q 022482 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 132 ~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~ 211 (296)
++++...+..++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ 238 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ 238 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence 9999999999999999999999999865 457999999999999999999999999 999999999999999999
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++|+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999987644332 2234679999999999864 357889999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=299.07 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=175.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecC-------
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG------- 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------- 138 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999999999999999998654322 245678999999999999999999998773
Q ss_pred -CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 139 -DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 139 -~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
+..++||||+. ++|.+.+.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++|+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999997 577777754 2456999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCC--cceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 218 GLAKLGPVGD--KTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 218 g~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9997543222 1222234578999999999876 45799999999999999999999999876543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=300.72 Aligned_cols=199 Identities=36% Similarity=0.491 Sum_probs=174.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4589999999999999999999999999999999754332 2346789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688887753 2467999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.....||+.|+|||++. +..++.++|||||||++|+|++|+.||.+.+.
T Consensus 207 ------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 207 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp ------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 12357999999999984 46789999999999999999999999986553
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=293.00 Aligned_cols=209 Identities=30% Similarity=0.486 Sum_probs=184.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..++|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 456799999999999999999999999999999999754 3445778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 90 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 90 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp CCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred cCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999762 3456899999999999999999999999 999999999999999999999999999864433
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+...
T Consensus 165 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~ 220 (288)
T 3kfa_A 165 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220 (288)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred c-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 2 223334557889999999998899999999999999999999 999998766543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=291.10 Aligned_cols=203 Identities=30% Similarity=0.406 Sum_probs=180.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.+.|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3569999999999999999999999999999999975432 345678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++......
T Consensus 101 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 9999999999853 56899999999999999999999999 999999999999999999999999999754322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 173 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 224 (303)
T 3a7i_A 173 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP 224 (303)
T ss_dssp B--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred c--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH
Confidence 2 122345789999999999998999999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=303.49 Aligned_cols=200 Identities=27% Similarity=0.380 Sum_probs=159.5
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecC------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------ 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------ 138 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4578999999999999999999999999999999996543 23345678999999999999999999998654
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
...++|||++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999998 6899888753 56999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 178 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 178 LARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9975322 1234579999999999877 6789999999999999999999999987664
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=294.76 Aligned_cols=206 Identities=23% Similarity=0.289 Sum_probs=170.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
..++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 457899999999999999999999999999999999654322 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999975 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 185 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 185 TDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred ccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 33221 122345689999999999988999999999999999999999999986553
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=304.23 Aligned_cols=204 Identities=27% Similarity=0.372 Sum_probs=178.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3579999999999999999999999999999999976532 334568899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~- 183 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI- 183 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH-
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccc-
Confidence 9999999999975 45689999999999999999999996 8 9999999999999999999999999986421
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 184 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 237 (360)
T 3eqc_A 184 ---DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237 (360)
T ss_dssp ---HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH
T ss_pred ---cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 112234579999999999999999999999999999999999999998765443
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.61 Aligned_cols=207 Identities=26% Similarity=0.348 Sum_probs=176.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecC-----Cc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~~ 140 (296)
+.++|++.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 456899999999999999999999999999999999754322 336688999999999999999999999765 36
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++|||++. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 899999997 699998864 46999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcc-eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKT-HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
......... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 239 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH
Confidence 754322211 112345799999999987554 58999999999999999999999998766443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=289.10 Aligned_cols=203 Identities=34% Similarity=0.616 Sum_probs=173.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchh-------HHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN-------REFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 3679999999999999999999999999999999865433221 56889999999999999999999987654
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc-----eEEc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH-----PKLS 215 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~-----~kl~ 215 (296)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ .+|+||||||+||+++.++. ++|+
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999998865 3457999999999999999999999875 35999999999999988776 9999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccc--cCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM--TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|||++..... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||......
T Consensus 172 Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 234 (287)
T 4f0f_A 172 DFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234 (287)
T ss_dssp CCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC
T ss_pred CCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc
Confidence 9999974222 233467999999999984 445788999999999999999999999865543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=297.03 Aligned_cols=211 Identities=28% Similarity=0.441 Sum_probs=178.5
Q ss_pred hcCCCccccccccCceEEEEEEEC-------CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE-------STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~ 138 (296)
.++|++.+.||+|+||.||+|.+. .++..||+|++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 357999999999999999999985 3567899999975532 2345688999999999 899999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999976322 1235899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
+.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 9999999999999986544333333334567889999999988889999999999999999999 99999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=304.26 Aligned_cols=200 Identities=24% Similarity=0.326 Sum_probs=168.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcC--CCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~~lv 144 (296)
.+|.+.+.||+|+||.||+|.+.. ++.||||++..... .....+.+|+.+++.+. ||||+++++++...+..++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 459999999999999999999876 88999999975433 23466889999999996 59999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++....
T Consensus 135 ~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Ee-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 99 567899999976 457899999999999999999999999 99999999999995 5799999999998654
Q ss_pred CCCcceeeecccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 4333333345679999999999865 36888999999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=290.81 Aligned_cols=205 Identities=28% Similarity=0.441 Sum_probs=175.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 457999999999999999999887 477899999976543 356788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 101 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 999999999965 2456999999999999999999999999 9999999999999999999999999997543221
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 175 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 175 -YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp -HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred -cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh
Confidence 112223456788999999998899999999999999999998 99999875543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=296.43 Aligned_cols=208 Identities=24% Similarity=0.372 Sum_probs=169.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
...+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3457999999999999999999999999999999997532 2334568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 99999999999998653334567899999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 187 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 187 SSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp --------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 322 122234568999999999999899999999999999999999999997643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=303.67 Aligned_cols=205 Identities=18% Similarity=0.248 Sum_probs=169.3
Q ss_pred hcCCCccccccccCceEEEEEEECCC-----CeEEEEEEecCCCcchh-----------HHHHHHHHHHhhcCCCcccce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST-----NQVVAIKQLDRNGLQGN-----------REFLVEVLMLSLLHHPNLVNL 131 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~~I~~~ 131 (296)
.++|++.+.||+|+||.||+|.+..+ ++.||||++........ .....|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45799999999999999999998764 57899999865532111 123445566777889999999
Q ss_pred eeEEecC----CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 132 IGYCADG----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 132 ~~~~~~~----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
++++... ...++||||+ |++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 9998764 4589999999 9999999976 2467999999999999999999999999 99999999999998
Q ss_pred --CCCceEEcccCCcccCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 208 --EGYHPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 208 --~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8899999999999754322111 11133459999999999999899999999999999999999999998643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.19 Aligned_cols=204 Identities=31% Similarity=0.417 Sum_probs=175.2
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
...++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.++||||+++++++...+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34568999999999999999999999999999999997543 3467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999863 2467899999999999999999999999 99999999999999999999999999975332
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 178 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 178 T--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp T--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred h--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 2 112234578999999999998899999999999999999999999998654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=312.98 Aligned_cols=208 Identities=30% Similarity=0.488 Sum_probs=182.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
..+|.+.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 356889999999999999999999889999999997653 3467789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999752 2456899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
........++..|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 373 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~ 427 (495)
T 1opk_A 373 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427 (495)
T ss_dssp -EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred -eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH
Confidence 122223446788999999998899999999999999999999 999998766443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=290.93 Aligned_cols=209 Identities=26% Similarity=0.367 Sum_probs=174.8
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC----cchhHHHHHHHHHHhhcCCCcccceeeEEe--cCC
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG----LQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGD 139 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~--~~~ 139 (296)
.+.++|++.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. +..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 35678999999999999999999999999999999996532 233567889999999999999999999984 456
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..++||||+.++ |.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccc
Confidence 789999999865 77776553 2467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 218 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI 218 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH
Confidence 98654433333344567999999999987643 37789999999999999999999987653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=293.14 Aligned_cols=200 Identities=28% Similarity=0.422 Sum_probs=174.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCC-------eEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTN-------QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357999999999999999999988766 5799999976655666788999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc--------e
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--------P 212 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~--------~ 212 (296)
.++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999976 2344899999999999999999999999 999999999999988887 9
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhC-CCCCCCCC
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITG-RKAIDNTR 279 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~ 279 (296)
+|+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++| .+||...+
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~ 223 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD 223 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc
Confidence 9999999864321 123458899999999987 6789999999999999999995 55554433
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=305.26 Aligned_cols=203 Identities=22% Similarity=0.307 Sum_probs=176.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc------CCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL------HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~~I~~~~~~~~~~~~ 140 (296)
+..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456899999999999999999999999999999999654 23345667788888776 57799999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc--eEEcccC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH--PKLSDFG 218 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~--~kl~Dfg 218 (296)
.++||||+. ++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999996 7999988762 2345899999999999999999999999 999999999999999887 9999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
++...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 248 ~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 248 SSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 99753322 23457999999999999999999999999999999999999999877643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=307.18 Aligned_cols=205 Identities=23% Similarity=0.343 Sum_probs=175.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCC--ceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~--~~~lv 144 (296)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 4679999999999999999999999999999999975432 23456789999999999999999999998765 67999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE----cCCCceEEcccCCc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHPKLSDFGLA 220 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili----~~~~~~kl~Dfg~~ 220 (296)
|||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997532 1234999999999999999999999999 9999999999999 77778999999999
Q ss_pred ccCCCCCcceeeecccccccccCcccccc--------CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMT--------GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 8643322 2234579999999999865 457789999999999999999999997544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=308.61 Aligned_cols=204 Identities=17% Similarity=0.200 Sum_probs=163.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCC---CcchhHHHHHHHH---HHhhcCCCccccee-------eE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRN---GLQGNREFLVEVL---MLSLLHHPNLVNLI-------GY 134 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~~I~~~~-------~~ 134 (296)
.++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+. +++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35799999999999999999999989999999999743 2334567889994 55555799999998 66
Q ss_pred EecCC-----------------ceEEEEecCCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 022482 135 CADGD-----------------QRLLVYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194 (296)
Q Consensus 135 ~~~~~-----------------~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~i 194 (296)
+.+.+ ..++||||+ +|+|.+++... ......+++..+..++.|++.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 66553 278999999 58999998752 111123345788889999999999999999 9
Q ss_pred EeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccC-----------CCCccchhHHHHH
Q 022482 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-----------QLTLKSDVYSFGV 263 (296)
Q Consensus 195 vHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~ 263 (296)
+||||||+|||++.++.+||+|||++..... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999985221 2334567 999999999887 7999999999999
Q ss_pred HHHHHHhCCCCCCCCCcc
Q 022482 264 VLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 264 ~l~~ll~g~~pf~~~~~~ 281 (296)
++|+|++|+.||...+..
T Consensus 302 il~elltg~~Pf~~~~~~ 319 (377)
T 3byv_A 302 VIYWIWCADLPITKDAAL 319 (377)
T ss_dssp HHHHHHHSSCCC------
T ss_pred HHHHHHHCCCCCcccccc
Confidence 999999999999866543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=295.01 Aligned_cols=206 Identities=24% Similarity=0.420 Sum_probs=174.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 45689999999999999999999999999999999977666667788999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 97 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~-- 168 (302)
T 2j7t_A 97 FCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-- 168 (302)
T ss_dssp CCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHH--
T ss_pred eCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccc--
Confidence 9999999998864 2456999999999999999999999999 9999999999999999999999999875211
Q ss_pred CcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||...+.
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 227 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 227 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence 0111122356899999999983 56788999999999999999999999987653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=294.45 Aligned_cols=214 Identities=29% Similarity=0.435 Sum_probs=180.7
Q ss_pred HHHHhcCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhc-CCCcccceeeEEe
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCA 136 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~I~~~~~~~~ 136 (296)
.....++|++.+.||+|+||.||+|.+ ..+++.||+|++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 334457899999999999999999985 456789999999765332 345688999999999 6999999999987
Q ss_pred cCC-ceEEEEecCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 137 DGD-QRLLVYEYMPLGSLEDHLHDLPPD------------KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 137 ~~~-~~~lv~e~~~~~sL~~~~~~~~~~------------~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
..+ ..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~N 178 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN 178 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccce
Confidence 754 589999999999999999763221 223889999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|+++.++.++|+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 9999999999999999986544433333444568899999999999999999999999999999998 9999987553
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=292.42 Aligned_cols=203 Identities=30% Similarity=0.459 Sum_probs=174.0
Q ss_pred cCCCccccccccCceEEEEEE----ECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecC--Cce
Q 022482 69 KNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~ 141 (296)
.+|++.+.||+|+||.||+|. +..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 458999999999999999999 56789999999997543 23346788999999999999999999999876 678
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999854 2456999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..|+..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 231 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence 64433221 223345688899999999998899999999999999999999998753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=294.80 Aligned_cols=204 Identities=28% Similarity=0.389 Sum_probs=172.6
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--------chhHHHHHHHHHHhhcCCCcccceeeEEec
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLHHPNLVNLIGYCAD 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~ 137 (296)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 456789999999999999999999999999999999865422 122347889999999999999999999876
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc---eEE
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKL 214 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~---~kl 214 (296)
.+ .++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++. ++|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEE
Confidence 54 8999999999999999865 567999999999999999999999999 999999999999987654 999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+|||++....... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.....
T Consensus 159 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 159 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred ccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9999998643221 122356899999999974 45788999999999999999999999976543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=297.28 Aligned_cols=207 Identities=31% Similarity=0.440 Sum_probs=172.6
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEec------C
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCAD------G 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~------~ 138 (296)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 35678999999999999999999999999999999996543 3456788999999998 79999999999976 4
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 6789999999999999999752 2356899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... ........||+.|+|||++. +..++.++|||||||++|+|++|..||...+.
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 175 VSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp TTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 98753322 11223457999999999987 45688999999999999999999999976553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=290.06 Aligned_cols=203 Identities=22% Similarity=0.264 Sum_probs=174.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~l 143 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 5577999999999999999999999999999999987542 33455678899999988 89999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC--------------
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-------------- 209 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-------------- 209 (296)
||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999999999653222366899999999999999999999999 9999999999999844
Q ss_pred -----CceEEcccCCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 210 -----YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 210 -----~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
..++|+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 479999999997643321 23589999999999776 5668999999999999999999887544
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.90 Aligned_cols=203 Identities=29% Similarity=0.408 Sum_probs=173.8
Q ss_pred cCCCccccccccCceEEEEEEEC---CCCeEEEEEEecCCCc----chhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLE---STNQVVAIKQLDRNGL----QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
++|++.+.||+|+||.||+|++. .+++.||||++..... .....+.+|+.+++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 57999999999999999999984 4789999999865321 2234566789999998 69999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999975 456999999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||....
T Consensus 207 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 207 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred eecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 7533222 2223346799999999999863 47889999999999999999999997544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=286.20 Aligned_cols=201 Identities=32% Similarity=0.510 Sum_probs=165.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc----hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ----GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+. +..||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 57999999999999999999986 888999998654322 235688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC--------CCceEEcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--------GYHPKLSD 216 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~--------~~~~kl~D 216 (296)
|||+++++|.+++. ...+++..+..++.|++.||.|||+.+..+|+||||||+||+++. ++.++|+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999985 357999999999999999999999988555889999999999986 77899999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++....... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred CCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99997533222 2235689999999999998999999999999999999999999987653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=290.32 Aligned_cols=206 Identities=29% Similarity=0.408 Sum_probs=165.6
Q ss_pred hcCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 45799999999999999999998653 55799999865432 23456889999999999999999999984 567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 93 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999975 2456899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 167 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~ 224 (281)
T 1mp8_A 167 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred Ccccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH
Confidence 33221 11223456789999999998899999999999999999997 99999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=306.43 Aligned_cols=201 Identities=27% Similarity=0.357 Sum_probs=167.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC------CceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------~~~~ 142 (296)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999999999999999986432 2234799999999999999999988542 2367
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-CceEEcccCCcc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-YHPKLSDFGLAK 221 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-~~~kl~Dfg~~~ 221 (296)
+||||++ ++|.+.+.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 8999997 4676665432234577999999999999999999999999 9999999999999854 678999999998
Q ss_pred cCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+.
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 6433222 2345789999999998765 789999999999999999999999987654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=287.68 Aligned_cols=208 Identities=26% Similarity=0.360 Sum_probs=172.4
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEE-ecCCceEEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLV 144 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~-~~~~~~~lv 144 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 456789999999999999999999999999999998754432 23577899999999988777666655 666788999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCcc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAK 221 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~ 221 (296)
|||+ +++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||++ +.++.++|+|||++.
T Consensus 84 ~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 8999999874 2456999999999999999999999999 9999999999999 789999999999997
Q ss_pred cCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 222 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 222 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 222 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 222 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhh
Confidence 54333221 12234579999999999999999999999999999999999999998765543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=296.32 Aligned_cols=205 Identities=34% Similarity=0.487 Sum_probs=179.1
Q ss_pred cCCCccccccccCceEEEEEE----ECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEe--cCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA--DGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~--~~~~~~ 142 (296)
++|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 579999999999999999999 56789999999998776666677899999999999999999999886 456688
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 103 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999998652 346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 4433222 22233568889999999998889999999999999999999999997544
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=288.10 Aligned_cols=205 Identities=27% Similarity=0.353 Sum_probs=178.7
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---------chhHHHHHHHHHHhhcC-CCcccceeeEE
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEVLMLSLLH-HPNLVNLIGYC 135 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~I~~~~~~~ 135 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 466789999999999999999999999999999999965431 11345778999999995 99999999999
Q ss_pred ecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 136 ~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEe
Confidence 999999999999999999999965 457899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccc------cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM------TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|||++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...+.
T Consensus 167 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 167 DFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp CCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 999997643322 223457899999999985 44678899999999999999999999976553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=288.82 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=171.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 4568999999999999999999999999999999986432 2234568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999965 356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.... ......|++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 3322 2234568999999999988765 6889999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=301.03 Aligned_cols=205 Identities=22% Similarity=0.258 Sum_probs=175.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC--------CCcccceeeEEe-
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH--------HPNLVNLIGYCA- 136 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~I~~~~~~~~- 136 (296)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++ |+||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3467899999999999999999999999999999999654 234566788999999885 788999999987
Q ss_pred ---cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCC--
Q 022482 137 ---DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGY-- 210 (296)
Q Consensus 137 ---~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~-- 210 (296)
.....++||||+ +++|.+++... ....+++..+..++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchh
Confidence 556889999999 56776666541 235699999999999999999999998 8 99999999999998775
Q ss_pred -----------------------------------------------ceEEcccCCcccCCCCCcceeeecccccccccC
Q 022482 211 -----------------------------------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243 (296)
Q Consensus 211 -----------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 243 (296)
.++|+|||++...... .....||+.|+|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~a 261 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCC
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccC
Confidence 7999999999764322 233578999999
Q ss_pred ccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 244 PE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
||++.+..++.++|||||||++|+|++|+.||...+..+
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 300 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccc
Confidence 999999999999999999999999999999998766544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=289.52 Aligned_cols=204 Identities=33% Similarity=0.524 Sum_probs=162.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
..++|++.+.||+|+||.||+|.+.. .+|+|++..... ...+.+.+|+.+++.++||||++++++. ..+..++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 35679999999999999999998753 499999865433 2345688999999999999999999954 55678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999865 3467999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCccccc---cCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAM---TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
............||+.|+|||++. +..++.++||||||+++|+|++|+.||.+...
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 230 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 230 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence 323333334467999999999986 55788899999999999999999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=295.02 Aligned_cols=207 Identities=28% Similarity=0.380 Sum_probs=174.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEe----cCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA----DGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~----~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++. .....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 357999999999999999999999999999999987665556677899999999999999999999987 3347889
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+.+++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998754334577999999999999999999999999 999999999999999999999999998753
Q ss_pred CCCCcc-------eeeecccccccccCccccccCC---CCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 224 PVGDKT-------HVSTRVMGTYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 224 ~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 211100 0011235799999999987654 68899999999999999999999964
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=298.60 Aligned_cols=210 Identities=28% Similarity=0.435 Sum_probs=179.2
Q ss_pred hcCCCccccccccCceEEEEEEECCCCe-----EEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQ-----VVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~ 140 (296)
.++|.+.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 4679999999999999999999976654 799999976533 3345688999999999 89999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLP----------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY 210 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~----------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~ 210 (296)
.++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCC
Confidence 999999999999999986421 01346899999999999999999999999 99999999999999999
Q ss_pred ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 211 HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
.++|+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999975433333333344567889999999998899999999999999999998 9999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=290.82 Aligned_cols=196 Identities=20% Similarity=0.312 Sum_probs=173.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEec--CCceEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCAD--GDQRLLV 144 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~--~~~~~lv 144 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999999999999999999643 3567889999999997 9999999999987 5678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~ 223 (296)
|||+.+++|.+++.. +++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .++|+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999843 888999999999999999999999 99999999999999766 8999999999764
Q ss_pred CCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 33322 234578999999999977 578999999999999999999999996544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=304.16 Aligned_cols=201 Identities=30% Similarity=0.465 Sum_probs=173.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC-ceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD-QRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~-~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 357899999999999999999986 7799999997653 4577899999999999999999999987665 7899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999752 2334789999999999999999999999 999999999999999999999999999753221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+
T Consensus 343 -----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~ 394 (450)
T 1k9a_A 343 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT
T ss_pred -----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 112357889999999999999999999999999999998 999998765443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=296.34 Aligned_cols=210 Identities=26% Similarity=0.341 Sum_probs=172.0
Q ss_pred CHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-----------hhHHHHHHHHHHhhcCCCcc
Q 022482 60 TFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-----------GNREFLVEVLMLSLLHHPNL 128 (296)
Q Consensus 60 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~I 128 (296)
...++..+.++|.+.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+.+++.++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 355677889999999999999999999999876 899999998643221 12668899999999999999
Q ss_pred cceeeEEec-----CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 129 VNLIGYCAD-----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 129 ~~~~~~~~~-----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
+++++++.. ....++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999854 336799999997 688888764 3457999999999999999999999999 9999999999
Q ss_pred EEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 204 ILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 204 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|+++.++.++|+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 239 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999743222 22334578999999999877 6789999999999999999999999987653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=299.29 Aligned_cols=203 Identities=18% Similarity=0.233 Sum_probs=167.2
Q ss_pred hcCCCccccccccCceEEEEEEECC---CCeEEEEEEecCCCcch-----------hHHHHHHHHHHhhcCCCcccceee
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGLQG-----------NREFLVEVLMLSLLHHPNLVNLIG 133 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~~I~~~~~ 133 (296)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|++....... ...+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 3579999999999999999999987 78899999987653221 123567888899999999999999
Q ss_pred EEec----CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC
Q 022482 134 YCAD----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (296)
Q Consensus 134 ~~~~----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~ 209 (296)
++.. ....++||||+ +++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9987 67889999999 9999999975 347999999999999999999999999 9999999999999887
Q ss_pred C--ceEEcccCCcccCCCCCc-----ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 210 Y--HPKLSDFGLAKLGPVGDK-----THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 210 ~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+ .++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7 999999999975432211 11113457999999999999989999999999999999999999999753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=285.77 Aligned_cols=206 Identities=26% Similarity=0.366 Sum_probs=175.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEE-ecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC-ADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~-~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 45789999999999999999999999999999999865432 34688999999999988876666555 5667789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~~ 222 (296)
||+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.++|+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8999999974 2457999999999999999999999999 9999999999999 4888999999999975
Q ss_pred CCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCch
Confidence 4333221 1123457999999999999999999999999999999999999999875543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=296.72 Aligned_cols=199 Identities=26% Similarity=0.392 Sum_probs=172.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCce---
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR--- 141 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~--- 141 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999999999999999999764332 245678999999999999999999999877655
Q ss_pred ---EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 142 ---LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 142 ---~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 78888873 34999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 190 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 190 LARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9975322 1234578999999999987 6789999999999999999999999987653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.00 Aligned_cols=206 Identities=34% Similarity=0.529 Sum_probs=174.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEE--EEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVV--AIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..++..+ |+|.+.... ......+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999998888865 999886432 23345688999999999 899999999999999999999
Q ss_pred EecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 145 YEYMPLGSLEDHLHDLP------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
|||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997632 22357999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 247 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence 9999999874221 112223457889999999988889999999999999999998 9999987654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=285.14 Aligned_cols=203 Identities=30% Similarity=0.464 Sum_probs=177.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 57999999999999999999987 477899999976543 3467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~- 158 (267)
T 3t9t_A 86 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 158 (267)
T ss_dssp TTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred CCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-
Confidence 99999999975 2456899999999999999999999999 9999999999999999999999999997543221
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
........+++.|+|||++.+..++.++|+||||+++|+|++ |+.||...+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 112223457788999999998899999999999999999999 9999987553
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=289.42 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=167.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh--cCCCcccceeeEEec----CCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCAD----GDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~----~~~ 140 (296)
+.++|++.+.||+|+||.||+|.+ +++.||||++... ....+..|..++.. ++||||+++++++.. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 467899999999999999999988 4899999998643 33455566666665 789999999998654 345
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeccCCCCcEEEcCCCce
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--------DKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH--------~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
.++||||+++++|.++++. ..+++..+..++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~ 152 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQC 152 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCE
T ss_pred eEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCE
Confidence 7899999999999999953 56999999999999999999999 888 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcce--eeecccccccccCccccccC------CCCccchhHHHHHHHHHHHhC----------CCC
Q 022482 213 KLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTG------QLTLKSDVYSFGVVLLEIITG----------RKA 274 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~ll~g----------~~p 274 (296)
||+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p 232 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232 (301)
T ss_dssp EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence 999999997533322211 12234799999999999876 345789999999999999999 899
Q ss_pred CCCCCc
Q 022482 275 IDNTRA 280 (296)
Q Consensus 275 f~~~~~ 280 (296)
|.....
T Consensus 233 f~~~~~ 238 (301)
T 3q4u_A 233 FYDVVP 238 (301)
T ss_dssp TTTTSC
T ss_pred ccccCC
Confidence 976543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=290.59 Aligned_cols=211 Identities=28% Similarity=0.428 Sum_probs=167.3
Q ss_pred hcCCCccccccccCceEEEEEEECC---CCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCC---
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--- 139 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~--- 139 (296)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3579999999999999999998764 566899999875432 23456889999999999999999999998755
Q ss_pred --ceEEEEecCCCCCHHHHhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 140 --QRLLVYEYMPLGSLEDHLHDL--PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 140 --~~~lv~e~~~~~sL~~~~~~~--~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
..++||||+++++|.+++... ......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 359999999999999998431 123467999999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 9999976443332223334567889999999999999999999999999999999 99999876544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=296.07 Aligned_cols=211 Identities=28% Similarity=0.438 Sum_probs=179.2
Q ss_pred HhcCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
..++|++.+.||+|+||.||+|.+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 4567999999999999999999876 3578899999975432 234568899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEE
Q 022482 141 RLLVYEYMPLGSLEDHLHDLP------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKL 214 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl 214 (296)
.++||||+++++|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 999999999999999986421 11245789999999999999999999999 999999999999999999999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 99999975433222222333457889999999998899999999999999999999 8999987654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=289.66 Aligned_cols=204 Identities=25% Similarity=0.308 Sum_probs=162.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch--hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG--NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467999999999999999999999999999999997543222 223445555678889999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||++ ++|.+++.........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 588877754333456799999999999999999999998 8 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||...
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCC
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCcccc
Confidence 222 22234699999999996 4557889999999999999999999999753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=290.86 Aligned_cols=211 Identities=26% Similarity=0.383 Sum_probs=176.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec--CCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 4679999999999999999999999999999999976543 234568899999999999999999998753 568899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~--~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
||||+++++|.+++.........+++..+..++.|++.||.|||+.+ ..+|+||||||+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999998753333456999999999999999999999865 2349999999999999999999999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
...... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 543221 112235689999999999988899999999999999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=289.99 Aligned_cols=205 Identities=24% Similarity=0.345 Sum_probs=170.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEe----------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA---------- 136 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~---------- 136 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4578999999999999999999999999999999997766556677889999999999999999999874
Q ss_pred ----cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCc
Q 022482 137 ----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYH 211 (296)
Q Consensus 137 ----~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~ 211 (296)
+....++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCe
Confidence 3467899999997 699999853 56899999999999999999999999 99999999999997 5679
Q ss_pred eEEcccCCcccCCCCCc-ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 212 PKLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++|+|||++........ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 99999999986432211 112233467999999998865 6789999999999999999999999987664
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=285.84 Aligned_cols=204 Identities=27% Similarity=0.379 Sum_probs=173.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMP 149 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~ 149 (296)
.|.....||+|+||.||+|.+..++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 35556699999999999999999999999999977665566778999999999999999999999999999999999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcccCCcccCCCCCc
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.++|+|||++.......
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 999999987531 2345678899999999999999999999 999999999999987 8999999999997543221
Q ss_pred ceeeecccccccccCccccccCC--CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 1223457899999999997653 7889999999999999999999997543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=287.32 Aligned_cols=200 Identities=29% Similarity=0.438 Sum_probs=175.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--------
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-------- 137 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-------- 137 (296)
.+..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46678999999999999999999999899999999996543 356689999999999999999998864
Q ss_pred --------CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC
Q 022482 138 --------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (296)
Q Consensus 138 --------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~ 209 (296)
....++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence 34579999999999999999652 2357899999999999999999999999 9999999999999999
Q ss_pred CceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
+.++|+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 159 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp TEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999999997643322 12335699999999999998999999999999999999999999853
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=293.80 Aligned_cols=210 Identities=31% Similarity=0.450 Sum_probs=171.8
Q ss_pred hcCCCccccccccCceEEEEEE-----ECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGR-----LESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||.||+|. +..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4579999999999999999999 55678899999996543 23445688999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPP---DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLS 215 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~---~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~ 215 (296)
++||||+++++|.+++..... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++. +..++|+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976321 2245899999999999999999999999 999999999999984 4469999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
|||++................|++.|+|||++.+..++.++||||||+++|+|++ |..||...+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 9999874322222222334568899999999998899999999999999999998 9999986654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=284.97 Aligned_cols=205 Identities=28% Similarity=0.437 Sum_probs=174.0
Q ss_pred cCCCccc-cccccCceEEEEEEEC--CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADC-LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+.. .||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566666 9999999999999864 4678899999976432 3456788999999999999999999999 45678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999864 3456999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 225 VGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 33221 11223456889999999988889999999999999999998 9999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=306.66 Aligned_cols=206 Identities=28% Similarity=0.460 Sum_probs=176.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred chHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 34578999999999999999999875 6789999997654 45678999999999999999999999986 567899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 263 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp CCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred ecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999641 1236888999999999999999999999 999999999999999999999999999864322
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
.. .......++..|+|||++....++.++|||||||++|||++ |+.||.+.+..
T Consensus 338 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 338 EY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp HH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred ce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 11 11122346788999999998899999999999999999999 99999876543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.92 Aligned_cols=211 Identities=26% Similarity=0.328 Sum_probs=164.4
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCc--
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ-- 140 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~-- 140 (296)
......++|++.+.||+|+||.||+|.+..+++.||||++.... .......+++..++.++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34456678999999999999999999999999999999886543 233456678888889999999999999865433
Q ss_pred -----eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeEeccCCCCcEEEcC-CCce
Q 022482 141 -----RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--DKANPPVIYRDLKCSNILLGE-GYHP 212 (296)
Q Consensus 141 -----~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH--~~~~~~ivHrdikp~Nili~~-~~~~ 212 (296)
.++||||+.+ +|.+.+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999985 555444322234667899999999999999999999 888 999999999999986 8999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..
T Consensus 172 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp EECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 999999998644322 22345789999999998665 4899999999999999999999999876644
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=292.39 Aligned_cols=207 Identities=28% Similarity=0.438 Sum_probs=170.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCC----eEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
..+|.+.+.||+|+||.||+|.+..++ ..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 356888999999999999999886543 4699999975432 23456889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999975 2467999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 223 GPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...+.
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~ 256 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 256 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence 4332211 11222346788999999998899999999999999999999 9999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=286.63 Aligned_cols=205 Identities=29% Similarity=0.464 Sum_probs=172.5
Q ss_pred cCCCccc-cccccCceEEEEEEE--CCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADC-LLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|.+.+ .||+|+||.||+|.+ ..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5688888 999999999999954 56688999999975432 2346788999999999999999999999 5677899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999976 456999999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 224 PVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
...... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 433222 11222346788999999988889999999999999999999 99999876543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=299.34 Aligned_cols=200 Identities=12% Similarity=0.035 Sum_probs=154.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhc--CCCccccee-------eEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLL--HHPNLVNLI-------GYCA 136 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l--~h~~I~~~~-------~~~~ 136 (296)
.+|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 358999999999999999999999999999999977543 2234567775545544 699988755 4444
Q ss_pred cC-----------------CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCC
Q 022482 137 DG-----------------DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTR------MRIAAGAAKGLEYLHDKANPP 193 (296)
Q Consensus 137 ~~-----------------~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~------~~i~~ql~~al~~lH~~~~~~ 193 (296)
.. ...++||||++ ++|.+++... +..+++..+ ..++.|++.||+|||+.+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 33 33799999998 8999999752 223344444 577799999999999999
Q ss_pred eEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhC
Q 022482 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITG 271 (296)
Q Consensus 194 ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g 271 (296)
|+||||||+|||++.++.+||+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999985321 1224567799999999987 6789999999999999999999
Q ss_pred CCCCCCCCc
Q 022482 272 RKAIDNTRA 280 (296)
Q Consensus 272 ~~pf~~~~~ 280 (296)
+.||.....
T Consensus 290 ~~Pf~~~~~ 298 (371)
T 3q60_A 290 FLPFGLVTP 298 (371)
T ss_dssp SCSTTBCCT
T ss_pred CCCCCCcCc
Confidence 999987743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=290.08 Aligned_cols=205 Identities=22% Similarity=0.283 Sum_probs=176.6
Q ss_pred HHhcCCCccccccccCceEEEEEEE-CCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC------cccceeeEEecC
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRL-ESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP------NLVNLIGYCADG 138 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------~I~~~~~~~~~~ 138 (296)
.+.++|++.+.||+|+||.||+|.+ ..+++.||+|++... ......+.+|+.+++.++|+ +++++++++...
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 3557899999999999999999998 567899999999643 23346678899999888765 499999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC----------
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---------- 208 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---------- 208 (296)
+..++||||+ +++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC--
T ss_pred CcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCc
Confidence 9999999999 79999998762 2346899999999999999999999999 999999999999987
Q ss_pred ---------CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 209 ---------GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 209 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 164 IKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp --CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred cccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999753322 234578999999999999899999999999999999999999998766
Q ss_pred ccc
Q 022482 280 AAG 282 (296)
Q Consensus 280 ~~~ 282 (296)
..+
T Consensus 239 ~~~ 241 (339)
T 1z57_A 239 SKE 241 (339)
T ss_dssp HHH
T ss_pred hHH
Confidence 543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=283.71 Aligned_cols=204 Identities=30% Similarity=0.418 Sum_probs=170.5
Q ss_pred CCCccccccccCceEEEEEEECCCC---eEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCce-EEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR-LLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~-~lv 144 (296)
.|.+.+.||+|+||.||+|.+..++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4667799999999999999975444 3799999975433 3346688999999999999999999999876655 999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999975 3467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCc--ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCC-CCCCCC
Q 022482 225 VGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK-AIDNTR 279 (296)
Q Consensus 225 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~-pf~~~~ 279 (296)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|.. ||...+
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~ 233 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID 233 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence 2221 112233567899999999999899999999999999999999554 454443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=291.19 Aligned_cols=211 Identities=28% Similarity=0.427 Sum_probs=160.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3568999999999999999999998889999999986543 233456788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 146 EYMPLGSLEDHLHDL----PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 146 e~~~~~sL~~~~~~~----~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
||+++++|.+++... ......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999988631 112456899999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCc---ceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDK---THVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 5432211 112234578999999999876 5689999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=283.54 Aligned_cols=201 Identities=32% Similarity=0.460 Sum_probs=173.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEec----CCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~~ 142 (296)
..|.+.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34888999999999999999999999999999986543 2334568899999999999999999999875 35689
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCceEEcccCCcc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAK 221 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~ 221 (296)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ .+|+||||||+||+++ .++.++|+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999965 356899999999999999999999875 2499999999999997 78999999999997
Q ss_pred cCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus 181 ~~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 181 LKRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp GCCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 533322 234569999999998864 58999999999999999999999997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=299.29 Aligned_cols=201 Identities=25% Similarity=0.371 Sum_probs=165.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC------ce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD------QR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~------~~ 141 (296)
..+|++.+.||+|+||.||+|.+..+++ +|+|++..... ...+|+.+++.++||||+++++++.... ..
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 4569999999999999999999988666 78887754321 2236999999999999999999986543 37
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCceEEcccCCc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLA 220 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~ 220 (296)
++||||+++ ++...+.........+++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a 189 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence 899999985 444433321123567999999999999999999999999 99999999999998 7999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+....... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 190 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 247 (394)
T 4e7w_A 190 KILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG 247 (394)
T ss_dssp EECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 86433322 2345789999999998765 589999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=290.11 Aligned_cols=204 Identities=34% Similarity=0.518 Sum_probs=176.6
Q ss_pred hcCCCccccccccCceEEEEEE----ECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC--ce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGR----LESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD--QR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~--~~ 141 (296)
.++|++.+.||+|+||.||+|. +..+++.||+|++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 3569999999999999999998 45679999999998766666678899999999999999999999987654 78
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999762 356899999999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 64433221 112234577889999999888899999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=300.65 Aligned_cols=206 Identities=26% Similarity=0.382 Sum_probs=175.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC-CcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.| ++|..+..++...+..++||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 45789999999999999999999999999999998865432 2357789999999987 55566666667778889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE---cCCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL---GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili---~~~~~~kl~Dfg~~~~ 222 (296)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.++|+|||++..
T Consensus 83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 89999999752 457999999999999999999999999 9999999999999 6889999999999975
Q ss_pred CCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~ 219 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch
Confidence 4433221 1122467999999999999999999999999999999999999999876553
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=285.12 Aligned_cols=206 Identities=31% Similarity=0.471 Sum_probs=170.3
Q ss_pred cCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEe-cCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCA-DGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~-~~~~~~l 143 (296)
.+|++.+.||+|+||.||+|.+..+ ...+|+|.+..... .....+.+|+.+++.++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4689999999999999999997543 34689999875433 33456889999999999999999999864 5567899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999965 3456899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCc--ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 224 PVGDK--THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
..... ........+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 33221 112233467889999999999999999999999999999999 6667765543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=292.73 Aligned_cols=203 Identities=22% Similarity=0.322 Sum_probs=176.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-----------------hHHHHHHHHHHhhcCCCccc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----------------NREFLVEVLMLSLLHHPNLV 129 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~~I~ 129 (296)
..++|++.+.||+|+||.||+|.+ +++.||+|++....... ...+.+|+.+++.++||||+
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 106 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL 106 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence 346899999999999999999999 79999999986432111 17788999999999999999
Q ss_pred ceeeEEecCCceEEEEecCCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCC
Q 022482 130 NLIGYCADGDQRLLVYEYMPLGSLEDH------LHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCS 202 (296)
Q Consensus 130 ~~~~~~~~~~~~~lv~e~~~~~sL~~~------~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~ 202 (296)
++++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||.|||+ .+ |+||||||+
T Consensus 107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~ 181 (348)
T 2pml_X 107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPS 181 (348)
T ss_dssp CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGG
T ss_pred eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChH
Confidence 999999999999999999999999998 433 225679999999999999999999999 88 999999999
Q ss_pred cEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccC-CCCc-cchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 203 NILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTL-KSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 203 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||+++.++.++|+|||.+...... ......|++.|+|||++.+. .++. ++|||||||++|+|++|+.||...+.
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred hEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999999999999999764322 23446799999999999887 6666 89999999999999999999986654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=284.45 Aligned_cols=205 Identities=27% Similarity=0.435 Sum_probs=171.9
Q ss_pred hcCCCccccccccCceEEEEEEECC---CCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES---TNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4579999999999999999998653 34569999987653 2345678899999999999999999999865 46789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999965 2456899999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
..... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 164 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 164 EDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred ccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 33221 11233457889999999988899999999999999999998 9999975544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=291.17 Aligned_cols=199 Identities=26% Similarity=0.395 Sum_probs=171.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCc----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ---- 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~---- 140 (296)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ....+.+|+.+++.++||||+++++++.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 456899999999999999999999999999999999764332 23567899999999999999999999987654
Q ss_pred --eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 141 --RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 141 --~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
.++||||+. ++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecc
Confidence 499999997 68887763 35899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 172 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 172 LARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred cccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99753221 233578999999999877 6789999999999999999999999987653
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.31 Aligned_cols=205 Identities=25% Similarity=0.371 Sum_probs=173.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecC-----Cc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG-----DQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~~ 140 (296)
+.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 45789999999999999999999999999999999965432 2345678999999999999999999987654 67
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.++||||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999997 689998864 46899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcce--------eeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 221 KLGPVGDKTH--------VSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 221 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 7543221111 1223578999999998765 6789999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=288.65 Aligned_cols=203 Identities=33% Similarity=0.480 Sum_probs=172.7
Q ss_pred hcCC-CccccccccCceEEEEEEE----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecC--C
Q 022482 68 TKNF-RADCLLGEGGFGRVYKGRL----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--D 139 (296)
Q Consensus 68 ~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~ 139 (296)
.++| ++.+.||+|+||.||++.. ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+. .
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 3455 9999999999999988754 45789999999976532 3345688999999999999999999999874 5
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~ 180 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL 180 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred eEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence 78999999999999999965 34899999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 220 AKLGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 220 ~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+......... .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 181 AKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 9865443221 2233456888999999999888999999999999999999999999754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=282.61 Aligned_cols=204 Identities=31% Similarity=0.495 Sum_probs=174.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 4679999999999999999999864 6789999997553 345678899999999999999999999864 568999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999998641 1236899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 1 12223456789999999988889999999999999999999 9999986554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.11 Aligned_cols=208 Identities=26% Similarity=0.394 Sum_probs=158.6
Q ss_pred HhcCCCc-cccccccCceEEEEEEEC--CCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec--CCce
Q 022482 67 VTKNFRA-DCLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQR 141 (296)
Q Consensus 67 ~~~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~ 141 (296)
+.+.|.+ .+.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+++.++||||+++++++.. ....
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4455776 458999999999999966 5688999999975533 3567899999999999999999999954 6788
Q ss_pred EEEEecCCCCCHHHHhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE----cCCCce
Q 022482 142 LLVYEYMPLGSLEDHLHDL-----PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL----GEGYHP 212 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~-----~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili----~~~~~~ 212 (296)
++||||+. ++|.+++... ......+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~ 171 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRV 171 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCE
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcE
Confidence 99999996 6888777421 112235999999999999999999999999 9999999999999 678899
Q ss_pred EEcccCCcccCCCCCc-ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 213 KLSDFGLAKLGPVGDK-THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||+|||++........ .......+||+.|+|||++.+. .++.++|||||||++|+|++|++||.....
T Consensus 172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 9999999986433211 1223346799999999999874 589999999999999999999999976554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=283.28 Aligned_cols=206 Identities=30% Similarity=0.436 Sum_probs=178.8
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 3466788999999999999999999999999999999986532 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC---CceEEcccC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG---YHPKLSDFG 218 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~---~~~kl~Dfg 218 (296)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.+ +.++|+|||
T Consensus 97 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg 169 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFG 169 (287)
T ss_dssp EEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTT
T ss_pred EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccC
Confidence 999999999999998865 356899999999999999999999999 9999999999999654 469999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (287)
T 2wei_A 170 LSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (287)
T ss_dssp GGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 987543322 1223468999999999866 588999999999999999999999987654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=279.51 Aligned_cols=200 Identities=24% Similarity=0.380 Sum_probs=171.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecC--CceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADG--DQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~--~~~~lv 144 (296)
++|.+.+.||+|+||.||+|.+. +..||+|++..... ...+.+.+|+.+++.++||||+++++++.+. +..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 57999999999999999999986 88899999976532 3345688999999999999999999999887 788999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ .+++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999999762 2346899999999999999999999864 349999999999999999999999888875321
Q ss_pred CCCcceeeecccccccccCccccccCCCCc---cchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTL---KSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. ....||+.|+|||++.+..++. ++|||||||++|+|++|+.||...+.
T Consensus 165 ~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 165 S-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp C-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred c-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 1 1246899999999998765544 79999999999999999999986554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=303.00 Aligned_cols=205 Identities=34% Similarity=0.511 Sum_probs=171.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 4578999999999999999999976 4679999997654 345678999999999999999999999876 678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 260 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 260 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred hcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 9999999999641 2345899999999999999999999999 9999999999999999999999999998643322
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
. .......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....
T Consensus 335 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 335 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred e-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 1 11223456788999999998899999999999999999999 99999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=284.72 Aligned_cols=196 Identities=36% Similarity=0.524 Sum_probs=164.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++. +..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 46899999999999999999986 788999998643 34567889999999999999999999886 3589999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCCeEeccCCCCcEEEcCCCc-eEEcccCCcccCC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD---KANPPVIYRDLKCSNILLGEGYH-PKLSDFGLAKLGP 224 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~---~~~~~ivHrdikp~Nili~~~~~-~kl~Dfg~~~~~~ 224 (296)
++++|.+++.... ....+++..+..++.|++.||.|||+ .+ |+||||||+||+++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999997521 12347889999999999999999999 66 999999999999988886 7999999997432
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 207 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIG 207 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence 21 223468999999999999899999999999999999999999998654
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=284.66 Aligned_cols=206 Identities=26% Similarity=0.370 Sum_probs=167.9
Q ss_pred HHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh--cCCCcccceeeEEecC
Q 022482 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCADG 138 (296)
Q Consensus 61 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~~~ 138 (296)
......+.++|++.+.||+|+||.||+|.+. ++.||||++... .......|..++.. ++||||+++++++...
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3344566788999999999999999999986 899999998543 23344455555544 4899999999999877
Q ss_pred ----CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC--------CCCCeEeccCCCCcEEE
Q 022482 139 ----DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK--------ANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ----~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~--------~~~~ivHrdikp~Nili 206 (296)
...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. + |+||||||+|||+
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill 175 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILV 175 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEE
Confidence 678999999999999999965 4689999999999999999999998 8 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcc--eeeecccccccccCccccccCCCCcc------chhHHHHHHHHHHHhC-------
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLK------SDVYSFGVVLLEIITG------- 271 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~~ll~g------- 271 (296)
+.++.+||+|||++......... .......||+.|+|||++.+..+... +|||||||++|+|++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999999653332211 11124579999999999988766655 9999999999999999
Q ss_pred ---CCCCCCCC
Q 022482 272 ---RKAIDNTR 279 (296)
Q Consensus 272 ---~~pf~~~~ 279 (296)
+.||....
T Consensus 256 ~~~~~p~~~~~ 266 (337)
T 3mdy_A 256 EEYQLPYHDLV 266 (337)
T ss_dssp CCCCCTTTTTS
T ss_pred ccccccHhhhc
Confidence 77776543
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=295.13 Aligned_cols=201 Identities=18% Similarity=0.241 Sum_probs=170.7
Q ss_pred hcCCCccccccccCceEEEEEEECC--------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccc---------
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES--------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVN--------- 130 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~--------- 130 (296)
.++|++.+.||+|+||.||+|.+.. .++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3679999999999999999999987 3789999998644 46778999999999999887
Q ss_pred ------eeeEEec-CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCc
Q 022482 131 ------LIGYCAD-GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSN 203 (296)
Q Consensus 131 ------~~~~~~~-~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~N 203 (296)
+++++.. ....++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 5666665 67889999999 89999999752 2367999999999999999999999999 9999999999
Q ss_pred EEEcCCC--ceEEcccCCcccCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 204 ILLGEGY--HPKLSDFGLAKLGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 204 ili~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
|+++.++ .++|+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 9999999999754322111 11233579999999999999899999999999999999999999998
Q ss_pred CCC
Q 022482 277 NTR 279 (296)
Q Consensus 277 ~~~ 279 (296)
...
T Consensus 270 ~~~ 272 (352)
T 2jii_A 270 NCL 272 (352)
T ss_dssp GGT
T ss_pred cCC
Confidence 765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=292.41 Aligned_cols=205 Identities=25% Similarity=0.315 Sum_probs=175.0
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CC-----cccceeeEEecC
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HP-----NLVNLIGYCADG 138 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~I~~~~~~~~~~ 138 (296)
..+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34567899999999999999999999999999999999643 233456677888888775 44 499999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc--CCCCCeEeccCCCCcEEEc--CCCceEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD--KANPPVIYRDLKCSNILLG--EGYHPKL 214 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~--~~~~~ivHrdikp~Nili~--~~~~~kl 214 (296)
+..++||||+. ++|.+++... ....+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEE
T ss_pred CceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEE
Confidence 99999999996 6999998762 23568999999999999999999994 57 99999999999994 4778999
Q ss_pred cccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 215 SDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 215 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..
T Consensus 203 ~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 203 VDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999864322 23457999999999999999999999999999999999999999976543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=285.67 Aligned_cols=205 Identities=27% Similarity=0.414 Sum_probs=172.9
Q ss_pred HhcCCCccccccccCceEEEEEEEC-CCCeEEEEEEecCCCc--chhHHHHHHHHHHhhc---CCCcccceeeEEe----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLE-STNQVVAIKQLDRNGL--QGNREFLVEVLMLSLL---HHPNLVNLIGYCA---- 136 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~---- 136 (296)
..++|++.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999864321 1223456777777666 8999999999987
Q ss_pred -cCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEc
Q 022482 137 -DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLS 215 (296)
Q Consensus 137 -~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~ 215 (296)
.....++||||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 6999998763 2345899999999999999999999999 9999999999999999999999
Q ss_pred ccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 216 DFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 216 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999975332 1223345789999999999998999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=293.83 Aligned_cols=206 Identities=30% Similarity=0.474 Sum_probs=163.8
Q ss_pred CCCccccccccCceEEEEEEECCC---CeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEec-CCceEEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLV 144 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~~lv 144 (296)
.|.+.+.||+|+||.||+|.+..+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 477889999999999999987532 3468999986533 3345678899999999999999999998654 5678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999975 3456889999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCcc--eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 225 VGDKT--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH
Confidence 22211 11223457889999999999999999999999999999999 78888765543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.63 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=159.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEe--------cCC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCA--------DGD 139 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~--------~~~ 139 (296)
.+|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.+. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 47999999999999999999999999999999987665556677889999999996 999999999984 334
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
.+++||||+. ++|.+++.... ....+++..+..++.|++.||.|||+.+ .+|+||||||+|||++.++.++|+|||+
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred eEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence 5789999996 78988875421 2456999999999999999999999875 2499999999999999999999999999
Q ss_pred cccCCCCCcce----------eeecccccccccCcccc---ccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 220 AKLGPVGDKTH----------VSTRVMGTYGYCAPEYA---MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 220 ~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+.......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 257 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA 257 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchh
Confidence 97643322111 11134689999999998 56678899999999999999999999997644
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=288.02 Aligned_cols=203 Identities=20% Similarity=0.270 Sum_probs=174.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCC-eEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc------ccceeeEEecCC
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTN-QVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN------LVNLIGYCADGD 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~------I~~~~~~~~~~~ 139 (296)
+.++|++.+.||+|+||.||+|.+..++ ..||+|++... ......+.+|+.+++.++|++ ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 5678999999999999999999998776 78999999654 234566788999999887655 899999999999
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE-------------
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL------------- 206 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili------------- 206 (296)
..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence 999999999 57777777552 2356999999999999999999999999 9999999999999
Q ss_pred ------cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 207 ------GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 207 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+.++.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 56789999999999753322 2345799999999999998999999999999999999999999987664
Q ss_pred c
Q 022482 281 A 281 (296)
Q Consensus 281 ~ 281 (296)
.
T Consensus 245 ~ 245 (355)
T 2eu9_A 245 R 245 (355)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=291.49 Aligned_cols=202 Identities=20% Similarity=0.274 Sum_probs=169.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-----------CCcccceeeEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCA 136 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~I~~~~~~~~ 136 (296)
..+|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.+. ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35799999999999999999999999999999999654 233456778998888876 899999999998
Q ss_pred cCC----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEc----
Q 022482 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLG---- 207 (296)
Q Consensus 137 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~---- 207 (296)
..+ ..++|||++ +++|.+++... ....+++..+..++.|++.||.|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 788999999 89999998763 245699999999999999999999998 9 99999999999994
Q ss_pred --CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 208 --EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 208 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..+.++|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 241 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccc
Confidence 3447999999999754321 22357899999999999989999999999999999999999999876643
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=287.86 Aligned_cols=202 Identities=22% Similarity=0.270 Sum_probs=149.8
Q ss_pred HhcCCCccc-cccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec----CCce
Q 022482 67 VTKNFRADC-LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQR 141 (296)
Q Consensus 67 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~ 141 (296)
+.++|.+.+ .||+|+||.||+|.+..+++.||||++... .....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 567899965 699999999999999999999999998543 1222233345667799999999999876 4458
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEcccC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDFG 218 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Dfg 218 (296)
++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999762 2357999999999999999999999999 999999999999976 4559999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 177 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 177 FAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp TCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred cceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 99753322 223456899999999998888999999999999999999999999765543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=289.37 Aligned_cols=205 Identities=25% Similarity=0.381 Sum_probs=175.6
Q ss_pred HHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcC--CCcccceeeE
Q 022482 63 ELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLH--HPNLVNLIGY 134 (296)
Q Consensus 63 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~I~~~~~~ 134 (296)
+...+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3445678899999999999999999999999999999998654322 2244667899999986 5999999999
Q ss_pred EecCCceEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCce
Q 022482 135 CADGDQRLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHP 212 (296)
Q Consensus 135 ~~~~~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~ 212 (296)
+...+..++|||++.+ ++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~ 189 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL 189 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence 9999999999999976 899999865 467899999999999999999999999 99999999999998 78999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+|+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp EECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 999999998643321 233569999999999987765 67889999999999999999999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=284.73 Aligned_cols=208 Identities=26% Similarity=0.385 Sum_probs=175.5
Q ss_pred cCHHHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhh--cCCCcccceeeEEe
Q 022482 59 FTFRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSL--LHHPNLVNLIGYCA 136 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~~I~~~~~~~~ 136 (296)
..+.....+.++|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|..+++. ++||||+++++++.
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 344555677889999999999999999999984 899999999643 34567788888887 78999999999998
Q ss_pred cCC----ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeccCCCCcE
Q 022482 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH--------DKANPPVIYRDLKCSNI 204 (296)
Q Consensus 137 ~~~----~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH--------~~~~~~ivHrdikp~Ni 204 (296)
... ..++||||+++++|.+++.. ..+++..+..++.|++.||.||| +.+ |+||||||+||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NI 178 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNI 178 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHE
Confidence 876 78999999999999999965 46899999999999999999999 888 99999999999
Q ss_pred EEcCCCceEEcccCCcccCCCCCcce--eeecccccccccCccccccCC------CCccchhHHHHHHHHHHHhC-----
Q 022482 205 LLGEGYHPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFGVVLLEIITG----- 271 (296)
Q Consensus 205 li~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~ll~g----- 271 (296)
+++.++.++|+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 179 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 258 (342)
T 1b6c_B 179 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258 (342)
T ss_dssp EECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred EECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCC
Confidence 99999999999999997543332211 223457999999999997752 33689999999999999999
Q ss_pred -----CCCCCCCC
Q 022482 272 -----RKAIDNTR 279 (296)
Q Consensus 272 -----~~pf~~~~ 279 (296)
..||....
T Consensus 259 ~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 259 IHEDYQLPYYDLV 271 (342)
T ss_dssp BCCCCCCTTTTTS
T ss_pred cccccccCccccC
Confidence 88997654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=290.15 Aligned_cols=200 Identities=30% Similarity=0.466 Sum_probs=160.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHH--HHHHhhcCCCcccceeeEEec-----CCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVE--VLMLSLLHHPNLVNLIGYCAD-----GDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e--~~~l~~l~h~~I~~~~~~~~~-----~~~ 140 (296)
.++|++.+.||+|+||.||+|.+ +++.||||++.... ...+..| +..+..++||||+++++.+.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35799999999999999999987 48999999986432 2333334 444556899999999985542 235
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC---------CCCCeEeccCCCCcEEEcCCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK---------ANPPVIYRDLKCSNILLGEGYH 211 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~---------~~~~ivHrdikp~Nili~~~~~ 211 (296)
+++||||+++++|.+++.. ...++..+..++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 87 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSC
T ss_pred EEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCc
Confidence 6899999999999999965 3458899999999999999999999 8 999999999999999999
Q ss_pred eEEcccCCcccCCCCC------cceeeecccccccccCcccccc-------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 212 PKLSDFGLAKLGPVGD------KTHVSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
+||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence 9999999997543221 1122234579999999999977 34567899999999999999998877654
Q ss_pred Cc
Q 022482 279 RA 280 (296)
Q Consensus 279 ~~ 280 (296)
..
T Consensus 239 ~~ 240 (336)
T 3g2f_A 239 ES 240 (336)
T ss_dssp SC
T ss_pred cc
Confidence 43
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=307.59 Aligned_cols=206 Identities=28% Similarity=0.426 Sum_probs=169.8
Q ss_pred CCCccc-cccccCceEEEEEEEC--CCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 70 NFRADC-LLGEGGFGRVYKGRLE--STNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 70 ~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++.+.+ .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 3567799999976432 345778999999999999999999999876 5689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 415 E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 99999999999965 3466999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 226 GDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+..+
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 547 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 2211 11122345688999999998999999999999999999998 999998766543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=282.09 Aligned_cols=200 Identities=31% Similarity=0.467 Sum_probs=166.3
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC-CceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG-DQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-~~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|.+. +..||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357999999999999999999885 8899999987543 456788999999999999999999997654 57899999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999998651 1223788999999999999999999999 999999999999999999999999998753221
Q ss_pred CcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 221 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 221 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 122357889999999998899999999999999999998 99999876543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=287.06 Aligned_cols=204 Identities=28% Similarity=0.422 Sum_probs=167.0
Q ss_pred HHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhc----CCCcccceee
Q 022482 64 LAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLL----HHPNLVNLIG 133 (296)
Q Consensus 64 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~~I~~~~~ 133 (296)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.+++.+ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 445678899999999999999999999999999999999765432 223355788888888 8999999999
Q ss_pred EEecCCceEEEEec-CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCc
Q 022482 134 YCADGDQRLLVYEY-MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYH 211 (296)
Q Consensus 134 ~~~~~~~~~lv~e~-~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~ 211 (296)
++...+..++|||+ +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++ .++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 99999999999999 788999999975 456899999999999999999999999 99999999999998 8899
Q ss_pred eEEcccCCcccCCCCCcceeeecccccccccCccccccCCCC-ccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 212 PKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT-LKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 212 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
++|+|||++....... .....||+.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus 179 ~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 179 AKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp EEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred EEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 9999999998643322 2345689999999999877664 4899999999999999999999753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=309.76 Aligned_cols=200 Identities=30% Similarity=0.463 Sum_probs=167.3
Q ss_pred ccccccCceEEEEEEE--CCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRL--ESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+ ..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.. +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999975432 235678999999999999999999999864 568899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc-c
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK-T 229 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 229 (296)
++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999965 467999999999999999999999999 99999999999999999999999999976433322 1
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 580 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 580 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 12223456788999999999999999999999999999998 999998766543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.69 Aligned_cols=205 Identities=34% Similarity=0.511 Sum_probs=175.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 4568899999999999999999976 4679999997654 345678999999999999999999999876 678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 343 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 343 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred hcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 9999999999641 1345899999999999999999999999 9999999999999999999999999998643211
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
........++..|+|||++.+..++.++|||||||++|||++ |+.||.+....
T Consensus 418 -~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 418 -YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp -HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred -eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 111222346788999999998899999999999999999999 99999876543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=284.62 Aligned_cols=204 Identities=25% Similarity=0.337 Sum_probs=153.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHH-HHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVL-MLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~-~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||.||+|.+..+++.||||++...... ....+..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 5799999999999999999999999999999999765322 2334555555 7777899999999999999999999999
Q ss_pred cCCCCCHHHHhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDL-PPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~-~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|+. ++|.+++... ......+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 998 5887776421 11246789999999999999999999998 9 9999999999999999999999999997543
Q ss_pred CCCcceeeecccccccccCcccc----ccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYA----MTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 221 12234699999999998 45678899999999999999999999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=280.69 Aligned_cols=197 Identities=29% Similarity=0.426 Sum_probs=163.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec---------
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------- 137 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--------- 137 (296)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 456799999999999999999999999999999998543 2344668899999999999999999998865
Q ss_pred ----CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceE
Q 022482 138 ----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPK 213 (296)
Q Consensus 138 ----~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~k 213 (296)
.+..++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEE
Confidence 3567899999999999999975 2456788999999999999999999999 99999999999999999999
Q ss_pred EcccCCcccCCCCCc------------ceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHh
Q 022482 214 LSDFGLAKLGPVGDK------------THVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIIT 270 (296)
Q Consensus 214 l~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~ 270 (296)
|+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999975432110 1122345689999999999764 68999999999999999998
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=285.08 Aligned_cols=203 Identities=24% Similarity=0.324 Sum_probs=167.3
Q ss_pred HHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcC--CCcccceeeEEecCCce
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLH--HPNLVNLIGYCADGDQR 141 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~~~~ 141 (296)
...++|++.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+|+.+++.++ ||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 345679999999999999999999865 88899999865432 23466889999999997 59999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||| +.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++ +.++|+|||++.
T Consensus 104 ~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~ 174 (313)
T 3cek_A 104 YMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIAN 174 (313)
T ss_dssp EEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSC
T ss_pred EEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccc
Confidence 99999 557899999976 457899999999999999999999999 999999999999965 799999999998
Q ss_pred cCCCCCcceeeecccccccccCcccccc-----------CCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 222 LGPVGDKTHVSTRVMGTYGYCAPEYAMT-----------GQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 222 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 6443333223334579999999999875 46788999999999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=282.08 Aligned_cols=206 Identities=33% Similarity=0.473 Sum_probs=165.1
Q ss_pred hcCCCccccccccCceEEEEEEECC-CC--eEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLES-TN--QVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||.||+|.+.. ++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 3579999999999999999998643 33 368999886542 234567889999999999999999999998755 8
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999865 2356899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
........ .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||...+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 64433222 12233457888999999988889999999999999999999 9999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.07 Aligned_cols=201 Identities=29% Similarity=0.392 Sum_probs=154.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-h-HHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-N-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|++.+.||+|+||.||+|.+..+++.||||++....... . +.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356999999999999999999999999999999997654322 2 23444556788889999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK-ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~-~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||+ ++.+..+... ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.++|+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5666655543 245689999999999999999999995 8 9999999999999999999999999997533
Q ss_pred CCCcceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||...
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC 232 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCC
Confidence 221 223456999999999984 456888999999999999999999999864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=301.52 Aligned_cols=205 Identities=29% Similarity=0.409 Sum_probs=171.8
Q ss_pred hcCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.++|++.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+++.++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 46799999999999999999998643 56799999865432 23356889999999999999999999985 467899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 468 v~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 9999999999999975 2456899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRA 280 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~ 280 (296)
..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 33221 12223456789999999998899999999999999999997 9999987654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=288.21 Aligned_cols=192 Identities=20% Similarity=0.197 Sum_probs=158.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--------chhHHHHHHHHHHhhcC---------CCcccc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--------QGNREFLVEVLMLSLLH---------HPNLVN 130 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------h~~I~~ 130 (296)
.++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45799999999999999999998 589999999975432 22367888999888876 555554
Q ss_pred -----------------eeeEEec-------------CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHH
Q 022482 131 -----------------LIGYCAD-------------GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180 (296)
Q Consensus 131 -----------------~~~~~~~-------------~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~ 180 (296)
+++++.+ .+..++||||+++|++.+.+.. ..+++..+..++.|++
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 4444443 6789999999999977666632 5689999999999999
Q ss_pred HHHHHHH-cCCCCCeEeccCCCCcEEEcCCC--------------------ceEEcccCCcccCCCCCcceeeecccccc
Q 022482 181 KGLEYLH-DKANPPVIYRDLKCSNILLGEGY--------------------HPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239 (296)
Q Consensus 181 ~al~~lH-~~~~~~ivHrdikp~Nili~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 239 (296)
.||+||| +.+ |+||||||+|||++.++ .+||+|||+++..... ..+||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEee
Confidence 9999999 899 99999999999999887 8999999999853321 347999
Q ss_pred cccCccccccCCCCccchhHHHHHH-HHHHHhCCCCCCC
Q 022482 240 GYCAPEYAMTGQLTLKSDVYSFGVV-LLEIITGRKAIDN 277 (296)
Q Consensus 240 ~y~aPE~~~~~~~~~~~DiwslG~~-l~~ll~g~~pf~~ 277 (296)
.|+|||++.+.. +.++||||||++ .+++++|..||.+
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 999999998766 889999998777 7788999999964
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.55 Aligned_cols=204 Identities=31% Similarity=0.430 Sum_probs=174.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEec------CCc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD------GDQ 140 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~------~~~ 140 (296)
.++|++.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 468999999999999999999999999999999986542 2334568899999999999999999998765 677
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCc---eEEccc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYH---PKLSDF 217 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~---~kl~Df 217 (296)
.++||||++|++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. ++|+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999997632 2346888999999999999999999999 999999999999987665 899999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 9998643332 223467999999999999999999999999999999999999999653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=280.28 Aligned_cols=203 Identities=26% Similarity=0.379 Sum_probs=167.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|++.+.||+|+||.||+|.+.. .+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 4679999999999999999999864 38999986532 223345678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++ ++.++|+|||++.....
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp BCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999965 2456899999999999999999999999 99999999999998 67999999999865322
Q ss_pred CC---cceeeecccccccccCcccccc---------CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 226 GD---KTHVSTRVMGTYGYCAPEYAMT---------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 226 ~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
.. .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.....
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 11 1112223468999999999864 3578899999999999999999999986553
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=304.39 Aligned_cols=198 Identities=25% Similarity=0.380 Sum_probs=169.4
Q ss_pred HHhcCCCccccccccCceEEEEEEECC-CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCc---
Q 022482 66 AVTKNFRADCLLGEGGFGRVYKGRLES-TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ--- 140 (296)
Q Consensus 66 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~--- 140 (296)
.+.++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 355789999999999999999999976 789999999865432 334567899999999999999999999987665
Q ss_pred --eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 141 --RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 141 --~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
.|+||||++|++|.+++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+ .+||+|||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCT
T ss_pred ceeEEEEEeCCCCcHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999988763 36999999999999999999999999 9999999999999885 89999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.....
T Consensus 227 ~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~ 281 (681)
T 2pzi_A 227 AVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYV 281 (681)
T ss_dssp TCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEEC
T ss_pred cchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccc
Confidence 99864322 345799999999998764 48899999999999999999999986543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=269.74 Aligned_cols=177 Identities=16% Similarity=0.150 Sum_probs=155.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+..++.++||||+++++++.+.+..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 456899999999999999999999999999999999765432 23568899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. ......+..++.|++.||+|||+.+ |+||||||+|||++.++.++|++++
T Consensus 109 v~e~~~g~~L~~~l~~------~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc------CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999853 2355678889999999999999999 9999999999999999999998443
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
|++ .++.++|||||||++|+|++|+.||...+..
T Consensus 175 -----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 175 -----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp -----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred -----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 223 3688999999999999999999999876653
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=288.64 Aligned_cols=204 Identities=25% Similarity=0.307 Sum_probs=157.4
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.+.|.+.+.||+|+||+||.+. ..+|+.||||++... ..+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 3456778999999999998754 446899999998643 234567899999876 89999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC-------------C
Q 022482 147 YMPLGSLEDHLHDLPPDKKR---LDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG-------------Y 210 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~---~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~-------------~ 210 (296)
|+. ++|.+++......... .++..+..++.|++.||+|||+.+ |+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 996 6999999763221111 133456789999999999999999 9999999999999754 4
Q ss_pred ceEEcccCCcccCCCCCcce--eeecccccccccCcccccc-------CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 211 HPKLSDFGLAKLGPVGDKTH--VSTRVMGTYGYCAPEYAMT-------GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 211 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
.++|+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+..
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 89999999998654332211 1234579999999999975 568899999999999999999 999997654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=286.32 Aligned_cols=199 Identities=26% Similarity=0.319 Sum_probs=157.9
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEEecC
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+|.+.+.||+|+||+|+.. ...+++.||||++...... .+.+|+.+++.+ +||||+++++++.+....++||||+
T Consensus 25 ~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 5888999999999997643 3456889999999654332 355799999998 7999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---C--CceEEcccCCcccC
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---G--YHPKLSDFGLAKLG 223 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~--~~~kl~Dfg~~~~~ 223 (296)
. ++|.+++... .....+..+..++.|++.||.|||+.+ |+||||||+|||++. + ..++|+|||++...
T Consensus 101 ~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 A-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp S-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred C-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 6 6999998752 334555567889999999999999999 999999999999953 2 35779999999764
Q ss_pred CCCCc-ceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 224 PVGDK-THVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||....
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~ 234 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence 43221 122334679999999999973 567789999999999999999 999996543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=263.88 Aligned_cols=180 Identities=22% Similarity=0.332 Sum_probs=154.5
Q ss_pred HhcCCCcc-ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHH-hhcCCCcccceeeEEec----CCc
Q 022482 67 VTKNFRAD-CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLML-SLLHHPNLVNLIGYCAD----GDQ 140 (296)
Q Consensus 67 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~~I~~~~~~~~~----~~~ 140 (296)
+.++|.+. +.||+|+||.||+|.+..+++.||+|++.. .....+|+.++ +..+||||+++++++.. ...
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 45678887 789999999999999999999999999853 34566788877 66689999999999876 677
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEccc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Df 217 (296)
.++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Df 164 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 164 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecc
Confidence 89999999999999999762 2356999999999999999999999999 999999999999987 788999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|++.... +..++.++|||||||++|+|++|+.||...+.
T Consensus 165 g~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 165 GFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp TTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred ccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9986321 24567889999999999999999999976543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=279.87 Aligned_cols=204 Identities=18% Similarity=0.197 Sum_probs=159.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc---chhHHHHHHHHHHhhcCC-Cccc---------ceeeE-
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHH-PNLV---------NLIGY- 134 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-~~I~---------~~~~~- 134 (296)
..|...+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.+.| +|.. ...+.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 347788999999999999999999999999999874322 235678899999999876 3211 11111
Q ss_pred -----------Eec-----CCceEEEEecCCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 022482 135 -----------CAD-----GDQRLLVYEYMPLGSLEDHLHDL---PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195 (296)
Q Consensus 135 -----------~~~-----~~~~~lv~e~~~~~sL~~~~~~~---~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~iv 195 (296)
+.. ...++++|+++ +++|.+++... ......+++..+..++.|++.||+|||+.+ |+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 111 12456777766 58999888421 123456788889999999999999999999 99
Q ss_pred eccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCcccc----------ccCCCCccchhHHHHHHH
Q 022482 196 YRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA----------MTGQLTLKSDVYSFGVVL 265 (296)
Q Consensus 196 Hrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~~l 265 (296)
||||||+|||++.++.+||+|||+++.... .....+| +.|+|||++ .+..++.++|||||||++
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 999999999999999999999999875321 1344567 999999999 555688899999999999
Q ss_pred HHHHhCCCCCCCCCccc
Q 022482 266 LEIITGRKAIDNTRAAG 282 (296)
Q Consensus 266 ~~ll~g~~pf~~~~~~~ 282 (296)
|+|++|+.||...+..+
T Consensus 308 ~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALG 324 (413)
T ss_dssp HHHHHSSCCCCTTGGGS
T ss_pred HHHHHCCCCCCCcchhh
Confidence 99999999998766543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=275.56 Aligned_cols=186 Identities=16% Similarity=0.093 Sum_probs=131.4
Q ss_pred ccccCceEEEEEEECCCCeEEEEEEecCCCc----------chhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEEE
Q 022482 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGL----------QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 77 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.+.|+.|.+..++..-.|+.+++|++..... ...+++.+|+.+|+.+ .|+||++++++++++...||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4566666666666666688999999965421 1224588999999999 6999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++|++|.+++.. ...+++. .|+.||+.||+|+|++| ||||||||+|||++++|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999976 4556654 58899999999999999 99999999999999999999999999986432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 275 (296)
. .......+||+.|+|||++.+ .+...+|+||+|+++++|.++..+|
T Consensus 392 ~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 D--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred C--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 2 223345789999999999976 4667899999999988776654443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=240.10 Aligned_cols=186 Identities=19% Similarity=0.217 Sum_probs=144.7
Q ss_pred CccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
...+.||+|+||.||+|... +..+++|........ ..+.+.+|+.+++.++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44678999999999999443 678899986543221 12347899999999999999966666667778899
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||++|++|.+++.. +..++.|++.||.|||+.+ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999853 4579999999999999999 999999999999998 9999999999865
Q ss_pred CCCCcce-----eeecccccccccCcccccc--CCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 224 PVGDKTH-----VSTRVMGTYGYCAPEYAMT--GQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 224 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
....... ......||+.|+|||++.. ..|+...|+||..+-..+-+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4322111 1235679999999999977 567888999999999988888887774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.1e-27 Score=200.17 Aligned_cols=147 Identities=14% Similarity=0.023 Sum_probs=119.2
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc------------------chhHHHHHHHHHHhhcCCCccc
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL------------------QGNREFLVEVLMLSLLHHPNLV 129 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~I~ 129 (296)
...|.+.+.||+|+||.||+|.+ .+|+.||+|+++.... .....+.+|+.+++.++ | +
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~ 164 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-L 164 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-S
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-C
Confidence 34567779999999999999999 7899999999964322 12345789999999998 5 6
Q ss_pred ceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCC
Q 022482 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEG 209 (296)
Q Consensus 130 ~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~ 209 (296)
++.+++.. +..++||||++|++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++ +
T Consensus 165 ~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 165 AVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred CcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 67775544 56799999999999988 421 224579999999999999999 99999999999999 9
Q ss_pred CceEEcccCCcccCCCCCcceeeecccccccccCcccccc
Q 022482 210 YHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT 249 (296)
Q Consensus 210 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 249 (296)
+.++|+|||++.. +..+.|||++.+
T Consensus 229 ~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9999999999863 334678888754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.1e-23 Score=172.72 Aligned_cols=136 Identities=15% Similarity=0.075 Sum_probs=107.4
Q ss_pred CCccccccccCceEEEEEEECCCCeE--EEEEEecCCCcch------------------------hHHHHHHHHHHhhcC
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRNGLQG------------------------NREFLVEVLMLSLLH 124 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 124 (296)
|.+.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+..++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999667888 9999975432110 125778999999998
Q ss_pred CCcc--cceeeEEecCCceEEEEecCCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeEe
Q 022482 125 HPNL--VNLIGYCADGDQRLLVYEYMPL-G----SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH-DKANPPVIY 196 (296)
Q Consensus 125 h~~I--~~~~~~~~~~~~~~lv~e~~~~-~----sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH-~~~~~~ivH 196 (296)
|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 8764 334432 367899999932 3 77776532 234567889999999999999 999 999
Q ss_pred ccCCCCcEEEcCCCceEEcccCCccc
Q 022482 197 RDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 197 rdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
|||||+|||++. .++|+|||++..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999988 999999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.4e-20 Score=162.63 Aligned_cols=136 Identities=13% Similarity=0.078 Sum_probs=98.0
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--------------hhHH--------HHHHHHHHhhcCCCcc
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--------------GNRE--------FLVEVLMLSLLHHPNL 128 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------~~~~--------~~~e~~~l~~l~h~~I 128 (296)
|.+.+.||+|++|.||+|.+. +|+.||||+++..... .... ...|...|..+.+.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999986 4899999987532110 0011 1345555665544433
Q ss_pred cceeeEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 129 ~~~~~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
.-.. .+.. ...++||||++|.+|..+... .....++.|++.+|.+||+.+ ||||||||.|||+++
T Consensus 176 ~vp~-p~~~-~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPE-PIAQ-SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCC-EEEE-ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred CCCe-eeec-cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence 2111 1111 234799999998888665321 134568899999999999999 999999999999987
Q ss_pred CC----------ceEEcccCCccc
Q 022482 209 GY----------HPKLSDFGLAKL 222 (296)
Q Consensus 209 ~~----------~~kl~Dfg~~~~ 222 (296)
++ .+.|+||+-+..
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.2e-14 Score=121.44 Aligned_cols=147 Identities=16% Similarity=0.078 Sum_probs=114.8
Q ss_pred HHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEE
Q 022482 65 AAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 65 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~l 143 (296)
......|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..++++++++.+.+..|+
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 345567999999999999999999754 6789999986532223345788999999885 6678899999988889999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--------------------------------- 190 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~--------------------------------- 190 (296)
|||+++|.+|.+.+.. ......++.++..+|..||+..
T Consensus 88 v~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred EEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999876421 1123467889999999999811
Q ss_pred -----------------------CCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 191 -----------------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 191 -----------------------~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13399999999999998765667999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=108.18 Aligned_cols=137 Identities=16% Similarity=0.104 Sum_probs=100.0
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccceeeEEecCCceEEEEec
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~~~~~~~~~~~~lv~e~ 147 (296)
.|.+....+.|..+.||++.. .+|..+++|+.... ....+..|+.+++.+.+.+ +++++.+....+..++|||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 455544445666799999965 45677999997654 2345678888888886444 56688888887889999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------- 190 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~------------------------------------- 190 (296)
++|.+|. ... .. ...++.+++.+|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 211 11 2356777888888888743
Q ss_pred ------------------CCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 191 ------------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 191 ------------------~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
...++|+|++|.||++++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776667999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.33 E-value=6.8e-12 Score=109.49 Aligned_cols=142 Identities=13% Similarity=0.170 Sum_probs=105.2
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEec--CCC-cchhHHHHHHHHHHhhcCC--CcccceeeEEecC---CceEEE
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLD--RNG-LQGNREFLVEVLMLSLLHH--PNLVNLIGYCADG---DQRLLV 144 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~I~~~~~~~~~~---~~~~lv 144 (296)
-.+.|+.|.++.||++... +..+++|+.. ... ......+.+|..+++.+.. ..+++++.++.+. +..|+|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 3567899999999998765 4578888875 322 1223467789999998874 4578888888766 348999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA---------------------------------- 190 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~---------------------------------- 190 (296)
||+++|..+.+.. ...++......++.+++.+|..||+..
T Consensus 120 me~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 120 MEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp EECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 9999987775422 234678888889999999999999731
Q ss_pred ---------------------CCCeEeccCCCCcEEEcCCCc--eEEcccCCccc
Q 022482 191 ---------------------NPPVIYRDLKCSNILLGEGYH--PKLSDFGLAKL 222 (296)
Q Consensus 191 ---------------------~~~ivHrdikp~Nili~~~~~--~kl~Dfg~~~~ 222 (296)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 234999999999999987653 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.27 E-value=2.1e-12 Score=110.11 Aligned_cols=185 Identities=17% Similarity=0.177 Sum_probs=122.0
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCc--ccceeeEEecCC---ceEEEEec
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPN--LVNLIGYCADGD---QRLLVYEY 147 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~--I~~~~~~~~~~~---~~~lv~e~ 147 (296)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +++++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568899999999863 34888986432 33466888999998873 333 344544433333 34789999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------- 190 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~------------------------------------- 190 (296)
++|.+|.+... ..++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99988865332 23667777888888888888888621
Q ss_pred ------------------CCCeEeccCCCCcEEEcC--CCceEEcccCCcccCCCCCcceeeecccccccc---cCcccc
Q 022482 191 ------------------NPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY---CAPEYA 247 (296)
Q Consensus 191 ------------------~~~ivHrdikp~Nili~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y---~aPE~~ 247 (296)
...++|+|++|.||++++ .+.+.|+||+.+....+... ......+ ..|+..
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~ 245 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFV 245 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHH
Confidence 134899999999999988 55678999999875432110 0000111 122211
Q ss_pred cc-----CC---------CCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 248 MT-----GQ---------LTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 248 ~~-----~~---------~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
.. +. .....+.|++|.++|.+.+|..+|..
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 10 00 11236899999999999999988853
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=2.8e-08 Score=84.58 Aligned_cols=137 Identities=21% Similarity=0.136 Sum_probs=94.5
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC---cccceeeEEe-cCCceEEEEecCC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCA-DGDQRLLVYEYMP 149 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~I~~~~~~~~-~~~~~~lv~e~~~ 149 (296)
.+.++.|....||+. +..+++|+... ......+..|..+|+.+.+. .+++++.+.. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456788888899988 45578888532 23345788999999998642 3566666664 4456789999999
Q ss_pred CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC---------------------------------------
Q 022482 150 LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--------------------------------------- 190 (296)
Q Consensus 150 ~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~--------------------------------------- 190 (296)
|.+|.+... ..++......++.++...|..||+..
T Consensus 97 G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 97 GQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp SEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred CeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 988876321 12344555555566666666555432
Q ss_pred ------------------CCCeEeccCCCCcEEEcC---CCc-eEEcccCCcccC
Q 022482 191 ------------------NPPVIYRDLKCSNILLGE---GYH-PKLSDFGLAKLG 223 (296)
Q Consensus 191 ------------------~~~ivHrdikp~Nili~~---~~~-~kl~Dfg~~~~~ 223 (296)
...++|+|+.|.||+++. ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 224799999999999987 455 479999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.76 E-value=8.1e-08 Score=80.04 Aligned_cols=135 Identities=17% Similarity=0.124 Sum_probs=98.5
Q ss_pred ccccCc-eEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCceEEEEecCCCCCHH
Q 022482 77 LGEGGF-GRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQRLLVYEYMPLGSLE 154 (296)
Q Consensus 77 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~~~lv~e~~~~~sL~ 154 (296)
+..|.. +.||+......+..+++|+-+.. ....+.+|...|+.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 333444 46899887777778899986532 3456778999888875 223678888888889999999999998887
Q ss_pred HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-------------------------------------------
Q 022482 155 DHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN------------------------------------------- 191 (296)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~------------------------------------------- 191 (296)
+.... .......+..++...|..||....
T Consensus 109 ~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 76532 112234566677777777775321
Q ss_pred ------------CCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 192 ------------PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 192 ------------~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..++|+|+.|.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1489999999999999887778999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=4.2e-07 Score=80.12 Aligned_cols=76 Identities=16% Similarity=0.094 Sum_probs=49.4
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCc-------chhHHHHHHHHHHhhcCC--Cc-ccceeeEEecCCceEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-------QGNREFLVEVLMLSLLHH--PN-LVNLIGYCADGDQRLL 143 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~~-I~~~~~~~~~~~~~~l 143 (296)
.+.||.|..+.||++....++..+++|....... .....+..|..+++.+.. +. +++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4678999999999997665577899998653211 123456778888887742 33 4455543 3456789
Q ss_pred EEecCCCC
Q 022482 144 VYEYMPLG 151 (296)
Q Consensus 144 v~e~~~~~ 151 (296)
|||++.+.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=2.3e-07 Score=80.52 Aligned_cols=81 Identities=6% Similarity=-0.015 Sum_probs=54.2
Q ss_pred cccc-cccCceEEEEEEEC---C---CCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCC---CcccceeeEEecC--
Q 022482 74 DCLL-GEGGFGRVYKGRLE---S---TNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHH---PNLVNLIGYCADG-- 138 (296)
Q Consensus 74 ~~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---~~I~~~~~~~~~~-- 138 (296)
.+.| +.|....+|++... . ++..+++|+..... ......+.+|..+++.+.. -.+++++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999988653 1 15678888865432 1112456788888887742 3467788776654
Q ss_pred -CceEEEEecCCCCCHH
Q 022482 139 -DQRLLVYEYMPLGSLE 154 (296)
Q Consensus 139 -~~~~lv~e~~~~~sL~ 154 (296)
+..++|||+++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.35 E-value=2.4e-05 Score=67.11 Aligned_cols=142 Identities=18% Similarity=0.308 Sum_probs=78.0
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC--Ccccceee------EEecCCceEEEEe
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH--PNLVNLIG------YCADGDQRLLVYE 146 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~~I~~~~~------~~~~~~~~~lv~e 146 (296)
+.|+.|..+.||++... +..+++|+.... ...+..|..+++.+.. -.+++++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 34666778899998764 345899998652 2334445555554431 12334443 1234567889999
Q ss_pred cCCCCCHH-----------H---Hhcc----CCCC-CC-----CCCHHH-------------------------------
Q 022482 147 YMPLGSLE-----------D---HLHD----LPPD-KK-----RLDWTT------------------------------- 171 (296)
Q Consensus 147 ~~~~~sL~-----------~---~~~~----~~~~-~~-----~~~~~~------------------------------- 171 (296)
|++|..+. . .++. .... .. ...+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 0 1111 1000 00 011110
Q ss_pred HHHHHHHHHHHHHHHHc----------CCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 172 RMRIAAGAAKGLEYLHD----------KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 172 ~~~i~~ql~~al~~lH~----------~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+..+..++..++.+|+. .....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 11112233445666652 0123399999999999998888999999999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=9.8e-06 Score=68.88 Aligned_cols=75 Identities=21% Similarity=0.159 Sum_probs=58.4
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC---CCcccceeeEEecCCceEEEEecCCC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH---HPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
.+.|+.|....+|+.... +..+++|+.... ....+..|...|+.+. ...+++++.+....+..++|||+++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 356889999999998753 667889987532 2456788988888874 35688888888878889999999998
Q ss_pred CCH
Q 022482 151 GSL 153 (296)
Q Consensus 151 ~sL 153 (296)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.6e-05 Score=70.62 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=44.9
Q ss_pred eEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcceeeecccc--cccccCccccccCC---CCccchhHHHHHHHHHH
Q 022482 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMG--TYGYCAPEYAMTGQ---LTLKSDVYSFGVVLLEI 268 (296)
Q Consensus 194 ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~~DiwslG~~l~~l 268 (296)
++|+|++|.|||++.++ +.++||+.+....+.... ....+ ...|++|+...... .....++.++...+|+.
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 99999999999998876 999999998753321110 01111 13455655443111 11234455777777777
Q ss_pred HhCC
Q 022482 269 ITGR 272 (296)
Q Consensus 269 l~g~ 272 (296)
+.+.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.08 E-value=4.2e-05 Score=64.12 Aligned_cols=78 Identities=21% Similarity=0.240 Sum_probs=55.4
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC---cccceeeEEecCCceEEEEe
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP---NLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---~I~~~~~~~~~~~~~~lv~e 146 (296)
...-...+|.|..+.||++... +|+.+++|+.+.........+..|...|+.+... -+++++.+ +..++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 3444677899999999999865 4788999987655444445678899999888532 24455544 23478999
Q ss_pred cCCCCC
Q 022482 147 YMPLGS 152 (296)
Q Consensus 147 ~~~~~s 152 (296)
++++..
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.02 E-value=0.00017 Score=61.33 Aligned_cols=160 Identities=13% Similarity=0.118 Sum_probs=86.1
Q ss_pred cCHHHHHHHhcCCCcc-----ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccce
Q 022482 59 FTFRELAAVTKNFRAD-----CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNL 131 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~ 131 (296)
++.+++..+..+|.+. +.|+.|....+|++.... + .+++|+.... .....+..|..+++.+...+ ++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 4555666666777662 346678888999987653 3 5889988653 12234556777766664212 3333
Q ss_pred eeE------EecCCceEEEEecCCCCCHHH--------------Hhc----cCCCCC-CCCC---HHHHHH---------
Q 022482 132 IGY------CADGDQRLLVYEYMPLGSLED--------------HLH----DLPPDK-KRLD---WTTRMR--------- 174 (296)
Q Consensus 132 ~~~------~~~~~~~~lv~e~~~~~sL~~--------------~~~----~~~~~~-~~~~---~~~~~~--------- 174 (296)
+.. ....+..+++|++++|..+.. .++ ...... .... +.....
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999999765321 011 111110 0011 111000
Q ss_pred ---HHHHHHHHHHHHHcC----CCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 175 ---IAAGAAKGLEYLHDK----ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 175 ---i~~ql~~al~~lH~~----~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+...+...+..+... ....++|+|+.|.||+++.++.+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001133344444421 123499999999999998876668999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.93 E-value=5.1e-05 Score=64.08 Aligned_cols=71 Identities=8% Similarity=0.062 Sum_probs=44.3
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecC-CCC
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYM-PLG 151 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~-~~~ 151 (296)
.+.|+.|....+|++ ..+++|+..... ....+...|...++.+...++ ++++.. +.+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCc
Confidence 677888999999998 347888875432 111223467777777643333 455543 344457899999 665
Q ss_pred CH
Q 022482 152 SL 153 (296)
Q Consensus 152 sL 153 (296)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.75 E-value=8.3e-05 Score=66.10 Aligned_cols=74 Identities=19% Similarity=0.248 Sum_probs=48.8
Q ss_pred cccccccCceEEEEEEECC-------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEE
Q 022482 74 DCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 145 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~ 145 (296)
.+.|+.|....+|++.... .+..+++|+...... ...+..|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567788889999998653 246788998843211 1455578888888753334 566665532 3899
Q ss_pred ecCCCCCH
Q 022482 146 EYMPLGSL 153 (296)
Q Consensus 146 e~~~~~sL 153 (296)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00044 Score=61.88 Aligned_cols=74 Identities=14% Similarity=0.042 Sum_probs=47.5
Q ss_pred ccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEEecCCCCCH
Q 022482 75 CLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+.|+.|-...+|++.....+..+++|+..... ...-+...|..+++.+...++ +++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 45777888899999876545788899875432 111223578888888865554 56666652 2 359999987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00042 Score=59.23 Aligned_cols=33 Identities=30% Similarity=0.315 Sum_probs=27.9
Q ss_pred CCeEeccCCCCcEEEcCC----CceEEcccCCcccCC
Q 022482 192 PPVIYRDLKCSNILLGEG----YHPKLSDFGLAKLGP 224 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~----~~~kl~Dfg~~~~~~ 224 (296)
..++|+|+.+.||+++.+ +.+.|+||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 349999999999999874 678999999987543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00022 Score=62.23 Aligned_cols=144 Identities=19% Similarity=0.205 Sum_probs=82.7
Q ss_pred cccccccCceEEEEEEECC-------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc-ccceeeEEecCCceEEEE
Q 022482 74 DCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~lv~ 145 (296)
.+.|..|-...+|++.... ++..+++|+... .......+.+|..+++.+...+ .+++++.+.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 3456667778899987642 346788888632 2233456678999888875322 3566666543 2899
Q ss_pred ecCCCCCHHHH-----------------hccCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 022482 146 EYMPLGSLEDH-----------------LHDLPP-DKKRL--DWTTRMRIAAGAAK-------------------GLEY- 185 (296)
Q Consensus 146 e~~~~~sL~~~-----------------~~~~~~-~~~~~--~~~~~~~i~~ql~~-------------------al~~- 185 (296)
||++|.+|..- ++.... ..... .+.++..++.++-. .+..
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99987554310 111111 11122 23455555544322 1222
Q ss_pred ---HHcC-CCCCeEeccCCCCcEEEcCC----CceEEcccCCccc
Q 022482 186 ---LHDK-ANPPVIYRDLKCSNILLGEG----YHPKLSDFGLAKL 222 (296)
Q Consensus 186 ---lH~~-~~~~ivHrdikp~Nili~~~----~~~kl~Dfg~~~~ 222 (296)
|... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2221 22359999999999999876 7899999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00085 Score=57.05 Aligned_cols=159 Identities=12% Similarity=0.070 Sum_probs=85.5
Q ss_pred cCHHHHHHHhcCCCc-----cccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc--ccce
Q 022482 59 FTFRELAAVTKNFRA-----DCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN--LVNL 131 (296)
Q Consensus 59 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~--I~~~ 131 (296)
.+.+.+..+...|.+ ...++ |....||++... +|+.+++|..+.... ....+..|..+++.+.... ++++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecce
Confidence 344444444444433 23466 777889987653 356789999864322 3455667877777764222 3444
Q ss_pred eeE-----EecCCceEEEEecCCCCCHH-----HH---------hcc----CCC-CCCCCCHHHH---------------
Q 022482 132 IGY-----CADGDQRLLVYEYMPLGSLE-----DH---------LHD----LPP-DKKRLDWTTR--------------- 172 (296)
Q Consensus 132 ~~~-----~~~~~~~~lv~e~~~~~sL~-----~~---------~~~----~~~-~~~~~~~~~~--------------- 172 (296)
+.. ....+..+++|++++|..+. .+ ++. ... .....+....
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 433 22245567899999875431 10 111 000 0011111110
Q ss_pred -------HHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 173 -------MRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 173 -------~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
...+.+++..+..+.. ..+..++|+|++|.||+++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1112222222222211 1233489999999999998 4 899999998864
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0013 Score=56.39 Aligned_cols=31 Identities=19% Similarity=0.257 Sum_probs=27.5
Q ss_pred CCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 192 ~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3499999999999999888899999988764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00045 Score=59.94 Aligned_cols=75 Identities=9% Similarity=0.050 Sum_probs=43.8
Q ss_pred cccccccCceEEEEEEECC--------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc-ccceeeEEecCCceEEE
Q 022482 74 DCLLGEGGFGRVYKGRLES--------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLV 144 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~lv 144 (296)
.+.|+.|....+|++.... .+..+++|+.... .....+...|..+++.+...+ ++++++.. . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH-VDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT-GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC-ccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3457778888999987653 1257888887543 222223457777777775333 44666544 2 3789
Q ss_pred EecCCCCCH
Q 022482 145 YEYMPLGSL 153 (296)
Q Consensus 145 ~e~~~~~sL 153 (296)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.004 Score=49.38 Aligned_cols=104 Identities=13% Similarity=0.032 Sum_probs=68.8
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcce
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTH 230 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 230 (296)
-+|.+.+.. .+.++++.++|.+++|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc---------
Confidence 378888876 37889999999999999999887622110 12334568999999999998764 1111
Q ss_pred eeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCC
Q 022482 231 VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAI 275 (296)
Q Consensus 231 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf 275 (296)
.....+.+||... ...+.+.=|||||+++|..+.-..|=
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 1122466888763 34467789999999999998765553
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.014 Score=51.61 Aligned_cols=75 Identities=12% Similarity=0.083 Sum_probs=47.2
Q ss_pred cccccccCceEEEEEEECCC-------CeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc-ccceeeEEecCCceEEEE
Q 022482 74 DCLLGEGGFGRVYKGRLEST-------NQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~lv~ 145 (296)
.+.+..|-...+|++..... +..+++++.... ....-+..+|..+++.+...+ .+++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~-t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKH-VGKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCC-C-CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCC-cchhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 34566777888999887531 467888886432 222223457888888775323 455665332 37899
Q ss_pred ecCCCCCH
Q 022482 146 EYMPLGSL 153 (296)
Q Consensus 146 e~~~~~sL 153 (296)
+|++|.+|
T Consensus 150 efI~G~~l 157 (424)
T 3mes_A 150 EFIDGEPL 157 (424)
T ss_dssp ECCCSEEC
T ss_pred EEeCCccC
Confidence 99998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.096 Score=45.78 Aligned_cols=29 Identities=31% Similarity=0.316 Sum_probs=24.9
Q ss_pred eEeccCCCCcEEE------cCCCceEEcccCCccc
Q 022482 194 VIYRDLKCSNILL------GEGYHPKLSDFGLAKL 222 (296)
Q Consensus 194 ivHrdikp~Nili------~~~~~~kl~Dfg~~~~ 222 (296)
++|+|+.+.||++ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=92.32 E-value=0.41 Score=37.75 Aligned_cols=116 Identities=11% Similarity=0.148 Sum_probs=74.3
Q ss_pred cCCCcccceeeEEecCCceEEEEecCC-CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 022482 123 LHHPNLVNLIGYCADGDQRLLVYEYMP-LGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (296)
Q Consensus 123 l~h~~I~~~~~~~~~~~~~~lv~e~~~-~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp 201 (296)
..||+++.. .+-.+.+.+.+.++.-+ +-++.. + ...+....++++.+++....+++. -+|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 357888876 55566666666555433 222222 2 347778889999999887744433 35778999
Q ss_pred CcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 202 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
+||+++.++.+++.--|+-.. ++|. ..+...=+-..=|++..+++++..|+
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred ceEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987665432 1221 11112222356667777888888875
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=88.94 E-value=1.2 Score=35.28 Aligned_cols=84 Identities=11% Similarity=0.109 Sum_probs=57.8
Q ss_pred cCCCcccceeeEEecCCceEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeEeccCC
Q 022482 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLG-SLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE-YLHDKANPPVIYRDLK 200 (296)
Q Consensus 123 l~h~~I~~~~~~~~~~~~~~lv~e~~~~~-sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~-~lH~~~~~~ivHrdik 200 (296)
..||++ -..+-.+++.+.+.++.-+++ ++. .+ ..++....++++.+++.... +++ . -+|--|.
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i-------~~~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~ 111 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI-------RKTTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVC 111 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH-------HTSCHHHHHHHHHHHHHHHSSCCS--S---SEECCCC
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH-------HhcCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEe
Confidence 357887 444446667777776654333 333 33 23677888888888877655 333 2 4677899
Q ss_pred CCcEEEcCCCceEEcccCCcc
Q 022482 201 CSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 201 p~Nili~~~~~~kl~Dfg~~~ 221 (296)
|+||+++.++.+++.-.|+-.
T Consensus 112 P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 112 PENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp GGGEEECTTCCEEESCCEETT
T ss_pred CceEEEeCCCcEEEEEcCCcc
Confidence 999999999999999777643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.43 E-value=0.13 Score=45.89 Aligned_cols=62 Identities=6% Similarity=0.077 Sum_probs=17.7
Q ss_pred CccccccccCceEEEEEEECCCCeEEEE------EEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEe
Q 022482 72 RADCLLGEGGFGRVYKGRLESTNQVVAI------KQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCA 136 (296)
Q Consensus 72 ~~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~ 136 (296)
.+.+.|| ||.||++........||+ |....... .....+.+|..+.+.++|||+++.+.+..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 3456666 999999988754557888 65543222 22345778888888899999999988654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 296 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-70 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-68 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-64 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-59 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-58 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-57 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-53 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-53 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-52 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-52 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-51 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-50 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-49 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-48 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-45 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-44 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-38 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-32 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 3e-70
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPN 127
+G G FG VYKG+ VA+K L+ Q + F EV +L H N
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
++ +GY Q +V ++ SL HLH + + + + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH 121
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
K +I+RDLK +NI L E K+ DFGLA + +H ++ G+ + APE
Sbjct: 122 AK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 248 MT---GQLTLKSDVYSFGVVLLEIITGRKAIDN 277
+ +SDVY+FG+VL E++TG+ N
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 3e-68
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 11/208 (5%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNL 128
+F LG G G V+K + + V+A K + R + E+ +L + P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V G + + E+M GSL+ L R+ +++ KGL YL +
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K +++RD+K SNIL+ KL DFG++ ++ +GT Y +PE
Sbjct: 123 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQ 176
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAID 276
+++SD++S G+ L+E+ GR I
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 3e-64
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 8/209 (3%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
++ +G G +GR K R +S +++ K+LD + + + EV +L L HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 128 LVNLIGYCADGDQRLL--VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+V D L V EY G L + +++ LD +R+ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 186 LHDK--ANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
H + V++RDLK +N+ L + KL DFGLA++ + T + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 244 PEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
PE KSD++S G +L E+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 7e-64
Identities = 64/205 (31%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+ + LG G FG V+ G + VA+K L + G FL E ++ L H L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRL 70
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + ++ EYM GSL D L P +L + +AA A+G+ ++ +
Sbjct: 71 VRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ I+RDL+ +NIL+ + K++DFGLA+L ++ + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAIN 183
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRK 273
G T+KSDV+SFG++L EI+T +
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-63
Identities = 58/210 (27%), Positives = 94/210 (44%), Gaps = 9/210 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPN 127
+++ LGEG +G V T + VA+K +D E E+ + +L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V G+ +G+ + L EY G L D + + R G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
+ +RD+K N+LL E + K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 248 MTGQL-TLKSDVYSFGVVLLEIITGRKAID 276
+ DV+S G+VL ++ G D
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-62
Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
LG+G FG+VYK + + T+ + A K +D + +++VE+ +L+ HPN+V L+
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 137 DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIY 196
+ ++ E+ G+++ + +L ++ L + + L YLHD +I+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 197 RDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL---- 252
RDLK NIL KL+DFG++ +GT + APE M
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 253 -TLKSDVYSFGVVLLEIITGR 272
K+DV+S G+ L+E+
Sbjct: 192 YDYKADVWSLGITLIEMAEIE 212
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-62
Identities = 58/205 (28%), Positives = 90/205 (43%), Gaps = 9/205 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K+ LG G FG V G+ VAIK + EF+ E ++ L H L
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKL 61
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L G C ++ EYM G L ++L + R + + + +EYL
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K ++RDL N L+ + K+SDFGL++ D+ S + PE M
Sbjct: 119 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLM 174
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRK 273
+ + KSD+++FGV++ EI + K
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 2e-61
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 17/212 (8%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + D +G G F VYKG T VA +L L + + F E ML L HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 127 NLVNLIGYCADGDQR----LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
N+V + +LV E M G+L+ +L K + KG
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKG 124
Query: 183 LEYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGY 241
L++LH + PP+I+RDLKC NI + G K+ D GLA L + + V+GT +
Sbjct: 125 LQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEF 179
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
APE + DVY+FG+ +LE+ T
Sbjct: 180 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-61
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHH 125
++F LG+G FG VY R + + ++A+K L + L+ + EV + S L H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
PN++ L GY D + L+ EY PLG++ L + D A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
H K VI+RD+K N+LLG K++DFG + P + T + GT Y PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPE 174
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
K D++S GV+ E + G+
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 4e-61
Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 22/232 (9%)
Query: 58 TFTFRELAAVTKNF---------RADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRN 105
FTF + + F + + ++G G FG V G L+ + VAIK L
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 106 GLQGN-REFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDK 164
+ R+FL E ++ HPN+++L G +++ E+M GSL+ L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---ND 122
Query: 165 KRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224
+ + + G A G++YL + ++RDL NIL+ K+SDFGL++
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 225 VGDKTHVSTRV---MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
T + APE + T SDV+S+G+V+ E+++ +
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 193 bits (491), Expect = 1e-60
Identities = 65/202 (32%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLIG 133
+G G FG VY R ++VVAIK++ +G Q N ++ + EV L L HPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
LV EY + + KK L + GA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT---G 250
+I+RD+K NILL E KL DFG A + + +GT + APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGTPYWMAPEVILAMDEG 189
Query: 251 QLTLKSDVYSFGVVLLEIITGR 272
Q K DV+S G+ +E+ +
Sbjct: 190 QYDGKVDVWSLGITCIELAERK 211
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 1e-60
Identities = 64/205 (31%), Positives = 105/205 (51%), Gaps = 7/205 (3%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+ LG G +G VY+G + + VA+K L + ++ EFL E ++ + HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L+G C ++ E+M G+L D+L + +++ + + +A + +EYL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
K I+RDL N L+GE + K++DFGL++L GD + APE
Sbjct: 134 K---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLA 189
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRK 273
+ ++KSDV++FGV+L EI T
Sbjct: 190 YNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 7e-60
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 10/206 (4%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
K + +G+G G VY +T Q VAI+Q++ + E+L++ +P
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+VN + GD+ +V EY+ GSL D + + +D + + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFL 132
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H VI+RD+K NILLG KL+DFG + + + ++GT + APE
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEV 187
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
K D++S G++ +E+I G
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 9e-60
Identities = 67/256 (26%), Positives = 104/256 (40%), Gaps = 30/256 (11%)
Query: 45 ASKDGGSDHIAAHTFTFRELAAVTK-NFRADCLLGEGGFGRVYKGRLESTNQ-----VVA 98
S D ++ + + + N +LG G FG+V ++ VA
Sbjct: 12 GSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVA 71
Query: 99 IKQLDRNGLQGNRE-FLVEV-LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDH 156
+K L RE + E+ +M L H N+VNL+G C L++EY G L ++
Sbjct: 72 VKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNY 131
Query: 157 LH-------------------DLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYR 197
L + D L + + A AKG+E+L K ++R
Sbjct: 132 LRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR 188
Query: 198 DLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSD 257
DL N+L+ G K+ DFGLA+ V + APE G T+KSD
Sbjct: 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 248
Query: 258 VYSFGVVLLEIITGRK 273
V+S+G++L EI +
Sbjct: 249 VWSYGILLWEIFSLGV 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 9e-60
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 29/230 (12%)
Query: 70 NFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSLL 123
N +GEG FGRV++ R +VA+K L + +F E +++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 124 HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD--------------------LPPD 163
+PN+V L+G CA G L++EYM G L + L P
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 164 KKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223
L ++ IA A G+ YL ++RDL N L+GE K++DFGL++
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
D + PE + T +SDV+++GVVL EI +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 3e-59
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 15/206 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
K + +G+G FG V G VA+K + + + FL E +++ L H NL
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNL 62
Query: 129 VNLIGYCADGDQRL-LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
V L+G + L +V EYM GSL D+L + L ++ + + +EYL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
++RDL N+L+ E K+SDFGL K + + + APE
Sbjct: 121 GN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 172
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGRK 273
+ + KSDV+SFG++L EI + +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-59
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 9/215 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
+G G FG V+ G VAIK + R G +F+ E ++ L HP L
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 62
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L G C + LV+E+M G L D+L + T + + +G+ YL +
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
VI+RDL N L+GE K+SDFG+ + D+ ST + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFS 175
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGE 283
+ + KSDV+SFGV++ E+ + K R+ E
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-58
Identities = 65/225 (28%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 76 LLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLS-LLHHPNL 128
LG G FG+V + VA+K L + RE + E+ +LS L +H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHD--------------LPPDKKRLDWTTRMR 174
VNL+G C G L++ EY G L + L + D+ LD +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 175 IAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTR 234
+ AKG+ +L K I+RDL NILL G K+ DFGLA+ V
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 235 VMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279
+ APE T +SDV+S+G+ L E+ + +
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 4e-58
Identities = 58/206 (28%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLHHP 126
+F+ +LGEG F V R +T++ AIK L++ + E ++S L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
V L D ++ Y G L ++ D T A LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYL 124
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H +I+RDLK NILL E H +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGR 272
SD+++ G ++ +++ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-58
Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 13/205 (6%)
Query: 76 LLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGLQGN-REFLVEVLMLSLLHHPNLVNL 131
++G G FG VY G L + A+K L+R G +FL E +++ HPN+++L
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 132 IGYCADGDQR-LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
+G C + L+V YM G L + + + + AKG+++L
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLA--- 147
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL--GPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ ++RDL N +L E + K++DFGLA+ D H T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRK 273
T + T KSDV+SFGV+L E++T
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA 232
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-58
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 62 RELAAVTKNFR-ADCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGLQGNRE-FLVEV 117
++L N AD LG G FG V +G VAIK L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 118 LMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAA 177
++ L +P +V LIG C + +LV E G L L ++ + + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 178 GAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVM 236
+ G++YL +K ++RDL N+LL ++ K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
+ APE + + +SDV+S+GV + E ++ +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-57
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 77 LGEGGFGRVYKGRLE--STNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPNLVNLI 132
LG G FG V KG + + VA+K L E L E ++ L +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANP 192
G C + + +LV E LG L +L + + + + + G++YL +
Sbjct: 75 GIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 193 PVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RDL N+LL ++ K+SDFGL+K L + T + APE +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 252 LTLKSDVYSFGVVLLEIITGRK 273
+ KSDV+SFGV++ E + +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 1e-57
Identities = 70/205 (34%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL 128
++ R + LG+G FG V+ G T +V AIK L + G FL E ++ L H L
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL-KPGTMSPEAFLQEAQVMKKLRHEKL 74
Query: 129 VNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
V L + +V EYM GSL D L K L + +AA A G+ Y+
Sbjct: 75 VQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
++RDL+ +NIL+GE K++DFGLA+L ++ + APE A+
Sbjct: 132 M---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAAL 187
Query: 249 TGQLTLKSDVYSFGVVLLEIITGRK 273
G+ T+KSDV+SFG++L E+ T +
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGR 212
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-57
Identities = 69/221 (31%), Positives = 103/221 (46%), Gaps = 22/221 (9%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTN--QVVAIKQLDRNGL-QGNREFLVEV-LMLSLLH 124
+ + ++GEG FG+V K R++ AIK++ +R+F E+ ++ L H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHD------------LPPDKKRLDWTTR 172
HPN++NL+G C L EY P G+L D L L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 173 MRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS 232
+ AA A+G++YL K I+RDL NIL+GE Y K++DFGL++ V K
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--- 183
Query: 233 TRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
T + A E T SDV+S+GV+L EI++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 3e-57
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCA 136
+G+G FG V++G+ + VA+K + + E+ +L H N++ I
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 137 DGD----QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-- 190
+ Q LV +Y GSL D+L+ + + +++A A GL +LH +
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 191 ---NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT--HVSTRVMGTYGYCAPE 245
P + +RDLK NIL+ + ++D GLA T +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 246 YAMT------GQLTLKSDVYSFGVVLLEIITGRK 273
+ ++D+Y+ G+V EI
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-56
Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 12/208 (5%)
Query: 71 FRADCLLGEGGFGRVYKGRLESTNQV----VAIKQLDR-NGLQGNREFLVEVLMLSLLHH 125
F+ +LG G FG VYKG + VAIK+L + N+E L E +++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P++ L+G C +L + + MP G L D++ + K + + AKG+ Y
Sbjct: 71 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNY 126
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
L D+ +++RDL N+L+ H K++DFGLAKL +K + + + A E
Sbjct: 127 LEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRK 273
+ T +SDV+S+GV + E++T
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 180 bits (458), Expect = 3e-55
Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 11/208 (5%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V ++ LG G FG V++ +T A K + E+ +S+L HP
Sbjct: 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHP 83
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
LVNL D ++ +++YE+M G L + + D + ++ + KGL ++
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHM 140
Query: 187 HDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
H+ ++ DLK NI+ KL DFGL D GT + AP
Sbjct: 141 HEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAP 194
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
E A + +D++S GV+ +++G
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 3e-55
Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRNGL---QGNREFLVEVLMLSL 122
K+ R LG+G FG V +G ++ + VA+K L + L + +F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKG 182
L H NL+ L G ++ V E PLGSL D L + T R A A+G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 123
Query: 183 LEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHV-STRVMGTYGY 241
+ YL K I+RDL N+LL K+ DFGL + P D +V + +
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 242 CAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
CAPE T + SD + FGV L E+ T +
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (456), Expect = 6e-55
Identities = 45/199 (22%), Positives = 90/199 (45%), Gaps = 11/199 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ ++T +V K ++ E+ +++ LHHP L+NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
D + +L+ E++ G L D + + ++ + A +GL+++H+ ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 196 YRDLKCSNILL--GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+ D+K NI+ + K+ DFGLA + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVG 206
Query: 254 LKSDVYSFGVVLLEIITGR 272
+D+++ GV+ +++G
Sbjct: 207 FYTDMWAIGVLGYVLLSGL 225
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 9e-55
Identities = 61/204 (29%), Positives = 102/204 (50%), Gaps = 12/204 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQ----VVAIKQLDRNGLQGNR-EFLVEVLMLSLLHHPNLVN 130
++G G FG VYKG L++++ VAIK L + R +FL E ++ H N++
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 73
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L G + +++ EYM G+L+ L + + + G A G++YL
Sbjct: 74 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYAMT 249
N ++RDL NIL+ K+SDFGL++ L + T+ ++ + APE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 250 GQLTLKSDVYSFGVVLLEIITGRK 273
+ T SDV+SFG+V+ E++T +
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (448), Expect = 1e-53
Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 18/227 (7%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---QGNREFLVEVLMLSLLH-- 124
+F ++G GGFG VY R T ++ A+K LD+ + QG L E +MLSL+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 125 -HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
P +V + D+ + + M G L HL AA GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 184 EYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCA 243
E++H++ V+YRDLK +NILL E H ++SD GLA +GT+GY A
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGYMA 173
Query: 244 PEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAW 289
PE G +D +S G +L +++ G + +H +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-53
Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 13/207 (6%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSL-LHH 125
+F +LG+G FG+V+ + TNQ AIK L ++ + + + +VE +LSL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P L ++ + V EY+ G L H+ + D + AA GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH K ++YRDLK NILL + H K++DFG+ K +GD GT Y APE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ + D +SFGV+L E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 8e-53
Identities = 52/213 (24%), Positives = 86/213 (40%), Gaps = 8/213 (3%)
Query: 61 FRELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLM 119
+++ + + +LG G F V + T ++VAIK + + L+G E+ +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
L + HPN+V L G L+ + + G L D + +K R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
++YLHD + L E +SDFGL+K+ D V + GT
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTP 173
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
GY APE + D +S GV+ ++ G
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 9e-53
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 15/217 (6%)
Query: 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQGNR-EFLVEVLMLSL 122
+ LG+G FG VY+G + VAIK ++ R EFL E ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 123 LHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDL------PPDKKRLDWTTRMRIA 176
+ ++V L+G + G L++ E M G L+ +L L P + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 177 AGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVM 236
A G+ YL+ ++RDL N ++ E + K+ DFG+ + D + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 237 GTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
+ +PE G T SDV+SFGVVL EI T +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 1e-52
Identities = 59/202 (29%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 76 LLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGLQGNRE-FLVEVLMLSLLHHPNLVNL 131
+GEG FG V++G S VAIK RE FL E L + HP++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 132 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
IG + + ++ E LG L L K LD + + A + L YL K
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-- 127
Query: 192 PPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 251
++RD+ N+L+ KL DFGL++ + +++ + APE +
Sbjct: 128 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFRR 185
Query: 252 LTLKSDVYSFGVVLLEIITGRK 273
T SDV+ FGV + EI+
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV 207
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 170 bits (431), Expect = 4e-52
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 15/205 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN---REFLVEVLMLSLLHHPNLVNLI 132
+LG GG V+ R ++ VA+K L + + F E + L+HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 133 GYCAD----GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD 188
G +V EY+ +L D +H + + + + A A + L + H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQ 129
Query: 189 KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAPEYA 247
+I+RD+K +NI++ K+ DFG+A+ + G+ + V+GT Y +PE A
Sbjct: 130 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ +SDVYS G VL E++TG
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-51
Identities = 36/199 (18%), Positives = 85/199 (42%), Gaps = 12/199 (6%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G FG V++ S+ + K + G E+ +L++ H N+++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 136 ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVI 195
++ ++++E++ + + ++ L+ + + L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 196 YRDLKCSNILLG--EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+ D++ NI+ K+ +FG A+ GD + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 254 LKSDVYSFGVVLLEIITGR 272
+D++S G ++ +++G
Sbjct: 182 TATDMWSLGTLVYVLLSGI 200
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 6e-51
Identities = 63/225 (28%), Positives = 100/225 (44%), Gaps = 24/225 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQ-------VVAIKQLDRNGLQGN-REFLVEV-LML 120
LGEG FG+V ++ VA+K L + + + + + E+ +M
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 121 SLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLD 168
+ H N++NL+G C ++ EY G+L ++L P +++L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 169 WTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228
+ A A+G+EYL K I+RDL N+L+ E K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
+T + APE T +SDV+SFGV+L EI T
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (424), Expect = 1e-50
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
++F+ LG G FGRV+ R + A+K L + + ++ E LMLS++ H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P ++ + G D Q ++ +Y+ L L +R AA LEY
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 119
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH K +IYRDLK NILL + H K++DFG AK P V+ + GT Y APE
Sbjct: 120 LHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPE 171
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGRK 273
T D +SFG+++ E++ G
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-50
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 23/224 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGLQG-NREFLVEV-LMLSL 122
+ LG G FG+V + +T + VA+K L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 123 LHHPNLVNLIGYCA-DGDQRLLVYEYMPLGSLEDHLHD------------LPPDKKRLDW 169
HH N+VNL+G C G +++ E+ G+L +L K L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 170 TTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT 229
+ + AKG+E+L + I+RDL NILL E K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRK 273
+ APE T++SDV+SFGV+L EI +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 3e-49
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 26/219 (11%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL---------QGNREFLVEV-LM 119
N+ +LG G V + + T + A+K +D G + L EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 120 LSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+ HPN++ L LV++ M G L D+L +K L +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+ + LH +++RDLK NILL + + KL+DFG + D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTP 173
Query: 240 GYCAPEYAMTGQL------TLKSDVYSFGVVLLEIITGR 272
Y APE + D++S GV++ ++ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 3e-49
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 15/203 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVN 130
LGEG F VYK R ++TNQ+VAIK++ NR L E+ +L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 131 LIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA 190
L+ LV+++M D + + L + +GLEYLH
Sbjct: 65 LLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 191 NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG 250
+++RDLK +N+LL E KL+DFGLAK G T + T Y APE
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 251 QL-TLKSDVYSFGVVLLEIITGR 272
++ + D+++ G +L E++
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRV 198
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 2e-48
Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 7/209 (3%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE-FLVEVLMLSLLHH 125
V + +GEG +G V VAIK++ Q + L E+ +L H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
N++ + + Y+ + L+ L + L +GL+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKL-LKTQHLSNDHICYFLYQILRGLKY 124
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK-LGPVGDKTHVSTRVMGTYGYCAP 244
+H V++RDLK SN+LL K+ DFGLA+ P D T T + T Y AP
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 245 EYAMTGQLTLKS-DVYSFGVVLLEIITGR 272
E + + KS D++S G +L E+++ R
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 3e-47
Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
++G G FG VY+ +L + ++VAIK++ ++ NR E+ ++ L H N+V L +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVRLRYFF 82
Query: 136 ADGDQR------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
++ LV +Y+P H K+ L + L Y+H
Sbjct: 83 YSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141
Query: 190 ANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ +RD+K N+LL + KL DFG AK + + + Y
Sbjct: 142 ---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPNVSYICSRYYRAPELIFG 196
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
T DV+S G VL E++ G+
Sbjct: 197 ATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 3e-47
Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 20/207 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNR------EFLVEVLMLSLLHHPNLV 129
LG G F V K R +ST A K + + + +R + EV +L + HPN++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 130 NLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDK 189
L + +L+ E + L D +K+ L G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 190 ANPPVIYRDLKCSNILL----GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
+ + DLK NI+L K+ DFGLA G++ + GT + APE
Sbjct: 133 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
L L++D++S GV+ +++G
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 154 bits (390), Expect = 7e-46
Identities = 46/235 (19%), Positives = 85/235 (36%), Gaps = 20/235 (8%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLL-HH 125
V +++ +GEG FG +++G NQ VAIK R + E LL
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGC 60
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ N+ + +G +LV + + L ++ T A ++
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQS 116
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHP-----KLSDFGLAKL-----GPVGDKTHVSTRV 235
+H+K ++YRD+K N L+G + DFG+ K +
Sbjct: 117 IHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 236 MGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLVAWV 290
GT Y + + + + + D+ + G V + + G +AA +
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-45
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 19/204 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
+LG G G+V + + T + A+K L ++ + RE L P++V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 136 ----ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN 191
A L+V E + G L + D + I + ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSIN- 131
Query: 192 PPVIYRDLKCSNILL---GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAM 248
+ +RD+K N+L KL+DFG AK + T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 249 TGQLTLKSDVYSFGVVLLEIITGR 272
+ D++S GV++ ++ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 2e-45
Identities = 54/207 (26%), Positives = 88/207 (42%), Gaps = 20/207 (9%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE------FLVEVLMLSLLH--HPN 127
LLG GGFG VY G S N VAIK ++++ + E +EV++L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
++ L+ + D +L+ E L D ++ L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 188 DKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
+ V++RD+K NIL+ KL DFG L K V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 247 AMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ + V+S G++L +++ G
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 7e-45
Identities = 50/230 (21%), Positives = 89/230 (38%), Gaps = 18/230 (7%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP 126
V +R +G G FG +Y G + + VAIK + + +E + ++
Sbjct: 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGG 62
Query: 127 NLVNLIGYC-ADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
+ I +C A+GD ++V E + + ++ T + +A +EY
Sbjct: 63 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEY 118
Query: 186 LHDKANPPVIYRDLKCSNIL---LGEGYHPKLSDFGLAKL-----GPVGDKTHVSTRVMG 237
+H K I+RD+K N L +G + DFGLAK + + G
Sbjct: 119 IHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 238 TYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAGEHNLV 287
T Y + + + + + D+ S G VL+ G +AA +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-44
Identities = 63/207 (30%), Positives = 89/207 (42%), Gaps = 12/207 (5%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHH 125
+F LLG+G FG+V R ++T + A+K L + + E + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 126 PNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEY 185
P L L D+ V EY G L HL ++ A LEY
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEY 120
Query: 186 LHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
LH + V+YRD+K N++L + H K++DFGL K G T GT Y APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPE 175
Query: 246 YAMTGQLTLKSDVYSFGVVLLEIITGR 272
D + GVV+ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 1e-44
Identities = 52/205 (25%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPN 127
NF+ +GEG +G VYK R + T +VVA+K++ + + E+ +L L+HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 128 LVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLH 187
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 188 DKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYA 247
V++RDLK N+L+ KL+DFGLA+ V +T+ + V+ +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVVTLWYRAPEILL 175
Query: 248 MTGQLTLKSDVYSFGVVLLEIITGR 272
+ D++S G + E++T R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 5e-44
Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 14/213 (6%)
Query: 68 TKNFRADCLLGEGGFGRVYKGR-LESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLL- 123
+ + +GEG +G+V+K R L++ + VA+K++ + + EV +L L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 124 --HHPNLVNLIGYCADGDQRLLVYEYMPLGSL--EDHLHDLPPDKKRLDWTTRMRIAAGA 179
HPN+V L C + + + + + + T +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTY 239
+GL++LH V++RDLK NIL+ KL+DFGLA++ T V+ T
Sbjct: 126 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTL 179
Query: 240 GYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G + E+ +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 3e-42
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 20/216 (9%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHPN 127
+ +G+G FG V+K R T Q VA+K++ + L E+ +L LL H N
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 128 LVNLIGYCADGDQR--------LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGA 179
+VNLI C LV+++ + L + + R+
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQML 126
Query: 180 AKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVS--TRVMG 237
GL Y+H +++RD+K +N+L+ KL+DFGLA+ + + + T +
Sbjct: 127 LNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 238 TYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGR 272
T Y PE + + D++ G ++ E+ T
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 1e-41
Identities = 45/208 (21%), Positives = 81/208 (38%), Gaps = 9/208 (4%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH 124
V +R +G G +G V T VAIK+L R + E+ +L +
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H N++ L+ + ++ + ++L + KGL
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y+H +RDLK N+ + E K+ DFGLA+ + ++ V+ +
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPE 188
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+ T D++S G ++ E+ITG+
Sbjct: 189 VILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 2e-41
Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 15/199 (7%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNRE---FLVEVLMLSLLHHPNLVNLIG 133
LG G FGRV + + + A+K LD+ + ++ L E +L ++ P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 134 YCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPP 193
D +V EY+ G + HL R AA EYLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---D 161
Query: 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLT 253
+IYRDLK N+L+ + + +++DFG AK T + GT APE ++
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYN 216
Query: 254 LKSDVYSFGVVLLEIITGR 272
D ++ GV++ E+ G
Sbjct: 217 KAVDWWALGVLIYEMAAGY 235
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-41
Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 10/207 (4%)
Query: 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLHHP 126
+ + +GEG +G V+K + T+++VA+K++ + L E+ +L L H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 127 NLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
N+V L + LV+E+ +D LD KGL +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 187 HDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEY 246
H + V++RDLK N+L+ KL++FGLA+ + + + S V+ +
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVL 173
Query: 247 AMTGQLTLKSDVYSFGVVLLEIITGRK 273
+ D++S G + E+ +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 140 bits (353), Expect = 1e-40
Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 11/198 (5%)
Query: 77 LGEGGFGRVYKGRLESTNQVVAIKQL--DRNGLQGNREFLVEVLMLSLLHHPNLVNLIGY 134
+GEG +G VYK + + + A+K++ ++ + E+ +L L H N+V L
Sbjct: 10 IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 135 CADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPV 194
+ +LV+E++ + + L+ T G+ Y HD+ V
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RV 121
Query: 195 IYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTL 254
++RDLK N+L+ K++DFGLA+ + + + ++ + + + +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKKYST 180
Query: 255 KSDVYSFGVVLLEIITGR 272
D++S G + E++ G
Sbjct: 181 TIDIWSVGCIFAEMVNGT 198
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 134 bits (338), Expect = 6e-38
Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 21/208 (10%)
Query: 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEV-LMLSLLHHPNL 128
+++ LG G + V++ + N+ V +K L + + E+ ++ +L PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 129 VNLIGYCADGDQRL--LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYL 186
+ L D R LV+E++ + L R K L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR-------FYMYEILKALDYC 145
Query: 187 HDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPE 245
H +++RD+K N+++ E +L D+GLA+ G + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 246 YAMTGQL-TLKSDVYSFGVVLLEIITGR 272
+ Q+ D++S G +L +I +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-36
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 69 KNFRADCLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL----QGNREFLVEVLMLS 121
+NF +LG G +G+V+ R T ++ A+K L + + + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 122 LL-HHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAA 180
+ P LV L + L+ +Y+ G L HL ++R
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIV 139
Query: 181 KGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYG 240
LE+LH +IYRD+K NILL H L+DFGL+K V D+T + GT
Sbjct: 140 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIE 195
Query: 241 YCAPEYAMTGQ--LTLKSDVYSFGVVLLEIITGR 272
Y AP+ G D +S GV++ E++TG
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-36
Identities = 45/208 (21%), Positives = 82/208 (39%), Gaps = 9/208 (4%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGN--REFLVEVLMLSLLH 124
V + ++ +G G +G V T VA+K+L R + E+ +L +
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 125 HPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLE 184
H N++ L+ + + L + ++L + +GL+
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 185 YLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAP 244
Y+H +RDLK SN+ + E K+ DFGLA+ +V+TR +
Sbjct: 136 YIHSADII---HRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPE 188
Query: 245 EYAMTGQLTLKSDVYSFGVVLLEIITGR 272
D++S G ++ E++TGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 6e-35
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 21/214 (9%)
Query: 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLH 124
V K ++ +G G G V ++ VAIK+L R + E++++ ++
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 125 HPNLVNLIGYCA------DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAG 178
H N+++L+ + LV E M + + LD +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQ 127
Query: 179 AAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGT 238
G+++LH + +I+RDLK SNI++ K+ DFGLA+ + + T + T
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVT 181
Query: 239 YGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
Y APE + D++S G ++ E++ +
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 2e-32
Identities = 39/210 (18%), Positives = 77/210 (36%), Gaps = 16/210 (7%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYC 135
LG G F V+ + N VA+K + + + E+ +L ++ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 136 ADGDQRLLVYEY------------MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGL 183
A+ +LL + + + + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 184 EYLHDKANPPVIYRDLKCSNILL-GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYC 242
+Y+H + +I+ D+K N+L+ L +A LG T + T Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 243 APEYAMTGQLTLKSDVYSFGVVLLEIITGR 272
+PE + +D++S ++ E+ITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.5 bits (190), Expect = 7e-18
Identities = 22/160 (13%), Positives = 46/160 (28%), Gaps = 30/160 (18%)
Query: 76 LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL----------QGNREFLVEVLMLSLLHH 125
L+GEG V+ E +K G+ F V + +
Sbjct: 7 LMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 126 PNLVNLIGYCA----DGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAK 181
L L G + ++ E + + R+ + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMILE 114
Query: 182 GLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221
+ + + +++ DL N+L+ E + DF +
Sbjct: 115 EVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 296 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.0 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.31 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=368.90 Aligned_cols=206 Identities=28% Similarity=0.414 Sum_probs=181.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 456899999999999999999999999999999999765332 3456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 83 Ey~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 83 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred eccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 99999999999865 567999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
..........+||+.|+|||++.+..+ +.++|||||||++|+|++|++||....
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~ 210 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSS
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCC
Confidence 443334455789999999999988776 577999999999999999999997654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=366.77 Aligned_cols=202 Identities=30% Similarity=0.431 Sum_probs=183.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.+++.++||||+++++++.+++.+|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
+|++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998864 46999999999999999999999999 9999999999999999999999999998643322
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 233456799999999999999999999999999999999999999987654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=366.59 Aligned_cols=206 Identities=29% Similarity=0.385 Sum_probs=180.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|.+..+++.||||++.+.. ......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999999999999999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999865 567999999999999999999999999 99999999999999999999999999987554
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 216 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 216 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH
Confidence 44444445578999999999999999999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=359.46 Aligned_cols=203 Identities=31% Similarity=0.494 Sum_probs=182.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46999999999999999999999999999999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|||++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999975 467999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. ......||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~ 211 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred C----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH
Confidence 2 2334679999999999999999999999999999999999999998766443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-54 Score=362.31 Aligned_cols=206 Identities=26% Similarity=0.410 Sum_probs=182.7
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
+.|++++.||+|+||.||+|++..++..||||++........+.+.+|+.+++.++||||+++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 46899999999999999999999999999999998776666778899999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++|+|.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999998764 2456999999999999999999999999 99999999999999999999999999974221 1
Q ss_pred ceeeecccccccccCccccc-----cCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 229 THVSTRVMGTYGYCAPEYAM-----TGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........||+.|+|||++. +..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~ 222 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH
Confidence 12233467999999999984 4468899999999999999999999998765443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-54 Score=368.03 Aligned_cols=203 Identities=27% Similarity=0.366 Sum_probs=180.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC-cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG-LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||+||+|++..+|+.||+|+++... ......+.+|+.+++.++||||++++++|.+++.+++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999999999999999997543 2334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|++|++|.+++.+ ...+++..+..++.|++.||.|||+ ++ |+||||||+|||++.++.+||+|||+|.....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999975 4579999999999999999999997 48 99999999999999999999999999975321
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~ 209 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 2233468999999999999999999999999999999999999999876543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-53 Score=364.19 Aligned_cols=205 Identities=30% Similarity=0.388 Sum_probs=184.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++++.||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 46999999999999999999999999999999997532 223456789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||++||+|.+++.. ...+++..++.++.|++.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999876 567999999999999999999999999 99999999999999999999999999985433
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
. .......+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+
T Consensus 158 ~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~ 212 (337)
T d1o6la_ 158 D--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212 (337)
T ss_dssp T--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred C--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH
Confidence 2 223445789999999999999999999999999999999999999999877544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5e-53 Score=360.59 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=167.8
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
+.+.|++.+.||+|+||+||+|++..+++.||||++...... ....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 556799999999999999999999999999999999765433 2345778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~~~ 222 (296)
|||+|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred eccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEE
Confidence 99999999999975 567999999999999999999999999 99999999999994 578999999999985
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
..... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 160 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 215 (307)
T d1a06a_ 160 EDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 43322 233467999999999999999999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=357.69 Aligned_cols=211 Identities=27% Similarity=0.385 Sum_probs=171.1
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEec--CCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD--GDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--~~~~~lv 144 (296)
++|++.+.||+|+||.||+|+++.+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999999999999999999765433 23567899999999999999999999865 4568999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA--NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~--~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
||||++|+|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653334567999999999999999999999854 12399999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.... ........||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 164 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 164 LNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH
Confidence 4332 22234568999999999999999999999999999999999999999876544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-52 Score=363.25 Aligned_cols=205 Identities=25% Similarity=0.359 Sum_probs=184.7
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+.+|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999999999999999999877666667789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc--CCCceEEcccCCcccCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~--~~~~~kl~Dfg~~~~~~~ 225 (296)
|+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||++.....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999854 2457999999999999999999999999 99999999999995 467899999999986443
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.. ......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 179 ~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 179 KQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp TS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred cc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 32 233467999999999999999999999999999999999999999876543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-52 Score=362.99 Aligned_cols=206 Identities=22% Similarity=0.338 Sum_probs=185.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||.||+|++..+|+.||||++..........+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34679999999999999999999999999999999987766666778899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc--CCCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG--EGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~--~~~~~kl~Dfg~~~~~~ 224 (296)
||+|++|.+++.. ...++++..+..++.|++.||.|||+.+ |+||||||+|||++ .++.+||+|||++....
T Consensus 107 ~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~ 180 (352)
T d1koba_ 107 FLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180 (352)
T ss_dssp CCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred cCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecC
Confidence 9999999998754 3457999999999999999999999999 99999999999997 67899999999998654
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... ......||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..
T Consensus 181 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 181 PDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp TTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 432 233467999999999999999999999999999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-52 Score=357.22 Aligned_cols=201 Identities=33% Similarity=0.486 Sum_probs=181.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++.+.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999999999999999996432 233467889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.|++|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999876 567889999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 207 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH
Confidence 2 23468999999999999999999999999999999999999999876644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=350.62 Aligned_cols=205 Identities=27% Similarity=0.370 Sum_probs=182.6
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc------chhHHHHHHHHHHhhcCCCcccceeeEEecCCc
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL------QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQ 140 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~ 140 (296)
+.++|++.+.||+|+||.||+|++..+|+.||||++.+... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 45689999999999999999999999999999999865432 234678899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC----ceEEcc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY----HPKLSD 216 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~----~~kl~D 216 (296)
+|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999975 457999999999999999999999999 99999999999998776 499999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 161 fG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 161 FGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp CTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 99998644332 233467999999999999989999999999999999999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.3e-52 Score=353.51 Aligned_cols=200 Identities=34% Similarity=0.450 Sum_probs=177.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
..|++++.||+|+||.||+|++..+++.||||++....... .+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 34999999999999999999999999999999997654332 345789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
|||.+++|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999999877654 567999999999999999999999999 99999999999999999999999999985322
Q ss_pred CCcceeeecccccccccCcccccc---CCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMT---GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.....||+.|+|||++.+ +.|+.++|||||||++|+|++|+.||.+.+..
T Consensus 168 ------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~ 220 (309)
T d1u5ra_ 168 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM 220 (309)
T ss_dssp ------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred ------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 234579999999999864 35889999999999999999999999876543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=343.63 Aligned_cols=199 Identities=33% Similarity=0.483 Sum_probs=171.8
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEec----CCceEEE
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCAD----GDQRLLV 144 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~----~~~~~lv 144 (296)
|++.+.||+|+||+||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ...+++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 3677889999999999999999999999999865432 234568899999999999999999999865 3467899
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc-CCCceEEcccCCcccC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG-EGYHPKLSDFGLAKLG 223 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~-~~~~~kl~Dfg~~~~~ 223 (296)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 999999999999975 467999999999999999999999875 3499999999999996 5789999999999863
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 322 2334689999999999865 69999999999999999999999997654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-51 Score=344.03 Aligned_cols=204 Identities=33% Similarity=0.513 Sum_probs=170.1
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
.++|.+.+.||+|+||.||+|+.. ..||||+++... ....+.+.+|+.+++.++||||+++++++. .+..++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEE
Confidence 357999999999999999999864 359999986543 334567889999999999999999999865 46789999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+++|+|.+++.. .+..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999965 2456999999999999999999999999 99999999999999999999999999986544
Q ss_pred CCcceeeecccccccccCccccccC---CCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTG---QLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
...........||+.|+|||++.+. .|+.++|||||||++|||+||+.||.+.+..
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~ 215 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH
Confidence 4444444557899999999998643 4789999999999999999999999876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-51 Score=356.39 Aligned_cols=201 Identities=28% Similarity=0.356 Sum_probs=181.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~ 145 (296)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999999999999986432 223456889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPV 225 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~ 225 (296)
||+.+++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999865 457999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 226 GDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 226 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
. .....||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 244 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH
Confidence 2 23467999999999999999999999999999999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=348.14 Aligned_cols=205 Identities=18% Similarity=0.276 Sum_probs=182.7
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
+.++|++.+.||+|+||+||+|.+..+++.||||+++... .+...+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4578999999999999999999999999999999997654 334567899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC--CCceEEcccCCcccCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE--GYHPKLSDFGLAKLGP 224 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~--~~~~kl~Dfg~~~~~~ 224 (296)
||+|++|.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+|||++. .+.++|+|||++....
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999975 2457999999999999999999999999 999999999999975 4589999999998643
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
... ......+|+.|+|||.+.+..|+.++|||||||++|+|++|.+||.+.+..
T Consensus 156 ~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 156 PGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp TTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 332 234467999999999999999999999999999999999999999877643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-51 Score=344.97 Aligned_cols=203 Identities=31% Similarity=0.481 Sum_probs=179.6
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++|++.+.||+|+||+||+|.+..++..||||+++... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 356889999999999999999999999999999997654 3456789999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 9999999998652 3567899999999999999999999999 9999999999999999999999999998644332
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
........|++.|+|||++.+..|+.++|||||||++|||++|..||..
T Consensus 170 -~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 170 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred -ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 2233345689999999999999999999999999999999997666543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=349.32 Aligned_cols=205 Identities=32% Similarity=0.513 Sum_probs=179.6
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC---cchhHHHHHHHHHHh-hcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG---LQGNREFLVEVLMLS-LLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+.+.||+|+||+||+|.+..+++.||||++++.. ......+..|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999999999999999996432 122345556666554 68999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999975 567899999999999999999999999 9999999999999999999999999998543
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.. ........||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~ 210 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred cc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH
Confidence 32 223344679999999999999999999999999999999999999998766544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-50 Score=341.95 Aligned_cols=208 Identities=26% Similarity=0.382 Sum_probs=174.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHHHHHHHhhcCCCcccceeeEEecCC----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLVEVLMLSLLHHPNLVNLIGYCADGD---- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~---- 139 (296)
+.++|++.+.||+|+||.||+|.+..+++.||||+++..... ....+.+|+.+++.++||||+++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~ 84 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 84 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence 457899999999999999999999999999999999765433 2346889999999999999999999997654
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
.+|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++|||.
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTT
T ss_pred eEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhh
Confidence 37899999999999998865 467999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCC-cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 220 AKLGPVGD-KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 220 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
+....... ........+||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 87533322 222334467999999999999999999999999999999999999999876543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-50 Score=352.87 Aligned_cols=203 Identities=30% Similarity=0.424 Sum_probs=175.3
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc---hhHHHHH---HHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ---GNREFLV---EVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~---e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++.+.||+|+||.||+|++..+|+.||||++.+.... ....+.+ ++.+++.++||||+++++++.+++.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999998643211 1122333 466777778999999999999999999
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||+|..
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999975 567899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+...
T Consensus 157 ~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~ 213 (364)
T d1omwa3 157 FSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213 (364)
T ss_dssp CSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC
T ss_pred cCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4332 2334679999999999975 468999999999999999999999998765543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3e-50 Score=338.46 Aligned_cols=205 Identities=27% Similarity=0.347 Sum_probs=180.8
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcch---------hHHHHHHHHHHhhcC-CCcccceeeEEec
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG---------NREFLVEVLMLSLLH-HPNLVNLIGYCAD 137 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-h~~I~~~~~~~~~ 137 (296)
.++|++.+.||+|+||+||+|++..+++.||||++.+..... .+.+.+|+.+++.++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 578999999999999999999999999999999997654321 134778999999997 9999999999999
Q ss_pred CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEccc
Q 022482 138 GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDF 217 (296)
Q Consensus 138 ~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Df 217 (296)
++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccc
Confidence 9999999999999999999975 467999999999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCcceeeecccccccccCcccccc------CCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMT------GQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
|++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+...
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 9998654332 2334679999999999864 346889999999999999999999999776443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-50 Score=342.61 Aligned_cols=207 Identities=28% Similarity=0.466 Sum_probs=167.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCe---EEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ---VVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||+||+|.+..+++ .||||.+..... ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 468889999999999999999976654 588998865433 3345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
||||++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998875 3456999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCcce---eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 225 VGDKTH---VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
...... ......||+.|+|||.+.++.++.++|||||||++|||+| |++||.+.+..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 332211 1122457899999999999999999999999999999998 89999876654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=345.56 Aligned_cols=210 Identities=30% Similarity=0.460 Sum_probs=177.8
Q ss_pred cCCCccccccccCceEEEEEEECCCC-----eEEEEEEecCCC-cchhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN-----QVVAIKQLDRNG-LQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
++|++.+.||+|+||+||+|++..++ ..||+|.+.... ......+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57999999999999999999986544 369999986542 33456788999999988 899999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCC
Q 022482 142 LLVYEYMPLGSLEDHLHDLPP-------------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCS 202 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~-------------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~ 202 (296)
++|||||++|+|.++++.... ....+++..+..++.|++.||+|||+++ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999975321 1245899999999999999999999999 999999999
Q ss_pred cEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 203 NILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 203 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |++||.+.+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544444444445678999999999999999999999999999999998 89999876544
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=335.22 Aligned_cols=202 Identities=30% Similarity=0.472 Sum_probs=168.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|.+.. +..||||+++... ...+++.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 578999999999999999999874 6789999997654 34577999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 99999999865 3467899999999999999999999999 99999999999999999999999999986433322
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTR 279 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~ 279 (296)
.......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+
T Consensus 157 -~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~ 207 (263)
T d1sm2a_ 157 -TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 207 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC
T ss_pred -eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC
Confidence 22234578999999999999999999999999999999999 566665544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-50 Score=344.23 Aligned_cols=201 Identities=23% Similarity=0.304 Sum_probs=173.4
Q ss_pred HhcCCCccc-cccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHh-hcCCCcccceeeEEec----CCc
Q 022482 67 VTKNFRADC-LLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLS-LLHHPNLVNLIGYCAD----GDQ 140 (296)
Q Consensus 67 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~~I~~~~~~~~~----~~~ 140 (296)
+.++|.+.. .||+|+||.||+|++..+++.||||+++. ...+.+|+.++. ..+||||++++++|.+ ...
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 346798875 69999999999999999999999999853 356778998765 4589999999999875 467
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC---CCceEEccc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE---GYHPKLSDF 217 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~---~~~~kl~Df 217 (296)
+|+|||||+||+|.+++... ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++. .+.+||+||
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DF 158 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 158 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccc
Confidence 89999999999999999752 2357999999999999999999999999 999999999999975 567999999
Q ss_pred CCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 218 GLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 218 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.
T Consensus 159 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 159 GFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp TTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred ceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 9998644332 23346799999999999999999999999999999999999999976553
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=334.66 Aligned_cols=206 Identities=28% Similarity=0.439 Sum_probs=175.2
Q ss_pred cCCCcccc-ccccCceEEEEEEECC--CCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCL-LGEGGFGRVYKGRLES--TNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|.+.+. ||+|+||.||+|.+.. ++..||||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 35667775 9999999999998754 455799999975432 335678999999999999999999999865 568999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++|+|.+++.. .+..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999754 3467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCcc-eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCcc
Q 022482 225 VGDKT-HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAA 281 (296)
Q Consensus 225 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~ 281 (296)
..... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+.+..
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 43322 22334568999999999999999999999999999999998 99999876544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=328.12 Aligned_cols=205 Identities=28% Similarity=0.444 Sum_probs=181.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||+||+|+++ ++..||||+++.... ..+++.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 57999999999999999999986 578899999976543 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 99999999765 3567899999999999999999999999 99999999999999999999999999976444322
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..+
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~ 209 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred e-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence 2 2334568999999999999999999999999999999998 899998776554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-49 Score=331.81 Aligned_cols=199 Identities=31% Similarity=0.483 Sum_probs=171.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|.++ ++..||||+++... ...+.+.+|+.+++.++||||+++++++.+ +..++||||+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 56899999999999999999986 47789999997654 345679999999999999999999998754 5679999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~- 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (272)
T ss_dssp TTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred CCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-
Confidence 999999987541 2346899999999999999999999999 9999999999999999999999999998654332
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAID 276 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~ 276 (296)
........||+.|+|||++.++.++.++|||||||++|||+||..||.
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 223334578999999999998899999999999999999999655544
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=337.03 Aligned_cols=199 Identities=31% Similarity=0.387 Sum_probs=169.4
Q ss_pred ccccccccCceEEEEEEECCCCeEEEEEEecCCCcch-----hHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEec
Q 022482 73 ADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQG-----NREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEY 147 (296)
Q Consensus 73 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~ 147 (296)
.++.||+|+||+||+|++..+|+.||||+++...... ...+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999999999999999986543221 24578999999999999999999999999999999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+.++++..+... ...+++..+..+++|++.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 998777666543 567899999999999999999999999 9999999999999999999999999997543322
Q ss_pred cceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
......+||+.|+|||++.+. .|+.++|||||||++|+|++|.+||.+.+.
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 155 --RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp --CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred --ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 223345799999999998654 679999999999999999999999986553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=332.59 Aligned_cols=200 Identities=30% Similarity=0.465 Sum_probs=169.3
Q ss_pred ccccccCceEEEEEEEC--CCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecCCC
Q 022482 75 CLLGEGGFGRVYKGRLE--STNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPL 150 (296)
Q Consensus 75 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~~~ 150 (296)
+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 456789999996532 2234678999999999999999999999865 567899999999
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCcc-
Q 022482 151 GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDKT- 229 (296)
Q Consensus 151 ~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 229 (296)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999875 567999999999999999999999999 999999999999999999999999999865443322
Q ss_pred eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 230 HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 230 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.......||+.|+|||++.+..++.++|||||||++|||++ |++||.+.+..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~ 218 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH
Confidence 22334578999999999999999999999999999999998 999998766443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=335.59 Aligned_cols=203 Identities=28% Similarity=0.408 Sum_probs=173.2
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++++.||+|+||+||+|.+..+++.||||+++.... .....+.+|+.++++++||||+++++++.+.+.+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 579999999999999999999999999999999965432 234678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
|+.+ .+.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9974 44444433 23567999999999999999999999999 999999999999999999999999999754332
Q ss_pred CcceeeecccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~ 207 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred c--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC
Confidence 2 2233457999999999987765 4788999999999999999999998665
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=334.07 Aligned_cols=201 Identities=26% Similarity=0.390 Sum_probs=173.3
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------hhHHHHHHHHHHhhcC--CCcccceeeEEecC
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------GNREFLVEVLMLSLLH--HPNLVNLIGYCADG 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~I~~~~~~~~~~ 138 (296)
+.++|++.+.||+|+||.||+|++..+++.||||++.+.... ....+.+|+.+++.++ ||||+++++++.++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 457899999999999999999999999999999998653221 1233568999999986 89999999999999
Q ss_pred CceEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-CCceEEcc
Q 022482 139 DQRLLVYEYMPL-GSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-GYHPKLSD 216 (296)
Q Consensus 139 ~~~~lv~e~~~~-~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-~~~~kl~D 216 (296)
+..++||||+.+ +++.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECc
Confidence 999999999976 578788765 467999999999999999999999999 999999999999984 57999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCC-CccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQL-TLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 155 FG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 155 FGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp CTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 9999864322 2234679999999999987765 56789999999999999999999764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=334.84 Aligned_cols=207 Identities=32% Similarity=0.507 Sum_probs=173.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCe----EEEEEEecCC-CcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQ----VVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|++++.||+|+||+||+|.+..+|+ .||+|.+... .....+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999988776 5888888643 234456789999999999999999999999864 5678
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
+||++.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998865 3567999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 224 PVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 224 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.............||+.|+|||++.++.++.++|||||||++|||+| |.+||.+.+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 55444444445678999999999999999999999999999999998 899998776554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=327.64 Aligned_cols=203 Identities=29% Similarity=0.423 Sum_probs=166.7
Q ss_pred cCCCccccccccCceEEEEEEECCCC----eEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTN----QVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLL 143 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~l 143 (296)
.+|.+.++||+|+||.||+|.+..++ ..||||++...... ....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46888999999999999999987554 47999999754333 33468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLG 223 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~ 223 (296)
||||+.++++.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998765 3467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCc-ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCC
Q 022482 224 PVGDK-THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDN 277 (296)
Q Consensus 224 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~ 277 (296)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..||..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 33322 2222335689999999999999999999999999999999996555543
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-48 Score=323.61 Aligned_cols=206 Identities=29% Similarity=0.410 Sum_probs=166.9
Q ss_pred cCCCccccccccCceEEEEEEECCC---CeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLEST---NQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..+ +..||||.+...... ....+.+|+.+++.++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5799999999999999999998654 356899998654333 3456889999999999999999999985 4678999
Q ss_pred EecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCC
Q 022482 145 YEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGP 224 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~ 224 (296)
|||+++|+|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999998765 3567899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 160 ~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~ 217 (273)
T d1mp8a_ 160 DST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred CCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence 322 222334568999999999999999999999999999999998 899998776544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=327.94 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=170.6
Q ss_pred hcCCCccccccccCceEEEEEEECCC-CeEEEEEEecCCCc--chhHHHHHHHHHHhhc---CCCcccceeeEEec----
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLEST-NQVVAIKQLDRNGL--QGNREFLVEVLMLSLL---HHPNLVNLIGYCAD---- 137 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~~I~~~~~~~~~---- 137 (296)
.++|++++.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999755 67899999864322 2233456777777665 79999999999853
Q ss_pred -CCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 138 -GDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 138 -~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
....+++||++.++.+...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++..+.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 3467899999987766554433 3567999999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 160 fg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 160 FGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 99987532 22334456899999999999999999999999999999999999999987654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-48 Score=324.48 Aligned_cols=201 Identities=34% Similarity=0.508 Sum_probs=167.8
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEecC
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYM 148 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e~~ 148 (296)
++|++.+.||+|+||.||+|++..+ ..||||++.... ...+.+.+|+.+++.++||||+++++++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 5799999999999999999999765 569999996553 445779999999999999999999999854 5689999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++|+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~--~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSH--HHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhh--cccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999998864 22456999999999999999999999999 99999999999999999999999999986433322
Q ss_pred ceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 229 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 229 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.......||+.|+|||++.++.++.++|||||||++|||++|..||...
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 2233457899999999999999999999999999999999965555443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-47 Score=323.71 Aligned_cols=202 Identities=24% Similarity=0.336 Sum_probs=172.4
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++.+.||+|+||+||+|++. +++.||||++...... ....+.+|+.+++.++||||+++++++.+++..+++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 58999999999999999999986 6899999999765332 24678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
++.++.+..+... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9987766666543 577999999999999999999999999 999999999999999999999999999764332
Q ss_pred CcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
. .......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 2 223345689999999998765 568999999999999999999999987653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-47 Score=325.35 Aligned_cols=212 Identities=30% Similarity=0.487 Sum_probs=179.4
Q ss_pred hcCCCccccccccCceEEEEEEEC-----CCCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCce
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLE-----STNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~ 141 (296)
.++|++.+.||+|+||+||+|++. .+++.||||++...... ...++.+|+.+++.++||||+++++++.+.+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 457999999999999999999875 35688999999765433 345689999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCC
Q 022482 142 LLVYEYMPLGSLEDHLHDLP--------------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKC 201 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~--------------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp 201 (296)
+++|||+.+++|.+++.... .....+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcc
Confidence 99999999999999986421 12345889999999999999999999999 99999999
Q ss_pred CcEEEcCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCc
Q 022482 202 SNILLGEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRA 280 (296)
Q Consensus 202 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~ 280 (296)
+|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++|. +||.+.+.
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999999997544443334444567899999999999999999999999999999999985 67877665
Q ss_pred cc
Q 022482 281 AG 282 (296)
Q Consensus 281 ~~ 282 (296)
.+
T Consensus 249 ~e 250 (301)
T d1lufa_ 249 EE 250 (301)
T ss_dssp HH
T ss_pred HH
Confidence 44
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-46 Score=319.69 Aligned_cols=206 Identities=24% Similarity=0.331 Sum_probs=177.5
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC-CcccceeeEEecCCceEEEEe
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~~~lv~e 146 (296)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ....+.+|+..++.+.| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986542 23456788899988875 899999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC-----CCceEEcccCCcc
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE-----GYHPKLSDFGLAK 221 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~-----~~~~kl~Dfg~~~ 221 (296)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. .+.++|+|||+++
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 6899998865 3457999999999999999999999999 999999999999964 5789999999998
Q ss_pred cCCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 222 LGPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 222 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
........ .......||+.|+|||++.+..+++++|||||||++|+|++|+.||.+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~ 220 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh
Confidence 64332211 12334679999999999999999999999999999999999999998665543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=323.46 Aligned_cols=212 Identities=30% Similarity=0.438 Sum_probs=176.9
Q ss_pred hcCCCccccccccCceEEEEEEECCCC-------eEEEEEEecCCCcc-hhHHHHHHHHHHhhc-CCCcccceeeEEecC
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTN-------QVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG 138 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~ 138 (296)
.++|.+.+.||+|+||.||+|++..++ ..||||+++..... ...++.+|...+..+ +||||+++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357999999999999999999976544 47999999765432 345677888888877 799999999999999
Q ss_pred CceEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEE
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILL 206 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili 206 (296)
+..++||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975321 2356899999999999999999999999 9999999999999
Q ss_pred cCCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 207 GEGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 207 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
+.++.+||+|||++................||+.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH
Confidence 9999999999999986544444444555779999999999999999999999999999999998 799998766554
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=322.97 Aligned_cols=209 Identities=30% Similarity=0.420 Sum_probs=165.5
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhc-CCCcccceeeEEecC-Cc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLL-HHPNLVNLIGYCADG-DQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~-~~ 140 (296)
++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+..|...+..+ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 579999999999999999999753 4578999998754332 344566777777666 689999999988664 46
Q ss_pred eEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcC
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPP------------DKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGE 208 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~------------~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~ 208 (296)
+++|||||++|+|.+++..... ....+++..+..++.|+++||+|||+++ |+||||||+|||++.
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECC
Confidence 8999999999999999864211 2345899999999999999999999999 999999999999999
Q ss_pred CCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCc
Q 022482 209 GYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRA 280 (296)
Q Consensus 209 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~ 280 (296)
++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999865444444444456799999999999999999999999999999999986 567876554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=324.77 Aligned_cols=206 Identities=24% Similarity=0.328 Sum_probs=171.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhcCCCcccceeeEEecCC----ce
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QR 141 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----~~ 141 (296)
+..+|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 45689999999999999999999999999999999975432 23456889999999999999999999987653 23
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcc
Q 022482 142 LLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAK 221 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~ 221 (296)
+++++++.+++|.+++.. ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 455566778999999964 46999999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCcc-eeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 222 LGPVGDKT-HVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 222 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 54332221 12334679999999999855 4678899999999999999999999987654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=317.25 Aligned_cols=200 Identities=31% Similarity=0.467 Sum_probs=166.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEec-CCceEEEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEY 147 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~ 147 (296)
++|++.+.||+|+||.||+|.++ |..||||+++... ..+.+.+|+.+++.++||||+++++++.+ ++.+++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46889999999999999999985 7889999996543 45678999999999999999999998855 4678999999
Q ss_pred CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCC
Q 022482 148 MPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGD 227 (296)
Q Consensus 148 ~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 227 (296)
+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999998641 1235899999999999999999999999 999999999999999999999999999853222
Q ss_pred cceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 228 KTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 228 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.....++..|+|||++.++.++.++|||||||++|||+| |++||...+..+
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 223468899999999999999999999999999999998 788888765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=318.68 Aligned_cols=207 Identities=32% Similarity=0.473 Sum_probs=166.2
Q ss_pred cCCCccccccccCceEEEEEEECC-C--CeEEEEEEecCCC---cchhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-T--NQVVAIKQLDRNG---LQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-~--~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|++.+.||+|+||.||+|++.. + ...||||++.+.. ....+++.+|+.+++.++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 569999999999999999998643 2 2468999886542 2334578999999999999999999999965 5678
Q ss_pred EEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 143 LVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||||++++++.+++.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999988764 2456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCcce-eeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 223 GPVGDKTH-VSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |++||.+.+..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~ 222 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence 54443322 2233567889999999999999999999999999999998 899998665443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=324.93 Aligned_cols=200 Identities=28% Similarity=0.371 Sum_probs=169.1
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecCC-----
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADGD----- 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----- 139 (296)
+.++|++++.||+|+||+||+|.+..+|+.||||++...... ..+.+.+|+.+|+.++||||++++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 567899999999999999999999999999999999764332 2456789999999999999999999997654
Q ss_pred -ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 140 -QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 140 -~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
.+++||||+ +.+|..+++. ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.++++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccc
Confidence 569999999 5788887753 56999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 167 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 167 LARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp TCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 99864322 2346799999999998764 568899999999999999999999987653
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=319.64 Aligned_cols=211 Identities=30% Similarity=0.454 Sum_probs=181.1
Q ss_pred cCCCccccccccCceEEEEEEE-----CCCCeEEEEEEecCCCc-chhHHHHHHHHHHhhc-CCCcccceeeEEecCCce
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL-----ESTNQVVAIKQLDRNGL-QGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQR 141 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~ 141 (296)
++|++.+.||+|+||.||+|.+ ..+++.||||+++.... .....+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 5799999999999999999986 34678999999976543 3345688999999998 699999999999999999
Q ss_pred EEEEecCCCCCHHHHhccCC--------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc
Q 022482 142 LLVYEYMPLGSLEDHLHDLP--------------PDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG 207 (296)
Q Consensus 142 ~lv~e~~~~~sL~~~~~~~~--------------~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~ 207 (296)
++|||||++++|.++++... .....+++..+..++.|++.||+|||+++ ++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccccc
Confidence 99999999999999986532 12346899999999999999999999999 99999999999999
Q ss_pred CCCceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHh-CCCCCCCCCccc
Q 022482 208 EGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIIT-GRKAIDNTRAAG 282 (296)
Q Consensus 208 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~-g~~pf~~~~~~~ 282 (296)
.++.++++|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..+
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999987655544455556789999999999999999999999999999999999 666666655443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-46 Score=319.26 Aligned_cols=205 Identities=25% Similarity=0.365 Sum_probs=170.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCC--cchhHHHHHHHHHHhhcCCCcccceeeEEec--------C
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNG--LQGNREFLVEVLMLSLLHHPNLVNLIGYCAD--------G 138 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~--------~ 138 (296)
++|++++.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999999999999999986542 2334668899999999999999999998855 3
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+..++||||+.++.+..+.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 46789999998666655543 3567999999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcc--eeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 219 LAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 219 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
++......... ......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~ 227 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 227 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH
Confidence 99754332221 222335799999999998765 688999999999999999999999986553
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-46 Score=319.56 Aligned_cols=208 Identities=34% Similarity=0.503 Sum_probs=173.9
Q ss_pred cCCCccccccccCceEEEEEEECCCCeE--EEEEEecCC-CcchhHHHHHHHHHHhhc-CCCcccceeeEEecCCceEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQV--VAIKQLDRN-GLQGNREFLVEVLMLSLL-HHPNLVNLIGYCADGDQRLLV 144 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~I~~~~~~~~~~~~~~lv 144 (296)
++|++.+.||+|+||.||+|.+..++.. ||||.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 4689999999999999999999888774 677777543 233456789999999998 799999999999999999999
Q ss_pred EecCCCCCHHHHhccC------------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 145 YEYMPLGSLEDHLHDL------------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 145 ~e~~~~~sL~~~~~~~------------~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
|||+++|+|.++++.. ......+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 123467999999999999999999999999 9999999999999999999
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCC-CCCCCCCccc
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGR-KAIDNTRAAG 282 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~-~pf~~~~~~~ 282 (296)
||+|||+++..... .......||..|+|||.+.++.++.++|||||||++|||++|. +||.+.+..+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~ 234 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999753221 2223356899999999999999999999999999999999965 5787665444
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=324.19 Aligned_cols=200 Identities=27% Similarity=0.338 Sum_probs=166.7
Q ss_pred CCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecC------CceEE
Q 022482 70 NFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADG------DQRLL 143 (296)
Q Consensus 70 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~------~~~~l 143 (296)
+|+..++||+|+||+||+|++..+|+.||||++..... ...+|+.+++.++||||++++++|... .+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 58899999999999999999999999999999965432 223799999999999999999998542 35789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCccc
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKL 222 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~ 222 (296)
||||++++ +.+.+.........+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999755 33333221123567999999999999999999999999 99999999999998765 899999999986
Q ss_pred CCCCCcceeeecccccccccCcccccc-CCCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 223 GPVGDKTHVSTRVMGTYGYCAPEYAMT-GQLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 223 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|++||...+.
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred ccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 43332 2334679999999998875 4689999999999999999999999986653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3e-45 Score=316.01 Aligned_cols=196 Identities=20% Similarity=0.298 Sum_probs=171.0
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecC--CceEEEE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADG--DQRLLVY 145 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~--~~~~lv~ 145 (296)
++|++++.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+|+.+. ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999653 3467889999999995 99999999999743 5689999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCC-ceEEcccCCcccCC
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGY-HPKLSDFGLAKLGP 224 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~-~~kl~Dfg~~~~~~ 224 (296)
||+.+++|..+. ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .++|+|||+|....
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987764 35899999999999999999999999 99999999999998654 69999999998644
Q ss_pred CCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 225 VGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 225 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.....
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 332 23346799999999998765 478999999999999999999999986554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=320.09 Aligned_cols=206 Identities=29% Similarity=0.408 Sum_probs=176.3
Q ss_pred cCCCccccccccCceEEEEEEE---CCCCeEEEEEEecCCCc----chhHHHHHHHHHHhhcCC-CcccceeeEEecCCc
Q 022482 69 KNFRADCLLGEGGFGRVYKGRL---ESTNQVVAIKQLDRNGL----QGNREFLVEVLMLSLLHH-PNLVNLIGYCADGDQ 140 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-~~I~~~~~~~~~~~~ 140 (296)
++|++.+.||+|+||+||+|.+ ..+|+.||||++++... ...+.+.+|+.+++.++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 34689999999865432 234567789999999976 899999999999999
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCc
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLA 220 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~ 220 (296)
.+++|||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999876 456789999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCcceeeecccccccccCccccccC--CCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 221 KLGPVGDKTHVSTRVMGTYGYCAPEYAMTG--QLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 221 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
....... ........|++.|+|||.+.+. .++.++|||||||++|+|++|+.||......+
T Consensus 177 ~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 177 KEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred hhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7543322 2223446799999999999765 46789999999999999999999998765444
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-45 Score=310.52 Aligned_cols=207 Identities=26% Similarity=0.332 Sum_probs=171.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc-cceeeEEecCCceEEEE
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL-VNLIGYCADGDQRLLVY 145 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I-~~~~~~~~~~~~~~lv~ 145 (296)
+.++|++.+.||+|+||.||+|++..+++.||||++..... ...+..|+.+++.++|+++ +.+.+++.+.+..++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 34679999999999999999999999999999999865432 3457789999999987665 45556667788889999
Q ss_pred ecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEc---CCCceEEcccCCccc
Q 022482 146 EYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLG---EGYHPKLSDFGLAKL 222 (296)
Q Consensus 146 e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~---~~~~~kl~Dfg~~~~ 222 (296)
||+ +++|.+.+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..++|+|||+++.
T Consensus 83 e~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~ 155 (299)
T d1ckia_ 83 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 155 (299)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred EEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCccee
Confidence 999 4677766654 3567999999999999999999999999 99999999999985 455799999999986
Q ss_pred CCCCCcc-----eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCccc
Q 022482 223 GPVGDKT-----HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAAG 282 (296)
Q Consensus 223 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~~ 282 (296)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHH
Confidence 4433221 12334679999999999999999999999999999999999999998765544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-45 Score=310.34 Aligned_cols=201 Identities=23% Similarity=0.321 Sum_probs=176.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCc--chhHHHHHHHHHHhhcCCCcccceeeEEecCCceEEEEe
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGL--QGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYE 146 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~lv~e 146 (296)
++|++++.||+|+||+||+|++..+++.||||+++.... .....+.+|+.+++.++||||+++++++.+.+..+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 579999999999999999999999999999999865432 334678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCC
Q 022482 147 YMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVG 226 (296)
Q Consensus 147 ~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~ 226 (296)
++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9998888888764 567899999999999999999999999 999999999999999999999999999864433
Q ss_pred CcceeeecccccccccCccccccCC-CCccchhHHHHHHHHHHHhCCCCCCCC
Q 022482 227 DKTHVSTRVMGTYGYCAPEYAMTGQ-LTLKSDVYSFGVVLLEIITGRKAIDNT 278 (296)
Q Consensus 227 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~ll~g~~pf~~~ 278 (296)
.. ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||...
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 22 233346788999999987664 688999999999999999999997543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=313.94 Aligned_cols=204 Identities=26% Similarity=0.363 Sum_probs=163.0
Q ss_pred hcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcccceeeEEecCC----ceEE
Q 022482 68 TKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGD----QRLL 143 (296)
Q Consensus 68 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~----~~~l 143 (296)
.++|.+.+.||+|+||.||+|++. |+.||||++.... ........|+..+..++||||+++++++.+.+ ..++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 456888999999999999999874 8899999996432 11122334556666789999999999997654 5789
Q ss_pred EEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 144 VYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA-----NPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 144 v~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~-----~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
||||+++|+|.+++++ ..+++..+..++.|++.||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999975 46899999999999999999999740 1129999999999999999999999999
Q ss_pred CcccCCCCCcc--eeeecccccccccCccccccCC------CCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKT--HVSTRVMGTYGYCAPEYAMTGQ------LTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
++......... .......||+.|+|||++.+.. ++.++|||||||++|||+||..||....
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccc
Confidence 99754332221 1233467999999999987643 5678999999999999999998885433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=310.84 Aligned_cols=200 Identities=31% Similarity=0.474 Sum_probs=168.6
Q ss_pred cccccccCceEEEEEEECCCC---eEEEEEEecCC-CcchhHHHHHHHHHHhhcCCCcccceeeEEec-CCceEEEEecC
Q 022482 74 DCLLGEGGFGRVYKGRLESTN---QVVAIKQLDRN-GLQGNREFLVEVLMLSLLHHPNLVNLIGYCAD-GDQRLLVYEYM 148 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~I~~~~~~~~~-~~~~~lv~e~~ 148 (296)
.++||+|+||+||+|.+..++ ..||||+++.. ......++.+|+.++++++||||+++++++.. +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 578999999999999986543 36899999753 33345679999999999999999999999765 46789999999
Q ss_pred CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCCcccCCCCCc
Q 022482 149 PLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKLGPVGDK 228 (296)
Q Consensus 149 ~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 228 (296)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999875 3556788889999999999999999999 99999999999999999999999999986443322
Q ss_pred c--eeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 229 T--HVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 229 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
. .......||+.|+|||.+.+..++.++||||||+++|||++|..||....
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC
Confidence 1 22233568999999999999999999999999999999999888876543
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=318.14 Aligned_cols=201 Identities=25% Similarity=0.353 Sum_probs=170.4
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEecC-----C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCADG-----D 139 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~-----~ 139 (296)
+.++|++++.||+|+||+||+|++..+|+.||||++.+.... ..+.+.+|+.+|+.++||||+++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 467899999999999999999999999999999999765332 345678999999999999999999998643 3
Q ss_pred ceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccCC
Q 022482 140 QRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFGL 219 (296)
Q Consensus 140 ~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~ 219 (296)
..+++|+++.|++|.+++.. .++++..++.++.|++.||+|||+++ |+||||||+|||++.++.++++|||.
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred ceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccch
Confidence 44667778889999999853 56999999999999999999999999 99999999999999999999999999
Q ss_pred cccCCCCCcceeeecccccccccCccccccC-CCCccchhHHHHHHHHHHHhCCCCCCCCCc
Q 022482 220 AKLGPVGDKTHVSTRVMGTYGYCAPEYAMTG-QLTLKSDVYSFGVVLLEIITGRKAIDNTRA 280 (296)
Q Consensus 220 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~ll~g~~pf~~~~~ 280 (296)
+.... .......||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.
T Consensus 168 a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 168 ARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp --CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 97532 223346799999999987765 468899999999999999999999987653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-45 Score=317.99 Aligned_cols=200 Identities=25% Similarity=0.314 Sum_probs=164.0
Q ss_pred HhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc--hhHHHHHHHHHHhhcCCCcccceeeEEec------C
Q 022482 67 VTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ--GNREFLVEVLMLSLLHHPNLVNLIGYCAD------G 138 (296)
Q Consensus 67 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~I~~~~~~~~~------~ 138 (296)
+.++|++++.||+|+||+||+|++..+|+.||||++...... ....+.+|+.+++.++||||++++++|.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 346899999999999999999999999999999999765332 33467899999999999999999999964 3
Q ss_pred CceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcccC
Q 022482 139 DQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSDFG 218 (296)
Q Consensus 139 ~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~Dfg 218 (296)
+.+|+||||+.++ +.+.+. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++|||
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechh
Confidence 6789999999754 445442 45899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCC
Q 022482 219 LAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTR 279 (296)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~ 279 (296)
+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 98754332 23344679999999999999999999999999999999999999998665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=313.84 Aligned_cols=211 Identities=28% Similarity=0.426 Sum_probs=179.4
Q ss_pred cCCCccccccccCceEEEEEEECC-----CCeEEEEEEecCCCcc-hhHHHHHHHHHHhhcCCCcccceeeEEecCCceE
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLES-----TNQVVAIKQLDRNGLQ-GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL 142 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~I~~~~~~~~~~~~~~ 142 (296)
++|.+.+.||+|+||.||+|.+.. ++..||||+++..... ....+.+|+.+++.++||||+++++++...+..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 578999999999999999998752 3578999999754332 3345889999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCceEEcc
Q 022482 143 LVYEYMPLGSLEDHLHDL------PPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHPKLSD 216 (296)
Q Consensus 143 lv~e~~~~~sL~~~~~~~------~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~kl~D 216 (296)
+||||+++|+|.+++... ......+++..+..++.|+++||.|||+.+ |+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 999999999999987531 112345788999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhC-CCCCCCCCccc
Q 022482 217 FGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG-RKAIDNTRAAG 282 (296)
Q Consensus 217 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g-~~pf~~~~~~~ 282 (296)
||+++...............||+.|+|||.+.++.++.++|||||||++|||+|| ++||.+.+..+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999865444444444455789999999999999999999999999999999998 57787665443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.5e-39 Score=281.51 Aligned_cols=202 Identities=20% Similarity=0.251 Sum_probs=160.5
Q ss_pred cCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-----------CCcccceeeEEec
Q 022482 69 KNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-----------HPNLVNLIGYCAD 137 (296)
Q Consensus 69 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~I~~~~~~~~~ 137 (296)
.+|++++.||+|+||+||+|++..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 36999999999999999999999999999999997653 23456778888887764 5789999998864
Q ss_pred --CCceEEEEecCCCCC-HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCC---
Q 022482 138 --GDQRLLVYEYMPLGS-LEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGY--- 210 (296)
Q Consensus 138 --~~~~~lv~e~~~~~s-L~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~--- 210 (296)
....+++|+++..+. ....... .....+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccc
Confidence 345566777665443 2222222 245678999999999999999999997 78 99999999999997655
Q ss_pred ---ceEEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHHHHHHHHhCCCCCCCCCcc
Q 022482 211 ---HPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITGRKAIDNTRAA 281 (296)
Q Consensus 211 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll~g~~pf~~~~~~ 281 (296)
.++++|||.+..... .....+||+.|+|||++.+..++.++|+||+||++++|++|+.||...+..
T Consensus 167 ~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp TEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccc
Confidence 389999999975322 223467999999999999999999999999999999999999999866543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=7.6e-27 Score=184.77 Aligned_cols=168 Identities=14% Similarity=0.062 Sum_probs=117.9
Q ss_pred CCccccccccCceEEEEEEECCCCeEEEEEEecCCCcc------------------hhHHHHHHHHHHhhcCCCccccee
Q 022482 71 FRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQ------------------GNREFLVEVLMLSLLHHPNLVNLI 132 (296)
Q Consensus 71 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~h~~I~~~~ 132 (296)
+.+.+.||+|+||.||+|.+. +|+.||||+++..... .......|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 456789999999999999986 5899999987532110 012245678888899999999887
Q ss_pred eEEecCCceEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeEeccCCCCcEEEcCCCce
Q 022482 133 GYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKANPPVIYRDLKCSNILLGEGYHP 212 (296)
Q Consensus 133 ~~~~~~~~~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~~~ivHrdikp~Nili~~~~~~ 212 (296)
++. ..+++|||+++..+.. ++...+..++.|++.++.|||+++ |+||||||+|||++++ .+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~ 141 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GI 141 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EE
T ss_pred Eec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CE
Confidence 653 3479999998755433 233446779999999999999999 9999999999999975 58
Q ss_pred EEcccCCcccCCCCCcceeeecccccccccCccccccCCCCccchhHHHHH
Q 022482 213 KLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGV 263 (296)
Q Consensus 213 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 263 (296)
+|+|||.+.............+.+.. -.+.+ ...|+..+|+||+.-
T Consensus 142 ~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHH
Confidence 99999999753322111100000000 01112 356788899999654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.00 E-value=1.6e-09 Score=87.99 Aligned_cols=150 Identities=17% Similarity=0.088 Sum_probs=106.2
Q ss_pred HHHHHHhcCCCccccccccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcC-CCcccceeeEEecCCc
Q 022482 62 RELAAVTKNFRADCLLGEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLH-HPNLVNLIGYCADGDQ 140 (296)
Q Consensus 62 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~I~~~~~~~~~~~~ 140 (296)
.++......|++.+..+.++.+.||+... ++..+++|+...........+.+|...++.+. +--+++++.+..+++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45667778888888766666688998853 35667889886554444445678888887774 3236778888888888
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-----------------------------
Q 022482 141 RLLVYEYMPLGSLEDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKAN----------------------------- 191 (296)
Q Consensus 141 ~~lv~e~~~~~sL~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~~----------------------------- 191 (296)
.++||++++|.++.+.... . .....++.++...+..||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~-----~----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED-----E----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT-----C----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred eEEEEEecccccccccccc-----c----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 9999999998888665422 1 1123345566666666775321
Q ss_pred ---------------------------CCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 192 ---------------------------PPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 192 ---------------------------~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
..++|+|+.|.||++++++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1389999999999999876667999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.44 E-value=8.8e-07 Score=75.87 Aligned_cols=77 Identities=16% Similarity=0.054 Sum_probs=49.1
Q ss_pred cccccccCceEEEEEEECCCCeEEEEEEecC------C-CcchhHHHHHHHHHHhhcC--CC-cccceeeEEecCCceEE
Q 022482 74 DCLLGEGGFGRVYKGRLESTNQVVAIKQLDR------N-GLQGNREFLVEVLMLSLLH--HP-NLVNLIGYCADGDQRLL 143 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~-~~~~~~~~~~e~~~l~~l~--h~-~I~~~~~~~~~~~~~~l 143 (296)
.+.||.|....||++.+..+++.+++|.-.. . ......+...|...|+.+. .| .+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4568999999999999887788899997542 1 1122345567887777663 23 35555543 4556789
Q ss_pred EEecCCCCC
Q 022482 144 VYEYMPLGS 152 (296)
Q Consensus 144 v~e~~~~~s 152 (296)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.43 E-value=9.5e-07 Score=70.73 Aligned_cols=130 Identities=18% Similarity=0.126 Sum_probs=84.9
Q ss_pred ccccC-ceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCC--cccceeeEEecCCceEEEEecCCCCCH
Q 022482 77 LGEGG-FGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHP--NLVNLIGYCADGDQRLLVYEYMPLGSL 153 (296)
Q Consensus 77 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~--~I~~~~~~~~~~~~~~lv~e~~~~~sL 153 (296)
+..|. -+.||+.... ++..+++|...... ...+..|...++.+... -+++++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 3678988764 36668889875443 23456777777766432 256788888888889999999987665
Q ss_pred HHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------------------
Q 022482 154 EDHLHDLPPDKKRLDWTTRMRIAAGAAKGLEYLHDKA------------------------------------------- 190 (296)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~i~~ql~~al~~lH~~~------------------------------------------- 190 (296)
.+.. ... ..++.++...|..||+..
T Consensus 94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3311 111 112234444444444311
Q ss_pred ------------CCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 191 ------------NPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 191 ------------~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
...++|+|+.|.||+++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 12389999999999999876678999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.53 E-value=0.00028 Score=59.87 Aligned_cols=74 Identities=18% Similarity=0.222 Sum_probs=49.5
Q ss_pred cccccccCceEEEEEEECC-------CCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCc-ccceeeEEecCCceEEEE
Q 022482 74 DCLLGEGGFGRVYKGRLES-------TNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPN-LVNLIGYCADGDQRLLVY 145 (296)
Q Consensus 74 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-I~~~~~~~~~~~~~~lv~ 145 (296)
++.|+.|-.-.+|++.... ..+.|.+++.-.. ....+..+|..+++.+.-.+ .+++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 3568888888999998653 2356777776532 23345668888888875334 4567776642 6899
Q ss_pred ecCCCCCH
Q 022482 146 EYMPLGSL 153 (296)
Q Consensus 146 e~~~~~sL 153 (296)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.34 E-value=0.0011 Score=54.00 Aligned_cols=161 Identities=13% Similarity=0.039 Sum_probs=83.8
Q ss_pred ccCHHHHHHHhcCCCccccc-----cccCceEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCC-----Cc
Q 022482 58 TFTFRELAAVTKNFRADCLL-----GEGGFGRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHH-----PN 127 (296)
Q Consensus 58 ~~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-----~~ 127 (296)
..+.+++..+..+|.+.+.. ..|---+.|+..... | .+++|+++... ...++..|..++..+.. |.
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccc
Confidence 35667888888999886554 345557789987653 4 48999986532 23445556666665532 22
Q ss_pred ccceee---EEecCCceEEEEecCCCCCHHH--------------Hhc----cCC-CCCCCC------------------
Q 022482 128 LVNLIG---YCADGDQRLLVYEYMPLGSLED--------------HLH----DLP-PDKKRL------------------ 167 (296)
Q Consensus 128 I~~~~~---~~~~~~~~~lv~e~~~~~sL~~--------------~~~----~~~-~~~~~~------------------ 167 (296)
.+...+ +.........++.++.|..... .++ ... ......
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 221110 1222344556666665432210 000 000 000000
Q ss_pred CHHHHHHHHHHHHHHHHHHHc-CCCCCeEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 168 DWTTRMRIAAGAAKGLEYLHD-KANPPVIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 168 ~~~~~~~i~~ql~~al~~lH~-~~~~~ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
........+......+..... .-+.++||+|+.++|++++.+...-++||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 001111222222333333332 1233599999999999999887778999999863
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.31 E-value=0.00066 Score=55.85 Aligned_cols=136 Identities=13% Similarity=0.096 Sum_probs=76.2
Q ss_pred eEEEEEEECCCCeEEEEEEecCCCcchhHHHHHHHHHHhhcCCCcc--ccee-----eEEecCCceEEEEecCCCCCHH-
Q 022482 83 GRVYKGRLESTNQVVAIKQLDRNGLQGNREFLVEVLMLSLLHHPNL--VNLI-----GYCADGDQRLLVYEYMPLGSLE- 154 (296)
Q Consensus 83 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~I--~~~~-----~~~~~~~~~~lv~e~~~~~sL~- 154 (296)
-.||++... +|..+++|+.+.. ......+..|...+..|....+ +..+ ..+......+.+++++.|..+.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 579999765 4788999998654 2345667788887777642222 1111 1234456678899998764321
Q ss_pred ----H-------------HhccCC-CCCCCCC-------------------H---HHHHHHHHHHHHHHHHHH-cCCCCC
Q 022482 155 ----D-------------HLHDLP-PDKKRLD-------------------W---TTRMRIAAGAAKGLEYLH-DKANPP 193 (296)
Q Consensus 155 ----~-------------~~~~~~-~~~~~~~-------------------~---~~~~~i~~ql~~al~~lH-~~~~~~ 193 (296)
. ...... ......+ . ......+.++...+.-.- ......
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 0 001000 0001111 1 112223333333333221 222345
Q ss_pred eEeccCCCCcEEEcCCCceEEcccCCccc
Q 022482 194 VIYRDLKCSNILLGEGYHPKLSDFGLAKL 222 (296)
Q Consensus 194 ivHrdikp~Nili~~~~~~kl~Dfg~~~~ 222 (296)
+||+|+.|.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999743 45899999875
|